Psyllid ID: psy15108
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 223 | 2.2.26 [Sep-21-2011] | |||||||
| Q91048 | 1051 | Inactive tyrosine-protein | yes | N/A | 0.825 | 0.175 | 0.484 | 6e-48 | |
| Q8BKG3 | 1062 | Inactive tyrosine-protein | yes | N/A | 0.820 | 0.172 | 0.476 | 2e-45 | |
| Q13308 | 1070 | Inactive tyrosine-protein | yes | N/A | 0.820 | 0.171 | 0.460 | 6e-44 | |
| Q290N5 | 1037 | Tyrosine-protein kinase-l | yes | N/A | 0.847 | 0.182 | 0.411 | 8e-42 | |
| B4GBH0 | 1035 | Tyrosine-protein kinase-l | N/A | N/A | 0.847 | 0.182 | 0.411 | 9e-42 | |
| B3MH43 | 1037 | Tyrosine-protein kinase-l | N/A | N/A | 0.856 | 0.184 | 0.406 | 1e-41 | |
| B4P5Q9 | 1033 | Tyrosine-protein kinase-l | N/A | N/A | 0.847 | 0.182 | 0.419 | 2e-41 | |
| Q6AWJ9 | 1033 | Tyrosine-protein kinase-l | yes | N/A | 0.847 | 0.182 | 0.419 | 2e-41 | |
| B4QC63 | 1029 | Tyrosine-protein kinase-l | N/A | N/A | 0.847 | 0.183 | 0.419 | 2e-41 | |
| B4HNW4 | 1029 | Tyrosine-protein kinase-l | N/A | N/A | 0.847 | 0.183 | 0.419 | 2e-41 |
| >sp|Q91048|PTK7_CHICK Inactive tyrosine-protein kinase 7 OS=Gallus gallus GN=PTK7 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 190 bits (483), Expect = 6e-48, Method: Compositional matrix adjust.
Identities = 92/190 (48%), Positives = 126/190 (66%), Gaps = 6/190 (3%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFL + SK K S KP+ LST V++ QVALG+EH+S+ R +H+D+AAR
Sbjct: 862 GDLKQFL----RISKSKDESLKPQ--PLSTKHKVSLCTQVALGMEHLSNGRFVHRDLAAR 915
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NCL+S+ VK+S LSKD Y EYY +R A +PLRW+P EAV +DEFSTKSDV+++
Sbjct: 916 NCLVSAQRQVKVSALSLSKDVYNSEYYHFRQAWIPLRWMPPEAVLEDEFSTKSDVWSFGV 975
Query: 147 LIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
L+WE+F +GEMP+ L+DD+VL+ L+S K P +T L ++C P P RP+F
Sbjct: 976 LMWEVFTQGEMPYAPLADDEVLAGLKSGKTKLPQPEGCPSRLTKLMQRCWAPSPKDRPSF 1035
Query: 207 PSIVTQLSDA 216
+ L D+
Sbjct: 1036 SELAAALGDS 1045
|
Inactive tyrosine kinase involved in Wnt signaling. pathway. Gallus gallus (taxid: 9031) |
| >sp|Q8BKG3|PTK7_MOUSE Inactive tyrosine-protein kinase 7 OS=Mus musculus GN=Ptk7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 2e-45, Method: Composition-based stats.
Identities = 91/191 (47%), Positives = 123/191 (64%), Gaps = 8/191 (4%)
Query: 27 GDLKQFL-LATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDLKQFL ++ KD K KS + LST Q V + QVALG+EH+S+ R +HKD+AA
Sbjct: 873 GDLKQFLRISKNKDEKLKS-------QPLSTKQKVALCSQVALGMEHLSNNRFVHKDLAA 925
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNCLIS+ VK+S GLSKD Y EYY +R A +PLRW+ EAV + +FSTKSDV+A+
Sbjct: 926 RNCLISAQRQVKVSALGLSKDVYNSEYYHFRQAWVPLRWMSPEAVLEGDFSTKSDVWAFG 985
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L+WE+F GEMP +DD+VL+ L++ K P + L ++C P+P RP+
Sbjct: 986 VLMWEVFTHGEMPHGGQADDEVLADLQAGKARLPQPEGCPSKLYRLMQRCWAPNPKDRPS 1045
Query: 206 FPSIVTQLSDA 216
F I + L D+
Sbjct: 1046 FSEIASTLGDS 1056
|
Inactive tyrosine kinase involved in Wnt signaling pathway. Component of both the non-canonical (also known as the Wnt/planar cell polarity signaling) and the canonical Wnt signaling pathway. Functions in cell adhesion, cell migration, cell polarity, proliferation, actin cytoskeleton reorganization and apoptosis. Has a role in embryogenesis, epithelial tissue organization and angiogenesis. Mus musculus (taxid: 10090) |
| >sp|Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens GN=PTK7 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 177 bits (448), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 88/191 (46%), Positives = 121/191 (63%), Gaps = 8/191 (4%)
Query: 27 GDLKQFL-LATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDLKQFL ++ KD K KS + LST Q V + QVALG+EH+S+ R +HKD+AA
Sbjct: 881 GDLKQFLRISKSKDEKLKS-------QPLSTKQKVALCTQVALGMEHLSNNRFVHKDLAA 933
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNCL+S+ VK+S GLSKD Y EYY +R A +PLRW+ EA+ + +FSTKSDV+A+
Sbjct: 934 RNCLVSAQRQVKVSALGLSKDVYNSEYYHFRQAWVPLRWMSPEAILEGDFSTKSDVWAFG 993
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L+WE+F GEMP +DD+VL+ L++ K P + L ++C P RP+
Sbjct: 994 VLMWEVFTHGEMPHGGQADDEVLADLQAGKARLPQPEGCPSKLYRLMQRCWALSPKDRPS 1053
Query: 206 FPSIVTQLSDA 216
F I + L D+
Sbjct: 1054 FSEIASALGDS 1064
|
Inactive tyrosine kinase involved in Wnt signaling pathway. Component of both the non-canonical (also known as the Wnt/planar cell polarity signaling) and the canonical Wnt signaling pathway. Functions in cell adhesion, cell migration, cell polarity, proliferation, actin cytoskeleton reorganization and apoptosis. Has a role in embryogenesis, epithelial tissue organization and angiogenesis. Homo sapiens (taxid: 9606) |
| >sp|Q290N5|PTK7_DROPS Tyrosine-protein kinase-like otk OS=Drosophila pseudoobscura pseudoobscura GN=otk PE=3 SV=2 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 8e-42, Method: Compositional matrix adjust.
Identities = 79/192 (41%), Positives = 125/192 (65%), Gaps = 3/192 (1%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFLLAT + + P +L+TSQ + +AYQ+A G++ I R H+D+A R
Sbjct: 842 GDLKQFLLATAGKVNTATATSSPP--ALTTSQVLAVAYQIARGMDAIYRSRCTHRDLATR 899
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NC+ISS+ VK+S L KD Y +EY+K+RN +LP+RWL E + +DE++TKSD++AY
Sbjct: 900 NCVISSEFVVKVSYPALCKDKYSREYHKHRNTLLPVRWLAPECIQEDEYTTKSDIFAYGV 959
Query: 147 LIWEIFNKG-EMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L+WE+FN+ ++P +L+ +QV+ + ++ L W + TP+ + + C +P +RP+
Sbjct: 960 LVWELFNQATKLPHEELTSEQVIQRSQAGTLEWTVAEATPDSLKEILLSCWLANPKERPS 1019
Query: 206 FPSIVTQLSDAM 217
F + + LS AM
Sbjct: 1020 FSQLGSALSKAM 1031
|
Acts as a calcium-dependent, homophilic cell adhesion molecule that regulates neural recognition during the development of the nervous system. Component of the repulsive Plexin signaling response to regulate motor axon guidance at the embryonic stage. Also component of a receptor complex that is required in the adult visual system to innervate the lamina layer; specific targeting of R1-R6 axons. Drosophila pseudoobscura pseudoobscura (taxid: 46245) |
| >sp|B4GBH0|PTK7_DROPE Tyrosine-protein kinase-like otk OS=Drosophila persimilis GN=otk PE=3 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 9e-42, Method: Compositional matrix adjust.
Identities = 79/192 (41%), Positives = 125/192 (65%), Gaps = 3/192 (1%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFLLAT + + P +L+TSQ + +AYQ+A G++ I R H+D+A R
Sbjct: 840 GDLKQFLLATAGKVNTATATSSPP--ALTTSQVLAVAYQIARGMDAIYRSRCTHRDLATR 897
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NC+ISS+ VK+S L KD Y +EY+K+RN +LP+RWL E + +DE++TKSD++AY
Sbjct: 898 NCVISSEFVVKVSYPALCKDKYSREYHKHRNTLLPVRWLAPECIQEDEYTTKSDIFAYGV 957
Query: 147 LIWEIFNKG-EMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L+WE+FN+ ++P +L+ +QV+ + ++ L W + TP+ + + C +P +RP+
Sbjct: 958 LVWELFNQATKLPHEELTSEQVIQRSQAGTLEWTVAEATPDSLKEILLSCWLANPKERPS 1017
Query: 206 FPSIVTQLSDAM 217
F + + LS AM
Sbjct: 1018 FSQLGSALSKAM 1029
|
Acts as a calcium-dependent, homophilic cell adhesion molecule that regulates neural recognition during the development of the nervous system. Component of the repulsive Plexin signaling response to regulate motor axon guidance at the embryonic stage. Also component of a receptor complex that is required in the adult visual system to innervate the lamina layer; specific targeting of R1-R6 axons. Drosophila persimilis (taxid: 7234) |
| >sp|B3MH43|PTK7_DROAN Tyrosine-protein kinase-like otk OS=Drosophila ananassae GN=otk PE=3 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (429), Expect = 1e-41, Method: Compositional matrix adjust.
Identities = 78/192 (40%), Positives = 123/192 (64%), Gaps = 1/192 (0%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFLLAT S + L+TSQ + +AYQ+A G++ I R H+D+A R
Sbjct: 841 GDLKQFLLATAGKVNTASAAATSSPPPLTTSQVLAVAYQIARGMDAIYRARFTHRDLATR 900
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NC+ISS+ VK+S L KD Y +EY+K+RN +LP+RWL E + +DE++TKSD++AY
Sbjct: 901 NCVISSEFIVKVSYPALCKDKYSREYHKHRNTLLPIRWLAPECIQEDEYTTKSDIFAYGV 960
Query: 147 LIWEIFNKG-EMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
++WE+FN+ ++P +L+++QV+ + ++ L W + TP+ + + C +P +RP+
Sbjct: 961 VVWELFNQATKLPHEELTNEQVIQKSQAGTLEWTVAESTPDSLREILLSCWVSNPKERPS 1020
Query: 206 FPSIVTQLSDAM 217
F + LS AM
Sbjct: 1021 FSQLGAALSKAM 1032
|
Acts as a calcium-dependent, homophilic cell adhesion molecule that regulates neural recognition during the development of the nervous system. Component of the repulsive Plexin signaling response to regulate motor axon guidance at the embryonic stage. Also component of a receptor complex that is required in the adult visual system to innervate the lamina layer; specific targeting of R1-R6 axons. Drosophila ananassae (taxid: 7217) |
| >sp|B4P5Q9|PTK7_DROYA Tyrosine-protein kinase-like otk OS=Drosophila yakuba GN=otk PE=3 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (428), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 81/193 (41%), Positives = 127/193 (65%), Gaps = 4/193 (2%)
Query: 27 GDLKQFLLATR-KDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDLKQFLLAT K + +GS P L+TSQ + +AYQ+A G++ I R H+D+A
Sbjct: 838 GDLKQFLLATAGKVNTATAGSSSPP--PLTTSQVLAVAYQIARGMDAIYRARFTHRDLAT 895
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNC+ISS+ VK+S L KD Y +EY+K+RN +LP+RWL E + +DE++TKSD++AY
Sbjct: 896 RNCVISSEFIVKVSYPALCKDKYSREYHKHRNTLLPIRWLAPECIQEDEYTTKSDIFAYG 955
Query: 146 CLIWEIFNKG-EMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
++WE+FN+ ++P +L+++QV+ + ++ L W + TP+ + + C +P +RP
Sbjct: 956 VVVWELFNQATKLPHEELTNEQVVQRSQAGSLEWSVAESTPDSLREILLSCWVANPKERP 1015
Query: 205 TFPSIVTQLSDAM 217
+F + LS AM
Sbjct: 1016 SFSQLGAALSKAM 1028
|
Acts as a calcium-dependent, homophilic cell adhesion molecule that regulates neural recognition during the development of the nervous system. Component of the repulsive Plexin signaling response to regulate motor axon guidance at the embryonic stage. Also component of a receptor complex that is required in the adult visual system to innervate the lamina layer; specific targeting of R1-R6 axons. Drosophila yakuba (taxid: 7245) |
| >sp|Q6AWJ9|PTK7_DROME Tyrosine-protein kinase-like otk OS=Drosophila melanogaster GN=otk PE=1 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (427), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 81/193 (41%), Positives = 127/193 (65%), Gaps = 4/193 (2%)
Query: 27 GDLKQFLLATR-KDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDLKQFLLAT K + +GS P L+TSQ + +AYQ+A G++ I R H+D+A
Sbjct: 838 GDLKQFLLATAGKVNTATAGSSSPP--PLTTSQVLAVAYQIARGMDAIYRARFTHRDLAT 895
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNC+ISS+ VK+S L KD Y +EY+K+RN +LP+RWL E + +DE++TKSD++AY
Sbjct: 896 RNCVISSEFIVKVSYPALCKDKYSREYHKHRNTLLPIRWLAPECIQEDEYTTKSDIFAYG 955
Query: 146 CLIWEIFNKG-EMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
++WE+FN+ ++P +L+++QV+ + ++ L W + TP+ + + C +P +RP
Sbjct: 956 VVVWELFNQATKLPHEELTNEQVVQRSQAGSLEWSVAEATPDSLREILLSCWVSNPKERP 1015
Query: 205 TFPSIVTQLSDAM 217
+F + LS AM
Sbjct: 1016 SFSQLGAALSKAM 1028
|
Acts as a calcium-dependent, homophilic cell adhesion molecule that regulates neural recognition during the development of the nervous system. Component of the repulsive Plexin signaling response to regulate motor axon guidance at the embryonic stage. Also component of a receptor complex that is required in the adult visual system to innervate the lamina layer; specific targeting of R1-R6 axons. Drosophila melanogaster (taxid: 7227) |
| >sp|B4QC63|PTK7_DROSI Tyrosine-protein kinase-like otk OS=Drosophila simulans GN=otk PE=3 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (427), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 81/193 (41%), Positives = 127/193 (65%), Gaps = 4/193 (2%)
Query: 27 GDLKQFLLATR-KDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDLKQFLLAT K + +GS P L+TSQ + +AYQ+A G++ I R H+D+A
Sbjct: 834 GDLKQFLLATAGKVNTATAGSSSPP--PLTTSQVLAVAYQIARGMDAIYRARFTHRDLAT 891
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNC+ISS+ VK+S L KD Y +EY+K+RN +LP+RWL E + +DE++TKSD++AY
Sbjct: 892 RNCVISSEFIVKVSYPALCKDKYSREYHKHRNTLLPIRWLAPECIQEDEYTTKSDIFAYG 951
Query: 146 CLIWEIFNKG-EMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
++WE+FN+ ++P +L+++QV+ + ++ L W + TP+ + + C +P +RP
Sbjct: 952 VVVWELFNQATKLPHEELTNEQVVQRSQAGSLEWSVAEATPDSLREILLSCWVSNPKERP 1011
Query: 205 TFPSIVTQLSDAM 217
+F + LS AM
Sbjct: 1012 SFSQLGAALSKAM 1024
|
Acts as a calcium-dependent, homophilic cell adhesion molecule that regulates neural recognition during the development of the nervous system. Component of the repulsive Plexin signaling response to regulate motor axon guidance at the embryonic stage. Also component of a receptor complex that is required in the adult visual system to innervate the lamina layer; specific targeting of R1-R6 axons. Drosophila simulans (taxid: 7240) |
| >sp|B4HNW4|PTK7_DROSE Tyrosine-protein kinase-like otk OS=Drosophila sechellia GN=otk PE=3 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (427), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 81/193 (41%), Positives = 127/193 (65%), Gaps = 4/193 (2%)
Query: 27 GDLKQFLLATR-KDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDLKQFLLAT K + +GS P L+TSQ + +AYQ+A G++ I R H+D+A
Sbjct: 834 GDLKQFLLATAGKVNTATAGSSSPP--PLTTSQVLAVAYQIARGMDAIYRARFTHRDLAT 891
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNC+ISS+ VK+S L KD Y +EY+K+RN +LP+RWL E + +DE++TKSD++AY
Sbjct: 892 RNCVISSEFIVKVSYPALCKDKYSREYHKHRNTLLPIRWLAPECIQEDEYTTKSDIFAYG 951
Query: 146 CLIWEIFNKG-EMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
++WE+FN+ ++P +L+++QV+ + ++ L W + TP+ + + C +P +RP
Sbjct: 952 VVVWELFNQATKLPHEELTNEQVVQRSQAGSLEWSVAEATPDSLREILLSCWVSNPKERP 1011
Query: 205 TFPSIVTQLSDAM 217
+F + LS AM
Sbjct: 1012 SFSQLGAALSKAM 1024
|
Acts as a calcium-dependent, homophilic cell adhesion molecule that regulates neural recognition during the development of the nervous system. Component of the repulsive Plexin signaling response to regulate motor axon guidance at the embryonic stage. Also component of a receptor complex that is required in the adult visual system to innervate the lamina layer; specific targeting of R1-R6 axons. Drosophila sechellia (taxid: 7238) |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 223 | ||||||
| 332031157 | 1128 | Tyrosine-protein kinase-like 7 [Acromyrm | 0.865 | 0.171 | 0.492 | 1e-54 | |
| 307173150 | 942 | Tyrosine-protein kinase-like 7 [Camponot | 0.865 | 0.204 | 0.487 | 1e-54 | |
| 156554986 | 1117 | PREDICTED: tyrosine-protein kinase-like | 0.874 | 0.174 | 0.520 | 4e-54 | |
| 380014239 | 517 | PREDICTED: tyrosine-protein kinase-like | 0.865 | 0.373 | 0.487 | 5e-54 | |
| 328792325 | 990 | PREDICTED: tyrosine-protein kinase-like | 0.865 | 0.194 | 0.487 | 6e-54 | |
| 307198546 | 1006 | Tyrosine-protein kinase-like 7 [Harpegna | 0.865 | 0.191 | 0.487 | 6e-54 | |
| 350419258 | 1110 | PREDICTED: tyrosine-protein kinase-like | 0.865 | 0.173 | 0.487 | 1e-53 | |
| 340709064 | 1092 | PREDICTED: tyrosine-protein kinase-like | 0.865 | 0.176 | 0.487 | 1e-53 | |
| 383865062 | 1012 | PREDICTED: tyrosine-protein kinase-like | 0.865 | 0.190 | 0.482 | 4e-53 | |
| 224047300 | 1041 | PREDICTED: inactive tyrosine-protein kin | 0.825 | 0.176 | 0.484 | 2e-46 |
| >gi|332031157|gb|EGI70734.1| Tyrosine-protein kinase-like 7 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 218 bits (555), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 96/195 (49%), Positives = 146/195 (74%), Gaps = 2/195 (1%)
Query: 27 GDLKQFLLATRKD--SKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDLKQFL+A+RKD S + PR LS +Q ++++ Q A GL+H++D RL+HKDIA
Sbjct: 931 GDLKQFLIASRKDNNSSPTHETKVPRAPQLSVAQILSLSNQAAKGLKHLADNRLVHKDIA 990
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
ARNCLI+S+L++KISL ++K+ YQ+EY K+RN I+PLRWLPYEAV++DE+STKSDVY++
Sbjct: 991 ARNCLIASNLTIKISLPCMTKEPYQQEYTKHRNQIIPLRWLPYEAVYEDEYSTKSDVYSF 1050
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
+CL+WE+F++GE+PF ++D+ VL+QL+++ L WK P + L +C P +RP
Sbjct: 1051 SCLVWEMFHQGELPFNKMNDESVLTQLKAQTLTWKPHKAAPPALQELQTQCWANDPRERP 1110
Query: 205 TFPSIVTQLSDAMCN 219
TF +V+++ + + +
Sbjct: 1111 TFDEVVSKIGEIVVD 1125
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307173150|gb|EFN64250.1| Tyrosine-protein kinase-like 7 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 218 bits (555), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 95/195 (48%), Positives = 146/195 (74%), Gaps = 2/195 (1%)
Query: 27 GDLKQFLLATRKDSKDKSG--SGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDLKQFL+A+RKD+ S PR LS +Q ++++ Q A GL+H++D RL+HKDIA
Sbjct: 745 GDLKQFLIASRKDNNPSPTHESKPPRAPQLSVAQILSLSNQAAKGLKHLADNRLVHKDIA 804
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
ARNCLI+S+L++KISL ++K+ YQ+EY K+RN ++PLRWLPYEAV++DEFSTKSDVY++
Sbjct: 805 ARNCLIASNLTIKISLPCMTKEPYQQEYTKHRNQVIPLRWLPYEAVYEDEFSTKSDVYSF 864
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
+CL+WE+F++GE+PF ++D+ VL+Q++++ L WK P + L +C P +RP
Sbjct: 865 SCLVWEMFHQGELPFNKMNDESVLAQIKAQTLIWKPHKAAPPALQELQTQCWANDPRERP 924
Query: 205 TFPSIVTQLSDAMCN 219
TF +V+++ + + +
Sbjct: 925 TFDEVVSKIGEIVVD 939
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156554986|ref|XP_001602704.1| PREDICTED: tyrosine-protein kinase-like otk-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 216 bits (551), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 103/198 (52%), Positives = 144/198 (72%), Gaps = 3/198 (1%)
Query: 27 GDLKQFLLATR-KDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDLK FLLA++ K+ + GKPR L+ +Q +++A Q A GL+HISD RL+HKD+AA
Sbjct: 920 GDLKTFLLASKSKEMAASTDGGKPRAPQLTVAQILSLANQAARGLKHISDHRLVHKDVAA 979
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNCLISS L VKISLS ++K+ +Q+EY K++N I+PLRWLP EAVF+DE+STKSDVY+Y+
Sbjct: 980 RNCLISSALHVKISLSCMTKEPHQQEYTKHKNQIIPLRWLPKEAVFEDEYSTKSDVYSYS 1039
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
CL+WE+F++GE+PF L+D+ VL+QL+S+ L W P + L +C P +RPT
Sbjct: 1040 CLVWEMFHQGELPFKKLNDESVLNQLKSQTLSWSAHKAAPPALQELQTQCWSYDPRERPT 1099
Query: 206 FPSIVTQLSDAM--CNDV 221
F IV +L + + C+ V
Sbjct: 1100 FDEIVDKLQEIVVDCSQV 1117
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380014239|ref|XP_003691147.1| PREDICTED: tyrosine-protein kinase-like otk-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 216 bits (550), Expect = 5e-54, Method: Compositional matrix adjust.
Identities = 95/195 (48%), Positives = 145/195 (74%), Gaps = 2/195 (1%)
Query: 27 GDLKQFLLATRKD--SKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDLKQFL+A+RKD S S PR LS +Q ++++ Q A GL+H++D RL+HKDIA
Sbjct: 320 GDLKQFLIASRKDNTSSPTHESKPPRAPQLSVAQILSLSNQAAKGLKHLADTRLVHKDIA 379
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
ARNCLI+S+L++KISL ++K+ YQ+EY K+RN ++PLRWLPYEAV++DE+STKSDVY++
Sbjct: 380 ARNCLIASNLTIKISLPCMTKEPYQQEYTKHRNQVIPLRWLPYEAVYEDEYSTKSDVYSF 439
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
+CL+WE+F++GE+PF ++D+ VL+ L+++ L WK P + L +C P +RP
Sbjct: 440 SCLVWEMFHQGELPFNKMNDESVLTALKAQTLAWKPHKAAPPALQELQAQCWANDPRERP 499
Query: 205 TFPSIVTQLSDAMCN 219
TF +V+++ + + +
Sbjct: 500 TFDEVVSKIGEIVVD 514
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328792325|ref|XP_394162.4| PREDICTED: tyrosine-protein kinase-like otk-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 216 bits (550), Expect = 6e-54, Method: Compositional matrix adjust.
Identities = 95/195 (48%), Positives = 145/195 (74%), Gaps = 2/195 (1%)
Query: 27 GDLKQFLLATRKD--SKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDLKQFL+A+RKD S S PR LS +Q ++++ Q A GL+H++D RL+HKDIA
Sbjct: 793 GDLKQFLIASRKDNTSSPTHESKAPRAPQLSVAQILSLSNQAAKGLKHLADTRLVHKDIA 852
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
ARNCLI+S+L++KISL ++K+ YQ+EY K+RN ++PLRWLPYEAV++DE+STKSDVY++
Sbjct: 853 ARNCLIASNLTIKISLPCMTKEPYQQEYTKHRNQVIPLRWLPYEAVYEDEYSTKSDVYSF 912
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
+CL+WE+F++GE+PF ++D+ VL+ L+++ L WK P + L +C P +RP
Sbjct: 913 SCLVWEMFHQGELPFNKMNDESVLAALKAQTLAWKPHKAAPPSLQELQAQCWANDPRERP 972
Query: 205 TFPSIVTQLSDAMCN 219
TF +V+++ + + +
Sbjct: 973 TFDEVVSKIGEIVVD 987
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307198546|gb|EFN79431.1| Tyrosine-protein kinase-like 7 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 216 bits (550), Expect = 6e-54, Method: Compositional matrix adjust.
Identities = 95/195 (48%), Positives = 143/195 (73%), Gaps = 2/195 (1%)
Query: 27 GDLKQFLLATRKDSKDKSG--SGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDLKQFL+A+RKDS S PR LS +Q + ++ Q A GL+H++D RL+HKDIA
Sbjct: 809 GDLKQFLIASRKDSNSSPTHESKPPRAPQLSVAQILALSNQAAKGLKHLADNRLVHKDIA 868
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
ARNCLI+S+L++KISL ++K+ Y +EY K+RN ++PLRWLPYEAV++DE+STKSDVY++
Sbjct: 869 ARNCLIASNLTIKISLPCMTKEPYHQEYTKHRNQVIPLRWLPYEAVYEDEYSTKSDVYSF 928
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
+CL+WE+F++GE+PF ++D+ VL+QL+++ L WK P + L +C P RP
Sbjct: 929 SCLVWEMFHQGELPFNKMNDESVLTQLKAQTLIWKPHKAAPPTLQELQTQCWATDPRDRP 988
Query: 205 TFPSIVTQLSDAMCN 219
TF +V+++ + + +
Sbjct: 989 TFDEVVSKIGEIVAD 1003
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350419258|ref|XP_003492122.1| PREDICTED: tyrosine-protein kinase-like otk-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 215 bits (548), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 95/195 (48%), Positives = 145/195 (74%), Gaps = 2/195 (1%)
Query: 27 GDLKQFLLATRKD--SKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDLKQFL+A+RKD S S PR LS +Q ++++ Q A GL+H++D RL+HKDIA
Sbjct: 913 GDLKQFLIASRKDNNSSPTHESKPPRAPQLSVAQILSLSNQAAKGLKHLADSRLVHKDIA 972
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
ARNCLI+S+L++KISL ++K+ YQ+EY K+RN ++PLRWLPYEAV++DE+STKSDVY++
Sbjct: 973 ARNCLIASNLTIKISLPCMTKEPYQQEYTKHRNQVIPLRWLPYEAVYEDEYSTKSDVYSF 1032
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
+CL+WE+F++GE+PF ++D+ VL+ L+++ L WK P + L +C P +RP
Sbjct: 1033 SCLVWEMFHQGELPFIKMNDESVLAALKAQTLAWKPHKAAPPALQELQAQCWANDPRERP 1092
Query: 205 TFPSIVTQLSDAMCN 219
TF +V+++ + + +
Sbjct: 1093 TFDEVVSKIGEIVVD 1107
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340709064|ref|XP_003393135.1| PREDICTED: tyrosine-protein kinase-like otk-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 215 bits (547), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 95/195 (48%), Positives = 145/195 (74%), Gaps = 2/195 (1%)
Query: 27 GDLKQFLLATRKD--SKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDLKQFL+A+RKD S S PR LS +Q ++++ Q A GL+H++D RL+HKDIA
Sbjct: 895 GDLKQFLIASRKDNNSSPTHESKPPRAPQLSVAQILSLSNQAAKGLKHLADSRLVHKDIA 954
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
ARNCLI+S+L++KISL ++K+ YQ+EY K+RN ++PLRWLPYEAV++DE+STKSDVY++
Sbjct: 955 ARNCLIASNLTIKISLPCMTKEPYQQEYTKHRNQVIPLRWLPYEAVYEDEYSTKSDVYSF 1014
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
+CL+WE+F++GE+PF ++D+ VL+ L+++ L WK P + L +C P +RP
Sbjct: 1015 SCLVWEMFHQGELPFIKMNDESVLAALKAQTLAWKPHKAAPPALQELQAQCWANDPRERP 1074
Query: 205 TFPSIVTQLSDAMCN 219
TF +V+++ + + +
Sbjct: 1075 TFDEVVSKIGEIVVD 1089
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383865062|ref|XP_003707994.1| PREDICTED: tyrosine-protein kinase-like otk-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 213 bits (543), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 94/195 (48%), Positives = 142/195 (72%), Gaps = 2/195 (1%)
Query: 27 GDLKQFLLATRKD--SKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDLKQFL+A+RKD S + PR LS +Q ++++ Q A GL+H++D RL+HKDIA
Sbjct: 815 GDLKQFLIASRKDNNSSPTQETKPPRAPQLSVAQILSLSNQAAKGLKHLADSRLVHKDIA 874
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
ARNCLI+S+L++KIS ++K+ YQ+EY K+RN ++PLRWLPYEAV++DE+STKSDVY++
Sbjct: 875 ARNCLIASNLTIKISFPCMTKEPYQQEYTKHRNQVIPLRWLPYEAVYEDEYSTKSDVYSF 934
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
+CL+WE+F++GE+PF ++D+ VL+ L+S+ L WK P + L +C P RP
Sbjct: 935 SCLVWEMFHQGELPFNKMNDESVLTALKSQSLAWKPHKAAPPALQELQAQCWSNDPRDRP 994
Query: 205 TFPSIVTQLSDAMCN 219
TF +V ++ + + +
Sbjct: 995 TFDEVVLKIGEIVVD 1009
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|224047300|ref|XP_002195189.1| PREDICTED: inactive tyrosine-protein kinase 7 [Taeniopygia guttata] | Back alignment and taxonomy information |
|---|
Score = 191 bits (484), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 92/190 (48%), Positives = 126/190 (66%), Gaps = 6/190 (3%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFL + SK K S KP+ L+T V++ QVALG+EH+S+ R +H+D+AAR
Sbjct: 852 GDLKQFL----RISKSKDESLKPQ--PLTTKHKVSLCTQVALGMEHLSNGRFVHRDLAAR 905
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NCL+S+ VK+S LSKD Y EYY +R A +PLRW+P EAV +DEFSTKSDV+++
Sbjct: 906 NCLVSAQRQVKVSSLSLSKDVYNSEYYHFRQAWIPLRWMPPEAVLEDEFSTKSDVWSFGV 965
Query: 147 LIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
L+WE+F GEMP+ L+DD+VL+ L+S K H P + L ++C P P RP+F
Sbjct: 966 LMWEVFTHGEMPYTPLADDEVLAGLQSGKTKLPHPEGCPSRLAKLMQRCWAPSPKDRPSF 1025
Query: 207 PSIVTQLSDA 216
+ T L D+
Sbjct: 1026 SELATTLGDS 1035
|
Source: Taeniopygia guttata Species: Taeniopygia guttata Genus: Taeniopygia Family: Estrildidae Order: Passeriformes Class: Aves Phylum: Chordata Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 223 | ||||||
| UNIPROTKB|Q91048 | 1051 | PTK7 "Inactive tyrosine-protei | 0.825 | 0.175 | 0.452 | 3e-42 | |
| UNIPROTKB|F1NLV8 | 1049 | PTK7 "Inactive tyrosine-protei | 0.825 | 0.175 | 0.447 | 7.9e-42 | |
| ZFIN|ZDB-GENE-050522-216 | 1061 | zgc:112211 "zgc:112211" [Danio | 0.820 | 0.172 | 0.476 | 1.3e-41 | |
| UNIPROTKB|H0Y8F1 | 365 | PTK7 "Inactive tyrosine-protei | 0.825 | 0.504 | 0.436 | 3.2e-41 | |
| UNIPROTKB|B4MR28 | 1059 | otk "Tyrosine-protein kinase-l | 0.865 | 0.182 | 0.408 | 6.5e-41 | |
| MGI|MGI:1918711 | 1062 | Ptk7 "PTK7 protein tyrosine ki | 0.825 | 0.173 | 0.452 | 2.7e-40 | |
| UNIPROTKB|B3MH43 | 1037 | otk "Tyrosine-protein kinase-l | 0.856 | 0.184 | 0.401 | 4.3e-40 | |
| UNIPROTKB|F1MWK8 | 1070 | PTK7 "Uncharacterized protein" | 0.825 | 0.171 | 0.442 | 2e-39 | |
| UNIPROTKB|B4P5Q9 | 1033 | otk "Tyrosine-protein kinase-l | 0.852 | 0.183 | 0.401 | 3e-39 | |
| UNIPROTKB|B4HNW4 | 1029 | otk "Tyrosine-protein kinase-l | 0.852 | 0.184 | 0.401 | 3.8e-39 |
| UNIPROTKB|Q91048 PTK7 "Inactive tyrosine-protein kinase 7" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 3.0e-42, Sum P(2) = 3.0e-42
Identities = 86/190 (45%), Positives = 122/190 (64%)
Query: 27 GDLKQFLLATRXXXXXXXXXXXPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFL ++ + + LST V++ QVALG+EH+S+ R +H+D+AAR
Sbjct: 862 GDLKQFLRISKSKDESL------KPQPLSTKHKVSLCTQVALGMEHLSNGRFVHRDLAAR 915
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NCL+S+ VK+S LSKD Y EYY +R A +PLRW+P EAV +DEFSTKSDV+++
Sbjct: 916 NCLVSAQRQVKVSALSLSKDVYNSEYYHFRQAWIPLRWMPPEAVLEDEFSTKSDVWSFGV 975
Query: 147 LIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
L+WE+F +GEMP+ L+DD+VL+ L+S K P +T L ++C P P RP+F
Sbjct: 976 LMWEVFTQGEMPYAPLADDEVLAGLKSGKTKLPQPEGCPSRLTKLMQRCWAPSPKDRPSF 1035
Query: 207 PSIVTQLSDA 216
+ L D+
Sbjct: 1036 SELAAALGDS 1045
|
|
| UNIPROTKB|F1NLV8 PTK7 "Inactive tyrosine-protein kinase 7" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 445 (161.7 bits), Expect = 7.9e-42, Sum P(2) = 7.9e-42
Identities = 85/190 (44%), Positives = 121/190 (63%)
Query: 27 GDLKQFLLATRXXXXXXXXXXXPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFL ++ + + LST V++ QVALG+EH+S+ R +H+D+AAR
Sbjct: 860 GDLKQFLRISKSKDESL------KPQPLSTKHKVSLCTQVALGMEHLSNGRFVHRDLAAR 913
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NCL+S+ VK+S LSKD Y EYY +R A +PLRW+P EAV +DEFSTKSDV+++
Sbjct: 914 NCLVSAQRQVKVSALSLSKDVYNSEYYHFRQAWIPLRWMPPEAVLEDEFSTKSDVWSFGV 973
Query: 147 LIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
L+WE+F +GEMP+ L+DD+VL+ L+S K P + L ++C P P RP+F
Sbjct: 974 LMWEVFTQGEMPYAPLADDEVLAGLQSGKTKLPQPEGCPSRLAKLMQRCWAPSPKDRPSF 1033
Query: 207 PSIVTQLSDA 216
+ L D+
Sbjct: 1034 SELAAALGDS 1043
|
|
| ZFIN|ZDB-GENE-050522-216 zgc:112211 "zgc:112211" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 452 (164.2 bits), Expect = 1.3e-41, P = 1.3e-41
Identities = 90/189 (47%), Positives = 124/189 (65%)
Query: 27 GDLKQFLLATRXXXXXXXXXXXPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQ+L ++ +V+ LST Q V++ QVA G+EH+S++R +HKD+AAR
Sbjct: 872 GDLKQYLRVSKSKDEKV------KVQPLSTKQKVSVCLQVARGMEHLSNQRFVHKDLAAR 925
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NCLISS +K+S GLSKD Y EYY YR + +PLRWLP EAVF+D+FSTK+DV+++A
Sbjct: 926 NCLISSKRQIKVSSLGLSKDVYSSEYYHYRQSYIPLRWLPSEAVFEDDFSTKTDVWSFAV 985
Query: 147 LIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
L+WE+F+ GEMP+ DL+DD+VL L+ KL P + L +C P R +F
Sbjct: 986 LMWEVFSFGEMPYADLADDKVLEALQDGKLKLCPPQGCPSRVFKLMVRCWAASPKDRLSF 1045
Query: 207 PSIVTQLSD 215
I + LSD
Sbjct: 1046 SEICSALSD 1054
|
|
| UNIPROTKB|H0Y8F1 PTK7 "Inactive tyrosine-protein kinase 7" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 418 (152.2 bits), Expect = 3.2e-41, Sum P(2) = 3.2e-41
Identities = 83/190 (43%), Positives = 117/190 (61%)
Query: 27 GDLKQFLLATRXXXXXXXXXXXPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFL ++ + + LST Q V + QVALG+EH+S+ R +HKD+AAR
Sbjct: 176 GDLKQFLRISKSKDEKL------KSQPLSTKQKVALCTQVALGMEHLSNNRFVHKDLAAR 229
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NCL+S+ VK+S GLSKD Y EYY +R A +PLRW+ EA+ + +FSTKSDV+A+
Sbjct: 230 NCLVSAQRQVKVSALGLSKDVYNSEYYHFRQAWVPLRWMSPEAILEGDFSTKSDVWAFGV 289
Query: 147 LIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
L+WE+F GEMP +DD+VL+ L++ K P + L ++C P RP+F
Sbjct: 290 LMWEVFTHGEMPHGGQADDEVLADLQAGKARLPQPEGCPSKLYRLMQRCWALSPKDRPSF 349
Query: 207 PSIVTQLSDA 216
I + L D+
Sbjct: 350 SEIASALGDS 359
|
|
| UNIPROTKB|B4MR28 otk "Tyrosine-protein kinase-like otk" [Drosophila willistoni (taxid:7260)] | Back alignment and assigned GO terms |
|---|
Score = 424 (154.3 bits), Expect = 6.5e-41, Sum P(2) = 6.5e-41
Identities = 80/196 (40%), Positives = 124/196 (63%)
Query: 27 GDLKQFLLAT--RXXXXXXXXXXXPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDLKQFLLAT + + L+TSQ + +AYQ+A G++ I R H+D+A
Sbjct: 862 GDLKQFLLATAGKVNTATTATSSTTPLPPLTTSQVLAVAYQIARGMDAIYRARFTHRDLA 921
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RNC+ISS+ VK+S L KD Y +EY+K+RN++LP+RWL E + +DE++TKSD+++Y
Sbjct: 922 TRNCVISSEFIVKVSYPALCKDKYSREYHKHRNSLLPIRWLAPECIQEDEYTTKSDIFSY 981
Query: 145 ACLIWEIFNKG-EMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
++WE+FN+ ++P DL+++QV+ + + L W + TPE + + C +P QR
Sbjct: 982 GVVVWELFNQATKLPHEDLTNEQVIEKSQDGTLKWTVAESTPESLKEILLSCWSVNPKQR 1041
Query: 204 PTFPSIVTQLSDAMCN 219
P+F + LS AM N
Sbjct: 1042 PSFSQLGAALSKAMQN 1057
|
|
| MGI|MGI:1918711 Ptk7 "PTK7 protein tyrosine kinase 7" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 431 (156.8 bits), Expect = 2.7e-40, Sum P(2) = 2.7e-40
Identities = 86/190 (45%), Positives = 119/190 (62%)
Query: 27 GDLKQFLLATRXXXXXXXXXXXPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFL ++ + + LST Q V + QVALG+EH+S+ R +HKD+AAR
Sbjct: 873 GDLKQFLRISKNKDEKL------KSQPLSTKQKVALCSQVALGMEHLSNNRFVHKDLAAR 926
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NCLIS+ VK+S GLSKD Y EYY +R A +PLRW+ EAV + +FSTKSDV+A+
Sbjct: 927 NCLISAQRQVKVSALGLSKDVYNSEYYHFRQAWVPLRWMSPEAVLEGDFSTKSDVWAFGV 986
Query: 147 LIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
L+WE+F GEMP +DD+VL+ L++ K P + L ++C P+P RP+F
Sbjct: 987 LMWEVFTHGEMPHGGQADDEVLADLQAGKARLPQPEGCPSKLYRLMQRCWAPNPKDRPSF 1046
Query: 207 PSIVTQLSDA 216
I + L D+
Sbjct: 1047 SEIASTLGDS 1056
|
|
| UNIPROTKB|B3MH43 otk "Tyrosine-protein kinase-like otk" [Drosophila ananassae (taxid:7217)] | Back alignment and assigned GO terms |
|---|
Score = 416 (151.5 bits), Expect = 4.3e-40, Sum P(2) = 4.3e-40
Identities = 77/192 (40%), Positives = 121/192 (63%)
Query: 27 GDLKQFLLATRXXXXXXXXXXXPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFLLAT L+TSQ + +AYQ+A G++ I R H+D+A R
Sbjct: 841 GDLKQFLLATAGKVNTASAAATSSPPPLTTSQVLAVAYQIARGMDAIYRARFTHRDLATR 900
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NC+ISS+ VK+S L KD Y +EY+K+RN +LP+RWL E + +DE++TKSD++AY
Sbjct: 901 NCVISSEFIVKVSYPALCKDKYSREYHKHRNTLLPIRWLAPECIQEDEYTTKSDIFAYGV 960
Query: 147 LIWEIFNKG-EMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
++WE+FN+ ++P +L+++QV+ + ++ L W + TP+ + + C +P +RP+
Sbjct: 961 VVWELFNQATKLPHEELTNEQVIQKSQAGTLEWTVAESTPDSLREILLSCWVSNPKERPS 1020
Query: 206 FPSIVTQLSDAM 217
F + LS AM
Sbjct: 1021 FSQLGAALSKAM 1032
|
|
| UNIPROTKB|F1MWK8 PTK7 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 423 (154.0 bits), Expect = 2.0e-39, Sum P(2) = 2.0e-39
Identities = 84/190 (44%), Positives = 117/190 (61%)
Query: 27 GDLKQFLLATRXXXXXXXXXXXPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFL ++ + + LST Q V + QVALG+EH+S+ R +HKD+AAR
Sbjct: 881 GDLKQFLRISKSKDEKL------KSQPLSTKQKVGLCTQVALGMEHLSNNRFVHKDLAAR 934
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NCL+S+ VK+S GLSKD Y EYY +R A +PLRW+P EA+ + +FSTKSDV+A+
Sbjct: 935 NCLVSAQRQVKVSALGLSKDVYNSEYYHFRQAWVPLRWMPPEAILEGDFSTKSDVWAFGV 994
Query: 147 LIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
L+WE+F GEMP +DD+VL+ L++ K P + L ++C P RP+F
Sbjct: 995 LMWEVFTHGEMPHGGQADDEVLADLQAGKARLPQPEGCPSKLYRLMQRCWALSPKDRPSF 1054
Query: 207 PSIVTQLSDA 216
I L D+
Sbjct: 1055 SEIANALGDS 1064
|
|
| UNIPROTKB|B4P5Q9 otk "Tyrosine-protein kinase-like otk" [Drosophila yakuba (taxid:7245)] | Back alignment and assigned GO terms |
|---|
Score = 408 (148.7 bits), Expect = 3.0e-39, Sum P(2) = 3.0e-39
Identities = 77/192 (40%), Positives = 121/192 (63%)
Query: 27 GDLKQFLLATRXXXXXXXXXXXPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFLLAT L+TSQ + +AYQ+A G++ I R H+D+A R
Sbjct: 838 GDLKQFLLATAGKVNTATAGSSSPP-PLTTSQVLAVAYQIARGMDAIYRARFTHRDLATR 896
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NC+ISS+ VK+S L KD Y +EY+K+RN +LP+RWL E + +DE++TKSD++AY
Sbjct: 897 NCVISSEFIVKVSYPALCKDKYSREYHKHRNTLLPIRWLAPECIQEDEYTTKSDIFAYGV 956
Query: 147 LIWEIFNKG-EMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
++WE+FN+ ++P +L+++QV+ + ++ L W + TP+ + + C +P +RP+
Sbjct: 957 VVWELFNQATKLPHEELTNEQVVQRSQAGSLEWSVAESTPDSLREILLSCWVANPKERPS 1016
Query: 206 FPSIVTQLSDAM 217
F + LS AM
Sbjct: 1017 FSQLGAALSKAM 1028
|
|
| UNIPROTKB|B4HNW4 otk "Tyrosine-protein kinase-like otk" [Drosophila sechellia (taxid:7238)] | Back alignment and assigned GO terms |
|---|
Score = 407 (148.3 bits), Expect = 3.8e-39, Sum P(2) = 3.8e-39
Identities = 77/192 (40%), Positives = 121/192 (63%)
Query: 27 GDLKQFLLATRXXXXXXXXXXXPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFLLAT L+TSQ + +AYQ+A G++ I R H+D+A R
Sbjct: 834 GDLKQFLLATAGKVNTATAGSSSPP-PLTTSQVLAVAYQIARGMDAIYRARFTHRDLATR 892
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NC+ISS+ VK+S L KD Y +EY+K+RN +LP+RWL E + +DE++TKSD++AY
Sbjct: 893 NCVISSEFIVKVSYPALCKDKYSREYHKHRNTLLPIRWLAPECIQEDEYTTKSDIFAYGV 952
Query: 147 LIWEIFNKG-EMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
++WE+FN+ ++P +L+++QV+ + ++ L W + TP+ + + C +P +RP+
Sbjct: 953 VVWELFNQATKLPHEELTNEQVVQRSQAGSLEWSVAEATPDSLREILLSCWVSNPKERPS 1012
Query: 206 FPSIVTQLSDAM 217
F + LS AM
Sbjct: 1013 FSQLGAALSKAM 1024
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 223 | |||
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-82 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-62 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-62 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-60 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-56 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-46 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-41 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-41 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-39 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-39 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-38 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-38 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-36 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-36 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-36 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-36 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-35 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-35 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-35 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-35 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-34 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-34 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-33 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-33 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-33 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-32 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-32 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-32 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-32 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-31 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-31 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-31 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-31 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-30 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-30 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-30 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-30 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-29 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-29 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-29 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-29 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-28 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-26 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-26 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-25 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-24 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-24 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-24 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-24 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-23 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-23 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-19 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-18 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-16 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-13 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-13 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-07 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-06 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-05 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-05 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-05 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-05 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-04 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-04 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-04 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 0.001 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 0.001 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.001 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.001 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 0.001 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.001 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.001 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.002 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.002 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.002 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 0.002 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 0.002 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.003 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.004 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 0.004 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.004 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 5e-82
Identities = 92/189 (48%), Positives = 129/189 (68%), Gaps = 6/189 (3%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLKQFL AT+ SKD+ P LST Q V + Q+ALG++H+S+ R +H+D+AAR
Sbjct: 93 GDLKQFLRATK--SKDEKLKPPP----LSTKQKVALCTQIALGMDHLSNARFVHRDLAAR 146
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
NCL+SS VK+SL LSKD Y EYYK RNA++PLRWL EAV +D+FSTKSDV+++
Sbjct: 147 NCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGV 206
Query: 147 LIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
L+WE+F +GE+PF LSD++VL++L++ KL P + L +C +P RP+F
Sbjct: 207 LMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSF 266
Query: 207 PSIVTQLSD 215
+V+ L +
Sbjct: 267 SELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 3e-62
Identities = 71/188 (37%), Positives = 106/188 (56%), Gaps = 14/188 (7%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL +L K R + LS S ++ A Q+A G+E++ K IH+D+AA
Sbjct: 85 GGDLLDYLR-------------KNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAA 131
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNCL+ +L VKIS GLS+D Y +YYK + LP+RW+ E++ + +F++KSDV+++
Sbjct: 132 RNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFG 191
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L+WEIF GE P+P +S+ +VL L+ K P + L +C P RPT
Sbjct: 192 VLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK-PPNCPPELYKLMLQCWAEDPEDRPT 250
Query: 206 FPSIVTQL 213
F +V L
Sbjct: 251 FSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 8e-62
Identities = 69/188 (36%), Positives = 106/188 (56%), Gaps = 15/188 (7%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL +L R LS S ++ A Q+A G+E++ K IH+D+AA
Sbjct: 85 GGDLLSYLRKNRP--------------KLSLSDLLSFALQIARGMEYLESKNFIHRDLAA 130
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNCL+ +L VKIS GLS+D Y +YY+ R LP+RW+ E++ + +F++KSDV+++
Sbjct: 131 RNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFG 190
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L+WEIF GE P+P +S+++VL L++ + P + L +C P RPT
Sbjct: 191 VLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ-PPNCPPELYDLMLQCWAEDPEDRPT 249
Query: 206 FPSIVTQL 213
F +V L
Sbjct: 250 FSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 2e-60
Identities = 70/189 (37%), Positives = 107/189 (56%), Gaps = 10/189 (5%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL +L +R S +LS ++ A Q+A G+E+++ K+ +H+D+AAR
Sbjct: 81 GDLLDYLRKSRPVFPSPEKS------TLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAAR 134
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKY-RNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
NCL+ DL VKIS GLS+D Y +YY+ LP+RW+ E++ D F++KSDV+++
Sbjct: 135 NCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFG 194
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLES-KKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
L+WEIF G P+P LS+++VL L +L P+ + L C P RP
Sbjct: 195 VLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL--PKPEYCPDELYELMLSCWQLDPEDRP 252
Query: 205 TFPSIVTQL 213
TF +V +L
Sbjct: 253 TFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 5e-56
Identities = 69/195 (35%), Positives = 106/195 (54%), Gaps = 28/195 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL FL L+ + MA Q+A G+E++ K +H+D+AA
Sbjct: 85 GGDLLDFLRKHG--------------EKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAA 130
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RNCL++ +L VKIS GLS+D Y+ +YY K LP++W+ E++ D +F++KSDV+++
Sbjct: 131 RNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSF 190
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHP 198
L+WEIF GE P+P +S+++VL LE + C P+ + L +C
Sbjct: 191 GVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENC-------PDELYELMLQCWAY 243
Query: 199 HPHQRPTFPSIVTQL 213
P RPTF +V L
Sbjct: 244 DPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 8e-46
Identities = 65/191 (34%), Positives = 114/191 (59%), Gaps = 7/191 (3%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
KGDLK +L + R ++++ G G P + + + MA ++A G+ +++ K+ +H+D+AA
Sbjct: 93 KGDLKSYLRSRRPEAENNPGLGPP-----TLQKFIQMAAEIADGMAYLAAKKFVHRDLAA 147
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RNC+++ DL+VKI G+++D Y+ +YY K +LP+RW+ E++ D F+TKSDV+++
Sbjct: 148 RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
++WE+ E P+ LS+++VL + P+ + L C +P RP
Sbjct: 208 GVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRP 266
Query: 205 TFPSIVTQLSD 215
TF IV+ L D
Sbjct: 267 TFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-41
Identities = 70/191 (36%), Positives = 117/191 (61%), Gaps = 7/191 (3%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVR-SLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL +FL+ S + SG V+ SL S + +A Q+A G+E++S +H+D+AA
Sbjct: 93 GDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAA 152
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RNCL+ L+VKIS GLS+D Y +YY+ + ++LP+RW+P EA+ +F+T+SD++++
Sbjct: 153 RNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL--CWKHSSKTPEYITSLHEKCIHPHPHQ 202
++WEIF+ G P+ S+ +V+ + S++L C P + +L +C + P +
Sbjct: 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPC---PEDCPARVYALMIECWNEIPAR 269
Query: 203 RPTFPSIVTQL 213
RP F I T+L
Sbjct: 270 RPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-41
Identities = 61/193 (31%), Positives = 108/193 (55%), Gaps = 13/193 (6%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRS-------LSTSQAVTMAYQVALGLEHISDKRLI 79
GDL +FL ++ R LS ++ + +A QVA G+ ++S+++ +
Sbjct: 93 GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV 152
Query: 80 HKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKY-RNAILPLRWLPYEAVFDDEFSTK 138
H+D+A RNCL+ ++ VKI+ GLS++ Y +YYK N +P+RW+P E++F + ++T+
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 139 SDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL--CWKHSSKTPEYITSLHEKCI 196
SDV+AY ++WEIF+ G P+ ++ ++V+ + + C P + +L C
Sbjct: 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSC---PDNCPLELYNLMRLCW 269
Query: 197 HPHPHQRPTFPSI 209
P RP+F SI
Sbjct: 270 SKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-39
Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 25/199 (12%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLK FL R + S SL+ + A VA G +++ + IH+DIAAR
Sbjct: 94 GDLKSFLRENRPRPERPS--------SLTMKDLLFCARDVAKGCKYLEENHFIHRDIAAR 145
Query: 87 NCLISS---DLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVY 142
NCL++ KI+ G+++D Y+ YY K A+LP++W+P EA D F++K+DV+
Sbjct: 146 NCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVW 205
Query: 143 AYACLIWEIFNKGEMPFPDLSDDQVL------SQLESKKLCWKHSSKTPEYITSLHEKCI 196
++ L+WEIF+ G MP+P ++ +V+ +L+ K C P + + C
Sbjct: 206 SFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGC-------PGPVYRIMTDCW 258
Query: 197 HPHPHQRPTFPSIVTQLSD 215
P RP F +I+ ++
Sbjct: 259 QHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-39
Identities = 62/195 (31%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL QFL + ++ +SLS S + MA Q+A G+ ++ +H+D+A R
Sbjct: 104 GDLNQFL----QKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
NCL+ + ++KI+ G+S++ Y +YY+ + A LP+RW+ +E+V +F+TKSDV+A+
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG 219
Query: 146 CLIWEIFNKG-EMPFPDLSDDQVLSQLE------SKKLCWKHSSKTPEYITSLHEKCIHP 198
+WEI E P+ L+D QV+ +++ P+ I L +C
Sbjct: 220 VTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRR 279
Query: 199 HPHQRPTFPSIVTQL 213
RPTF I L
Sbjct: 280 DEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-38
Identities = 69/194 (35%), Positives = 110/194 (56%), Gaps = 4/194 (2%)
Query: 26 KGDLKQFLLATR-KDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
G+L+ FL A R +P +L+ V+ AYQVA G+E ++ K+ IH+D+A
Sbjct: 100 HGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYA 143
ARN L++ D +KI+ GL++D + +YY+ N LP++W+ EA+FD ++ +SDV++
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
+ L+WEIF G P+P + +++ L+ K + T E + L C H P QR
Sbjct: 220 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQE-LYHLMRDCWHEVPSQR 278
Query: 204 PTFPSIVTQLSDAM 217
PTF +V L D M
Sbjct: 279 PTFKQLVEDL-DRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-38
Identities = 65/191 (34%), Positives = 114/191 (59%), Gaps = 9/191 (4%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLK +L + R ++++ G P ++ + + MA ++A G+ +++ K+ +H+D+AAR
Sbjct: 94 GDLKSYLRSLRPEAENNPGRPPPTLQEM-----IQMAAEIADGMAYLNAKKFVHRDLAAR 148
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
NC+++ D +VKI G+++D Y+ +YY K +LP+RW+ E++ D F+T SD++++
Sbjct: 149 NCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 208
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLS-QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
++WEI + E P+ LS++QVL ++ L PE +T L C +P RP
Sbjct: 209 VVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL--DQPDNCPERVTDLMRMCWQFNPKMRP 266
Query: 205 TFPSIVTQLSD 215
TF IV L D
Sbjct: 267 TFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-36
Identities = 61/189 (32%), Positives = 107/189 (56%), Gaps = 5/189 (2%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL +FL + D+ P L+ SQ + +A Q+A G+ +++ + +H+D+A R
Sbjct: 93 GDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQIAVQIASGMVYLASQHFVHRDLATR 151
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
NCL+ DL VKI G+S+D Y +YY+ + +LP+RW+P E++ +F+T+SDV+++
Sbjct: 152 NCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 211
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKT-PEYITSLHEKCIHPHPHQRP 204
++WEIF G+ P+ LS+++V+ + +L +T P + + C P QR
Sbjct: 212 VVLWEIFTYGKQPWYGLSNEEVIECITQGRL--LQRPRTCPSEVYDIMLGCWKRDPQQRI 269
Query: 205 TFPSIVTQL 213
I +L
Sbjct: 270 NIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-36
Identities = 66/196 (33%), Positives = 113/196 (57%), Gaps = 28/196 (14%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL+ F+ R ++ + P V+ L + QVA G+E+++ K+ +H+D+AAR
Sbjct: 82 GDLRNFI---RSETHN------PTVKDL-----IGFGLQVAKGMEYLASKKFVHRDLAAR 127
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRN---AILPLRWLPYEAVFDDEFSTKSDVYA 143
NC++ +VK++ GL++D Y KEYY N A LP++W+ E++ +F+TKSDV++
Sbjct: 128 NCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWS 187
Query: 144 YACLIWEIFNKGEMPFPDL-SDDQVLSQLESKKLCWKHSSKTPEY----ITSLHEKCIHP 198
+ L+WE+ +G P+PD+ S D + L+ ++L PEY + + C HP
Sbjct: 188 FGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL------LQPEYCPDPLYEVMLSCWHP 241
Query: 199 HPHQRPTFPSIVTQLS 214
P RPTF +V+++
Sbjct: 242 KPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 3e-36
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 27/199 (13%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL +L R + L+ + + + VA G ++ IH+D+AAR
Sbjct: 84 GDLLSYLRDARVERFGPPL--------LTLKELLDICLDVAKGCVYLEQMHFIHRDLAAR 135
Query: 87 NCLISS-----DLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSD 140
NCL+S D VKI GL++D Y+ +YY+ +LP+RW+ E++ D +F+T+SD
Sbjct: 136 NCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSD 195
Query: 141 VYAYACLIWEIFNKGEMPFPDLSDDQVLS------QLESKKLCWKHSSKTPEYITSLHEK 194
V+++ L+WEI G+ P+P L++ +VL +L+ + C P+ I L
Sbjct: 196 VWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC-------PDKIYQLMTN 248
Query: 195 CIHPHPHQRPTFPSIVTQL 213
C P +RPTF I L
Sbjct: 249 CWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-36
Identities = 71/191 (37%), Positives = 110/191 (57%), Gaps = 5/191 (2%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRV--RSLSTSQAVTMAYQVALGLEHISDKRLIHKDI 83
KG+L++FL A R D + +V LS V+ AYQVA G+E++ +R IH+D+
Sbjct: 102 KGNLREFLRARRPPGPDYTFDI-TKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDL 160
Query: 84 AARNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVY 142
AARN L++ D +KI+ GL++ + +YY K N LP++W+ EA+FD ++ +SDV+
Sbjct: 161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 143 AYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQ 202
++ L+WEIF G P+P + +++ L K S+ T E + E C H P Q
Sbjct: 221 SFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRE-CWHAVPTQ 279
Query: 203 RPTFPSIVTQL 213
RPTF +V L
Sbjct: 280 RPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-35
Identities = 59/191 (30%), Positives = 110/191 (57%), Gaps = 7/191 (3%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
+GDLK +L + R + ++ P S + + MA ++A G+ +++ + +H+D+AA
Sbjct: 93 RGDLKSYLRSLRPEMENNPVQAPP-----SLKKMIQMAGEIADGMAYLNANKFVHRDLAA 147
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RNC+++ D +VKI G+++D Y+ +YY K +LP+RW+ E++ D F+T SDV+++
Sbjct: 148 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 207
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
++WEI E P+ +S++QVL + L K P+ + L C +P RP
Sbjct: 208 GVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRP 266
Query: 205 TFPSIVTQLSD 215
+F I++ + +
Sbjct: 267 SFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-35
Identities = 71/196 (36%), Positives = 115/196 (58%), Gaps = 14/196 (7%)
Query: 26 KGDLKQFLL--ATRKD---SKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIH 80
+GDL +FL+ + D S D+ G+ K SL + +A Q+A G+E++S +H
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVK---SSLDHGDFLHIAIQIAAGMEYLSSHFFVH 147
Query: 81 KDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKS 139
KD+AARN LI L VKIS GLS++ Y +YY+ + ++LP+RW+P EA+ +FS+ S
Sbjct: 148 KDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDS 207
Query: 140 DVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL--CWKHSSKTPEYITSLHEKCIH 197
D++++ ++WEIF+ G P+ S+ +V+ + ++L C S P + SL +C
Sbjct: 208 DIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC---SEDCPPRMYSLMTECWQ 264
Query: 198 PHPHQRPTFPSIVTQL 213
P +RP F I T+L
Sbjct: 265 EGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-35
Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 25/210 (11%)
Query: 18 SGSGKPRV------KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLE 71
P V G+LK FL R + ++LST Q V MA Q+A G+
Sbjct: 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP-------QALSTQQLVHMAIQIACGMS 131
Query: 72 HISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY-----KYRNAILPLRWLP 126
++ + +IHKDIAARNC+I +L VKI+ + LS+D + +Y+ + R P++W+
Sbjct: 132 YLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR----PVKWMA 187
Query: 127 YEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-KKLCWKHSSKTP 185
E++ + E+S+ SDV+++ L+WE+ G+ P+ ++ ++ + L+ +L P
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL--AQPINCP 245
Query: 186 EYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ + ++ C P +RP+F +V L+D
Sbjct: 246 DELFAVMACCWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-35
Identities = 69/190 (36%), Positives = 113/190 (59%), Gaps = 3/190 (1%)
Query: 26 KGDLKQFLLATRKDSKDKS-GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
KG+L+++L A R D S + K L+ V+ AYQVA G+E+++ ++ IH+D+A
Sbjct: 102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYA 143
ARN L++ D +KI+ GL++D + +YY K N LP++W+ EA+FD ++ +SDV++
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
+ L+WEIF G P+P + +++ L+ K ++ T E + E C H P QR
Sbjct: 222 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRE-CWHAVPSQR 280
Query: 204 PTFPSIVTQL 213
PTF +V L
Sbjct: 281 PTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-34
Identities = 68/190 (35%), Positives = 111/190 (58%), Gaps = 3/190 (1%)
Query: 26 KGDLKQFLLATRKDSKDKS-GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
KG+L+++L A R + + LS V+ AYQVA G+E+++ K+ IH+D+A
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYA 143
ARN L++ D +KI+ GL++D + +YY K N LP++W+ EA+FD ++ +SDV++
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 227
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
+ L+WEIF G P+P + +++ L+ K S+ T E + + C H P QR
Sbjct: 228 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQR 286
Query: 204 PTFPSIVTQL 213
PTF +V L
Sbjct: 287 PTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-34
Identities = 73/237 (30%), Positives = 128/237 (54%), Gaps = 23/237 (9%)
Query: 1 GDLKQFLLATRKD---SKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTS 57
G+L +L + R+ ++KS + + + K+ L + S+ + SG +SLS
Sbjct: 97 GNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV 156
Query: 58 QA-----------------VTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISL 100
+ ++ ++QVA G+E ++ ++ IH+D+AARN L+S + VKI
Sbjct: 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICD 216
Query: 101 SGLSKDTYQK-EYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159
GL++D Y+ +Y + +A LPL+W+ E++FD ++T+SDV+++ L+WEIF+ G P+
Sbjct: 217 FGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
Query: 160 PDLS-DDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
P + D++ +L+ TPE I S+ C H +P RPTF +V L D
Sbjct: 277 PGVQIDEEFCRRLKEGTRMRAPEYATPE-IYSIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-33
Identities = 60/190 (31%), Positives = 109/190 (57%), Gaps = 4/190 (2%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL +FL A D+ + +P L+ SQ + +A Q+A G+ +++ + +H+D+A R
Sbjct: 92 GDLNKFLRAHGPDAVLMAEGNRPA--ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 149
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKY-RNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
NCL+ +L VKI G+S+D Y +YY+ + +LP+RW+P E++ +F+T+SDV++
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 209
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
++WEIF G+ P+ LS+++V+ + ++ + P+ + L C PH R
Sbjct: 210 VVLWEIFTYGKQPWYQLSNNEVIECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLN 268
Query: 206 FPSIVTQLSD 215
I + L +
Sbjct: 269 IKEIHSLLQN 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-33
Identities = 60/195 (30%), Positives = 108/195 (55%), Gaps = 12/195 (6%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL QFL + + K V ++S S + MA Q+A G++++S +H+D+A R
Sbjct: 104 GDLNQFLSRHEP----QEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRN-AILPLRWLPYEAVFDDEFSTKSDVYAYA 145
NCL+ + ++KI+ G+S++ Y +YY+ + A+LP+RW+ +E++ +F+T SDV+A+
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 219
Query: 146 CLIWEIFNK-GEMPFPDLSDDQVLSQL------ESKKLCWKHSSKTPEYITSLHEKCIHP 198
+WEI E P+ LSD+QV+ + +++ + P+ + L C
Sbjct: 220 VTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRR 279
Query: 199 HPHQRPTFPSIVTQL 213
+ +RP+F I L
Sbjct: 280 NAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-33
Identities = 52/166 (31%), Positives = 86/166 (51%), Gaps = 13/166 (7%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
L T + M V +E++ IH+D+AARNCL+ D VK+S GL++ +Y
Sbjct: 97 LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS---- 169
+ P++W P E FS+KSDV+++ L+WE+F++G+MP+ S+ +V+
Sbjct: 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216
Query: 170 --QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
+L KL P + ++ C H P RP F +++QL
Sbjct: 217 GYRLYRPKLA-------PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-32
Identities = 59/194 (30%), Positives = 106/194 (54%), Gaps = 14/194 (7%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL +FL + D+K +G L+ Q + +A Q+A G+ +++ +H+D+A R
Sbjct: 92 GDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRN-AILPLRWLPYEAVFDDEFSTKSDVYAYA 145
NCL+ L VKI G+S+D Y +YY+ +LP+RW+P E++ +F+T+SD++++
Sbjct: 152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLS------QLESKKLCWKHSSKTPEYITSLHEKCIHPH 199
++WEIF G+ P+ LS+ + + +LE + C P + ++ + C
Sbjct: 212 VVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTC-------PPEVYAIMQGCWQRE 264
Query: 200 PHQRPTFPSIVTQL 213
P QR I ++L
Sbjct: 265 PQQRMVIKDIHSRL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-32
Identities = 62/189 (32%), Positives = 104/189 (55%), Gaps = 13/189 (6%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL FLL +R + P L T V +A G+E++S K IH+D+AAR
Sbjct: 92 GDLHTFLLMSRIGEE-------PFTLPLQT--LVRFMIDIASGMEYLSSKNFIHRDLAAR 142
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAI-LPLRWLPYEAVFDDEFSTKSDVYAYA 145
NC+++ +++V ++ GLSK Y +YY+ A LP++WL E++ D+ ++T SDV+A+
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG 202
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQL-ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
+WEI +G+ P+ + + ++ + L + +L K E + L +C P P RP
Sbjct: 203 VTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL--KQPPDCLEDVYELMCQCWSPEPKCRP 260
Query: 205 TFPSIVTQL 213
+F + QL
Sbjct: 261 SFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 8e-32
Identities = 74/244 (30%), Positives = 129/244 (52%), Gaps = 32/244 (13%)
Query: 1 GDLKQFLLATRK---DSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVR--SLS 55
G+L FL A R+ ++KS P+ +G + + +R D + ++G S
Sbjct: 97 GNLSNFLRAKREFFSPYREKS----PKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPS 152
Query: 56 TSQAV--------------TM------AYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95
TS + TM ++QVA G+E ++ ++ IH+D+AARN L+S +
Sbjct: 153 TSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV 212
Query: 96 VKISLSGLSKDTYQK-EYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNK 154
VKI GL++D Y+ +Y + +A LPL+W+ E++FD ++T+SDV+++ L+WEIF+
Sbjct: 213 VKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 272
Query: 155 GEMPFPDLS-DDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
G P+P + +++ +L+ + TPE I + C P +RPTF ++V L
Sbjct: 273 GASPYPGVQINEEFCQRLKDGTRMRAPENATPE-IYRIMLACWQGDPKERPTFSALVEIL 331
Query: 214 SDAM 217
D +
Sbjct: 332 GDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-32
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 14 SKDKSGSGKPRV------KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVA 67
+ KP V GDL FLL +R + L + +A
Sbjct: 73 ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK---------LPLQTLLKFMVDIA 123
Query: 68 LGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKY-RNAILPLRWLP 126
LG+E++S++ IH+D+AARNC++ D++V ++ GLSK Y +YY+ R A +P++W+
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 127 YEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL-ESKKLCWKHSSKTP 185
E++ D +++KSDV+A+ +WEI +G+ P+P + + ++ L +L K
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL--KQPEDCL 241
Query: 186 EYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ + L C P RPTF + L +
Sbjct: 242 DELYDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 4e-31
Identities = 62/191 (32%), Positives = 106/191 (55%), Gaps = 7/191 (3%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRS-LSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
DL +FL+ S S V+S L + V + Q+A G+E +S ++HKD+A
Sbjct: 93 SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLAT 152
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RN L+ L+VKIS GL ++ Y +YYK N++LP+RW+ EA+ +FS SD+++Y
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKK--LCWKHSSKTPEYITSLHEKCIHPHPHQ 202
++WE+F+ G P+ S+ V+ + +++ C P ++ +L +C + P +
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC---PDDCPAWVYTLMLECWNEFPSR 269
Query: 203 RPTFPSIVTQL 213
RP F I ++L
Sbjct: 270 RPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-31
Identities = 62/193 (32%), Positives = 96/193 (49%), Gaps = 20/193 (10%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
KG L FL KSG G + L Q V MA Q+A G+ ++ + IH+D+AA
Sbjct: 85 KGSLLDFL---------KSGEG----KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAA 131
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L+ +L KI+ GL++ EY A P++W EA F+ KSDV+++
Sbjct: 132 RNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFG 191
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHE---KCIHPHPHQ 202
L+ EI G +P+P +++ +VL Q+E + P L++ +C P +
Sbjct: 192 ILLTEIVTYGRVPYPGMTNREVLEQVERG----YRMPRPPNCPEELYDLMLQCWDKDPEE 247
Query: 203 RPTFPSIVTQLSD 215
RPTF + + L D
Sbjct: 248 RPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 7e-31
Identities = 57/169 (33%), Positives = 98/169 (57%), Gaps = 9/169 (5%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQK-EY 112
L+ + ++QVA G+E ++ ++ IH+D+AARN L+S + VKI GL++D Y+ +Y
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 113 YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172
+ +A LPL+W+ E +FD ++ +SDV+++ L+WEIF+ G P+P + D+
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---- 291
Query: 173 SKKLCWKHSSKTPEYITSLHEK----CIHPHPHQRPTFPSIVTQLSDAM 217
++L + P+Y T + C H P QRPTF +V L + +
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-31
Identities = 62/186 (33%), Positives = 107/186 (57%), Gaps = 17/186 (9%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRS--LSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDL +FL A D+ G+PR L SQ + +A Q+A G+ +++ + +H+D+A
Sbjct: 92 GDLNKFLRAHGPDAMILV-DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLA 150
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKY-RNAILPLRWLPYEAVFDDEFSTKSDVYA 143
RNCL+ ++L VKI G+S+D Y +YY+ + +LP+RW+P E++ +F+T+SDV++
Sbjct: 151 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 210
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLS------QLESKKLCWKHSSKTPEYITSLHEKCIH 197
+ ++WEIF G+ P+ LS+ +V+ LE ++C P+ + + C
Sbjct: 211 FGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVC-------PKEVYDIMLGCWQ 263
Query: 198 PHPHQR 203
P QR
Sbjct: 264 REPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 9e-31
Identities = 62/190 (32%), Positives = 109/190 (57%), Gaps = 3/190 (1%)
Query: 26 KGDLKQFLLATRKDSKDKSGS-GKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
KG+L+++L A R + S + ++ V+ YQVA G+E+++ ++ IH+D+A
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYK-YRNAILPLRWLPYEAVFDDEFSTKSDVYA 143
ARN L++ + +KI+ GL++D +YYK N LP++W+ EA+FD ++ +SDV++
Sbjct: 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 224
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
+ L+WEIF G P+P + +++ L+ K ++ T E + + C H P R
Sbjct: 225 FGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD-CWHAIPSHR 283
Query: 204 PTFPSIVTQL 213
PTF +V L
Sbjct: 284 PTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 60/207 (28%), Positives = 117/207 (56%), Gaps = 19/207 (9%)
Query: 27 GDLKQFLLATRK---------DSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR 77
G L+ FL +RK +++ S P R+L+ ++ A+Q++ G++++++ +
Sbjct: 88 GSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK 147
Query: 78 LIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFS 136
L+H+D+AARN L++ +KIS GLS+D Y+++ Y K +P++W+ E++FD ++
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT 207
Query: 137 TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTP----EYITSLH 192
T+SDV+++ L+WEI G P+P ++ +++ + L++ + + P E + +L
Sbjct: 208 TQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT-----GYRMERPENCSEEMYNLM 262
Query: 193 EKCIHPHPHQRPTFPSIVTQLSDAMCN 219
C P +RPTF I +L M
Sbjct: 263 LTCWKQEPDKRPTFADISKELEKMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-30
Identities = 48/162 (29%), Positives = 88/162 (54%), Gaps = 1/162 (0%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
+ SQ + M V G+ ++ K+ IH+D+AARNCL+ VK+S GLS+ E
Sbjct: 95 KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
Query: 112 YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
Y + P+RW P E + +FS+KSDV+A+ L+WE+++ G+MP+ ++ + + ++
Sbjct: 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214
Query: 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
++ E + ++ C H +RPTF +++ +
Sbjct: 215 SQGLRLYR-PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-30
Identities = 59/191 (30%), Positives = 106/191 (55%), Gaps = 11/191 (5%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL QFL +S + P S+S + + MA Q+A G+++++ +H+D+A R
Sbjct: 102 GDLNQFLSQREIESTFTHANNIP---SVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRN-AILPLRWLPYEAVFDDEFSTKSDVYAYA 145
NCL+ + ++KI+ G+S++ Y +YY+ + A+LP+RW+ +E++ +F+T SDV+A+
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218
Query: 146 CLIWEIFNK-GEMPFPDLSDDQVLSQL------ESKKLCWKHSSKTPEYITSLHEKCIHP 198
+WE+F E P+ LSD+QV+ + +++ + P + L +C
Sbjct: 219 VTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSR 278
Query: 199 HPHQRPTFPSI 209
RPTF I
Sbjct: 279 DIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 8e-30
Identities = 50/156 (32%), Positives = 86/156 (55%), Gaps = 3/156 (1%)
Query: 62 MAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT-YQKEYYKYRNA-I 119
+A+QVA+G+ ++ K +H+D+AARN L+ + KIS G+S+ +YY+ A
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159
Query: 120 LPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWK 179
PL+W E + +FS+KSDV++Y +WE F+ G P+ ++ +V++ LES + +
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR 219
Query: 180 HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ P+ I S+ C P RPTF + +
Sbjct: 220 -PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 61/197 (30%), Positives = 110/197 (55%), Gaps = 16/197 (8%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVR------SLSTSQAVTMAYQVALGLEHISDKRLIH 80
GDL QFL + D DK +G V ++S S + +A Q+A G++++S +H
Sbjct: 104 GDLNQFLSSHHLD--DKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161
Query: 81 KDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRN-AILPLRWLPYEAVFDDEFSTKS 139
+D+A RNCL+ +L++KI+ G+S++ Y +YY+ + A+LP+RW+ +E + +F+T S
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS 221
Query: 140 DVYAYACLIWEIFNK-GEMPFPDLSDDQVLSQL------ESKKLCWKHSSKTPEYITSLH 192
DV+A+ +WEI E P+ +L+D+QV+ + +++ P+ + L
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM 281
Query: 193 EKCIHPHPHQRPTFPSI 209
+C +RP+F I
Sbjct: 282 LQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 53/163 (32%), Positives = 88/163 (53%), Gaps = 1/163 (0%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
L+ ++ +YQVA G+ ++ K IH+D+AARN L++ VKI GL++D Y
Sbjct: 138 LTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197
Query: 114 KYR-NAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172
+ NA LP++W+ E++F+ ++ +SDV++Y L+WEIF+ G P+P + D +L
Sbjct: 198 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI 257
Query: 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ P I + + C P +RPTF IV +
Sbjct: 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-29
Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L+ +L K S L + + +YQ++ L ++ KR +H+DIAA
Sbjct: 90 LGELRSYL-QVNKYS-------------LDLASLILYSYQLSTALAYLESKRFVHRDIAA 135
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L+SS VK+ GLS+ + YYK LP++W+ E++ F++ SDV+ +
Sbjct: 136 RNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 195
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
+WEI G PF + ++ V+ ++E+ + P + SL KC P +RP
Sbjct: 196 VCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM-PPNCPPTLYSLMTKCWAYDPSKRPR 254
Query: 206 FPSIVTQLSD 215
F + QLSD
Sbjct: 255 FTELKAQLSD 264
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-29
Identities = 60/193 (31%), Positives = 107/193 (55%), Gaps = 13/193 (6%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL FLL +R + L T V +A G+E++S K IH+D+AAR
Sbjct: 91 GDLHSFLLYSRLGDCPQY---------LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAAR 141
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKY-RNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
NC+++ +++V ++ GLSK Y +YY+ R A +P++W+ E++ D ++TKSDV+++
Sbjct: 142 NCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFG 201
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQL-ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
+WEI +G+ P+P + + ++ L + +L K + + SL C +P RP
Sbjct: 202 VTMWEIATRGQTPYPGVENSEIYDYLRQGNRL--KQPPDCLDGLYSLMSSCWLLNPKDRP 259
Query: 205 TFPSIVTQLSDAM 217
+F ++ +L A+
Sbjct: 260 SFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-29
Identities = 61/190 (32%), Positives = 98/190 (51%), Gaps = 20/190 (10%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSL-STSQAVTMAYQVALGLEHISDKRLIHKDIA 84
KG+L FL + R R+L S Q + + VA G+E++ K+L+H+D+A
Sbjct: 82 KGNLVNFL--------------RTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLA 127
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
ARN L+S D K+S GL++ N+ LP++W EA+ +FS+KSDV++Y
Sbjct: 128 ARNILVSEDGVAKVSDFGLAR----VGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSY 183
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
L+WE+F+ G P+P +S +V +E K + P + L C P +RP
Sbjct: 184 GVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCWETEPKKRP 242
Query: 205 TFPSIVTQLS 214
+F + +L
Sbjct: 243 SFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-28
Identities = 52/166 (31%), Positives = 88/166 (53%), Gaps = 5/166 (3%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
R+L Q + MA QVA G+ ++ + IH+D+AARN L+ + K++ GL++ +
Sbjct: 98 RALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157
Query: 112 YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
Y A P++W EA + FS KSDV+++ L+ EI G MP+P +++ +VL Q+
Sbjct: 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
Query: 172 ES--KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ + C P+ + + C P RPTF ++ +L D
Sbjct: 218 DQGYRMPC---PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-28
Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 15/171 (8%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE-Y 112
+ Q V M +A G++++S+ +H+D+AARN L++S+L K+S GLS+ E
Sbjct: 103 FTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162
Query: 113 YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172
Y + +P+RW EA+ +F++ SDV+++ ++WE+ + GE P+ D+S+ V+ +E
Sbjct: 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE 222
Query: 173 S------KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217
C P + L C ++RPTF IV+ L D M
Sbjct: 223 DGYRLPPPMDC-------PSALYQLMLDCWQKDRNERPTFSQIVSTL-DKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-28
Identities = 52/170 (30%), Positives = 88/170 (51%), Gaps = 2/170 (1%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT 107
K + S A Q+A G+ ++ KR IH+D+AARN L++SD VKI GL +
Sbjct: 88 KDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147
Query: 108 YQ-KEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD 165
Q +++Y + +P W E++ FS SDV+ + +WE+F GE P+ LS
Sbjct: 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207
Query: 166 QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
Q+L +++ + + P+ I ++ +C +P RPTF ++ L +
Sbjct: 208 QILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-28
Identities = 51/162 (31%), Positives = 87/162 (53%), Gaps = 3/162 (1%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
LS ++M V G+E++ IH+D+AARNCL+SS VK+S G+++ EY
Sbjct: 97 LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL-E 172
A P++W P E ++S+KSDV+++ L+WE+F +G+MPF S+ +V+ +
Sbjct: 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
Query: 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
+L + + + C H P RPTF ++ ++
Sbjct: 217 GFRLYRPKLA--SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-28
Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 18/169 (10%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
L+ + + M+ A G+E++ K IH+D+AARNCL+ + +KIS G+S++ Y
Sbjct: 90 LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149
Query: 114 ---KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170
+ +P++W EA+ ++++SDV++Y L+WE F+ G+ P+P +S+ Q +
Sbjct: 150 VSDGLKQ--IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER 207
Query: 171 LES------KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
+ES +LC PE I L +C P RP+F I +L
Sbjct: 208 IESGYRMPAPQLC-------PEEIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-28
Identities = 56/191 (29%), Positives = 101/191 (52%), Gaps = 19/191 (9%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
KG L FL P + L + + MA QVA G+ ++ ++ IH+D+AA
Sbjct: 86 KGSLLAFL-------------RSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAA 132
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L+ DL K++ GL++ +++ Y + +P +W EA FSTKSDV+++
Sbjct: 133 RNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFG 191
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLES--KKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
L++E+F G++P+P +++ +V Q+ + + C +K P+ I + +C P R
Sbjct: 192 ILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC---PAKCPQEIYKIMLECWAAEPEDR 248
Query: 204 PTFPSIVTQLS 214
P+F ++ +L
Sbjct: 249 PSFKALREELD 259
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-27
Identities = 51/163 (31%), Positives = 92/163 (56%), Gaps = 9/163 (5%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
++ +Q + A V G+E++ +K +H+D+AARN L+S DL K+S GL+K+
Sbjct: 99 ITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE----ASQ 154
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173
+ LP++W EA+ + +FSTKSDV+++ L+WEI++ G +P+P + V+ +E
Sbjct: 155 GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214
Query: 174 KKLCWKHSS--KTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
++ + P + + + C P +RPTF + QL+
Sbjct: 215 G---YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-26
Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 1/150 (0%)
Query: 60 VTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAI 119
+ MA Q++ +E++ K IH+D+AARNCL+ + VK++ GLS+ Y + A
Sbjct: 107 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 166
Query: 120 LPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWK 179
P++W E++ ++FS KSDV+A+ L+WEI G P+P + QV LE K +
Sbjct: 167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRME 225
Query: 180 HSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
P + L C +P RP+F I
Sbjct: 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-26
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 35/206 (16%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLK +L + RK + P +L MA ++ALGL H+ IH D+A R
Sbjct: 80 GDLKGYLRSCRK-----AELMTPDPTTLQR-----MACEIALGLLHLHKNNFIHSDLALR 129
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAI-LPLRWLPYEAVFDDEF---------S 136
NCL+++DL+VKI GLS + Y+++YY + + +PLRW+ E V DE +
Sbjct: 130 NCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV--DEVHGNLLVVDQT 187
Query: 137 TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS--------QLESKKLCWKHSSKTPEYI 188
+S+V++ IWE+F G P+ LSD+QVL+ +L +L S +
Sbjct: 188 KESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS----DRW 243
Query: 189 TSLHEKCIHPHPHQRPTFPSIVTQLS 214
+ + C P QRP+ + LS
Sbjct: 244 YEVMQFCWLQ-PEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-25
Identities = 58/189 (30%), Positives = 105/189 (55%), Gaps = 4/189 (2%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRS-LSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L FL +R D + + + S L++ Q + A VA G++++S+K+ IH+D+AA
Sbjct: 88 GNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAA 147
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L+ +L+ KI+ GLS+ ++ Y K LP+RW+ E++ ++TKSDV+++
Sbjct: 148 RNVLVGENLASKIADFGLSRG--EEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFG 205
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L+WEI + G P+ ++ ++ +L + + + + L +C P++RP
Sbjct: 206 VLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPP 264
Query: 206 FPSIVTQLS 214
F I QLS
Sbjct: 265 FAQISVQLS 273
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 2e-25
Identities = 64/192 (33%), Positives = 94/192 (48%), Gaps = 18/192 (9%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
KG L FL K G GK L Q V MA Q+A G+ +I IH+D+ A
Sbjct: 84 KGSLLDFL---------KEGDGK----YLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA 130
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
N L+ +L KI+ GL++ EY + A P++W EA F+ KSDV+++
Sbjct: 131 ANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLES--KKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
L+ E+ KG +P+P + + +VL Q+E + C PE + L + C P +R
Sbjct: 191 ILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC---PQGCPESLHELMKLCWKKDPDER 247
Query: 204 PTFPSIVTQLSD 215
PTF I + L D
Sbjct: 248 PTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 7e-25
Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 1/161 (0%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
L T Q V A A G+ ++ K IH+D+AARNCL+ + +KIS G+S+ Y
Sbjct: 90 LKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS 149
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173
+P++W EA+ +S++SDV++Y L+WE F+ G P+P +++ Q Q+E
Sbjct: 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE- 208
Query: 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
K K P+ + + ++C P RP F + +L+
Sbjct: 209 KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 8e-25
Identities = 54/181 (29%), Positives = 93/181 (51%), Gaps = 6/181 (3%)
Query: 35 ATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL 94
+ KD +D S L + + QVA G++ ++ K IH+D+AARN L++
Sbjct: 195 SDSKDEEDTEDS-----WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR 249
Query: 95 SVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFN 153
KI GL++D Y + NA LP++W+ E++FD ++ +SDV++Y L+WEIF+
Sbjct: 250 VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
Query: 154 KGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
G+ P+P + + ++ + P I S+ + C + P +RPTF I +
Sbjct: 310 LGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369
Query: 214 S 214
Sbjct: 370 Q 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-24
Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 24/195 (12%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
KG L FL K G G R+L V MA QVA G+ +I IH+D+ +
Sbjct: 84 KGSLLDFL---------KDGEG----RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRS 130
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
N L+ L KI+ GL++ EY + A P++W EA F+ KSDV+++
Sbjct: 131 ANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLES--KKLCWKHSSKTPEYITSLHE---KCIHPHP 200
L+ E+ KG +P+P +++ +VL Q+E + C + SLHE +C P
Sbjct: 191 ILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCP------ISLHELMLQCWKKDP 244
Query: 201 HQRPTFPSIVTQLSD 215
+RPTF + + L D
Sbjct: 245 EERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-24
Identities = 53/152 (34%), Positives = 80/152 (52%), Gaps = 18/152 (11%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLK +L R + + + V MA +VA GL + IH D+A R
Sbjct: 80 GDLKNYL---RSNRGMVAQMAQKDVLQ-------RMACEVASGLLWLHQADFIHSDLALR 129
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNA-ILPLRWLPYEAV--FDDEFST-----K 138
NC +++DLSVKI GL+ + Y ++YY ++ +PLRWL E V + K
Sbjct: 130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK 189
Query: 139 SDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170
S++++ +WE+F + P+PDLSD+QVL Q
Sbjct: 190 SNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ 221
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-24
Identities = 57/192 (29%), Positives = 95/192 (49%), Gaps = 14/192 (7%)
Query: 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD 75
D+ S K ++K L S D S L+T ++ YQVA G+E ++
Sbjct: 209 DRPASYKGSNDSEVKNLL------SDDGS-------EGLTTLDLLSFTYQVARGMEFLAS 255
Query: 76 KRLIHKDIAARNCLISSDLSVKISLSGLSKD-TYQKEYYKYRNAILPLRWLPYEAVFDDE 134
K +H+D+AARN L++ VKI GL++D + Y + LP++W+ E++FD+
Sbjct: 256 KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL 315
Query: 135 FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEK 194
++T SDV++Y L+WEIF+ G P+P + D + + + K
Sbjct: 316 YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVK 375
Query: 195 CIHPHPHQRPTF 206
C + P +RP+F
Sbjct: 376 CWNSEPEKRPSF 387
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-24
Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 15/163 (9%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK--DTYQKEYYKYRNAILPL 122
Q+A G+ ++ +KRL+H+D+AARN L+ + VKI+ GL+K D +KEY +P+
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY-HAEGGKVPI 175
Query: 123 RWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSS 182
+W+ E++ ++ KSDV++Y +WE+ G P+ + ++ LE K
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE------KGER 229
Query: 183 KTPEYITSLH-----EKCIHPHPHQRPTFPSIVTQLSDAMCND 220
I ++ KC RPTF ++ + S M D
Sbjct: 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFS-KMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-24
Identities = 57/188 (30%), Positives = 100/188 (53%), Gaps = 4/188 (2%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRS-LSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L FL +R D + + S LS+ Q + A VA G++++S K+ IH+D+AA
Sbjct: 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 140
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L+ + KI+ GLS+ Q+ Y K LP+RW+ E++ ++T SDV++Y
Sbjct: 141 RNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 198
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L+WEI + G P+ ++ ++ +L + + + + L +C P++RP+
Sbjct: 199 VLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS 257
Query: 206 FPSIVTQL 213
F I+ L
Sbjct: 258 FAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 7e-24
Identities = 46/153 (30%), Positives = 81/153 (52%), Gaps = 5/153 (3%)
Query: 63 AYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPL 122
+ V +E++ +H+D+AARN L+S D K+S GL+K+ + LP+
Sbjct: 108 SLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPV 163
Query: 123 RWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSS 182
+W EA+ + +FSTKSDV+++ L+WEI++ G +P+P + V+ ++E K
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPD 222
Query: 183 KTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
P + + ++C H RP+F + QL
Sbjct: 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-24
Identities = 52/162 (32%), Positives = 84/162 (51%), Gaps = 1/162 (0%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
L+ ++ + MA Q+A G+ I K IH+D+ A N L+S L KI+ GL++ EY
Sbjct: 99 LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173
A P++W EA+ F+ KSDV+++ L+ EI G +P+P +++ +V+ LE
Sbjct: 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE- 217
Query: 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ PE + L C P +RPTF + + L D
Sbjct: 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 1e-23
Identities = 51/159 (32%), Positives = 87/159 (54%), Gaps = 1/159 (0%)
Query: 53 SLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEY 112
+L T ++ +YQVA G+ ++ K IH+D+AARN L++ KI GL++D
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269
Query: 113 YKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
Y + NA LP++W+ E++F+ ++ +SDV++Y L+WEIF+ G P+P + D ++
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329
Query: 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210
+ P + + + C P +RPTF IV
Sbjct: 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-23
Identities = 43/162 (26%), Positives = 85/162 (52%), Gaps = 1/162 (0%)
Query: 53 SLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEY 112
S + M V G+ ++ +IH+D+AARNCL+ + VK+S G+++ +Y
Sbjct: 96 KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155
Query: 113 YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172
P++W E ++S+KSDV+++ L+WE+F++G+ P+ + S+ +V+ +
Sbjct: 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN 215
Query: 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
+ +K + + L + C P RP+F ++ QL+
Sbjct: 216 AGFRLYK-PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-23
Identities = 51/164 (31%), Positives = 85/164 (51%), Gaps = 5/164 (3%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
L Q V MA Q+A G+ ++ +H+D+ A N L+ +L K++ GL++ EY
Sbjct: 99 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173
+ A P++W EA F+ KSDV+++ L+ E+ KG +P+P + + +VL Q+E
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
Query: 174 --KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ C + PE + L +C P +RPTF + L D
Sbjct: 219 GYRMPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-23
Identities = 50/163 (30%), Positives = 88/163 (53%), Gaps = 6/163 (3%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
L + + M A G+E++ K IH+D+AARNCL++ +KIS G+S++ Y
Sbjct: 91 LKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA 150
Query: 114 KYRN-AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172
+P++W EA+ +S++SDV+++ L+WE F+ G +P+ +LS+ Q +E
Sbjct: 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE 210
Query: 173 S--KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
+ C P+ + L E+C P QRP+F ++ +L
Sbjct: 211 QGVRLPC---PELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-23
Identities = 59/189 (31%), Positives = 101/189 (53%), Gaps = 4/189 (2%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRS-LSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L FL +R D + + S LS+ Q + A VA G++++S K+ IH+D+AA
Sbjct: 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 152
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L+ + KI+ GLS+ Q+ Y K LP+RW+ E++ ++T SDV++Y
Sbjct: 153 RNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 210
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L+WEI + G P+ ++ ++ +L K + E + L +C P++RP+
Sbjct: 211 VLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE-VYDLMRQCWREKPYERPS 269
Query: 206 FPSIVTQLS 214
F I+ L+
Sbjct: 270 FAQILVSLN 278
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-23
Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK-DTYQKEY 112
++ + + + Q+ G++++ +R IH+D+AARN L+ S+ VKIS GL+K K+Y
Sbjct: 106 INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY 165
Query: 113 YKYRN-AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGE-----------MPFP 160
Y + P+ W E + +FS+ SDV+++ ++E+F G+ M
Sbjct: 166 YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI 225
Query: 161 DLSDDQVLSQLE----SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
V LE ++L P+ + L + C P RP+F ++ +
Sbjct: 226 AQGQMIVTRLLELLKEGERL--PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-23
Identities = 55/166 (33%), Positives = 93/166 (56%), Gaps = 3/166 (1%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
LS V +YQVA G+E ++ K +H+D+AARN LI VKI GL++D + Y
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY 295
Query: 114 KYRNA-ILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS-DDQVLSQL 171
+ + LPL+W+ E++F++ ++T SDV+++ L+WEIF G P+P+L ++Q + +
Sbjct: 296 ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355
Query: 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217
+ K + + E I + +KC RP F +V + D +
Sbjct: 356 KRGYRMAKPAHASDE-IYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-23
Identities = 52/163 (31%), Positives = 89/163 (54%), Gaps = 11/163 (6%)
Query: 58 QAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK----DTYQKEYY 113
Q V M +A G++++S+ +H+D+AARN L++S+L K+S GLS+ DT Y
Sbjct: 107 QLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 166
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173
+P+RW EA+ +F++ SDV++Y ++WE+ + GE P+ D+S+ V++ +E
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ 226
Query: 174 KKLCWKHSSKTPEYITSLHE---KCIHPHPHQRPTFPSIVTQL 213
+ T+LH+ C + RP F IV+ L
Sbjct: 227 D----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-23
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 19/190 (10%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
G L ++L +D G S+ Q V M +A G++++SD +H+D+AAR
Sbjct: 91 GALDKYL-------RDHDGE-------FSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAAR 136
Query: 87 NCLISSDLSVKISLSGLSK--DTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
N L++S+L K+S GLS+ + + Y +P+RW EA+ +F++ SDV+++
Sbjct: 137 NILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSF 196
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQL-ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
++WE+ + GE P+ D+S+ +V+ + + +L P + L +C +R
Sbjct: 197 GIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL--PAPMDCPSAVYQLMLQCWQQDRARR 254
Query: 204 PTFPSIVTQL 213
P F IV L
Sbjct: 255 PRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-21
Identities = 47/158 (29%), Positives = 82/158 (51%), Gaps = 1/158 (0%)
Query: 58 QAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRN 117
+ + + Q+A G+ +I K IH+D+ A N L+S L KI+ GL++ EY
Sbjct: 104 KLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163
Query: 118 AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177
A P++W EA+ F+ KSDV+++ L++EI G++P+P +S+ V+S L +
Sbjct: 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYR 222
Query: 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
P+ + + + C +RPTF + + L D
Sbjct: 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-21
Identities = 51/159 (32%), Positives = 89/159 (55%), Gaps = 5/159 (3%)
Query: 58 QAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK--DTYQKEYYKY 115
Q V M +A G++++SD +H+D+AARN L++S+L K+S GLS+ + + Y
Sbjct: 107 QLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166
Query: 116 RNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL-ESK 174
R +P+RW EA+ +F++ SDV++Y ++WE+ + GE P+ ++S+ V+ + E
Sbjct: 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226
Query: 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
+L P + L C ++RP F IV+ L
Sbjct: 227 RL--PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-21
Identities = 51/161 (31%), Positives = 89/161 (55%), Gaps = 7/161 (4%)
Query: 53 SLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE- 111
++ S V + +QV++G++++ K +H+D+AARN L+ + KIS GLSK +
Sbjct: 91 EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150
Query: 112 YYKYRNA-ILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170
YYK R+A PL+W E + +FS++SDV++Y +WE F+ G+ P+ + +V+S
Sbjct: 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF 210
Query: 171 LESKKL--CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
+E K C ++ P + +L + C RP F +
Sbjct: 211 IEQGKRLDC---PAECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-21
Identities = 49/156 (31%), Positives = 82/156 (52%), Gaps = 1/156 (0%)
Query: 60 VTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAI 119
+ + Q+A G+ I + IH+D+ A N L+S+ L KI+ GL++ EY A
Sbjct: 105 IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 164
Query: 120 LPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWK 179
P++W EA+ F+ KSDV+++ L+ EI G +P+P +S+ +V+ LE +
Sbjct: 165 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMP 223
Query: 180 HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
PE + ++ +C P +RPTF I + L D
Sbjct: 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-19
Identities = 47/164 (28%), Positives = 88/164 (53%), Gaps = 3/164 (1%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
+ ++ + +QV++G++++ + +H+D+AARN L+ + KIS GLSK E
Sbjct: 90 KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
Query: 112 -YYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169
YYK + + P++W E + +FS+KSDV+++ L+WE F+ G+ P+ + ++V
Sbjct: 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ 209
Query: 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
+ES + PE + L + C +RP F + +L
Sbjct: 210 MIESGERMECPQRCPPE-MYDLMKLCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-19
Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 8/165 (4%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
LS +A +A Q+ GLE++ +IH+D+ N L+ + VKI+ GL+K K
Sbjct: 93 GPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLL-KS 151
Query: 112 YYKYRNAILPLRWLPYEAV-FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170
+ ++ E + + + K DV++ +++E+ G+ PF + L
Sbjct: 152 SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLT-GKPPFSGENILDQLQL 210
Query: 171 LESKKLC-----WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210
+ S E L +KC++ P +RPT I+
Sbjct: 211 IRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-18
Identities = 43/152 (28%), Positives = 80/152 (52%), Gaps = 4/152 (2%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK--DTYQKEYYKYRNAILPL 122
Q+A G+ ++ + RL+H+D+AARN L+ S VKI+ GL++ D + EY+ +P+
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA-DGGKVPI 175
Query: 123 RWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSS 182
+W+ E++ F+ +SDV++Y +WE+ G P+ + ++ LE + +
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPI 235
Query: 183 KTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
T + + + KC RP F +V + S
Sbjct: 236 CTID-VYMIMVKCWMIDSECRPRFRELVDEFS 266
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-18
Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDLK +L + + + MA ++A G+ H+ +H D+A R
Sbjct: 80 GDLKSYL----SQEQWHRRNSQ-------LLLLQRMACEIAAGVTHMHKHNFLHSDLALR 128
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRN-AILPLRWLPYEAV--FDD-----EFSTK 138
NC ++SDL+VK+ G+ Y+++Y + + +PLRWL E V F E +
Sbjct: 129 NCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP 188
Query: 139 SDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
S+V+A +WE+F P+ LSD +VL+ +
Sbjct: 189 SNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 9e-17
Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 16/180 (8%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ-KEY 112
L + + A Q+ G+E++ KR +H+D+A RN L+ S+ VKI GL+K Q KEY
Sbjct: 105 LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164
Query: 113 YKYRN-AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGE-----------MPFP 160
YK R P+ W E++ + +FS SDV+++ +++E+F + M
Sbjct: 165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN 224
Query: 161 DLSDDQVLSQL-ESKKLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217
D ++ L E K + P I ++ ++C + P QRP+F + Q+
Sbjct: 225 DKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-16
Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 3/162 (1%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS-LSGLSKDTYQKEY 112
L Q + M +A G++++S+ +HK +AA L++SDL KIS L +D + Y
Sbjct: 104 LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163
Query: 113 YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172
L W EA+ FS+ SDV+++ ++WE+ + GE P+ D+S V+ +E
Sbjct: 164 TTMSGKSPVL-WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE 222
Query: 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
P + L C +RP F I + LS
Sbjct: 223 D-GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 1e-16
Identities = 32/160 (20%), Positives = 62/160 (38%), Gaps = 5/160 (3%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
LS +A Q+ LE++ K ++H+D+ N L+ D VK++ GL++ E
Sbjct: 92 GRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE 151
Query: 112 YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
K + ++ E + + D+++ +++E+ G+ PFP L +
Sbjct: 152 --KLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLT-GKPPFPGDDQLLELFKK 208
Query: 172 --ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
+ K L K + P +R T
Sbjct: 209 IGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-16
Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK--DTYQKEYYKYRNAILPL 122
Q+A G+ ++ ++RL+H+D+AARN L+ + VKI+ GL+K +KEY+ +P+
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA-EGGKVPI 175
Query: 123 RWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-KKLCWKHS 181
+W+ E++ ++ +SDV++Y +WE+ G P+ + ++ S LE ++L
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 235
Query: 182 SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
Y+ + KC RP F ++ + S
Sbjct: 236 CTIDVYMIMV--KCWMIDADSRPKFRELIIEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 9e-16
Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 16/182 (8%)
Query: 53 SLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ-KE 111
L+ +Q + A Q+ G+ ++ + IH+D+AARN L+ +D VKI GL+K + E
Sbjct: 103 KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162
Query: 112 YYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKG-----------EM-- 157
YY+ R + P+ W E + +++FS SDV+++ ++E+ EM
Sbjct: 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG 222
Query: 158 PFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217
P L +L + + P+ + L + C RPTF S++ L + M
Sbjct: 223 PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE-M 281
Query: 218 CN 219
+
Sbjct: 282 HH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-15
Identities = 44/153 (28%), Positives = 80/153 (52%), Gaps = 6/153 (3%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK--DTYQKEYYKYRNAILPL 122
Q+A G+ ++ ++RL+H+D+AARN L+ S VKI+ GL++ + +KE Y +P+
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE-YNADGGKMPI 175
Query: 123 RWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-KKLCWKHS 181
+W+ E + +F+ +SDV++Y IWE+ G P+ + ++ LE ++L
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPI 235
Query: 182 SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
Y+ + KC RP F + + S
Sbjct: 236 CTIDVYMVMV--KCWMIDADSRPKFKELAAEFS 266
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-15
Identities = 43/165 (26%), Positives = 86/165 (52%), Gaps = 6/165 (3%)
Query: 53 SLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY--QK 110
SL + + Q+A G+ ++ + R++H+++AARN L+ SD V+I+ G++ Y K
Sbjct: 105 SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164
Query: 111 EYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170
+Y+ Y P++W+ E++ ++ +SDV++Y +WE+ + G P+ + +V
Sbjct: 165 KYF-YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223
Query: 171 LES-KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
LE ++L Y+ + KC + RPTF + + +
Sbjct: 224 LEKGERLAQPQICTIDVYMVMV--KCWMIDENVRPTFKELANEFT 266
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 2e-13
Identities = 37/190 (19%), Positives = 68/190 (35%), Gaps = 51/190 (26%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G LK L K LS + + + Q+ GLE++ +IH+D+
Sbjct: 75 GGSLKDLL--------------KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 86 RNCLISSD-LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYA 143
N L+ SD VK++ GLSK + + + ++ E + +S KSD+++
Sbjct: 121 ENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
+++E+ + L K + P +R
Sbjct: 180 LGVILYEL----------------------------------PELKDLIRKMLQKDPEKR 205
Query: 204 PTFPSIVTQL 213
P+ I+ L
Sbjct: 206 PSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 5e-13
Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 21/154 (13%)
Query: 63 AYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAIL-P 121
Q+ GL ++ ++H+DI N L+ SD VK++ G +K E + ++
Sbjct: 107 TRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 122 LRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQVLSQLESKKLCWK- 179
W+ E + +E+ +D+++ C + E+ G+ P+ +L + L +K
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELGNPMAAL---------YKI 216
Query: 180 -HSSKTPEYITSLHE-------KCIHPHPHQRPT 205
S + PE L E KC+ P +RPT
Sbjct: 217 GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 6e-13
Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 14/170 (8%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT 107
K ++L+ SQ + ++ GLE++ +IH+DI A N L++SD VK+ GLS
Sbjct: 89 KSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA-- 146
Query: 108 YQKEYYKYRNAIL-PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166
Q K RN ++ W+ E + + K+D+++ E+ G+ P+ +L +
Sbjct: 147 -QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE-GKPPYSELPPMK 204
Query: 167 VL---SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
L + L ++ K + +KC+ +P +RPT QL
Sbjct: 205 ALFKIATNGPPGL--RNPEKWSDEFKDFLKKCLQKNPEKRPT----AEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-12
Identities = 37/173 (21%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 53 SLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD-------LSVKISLSGLSK 105
++S + +A Q+A L ++ DK+L+H ++ +N L++ +K+S G+
Sbjct: 97 NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
Query: 106 DTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKS--DVYAYACLIWEIFNKGEMPFPDLS 163
+E + + W+ E + + + S D +++ + EI + GE P LS
Sbjct: 157 TVLSREE-----RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211
Query: 164 DDQVLSQLESKKLCWKHSSKTPEY--ITSLHEKCIHPHPHQRPTFPSIVTQLS 214
S + + +H P+ + +L +C P +RP+F +I+ L+
Sbjct: 212 -----SSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-11
Identities = 44/178 (24%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI--------SSDLSVKIS 99
K ++ S + +A Q+A L + DK L H ++ A+N L+ + +K+S
Sbjct: 91 KKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150
Query: 100 LSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMP 158
G+S KE R + W+P E + + + S +D +++ +WEIF+ G+ P
Sbjct: 151 DPGISITVLPKEILLER-----IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205
Query: 159 FPDLSDDQVLSQLESKKLCWKHSSKTPEYI--TSLHEKCIHPHPHQRPTFPSIVTQLS 214
L + L E +H P++ +L +C+ P RP+F +I+ L+
Sbjct: 206 LSALDSQKKLQFYED-----RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-11
Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILP--- 121
Q+ GL ++ ++ +IH+DI N L+ + +KIS G+SK N P
Sbjct: 114 QILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 122 --LRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWK 179
+ W+ E V ++ K+D+++ CL+ E+ G+ PFPD + Q + ++
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAIFKIGENA---- 228
Query: 180 HSSKTPEYITS----LHEKCIHPHPHQRPT 205
S + P I+S EK ++RPT
Sbjct: 229 -SPEIPSNISSEAIDFLEKTFEIDHNKRPT 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-11
Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 24/197 (12%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL + + +K R + Q+ LEH+ KR++H+DI
Sbjct: 87 GDLSRMIKHFKKQK-----------RLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPA 135
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
N I++ VK+ GL + K + P P E + ++ ++ KSD+++ C
Sbjct: 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP-ERIHENGYNFKSDIWSLGC 194
Query: 147 LIWEI------FNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHP 200
L++E+ F +M L + + + + L H S E + L +CI+P P
Sbjct: 195 LLYEMAALQSPFYGDKMNLYSLC--KKIEKCDYPPLPADHYS---EELRDLVSRCINPDP 249
Query: 201 HQRPTFPSIVTQLSDAM 217
+RP S V Q++ M
Sbjct: 250 EKRPDI-SYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 1e-10
Identities = 40/206 (19%), Positives = 74/206 (35%), Gaps = 37/206 (17%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
G+L Q++ + SL A ++ L LE++ K +IH+D+
Sbjct: 87 GELLQYIR---------------KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPE 131
Query: 87 NCLISSDLSVKISLSGLSK--DTYQKEYYKYRNAILPLRWLPY----------------- 127
N L+ D+ +KI+ G +K D +A +
Sbjct: 132 NILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP 191
Query: 128 EAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEY 187
E + + SD++A C+I+++ G+ PF ++ ++ KL + P
Sbjct: 192 ELLNEKPAGKSSDLWALGCIIYQMLT-GKPPFRGSNEYLTFQKI--LKLEYSFPPNFPPD 248
Query: 188 ITSLHEKCIHPHPHQRPTFPSIVTQL 213
L EK + P R +L
Sbjct: 249 AKDLIEKLLVLDPQDRLGVNEGYDEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 31/192 (16%)
Query: 44 SGSGK---PR-VRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS 99
SGS K PR ++ Q + A Q+ G++++ ++ +H+D+AARN L+ S+ VKI
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 151
Query: 100 LSGLSKDTY-QKEYYKYRNAI-LPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIF----- 152
GL+K KEYY ++ + P+ W E + +F SDV+++ ++E+
Sbjct: 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS 211
Query: 153 --------------NKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHP 198
G+M L +VL E K+L PE + L KC
Sbjct: 212 ESSPMTLFLKMIGPTHGQMTVTRLV--RVLE--EGKRL--PRPPNCPEEVYQLMRKCWEF 265
Query: 199 HPHQRPTFPSIV 210
P +R TF +++
Sbjct: 266 QPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 40/172 (23%), Positives = 76/172 (44%), Gaps = 10/172 (5%)
Query: 52 RSLSTSQAVTMAYQVALGLE--HISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
+ LS + MA GL + + +K++ + + L++ + +KI GL K
Sbjct: 117 KDLSFKTKLDMAIDCCKGLYNLYKYTNK-PYKNLTSVSFLVTENYKLKIICHGLEK-ILS 174
Query: 110 KEYYKYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
+K N ++ + Y+ + D E++ K D+Y+ ++WEIF G++PF +L+ ++
Sbjct: 175 SPPFKNVNFMV---YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT-GKIPFENLTTKEI 230
Query: 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219
+ +K K P I + E C +RP I+ LS
Sbjct: 231 YDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKFY 282
|
Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-09
Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRW 124
Q+ +EH+ +R++H+DI N I++ VK+ GL + K + P
Sbjct: 114 QLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 125 LPYEAVFDDEFSTKSDVYAYACLIWEI------FNKGEMPFPDLSDDQVLSQLESKKLCW 178
P E + ++ ++ KSD+++ CL++E+ F +M L Q + Q + L
Sbjct: 174 SP-ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC--QKIEQCDYPPLPT 230
Query: 179 KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217
+H S+ + S+ CI+P P QRP V Q++ M
Sbjct: 231 EHYSEKLRELVSM---CIYPDPDQRPDI-GYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 52.8 bits (125), Expect = 3e-08
Identities = 38/177 (21%), Positives = 66/177 (37%), Gaps = 21/177 (11%)
Query: 49 PRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS-VKISLSGLSK-- 105
R LS S+A+ + Q+ LE++ K +IH+DI N L+ D VK+ GL+K
Sbjct: 93 GRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152
Query: 106 ---DTYQKEYYKYRNAILPLRWLPYEAVFDDEF---STKSDVYAYACLIWEIFNKGEMPF 159
+ ++ ++ E + S+ SD+++ ++E+ G PF
Sbjct: 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT-GLPPF 211
Query: 160 PDLSDDQVLSQLESKKLCWKHSSKTPEYITS-----------LHEKCIHPHPHQRPT 205
+ SQ L S S L +K + P R +
Sbjct: 212 EGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
|
Length = 384 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-08
Identities = 38/166 (22%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD-------LSVKISLSGLSKD 106
L+T +A Q+A L ++ DK L+H ++ +N L++ + +K+S G+
Sbjct: 102 LTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPIT 161
Query: 107 TYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDD 165
++ + + W+ E V D + S +D +++ +WEI GE+P D
Sbjct: 162 VLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL----KD 212
Query: 166 QVLSQLES-KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210
+ L++ E + + + + + L C++ P+QRP F +I+
Sbjct: 213 KTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 30/100 (30%), Positives = 53/100 (53%), Gaps = 4/100 (4%)
Query: 64 YQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAIL-PL 122
YQV GL ++ ++ +IH+DI A N L + D VK++ G++ T + K +++
Sbjct: 106 YQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTP 163
Query: 123 RWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL 162
W+ E + ST SD+++ C + E+ G P+ DL
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDL 202
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-07
Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 13/134 (9%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRW 124
Q+ GL + K +H+DI N L+++ +K++ GL++ +E Y N ++ L +
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183
Query: 125 LPYEAVFDDEFSTKS-DVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-KKLC----- 177
P E + +E + DV++ C++ E+F K P +Q L+QLE +LC
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFTKK----PIFQANQELAQLELISRLCGSPCP 239
Query: 178 --WKHSSKTPEYIT 189
W K P + T
Sbjct: 240 AVWPDVIKLPYFNT 253
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-07
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
L + T+ ++ GL+++ +R IH+DI A N L+S VK++ G++ +
Sbjct: 98 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173
+ P W+ E + + K+D+++ E+ KGE P DL +VL +
Sbjct: 158 RNTFVGTPF-WMAPEVIKQSAYDFKADIWSLGITAIEL-AKGEPPNSDLHPMRVLFLIPK 215
Query: 174 KK---LCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L ++S E++ E C++ P RPT
Sbjct: 216 NSPPTLEGQYSKPFKEFV----EACLNKDPRFRPT 246
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-07
Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 12/146 (8%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRW 124
Q+ LEH+ +R++H+DI N I++ VK+ GL + K + P
Sbjct: 114 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 125 LPYEAVFDDEFSTKSDVYAYACLIWEI------FNKGEMPFPDLSDDQVLSQLESKKLCW 178
P E + ++ ++ KSD+++ CL++E+ F +M L + + Q + L
Sbjct: 174 SP-ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC--KKIEQCDYPPLPS 230
Query: 179 KHSSKTPEYITSLHEKCIHPHPHQRP 204
H S E + L CI+P P +RP
Sbjct: 231 DHYS---EELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-07
Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL + L R R L Q Q+ LGL H+ K+++H+DI +
Sbjct: 83 NGDLHKLLKMQRG-------------RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKS 129
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
N + + +VKI G++K + P +L E D ++ KSDV+A
Sbjct: 130 LNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY-YLSPELCEDKPYNEKSDVWALG 188
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKH-SSKTPEYITSLHEKCIHPHPHQRP 204
+++E G+ PF +++Q L+ + + S + + L ++C+ QRP
Sbjct: 189 VVLYECCT-GKHPFD--ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 9e-07
Identities = 29/130 (22%), Positives = 57/130 (43%), Gaps = 23/130 (17%)
Query: 28 DLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARN 87
DL +L K G ++ L Q+ G++ + R++H+D+ +N
Sbjct: 91 DLATYL-----SKCPKPGLPPETIKDLM--------RQLLRGVDFLHSHRIVHRDLKPQN 137
Query: 88 CLISSDLSVKISLSGLSKDTYQKEYYKYRNAILP----LRWLPYEAVFDDEFSTKSDVYA 143
L++SD VKI+ GL++ Y + A+ L + E + ++T D+++
Sbjct: 138 ILVTSDGQVKIADFGLAR------IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWS 191
Query: 144 YACLIWEIFN 153
C+ E+F
Sbjct: 192 VGCIFAELFR 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 12/154 (7%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY-QKEY 112
L A +V LG+E + + +IH+DI N LI +K++ GLS++ K++
Sbjct: 94 LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF 153
Query: 113 YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172
+ + P E + SD ++ C+I+E F G PF + D V +
Sbjct: 154 VGTPDYLAP------ETILGVGDDKMSDWWSLGCVIFE-FLFGYPPFHAETPDAVFDNIL 206
Query: 173 SKKLCW---KHSSKTPEYITSLHEKCIHPHPHQR 203
S+++ W +PE + L + + P +R
Sbjct: 207 SRRINWPEEVKEFCSPEAV-DLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-06
Identities = 37/162 (22%), Positives = 79/162 (48%), Gaps = 12/162 (7%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV-KISLSGLSKDTYQKEY 112
S Q ++ Q++LGL+HI D++++H+DI ++N +S + V K+ G+++
Sbjct: 98 FSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157
Query: 113 YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172
Y P +L E + ++ K+D+++ C+++E+ + PF + Q++
Sbjct: 158 LAYTCVGTPY-YLSPEICQNRPYNNKTDIWSLGCVLYELCTL-KHPFEGNNLHQLVL--- 212
Query: 173 SKKLCWKHSSK-TPEYITSLH---EKCIHPHPHQRPTFPSIV 210
K+C + + +P + L + P RP+ SI+
Sbjct: 213 --KICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-06
Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
L +Q T+ ++ GL+++ ++ IH+DI A N L+S VK++ G++ +
Sbjct: 98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173
+ P W+ E + + +K+D+++ E+ KGE P +L +VL +
Sbjct: 158 RNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPHSELHPMKVLFLIPK 215
Query: 174 KK---LCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L +S E++ E C++ P RPT
Sbjct: 216 NNPPTLEGNYSKPLKEFV----EACLNKEPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-06
Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 9/151 (5%)
Query: 58 QAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRN 117
Q TM ++ GL+++ ++ IH+DI A N L+S VK++ G++ + +
Sbjct: 102 QIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161
Query: 118 AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL---SQLESK 174
P W+ E + + +K+D+++ E+ KGE P D+ +VL +
Sbjct: 162 VGTPF-WMAPEVIQQSAYDSKADIWSLGITAIEL-AKGEPPNSDMHPMRVLFLIPKNNPP 219
Query: 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L + S E+I + C++ P RPT
Sbjct: 220 TLTGEFSKPFKEFI----DACLNKDPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-06
Identities = 34/148 (22%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 58 QAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRN 117
+AV A ++ GLE + +R++++D+ N L+ ++IS GL+ + + E + R
Sbjct: 103 RAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR- 161
Query: 118 AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES--KK 175
+ + ++ E V ++ ++ D + CLI+E+ +G+ PF + ++E K+
Sbjct: 162 -VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI-EGKSPFRQRKEKVKREEVERRVKE 219
Query: 176 LCWKHSSKTPEYITSLHEKCIHPHPHQR 203
++S K E S+ + + P R
Sbjct: 220 DQEEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-06
Identities = 41/167 (24%), Positives = 81/167 (48%), Gaps = 24/167 (14%)
Query: 60 VTMAYQVALGLEHISDKRLIHKDIAARNCLIS-------SDLSVKISLSGLSKDTYQKEY 112
+T+A Q+A L ++ DK L+H ++ A+N L++ + +K+S G+S +E
Sbjct: 120 ITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 113 YKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
R + W+ E V + ST +D +++ + EI GE+P + + +
Sbjct: 180 RVER-----IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE----- 229
Query: 172 ESKKLCWKHSSKTPE----YITSLHEKCIHPHPHQRPTFPSIVTQLS 214
K+ ++ + PE + +L +C+ P QRP+F +I+ L+
Sbjct: 230 --KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (111), Expect = 3e-06
Identities = 41/193 (21%), Positives = 80/193 (41%), Gaps = 42/193 (21%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL Q + +K+ K Q + Q+ L L+++ ++++H+DI +
Sbjct: 84 GDLSQKIKKQKKEGK-----------PFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQ 132
Query: 87 NCLISSDLSVKISLSGLSK---DTYQKE-------YYKYRNAILPLRWLPYEAVFDDEFS 136
N ++S+ VK+ G+SK T YY L E + ++
Sbjct: 133 NIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY-----------LSPELCQNKPYN 181
Query: 137 TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPE-YITSLHE-- 193
KSD+++ C+++E+ + PF + + L +L + K+ P Y + L
Sbjct: 182 YKSDIWSLGCVLYELCT-LKHPF----EGENLLEL-ALKILKGQYPPIPSQYSSELRNLV 235
Query: 194 -KCIHPHPHQRPT 205
+ P +RP+
Sbjct: 236 SSLLQKDPEERPS 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-06
Identities = 26/102 (25%), Positives = 55/102 (53%), Gaps = 3/102 (2%)
Query: 58 QAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRN 117
+AV A ++ GLE + +R++++D+ N L+ ++IS GL+ + + K R
Sbjct: 103 RAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR- 161
Query: 118 AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159
+ + ++ E V ++ ++ D +A CL++E+ G+ PF
Sbjct: 162 -VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI-AGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 8e-06
Identities = 31/110 (28%), Positives = 58/110 (52%), Gaps = 5/110 (4%)
Query: 64 YQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLR 123
+Q+ GL +I + ++H+D+ +N LIS +K++ GL++ + Y N ++ L
Sbjct: 110 FQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLW 168
Query: 124 WLPYEAVF-DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172
+ P + + E+ST D++ C+ E+ +G FP + D Q QLE
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMI-QGVAAFPGMKDIQ--DQLE 215
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-06
Identities = 36/139 (25%), Positives = 66/139 (47%), Gaps = 25/139 (17%)
Query: 64 YQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK------DTYQKEYYKYRN 117
+Q+ GL +I + ++H+D+ +N LIS +K++ GL++ TY E
Sbjct: 110 FQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE------ 163
Query: 118 AILPLRWLPYEAVF-DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES--- 173
++ L + P + + ++S+ D++ C+ E+ +G+ FP +SD V QLE
Sbjct: 164 -VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML-QGQPAFPGVSD--VFEQLEKIWT 219
Query: 174 -----KKLCWKHSSKTPEY 187
+ W SK P Y
Sbjct: 220 VLGVPTEDTWPGVSKLPNY 238
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-06
Identities = 25/99 (25%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRW 124
Q+ L L+H+ D++++H+DI ++N ++ D ++K+ G+++ R I +
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYY 167
Query: 125 LPYEAVFDDEFSTKSDVYAYACLIWEI------FNKGEM 157
L E + ++ KSD++A C+++E+ F G M
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 18/45 (40%), Positives = 30/45 (66%), Gaps = 1/45 (2%)
Query: 62 MAYQVALGLEHI-SDKRLIHKDIAARNCLISSDLSVKISLSGLSK 105
+A Q+ GL+++ + + +IH+DI N LI+S VKI+ G+SK
Sbjct: 104 IARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISK 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-05
Identities = 38/165 (23%), Positives = 70/165 (42%), Gaps = 10/165 (6%)
Query: 53 SLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEY 112
SL A ++ L LE++ +IH+D+ N LI S+ +K++ GLSK +
Sbjct: 89 SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148
Query: 113 YKYRNAILPLR-------WLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD 165
+ + ++ E + S D ++ C+++E F G PF + +
Sbjct: 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYE-FLVGIPPFHGETPE 207
Query: 166 QVLSQLESKKLCWKHS-SKTPEYITSLHEKCIHPHPHQRPTFPSI 209
++ + + K+ W + E I L K + P P +R SI
Sbjct: 208 EIFQNILNGKIEWPEDVEVSDEAI-DLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-05
Identities = 40/188 (21%), Positives = 75/188 (39%), Gaps = 25/188 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHI-----SDKRLIH 80
GDL Q + +K+ K + + Q+ L L ++H
Sbjct: 85 GGDLAQLIQKCKKERK-----------YIEEEFIWRILTQLLLALYECHNRSDPGNTVLH 133
Query: 81 KDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSD 140
+D+ N + ++ +VK+ GL+K + P P E + + KSD
Sbjct: 134 RDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP-EQLNHMSYDEKSD 192
Query: 141 VYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL-CWKH--SSKTPEYITSLHEKCIH 197
+++ CLI+E+ PF + Q+ S+++ K + SS+ E I S ++
Sbjct: 193 IWSLGCLIYELC-ALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKS----MLN 247
Query: 198 PHPHQRPT 205
P +RP+
Sbjct: 248 VDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-05
Identities = 29/110 (26%), Positives = 53/110 (48%), Gaps = 3/110 (2%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
++A+ A Q+ GLEH+ +R++++D+ N L+ +V+IS GL+ + +
Sbjct: 90 PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK 149
Query: 112 YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPD 161
K R A P P E + + + D +A C ++E+ G PF
Sbjct: 150 KIKGR-AGTPGYMAP-EVLQGEVYDFSVDWFALGCTLYEMI-AGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-05
Identities = 35/165 (21%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
L +Q V Q+A+ L+++ +K ++H+D+ +N ++ +K+ G+++ + +
Sbjct: 99 LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCD 157
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEI------FNKGEMPFPDLSDDQV 167
I ++ E + ++ KSDV+A C ++E+ FN +M + +
Sbjct: 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSL 210
Query: 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212
+ ++ KL +PE + L + P +RP+ SI+ Q
Sbjct: 211 VYRIIEGKLPPMPKDYSPE-LGELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 23/87 (26%), Positives = 50/87 (57%), Gaps = 1/87 (1%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRW 124
Q+ LG++HI +KR++H+DI ++N ++ + VK+ G ++ Y P +
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY-Y 166
Query: 125 LPYEAVFDDEFSTKSDVYAYACLIWEI 151
+P E + ++ KSD+++ C+++E+
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 28/125 (22%), Positives = 60/125 (48%), Gaps = 5/125 (4%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT 107
+ R L +Q + + G+ ++ ++H+D+ N LIS+D +KI+ GL++
Sbjct: 90 RDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLF 149
Query: 108 YQKEYYKYRNAILPLRWLPYEAVF-DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166
++E Y + + + E ++ ++ D++A C+ E+ N + FP +D
Sbjct: 150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPL-FPGEND-- 206
Query: 167 VLSQL 171
+ QL
Sbjct: 207 -IEQL 210
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 3e-05
Identities = 30/120 (25%), Positives = 62/120 (51%), Gaps = 5/120 (4%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
+ SQ Q+ GL+++ ++H+DI N LI++D +K++ GL++ ++
Sbjct: 97 FTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156
Query: 114 KYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172
Y N ++ L + P E + + + D+++ C++ E+F G+ F ++ L QLE
Sbjct: 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GKPIFQGSTE---LEQLE 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-05
Identities = 34/131 (25%), Positives = 62/131 (47%), Gaps = 14/131 (10%)
Query: 49 PRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY 108
VR + QV GL ++ K ++H+D+ A N L+ +D KIS G+SK +
Sbjct: 108 QLVRFFTE--------QVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS- 158
Query: 109 QKEYYKYRNAIL--PLRWLPYEAVFDDE--FSTKSDVYAYACLIWEIFNKGEMPFPDLSD 164
Y +N + + W+ E + +S K D+++ C++ E+F G P+ D
Sbjct: 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF-AGRRPWSDEEA 217
Query: 165 DQVLSQLESKK 175
+ +L +K+
Sbjct: 218 IAAMFKLGNKR 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-05
Identities = 38/180 (21%), Positives = 80/180 (44%), Gaps = 15/180 (8%)
Query: 40 SKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLSVKI 98
S DK +G + + Y V GL+ + ++ +IH+D+ N L++ + VK+
Sbjct: 85 SLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKL 144
Query: 99 SLSGLSKD---TYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKG 155
G+S + + K ++ + P R + ++ +SDV++ I E+ G
Sbjct: 145 CDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM-ALG 203
Query: 156 EMPFPDLSDDQVLSQLES------KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
P+P + + +QL + L +S +++ KC++ P++RPT+ +
Sbjct: 204 RYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVA----KCLNKIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-05
Identities = 31/168 (18%), Positives = 64/168 (38%), Gaps = 19/168 (11%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
+ +Q+ + +I ++H+DI N ++ +K+ G+SK EY
Sbjct: 98 FEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYS 156
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173
+ ++ E +++ KSD++A C+++E+ L+ +
Sbjct: 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYEL----------LTLKRTFDATNP 206
Query: 174 KKLCWK--HSSKTPE---YITSLHE---KCIHPHPHQRPTFPSIVTQL 213
L K + TP Y + L + P +RPT ++ Q
Sbjct: 207 LNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 4e-05
Identities = 28/109 (25%), Positives = 49/109 (44%), Gaps = 15/109 (13%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
+ S S ++ YQ+ GL HI H+D+ N L+S VKI+ GL+++ +
Sbjct: 94 KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153
Query: 112 YYK-------YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFN 153
Y YR + LR +S+ D++A C++ E++
Sbjct: 154 PYTDYVSTRWYRAPEILLR--------STSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-05
Identities = 35/153 (22%), Positives = 72/153 (47%), Gaps = 3/153 (1%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
L+ Q T+ V L ++ + +IH+DI + + L++ D VK+S G K+
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVP 172
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL-E 172
K ++ + W+ E + + T+ D+++ ++ E+ + GE P+ S Q + +L +
Sbjct: 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRD 231
Query: 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
S K++ K + E+ + P +R T
Sbjct: 232 SPPPKLKNAHKISPVLRDFLERMLTREPQERAT 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 27/113 (23%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
++L+ + + YQ GLE++ + IH+DI A N L++ + K++ G+S +
Sbjct: 94 KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTD 151
Query: 112 YYKYRNAIL--PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL 162
RN ++ P W+ E + + ++ K+D+++ E+ +G+ P+ D+
Sbjct: 152 TMAKRNTVIGTPF-WMAPEVIQEIGYNNKADIWSLGITAIEMA-EGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 27/115 (23%), Positives = 56/115 (48%), Gaps = 14/115 (12%)
Query: 64 YQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK--DTYQKEYYKYRNAILP 121
YQ+ GL++I +IH+D+ N L++ D ++I G+++ + E+ + +
Sbjct: 114 YQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 122 LRWLPYEA-----VFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
RW Y A E++T D+++ C+ E+ + ++ FP + + QL
Sbjct: 174 TRW--YRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQL-FPGKN---YVHQL 221
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 7e-05
Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 53 SLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSG----LSKDTY 108
++ Q + +V GLE++ + +IH+DI + N L+S D SVK++ G L+K+
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171
Query: 109 QKEYYKYRNAIL--PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166
+ RN+++ P W+ E + ++ K D+++ + E+ +GE P+ +
Sbjct: 172 K------RNSVVGTPY-WMAPEVIKRKDYGPKVDIWSLGIMCIEMA-EGEPPYLREPPLR 223
Query: 167 VLSQLESK---KLCWKHSSK-TPEYITSLHEKCIHPHPHQRPT 205
L + +K L K+ K +PE+ L KC+ P +RP+
Sbjct: 224 ALFLITTKGIPPL--KNPEKWSPEFKDFL-NKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-05
Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 12/109 (11%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT 107
K R R L + + YQ+ L+H+ + H+DI N LI D+ +K++ G +
Sbjct: 91 KGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGI 149
Query: 108 YQKE-YYKYRNAILPLRWLPYEA----VFDDEFSTKSDVYAYACLIWEI 151
Y K Y +Y + RW Y A + D + K D++A C+ +EI
Sbjct: 150 YSKPPYTEY----ISTRW--YRAPECLLTDGYYGPKMDIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-05
Identities = 23/102 (22%), Positives = 52/102 (50%), Gaps = 3/102 (2%)
Query: 58 QAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRN 117
+A+ A ++ GLE + + +++D+ N L+ ++IS GL+ + E + R
Sbjct: 103 RALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR- 161
Query: 118 AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159
+ + ++ E + + ++ D + CLI+E+ +G+ PF
Sbjct: 162 -VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMI-EGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 22/97 (22%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 62 MAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNA--- 118
M +Q+ GL+ + R++H+D+ +N L++S +K++ GL++ Y ++ A
Sbjct: 115 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR------IYSFQMALTS 168
Query: 119 -ILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNK 154
++ L + E + ++T D+++ C+ E+F +
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 1e-04
Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 61 TMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS---LSGLSKDTYQKEYYKYRN 117
+ +V LGLE++ ++ IH+DI A N L+S + VK++ +SG T K RN
Sbjct: 102 FILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-----RN 156
Query: 118 AIL--PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL---SQLE 172
+ P W+ E + + K+D+++ E+ KGE P DL +VL +
Sbjct: 157 TFVGTPF-WMAPEVIKQSGYDEKADIWSLGITAIELA-KGEPPLSDLHPMRVLFLIPKNN 214
Query: 173 SKKLCWKHSSKT-PEYITSLHEKCIHPHPHQRPT 205
L SK +++ C++ P +RP+
Sbjct: 215 PPSLEGNKFSKPFKDFV----SLCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 17/114 (14%)
Query: 69 GLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLS----------KDTYQKEYYKYRNA 118
GL ++ IH++I A + LIS D V SLSGLS K ++ ++ +
Sbjct: 113 GLNYLHQNGYIHRNIKASHILISGDGLV--SLSGLSHLYSLVRNGQKAKVVYDFPQFSTS 170
Query: 119 ILPLRWLPYEAVFDD--EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170
+LP WL E + D ++ KSD+Y+ E+ G +PF D+ Q+L Q
Sbjct: 171 VLP--WLSPELLRQDLYGYNVKSDIYSVGITACELAT-GRVPFQDMLRTQMLLQ 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 1e-04
Identities = 24/102 (23%), Positives = 55/102 (53%), Gaps = 3/102 (2%)
Query: 58 QAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRN 117
+A+ A ++ GLE + +R++++D+ N L+ ++IS GL+ + E R
Sbjct: 103 RAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TVRG 160
Query: 118 AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159
+ + ++ E + +++++ D + CLI+E+ +G+ PF
Sbjct: 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMI-QGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 26/169 (15%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS---LSGLSKDTY 108
R L+ Q + Q+ L + ++IH+D+ A N L++ D VK++ +S +K T
Sbjct: 98 RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157
Query: 109 QKEYYKYRNA-ILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEI------FNKGEMPFPD 161
QK R+ I W+ E V + F K + Y Y IW + + E P +
Sbjct: 158 QK-----RDTFIGTPYWMAPEVVACETF--KDNPYDYKADIWSLGITLIELAQMEPPHHE 210
Query: 162 LSDDQVLSQL---ESKKLCWKH--SSKTPEYITSLHEKCIHPHPHQRPT 205
L+ +VL ++ E L SS +++ C+ P RPT
Sbjct: 211 LNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK----SCLVKDPDDRPT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 28/123 (22%), Positives = 61/123 (49%), Gaps = 20/123 (16%)
Query: 38 KDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97
+D K K ++LS +Q Q+ LG+ ++ +R++H+D+ A+N + ++L +K
Sbjct: 87 RDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LK 145
Query: 98 ISLSGLSK---------DTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLI 148
I G+S+ T+ Y ++ EA+ + +KSD+++ C++
Sbjct: 146 IGDFGVSRLLMGSCDLATTFTGTPY----------YMSPEALKHQGYDSKSDIWSLGCIL 195
Query: 149 WEI 151
+E+
Sbjct: 196 YEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 42/188 (22%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL+Q + K ++ + + +A + QV L + H+ K +IH+DI +
Sbjct: 124 GDLRQ-------EIKSRAKTNRT----FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172
Query: 87 NCLISSDLSVKISLSGLSK-------DTYQKEYYKYRNAILPLRW--LPYEAVFDDEFST 137
N L+ S+ VK+ G SK D + + + P W PY S
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY--------SK 224
Query: 138 KSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIH 197
K+D+++ L++E+ + PF + ++V+ + + + S +PE + + +
Sbjct: 225 KADMFSLGVLLYELLTL-KRPFDGENMEEVMHKTLAGRYDPLPPSISPE-MQEIVTALLS 282
Query: 198 PHPHQRPT 205
P +RP+
Sbjct: 283 SDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 30/118 (25%), Positives = 56/118 (47%), Gaps = 14/118 (11%)
Query: 49 PRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY 108
P V+ L+ SQ Q+ G+ ++ + ++H+DI A N LI + +KI+ GL++
Sbjct: 108 PSVK-LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 109 QKEY----------YKYRNAILPLRWL-PYEAVFDD-EFSTKSDVYAYACLIWEIFNK 154
KY N ++ RW P E + + ++T D++ C+ E+F +
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVT-RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 3e-04
Identities = 25/106 (23%), Positives = 55/106 (51%), Gaps = 2/106 (1%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
++ Q T+ V L ++ ++ +IH+DI + + L++SD +K+S G KE
Sbjct: 115 MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV-SKEVP 173
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159
K ++ + W+ E + + T+ D+++ ++ E+ + GE P+
Sbjct: 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 30/113 (26%), Positives = 57/113 (50%), Gaps = 9/113 (7%)
Query: 66 VALGLEHISDKRLIHKDIAARNCLISSDLSVKIS-----LSGLSKDTYQKEYYKY-RNAI 119
V L++I K IH+ + A + L+S D V +S +S + Q+ + + ++++
Sbjct: 110 VLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169
Query: 120 LPLRWLPYEAVFDD--EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170
L WL E + + ++ KSD+Y+ E+ N G +PF D+ Q+L +
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN-GHVPFKDMPATQMLLE 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 4e-04
Identities = 34/148 (22%), Positives = 66/148 (44%), Gaps = 11/148 (7%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRW 124
Q+ GL+ + +++++H+D+ + N L+ ++ VKI G+SK K+ P +
Sbjct: 111 QLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQIGTPH-Y 167
Query: 125 LPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKT 184
+ E +S KSD+++ CL++E+ PF + + + L K K+
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMA-TFAPPF----EARSMQDLRYKVQRGKYPPIP 222
Query: 185 PEY---ITSLHEKCIHPHPHQRPTFPSI 209
P Y + + + P RP I
Sbjct: 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 24/107 (22%), Positives = 51/107 (47%), Gaps = 10/107 (9%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILP--- 121
Q GL+ + ++H+D+ N L++S VK++ GL++ Y + A+ P
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVV 169
Query: 122 -LRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
L + E + ++T D+++ C+ E+F + + + DQ+
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 5e-04
Identities = 25/98 (25%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 64 YQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLR 123
YQ+ GL + ++++H+D+ +N LI+ +K++ GL++ Y N ++ L
Sbjct: 111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLW 169
Query: 124 WLPYEAVF-DDEFSTKSDVYAYACLIWEIFNKGEMPFP 160
+ P + + E+ST+ D++ C+ +E+ G FP
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEM-ASGRPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 5e-04
Identities = 25/104 (24%), Positives = 49/104 (47%), Gaps = 7/104 (6%)
Query: 64 YQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLR 123
Y LGL+H+ + R+IH+D+ N L++++ VK+ G+S + + P
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF- 193
Query: 124 WLPYEAV-----FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL 162
W+ E + +D + + DV++ E+ G+ P D+
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIEL-GDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 6e-04
Identities = 25/98 (25%), Positives = 47/98 (47%), Gaps = 1/98 (1%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
+A Q+ GLEH+ +R+I++D+ N L+ +D +V+IS GL+ + +
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK 153
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEI 151
A P P E + +E+ D +A ++E+
Sbjct: 154 TKGYAGTPGFMAP-ELLQGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 14/111 (12%)
Query: 64 YQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK--DTYQKEYYKYRNAILP 121
+Q+ G+E +IH+DI N L+S VK+ G ++ + Y Y +
Sbjct: 107 FQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY----VA 162
Query: 122 LRWLPYEA----VFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQV 167
RW Y A V D ++ D++A CL+ E+ GE FP SD DQ+
Sbjct: 163 TRW--YRAPELLVGDTKYGRAVDIWAVGCLVTEMLT-GEPLFPGDSDIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.001
Identities = 34/161 (21%), Positives = 69/161 (42%), Gaps = 20/161 (12%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISS-DLSVKISLSGLSKDTYQKEYYKYRNAILPLR 123
Q+ L L H+ K ++H+D+ +N L+ + VKI G+SK K K +
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPC 166
Query: 124 WLPYEAVFDDEFSTKSDVYAYACLIWEI------FNKGEMPFPDLSDDQVLSQLESKKLC 177
++ E ++ KSD++A C+++E+ F +P ++ ++ S
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALVLKIMSGTFA 219
Query: 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218
+P+ + L ++ P +RP I ++ +C
Sbjct: 220 PISDRYSPD-LRQLILSMLNLDPSKRPQLSQI---MAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.001
Identities = 34/126 (26%), Positives = 60/126 (47%), Gaps = 14/126 (11%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK-- 105
K R R L S + YQ+ GL ++H+D+ N LI+++ +K++ GL++
Sbjct: 89 KDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF 148
Query: 106 DTYQKEYYKYRNAILPLRWLPYEA----VFDDEFSTKSDVYAYACLIWEIFNKGEMPFPD 161
+ + Y Y + RW Y A + D +ST D+++ C+ E+ + FP
Sbjct: 149 GSPVRPYTHY----VVTRW--YRAPELLLGDKGYSTPVDIWSVGCIFAELLS-RRPLFPG 201
Query: 162 LSD-DQ 166
S+ DQ
Sbjct: 202 KSEIDQ 207
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.001
Identities = 28/114 (24%), Positives = 50/114 (43%), Gaps = 14/114 (12%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK--DTYQ 109
R L YQ+ GL+++ ++H+D+ N LI+ + +KI GL++ D
Sbjct: 103 RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162
Query: 110 KEYYK---YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFP 160
Y YR + L W Y+ + D+++ C+ E+ G+ FP
Sbjct: 163 TGYVSTRYYRAPEIMLTWQKYD--------VEVDIWSAGCIFAEMLE-GKPLFP 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.001
Identities = 34/145 (23%), Positives = 62/145 (42%), Gaps = 7/145 (4%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRW 124
++ GL H+ ++IH+DI +N L++ + VK+ G+S + + I W
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTFIGTPYW 177
Query: 125 LPYEAVFDDE-----FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWK 179
+ E + DE + KSD+++ E+ +G P D+ + L +
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEM-AEGAPPLCDMHPMRALFLIPRNPAPRL 236
Query: 180 HSSKTPEYITSLHEKCIHPHPHQRP 204
S K + S E C+ + QRP
Sbjct: 237 KSKKWSKKFQSFIESCLVKNHSQRP 261
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (91), Expect = 0.001
Identities = 21/78 (26%), Positives = 39/78 (50%), Gaps = 14/78 (17%)
Query: 28 DLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARN 87
DLK++L R LS + ++ YQ+ GL + R++H+D+ +N
Sbjct: 83 DLKKYL--------------DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQN 128
Query: 88 CLISSDLSVKISLSGLSK 105
LI+ D +K++ GL++
Sbjct: 129 ILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 8/116 (6%)
Query: 55 STSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYK 114
S +AV A V LGL+++ + +++++D+ N L+ ++ VKI+ GL K+ +
Sbjct: 99 SEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM---GFG 155
Query: 115 YRNAIL---PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
R + P +L E + + ++ D + LI+E+ GE PFP +++V
Sbjct: 156 DRTSTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIYEML-VGESPFPGDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.001
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 25/162 (15%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT-- 107
+ + LS + YQ+ GL++I +IH+D+ N ++ D ++I GL++
Sbjct: 111 KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170
Query: 108 ----YQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS 163
Y + YR + L W+ Y D+++ C++ E+ KG+ FP
Sbjct: 171 EMTGYVATRW-YRAPEIMLNWMHYNQTV--------DIWSVGCIMAELL-KGKALFP--- 217
Query: 164 DDQVLSQLESKKLCWKHSSKTPEY---ITSLH-EKCIHPHPH 201
+ + QL K++ + +PE I+S H K I PH
Sbjct: 218 GNDYIDQL--KRIMEVVGTPSPEVLKKISSEHARKYIQSLPH 257
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 23/148 (15%)
Query: 28 DLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARN 87
DLKQ++ D G G LS +Q+ GL + +R++H+D+ +N
Sbjct: 88 DLKQYM--------DDCGGG------LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQN 133
Query: 88 CLISSDLSVKISLSGL--SKDTYQKEYYKYRNAILPLRWLPYEAVF-DDEFSTKSDVYAY 144
LIS +K++ GL +K K Y N ++ L + P + + E+ST D++
Sbjct: 134 LLISERGELKLADFGLARAKSVPSK---TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV 190
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLE 172
C+ +E+ G FP +D V QL
Sbjct: 191 GCIFYEMAT-GRPLFPGSTD--VEDQLH 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.001
Identities = 36/160 (22%), Positives = 73/160 (45%), Gaps = 8/160 (5%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
R L+ Q + Q+ L+++ ++IH+D+ A N L++ D +K++ G+S K
Sbjct: 105 RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV-KT 163
Query: 112 YYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166
+ + I W+ E V D + K+D+++ + E+ + E P +L+ +
Sbjct: 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM-AQIEPPHHELNPMR 222
Query: 167 VLSQL-ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
VL ++ +S+ SK + + HP RP+
Sbjct: 223 VLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS 262
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 32/134 (23%), Positives = 63/134 (47%), Gaps = 17/134 (12%)
Query: 28 DLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARN 87
DLKQ+L D G+ +S +Q+ GL + ++++H+D+ +N
Sbjct: 88 DLKQYL--------DNCGN------LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQN 133
Query: 88 CLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-DDEFSTKSDVYAYAC 146
LI+ +K++ GL++ Y N ++ L + P + + E+ST D++ C
Sbjct: 134 LLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGC 192
Query: 147 LIWEIFNKGEMPFP 160
+++E+ M FP
Sbjct: 193 ILYEMATGRPM-FP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 21/161 (13%)
Query: 17 KSGSGKPRV-------KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALG 69
+ +GKP + DLK+F+ + + G G+P L + YQ+ G
Sbjct: 73 EEKNGKPSLYLVFEYLDSDLKKFMDSNGR------GPGRP----LPAKTIKSFMYQLLKG 122
Query: 70 LEHISDKRLIHKDIAARNCLISSDLSV-KISLSGLSKDTYQKEYYKYRNAILPLRWLPYE 128
+ H ++H+D+ +N L+ + KI+ GL + + Y + I+ L + E
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIVTLWYRAPE 181
Query: 129 AVF-DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168
+ +ST D+++ C+ E+ K + FP S+ Q L
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPL-FPGDSELQQL 221
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 29/159 (18%), Positives = 66/159 (41%), Gaps = 14/159 (8%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK---- 105
R +A A ++ LGL+ + ++ +I++D+ N L+ S+ +KI+ G+ K
Sbjct: 89 RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148
Query: 106 -DTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD 164
+ + I P E + + D +A L++E+ G+ PF +
Sbjct: 149 GGVTTSTFCGTPDYIAP------EILSYQPYGPAVDWWALGVLLYEML-AGQSPFEGDDE 201
Query: 165 DQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
D++ + ++ + S+ + + +P +R
Sbjct: 202 DELFQSILEDEVRYPRWLSKEA--KSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 26/112 (23%), Positives = 52/112 (46%), Gaps = 5/112 (4%)
Query: 45 GSGKPRVRS---LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLS 101
GS K ++++ L+ + Q+ G+E++ ++H+DI N L S +VK+
Sbjct: 89 GSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDF 148
Query: 102 GLSK--DTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEI 151
G SK T ++ W+ E + + + K+DV++ C + E+
Sbjct: 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEM 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 39/150 (26%), Positives = 62/150 (41%), Gaps = 19/150 (12%)
Query: 69 GLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ--KEYYKYRNAIL--PLRW 124
GLE++ IH+DI A N L+ D SVKI+ G+S K R + P W
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC-W 172
Query: 125 LPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL--------SQLESKK 175
+ E + + K+D++++ E+ G P+ +VL LE+
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELAT-GAAPYSKYPPMKVLMLTLQNDPPSLETGA 231
Query: 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
K+S + I C+ P +RPT
Sbjct: 232 DYKKYSKSFRKMI----SLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 33/153 (21%), Positives = 72/153 (47%), Gaps = 3/153 (1%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
++ Q T+ V L + + +IH+DI + + L++SD VK+S G KE
Sbjct: 112 MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV-SKEVP 170
Query: 114 KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL-E 172
+ ++ + W+ E + + T+ D+++ ++ E+ + GE P+ + Q + ++ +
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD-GEPPYFNEPPLQAMKRIRD 229
Query: 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
+ K+ K + S ++ + P QR T
Sbjct: 230 NLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 27/116 (23%), Positives = 51/116 (43%), Gaps = 14/116 (12%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
+ + L+ + YQ+ GL++I +IH+D+ N ++ D +KI GL++ T
Sbjct: 113 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172
Query: 110 K-----EYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFP 160
+ YR + L W+ Y D+++ C++ E+ G FP
Sbjct: 173 EMTGYVATRWYRAPEIMLNWMHYNQTV--------DIWSVGCIMAELLT-GRTLFP 219
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.003
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 70 LEHISDKRLIHKDIAARNCLISSDLSVKIS-----LSGLSKDTYQK---EYYKYRNAILP 121
L++I +H+ + A + LIS D V +S LS ++ + ++ KY +LP
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP 173
Query: 122 LRWLPYEAVFDD--EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168
WL E + + + KSD+Y+ E+ N G +PF D+ Q+L
Sbjct: 174 --WLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 27/132 (20%), Positives = 62/132 (46%), Gaps = 2/132 (1%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
+V QAV A ++++GL + + +I++D+ N ++ S+ +KI+ G+ K+ +
Sbjct: 94 QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-HM 152
Query: 110 KEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169
+ R ++ E + + D +AY L++E+ G+ PF +D++
Sbjct: 153 VDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML-AGQPPFDGEDEDELFQ 211
Query: 170 QLESKKLCWKHS 181
+ + + S
Sbjct: 212 SIMEHNVSYPKS 223
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.004
Identities = 23/98 (23%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 64 YQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLR 123
+Q+ GL + ++++H+D+ +N LI+ +K++ GL++ Y N ++ L
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLW 169
Query: 124 WLPYEAVF-DDEFSTKSDVYAYACLIWEIFNKGEMPFP 160
+ P + + ++ST+ D++ C+ +E+ + G FP
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEM-STGRPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 0.004
Identities = 30/115 (26%), Positives = 49/115 (42%), Gaps = 23/115 (20%)
Query: 64 YQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI-------SLSGLSKDTYQKEYYKYR 116
+Q+ + + +IH+DI N L+S +K+ +L + +Y
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA-RPASPLTDY---- 161
Query: 117 NAILPLRWLPYEA----VFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQ 166
+ RW Y A V D + DV+A C++ E+ + GE FP SD DQ
Sbjct: 162 ---VATRW--YRAPELLVGDTNYGKPVDVWAIGCIMAELLD-GEPLFPGDSDIDQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 0.004
Identities = 32/151 (21%), Positives = 69/151 (45%), Gaps = 26/151 (17%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK------ 105
+L + + YQ+ G+ + R++H+D+ +N LI+ +K++ GL++
Sbjct: 95 GALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154
Query: 106 DTYQKE----YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPD 161
+T+ E +Y+ + +L R +ST D+++ C++ E+ G FP
Sbjct: 155 NTFSNEVVTLWYRAPDVLLGSR----------TYSTSIDIWSVGCIMAEMIT-GRPLFPG 203
Query: 162 LSDDQVLSQL-----ESKKLCWKHSSKTPEY 187
+++ L ++ + W S+ PEY
Sbjct: 204 TNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.004
Identities = 36/161 (22%), Positives = 67/161 (41%), Gaps = 35/161 (21%)
Query: 62 MAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILP 121
+ YQ+ G++H+ +IH+D+ N ++ SD ++KI GL+ R A
Sbjct: 128 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----------RTACTN 176
Query: 122 LRWLPY---------EAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF--PDLSD--DQVL 168
PY E + + D+++ C++ E+ KG + F D D ++V+
Sbjct: 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKVI 235
Query: 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
QL + E++ L + + RP +P I
Sbjct: 236 EQLGTPSA---------EFMNRLQPT-VRNYVENRPQYPGI 266
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 223 | |||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0615|consensus | 475 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616|consensus | 355 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0589|consensus | 426 | 100.0 | ||
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605|consensus | 550 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024|consensus | 563 | 100.0 | ||
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| KOG0580|consensus | 281 | 99.98 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.98 | |
| KOG0660|consensus | 359 | 99.98 | ||
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0694|consensus | 694 | 99.98 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.98 | |
| KOG0659|consensus | 318 | 99.98 | ||
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.98 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| KOG1025|consensus | 1177 | 99.97 | ||
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0663|consensus | 419 | 99.97 | ||
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0032|consensus | 382 | 99.97 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| KOG1094|consensus | 807 | 99.97 | ||
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| KOG4645|consensus | 1509 | 99.97 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG0667|consensus | 586 | 99.97 | ||
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| KOG0579|consensus | 1187 | 99.97 | ||
| KOG0690|consensus | 516 | 99.97 | ||
| KOG0658|consensus | 364 | 99.97 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4279|consensus | 1226 | 99.97 | ||
| KOG4717|consensus | 864 | 99.97 | ||
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| KOG0594|consensus | 323 | 99.97 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0603|consensus | 612 | 99.97 | ||
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0614|consensus | 732 | 99.97 | ||
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0574|consensus | 502 | 99.97 | ||
| KOG0612|consensus | 1317 | 99.97 | ||
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0577|consensus | 948 | 99.97 | ||
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| KOG0983|consensus | 391 | 99.97 | ||
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| KOG0986|consensus | 591 | 99.96 | ||
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| KOG0596|consensus | 677 | 99.96 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG0584|consensus | 632 | 99.96 | ||
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| KOG1035|consensus | 1351 | 99.96 | ||
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG0696|consensus | 683 | 99.96 | ||
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0669|consensus | 376 | 99.96 | ||
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| KOG0586|consensus | 596 | 99.95 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| KOG0666|consensus | 438 | 99.95 | ||
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| KOG4250|consensus | 732 | 99.95 | ||
| KOG2052|consensus | 513 | 99.95 | ||
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| KOG0671|consensus | 415 | 99.95 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0587|consensus | 953 | 99.94 | ||
| KOG0607|consensus | 463 | 99.94 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| KOG0668|consensus | 338 | 99.94 | ||
| KOG3653|consensus | 534 | 99.94 | ||
| KOG1151|consensus | 775 | 99.94 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0664|consensus | 449 | 99.93 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG0665|consensus | 369 | 99.93 | ||
| KOG0695|consensus | 593 | 99.93 | ||
| KOG4236|consensus | 888 | 99.92 | ||
| KOG1027|consensus | 903 | 99.92 | ||
| KOG1006|consensus | 361 | 99.92 | ||
| KOG0608|consensus | 1034 | 99.92 | ||
| KOG0662|consensus | 292 | 99.92 | ||
| KOG0984|consensus | 282 | 99.91 | ||
| KOG1345|consensus | 378 | 99.9 | ||
| KOG0670|consensus | 752 | 99.9 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG0576|consensus | 829 | 99.87 | ||
| KOG0590|consensus | 601 | 99.86 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.84 | |
| KOG1152|consensus | 772 | 99.83 | ||
| KOG1023|consensus | 484 | 99.83 | ||
| KOG1164|consensus | 322 | 99.83 | ||
| KOG1167|consensus | 418 | 99.83 | ||
| KOG0195|consensus | 448 | 99.82 | ||
| KOG1290|consensus | 590 | 99.81 | ||
| KOG1165|consensus | 449 | 99.77 | ||
| KOG1033|consensus | 516 | 99.77 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG1240|consensus | 1431 | 99.76 | ||
| KOG1163|consensus | 341 | 99.73 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.73 | |
| KOG4158|consensus | 598 | 99.73 | ||
| KOG0603|consensus | 612 | 99.71 | ||
| KOG0606|consensus | 1205 | 99.69 | ||
| KOG1166|consensus | 974 | 99.64 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.51 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.48 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.47 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.45 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.43 | |
| KOG1266|consensus | 458 | 99.39 | ||
| KOG0590|consensus | 601 | 99.33 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.26 | |
| KOG0606|consensus | 1205 | 99.18 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.17 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.17 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.14 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.05 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.02 | |
| KOG2137|consensus | 700 | 98.96 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.94 | |
| KOG0601|consensus | 524 | 98.91 | ||
| KOG0601|consensus | 524 | 98.8 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| KOG3087|consensus | 229 | 98.66 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.66 | |
| KOG3741|consensus | 655 | 98.65 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.61 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.5 | |
| KOG1243|consensus | 690 | 98.4 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.18 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.15 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.1 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.83 | |
| KOG1035|consensus | 1351 | 97.5 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.84 | |
| KOG1235|consensus | 538 | 96.51 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.43 | |
| KOG1826|consensus | 2724 | 96.07 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 95.82 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.88 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.65 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.64 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.17 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.17 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.05 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.97 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.97 | |
| KOG2268|consensus | 465 | 93.88 | ||
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.82 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.38 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.17 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.88 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 92.73 | |
| KOG0576|consensus | 829 | 92.62 | ||
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.42 | |
| PLN02236 | 344 | choline kinase | 91.98 | |
| KOG1093|consensus | 725 | 91.88 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 91.73 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 91.63 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 91.09 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.0 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 90.94 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 89.96 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 89.95 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 89.03 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 88.73 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 88.32 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 87.35 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 87.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 86.75 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 85.25 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 85.16 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 84.61 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 83.93 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 81.63 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 80.31 |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=288.73 Aligned_cols=190 Identities=33% Similarity=0.545 Sum_probs=177.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.-+|+||+..|+|.++|+...+ +.++..+.+.++.||++|++||++++++||||.++|||++.+..+
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~-------------~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~v 342 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREG-------------GLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVV 342 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCC-------------CccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceE
Confidence 4589999999999999997433 579999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++...+..+........|+.|.|||++....++.++|||||||++||++|.|+.||.++...++++.+.++ +
T Consensus 343 KIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-y 421 (468)
T KOG0197|consen 343 KISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-Y 421 (468)
T ss_pred EEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-C
Confidence 999999999666666666777788999999999999999999999999999999999999999999999999999998 8
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
+++.|..||++++++|..||+.+|++||||+.+...|.++...+
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 89999999999999999999999999999999999999887654
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=269.90 Aligned_cols=203 Identities=28% Similarity=0.457 Sum_probs=176.7
Q ss_pred chHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-ccc
Q psy15108 2 DLKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR-LIH 80 (223)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H 80 (223)
|+++|+.++.+......+||||+++|+|.++++.... ..++...++.++.+|++|+.|||+++ |+|
T Consensus 100 NIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~-------------~~l~~~~~l~~aldiArGm~YLH~~~~iIH 166 (362)
T KOG0192|consen 100 NIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRK-------------RKLPLKVRLRIALDIARGMEYLHSEGPIIH 166 (362)
T ss_pred CeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhccc-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCeee
Confidence 4555666666655567899999999999999987411 47999999999999999999999999 999
Q ss_pred CCCCCCCeeeecCC-CeEEcCCCCCcccchhhhhhhhcCCcccccccccccc--cCCCCcccchHHHHHHHHHHHhCCCC
Q psy15108 81 KDIAARNCLISSDL-SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF--DDEFSTKSDVYAYACLIWEIFNKGEM 157 (223)
Q Consensus 81 ~di~~~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slG~il~~l~~~~~~ 157 (223)
||+|+.|||++..+ ++||+|||+++...... .......||..|+|||++. ...|+.++||||||+++|||+ ++..
T Consensus 167 rDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~-t~~~ 244 (362)
T KOG0192|consen 167 RDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELL-TGEI 244 (362)
T ss_pred cccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHH-HCCC
Confidence 99999999999997 99999999997654432 1223367889999999999 568999999999999999999 7999
Q ss_pred CCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 158 PFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
||.+....+....+.....++..+..+++.+..+|..||..||..||++.+++..|+.+...
T Consensus 245 Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 99999998888888777788888888999999999999999999999999999999987654
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=258.55 Aligned_cols=176 Identities=20% Similarity=0.273 Sum_probs=157.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~ 95 (223)
..++||||.+|||.++++..++ ++|..+-+++.++++||.|||+ .+|+||||||+|||++..|.
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~---------------i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe 217 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGR---------------IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE 217 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCC---------------CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC
Confidence 5588999999999999997654 9999999999999999999995 89999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL-----SDDQVLSQ 170 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~-----~~~~~~~~ 170 (223)
+|++|||.+...... .-++..||..||+||-+.+..|+.++||||||+.++|++ .|+.||... +..+.+..
T Consensus 218 VKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a-~GrfP~~~~~~~~~~~~~Ll~~ 293 (364)
T KOG0581|consen 218 VKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELA-IGRFPYPPPNPPYLDIFELLCA 293 (364)
T ss_pred EEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHh-hCCCCCCCcCCCCCCHHHHHHH
Confidence 999999998765444 346789999999999999999999999999999999999 899999764 56778888
Q ss_pred HHhCcccCCCCCC-ChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKKLCWKHSSK-TPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
|..+ ..+..+.. +++++++|+..||++||.+||+++|+++|
T Consensus 294 Iv~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 294 IVDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HhcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 8886 44444554 99999999999999999999999999977
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=284.36 Aligned_cols=199 Identities=36% Similarity=0.652 Sum_probs=181.0
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|+||+..|||.+||+.+.+...-..+ +.+..++++..+.+.|+.||+.|+.||-++.++|||+.++|+|+..+..|||
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~-g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLAS-GQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccC-CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence 789999999999999988764333222 2223678999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhh-cCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 99 SLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
+|||+++...+.+++..+ ....+++|||||.+.+.+++.++||||+||++||++++|..||.+..+.++++.+.++..
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l- 723 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL- 723 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-
Confidence 999999998888877655 678899999999999999999999999999999999999999999999999999999966
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
++.+..||.++++||..||+.+|++||+|+||...|+.....
T Consensus 724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 724 LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 889999999999999999999999999999999999887543
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=241.12 Aligned_cols=198 Identities=19% Similarity=0.249 Sum_probs=165.9
Q ss_pred HHHHHhh----cCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc--CC-
Q psy15108 5 QFLLATR----KDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD--KR- 77 (223)
Q Consensus 5 ~~~~~~~----~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~- 77 (223)
|++..+. ++.+...+|||+|.+|+|.++|+.-+. ....+++..+++++.|++.||..+|. .+
T Consensus 79 NIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~-----------qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~ 147 (375)
T KOG0591|consen 79 NIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKK-----------QKRLIPEKTVWKYFVQLCRALYHCHSKIPRG 147 (375)
T ss_pred hHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHh-----------ccccCchHHHHHHHHHHHHHHHHHhcccccc
Confidence 4555555 234446699999999999999997765 45679999999999999999999999 44
Q ss_pred -cccCCCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCC
Q psy15108 78 -LIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGE 156 (223)
Q Consensus 78 -i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~ 156 (223)
++||||||.||+++.+|.+|++|||+++...+... .....+||+.|++||.+...+|+.++||||+||++|||+ .-+
T Consensus 148 ~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMc-aL~ 225 (375)
T KOG0591|consen 148 TVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMC-ALQ 225 (375)
T ss_pred ceeeccCcchheEEcCCCceeeccchhHhHhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHH-hcC
Confidence 89999999999999999999999999986554432 234578999999999999999999999999999999999 688
Q ss_pred CCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 157 MPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
.||.+.+..+.-.+|.++.+.+....-++..+..++..|+..||+.||+.-.++..++.
T Consensus 226 ~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 226 SPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 99999998888888988854433335678889999999999999999995555554443
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=258.56 Aligned_cols=192 Identities=18% Similarity=0.298 Sum_probs=165.7
Q ss_pred chHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccC
Q psy15108 2 DLKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHK 81 (223)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 81 (223)
|+++|+..+... +..-+||||++||+|.+.+... .++|.++..+++++++||+|||.+||+||
T Consensus 331 NiVnfl~Sylv~-deLWVVMEym~ggsLTDvVt~~----------------~~~E~qIA~Icre~l~aL~fLH~~gIiHr 393 (550)
T KOG0578|consen 331 NIVNFLDSYLVG-DELWVVMEYMEGGSLTDVVTKT----------------RMTEGQIAAICREILQGLKFLHARGIIHR 393 (550)
T ss_pred HHHHHHHHhccc-ceeEEEEeecCCCchhhhhhcc----------------cccHHHHHHHHHHHHHHHHHHHhcceeee
Confidence 456666655444 3355899999999999999764 48999999999999999999999999999
Q ss_pred CCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q psy15108 82 DIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPD 161 (223)
Q Consensus 82 di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~ 161 (223)
|||..||+++.++.+|++|||++........ .....+||++|+|||++....|..++||||||++..||+ .|..||..
T Consensus 394 DIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMv-eGEPPYln 471 (550)
T KOG0578|consen 394 DIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMV-EGEPPYLN 471 (550)
T ss_pred ccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHh-cCCCCccC
Confidence 9999999999999999999999986654432 346789999999999999999999999999999999999 89999987
Q ss_pred CCHHHHHHHHH-hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 162 LSDDQVLSQLE-SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.++...+..+. .+.+....+..++.++++|+.+||..|+.+|++++|+|+|
T Consensus 472 E~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 472 ENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 66655555554 4555666778899999999999999999999999999977
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=262.98 Aligned_cols=177 Identities=18% Similarity=0.319 Sum_probs=161.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.-+|.|.|.+|+|-++++.++ +++|.++..++.||+.|+.|||+.+|+|||+|-.|++++.+.++
T Consensus 93 VYivLELC~~~sL~el~Krrk---------------~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~V 157 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK---------------PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNV 157 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC---------------CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcE
Confidence 336889999999999999654 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+|......+. ...+..||+.|.|||++....++..+||||+||++|.|+ .|++||...+..+++..|+...+
T Consensus 158 KIgDFGLAt~le~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL-~G~PPFetk~vkety~~Ik~~~Y 235 (592)
T KOG0575|consen 158 KIGDFGLATQLEYDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLL-VGRPPFETKTVKETYNKIKLNEY 235 (592)
T ss_pred EecccceeeeecCccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhh-hCCCCcccchHHHHHHHHHhcCc
Confidence 9999999987654321 345788999999999999999999999999999999999 89999999999999999998876
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. |..++.+.++||.++|+.+|.+|||+++|+.+
T Consensus 236 ~~--P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 SM--PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cc--ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 65 45788999999999999999999999999976
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=272.82 Aligned_cols=195 Identities=34% Similarity=0.573 Sum_probs=173.4
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
...+++|||++|||..+|++.+.. .-....++..+++.++.+|++|+.||++++++||||..+|+|++....
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~--------~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPA--------PFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV 840 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccc--------cCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc
Confidence 355889999999999999987441 112457999999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhc-CCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRN-AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~-~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+|+.|||+|+......++.... ...+..|+|||.+....++.++|||||||++||+++.|..||.+.++.+++..+..+
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g 920 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG 920 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC
Confidence 9999999999666555554443 477899999999999999999999999999999999999999999999999977777
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
. +++.+..||+.++++|..||+.+|++||+|..|++.+..++..
T Consensus 921 g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 921 G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 5 8888999999999999999999999999999999988887654
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=246.58 Aligned_cols=184 Identities=17% Similarity=0.247 Sum_probs=154.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-CCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS-DLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~-~~~ 95 (223)
+.+.|||+++|||.++++..+. +|++..+..+..||++||.|||++|++||||||.|||++. ++.
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~--------------~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~ 156 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG--------------KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD 156 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe
Confidence 6688999999999999997652 5999999999999999999999999999999999999999 699
Q ss_pred eEEcCCCCCcccch--hhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Q psy15108 96 VKISLSGLSKDTYQ--KEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPD-LSDDQVLSQL 171 (223)
Q Consensus 96 ~~l~df~~~~~~~~--~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~-~~~~~~~~~~ 171 (223)
+|+.|||++..... ..........+++.|++||++.+.. ...++||||+||++.||+ +|+.||.. ....+....+
T Consensus 157 ~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~-Tg~~PW~~~~~~~~~~~~i 235 (313)
T KOG0198|consen 157 VKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEML-TGKPPWSEFFEEAEALLLI 235 (313)
T ss_pred EEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEecc-CCCCcchhhcchHHHHHHH
Confidence 99999998876553 1112234578899999999998533 335999999999999999 78999988 4444444455
Q ss_pred HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
......+..+..++++.++++.+|+..+|++|||+++++.|-..
T Consensus 236 g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 236 GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 54445567788899999999999999999999999999988643
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=249.01 Aligned_cols=178 Identities=20% Similarity=0.267 Sum_probs=159.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
-+|++|+++|+|.++|++-+ .|++..+..++.||+.||+|||++||+||||||+|||++.+++++
T Consensus 150 YFvLe~A~nGdll~~i~K~G---------------sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG---------------SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC---------------cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEE
Confidence 37899999999999999765 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhh----------hh--hcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH
Q psy15108 98 ISLSGLSKDTYQKEYY----------KY--RNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD 165 (223)
Q Consensus 98 l~df~~~~~~~~~~~~----------~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~ 165 (223)
|+|||-++........ .. ...+||..|.+||.+.....+..+|+|+|||++|.|+ .|+.||.+.+..
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQml-aG~PPFra~Ney 293 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQML-AGQPPFRAANEY 293 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHh-cCCCCCccccHH
Confidence 9999998865543211 11 3478999999999999999999999999999999999 799999999999
Q ss_pred HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 166 QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
.+.+.|..-.+ ..+...++.+.+|+.++|..||.+|++..+|.+|-
T Consensus 294 liFqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 294 LIFQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 99999887544 44678899999999999999999999999998874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=248.68 Aligned_cols=168 Identities=32% Similarity=0.624 Sum_probs=137.7
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhh-hhhhhcCCccccccccccc
Q psy15108 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAV 130 (223)
Q Consensus 52 ~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~ 130 (223)
.++++..+..++.||++||.|||+.|++||||||.||+++.++.++++|||+++...... ........++..|+|||.+
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 468999999999999999999999999999999999999999999999999987543221 1122333456789999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy15108 131 FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210 (223)
Q Consensus 131 ~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 210 (223)
.+..++.++||||||+++|+|++.|..||.+....+..............+..+++++.+++.+||+.||.+||++.+++
T Consensus 249 ~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~ 328 (338)
T cd05102 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328 (338)
T ss_pred hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 88889999999999999999996699999876543333332222233444567889999999999999999999999999
Q ss_pred HHHHHHhhh
Q psy15108 211 TQLSDAMCN 219 (223)
Q Consensus 211 ~~L~~~~~~ 219 (223)
+.|++++.+
T Consensus 329 ~~l~~~~~~ 337 (338)
T cd05102 329 EILGDLLQE 337 (338)
T ss_pred HHHHHHHhc
Confidence 999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=247.43 Aligned_cols=178 Identities=18% Similarity=0.254 Sum_probs=155.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC---
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD--- 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~--- 93 (223)
.-+|+||+.||+|.+++-.++. +.++.-..+++|++.|+.|||++||+||||||+|||+..+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~---------------l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY---------------LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAED 315 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc---------------cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcc
Confidence 3589999999999999988765 8999999999999999999999999999999999999877
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCC---CcccchHHHHHHHHHHHhCCCCCCCCCCHHH-HHH
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEF---STKSDVYAYACLIWEIFNKGEMPFPDLSDDQ-VLS 169 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~---~~~~Di~slG~il~~l~~~~~~p~~~~~~~~-~~~ 169 (223)
..+|++|||+|+..+... ..++..||+.|.|||++....+ ..++|+||+||++|-++ +|.+||.+..... ..+
T Consensus 316 ~llKItDFGlAK~~g~~s--fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcL-sG~pPFS~~~~~~sl~e 392 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEGS--FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCL-SGYPPFSEEYTDPSLKE 392 (475)
T ss_pred eEEEecccchhhccccce--ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEe-ccCCCcccccCCccHHH
Confidence 678999999998765333 3467899999999999986653 34789999999999999 8999999887766 888
Q ss_pred HHHhCcccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 170 QLESKKLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 170 ~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
++.++.+... ....++++..++|.+||..||++||+++|+++|
T Consensus 393 QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 393 QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 8888776543 345788999999999999999999999999875
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=250.36 Aligned_cols=203 Identities=28% Similarity=0.443 Sum_probs=188.7
Q ss_pred chHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccC
Q psy15108 2 DLKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHK 81 (223)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 81 (223)
||++++..|....+.+ +|.||++.|+|.+||+.... ..++.-.++.++.||.+|++||..++++||
T Consensus 324 NLVqLLGVCT~EpPFY-IiTEfM~yGNLLdYLRecnr-------------~ev~avvLlyMAtQIsSaMeYLEkknFIHR 389 (1157)
T KOG4278|consen 324 NLVQLLGVCTHEPPFY-IITEFMCYGNLLDYLRECNR-------------SEVPAVVLLYMATQISSAMEYLEKKNFIHR 389 (1157)
T ss_pred cHHHHhhhhccCCCeE-EEEecccCccHHHHHHHhch-------------hhcchhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 7899999999876655 47899999999999998876 568899999999999999999999999999
Q ss_pred CCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q psy15108 82 DIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPD 161 (223)
Q Consensus 82 di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~ 161 (223)
|+..+|+|+..+..+|+.|||+++......+.......-++.|.+||.+....++.++|||+|||++||+.|+|-.||++
T Consensus 390 DLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 390 DLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999999988888777777788899999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 162 LSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.+..+++..+..+ ++...+..||+.+++||+.||++.|.+||+|+|+.+.++.++.+
T Consensus 470 idlSqVY~LLEkg-yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 470 IDLSQVYGLLEKG-YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ccHHHHHHHHhcc-ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 9999999888877 88999999999999999999999999999999999999988754
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=236.97 Aligned_cols=178 Identities=18% Similarity=0.202 Sum_probs=155.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.-+|++|+.||+|.-.|++.+. |+++.+..++.+|+.||.|||+.||+|||+||+|||++..|++
T Consensus 100 LylVld~~~GGeLf~hL~~eg~---------------F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi 164 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGR---------------FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHI 164 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCC---------------cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcE
Confidence 3488999999999999998765 9999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||+++..-.. .....+..||+.|+|||.+....|+..+|.||+|+++|+|+ +|..||.+.+...+.+.+...+
T Consensus 165 ~LtDFgL~k~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML-~G~pPF~~~~~~~~~~~I~~~k- 241 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEML-TGKPPFYAEDVKKMYDKILKGK- 241 (357)
T ss_pred EEeccccchhcccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHh-hCCCCCcCccHHHHHHHHhcCc-
Confidence 99999999754322 22345579999999999999999999999999999999999 8999999999999999998875
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCC----CHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRP----TFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~~ll~~ 212 (223)
....+.-.+.+.++++.++++.||++|. ++.++.+|
T Consensus 242 ~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 242 LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 2333445789999999999999999995 45555433
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=244.31 Aligned_cols=179 Identities=19% Similarity=0.244 Sum_probs=157.1
Q ss_pred CCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC
Q psy15108 14 SKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD 93 (223)
Q Consensus 14 ~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~ 93 (223)
...+.+|||||.+|+|.+++.+.+ .+++..+..++.|+++|+.|||++|++||||||+||+++.+
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g---------------~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~ 156 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKG---------------RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGN 156 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcC---------------CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCC
Confidence 333568999999999999999854 49999999999999999999999999999999999999999
Q ss_pred -CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy15108 94 -LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FS-TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170 (223)
Q Consensus 94 -~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~-~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~ 170 (223)
+.+|++|||++.... ..........|++.|+|||++.+.. |+ .++||||+||++|.|+ +|..||...+...+...
T Consensus 157 ~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml-~G~~PF~d~~~~~l~~k 234 (370)
T KOG0583|consen 157 EGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL-CGRLPFDDSNVPNLYRK 234 (370)
T ss_pred CCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH-hCCCCCCCccHHHHHHH
Confidence 999999999998653 1222456788999999999999888 85 7899999999999999 89999999888888888
Q ss_pred HHhCcccCCCCCCC-hHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15108 171 LESKKLCWKHSSKT-PEYITSLHEKCIHPHPHQRPTFPSIVT 211 (223)
Q Consensus 171 ~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~Rps~~~ll~ 211 (223)
+..+... .+..+ +.+++.++.+|+..+|.+|+++.+++.
T Consensus 235 i~~~~~~--~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 IRKGEFK--IPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HhcCCcc--CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 7776544 34555 999999999999999999999999993
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=235.50 Aligned_cols=181 Identities=15% Similarity=0.261 Sum_probs=154.5
Q ss_pred CCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC
Q psy15108 14 SKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD 93 (223)
Q Consensus 14 ~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~ 93 (223)
.+...+|||||.||||.+||+.++. +++..+..++.||+.|+++||+++|+||||||+|||++..
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~~---------------l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~ 145 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRGR---------------LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTT 145 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccC
Confidence 3345599999999999999998755 9999999999999999999999999999999999999875
Q ss_pred ------CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy15108 94 ------LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167 (223)
Q Consensus 94 ------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~ 167 (223)
..+||.|||+++...... ...+..|++.|||||++...+|+.++|+||+|+++|+|+ +|+.||......+.
T Consensus 146 ~~~~~~~~LKIADFGfAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l-~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 146 ARNDTSPVLKIADFGFARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCL-TGKPPFDAETPKEL 222 (429)
T ss_pred CCCCCCceEEecccchhhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHH-hCCCCccccCHHHH
Confidence 457999999999776443 345678899999999999999999999999999999999 89999999999998
Q ss_pred HHHHHhCcccCCC-CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 168 LSQLESKKLCWKH-SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+..+....+. +...+....+++...++.++.+|.++.+...+
T Consensus 223 ~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 223 LLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred HHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 8888776544433 33456667788888889999999888766543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=231.77 Aligned_cols=180 Identities=23% Similarity=0.369 Sum_probs=154.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+.+|+|.+++...+ .+++.....++.+++.|+.|||+. +++||||+|.||+++.++.
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~~~---------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDKEK---------------DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred eEEEEEeCCCCcHHHHHhhCC---------------CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc
Confidence 348899999999999998643 489999999999999999999984 8999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
++++|||++....... ....++..|+|||.+.+ ..++.++|||||||++|+++ +|..||.+.+..+....+..
T Consensus 162 ~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~-~g~~Pf~~~~~~~~~~~i~~ 236 (283)
T PHA02988 162 LKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF-TGKIPFENLTTKEIYDLIIN 236 (283)
T ss_pred EEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH-HCCCCCCCCCHHHHHHHHHh
Confidence 9999999986443221 23456778999999865 67899999999999999999 69999998888777777765
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
....+..+..+++++.+++.+||+.||++||++++++..|+.+
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 237 KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 5555555667899999999999999999999999999999865
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=224.34 Aligned_cols=165 Identities=21% Similarity=0.250 Sum_probs=152.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||+|.+||.|..++++.+. |++..++.++.||+.|++|||+.+|++||+||+|||+|++|.+
T Consensus 119 lymvmeyv~GGElFS~Lrk~~r---------------F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~i 183 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGR---------------FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHI 183 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCC---------------CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcE
Confidence 4489999999999999998765 9999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
|++|||+++...... .+..||+.|+|||.+...++..++|.|+|||++|||+ .|..||...+..++++.|..+..
T Consensus 184 KitDFGFAK~v~~rT----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMl-aG~pPF~~~~~~~iY~KI~~~~v 258 (355)
T KOG0616|consen 184 KITDFGFAKRVSGRT----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEML-AGYPPFYDDNPIQIYEKILEGKV 258 (355)
T ss_pred EEEeccceEEecCcE----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHH-cCCCCCcCCChHHHHHHHHhCcc
Confidence 999999998765442 5578999999999999999999999999999999999 89999999999999999999876
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQR 203 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~R 203 (223)
.. |..++..+++|+.++++.|-.+|
T Consensus 259 ~f--P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 KF--PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cC--CcccCHHHHHHHHHHHhhhhHhh
Confidence 55 56788899999999999999988
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=243.63 Aligned_cols=180 Identities=27% Similarity=0.441 Sum_probs=163.4
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|||||..|-|++.|+..+ +++...+..+..+|+.|+.|||.+.|+|||+|.-|||+..+..+||
T Consensus 189 IiMEfCa~GqL~~VLka~~---------------~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKI 253 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGR---------------PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKI 253 (904)
T ss_pred EeeeccccccHHHHHhccC---------------ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEe
Confidence 8899999999999999764 4999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW 178 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 178 (223)
+|||-++...... ..-...||+.|||||++...+.+.++|||||||++|||+ ++..||.+.+..+++.-+....+.+
T Consensus 254 sDFGTS~e~~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmL-T~EiPYkdVdssAIIwGVGsNsL~L 330 (904)
T KOG4721|consen 254 SDFGTSKELSDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEML-TGEIPYKDVDSSAIIWGVGSNSLHL 330 (904)
T ss_pred ccccchHhhhhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHH-hcCCCccccchheeEEeccCCcccc
Confidence 9999887544332 223467899999999999999999999999999999999 8999999999988887777777888
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 179 KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 179 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
+.+..+|+.++-|+++||+..|.+||+|++++.||.-+
T Consensus 331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 88999999999999999999999999999999998643
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=235.18 Aligned_cols=179 Identities=22% Similarity=0.315 Sum_probs=147.7
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
...+||||+ ..+|+++++.++ ..|++..++.|++||++||+|+|++|+.|||+||+|||+.....
T Consensus 84 ~L~fVfE~M-d~NLYqLmK~R~--------------r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~ 148 (538)
T KOG0661|consen 84 ILYFVFEFM-DCNLYQLMKDRN--------------RLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV 148 (538)
T ss_pred eEeeeHHhh-hhhHHHHHhhcC--------------CcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce
Confidence 344666665 579999999874 48999999999999999999999999999999999999998889
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES- 173 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~- 173 (223)
+||+|||+|+...+.. .+...+.|.+|.|||++... -|+.+.|+|++|||++|+. .-+.-|++.+....+..++.
T Consensus 149 iKiaDFGLARev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~-sLrPLFPG~sE~Dqi~KIc~V 225 (538)
T KOG0661|consen 149 IKIADFGLAREVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELY-SLRPLFPGASEIDQIYKICEV 225 (538)
T ss_pred eEecccccccccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHH-HhcccCCCCcHHHHHHHHHHH
Confidence 9999999999877665 34567889999999998755 4889999999999999998 67777888876554444433
Q ss_pred ------------------CcccCCC---------CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 ------------------KKLCWKH---------SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ------------------~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
-.+.++. .+.++.++.++|..|+++||.+|||+++++++
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1112221 13467889999999999999999999999986
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=227.84 Aligned_cols=186 Identities=26% Similarity=0.417 Sum_probs=156.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ ..+++..++.++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--------------~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~ 146 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE--------------GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVC 146 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcE
Confidence 448999999999999997643 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+...............++..|+|||.+.+..++.++|||||||++|+++++|..||.+....+....+... .
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~ 225 (266)
T cd05064 147 KISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-F 225 (266)
T ss_pred EECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-C
Confidence 999999775432222111122334567999999988889999999999999999876799999988887777777655 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
..+.+..++..+.+++..||+.+|.+||+++++.+.|.+++
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~ 266 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence 44556778999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=244.14 Aligned_cols=199 Identities=24% Similarity=0.384 Sum_probs=165.2
Q ss_pred hHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCC
Q psy15108 3 LKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKD 82 (223)
Q Consensus 3 ~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 82 (223)
++=||.++.++.- .+|.-.|+|.+|+.+|+.... +|...+.+.|+.||++|+.|||.++|+|+|
T Consensus 450 IlLFMG~~~~p~~--AIiTqwCeGsSLY~hlHv~et--------------kfdm~~~idIAqQiaqGM~YLHAK~IIHrD 513 (678)
T KOG0193|consen 450 ILLFMGACMNPPL--AIITQWCEGSSLYTHLHVQET--------------KFDMNTTIDIAQQIAQGMDYLHAKNIIHRD 513 (678)
T ss_pred heeeehhhcCCce--eeeehhccCchhhhhccchhh--------------hhhHHHHHHHHHHHHHhhhhhhhhhhhhhh
Confidence 3345555555333 677889999999999997765 699999999999999999999999999999
Q ss_pred CCCCCeeeecCCCeEEcCCCCCcccchh-hhhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCC
Q psy15108 83 IAARNCLISSDLSVKISLSGLSKDTYQK-EYYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMP 158 (223)
Q Consensus 83 i~~~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p 158 (223)
+|+.||++..++.|+|+|||++.....- .........+...|+|||++. ..+|+..+||||||+++|||+ +|.+|
T Consensus 514 LKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELl-tg~lP 592 (678)
T KOG0193|consen 514 LKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELL-TGELP 592 (678)
T ss_pred ccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHH-hCcCC
Confidence 9999999999999999999998654322 122234456678899999986 346899999999999999999 89999
Q ss_pred CCCCCHHHHHHHHHhCcc---cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 159 FPDLSDDQVLSQLESKKL---CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
|......+++..+.++.. ......++++++++|+..||.+++++||.|.+|+..|+.++.
T Consensus 593 ysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 593 YSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 998888888777777622 233346789999999999999999999999999999888775
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=234.35 Aligned_cols=180 Identities=19% Similarity=0.304 Sum_probs=152.1
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+||.|+.+||+.++|+..-. ..++|..+..+++++++||.|||.+|.+|||||+.|||++.+|.+++
T Consensus 101 vVmpfMa~GS~ldIik~~~~-------------~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkL 167 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYP-------------DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKL 167 (516)
T ss_pred EeehhhcCCcHHHHHHHHcc-------------ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEE
Confidence 89999999999999997654 45999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhh---hhhhhcCCccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 99 SLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 99 ~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+|||.+......+ ...++...++++|++||++.. ..|+.++|||||||+..|++ +|..||....+.+++....+
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA-~G~aPf~k~pPmkvLl~tLq 246 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELA-HGHAPFSKYPPMKVLLLTLQ 246 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHh-cCCCCcccCChHHHHHHHhc
Confidence 9999876655433 112366789999999999543 45999999999999999999 89999999998877665544
Q ss_pred CcccC--------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCW--------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+.+.. .....++..+++++..||..||.+|||+++++++
T Consensus 247 n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 247 NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 43321 1123456789999999999999999999999876
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=238.13 Aligned_cols=188 Identities=16% Similarity=0.245 Sum_probs=167.2
Q ss_pred HhhcCCCCCC---CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCC
Q psy15108 9 ATRKDSKDKS---GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85 (223)
Q Consensus 9 ~~~~~~~~~~---~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~ 85 (223)
+++.+.++.. +||+||+||+|.+.|+..++ ..|+++.+..++.|++.|+.|||+++|+|||+|+
T Consensus 68 y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~-------------~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~ 134 (426)
T KOG0589|consen 68 YKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKG-------------VLFPEERILKWFVQILLAVNYLHENRVLHRDLKC 134 (426)
T ss_pred eccchhcCCceEEEEEeecCCCCHHHHHHHHhh-------------ccccHHHHHHHHHHHHHHHHHHHhhhhhcccchh
Confidence 3344444433 78999999999999998874 4799999999999999999999999999999999
Q ss_pred CCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH
Q psy15108 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD 165 (223)
Q Consensus 86 ~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~ 165 (223)
.||+++.++.++++|||+++....... ......||+.|++||.+.+.+|..++|||||||++|||+ .-+.+|...+..
T Consensus 135 ~Nifltk~~~VkLgDfGlaK~l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~-~lk~aF~a~~m~ 212 (426)
T KOG0589|consen 135 ANIFLTKDKKVKLGDFGLAKILNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC-TLKPAFKASNMS 212 (426)
T ss_pred hhhhccccCceeecchhhhhhcCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH-hcccccCccchH
Confidence 999999999999999999987765542 235678999999999999999999999999999999999 789999999999
Q ss_pred HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 166 QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+....+.... ..+.+...+.+++.++..|+..+|..||++.+++.+
T Consensus 213 ~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 213 ELILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 9999888874 556678899999999999999999999999999876
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=233.57 Aligned_cols=168 Identities=33% Similarity=0.644 Sum_probs=136.9
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhh-hhhhhcCCccccccccccc
Q psy15108 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAV 130 (223)
Q Consensus 52 ~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~ 130 (223)
..+++..+..++.||++||.|||+.+++||||||.||+++.++.++++|||++....... ........++..|++||.+
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence 368999999999999999999999999999999999999999999999999987643222 1122334456779999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy15108 131 FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210 (223)
Q Consensus 131 ~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 210 (223)
.+..++.++|+||+||+++++++.|..||.+....+..............+...++++.+++.+||+.+|++||++.+++
T Consensus 248 ~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell 327 (337)
T cd05054 248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELV 327 (337)
T ss_pred cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 98999999999999999999995599999875543333222222233344556788899999999999999999999999
Q ss_pred HHHHHHhhh
Q psy15108 211 TQLSDAMCN 219 (223)
Q Consensus 211 ~~L~~~~~~ 219 (223)
++|++++.+
T Consensus 328 ~~l~~~~~~ 336 (337)
T cd05054 328 EILGDLLQE 336 (337)
T ss_pred HHHHHHHhc
Confidence 999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=225.72 Aligned_cols=187 Identities=28% Similarity=0.473 Sum_probs=157.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++..... ..+++..++.++.|+++||.|||+.+++|+||+|+||+++.++.+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~-------------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~ 143 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNR-------------QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 143 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcE
Confidence 4588999999999999976433 458999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++................+..|++||...+..++.++|+||||+++|+|++.|..||.+....+....+... .
T Consensus 144 kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~ 222 (263)
T cd05052 144 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-Y 222 (263)
T ss_pred EeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-C
Confidence 999999987554322211122333567999999988889999999999999999995599999888777776666554 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
....+..++.++.+++.+||..+|++||++.++++.|+.++
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 45556778999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=223.46 Aligned_cols=196 Identities=13% Similarity=0.226 Sum_probs=165.7
Q ss_pred CchHHHHHHhhcCCCCCC---CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q psy15108 1 GDLKQFLLATRKDSKDKS---GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR 77 (223)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~---~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 77 (223)
+++++|++.+.+...+.. +|||.++||+|...|++++. ..|++.++..|+.||..|+.|||+.+
T Consensus 115 ~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~-------------~afTErea~eI~~qI~~Av~~lH~~n 181 (400)
T KOG0604|consen 115 PHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD-------------QAFTEREASEIMKQIGLAVRYLHSMN 181 (400)
T ss_pred CceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc-------------ccchHHHHHHHHHHHHHHHHHHHhcc
Confidence 367889999998666633 89999999999999998866 67999999999999999999999999
Q ss_pred cccCCCCCCCeeeecC---CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhC
Q psy15108 78 LIHKDIAARNCLISSD---LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNK 154 (223)
Q Consensus 78 i~H~di~~~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~ 154 (223)
|+|||+||+|+|...+ ..+|++|||+++...... ...+...|+.|.|||++...+|+.+.|+||+||++|-|+ +
T Consensus 182 IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlL-C 258 (400)
T KOG0604|consen 182 IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL-C 258 (400)
T ss_pred hhhccCChhheeeecCCCCcceEecccccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhh-c
Confidence 9999999999998754 558999999998765433 334566789999999998888999999999999999999 9
Q ss_pred CCCCCCCCCHH----HHHHHHHhCcccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 155 GEMPFPDLSDD----QVLSQLESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 155 ~~~p~~~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
|..||...... .....|..+.+.++.+ ...++..+++|+++|..+|.+|.|+.+++++
T Consensus 259 GyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 259 GYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 99999876543 3455566666655544 3567889999999999999999999999865
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=221.45 Aligned_cols=193 Identities=17% Similarity=0.258 Sum_probs=153.5
Q ss_pred chHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccC
Q psy15108 2 DLKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHK 81 (223)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 81 (223)
||++++-+++.. ....+|+|||++.=|.++=+.- ..++.+.+.++++|++.|+.|+|+++++||
T Consensus 62 NLVnLiEVFrrk-rklhLVFE~~dhTvL~eLe~~p---------------~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHR 125 (396)
T KOG0593|consen 62 NLVNLIEVFRRK-RKLHLVFEYCDHTVLHELERYP---------------NGVPSELVKKYLYQLLKAIHFCHKNNCIHR 125 (396)
T ss_pred hHHHHHHHHHhc-ceeEEEeeecchHHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHhhhhhhcCeecc
Confidence 677787777652 2356999999987666665433 359999999999999999999999999999
Q ss_pred CCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCC
Q psy15108 82 DIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFP 160 (223)
Q Consensus 82 di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~ 160 (223)
||||+||+++.++.+|+||||+|+.... ....+...+.|.+|.|||.+.+ .+|..++|||++||++.||+ +|..-|+
T Consensus 126 DIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~-~G~pL~P 203 (396)
T KOG0593|consen 126 DIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELL-TGEPLWP 203 (396)
T ss_pred cCChhheEEecCCcEEeccchhhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHh-cCCcCCC
Confidence 9999999999999999999999987653 2223455678899999999987 67999999999999999999 8999999
Q ss_pred CCCHHHHHHHHHhC-------------------cccCCC----------CCCChHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15108 161 DLSDDQVLSQLESK-------------------KLCWKH----------SSKTPEYITSLHEKCIHPHPHQRPTFPSIVT 211 (223)
Q Consensus 161 ~~~~~~~~~~~~~~-------------------~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 211 (223)
+.+....+..|... ....+. .++.+..+.+++.+|++.||.+|++.++++.
T Consensus 204 G~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 204 GRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 88765444333220 011111 1334567889999999999999999999986
Q ss_pred H
Q psy15108 212 Q 212 (223)
Q Consensus 212 ~ 212 (223)
|
T Consensus 284 H 284 (396)
T KOG0593|consen 284 H 284 (396)
T ss_pred C
Confidence 5
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=240.80 Aligned_cols=176 Identities=17% Similarity=0.228 Sum_probs=160.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.-+|.||+++|.|+++|-..+. +++.++.++++||+.|+.|+|..+|+|||+||.|++++..+++
T Consensus 87 lylvlEyv~gGELFdylv~kG~---------------l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nI 151 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGP---------------LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNI 151 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCC---------------CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCE
Confidence 3488999999999999987654 9999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFS-TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
||.|||+|..-.... ...+..|.++|.+||++.+.+|. .++||||-|||+|.|+ +|.+||.+.+...++.+++++.
T Consensus 152 KIADFGMAsLe~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALL-tG~LPFdDdNir~LLlKV~~G~ 228 (786)
T KOG0588|consen 152 KIADFGMASLEVPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALL-TGKLPFDDDNIRVLLLKVQRGV 228 (786)
T ss_pred eeeccceeecccCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHH-hCCCCCCCccHHHHHHHHHcCc
Confidence 999999986544333 45677899999999999999985 6899999999999999 8999999999999999999987
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+.. |..++.++.+|+.+|+..||..|.|.+||++|
T Consensus 229 f~M--Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 FEM--PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ccC--CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 665 58899999999999999999999999999987
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=248.02 Aligned_cols=216 Identities=31% Similarity=0.566 Sum_probs=177.8
Q ss_pred CchHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhh-hccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcc
Q psy15108 1 GDLKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATR-KDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLI 79 (223)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~ 79 (223)
+|+++++.++.. .....+|+||+..|+|.++++.++ .......+........++..+++.+++||+.|++||++.+++
T Consensus 362 ~niv~llG~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 362 PNIVNLLGACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred cchhhheeeecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 467888888888 444668999999999999999887 111111111111113599999999999999999999999999
Q ss_pred cCCCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCC--cccccccccccccCCCCcccchHHHHHHHHHHHhCCCC
Q psy15108 80 HKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAI--LPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEM 157 (223)
Q Consensus 80 H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~--~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~ 157 (223)
|||+..+||++..+..+|++|||+++.............. .+..|+|||.+....|+.++|||||||++||+++.|..
T Consensus 441 HRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 441 HRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred chhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 9999999999999999999999999865554433322112 57789999999999999999999999999999999999
Q ss_pred CCCCCC-HHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 158 PFPDLS-DDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 158 p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
||.+.. .....+.+..+ .+...|..++++++++|+.||+.+|++||+|.++.+.+...+.
T Consensus 521 PYp~~~~~~~l~~~l~~G-~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 521 PYPGIPPTEELLEFLKEG-NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCcHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 999876 56666666666 7788889999999999999999999999999999999988654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=226.67 Aligned_cols=197 Identities=32% Similarity=0.596 Sum_probs=158.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCC-CCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSG-SGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.+++||+++|+|.+++............ ........+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 3788999999999999875431111000 011122468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ........++..|+|||.+....++.++|+|||||++|++++.|..||.+....+....+...
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~- 242 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR- 242 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999987543222 112233455678999999888889999999999999999995599999988888777777655
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
.....+..++.++.+++.+||+.+|.+||++++++++|++
T Consensus 243 ~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 243 QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 3445567789999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=234.60 Aligned_cols=166 Identities=30% Similarity=0.559 Sum_probs=136.4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhh-hhhhcCCccccccccccc
Q psy15108 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAV 130 (223)
Q Consensus 52 ~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~ 130 (223)
.++++..++.++.||++||.|||+.|++||||||.||+++.++.++++|||++........ .......++..|+|||.+
T Consensus 207 ~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 286 (374)
T cd05106 207 WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 286 (374)
T ss_pred CCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHh
Confidence 4689999999999999999999999999999999999999999999999999865432211 111223345679999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy15108 131 FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210 (223)
Q Consensus 131 ~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 210 (223)
....++.++|+|||||++|+|++.|..||.....................+...+.++.+++.+||+.||.+||++.+++
T Consensus 287 ~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~ 366 (374)
T cd05106 287 FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366 (374)
T ss_pred cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 88889999999999999999995599999877655444444443344444556789999999999999999999999999
Q ss_pred HHHHHHh
Q psy15108 211 TQLSDAM 217 (223)
Q Consensus 211 ~~L~~~~ 217 (223)
+.|++++
T Consensus 367 ~~l~~~~ 373 (374)
T cd05106 367 QLIQRQL 373 (374)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=217.74 Aligned_cols=178 Identities=19% Similarity=0.283 Sum_probs=158.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|++-|+.|.|.|+|...- ++++....+++.|+.+|++|||.++|+|||+||.||+++.+-++
T Consensus 98 ~FlVFdl~prGELFDyLts~V---------------tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKV---------------TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNI 162 (411)
T ss_pred hhhhhhhcccchHHHHhhhhe---------------eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccce
Confidence 568999999999999998654 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF------DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~------~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~ 170 (223)
+++|||++......+ ......||+.|+|||.+. ...|+..+|.|+.|+|+|.++ -|..||....+.-++..
T Consensus 163 ~isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL-aGcpPFwHRkQmlMLR~ 239 (411)
T KOG0599|consen 163 KISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL-AGCPPFWHRKQMLMLRM 239 (411)
T ss_pred EEeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH-cCCCchhHHHHHHHHHH
Confidence 999999998776554 446678999999999864 234788899999999999999 79999988888888888
Q ss_pred HHhCcccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
++.+++....+ .+.+...+++|.+||+.||.+|.|++|++.|
T Consensus 240 ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 98887765443 5678889999999999999999999999976
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=222.25 Aligned_cols=184 Identities=26% Similarity=0.444 Sum_probs=154.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++...+ .+++..+..++.|++.|+.|||++|++|+||+|.||+++.++.+
T Consensus 70 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~ 134 (257)
T cd05116 70 WMLVMELAELGPLNKFLQKNK---------------HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYA 134 (257)
T ss_pred cEEEEecCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeE
Confidence 347899999999999997543 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh--hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYY--KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++......... ......++..|++||.+....++.++|+||||+++|++++.|..||......+....+...
T Consensus 135 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~ 214 (257)
T cd05116 135 KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG 214 (257)
T ss_pred EECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC
Confidence 99999998754332211 1112233467999999887788899999999999999995599999988877777777665
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
..++.+..++.++.++|.+||+.||++||++++|...|++.
T Consensus 215 -~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 215 -ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 34556677899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=239.25 Aligned_cols=186 Identities=31% Similarity=0.528 Sum_probs=172.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|||.++.|.|.+||+.++. .++...+..+++||+.|+.|||+.+++||||..+||++....-+|+
T Consensus 467 ivmEL~~~GELr~yLq~nk~--------------sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKD--------------SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred EEEecccchhHHHHHHhccc--------------cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeee
Confidence 78999999999999998765 6999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW 178 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 178 (223)
+|||+++......++.......++.|++||.++.+.++.++|||.|||.+||+++.|..||.+..+..++..+..+ .++
T Consensus 533 aDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-eRl 611 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-ERL 611 (974)
T ss_pred cccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-CCC
Confidence 9999999888777776667778899999999999999999999999999999999999999999888888777777 678
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 179 KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 179 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
+.|++||+.++.++.+||.+||.+||.|.++...|..++.+
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 88999999999999999999999999999999999987653
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=223.38 Aligned_cols=187 Identities=29% Similarity=0.592 Sum_probs=153.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+|+|.++++.... .+++..++.++.|+++|+.|||+.+++|+||+|+||+++.++.+
T Consensus 72 ~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~ 137 (262)
T cd05058 72 PLVVLPYMKHGDLRNFIRSETH--------------NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTV 137 (262)
T ss_pred cEEEEecCCCCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcE
Confidence 4478999999999999975432 46788889999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh---hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+++|||++....... ........++..|++||.+....++.++||||||+++|++++.+..||...........+..
T Consensus 138 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~ 217 (262)
T cd05058 138 KVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217 (262)
T ss_pred EECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 999999986543221 11112234466799999988888999999999999999999557778887777666666555
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
. ..+..+..+++.+.+++.+||+.+|++||++.+++..|++++.
T Consensus 218 ~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 218 G-RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred C-CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 4 3344455678899999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=232.48 Aligned_cols=164 Identities=30% Similarity=0.575 Sum_probs=133.7
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhh-hhhhcCCccccccccccc
Q psy15108 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAV 130 (223)
Q Consensus 52 ~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~ 130 (223)
..+++..+..++.||++||.|||+.+++||||||.||+++.++.++++|||++........ ...+....+..|+|||.+
T Consensus 209 ~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 288 (375)
T cd05104 209 LALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESI 288 (375)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHh
Confidence 3689999999999999999999999999999999999999999999999999875433221 112223445679999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHH
Q psy15108 131 FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ-VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209 (223)
Q Consensus 131 ~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 209 (223)
.+..++.++|+||||+++|++++.|..||....... ....+... .....+...+.++.+++.+||+.||++||+++++
T Consensus 289 ~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 367 (375)
T cd05104 289 FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG-YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367 (375)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC-ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 888899999999999999999966899998765443 33333333 3344455668899999999999999999999999
Q ss_pred HHHHHHH
Q psy15108 210 VTQLSDA 216 (223)
Q Consensus 210 l~~L~~~ 216 (223)
++.|++.
T Consensus 368 l~~l~~~ 374 (375)
T cd05104 368 VQLIEQQ 374 (375)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=222.58 Aligned_cols=188 Identities=23% Similarity=0.427 Sum_probs=155.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++|+++|+|.++++..+. .+++..+..++.||+.|+.|||+.+++|+||||.||+++.++.++
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~k 149 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRD--------------SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQ 149 (279)
T ss_pred EEEEEeCCCCcHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEE
Confidence 478899999999999986433 589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++....... ........++..|++||...+..++.++|+||||+++|++++.|..||.+.........+..+ .
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~ 228 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-E 228 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-C
Confidence 99999987543221 111223345667999999988889999999999999999995599999888776655555444 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
..+.+..++..+.+++..||..+|.+||++.++++.|..+..+.
T Consensus 229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 229 RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 34445567788999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=223.45 Aligned_cols=203 Identities=29% Similarity=0.516 Sum_probs=162.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.+++...+....... ...+...+++..++.++.|++.||.|||+.|++||||+|.||+++.++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~--~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMA--EGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCcccccc--ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 4588999999999999987653211110 11123459999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ........++..|+|||.+.+..++.++|+||||+++++|++.|..||...........+....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987543221 1111223346679999999888889999999999999999955999998888777777776653
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhccC
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDVN 222 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 222 (223)
....+..++.++.+++.+||+.+|.+||++.++...|+++...+..
T Consensus 240 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~ 285 (288)
T cd05093 240 -VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPV 285 (288)
T ss_pred -cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhccc
Confidence 2334556788999999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=223.67 Aligned_cols=205 Identities=28% Similarity=0.491 Sum_probs=162.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccC-CCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDK-SGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+|+||+++++|.+++...+...... ..........+++..++.++.||+.|+.|||++|++|+||+|.||+++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 448899999999999998754311110 0001112245899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||++........ .......++..|++||.+.+..++.++|+||||+++|+|++.|..||...+..+....+...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 99999999865433221 11123345677999999988889999999999999999995599999888877777666554
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhccC
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDVN 222 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 222 (223)
.....+..++..+.+++.+||+.+|++||+++++++.|.++.....+
T Consensus 242 -~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~ 288 (291)
T cd05094 242 -RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288 (291)
T ss_pred -CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence 33344556788999999999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=248.38 Aligned_cols=187 Identities=29% Similarity=0.489 Sum_probs=171.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
+.+.|||++|+|..+|+++.+ .|+..++..+++.|+.|++||.+.+++||||.++|||++.+..+|
T Consensus 706 MIiTEyMENGsLDsFLR~~DG--------------qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCK 771 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDG--------------QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCK 771 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCC--------------ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEE
Confidence 367899999999999998755 599999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 98 ISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 98 l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+.|||+++...+.. .........++.|.|||++..++++.++||||+||++||.+++|..||-++.+.++++.+..+
T Consensus 772 VsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g- 850 (996)
T KOG0196|consen 772 VSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG- 850 (996)
T ss_pred eccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc-
Confidence 99999998654332 233344567899999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
++++.|..||..+.+||..||++|=..||.|.+|+..|.+++.+
T Consensus 851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 88888999999999999999999999999999999999998865
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=230.62 Aligned_cols=183 Identities=31% Similarity=0.514 Sum_probs=150.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++|+|.++|+.... ..+++..+..++.||++||.|||+.+++|++|+++||+++.++.+
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~-------------~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~ 142 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNK-------------EPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQV 142 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCT-------------TTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEE
T ss_pred cccccccccccccccccccccc-------------ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5688999999999999998622 469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
|++|||++....... .........+..|+|||.+....++.++||||||+++||+++.+..||.+.........+...
T Consensus 143 Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~- 221 (259)
T PF07714_consen 143 KLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG- 221 (259)
T ss_dssp EEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 999999987652211 112233455678999999988889999999999999999995588999999888888888655
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
.....+..++..+.+++..||+.+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 55566778899999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=223.10 Aligned_cols=181 Identities=28% Similarity=0.507 Sum_probs=153.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.++++.++. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~ 141 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGR-------------SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVA 141 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcE
Confidence 4588999999999999986543 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .....+..|++||.+....++.++|+||+|+++|++++.|..||...........+... .
T Consensus 142 kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~ 216 (256)
T cd05082 142 KVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-Y 216 (256)
T ss_pred EecCCccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-C
Confidence 999999886543221 22334567999999988888999999999999999996699999887777766666554 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
....+..++..+.+++.+||+.+|++||++.++++.|..
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 444556788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=221.02 Aligned_cols=185 Identities=28% Similarity=0.477 Sum_probs=155.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.++++.... ..+++..++.++.|+++|+.|||+.+++|+||+|.||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~ 142 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEG-------------GKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMC 142 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcE
Confidence 4488999999999999986533 468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|++||......++.++|+||||+++|++++.|..||...........+... .
T Consensus 143 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~ 221 (261)
T cd05072 143 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-Y 221 (261)
T ss_pred EECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999987543322111223344667999999888888899999999999999995599999888777777666554 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..+....++.++.+++.+||+.+|++||+++++.+.|++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 445556788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=224.30 Aligned_cols=182 Identities=18% Similarity=0.221 Sum_probs=159.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.-++||||+||+|..+++.+.. .-|+++.+..++.+++-||+|||..||++||+||+|||+..+|++
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~-------------~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHI 218 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPG-------------KRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHI 218 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCC-------------CccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcE
Confidence 3489999999999999998755 679999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccch-----------------------------h---h-h----------------------hhhhcCCcc
Q psy15108 97 KISLSGLSKDTYQ-----------------------------K---E-Y----------------------YKYRNAILP 121 (223)
Q Consensus 97 ~l~df~~~~~~~~-----------------------------~---~-~----------------------~~~~~~~~~ 121 (223)
.++||.++..... . . . ...+..+||
T Consensus 219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT 298 (459)
T KOG0610|consen 219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT 298 (459)
T ss_pred EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence 9999988643110 0 0 0 011234778
Q ss_pred cccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCC
Q psy15108 122 LRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPH 201 (223)
Q Consensus 122 ~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 201 (223)
..|+|||++.+...+.++|.|+|||++|||+ +|..||.+.+..+++.++.......+..+..+..+++||+++|.+||.
T Consensus 299 hEYlAPEvI~G~GHgsAVDWWtfGIflYEmL-yG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 299 HEYLAPEVIRGEGHGSAVDWWTFGIFLYEML-YGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred cccccceeeecCCCCchhhHHHHHHHHHHHH-hCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 8899999999999999999999999999999 899999999999999999988787777777889999999999999999
Q ss_pred CCCC----HHHHHHH
Q psy15108 202 QRPT----FPSIVTQ 212 (223)
Q Consensus 202 ~Rps----~~~ll~~ 212 (223)
+|.. +.||.+|
T Consensus 378 kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhccccchHHhhcC
Confidence 9988 7887765
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=226.08 Aligned_cols=189 Identities=22% Similarity=0.420 Sum_probs=156.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+++|+|.++++.... .+++..++.++.||+.||.|||+.+++||||||.||+++.++.+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKD--------------NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccc--------------cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcE
Confidence 4588999999999999986432 58899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++........ ........+..|++||.+....++.++|+||||+++|++++.|..||.+....+....+...
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~- 227 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 227 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC-
Confidence 9999999975433221 11122334567999999988889999999999999999985699999887766655444433
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
..++.+..++..+.+++.+||+.+|.+||++.+++..+.++..+.
T Consensus 228 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 455556678889999999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=220.41 Aligned_cols=186 Identities=26% Similarity=0.433 Sum_probs=155.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++|+|.+++.... ..+++..++.++.|++.|+.|||++|++|+||+|.||+++.++.+
T Consensus 69 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~ 134 (257)
T cd05115 69 LMLVMEMASGGPLNKFLSGKK--------------DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYA 134 (257)
T ss_pred eEEEEEeCCCCCHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcE
Confidence 448899999999999997533 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++........ ........+..|++||.+....++.++|+||||+++|++++.|..||...........+..+
T Consensus 135 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05115 135 KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214 (257)
T ss_pred EeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence 9999999875432221 11111223567999999888888999999999999999985699999988887777666665
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
.....+..+++++.+++..||..+|++||++.++.+.|+..+
T Consensus 215 -~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 215 -KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 344556678899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=226.53 Aligned_cols=174 Identities=18% Similarity=0.215 Sum_probs=150.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++..+ .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~ 140 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG---------------RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHI 140 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCE
Confidence 458999999999999998653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...... .....+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+....+....+.....
T Consensus 141 kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~-~g~~pf~~~~~~~~~~~i~~~~~ 215 (291)
T cd05612 141 KLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML-VGYPPFFDDNPFGIYEKILAGKL 215 (291)
T ss_pred EEEecCcchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCc
Confidence 99999998654322 12345788899999998888999999999999999999 79999998888887777766543
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
. .+...+..+++++.+||+.||.+||+ ++++++|
T Consensus 216 ~--~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 E--FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred C--CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 3 34566888999999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=240.01 Aligned_cols=182 Identities=20% Similarity=0.251 Sum_probs=154.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+.+|+|.++|+.... ....+++..+..++.|++.||.|||+.+++||||||+||+++.++.++
T Consensus 115 ~lV~Ey~~~gsL~~~l~~~~~-----------~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 115 ALVLDYANAGDLRQEIKSRAK-----------TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred EEEEeCCCCCcHHHHHHHhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 378999999999999986543 235699999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
|+|||+++...... ........+++.|+|||.+.+..++.++|||||||++|+|+ +|..||...+..+....+.....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLl-tG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL-TLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999987543221 11123456788999999999888999999999999999999 79999998887777776665533
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+.+..+++++.+++.+||+.+|.+||++.+++.+
T Consensus 263 -~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 -DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 34466788999999999999999999999999875
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=232.72 Aligned_cols=176 Identities=20% Similarity=0.275 Sum_probs=154.5
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++||||.+|++.++++..+ .+.+..+.-++.+++.|+.|||.++.+|||||+.||++...|.+++
T Consensus 88 iiMey~~gGsv~~lL~~~~---------------~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl 152 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN---------------ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKL 152 (467)
T ss_pred HHHHHhcCcchhhhhccCC---------------CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEE
Confidence 7899999999999998543 3699999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW 178 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 178 (223)
.|||.+........++ ...+||+.|||||++....|+.++||||||++.+||+ +|..|+....+...+..|-+. .++
T Consensus 153 ~DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla-~GePP~s~~hPmrvlflIpk~-~PP 229 (467)
T KOG0201|consen 153 ADFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELA-KGEPPHSKLHPMRVLFLIPKS-APP 229 (467)
T ss_pred Eecceeeeeechhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHh-cCCCCCcccCcceEEEeccCC-CCC
Confidence 9999998776655444 7889999999999999889999999999999999999 899999988876555444444 233
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 179 KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 179 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+++.+++|+..||..+|+.||++.++++|
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3345788999999999999999999999999976
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=231.26 Aligned_cols=176 Identities=16% Similarity=0.238 Sum_probs=150.5
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+||+++.++.++
T Consensus 71 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~k 135 (323)
T cd05571 71 CFVMEYANGGELFFHLSRER---------------VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIK 135 (323)
T ss_pred EEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEE
Confidence 38899999999999998653 489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++....... .......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||...+.......+....
T Consensus 136 l~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-tg~~Pf~~~~~~~~~~~~~~~~-- 211 (323)
T cd05571 136 ITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHEKLFELILMEE-- 211 (323)
T ss_pred EeeCCCCcccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhh-cCCCCCCCCCHHHHHHHHHcCC--
Confidence 99999986432211 1123346788999999998888999999999999999999 8999999888777777666543
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
...+...+.++.+++.+||+.||++|| ++.++++|
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 334567889999999999999999999 78998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=219.46 Aligned_cols=187 Identities=29% Similarity=0.476 Sum_probs=155.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+|+|.+++..... ..+++..+..++.|+++||.|||+.+++|+||+|.||+++.++.+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~ 141 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMG-------------KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 141 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccc-------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcE
Confidence 3488999999999999976432 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+...............++..|++||......++.++|+||||+++|++++.|..||.+....+....+... .
T Consensus 142 ~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~ 220 (262)
T cd05071 142 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 220 (262)
T ss_pred EeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-C
Confidence 999999986543332222223345667999999888889999999999999999995589999888777776666554 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
..+.+..++..+.+++.+|++.+|++||+++++++.|+..+
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 34445678899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=235.38 Aligned_cols=186 Identities=34% Similarity=0.530 Sum_probs=166.4
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|||+|.||+|+++|++.+. .++..+...++.+.+.||+|||+++++||||-++|+|++.++.+|+
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--------------~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--------------SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--------------CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEe
Confidence 88999999999999998653 5999999999999999999999999999999999999999989999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW 178 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 178 (223)
+|||+++...... ........|..|+|||.+....++.++|||||||++||+++.|..||.+....++...+....++.
T Consensus 304 SDFGLs~~~~~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 304 SDFGLSRAGSQYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM 382 (474)
T ss_pred CccccccCCccee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC
Confidence 9999987654111 111234678999999999999999999999999999999988899999999999999996666888
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 179 KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 179 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
+.+...|.++..++.+||..+|++||++.++.+.++.+...
T Consensus 383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 88889999999999999999999999999999999987654
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=219.09 Aligned_cols=186 Identities=29% Similarity=0.509 Sum_probs=155.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++.... ..+++..++.++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 80 VMIITEYMENGSLDKFLREND--------------GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVC 145 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCE
Confidence 347899999999999997643 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .........+..|++||.+.+..++.++|+||+|+++|++++.|..||...........+...
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~- 224 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG- 224 (266)
T ss_pred EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-
Confidence 999999987653111 111112334567999999988889999999999999999985699999888877777666554
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
...+.+..++..+.+++.+||+.+|++||++++++++|++++
T Consensus 225 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 344445678899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=219.65 Aligned_cols=184 Identities=29% Similarity=0.523 Sum_probs=156.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.++++.... ..+++..++.++.|++.|+.|||+.|++|+||+|.||+++.++.+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~ 143 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEG-------------QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVC 143 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceE
Confidence 4589999999999999986432 468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+......... ......+..|++||......++.++|+||||++++++++.|..||......+....+... .
T Consensus 144 kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~ 221 (261)
T cd05148 144 KVADFGLARLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-Y 221 (261)
T ss_pred EEccccchhhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-C
Confidence 99999988654332211 123344667999999888888999999999999999995589999988877777776654 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..+.+..+++++.+++.+||+.+|.+||+++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 455567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=219.65 Aligned_cols=191 Identities=31% Similarity=0.570 Sum_probs=156.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+|+|.+++...+.. .....+++..+..++.|++.|+.|||+.+++|+||||.||+++.++.+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 151 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG---------DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNV 151 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc---------CCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCE
Confidence 34788999999999998654320 112358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++......... .......+..|++||......++.++|+||||+++|++++.|..||......+....+..+
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~- 230 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG- 230 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 99999998764332211 1122345677999999988889999999999999999995589999888877777776655
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
.....+..++..+.+++.+||+.+|++||++.++++.|.+++
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 231 NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 333445678889999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=227.25 Aligned_cols=168 Identities=32% Similarity=0.621 Sum_probs=134.9
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhh-hhhhhcCCccccccccccc
Q psy15108 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAV 130 (223)
Q Consensus 52 ~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~ 130 (223)
..+++.++..++.|+++||.|||+.+++|+||||.||+++.++.++++|||++....... ........++..|++||.+
T Consensus 174 ~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 253 (343)
T cd05103 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 253 (343)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHh
Confidence 357899999999999999999999999999999999999999999999999987543221 1122223445679999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy15108 131 FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210 (223)
Q Consensus 131 ~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 210 (223)
....++.++|+||||+++|++++.|..||.....................+...++++.+++..||+.+|++||++.+++
T Consensus 254 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil 333 (343)
T cd05103 254 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333 (343)
T ss_pred cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 88889999999999999999996699999876543322222222233344455678899999999999999999999999
Q ss_pred HHHHHHhhh
Q psy15108 211 TQLSDAMCN 219 (223)
Q Consensus 211 ~~L~~~~~~ 219 (223)
++|+.++..
T Consensus 334 ~~l~~~~~~ 342 (343)
T cd05103 334 EHLGNLLQA 342 (343)
T ss_pred HHHHHHHhc
Confidence 999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=218.59 Aligned_cols=183 Identities=28% Similarity=0.543 Sum_probs=152.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++..+.. .+++..++.++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~ 139 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKG--------------KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVV 139 (256)
T ss_pred eEEEEecCCCCCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcE
Confidence 3488999999999999976432 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++................+..|++||.+....++.++|+||||+++|++++.|..||......+....+... .
T Consensus 140 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~ 218 (256)
T cd05059 140 KVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-Y 218 (256)
T ss_pred EECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999887543322111122233457999999988889999999999999999995589999888777777666554 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
....+..++.++.+++.+||..+|++||++.++++.|+
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 44555678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=218.08 Aligned_cols=183 Identities=29% Similarity=0.502 Sum_probs=152.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||+++|+|.++++... ..+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.+
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~ 139 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQ--------------GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVV 139 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCc--------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeE
Confidence 448899999999999997542 248999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+................+..|+|||.+.+..++.++|+||||+++|++++.|+.||...+..+....+....
T Consensus 140 kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~- 218 (256)
T cd05114 140 KVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF- 218 (256)
T ss_pred EECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-
Confidence 9999998875433222222223445679999999888889999999999999999944899999888877777776653
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
....+...+.++.+++.+||+.+|++||+++++++.|+
T Consensus 219 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 33345556788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=218.78 Aligned_cols=189 Identities=30% Similarity=0.517 Sum_probs=157.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++.... ..+++..++.++.+++.|+.|||+.+++|+||+|+||+++.++.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~ 146 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK--------------YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCV 146 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCe
Confidence 448899999999999997542 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++................+..|++||.+....++.++|+||||++++++++.|..||......+....+... .
T Consensus 147 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~ 225 (270)
T cd05056 147 KLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-E 225 (270)
T ss_pred EEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999886543332111122233467999999888888999999999999999986799999888877766666554 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
....+..++..+.+++.+|+..+|.+||++.++++.|.++..+.
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 44556778899999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=224.13 Aligned_cols=175 Identities=19% Similarity=0.259 Sum_probs=156.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
+-+||||..+|+|++||..++. +++..+..++.||.+|+.|+|+++++|||+|..|||+|.++++
T Consensus 128 IvivMEYaS~GeLYDYiSer~~---------------LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~Ni 192 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGS---------------LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNI 192 (668)
T ss_pred EEEEEEecCCccHHHHHHHhcc---------------ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCe
Confidence 4488999999999999998755 9999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFS-TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
|+.|||++..+.... -..+..|.+-|.+||.+++.+|. ..+|.||||+++|.+. +|.+||.+.+....+.+|..+.
T Consensus 193 KIADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLV-yGtMPFDG~Dhk~lvrQIs~Ga 269 (668)
T KOG0611|consen 193 KIADFGLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLV-YGTMPFDGRDHKRLVRQISRGA 269 (668)
T ss_pred eeeccchhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHh-hcccccCCchHHHHHHHhhccc
Confidence 999999997665444 23567888999999999999985 6799999999999999 9999999999999999999987
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
++-+ ..|....-+|++||..+|+.|.|+.+|-.|
T Consensus 270 YrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 270 YREP---ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 6543 335557889999999999999999999776
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=217.71 Aligned_cols=185 Identities=29% Similarity=0.479 Sum_probs=154.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++..... ..+++..+..++.|++.|+.+||+.|++|+||+|.||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 142 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAG-------------RALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNIC 142 (261)
T ss_pred eeeeeecccCCcHHHHHhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCE
Confidence 4488999999999999976532 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++................+..|++||......++.++|+||||++++++++.|..||.+.........+... .
T Consensus 143 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~ 221 (261)
T cd05068 143 KVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-Y 221 (261)
T ss_pred EECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999887654222111122223457999999988888999999999999999995599999988877777766554 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..+.+...+..+.+++.+|++.+|.+||++.+++..|+.
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 444556778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=209.95 Aligned_cols=182 Identities=18% Similarity=0.233 Sum_probs=158.7
Q ss_pred CCCC-CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee
Q psy15108 13 DSKD-KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS 91 (223)
Q Consensus 13 ~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~ 91 (223)
.+++ ..+|+|++.||+|..=|-++-. +++..+-..+.||++||.|+|.++|+|||+||.|+++.
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R~~---------------ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLA 144 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVAREF---------------YSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLA 144 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHHHH---------------HHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeee
Confidence 4444 3489999999999887777655 89999999999999999999999999999999999985
Q ss_pred cC---CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy15108 92 SD---LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168 (223)
Q Consensus 92 ~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~ 168 (223)
.. ..+|++|||++...... ..-....|++.|++||++...+|+.++|||+-|+++|-++ .|.+||.+.+...++
T Consensus 145 SK~~~A~vKL~~FGvAi~l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL-~G~~PF~~~~~~rly 221 (355)
T KOG0033|consen 145 SKAKGAAVKLADFGLAIEVNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL-VGYPPFWDEDQHRLY 221 (355)
T ss_pred eccCCCceeecccceEEEeCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH-hCCCCCCCccHHHHH
Confidence 43 45899999999877632 2345678999999999999999999999999999999999 899999999999999
Q ss_pred HHHHhCcccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 169 SQLESKKLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 169 ~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
++|+++.+..+ ..+..+++.++++++||..||.+|.|+.|.++|
T Consensus 222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 99998876543 345788999999999999999999999999865
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=221.14 Aligned_cols=197 Identities=28% Similarity=0.526 Sum_probs=156.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++...+................+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 34788999999999999876542222111112223468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++........ .......++..|++||.+.+..++.++|+|||||++|++++.|..||...........+..+
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~- 240 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG- 240 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC-
Confidence 9999998864432211 11122334577999999988889999999999999999995599999887777766666554
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.....+..++..+.+++.+||+.||.+||++++++..|+
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 241 RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 334455678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=218.22 Aligned_cols=185 Identities=32% Similarity=0.483 Sum_probs=154.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||+.+|+|.++++.... ..+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.+
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~ 141 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDG-------------KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVC 141 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeE
Confidence 3488999999999999986432 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|++||...+..++.++|+||||+++|++++.|..||.+....+....+... .
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~ 220 (260)
T cd05069 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-Y 220 (260)
T ss_pred EECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999986543322222223345567999999888888999999999999999995489999988777777766554 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..+.+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 444556778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=220.56 Aligned_cols=199 Identities=28% Similarity=0.452 Sum_probs=157.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhcccc-CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKD-KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+++|+|.+++...+..... ...........+++..+..++.|++.|+.|||+.|++|+||||.||+++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence 45889999999999999865432111 00011112346899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++++|||++....... .......+..|++||......++.++|||||||++|+|++.|..||...........+...
T Consensus 158 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~- 234 (297)
T cd05089 158 SKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 234 (297)
T ss_pred EEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-
Confidence 9999999885322110 1111223456999999988888999999999999999995599999988877776666554
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.....+..++.++.+++.+||+.+|.+||+++++++.|..++.
T Consensus 235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 3444556788999999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=217.77 Aligned_cols=185 Identities=31% Similarity=0.486 Sum_probs=154.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|+|+.+++|.++++.... ..+++..++.++.+++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~ 141 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEG-------------RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVC 141 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceE
Confidence 4488999999999999986432 458999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|+|||......++.++|+||||+++|++++.|..||.+....+....+... .
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~ 220 (260)
T cd05070 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-Y 220 (260)
T ss_pred EeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999986543322112222344567999999888888999999999999999995589999888777777766554 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..+.+...+..+.+++.+||..+|.+|||++++.+.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 445566788999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=221.06 Aligned_cols=200 Identities=33% Similarity=0.611 Sum_probs=159.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGS-GKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+++|+|.++++............ .......+++..++.++.|++.|+.|||+.+++|+||+|.||+++.++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe
Confidence 347899999999999998654211111110 1123457999999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||++......... .......+..|++||......++.++|+|||||++|++++.|..||......+....+...
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 250 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998754332211 1112234567999999888889999999999999999996699999888777776666554
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
..+..+..++..+.+++.+||..+|++|||+.++++.|.+++
T Consensus 251 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 251 -YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 444556677889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=217.37 Aligned_cols=185 Identities=29% Similarity=0.466 Sum_probs=154.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+|+|.+++...+ .+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++.+
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~ 134 (257)
T cd05060 70 LMLVMELAPLGPLLKYLKKRR---------------EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQA 134 (257)
T ss_pred eEEEEEeCCCCcHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcE
Confidence 458899999999999998653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh--hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYY--KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++......... ......++..|++||...+..++.++|+||||+++|++++.|..||...+..+....+...
T Consensus 135 kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05060 135 KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG 214 (257)
T ss_pred EeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 99999998755332211 1111223456999999988889999999999999999995599999888877777666555
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
...+.+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus 215 -~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 215 -ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 344556678899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=219.85 Aligned_cols=186 Identities=23% Similarity=0.420 Sum_probs=153.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++|+++|+|.++++... ..+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~--------------~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~k 149 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENK--------------DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVK 149 (279)
T ss_pred EEEEEcCCCCCHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEE
Confidence 47889999999999997642 2589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++........ ........+..|++||...+..++.++|+|||||++||+++.|..||...........+... .
T Consensus 150 L~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~ 228 (279)
T cd05109 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-E 228 (279)
T ss_pred ECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-C
Confidence 999999875432211 11112234567999999988889999999999999999985599999887776666555554 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
..+.+..++..+.+++.+||+.||++||++.+++..|.++..
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 344456788999999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=220.88 Aligned_cols=205 Identities=29% Similarity=0.536 Sum_probs=162.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccc-cCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSK-DKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+.+|+|.+++...+.... ............+++..++.++.||++||.|||+.|++|+||||.||+++.++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~ 175 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV 175 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCc
Confidence 3488999999999999987543111 111111112346899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||++......... ......++..|+|||.+.+..++.++|+||||+++|++++.|..||......+....+...
T Consensus 176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 255 (304)
T cd05101 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 255 (304)
T ss_pred EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 999999998755332211 1122334567999999988889999999999999999996688899888887777776655
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhccC
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDVN 222 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 222 (223)
.....+..++.++.+++.+||+.+|.+||++.++++.|.+++.-.-|
T Consensus 256 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 256 -HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 34445567889999999999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=231.64 Aligned_cols=176 Identities=19% Similarity=0.296 Sum_probs=158.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.-+|.|||.| +|..+|.+.+. ++++++..+++++++||.|||+.+|+|||+||+||++.+.+.+
T Consensus 76 ~~vVte~a~g-~L~~il~~d~~---------------lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~ 139 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQDGK---------------LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTL 139 (808)
T ss_pred EEEEehhhhh-hHHHHHHhccC---------------CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCce
Confidence 4488899988 99999998765 9999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
|++|||+++....+.. ......|++.|+|||.+.+.+|+..+|+||+||++||++ .|+.||......+..+.|.....
T Consensus 140 KlcdFg~Ar~m~~~t~-vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~-~G~PPF~a~si~~Lv~~I~~d~v 217 (808)
T KOG0597|consen 140 KLCDFGLARAMSTNTS-VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELY-VGQPPFYARSITQLVKSILKDPV 217 (808)
T ss_pred eechhhhhhhcccCce-eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHh-cCCCCchHHHHHHHHHHHhcCCC
Confidence 9999999987655432 235578999999999999999999999999999999999 89999999999999998888755
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.| +...+.++..+++.++..||.+|.++.+++.|
T Consensus 218 ~~--p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 KP--PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CC--cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 55 34778899999999999999999999999876
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=236.56 Aligned_cols=183 Identities=17% Similarity=0.231 Sum_probs=154.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++|++... ...++++..+..++.|++.||.|||+.+++||||||.||+++.++.+
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~ 208 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLK-----------EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGII 208 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcE
Confidence 4489999999999999976432 23468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++........ .......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||......+....+..+.
T Consensus 209 kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~-tg~~Pf~~~~~~~~~~~~~~~~ 287 (478)
T PTZ00267 209 KLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL-TLHRPFKGPSQREIMQQVLYGK 287 (478)
T ss_pred EEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999876533221 1123445788999999998888999999999999999999 7999999888877777766653
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .+.+..++.++.+++.+||+.+|++||++++++.+
T Consensus 288 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 288 Y-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred C-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 3 23455678899999999999999999999998754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=217.59 Aligned_cols=183 Identities=29% Similarity=0.542 Sum_probs=151.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++..... .+++..++.++.||+.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~ 139 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGK--------------RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCV 139 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCE
Confidence 4588999999999999976432 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+...............++..|++||......++.++|+||||+++|++++.|..||...........+... .
T Consensus 140 kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~ 218 (256)
T cd05113 140 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-L 218 (256)
T ss_pred EECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-C
Confidence 999999886543332222222344567999999988888999999999999999995499999888777766666555 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
....+...+..+.+++.+||+.+|.+||++.+++..|+
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 33345567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=226.18 Aligned_cols=176 Identities=18% Similarity=0.238 Sum_probs=149.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++..+ .+++..+..++.|++.||.|||+.+++||||||+||+++.++.+
T Consensus 71 ~~lv~e~~~gg~L~~~~~~~~---------------~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~ 135 (316)
T cd05592 71 LFFVMEYLNGGDLMFHIQSSG---------------RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHI 135 (316)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCE
Confidence 348999999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.+..+....+...
T Consensus 136 kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell-~G~~Pf~~~~~~~~~~~i~~~-- 211 (316)
T cd05592 136 KIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML-IGQSPFHGEDEDELFDSILND-- 211 (316)
T ss_pred EEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcC--
Confidence 999999986532221 1223456788999999998888999999999999999999 799999988887777766553
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFP-SIVT 211 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~ 211 (223)
.+..+..++.++.+++.+||+.+|.+||++. ++++
T Consensus 212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 2344566888999999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=217.24 Aligned_cols=199 Identities=27% Similarity=0.447 Sum_probs=156.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhcccc-CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKD-KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..++|||+++|+|.+++...+....+ ...........+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.
T Consensus 71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~ 150 (270)
T cd05047 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 150 (270)
T ss_pred ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe
Confidence 44889999999999999875431111 11111122346899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++++|||++...... ........+..|++||.+....++.++|+||||++++++++.|..||...+.......+...
T Consensus 151 ~kl~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~- 227 (270)
T cd05047 151 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 227 (270)
T ss_pred EEECCCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-
Confidence 999999988532211 11111223456999999888888999999999999999995599999887776666665544
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.....+..++.++.+++.+||..+|.+||++.+++..|.++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 3344455678899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=220.57 Aligned_cols=201 Identities=27% Similarity=0.443 Sum_probs=157.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhcccc-CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKD-KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+++|+|.++++..+....+ ......+....+++..++.++.|++.|+.|||+.|++||||+|.||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 44889999999999999876532111 11111123346899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++++|||++...... ........+..|++||......++.++|+||||++++++++.|..||......+....+...
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~- 239 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 239 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-
Confidence 999999988632211 11111223566999999887788899999999999999995599999887776666655443
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
..+..+...+.++.+++.+||+.+|++||++++++..|.++++..
T Consensus 240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 344445567889999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=218.56 Aligned_cols=189 Identities=32% Similarity=0.602 Sum_probs=152.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
..+++||+++|+|.+++...+.. ......+++..++.++.||+.|+.|||+.+++|+||+|+||+++.++
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~--------~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPR--------PERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCC
Confidence 44789999999999999876431 11223589999999999999999999999999999999999998754
Q ss_pred -CeEEcCCCCCcccchhhhhh-hhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 95 -SVKISLSGLSKDTYQKEYYK-YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 95 -~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
.++++|||++.......... ......+..|++||.+.+..++.++|||||||++|++++.|..||......+....+.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred cceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 58999999987543222111 1122335679999999888899999999999999999966999999887776666554
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.. ..+..+..++..+.+++.+||+.+|++||++.+++++|+
T Consensus 236 ~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GG-GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 43 344556678899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=217.18 Aligned_cols=190 Identities=30% Similarity=0.581 Sum_probs=156.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++|+++|+|.+++....... ....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~---------~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGG---------LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccC---------CcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEE
Confidence 46789999999999997654311 123689999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++......... .......+..|++||.+....++.++|+||||+++|++++.|..||.+....+....+... .
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~ 232 (273)
T cd05035 154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-N 232 (273)
T ss_pred ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C
Confidence 9999998754332211 1112234567999999888888999999999999999995599999888887777766655 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
....+..++.++.+++.+||+.||++||++.++++.|++++
T Consensus 233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 44456678899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=218.41 Aligned_cols=196 Identities=30% Similarity=0.547 Sum_probs=157.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.++++..+....... ........+++..+..++.|++.|+.+||+.|++|+||+|.||+++.++.+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLK-SPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhc-ccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 4488999999999999987643211110 011233568999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++........ ........+..|+|||.+.+..++.++|+||+|+++|+|++.|..||...+.......+..+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999865432221 112233456789999999888899999999999999999944999998888877777776553
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
....+...+..+.+++.+||..+|++||++.|+++.|.
T Consensus 242 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 242 -LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 33345578899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=217.40 Aligned_cols=191 Identities=36% Similarity=0.631 Sum_probs=157.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++....... .......+++..++.++.|+++|+.+||+.+++|+||+|+||+++.++.+
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~ 144 (262)
T cd00192 71 LYLVLEYMEGGDLLDYLRKSRPVF------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVV 144 (262)
T ss_pred eEEEEEeccCCcHHHHHhhccccc------cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcE
Confidence 458899999999999998752100 00012469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||.+....... ........++..|++||......++.++|+||+|++++++++.|..||...........+...
T Consensus 145 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~- 223 (262)
T cd00192 145 KISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG- 223 (262)
T ss_pred EEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-
Confidence 999999987654332 112233456778999999888788999999999999999996579999988887777777664
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.....+..++.++.+++.+||..+|.+||++.+++++|+
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 445556677899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=226.38 Aligned_cols=177 Identities=16% Similarity=0.207 Sum_probs=150.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.|++.||.|||+.+++||||||.||+++.++.+
T Consensus 71 ~~iv~Ey~~~g~L~~~i~~~~---------------~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~ 135 (320)
T cd05590 71 LFFVMEFVNGGDLMFHIQKSR---------------RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHC 135 (320)
T ss_pred EEEEEcCCCCchHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcE
Confidence 448899999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||...+..+....+.....
T Consensus 136 kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~Pf~~~~~~~~~~~i~~~~~ 213 (320)
T cd05590 136 KLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML-CGHAPFEAENEDDLFEAILNDEV 213 (320)
T ss_pred EEeeCCCCeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHh-hCCCCCCCCCHHHHHHHHhcCCC
Confidence 999999986432211 1123346788999999998888999999999999999999 79999999888888777766533
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTF------PSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~ 212 (223)
..+...+.++.+++.+||+.||.+||++ ++++.|
T Consensus 214 --~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 --VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 3355678999999999999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=220.86 Aligned_cols=205 Identities=32% Similarity=0.552 Sum_probs=160.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSG-KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+.+|+|.+++...+......+... ......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~ 178 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 178 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCc
Confidence 4488999999999999987543111000000 001235899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhh-hhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYYK-YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||.+.......... ......+..|++||.+.+..++.++|+||+||++|+|++.|..||......+....+...
T Consensus 179 ~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 258 (307)
T cd05098 179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 258 (307)
T ss_pred EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC
Confidence 9999999886543222111 111223457999999988888999999999999999995589999887776666665544
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhccC
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDVN 222 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 222 (223)
.....+..++.++.+++.+||+.+|.+||++.++++.|.+++....|
T Consensus 259 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 259 -HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 34455567789999999999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=227.45 Aligned_cols=174 Identities=17% Similarity=0.186 Sum_probs=150.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~ 157 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG---------------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHV 157 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCE
Confidence 348899999999999998653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... ....+++.|+|||.+.+..++.++|+|||||++|+|+ +|..||.+.........+.....
T Consensus 158 kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~ 232 (329)
T PTZ00263 158 KVTDFGFAKKVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI-AGYPPFFDDTPFRIYEKILAGRL 232 (329)
T ss_pred EEeeccCceEcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHH-cCCCCCCCCCHHHHHHHHhcCCc
Confidence 999999987543322 2346788899999998888999999999999999999 79999998888777777766543
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
..+...+..+++++.+||+.||.+||+ +++++.|
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 345567888999999999999999987 6888766
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=227.03 Aligned_cols=176 Identities=17% Similarity=0.218 Sum_probs=149.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.++++..+ .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 140 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG---------------VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHI 140 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCE
Confidence 348899999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++..... ......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||...+..+....+.....
T Consensus 141 kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~ 215 (333)
T cd05600 141 KLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFL-CGFPPFSGSTPNETWENLKYWKE 215 (333)
T ss_pred EEEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhh-hCCCCCCCCCHHHHHHHHHhccc
Confidence 9999999875433 223456788999999998888999999999999999999 79999998887776666554322
Q ss_pred cCCCC------CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHS------SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+ ..++.++.+++.+||..+|.+||++++++++
T Consensus 216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11111 2458899999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=216.20 Aligned_cols=185 Identities=30% Similarity=0.488 Sum_probs=155.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+|+|.+++..... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~ 141 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEG-------------IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCC 141 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCE
Confidence 4588999999999999976433 468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|++||.+....++.++|+||||++++++++.|..||.+.+..+....+... .
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~ 220 (260)
T cd05067 142 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-Y 220 (260)
T ss_pred EEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-C
Confidence 999999886543222222223345677999999988888999999999999999994499999988877776666554 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..+.+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 445566778899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=225.43 Aligned_cols=177 Identities=16% Similarity=0.174 Sum_probs=149.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+++||||||.||+++.++.+
T Consensus 68 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~ 132 (312)
T cd05585 68 LYLVLAFINGGELFHHLQREG---------------RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHI 132 (312)
T ss_pred EEEEEcCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcE
Confidence 448899999999999998643 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||.+....+....+....
T Consensus 133 kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~-tg~~pf~~~~~~~~~~~~~~~~- 209 (312)
T cd05585 133 ALCDFGLCKLNMKDDD-KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML-TGLPPFYDENVNEMYRKILQEP- 209 (312)
T ss_pred EEEECcccccCccCCC-ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHH-hCCCCcCCCCHHHHHHHHHcCC-
Confidence 9999999874322211 123346788999999998888999999999999999999 8999999888777777666543
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPT---FPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~ 212 (223)
...+..+++++.+++.+||+.||.+||+ +.+++.|
T Consensus 210 -~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 210 -LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred -CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 3345678899999999999999999985 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=218.32 Aligned_cols=202 Identities=29% Similarity=0.567 Sum_probs=160.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCC---------CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKS---------GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARN 87 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~---------~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~n 87 (223)
..+++||+.+|+|.+++........... -........+++..++.++.|++.|+.|||+.+++|+||+|+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 3378999999999999986432111000 0111223468999999999999999999999999999999999
Q ss_pred eeeecCCCeEEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy15108 88 CLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166 (223)
Q Consensus 88 il~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~ 166 (223)
|+++.++.++++|||++....... .........+..|++||...+..++.++|+||||+++++|++.|..||.+....+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987543222 1111223445679999998888889999999999999999955999998888777
Q ss_pred HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 167 VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
....+... ..+..+..++.++.+++..||+.+|++||+++++++.|++++.+
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 LFNLLKTG-YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHhCC-CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 76665544 45555667889999999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=226.01 Aligned_cols=177 Identities=18% Similarity=0.254 Sum_probs=151.8
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+||||++||++..+|...+ .|+++.+..++.+++-|+..+|+.|++||||||.|+|+|..|++||
T Consensus 218 LiMEylPGGD~mTLL~~~~---------------~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKL 282 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD---------------TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKL 282 (550)
T ss_pred EEEEecCCccHHHHHHhcC---------------cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEee
Confidence 8999999999999998764 4999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchh----------------------h-h-----------------------hhhhcCCccccccccccccc
Q psy15108 99 SLSGLSKDTYQK----------------------E-Y-----------------------YKYRNAILPLRWLPYEAVFD 132 (223)
Q Consensus 99 ~df~~~~~~~~~----------------------~-~-----------------------~~~~~~~~~~~~~~pe~~~~ 132 (223)
+|||++...... . . ......+||+.|+|||++.+
T Consensus 283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~ 362 (550)
T KOG0605|consen 283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG 362 (550)
T ss_pred ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc
Confidence 999998432110 0 0 00113478999999999999
Q ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC--CCCCCChHHHHHHHHHhcCCCCCCCCC---HH
Q psy15108 133 DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW--KHSSKTPEYITSLHEKCIHPHPHQRPT---FP 207 (223)
Q Consensus 133 ~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ 207 (223)
..|....|.||+|||+|||+ .|.+||.+.++.++...|......+ +....++++.+++|.+|+. ||++|.. +.
T Consensus 363 kgY~~~cDwWSLG~ImyEmL-vGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 363 KGYGKECDWWSLGCIMYEML-VGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred CCCCccccHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence 99999999999999999999 8999999999999999998766444 4445678999999999999 9999965 67
Q ss_pred HHHHH
Q psy15108 208 SIVTQ 212 (223)
Q Consensus 208 ~ll~~ 212 (223)
||.+|
T Consensus 441 EIK~H 445 (550)
T KOG0605|consen 441 EIKKH 445 (550)
T ss_pred HHhcC
Confidence 76654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=222.27 Aligned_cols=180 Identities=19% Similarity=0.306 Sum_probs=145.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++...+. ..+++..+..++.|++.|+.|||+.+++||||||+||+++.++.+
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~ 141 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNMGN-------------PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHI 141 (285)
T ss_pred EEEEEEecCCCcHHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCE
Confidence 3488999999999999875432 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--C
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES--K 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~--~ 174 (223)
+++|||++....... ......++..|+|||.+.+..++.++||||+||++|+|+ +|..||...........+.. .
T Consensus 142 kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~-~g~~pf~~~~~~~~~~~~~~~~~ 218 (285)
T cd05631 142 RISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMI-QGQSPFRKRKERVKREEVDRRVK 218 (285)
T ss_pred EEeeCCCcEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHH-hCCCCCCCCCcchhHHHHHHHhh
Confidence 999999987543221 123346788999999999889999999999999999999 79999987654322222211 1
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
......+...+.++.+++.+||+.||.+||+ ++++++|
T Consensus 219 ~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 219 EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1223345568899999999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=225.98 Aligned_cols=177 Identities=16% Similarity=0.258 Sum_probs=149.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+
T Consensus 70 ~~lv~E~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 134 (323)
T cd05595 70 LCFVMEYANGGELFFHLSRER---------------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHI 134 (323)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCE
Confidence 338899999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||...+.......+.....
T Consensus 135 kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell-~g~~Pf~~~~~~~~~~~~~~~~~ 212 (323)
T cd05595 135 KITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHERLFELILMEEI 212 (323)
T ss_pred EecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHH-hCCCCCCCCCHHHHHHHHhcCCC
Confidence 999999876432211 1122346788999999998888999999999999999999 79999988887777766655433
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
..+..+++++.+++.+||+.||.+|+ ++.+++++
T Consensus 213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 33567889999999999999999998 78888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=219.88 Aligned_cols=195 Identities=30% Similarity=0.523 Sum_probs=157.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+|+|.+++...... .+.....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLG-------EANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhcccc-------ccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcE
Confidence 44677889999999999765331 01122469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||+++........ ......++..|++||.+....++.++||||+|+++|++++.|..||...+.......+...
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 235 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG- 235 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-
Confidence 99999998754332211 1112334567999999988888999999999999999995599999888777766665554
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..+.....+++++.+++.+||..+|++||++.++++.|+++.+.
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 236 YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 44445566789999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=226.19 Aligned_cols=177 Identities=16% Similarity=0.248 Sum_probs=149.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+++||||||+||+++.++.+
T Consensus 70 ~~lv~Ey~~~g~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~ 134 (328)
T cd05593 70 LCFVMEYVNGGELFFHLSRER---------------VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHI 134 (328)
T ss_pred EEEEEeCCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcE
Confidence 338899999999999997643 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||...+..+....+.....
T Consensus 135 kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell-tG~~Pf~~~~~~~~~~~~~~~~~ 212 (328)
T cd05593 135 KITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHEKLFELILMEDI 212 (328)
T ss_pred EEecCcCCccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHh-hCCCCCCCCCHHHHHHHhccCCc
Confidence 999999986432211 1122346788999999998888999999999999999999 79999988887777666654432
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
..+..++.++.+++.+||+.||.+|+ ++.++++|
T Consensus 213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 --KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 34567889999999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=216.83 Aligned_cols=185 Identities=30% Similarity=0.450 Sum_probs=154.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++.++.. ..+++..++.++.|++.||.|||+.+++|+||+|.||+++.++.+
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~ 136 (257)
T cd05040 70 LMMVTELAPLGSLLDRLRKDAL-------------GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKV 136 (257)
T ss_pred EEEEEEecCCCcHHHHHHhccc-------------ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEE
Confidence 4478899999999999987542 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++....... ........++..|++||.+....++.++|+||||+++++|++.|..||......+....+...
T Consensus 137 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 216 (257)
T cd05040 137 KIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE 216 (257)
T ss_pred EeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 999999987653321 111112345677999999988889999999999999999995599999888777777666654
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
...+..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 4445555677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=216.94 Aligned_cols=192 Identities=30% Similarity=0.600 Sum_probs=153.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++.+.+...... +....+++..+..++.|+++|+.|||+.+++|+||||+||+++.++.+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENN-----PVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCcccccc-----ccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 448899999999999997643311100 112357889999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++......... .......+..|++||.+....++.++|+||||+++|++++.+..||.+....+....+....
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998654322211 11123446779999999888899999999999999999955889998888777766665542
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 239 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 239 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 23345677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=224.12 Aligned_cols=176 Identities=16% Similarity=0.225 Sum_probs=147.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.+++...+ .+++..+..++.|+++||+|||+.|++||||||.||+++.++.++
T Consensus 72 ~lv~E~~~~g~L~~~i~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~k 136 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDKG---------------RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIK 136 (316)
T ss_pred EEEECCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence 38899999999999997643 489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++....... .......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||...+..+..+.+....
T Consensus 137 l~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~-~g~~Pf~~~~~~~~~~~~~~~~-- 212 (316)
T cd05620 137 IADFGMCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML-IGQSPFHGDDEDELFESIRVDT-- 212 (316)
T ss_pred eCccCCCeecccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCC--
Confidence 99999886422111 1123345788999999999888999999999999999999 7999999888877777765543
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFP-SIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~~ 212 (223)
...+..++.++++++.+||+.||++||++. ++++|
T Consensus 213 ~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 213 PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 333456788999999999999999999984 66533
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=219.94 Aligned_cols=188 Identities=31% Similarity=0.556 Sum_probs=152.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.++++.... ..+++.++..++.|++.|+.|||+++++|+||+|.||+++.++.+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 180 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-------------SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIV 180 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeE
Confidence 4488999999999999976432 348999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ........++..|++||.+....++.++|+||+|+++|++++.|..||................
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~ 260 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG 260 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC
Confidence 999999987543221 1111223446779999999888899999999999999999955899998776554443333332
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
.....+...+.++.+++.+||..+|++||++.++++.|.+++
T Consensus 261 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 261 YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 344445567889999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=214.30 Aligned_cols=183 Identities=29% Similarity=0.503 Sum_probs=149.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+++|.+++...+ ..+++..++.++.|++.||.|||+.+++|+||+|.||+++.++.+
T Consensus 68 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~ 133 (252)
T cd05084 68 IYIVMELVQGGDFLTFLRTEG--------------PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVL 133 (252)
T ss_pred eEEEEeeccCCcHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcE
Confidence 448899999999999997543 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhh-hhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYK-YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++.......... ......+..|++||.+....++.++|+||+|+++|++++.+..||...........+...
T Consensus 134 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~- 212 (252)
T cd05084 134 KISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG- 212 (252)
T ss_pred EECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-
Confidence 999999986533211111 111123456999999988889999999999999999995699999877766655555443
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 213 VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 334455677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=219.89 Aligned_cols=198 Identities=29% Similarity=0.541 Sum_probs=150.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKS----GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS 92 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~----~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~ 92 (223)
..+++||+.+|+|.+++........... .........+++..++.++.||+.||.|||+.|++|+||||.||+++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~ 173 (304)
T cd05096 94 LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE 173 (304)
T ss_pred eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcC
Confidence 4488999999999999976532111100 011223356899999999999999999999999999999999999999
Q ss_pred CCCeEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCHHHHHHH
Q psy15108 93 DLSVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFN-KGEMPFPDLSDDQVLSQ 170 (223)
Q Consensus 93 ~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~-~~~~p~~~~~~~~~~~~ 170 (223)
++.++++|||++........ .......++..|+|||.+....++.++|+||||+++|+|++ ++..||......+....
T Consensus 174 ~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~ 253 (304)
T cd05096 174 NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253 (304)
T ss_pred CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHH
Confidence 99999999999875432221 11223344678999999888889999999999999999974 36778887776665544
Q ss_pred HHhC------cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 171 LESK------KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 171 ~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.... ......+..++..+.+++.+||+.+|++||++.++.+.|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 254 AGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 3221 0112234567889999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=218.39 Aligned_cols=202 Identities=34% Similarity=0.567 Sum_probs=159.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccC-CCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDK-SGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+.+|+|.+++.......... ..........+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~ 172 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV 172 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCc
Confidence 447899999999999998754311110 0011112346899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||+++........ .......+..|++||.+.+..++.++|+||||+++|++++.|..||......+....+...
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 252 (314)
T cd05099 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG 252 (314)
T ss_pred EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998754332211 1112223456999999988889999999999999999995589999888877777766554
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.....+..++.++.+++.+||+.+|++||++.++++.|.++...
T Consensus 253 -~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 253 -HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 33445567788999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=216.71 Aligned_cols=195 Identities=30% Similarity=0.559 Sum_probs=155.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCC-CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKS-GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
++++|+.+++|.+++........... .........+++..+..++.|++.||.|||+.|++||||||.||+++.++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 57799999999999975432111100 01111234689999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||+++....... ........++.|+|||.+....++.++|+||+|+++|+|++.|..||.+....+....+....
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~- 243 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ- 243 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 999999875433221 112334456789999999888889999999999999999955889999888888777776663
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
....+..++.++.+++..||+.+|.+||++++++..|.
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 244 VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 33456678999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=215.30 Aligned_cols=186 Identities=27% Similarity=0.458 Sum_probs=154.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.++++... +.+++.++..++.|++.|+.|||+.|++|+|++|.||+++.++.+
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD--------------GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLEC 146 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcE
Confidence 348899999999999997532 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhh--hhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYYK--YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++.......... ......+..|++||.+....++.++|+||||+++|++++.|..||......+....+...
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~ 226 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226 (268)
T ss_pred EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC
Confidence 999999886543221111 111223456999999988888999999999999999985599999888777777776654
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
...+.+..++.++.+++.+||+.+|++||++.++++.|.+++
T Consensus 227 -~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 227 -FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 344445567889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=212.70 Aligned_cols=183 Identities=30% Similarity=0.518 Sum_probs=151.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++.... ..+++..++.++.+++.|+.|+|+.|++|+||+|.||+++.++.+
T Consensus 67 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~ 132 (250)
T cd05085 67 IYIVMELVPGGDFLSFLRKKK--------------DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVL 132 (250)
T ss_pred cEEEEECCCCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeE
Confidence 448899999999999997543 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++................+..|++||.+....++.++|+||||+++|++++.|..||...........+... .
T Consensus 133 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-~ 211 (250)
T cd05085 133 KISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-Y 211 (250)
T ss_pred EECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999886433222111122234567999999988888999999999999999995599999888777666666544 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
....+..++..+.+++.+||+.+|++||++.++.+.|.
T Consensus 212 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 44455678899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=218.17 Aligned_cols=188 Identities=23% Similarity=0.417 Sum_probs=155.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+++|+|.+++..... .+++..+..++.|++.||.|||+++++|+||+|.||+++.++.+
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~ 148 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKD--------------NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHV 148 (303)
T ss_pred ceeeehhcCCCCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCce
Confidence 4478999999999999976432 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++........ .......++..|++||.+.+..++.++|+||||+++|++++.|..||.+.........+...
T Consensus 149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~- 227 (303)
T cd05110 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG- 227 (303)
T ss_pred EEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-
Confidence 9999999875432221 11122344567999999988889999999999999999986689999887766655555443
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
...+.+..++..+.+++..||..+|++||+++++++.|.++..+
T Consensus 228 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 228 ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 44444566788899999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=227.82 Aligned_cols=179 Identities=17% Similarity=0.255 Sum_probs=151.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||.||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~ 140 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD---------------VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHI 140 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCE
Confidence 458899999999999998653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh----------------------------hhhhhcCCcccccccccccccCCCCcccchHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKE----------------------------YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLI 148 (223)
Q Consensus 97 ~l~df~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il 148 (223)
+++|||++....... ........++..|+|||.+.+..++.++|||||||++
T Consensus 141 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 220 (350)
T cd05573 141 KLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220 (350)
T ss_pred EeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhh
Confidence 999999987543221 0112345678899999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHHh--CcccCCCCCCChHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q psy15108 149 WEIFNKGEMPFPDLSDDQVLSQLES--KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT-FPSIVTQ 212 (223)
Q Consensus 149 ~~l~~~~~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~~ 212 (223)
|+|+ +|..||...........+.. .....+....+++++.+++..|+. +|.+||+ +++++++
T Consensus 221 ~ell-~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 221 YEML-YGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred hhhc-cCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9999 89999998887777776665 223333334468999999999998 9999999 9999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=215.53 Aligned_cols=180 Identities=17% Similarity=0.231 Sum_probs=151.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++...+ .+++..+..++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYG---------------ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE
Confidence 337789999999999998653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhh--hcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYYKY--RNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++........... ....++..|+|||.+.+..++.++|+||+|+++|+++ +|+.||...............
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~~~~~~~~~~~ 222 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML-TEKPPWAEFEAMAAIFKIATQ 222 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHH-hCCCCccccchHHHHHHHhcc
Confidence 9999999865432211111 2344667899999998888999999999999999999 799999887766666555555
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
......+..++.++.+++.+||..+|.+||++.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 45556667789999999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=216.22 Aligned_cols=192 Identities=46% Similarity=0.786 Sum_probs=158.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.++++....... ..+...+++..+..++.|++.||.|||+.+++|+||+|.||+++..+.+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~------~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDE------KLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccc------cccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcE
Confidence 4588999999999999987642100 0112258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|++||.+.+..++.++|+||||++++++++.|..||...........+.....
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 99999988654333222333445567799999988888889999999999999999558899988877777777766655
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.+..+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 66666778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=226.13 Aligned_cols=174 Identities=14% Similarity=0.152 Sum_probs=150.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||.||+++.++.+
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNK---------------RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCE
Confidence 348899999999999998653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...... .....+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||...+.......+.....
T Consensus 171 kL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell-~G~~Pf~~~~~~~~~~~i~~~~~ 245 (340)
T PTZ00426 171 KMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL-VGCPPFYANEPLLIYQKILEGII 245 (340)
T ss_pred EEecCCCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHh-cCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999998754322 12346788899999998888899999999999999999 89999998888777777766543
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
..+...++.+.+++.+|++.||.+|+ +++++++|
T Consensus 246 --~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 --YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 33556788899999999999999995 89998876
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=224.61 Aligned_cols=177 Identities=16% Similarity=0.204 Sum_probs=150.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.|+++||.|||+.|++||||||+||+++.++.+
T Consensus 71 ~~lv~E~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~ 135 (321)
T cd05591 71 LFFVMEYVNGGDLMFQIQRSR---------------KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHC 135 (321)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCE
Confidence 348999999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||...+.......+.....
T Consensus 136 kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~-tg~~Pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05591 136 KLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMM-AGQPPFEADNEDDLFESILHDDV 213 (321)
T ss_pred EEeecccceecccCCc-cccccccCccccCHHHHcCCCCCCccceechhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999998864322211 122345788899999998888999999999999999999 79999999888888877766533
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCC-------CHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRP-------TFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-------s~~~ll~~ 212 (223)
..+..++.++.+++.+||+.||++|| ++++++++
T Consensus 214 --~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 --LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 23456788999999999999999999 77788765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=224.16 Aligned_cols=177 Identities=18% Similarity=0.264 Sum_probs=149.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 140 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG---------------KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHI 140 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCE
Confidence 337899999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|+|||.+.+..++.++|+||+||++|+|+ +|+.||.+.+..+....+....
T Consensus 141 kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell-tG~~pf~~~~~~~~~~~i~~~~- 217 (324)
T cd05587 141 KIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQPPFDGEDEDELFQSIMEHN- 217 (324)
T ss_pred EEeecCcceecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCC-
Confidence 999999886432111 1123345788999999999888999999999999999999 7999999888877777776543
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTF-----PSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~ 212 (223)
...+...+.++.+++.+||+.||.+|++. +++++|
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 33456788899999999999999999986 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=217.16 Aligned_cols=207 Identities=30% Similarity=0.514 Sum_probs=175.8
Q ss_pred hHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCC
Q psy15108 3 LKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKD 82 (223)
Q Consensus 3 ~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 82 (223)
+.+++..+.++.+...+...+..-|+|..+|...+.+- ++ ....++-.++..++.|++.|+.|||+.+++|.|
T Consensus 349 ll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~-~~------~aqtvtt~qlV~masQla~am~hlh~~~ViHkD 421 (563)
T KOG1024|consen 349 LLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDD-PS------YAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKD 421 (563)
T ss_pred ccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCC-Cc------cccchhHHHHHHHHHHHHHHHHHHHhcCcccch
Confidence 44444555554444555566677799999999766421 11 235788999999999999999999999999999
Q ss_pred CCCCCeeeecCCCeEEcCCCCCcccchhhhhhhh-cCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q psy15108 83 IAARNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPD 161 (223)
Q Consensus 83 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~ 161 (223)
|.++|++++...++|++|-.+++..++..+.-.+ ....|..|+++|.+....|+..+|+||||+++||++|.|+.|+..
T Consensus 422 iAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae 501 (563)
T KOG1024|consen 422 IAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE 501 (563)
T ss_pred hhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence 9999999999999999999999987766533322 345578899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 162 LSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
.++.++...++++ ++..+|-+||+++..+|..||+.+|++||+++++...|.+..
T Consensus 502 IDPfEm~~ylkdG-yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 502 IDPFEMEHYLKDG-YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred cCHHHHHHHHhcc-ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 9999999999888 888889999999999999999999999999999999998754
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=212.88 Aligned_cols=185 Identities=32% Similarity=0.504 Sum_probs=155.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++..... ..+++..+..++.+++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~-------------~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~ 142 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEG-------------KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVC 142 (261)
T ss_pred eEEEEeccCCCCHHHHHhcccc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCE
Confidence 4588999999999999986432 468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+................+..|++||.+.+..++.++|+||+|++++++++.|+.||.+.........+... .
T Consensus 143 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~ 221 (261)
T cd05034 143 KIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-Y 221 (261)
T ss_pred EECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999987654332222233344567999999988888999999999999999995599999888877777766554 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..+.+...+.++.+++.+||..+|.+||+++++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 445556678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=215.73 Aligned_cols=198 Identities=33% Similarity=0.556 Sum_probs=155.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCC--CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGS--GKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~ 94 (223)
..++|||+.+|+|.+++..........+.. .......+++.++..++.|++.|+.|||+++++|+||+|.||+++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 348899999999999997554321111110 111234589999999999999999999999999999999999999999
Q ss_pred CeEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 95 SVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
.++++|||++........ .......++..|++||.+.+..++.++|+||||+++|+|++.|..||.+.......+.+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999875433221 1122334456799999998888899999999999999999559999988777666666655
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
. ...+.+..++..+.+++.+||+.+|.+||++.++.++|..
T Consensus 242 ~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 R-QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred C-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 4 3344566788999999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=222.93 Aligned_cols=176 Identities=16% Similarity=0.238 Sum_probs=148.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+++||||||.||+++.++.+
T Consensus 71 ~~lv~ey~~~g~L~~~l~~~~---------------~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~ 135 (316)
T cd05619 71 LFFVMEYLNGGDLMFHIQSCH---------------KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHI 135 (316)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCE
Confidence 338899999999999998643 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||...+..+....+....
T Consensus 136 kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~-~G~~pf~~~~~~~~~~~i~~~~- 212 (316)
T cd05619 136 KIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML-IGQSPFHGHDEEELFQSIRMDN- 212 (316)
T ss_pred EEccCCcceECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCC-
Confidence 999999886432111 1122345788899999998888999999999999999999 7999999888877777765543
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFP-SIVT 211 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~ 211 (223)
+..+..++.++.+++.+||+.+|++||++. ++++
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 213 -PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 233456788899999999999999999996 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=226.56 Aligned_cols=166 Identities=30% Similarity=0.613 Sum_probs=136.7
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhh-hhhhhcCCccccccccccc
Q psy15108 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAV 130 (223)
Q Consensus 52 ~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~ 130 (223)
..+++..+..++.|+++|+.|||+.+++|+||||.||+++.++.++++|||++....... ........++..|++||.+
T Consensus 232 ~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 311 (400)
T cd05105 232 EGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI 311 (400)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence 358999999999999999999999999999999999999999999999999987543222 1122234456779999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHH
Q psy15108 131 FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV-LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209 (223)
Q Consensus 131 ~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 209 (223)
.+..++.++||||||+++|+|++.|..||........ ...+... ..+..+..++.++.+++.+||+.+|++||++.++
T Consensus 312 ~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l 390 (400)
T cd05105 312 FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG-YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390 (400)
T ss_pred cCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence 8888999999999999999999668899987654333 3333333 4455566788999999999999999999999999
Q ss_pred HHHHHHHhh
Q psy15108 210 VTQLSDAMC 218 (223)
Q Consensus 210 l~~L~~~~~ 218 (223)
.+.|+++++
T Consensus 391 ~~~l~~l~~ 399 (400)
T cd05105 391 SDIVESLLP 399 (400)
T ss_pred HHHHHHHcC
Confidence 999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=223.90 Aligned_cols=176 Identities=18% Similarity=0.277 Sum_probs=149.5
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||.||+++.++.++
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~k 141 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQVG---------------RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred EEEEcCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEE
Confidence 38899999999999997653 489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++....... .......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.+.......+.....
T Consensus 142 L~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell-tg~~Pf~~~~~~~~~~~i~~~~~- 218 (323)
T cd05616 142 IADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQAPFEGEDEDELFQSIMEHNV- 218 (323)
T ss_pred EccCCCceecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCC-
Confidence 99999986432211 1123456788999999999888999999999999999999 79999998888888777776543
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTF-----PSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~ 212 (223)
..+...+.++.+++.+|++.+|.+|++. ++++++
T Consensus 219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 3356788999999999999999999985 565543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=212.63 Aligned_cols=181 Identities=31% Similarity=0.518 Sum_probs=152.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++..... ..+++..++.++.|++.|+.|||+.|++||||+|.||+++.++.+
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~ 139 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGR-------------ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVA 139 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcE
Confidence 4588999999999999986533 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...... ......+..|++||.+....++.++|+||||++++++++.|..||......+....+... .
T Consensus 140 kl~Dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~ 214 (254)
T cd05083 140 KVSDFGLARVGSMG----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-Y 214 (254)
T ss_pred EECCCccceecccc----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-C
Confidence 99999988643221 122334567999999888888999999999999999995699999988877776666554 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
....+..++..+.+++.+||+.+|++||++++++..|++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 444456788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=215.84 Aligned_cols=192 Identities=32% Similarity=0.622 Sum_probs=155.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++......... ......+++..++.++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAEN-----NPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhh-----ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 44789999999999999865431110 0112357899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||+++........ ......++..|++||.+....++.++|+||||+++|++++.|..||......+....+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~- 237 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG- 237 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-
Confidence 99999998754433211 1223345677999999888888999999999999999995599999888887777777644
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
..+..+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 344556678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=222.92 Aligned_cols=177 Identities=17% Similarity=0.247 Sum_probs=149.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~---------------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~ 135 (318)
T cd05570 71 LFFVMEYVNGGDLMFHIQRSG---------------RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHI 135 (318)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcE
Confidence 348899999999999997653 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|+|||.+.+..++.++|+||+||++|+++ +|..||...+.......+.....
T Consensus 136 kl~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~-~G~~pf~~~~~~~~~~~i~~~~~ 213 (318)
T cd05570 136 KIADFGMCKEGILGGV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEML-AGQSPFEGDDEDELFQSILEDEV 213 (318)
T ss_pred EecccCCCeecCcCCC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHh-hCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999998864222111 112345778899999999888999999999999999999 79999998887777776665433
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTF-----PSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~ 212 (223)
..+..++.++.+++.+||+.||.+||++ .+++++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 --RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 3355678999999999999999999999 777754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=230.54 Aligned_cols=183 Identities=30% Similarity=0.439 Sum_probs=165.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.++|+|.++.|+|.+.|++... ..|-...+..++.||+.|+.||.+++++|||+..+|+++.....+
T Consensus 185 ~mMV~ELaplGSLldrLrka~~-------------~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtV 251 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKK-------------AILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTV 251 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccc-------------cceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccccee
Confidence 3488999999999999998443 579999999999999999999999999999999999999988899
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
||+|||+.+.....+ +........++.|.+||++....++.++|+|++||++|||+++|..||.+-....+++.+..+
T Consensus 252 KI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~ 331 (1039)
T KOG0199|consen 252 KICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG 331 (1039)
T ss_pred eeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc
Confidence 999999999876554 333445677888999999999999999999999999999999999999999999999999854
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
.+++.+..|++.+++++..||..+|++||+|..|.+.+
T Consensus 332 -erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 -ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 78888999999999999999999999999999997554
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=214.59 Aligned_cols=198 Identities=31% Similarity=0.603 Sum_probs=157.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||+.+|+|.++++..+.... .......++...+..++.|++.||.|||+.+++|+||||.||+++.++.+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAE-----NNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccc-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 4488999999999999987543211 11122456788999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhh-hhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYK-YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||+++......... .....++..|++||.+....++.++|+|||||++|++++.+..||.+....+....+...
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~- 237 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG- 237 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999987543322111 122334567999999988888999999999999999996688999888877766665544
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
.....+..+++.+.+++.+||+.+|++||++.++++.|.+.+...
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 233445567889999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=211.96 Aligned_cols=181 Identities=31% Similarity=0.555 Sum_probs=153.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.++++.... ..+++..+..++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~ 141 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGR-------------AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVA 141 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCE
Confidence 4488999999999999986542 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+....... .....+..|++||.+....++.++|+||+|++++++++.|..||...........+... .
T Consensus 142 ~l~d~g~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~ 216 (256)
T cd05039 142 KVSDFGLAKEASQGQ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-Y 216 (256)
T ss_pred EEccccccccccccc----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-C
Confidence 999999987552221 12334567999999888888899999999999999995699999888777766665554 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
.+..+..+++++.+++.+||..+|++||+++++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 445556788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=212.58 Aligned_cols=185 Identities=29% Similarity=0.488 Sum_probs=153.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++..... ..+++..++.++.|++.|+.|||+.|++|+||+|.||+++..+.+
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~ 141 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEG-------------SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVC 141 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCc-------------cccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcE
Confidence 4478999999999999976432 457899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+...............++..|++||.+....++.++|+||||++++++++.|..||...+.......+... .
T Consensus 142 ~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~ 220 (260)
T cd05073 142 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-Y 220 (260)
T ss_pred EECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-C
Confidence 999999886543322112222344567999999988888999999999999999995599999988777666666554 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..+.+...+.++.+++.+||+.+|++||++.++++.|..
T Consensus 221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 444556788899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=222.30 Aligned_cols=177 Identities=16% Similarity=0.231 Sum_probs=150.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||+.+|+|.++++..+ .+++..+..++.|++.||.|||+.|++||||||.||+++.++.+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 139 (323)
T cd05584 75 LYLILEYLSGGELFMHLEREG---------------IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHV 139 (323)
T ss_pred EEEEEeCCCCchHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCE
Confidence 448899999999999998654 48899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+|+|||++........ ......++..|+|||.+.+..++.++||||+||++|+|+ +|..||...+.......+....
T Consensus 140 kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~G~~pf~~~~~~~~~~~~~~~~- 216 (323)
T cd05584 140 KLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDML-TGAPPFTAENRKKTIDKILKGK- 216 (323)
T ss_pred EEeeCcCCeecccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHh-cCCCCCCCCCHHHHHHHHHcCC-
Confidence 9999999864322211 122346788999999998888899999999999999999 8999999888877777766653
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
...+..+++.+.+++.+||+.+|++|| ++.+++.+
T Consensus 217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 344567789999999999999999999 78888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=224.09 Aligned_cols=177 Identities=19% Similarity=0.201 Sum_probs=143.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++|||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||.||+++.++.++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~k 145 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---------------NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVV 145 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEE
Confidence 38899999999999997653 489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLS----DDQVLSQLE 172 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~----~~~~~~~~~ 172 (223)
++|||++...............++..|+|||.+.+.. ++.++|||||||++|+|+ +|..||.... .......+.
T Consensus 146 l~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~ 224 (332)
T cd05614 146 LTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL-TGASPFTLEGERNTQSEVSRRIL 224 (332)
T ss_pred EeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhh-cCCCCCCCCCCCCCHHHHHHHHh
Confidence 9999998754332211223346788999999987654 788999999999999999 7999996432 223333333
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
.. ....+...+..+.+++.+||+.||++|| +++++++|
T Consensus 225 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 225 KC--DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 32 2344566889999999999999999999 67788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=226.13 Aligned_cols=195 Identities=24% Similarity=0.286 Sum_probs=158.7
Q ss_pred hHHHHHHhhc-CCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccC
Q psy15108 3 LKQFLLATRK-DSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHK 81 (223)
Q Consensus 3 ~~~~~~~~~~-~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 81 (223)
+++++-+-++ .++..-+|+|||.+|.+..-= .....+++.++++++..++.||+|||.+||+||
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---------------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHR 234 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---------------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHR 234 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCC---------------CCcccccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 3344444444 333355899999999854322 112239999999999999999999999999999
Q ss_pred CCCCCCeeeecCCCeEEcCCCCCcccch----hhhhhhhcCCcccccccccccccCC----CCcccchHHHHHHHHHHHh
Q psy15108 82 DIAARNCLISSDLSVKISLSGLSKDTYQ----KEYYKYRNAILPLRWLPYEAVFDDE----FSTKSDVYAYACLIWEIFN 153 (223)
Q Consensus 82 di~~~nil~~~~~~~~l~df~~~~~~~~----~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slG~il~~l~~ 153 (223)
||||.|+|++.+|.+||.|||.+..... ..........||+.|+|||.+.... .+.+.||||+||++|.++
T Consensus 235 DIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll- 313 (576)
T KOG0585|consen 235 DIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL- 313 (576)
T ss_pred ccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh-
Confidence 9999999999999999999998875411 1112234489999999999987632 356899999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 154 KGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 154 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
.|+.||.+....++...|.......+..+.+.+.++++|.+||.+||++|.++.+|..|.
T Consensus 314 fG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 314 FGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred hccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 899999999999999999998777777777889999999999999999999999997764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=226.01 Aligned_cols=180 Identities=13% Similarity=0.201 Sum_probs=148.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.++++.... .+++..+..++.|++.||.|||+.+++||||||.||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~--------------~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~ 141 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED--------------QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHI 141 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCE
Confidence 4488999999999999986532 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF------DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~------~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~ 170 (223)
+++|||++...............++..|+|||.+. ...++.++||||+||++|+|+ +|..||...........
T Consensus 142 kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~-~g~~Pf~~~~~~~~~~~ 220 (330)
T cd05601 142 KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI-YGRSPFHEGTSAKTYNN 220 (330)
T ss_pred EeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeec-cCCCCCCCCCHHHHHHH
Confidence 99999998754433222222346788899999986 345778999999999999999 79999988877777666
Q ss_pred HHhCcc--cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKKL--CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+..... ..+.....+.++.+++.+|+. +|.+||++++++.|
T Consensus 221 i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 221 IMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 655322 223334578899999999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=218.07 Aligned_cols=180 Identities=15% Similarity=0.208 Sum_probs=141.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.++++..+.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~ 139 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMP---------------NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVL 139 (287)
T ss_pred EEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcE
Confidence 45899999988776655432 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc-
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK- 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~- 175 (223)
+++|||++...............++..|+|||.+.+..++.++|+||+||++|+|+ +|+.||...+.......+....
T Consensus 140 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~-~g~~pf~~~~~~~~~~~~~~~~~ 218 (287)
T cd07848 140 KLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELS-DGQPLFPGESEIDQLFTIQKVLG 218 (287)
T ss_pred EEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhhC
Confidence 99999998764332222223346788899999998888999999999999999999 7999998776544332221100
Q ss_pred ------------------ccCCC-----------CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ------------------LCWKH-----------SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ------------------~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+. ...++.++.+++.+||+.||++|||++++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 219 PLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred CCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 11357789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=219.89 Aligned_cols=178 Identities=16% Similarity=0.242 Sum_probs=143.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~ 95 (223)
..+||||+++|+|.++++..+ .+++..+..++.|++.|+.|||+. +++|+||||.||+++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~ 142 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAK---------------RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE 142 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc
Confidence 448899999999999998653 489999999999999999999986 6999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE--- 172 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~--- 172 (223)
++++|||++...... ......++..|+|||.+.+..++.++|+||+||++|+++ +|+.||......+....+.
T Consensus 143 ~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~-tg~~p~~~~~~~~~~~~~~~~~ 218 (331)
T cd06649 143 IKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA-IGRYPIPPPDAKELEAIFGRPV 218 (331)
T ss_pred EEEccCccccccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHhcccc
Confidence 999999998654322 123346788999999998888999999999999999999 7999997665443322211
Q ss_pred -------------------------------------------hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHH
Q psy15108 173 -------------------------------------------SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209 (223)
Q Consensus 173 -------------------------------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 209 (223)
...........++.++.+++.+||+.||++||+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el 298 (331)
T cd06649 219 VDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML 298 (331)
T ss_pred cccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH
Confidence 1100111112467889999999999999999999999
Q ss_pred HHHH
Q psy15108 210 VTQL 213 (223)
Q Consensus 210 l~~L 213 (223)
+++-
T Consensus 299 l~h~ 302 (331)
T cd06649 299 MNHT 302 (331)
T ss_pred hcCh
Confidence 9874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=233.63 Aligned_cols=185 Identities=16% Similarity=0.268 Sum_probs=154.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCCCCCeeeecCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR--LIHKDIAARNCLISSDL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~~~nil~~~~~ 94 (223)
+.+.||||.+|.|-|+|+++.. ..|++.++++|++++++|+.+||... |+|||||.+|||+..++
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq-------------~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ-------------TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG 183 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh-------------ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence 3478999999999999997755 45999999999999999999999886 99999999999999999
Q ss_pred CeEEcCCCCCcccchhh-------hh-hhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q psy15108 95 SVKISLSGLSKDTYQKE-------YY-KYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS 163 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~-------~~-~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~ 163 (223)
..||||||-+....... .. ..-...-|+.|++||.+. +.+.+.|+|||+|||+||.|| +...||.+..
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLC-y~t~PFe~sg 262 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLC-YFTTPFEESG 262 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHH-HhCCCcCcCc
Confidence 99999999775432111 11 112345578899999875 556899999999999999999 8999998764
Q ss_pred HHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 164 DDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
... |..+.+..+..+.++..+++||+.||+.+|.+||++-+++..+.++...
T Consensus 263 ~la----Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 KLA----ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred cee----EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 433 4455677777788999999999999999999999999999999887654
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=223.33 Aligned_cols=172 Identities=17% Similarity=0.180 Sum_probs=146.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.||++||.|||+.|++||||||.||+++.++.+
T Consensus 71 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~ 135 (323)
T cd05575 71 LYFVLDYVNGGELFFHLQRER---------------SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHV 135 (323)
T ss_pred EEEEEcCCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcE
Confidence 348899999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|+|||.+.+..++.++|+|||||++|+|+ +|..||...+..+....+.....
T Consensus 136 kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~ 213 (323)
T cd05575 136 VLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRDTAEMYDNILNKPL 213 (323)
T ss_pred EEeccCCCcccccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhh-cCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999886432211 1122345788999999998888999999999999999999 89999998888777777665533
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFP 207 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 207 (223)
..+...+.++.+++.+||+.||.+||+++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 --RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 33456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=225.82 Aligned_cols=179 Identities=16% Similarity=0.181 Sum_probs=149.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++|+|.++++.. .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~----------------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~ 181 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY----------------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 181 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCE
Confidence 34899999999999999642 47899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD----EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~----~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
+++|||++...............+++.|+|||.+... .++.++|+||+||++|+|+ +|..||...+.......+.
T Consensus 182 kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyell-tG~~Pf~~~~~~~~~~~i~ 260 (370)
T cd05596 182 KLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYADSLVGTYSKIM 260 (370)
T ss_pred EEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHH-hCCCCcCCCCHHHHHHHHH
Confidence 9999999875433222222345688999999998643 3778999999999999999 7999999888877777776
Q ss_pred hCcccC--CCCCCChHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q psy15108 173 SKKLCW--KHSSKTPEYITSLHEKCIHPHPHQ--RPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~ 212 (223)
...... +....++.++.+++.+|++.+|.+ |++++++++|
T Consensus 261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 261 DHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 543333 223357899999999999999987 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=212.91 Aligned_cols=186 Identities=28% Similarity=0.470 Sum_probs=154.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++.... ..+++.+++.++.|++.|+.+||+.+++|+||+|.||+++.++.+
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 145 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHD--------------GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC 145 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeE
Confidence 447899999999999997542 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhh--hhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYYK--YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++.......... ......+..|++||.+.+..++.++|+||||++++++++.|..||......+....+...
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~ 225 (267)
T cd05066 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225 (267)
T ss_pred EeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC
Confidence 999999887543322111 111223457999999988889999999999999999885699999888777666666654
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
...+.+..++..+.+++.+||+.+|.+||++.++++.|.+++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 226 -YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 344555677889999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=224.79 Aligned_cols=177 Identities=17% Similarity=0.263 Sum_probs=149.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~ 95 (223)
..+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+ .|++||||||.||+++.++.
T Consensus 70 ~~lv~E~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~ 134 (325)
T cd05594 70 LCFVMEYANGGELFFHLSRER---------------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH 134 (325)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC
Confidence 338899999999999997543 48999999999999999999997 79999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++++|||++....... .......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||...+.......+....
T Consensus 135 ~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-tG~~Pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05594 135 IKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHEKLFELILMEE 212 (325)
T ss_pred EEEecCCCCeecCCCC-cccccccCCcccCCHHHHccCCCCCccccccccceeeeec-cCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999886432211 1122345788999999998888999999999999999999 8999998888777766665443
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
. ..+...++++.+++.+||+.||++|+ ++.++++|
T Consensus 213 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 213 I--RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C--CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2 33566789999999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=217.14 Aligned_cols=178 Identities=21% Similarity=0.328 Sum_probs=143.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+. ++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 85 ~lv~e~~~-~~l~~~~~~~~~-------------~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~k 150 (290)
T cd07862 85 TLVFEHVD-QDLTTYLDKVPE-------------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 150 (290)
T ss_pred EEEEccCC-CCHHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEE
Confidence 37788886 699999976432 4589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc-
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL- 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~- 176 (223)
++|||++....... ......++..|+|||.+....++.++|+||+||++|+|+ +|..||.+....+.+..+.....
T Consensus 151 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 151 LADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred EccccceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHH-cCCCCcCCCCHHHHHHHHHHHhCC
Confidence 99999986543221 223446788899999998888999999999999999999 89999988776665555432100
Q ss_pred ----cC--------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 ----CW--------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ----~~--------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+ ...+..++.+.+++.+||+.||++||++.++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 0013456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=212.58 Aligned_cols=189 Identities=23% Similarity=0.418 Sum_probs=157.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++..... .+++..+..++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~ 148 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKD--------------NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHV 148 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeE
Confidence 4478999999999999986433 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||.+....... .........+..|++||......++.++|+||||++++++++.|..||......+....+...
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 227 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG- 227 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-
Confidence 999999987543221 111112223567999999888888999999999999999994499999988877776666654
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
...+.+..++..+.+++.+||..+|..||++.++++.|.++..+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 228 ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 344555667888999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=210.17 Aligned_cols=180 Identities=23% Similarity=0.314 Sum_probs=151.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++..... ..+++..++.++.|++.|+.|||+.|++|+|++|+||+++.++.+
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~ 140 (256)
T cd08529 74 LNIVMEYAENGDLHKLLKMQRG-------------RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNV 140 (256)
T ss_pred EEEEEEeCCCCcHHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCE
Confidence 3488999999999999986532 468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|++||......++.++|+||||+++++++ +|..||...........+....
T Consensus 141 ~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~- 217 (256)
T cd08529 141 KIGDLGVAKLLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC-TGKHPFDANNQGALILKIIRGV- 217 (256)
T ss_pred EEcccccceeccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCC-
Confidence 9999998875443321 122345677899999998888899999999999999999 7999998887766666655542
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+..++.++.+++.+||+.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 333444678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=210.90 Aligned_cols=183 Identities=26% Similarity=0.509 Sum_probs=151.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+++|.+++.... +.++++.+..++.|++.|+.+||+.+++|+||+|.||+++.++.+
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~ 139 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQR--------------GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVV 139 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCc--------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeE
Confidence 347899999999999997543 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++................+..|++||.+.+..++.++|+||+|+++|++++.|..||...........+... .
T Consensus 140 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~ 218 (256)
T cd05112 140 KVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-F 218 (256)
T ss_pred EECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-C
Confidence 999999886543322222223344567999999988888999999999999999995599999888777777776554 2
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
....+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 219 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 219 RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 33334557899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=217.50 Aligned_cols=201 Identities=32% Similarity=0.572 Sum_probs=158.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhcccc-CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKD-KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+.+|+|.+++...+....+ ....-..+...+++..++.++.|+++||.|||+.|++|+||+|.||+++.++.
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~ 172 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV 172 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc
Confidence 34789999999999999875421100 00000112345899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||+++........ .......+..|++||.+....++.++|+||||+++|+|++.|..||.+.+..+....+...
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 252 (334)
T cd05100 173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 252 (334)
T ss_pred EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999998654322211 1112233456999999988889999999999999999995589999988877777766554
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.....+..++.++.+++.+||+.+|.+||++.+++..|.++..
T Consensus 253 -~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 253 -HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 3445566778899999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=222.04 Aligned_cols=173 Identities=15% Similarity=0.167 Sum_probs=146.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++|||+.+|+|.+++...+ .+++..+..++.||++||.|||+.|++||||||.||+++.++.++
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~k 136 (325)
T cd05602 72 YFVLDYINGGELFYHLQRER---------------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 136 (325)
T ss_pred EEEEeCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence 37899999999999998653 488999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++........ ......++..|+|||.+.+..++.++||||+||++|+|+ +|..||...+..+....+....
T Consensus 137 l~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~i~~~~-- 212 (325)
T cd05602 137 LTDFGLCKENIEHNG-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILNKP-- 212 (325)
T ss_pred EccCCCCcccccCCC-CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHh-cCCCCCCCCCHHHHHHHHHhCC--
Confidence 999999864322111 123346788999999998888999999999999999999 8999999888877777766543
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 209 (223)
.......+.++.+++.+|++.+|.+|+++.+.
T Consensus 213 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 213 LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 23345788999999999999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=213.62 Aligned_cols=198 Identities=29% Similarity=0.546 Sum_probs=155.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCC-------CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCee
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKS-------GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCL 89 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~-------~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil 89 (223)
..+++||+.+|+|.+++........... .........+++..++.++.|++.||.|||+.+++|+||+|.||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 4588999999999999986532111100 001112346899999999999999999999999999999999999
Q ss_pred eecCCCeEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy15108 90 ISSDLSVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168 (223)
Q Consensus 90 ~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~ 168 (223)
++.++.++++|||++........ ........+..|++||.+.+..++.++|+|||||++|+|++.+..||.+....+..
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999998865432221 11122334567999999888889999999999999999996588899888877777
Q ss_pred HHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..+.... .+..+..++.++.+++.+||+.+|.+||++.|+++.|++
T Consensus 243 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 243 YYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 7666553 333455678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=201.84 Aligned_cols=189 Identities=18% Similarity=0.293 Sum_probs=152.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCCCCCeeeecCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR--LIHKDIAARNCLISSDL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~~~nil~~~~~ 94 (223)
.-+++.|+..|||.+.++..+. ++..+++.+++.++.++++||++||+.. ++|+||||.||++...+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~-----------kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~ 166 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKI-----------KGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG 166 (302)
T ss_pred EEEEeehhccccHHHHHHHHhh-----------cCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC
Confidence 3378999999999999998766 5568999999999999999999999998 99999999999999999
Q ss_pred CeEEcCCCCCcccc-----hhhh---hhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q psy15108 95 SVKISLSGLSKDTY-----QKEY---YKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS 163 (223)
Q Consensus 95 ~~~l~df~~~~~~~-----~~~~---~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~ 163 (223)
.+++.|||-+.... +... ........+..|.|||.+. +...+.++|||||||++|+|+ ++..||....
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m-f~~sPfe~~~ 245 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM-FGESPFERIY 245 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH-HcCCcchHHh
Confidence 99999999775432 1111 1112335577899999875 334688999999999999999 8999996433
Q ss_pred HHH--HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 164 DDQ--VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 164 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
... +.-.+..+...++....+++.+.+++.+|++.||.+||++.+++.++.+++
T Consensus 246 ~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 246 QQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 211 111233445667777779999999999999999999999999999998765
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=210.40 Aligned_cols=187 Identities=21% Similarity=0.286 Sum_probs=150.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++..... ....+++..+..++.|+++|+.|||+.+++|+||+|+||+++.++.+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~ 145 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKK-----------QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVV 145 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhh-----------ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCE
Confidence 4478999999999999975432 22458999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS--DDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~--~~~~~~~~~~~ 174 (223)
+++|||++........ ......++..|++||.+.+..++.++|+||+|+++|+++ +|..||.... .......+...
T Consensus 146 ~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~ 223 (267)
T cd08228 146 KLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA-ALQSPFYGDKMNLFSLCQKIEQC 223 (267)
T ss_pred EECccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh-cCCCCCccccccHHHHHHHHhcC
Confidence 9999998875543321 123345777899999998888899999999999999999 7888886543 23444444443
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
..........+..+.+++.+||..+|.+||+++++++.++.+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 222222345678899999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=219.72 Aligned_cols=171 Identities=19% Similarity=0.287 Sum_probs=146.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||.||+++.++.+
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~---------------~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~i 140 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG---------------KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHI 140 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCE
Confidence 448899999999999997653 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.........+.....
T Consensus 141 kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell-tG~~pf~~~~~~~~~~~i~~~~~ 218 (323)
T cd05615 141 KIADFGMCKEHMVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML-AGQPPFDGEDEDELFQSIMEHNV 218 (323)
T ss_pred EEeccccccccCCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999999864322211 123345788999999998888999999999999999999 79999998888877777766543
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 206 (223)
..+...+.++.+++.+||+.+|.+|++.
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 3456678899999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=219.43 Aligned_cols=176 Identities=20% Similarity=0.300 Sum_probs=148.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|..+++. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 77 ~~lv~E~~~~~~L~~~~~~----------------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~ 140 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT----------------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFV 140 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcE
Confidence 3488999999999988853 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|+|||.+.+..++.++|+|||||++|+|+ +|..||.+.+..+....+.....
T Consensus 141 kL~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~G~~pf~~~~~~~~~~~i~~~~~ 218 (324)
T cd05589 141 KIADFGLCKEGMGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML-VGESPFPGDDEEEVFDSIVNDEV 218 (324)
T ss_pred EeCcccCCccCCCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999998764322111 123456788999999998888999999999999999999 79999998888777777666533
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
..+..++.++.+++.+||+.||.+|| ++.+++++
T Consensus 219 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 --RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 34566889999999999999999999 56777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=211.56 Aligned_cols=186 Identities=28% Similarity=0.484 Sum_probs=152.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.++++..+ +.+++.+++.++.|++.|+.|||+.|++|+||+|+||+++.++.+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~ 145 (269)
T cd05065 80 VMIITEFMENGALDSFLRQND--------------GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVC 145 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcE
Confidence 447899999999999997643 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-hhhc---CCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYY-KYRN---AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-~~~~---~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
+++|||++......... .... ...+..|++||.+....++.++|+||+|+++||+++.|..||...........+.
T Consensus 146 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~ 225 (269)
T cd05065 146 KVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE 225 (269)
T ss_pred EECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 99999987643322110 0111 1123469999999888899999999999999998856999998887777666665
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
.. ...+.+..++..+.+++..||+.+|.+||++++++..|++++
T Consensus 226 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 226 QD-YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred cC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 44 444555678889999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=210.38 Aligned_cols=189 Identities=32% Similarity=0.574 Sum_probs=152.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
..+++||+++|+|.+++........ ....+++.+++.++.|++.|+.|||+.+++|+|++|+||+++.++
T Consensus 74 ~~~v~e~~~~~~L~~~l~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~ 145 (269)
T cd05044 74 QYIIMELMEGGDLLSYLRDARVERF--------GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYD 145 (269)
T ss_pred eEEEEeccCCCcHHHHHHHhhhccc--------CCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCC
Confidence 4488999999999999986533100 123478999999999999999999999999999999999999877
Q ss_pred ---CeEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy15108 95 ---SVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170 (223)
Q Consensus 95 ---~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~ 170 (223)
.++++|||++........ ........+..|++||.+.+..++.++|+||||+++|++++.|..||......+....
T Consensus 146 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~ 225 (269)
T cd05044 146 ADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH 225 (269)
T ss_pred CCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH
Confidence 799999998865432221 1122334467799999998888999999999999999999559999988777666665
Q ss_pred HHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 171 LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
+... .....+...+..+.+++.+||..+|.+||+++++++.|+
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 VTAG-GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HhcC-CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 5443 333445667899999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=221.39 Aligned_cols=166 Identities=31% Similarity=0.593 Sum_probs=136.8
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhh-hhhhhcCCccccccccccc
Q psy15108 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAV 130 (223)
Q Consensus 52 ~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~ 130 (223)
..+++..+..++.|++.||.|||+.+++|+||||.||+++..+.++++|||++....... ........++..|++||.+
T Consensus 234 ~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 234 PALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI 313 (401)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence 468899999999999999999999999999999999999999999999999987543221 1112233556789999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy15108 131 FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210 (223)
Q Consensus 131 ~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 210 (223)
....++.++|+||||++++++++.|..||......+..........+...+..++.++.+++.+||..+|.+||++++++
T Consensus 314 ~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell 393 (401)
T cd05107 314 FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393 (401)
T ss_pred cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 88888999999999999999996588999876655544443333344555667889999999999999999999999999
Q ss_pred HHHHHHh
Q psy15108 211 TQLSDAM 217 (223)
Q Consensus 211 ~~L~~~~ 217 (223)
..|++++
T Consensus 394 ~~L~~~~ 400 (401)
T cd05107 394 HLVGDLL 400 (401)
T ss_pred HHHHHHh
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=209.56 Aligned_cols=179 Identities=19% Similarity=0.253 Sum_probs=149.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+++++|.++++.... ..+++.++..++.+++.|+.+||+.|++|+||+|+||+++.++.++
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~-------------~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~ 142 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKG-------------KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIK 142 (257)
T ss_pred EEEecccCCCcHHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEE
Confidence 378999999999999986433 4589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++....... .......++..|+|||...+..++.++|+||+|+++++++ +|..||...+.......+.... .
T Consensus 143 l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~-~g~~~~~~~~~~~~~~~~~~~~-~ 219 (257)
T cd08223 143 VGDLGIARVLENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA-TLKHAFNAKDMNSLVYRIIEGK-L 219 (257)
T ss_pred EecccceEEecccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHhcC-C
Confidence 99999886543221 1123345678899999998888899999999999999999 7889998777666555555442 2
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+..+...++++.+++.+||+.+|++||++.+++.+
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 33456788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=212.45 Aligned_cols=184 Identities=23% Similarity=0.341 Sum_probs=145.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||+.+|+|.+++... .+++.+++.++.|++.|+.|||+.+++|+||||.||+++.++.+
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----------------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 146 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----------------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLV 146 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcE
Confidence 34889999999999999642 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---------
Q psy15108 97 KISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD--------- 165 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~--------- 165 (223)
+++|||++........ ........+..|++||.+....++.++|+||||+++++|+ +|..||......
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~-tg~~p~~~~~~~~~~~~~~~~ 225 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL-THCDSKQSPPKKFEEMIGPKQ 225 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH-hCCCCCCCCcchhhhhhcccc
Confidence 9999999875432211 1112233456689999988888899999999999999999 788887543211
Q ss_pred -----HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 166 -----QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 166 -----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
.............+.+..++.++.+++..||+.+|++||++++++..|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 226 GQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0011111111233345667899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=220.97 Aligned_cols=177 Identities=17% Similarity=0.261 Sum_probs=142.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 71 ~~lv~e~~~~g~L~~~~~~~~---------------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~ 135 (329)
T cd05588 71 LFFVIEFVSGGDLMFHMQRQR---------------KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHI 135 (329)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCE
Confidence 348899999999999997653 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--------H-HHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS--------D-DQV 167 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~--------~-~~~ 167 (223)
+++|||++....... .......++..|+|||.+.+..++.++|+||+||++|+++ +|..||.... . ...
T Consensus 136 kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~-~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05588 136 KLTDYGMCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-AGRSPFDIVGMSDNPDQNTEDYL 213 (329)
T ss_pred EECcCccccccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHH-HCCCCcccccccccccccchHHH
Confidence 999999886422111 1123346788999999999888999999999999999999 7999996321 1 122
Q ss_pred HHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q psy15108 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT------FPSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~~ 212 (223)
...+.... ...+..++.++.+++.+||+.||.+|++ ++++++|
T Consensus 214 ~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 214 FQVILEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 33333332 3345678889999999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=212.51 Aligned_cols=180 Identities=21% Similarity=0.289 Sum_probs=146.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+.+|+|.+++...+. ..+++..+..++.|++.|+.|||+.+++|+|++|.||+++.++.++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~-------------~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~ 151 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKG-------------NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 151 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEE
Confidence 478999999999999986433 4689999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
++|||++....... .......++..|++||.+. ...++.++|+||+||++|+++ +|..||...........+.
T Consensus 152 l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~-~g~~p~~~~~~~~~~~~~~ 229 (272)
T cd06637 152 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA-EGAPPLCDMHPMRALFLIP 229 (272)
T ss_pred EccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHH-hCCCCccccCHHHHHHHHh
Confidence 99999986542211 1123345677899999875 335788999999999999999 7999998766655544444
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...........++.++.+++.+||..+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 4333333345678899999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=224.24 Aligned_cols=200 Identities=22% Similarity=0.340 Sum_probs=152.9
Q ss_pred chHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---c
Q psy15108 2 DLKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR---L 78 (223)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i 78 (223)
||++++.+|.++.+...+|+||+++|||.++|+.... .+++|..+++|+.++++||+|||... |
T Consensus 132 Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~-------------~~L~W~~R~kIa~g~A~gL~yLH~~~~~~i 198 (361)
T KOG1187|consen 132 NLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKG-------------EPLDWETRLKIALGAARGLAYLHEGCPPPI 198 (361)
T ss_pred CcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCC-------------CCCCHHHHHHHHHHHHHHHHHHccCCCCCE
Confidence 6788888888877667799999999999999986532 16899999999999999999999854 9
Q ss_pred ccCCCCCCCeeeecCCCeEEcCCCCCcccch-hhhhhhhcC-CcccccccccccccCCCCcccchHHHHHHHHHHHhCCC
Q psy15108 79 IHKDIAARNCLISSDLSVKISLSGLSKDTYQ-KEYYKYRNA-ILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGE 156 (223)
Q Consensus 79 ~H~di~~~nil~~~~~~~~l~df~~~~~~~~-~~~~~~~~~-~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~ 156 (223)
+|||||++|||+|.+...|++|||+++.... .. ..... .++..|++||.......+.++||||||+++.|++ +|+
T Consensus 199 iHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli-tgr 275 (361)
T KOG1187|consen 199 IHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI-TGR 275 (361)
T ss_pred ecCCCCHHHeeECCCCCEEccCccCcccCCcccc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHH-hCC
Confidence 9999999999999999999999999965433 21 11122 7889999999998888999999999999999999 677
Q ss_pred CCCCCCC---H---HHH-HHHHHhCccc----CCCC-CCC-----hHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 157 MPFPDLS---D---DQV-LSQLESKKLC----WKHS-SKT-----PEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 157 ~p~~~~~---~---~~~-~~~~~~~~~~----~~~~-~~~-----~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
.+..... . ... ...+...... +... ... -..+..+...|++.+|..||++.++++.|..+.
T Consensus 276 ~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 276 KAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 6665322 1 111 1122221111 0000 122 223556778999999999999999999996654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=223.73 Aligned_cols=178 Identities=16% Similarity=0.221 Sum_probs=147.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.||++||.|||+.|++||||||+||+++.++.+
T Consensus 71 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~ 135 (330)
T cd05586 71 LYLVTDYMSGGELFWHLQKEG---------------RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHI 135 (330)
T ss_pred EEEEEcCCCCChHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCE
Confidence 448899999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......++..|+|||.+.+. .++.++||||+||++|+|+ +|..||...+..+....+....
T Consensus 136 kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 136 ALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC-CGWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred EEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEec-cCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986532221 112345678899999998654 4788999999999999999 7999999888877777776654
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCC----CHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRP----TFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~~ll~~ 212 (223)
...+ ...+++++.+++.+||+.||.+|| ++.++++|
T Consensus 214 ~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 214 VRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 4332 234688899999999999999998 56666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=211.17 Aligned_cols=188 Identities=21% Similarity=0.301 Sum_probs=149.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+++++|.++++.... ....+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~ 145 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKK-----------QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVV 145 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCE
Confidence 4488999999999999975322 22468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD--DQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~--~~~~~~~~~~ 174 (223)
+++|||++........ ......++..|++||.+....++.++|+||+|+++|+++ +|..||..... ......+...
T Consensus 146 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 223 (267)
T cd08229 146 KLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA-ALQSPFYGDKMNLYSLCKKIEQC 223 (267)
T ss_pred EECcchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHH-hCCCCcccccchHHHHhhhhhcC
Confidence 9999998765432221 112345677899999998888899999999999999999 79999865433 2333333333
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
..........+..+.+++.+||+.+|++|||+.++++.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 2222223457889999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=214.05 Aligned_cols=181 Identities=19% Similarity=0.265 Sum_probs=144.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++..... ....+++..+..++.||++||.|||+.+++|+||+|.||+++.++.+
T Consensus 68 ~~lv~e~~~~g~L~~~~~~~~~-----------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 136 (280)
T cd05608 68 LCLVMTIMNGGDLRYHIYNVDE-----------ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNV 136 (280)
T ss_pred EEEEEeCCCCCCHHHHHHhccc-----------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 3388999999999998864322 23468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD----QVLSQLE 172 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~----~~~~~~~ 172 (223)
+++|||++........ ......++..|++||.+.+..++.++|+||+|+++|+++ +|..||...... .....+.
T Consensus 137 ~l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~-~g~~pf~~~~~~~~~~~~~~~~~ 214 (280)
T cd05608 137 RISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI-AARGPFRARGEKVENKELKQRIL 214 (280)
T ss_pred EEeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHH-hCCCCCCCCCcchhHHHHHHhhc
Confidence 9999999865433221 122346778899999999888999999999999999999 799999765432 2222222
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
.. ....+..++..+.+++.+||+.||++|| +++++++|
T Consensus 215 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 ND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 21 2233456889999999999999999999 66777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=214.31 Aligned_cols=180 Identities=16% Similarity=0.239 Sum_probs=143.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||+.+|+|.+++...+. ..+++..+..++.|++.|+.|||+.|++|+||+|.||+++.++.+
T Consensus 68 ~~lv~e~~~g~~L~~~~~~~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~ 134 (277)
T cd05607 68 LCLVMSLMNGGDLKYHIYNVGE-------------RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNC 134 (277)
T ss_pred EEEEEecCCCCCHHHHHHhccc-------------cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCE
Confidence 4488999999999999976543 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD----QVLSQLE 172 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~----~~~~~~~ 172 (223)
+++|||++....... ......++..|+|||.+.+..++.++|+||+||++|+++ +|..||...... .......
T Consensus 135 ~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~-~g~~p~~~~~~~~~~~~~~~~~~ 211 (277)
T cd05607 135 RLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV-AGRTPFKDHKEKVAKEELKRRTL 211 (277)
T ss_pred EEeeceeeeecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHH-hCCCCCCCCcchhhHHHHHHHhh
Confidence 999999886543321 112345778899999998888999999999999999999 799999765332 2222222
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
..... .....++.++.+++.+||+.||++||+++|+++.+
T Consensus 212 ~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 212 EDEVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 22111 11245788999999999999999999997665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=208.61 Aligned_cols=175 Identities=22% Similarity=0.385 Sum_probs=139.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC-
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS- 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~- 95 (223)
..+++||+.+|+|..++.... ..+++..++.++.||++|+.|||+.+++|+||+|.||+++.++.
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~ 144 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKS--------------DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGID 144 (262)
T ss_pred CEEEEecccCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCcc
Confidence 448899999999999987533 35899999999999999999999999999999999999986654
Q ss_pred ------eEEcCCCCCcccchhhhhhhhcCCcccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy15108 96 ------VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168 (223)
Q Consensus 96 ------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~ 168 (223)
++++|||++...... ....++..|+|||.+. ...++.++||||||+++|++++.+..||......+..
T Consensus 145 ~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 219 (262)
T cd05077 145 GECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219 (262)
T ss_pred CCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH
Confidence 899999988644322 2344567799999886 4568889999999999999986788888766544432
Q ss_pred HHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
. +..... ......++++.+++.+||+.||.+||++.++++++
T Consensus 220 ~-~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 R-FYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred H-HHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2 222211 22334567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=219.75 Aligned_cols=178 Identities=21% Similarity=0.289 Sum_probs=146.6
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|+||+++ ||.-++..-+ -.|++.++..++.|++.||+|||++|++|||||.+|||++.+|.+||
T Consensus 195 lVFeYMdh-DL~GLl~~p~--------------vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPG--------------VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred EEEecccc-hhhhhhcCCC--------------cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEe
Confidence 77777765 7888886533 37999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---C
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES---K 174 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~---~ 174 (223)
.|||+++.............+.|.+|.|||.+.+. .|+..+|+||.|||+.||+ .|+..|.+....+.++.|.. .
T Consensus 260 aDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~-~gkPI~~G~tEveQl~kIfklcGS 338 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELF-LGKPILQGRTEVEQLHKIFKLCGS 338 (560)
T ss_pred ccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHH-cCCCCcCCccHHHHHHHHHHHhCC
Confidence 99999997666655556778899999999999875 4999999999999999999 89999998877665555432 0
Q ss_pred c--ccCC----------------------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 K--LCWK----------------------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~--~~~~----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ..|+ ....++....+|+..+|..||.+|.|+.++++.
T Consensus 339 P~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 339 PTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 0011 013346778899999999999999999988754
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=207.98 Aligned_cols=186 Identities=27% Similarity=0.442 Sum_probs=144.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++++... ....+++..+..++.||++||.|||+.+++|+||||.||+++.++.+
T Consensus 70 ~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~ 138 (268)
T cd05086 70 YLLVFEYCELGDLKSYLSQEQW-----------HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTV 138 (268)
T ss_pred cEEEEecCCCCcHHHHHHhhhc-----------ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccE
Confidence 4489999999999999986533 12346788889999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh-hhhhcCCccccccccccccc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy15108 97 KISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFD-------DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~ 168 (223)
+++|||++........ .......++..|++||.+.. ..++.++|+||||+++|+|++.+..||......+..
T Consensus 139 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 218 (268)
T cd05086 139 KVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL 218 (268)
T ss_pred EecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999998754322211 11223456778999998743 235678999999999999997778899877776666
Q ss_pred HHHHhCc-c---cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 169 SQLESKK-L---CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 169 ~~~~~~~-~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
..+.... . .+......++.+.+++..|| .+|++||+++++++.|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 219 NHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 6543321 1 22233456788999999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=219.28 Aligned_cols=178 Identities=19% Similarity=0.278 Sum_probs=138.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+. ++|.+++...+ .+++..+..++.||++||.|||+.|++||||||+||+++.++.++
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~k 143 (338)
T cd07859 80 YVVFELME-SDLHQVIKAND---------------DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLK 143 (338)
T ss_pred EEEEecCC-CCHHHHHHhcc---------------cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEE
Confidence 47889984 79999997643 489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh--hhhhhcCCccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 98 ISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 98 l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
++|||++....... ........++..|+|||.+.+ ..++.++||||+||++|+|+ +|+.||.+.+.......+..
T Consensus 144 L~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~-tg~~pf~~~~~~~~~~~~~~ 222 (338)
T cd07859 144 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKNVVHQLDLITD 222 (338)
T ss_pred EccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHH
Confidence 99999987543221 111233567889999999765 56888999999999999999 79999976654322211100
Q ss_pred --------------------------CcccC---CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 --------------------------KKLCW---KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 --------------------------~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ......++.+.+++.+||+.||++||++++++++
T Consensus 223 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0112456778999999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=220.91 Aligned_cols=180 Identities=17% Similarity=0.203 Sum_probs=145.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~v 140 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD---------------TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHV 140 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCE
Confidence 448999999999999998653 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh----------------------------------hhhhcCCcccccccccccccCCCCcccchH
Q psy15108 97 KISLSGLSKDTYQKEY----------------------------------YKYRNAILPLRWLPYEAVFDDEFSTKSDVY 142 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~ 142 (223)
+++|||++........ .......+++.|+|||.+.+..++.++|+|
T Consensus 141 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~Dvw 220 (363)
T cd05628 141 KLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220 (363)
T ss_pred EEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhh
Confidence 9999999864321100 001134688999999999888899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc--CCCCCCChHHHHHHHHHhcC--CCCCCCCCHHHHHHH
Q psy15108 143 AYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC--WKHSSKTPEYITSLHEKCIH--PHPHQRPTFPSIVTQ 212 (223)
Q Consensus 143 slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~--~dp~~Rps~~~ll~~ 212 (223)
|+||++|+|+ +|..||.+....+....+...... .+.....++++++++.+++. .++..||+++++++|
T Consensus 221 SlGvil~ell-~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 221 SLGVIMYEML-IGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred hhHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9999999999 799999988888877777653222 22223467889999988654 233356899999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=216.70 Aligned_cols=177 Identities=17% Similarity=0.237 Sum_probs=140.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~ 95 (223)
..+|+||+.+|+|.++++..+ .+++..+..++.+++.|+.|||+. +++|+||||+||+++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~ 142 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAG---------------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 142 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC
Confidence 448899999999999998653 389999999999999999999975 7999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL---- 171 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~---- 171 (223)
++++|||++...... ......++..|+|||.+.+..++.++|+||+||++|+++ +|..||...........+
T Consensus 143 ~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~ 218 (333)
T cd06650 143 IKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA-IGRYPIPPPDAKELELMFGCPV 218 (333)
T ss_pred EEEeeCCcchhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCcchhHHHHHhcCcc
Confidence 999999988644221 123345778899999998888999999999999999999 799999765443322111
Q ss_pred ----------------------------------------HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15108 172 ----------------------------------------ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVT 211 (223)
Q Consensus 172 ----------------------------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 211 (223)
.............+.++++++.+||+.||++||++++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 219 EGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 1110011111235678999999999999999999999987
Q ss_pred H
Q psy15108 212 Q 212 (223)
Q Consensus 212 ~ 212 (223)
+
T Consensus 299 h 299 (333)
T cd06650 299 H 299 (333)
T ss_pred C
Confidence 6
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=221.62 Aligned_cols=173 Identities=19% Similarity=0.239 Sum_probs=146.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++.... .+++..+..++.||++||.|||+.+++||||||.||+++.++.+
T Consensus 73 ~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 137 (318)
T cd05582 73 LYLILDFLRGGDLFTRLSKEV---------------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 137 (318)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcE
Confidence 348899999999999997543 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|++||.+....++.++|+|||||++|+|+ +|..||......+....+.....
T Consensus 138 kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~-tg~~p~~~~~~~~~~~~i~~~~~ 215 (318)
T cd05582 138 KLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML-TGSLPFQGKDRKETMTMILKAKL 215 (318)
T ss_pred EEeeccCCcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeec-cCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999986543221 1122345788899999998888899999999999999999 79999998888777777665432
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPS 208 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 208 (223)
..+..+++.+.+++.+||+.||.+||++.+
T Consensus 216 --~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 --GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 345667899999999999999999999433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=206.83 Aligned_cols=183 Identities=39% Similarity=0.688 Sum_probs=153.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+++++|.++++.... ..+++..+..++.|++.|+.+||+.+++|+||+|.||+++.++.+
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~ 142 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP-------------KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVV 142 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh-------------ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeE
Confidence 4588999999999999986543 228999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|++||......++.++|+|++|++++++++.|..||...........+... .
T Consensus 143 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~ 221 (258)
T smart00219 143 KISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-Y 221 (258)
T ss_pred EEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-C
Confidence 999999987654432222112335678999999877888999999999999999996689999888777777776665 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
....+...+.++.+++.+|+..+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 3444566889999999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=218.41 Aligned_cols=172 Identities=17% Similarity=0.159 Sum_probs=145.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+.+...+ .+++..+..++.||++||.|||+.+++||||||.||+++.++.+
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 135 (321)
T cd05603 71 LYFVLDYVNGGELFFHLQRER---------------CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHV 135 (321)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCE
Confidence 348899999999999987543 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||...+.......+....
T Consensus 136 kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~i~~~~- 212 (321)
T cd05603 136 VLTDFGLCKEGVEPEE-TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML-YGLPPFYSRDVSQMYDNILHKP- 212 (321)
T ss_pred EEccCCCCccCCCCCC-ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhh-cCCCCCCCCCHHHHHHHHhcCC-
Confidence 9999998864322211 123345788899999998888999999999999999999 8999999888777777666543
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFP 207 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 207 (223)
...+...+.++.+++.+||+.+|.+||+..
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 -LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 334556788899999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=212.67 Aligned_cols=194 Identities=32% Similarity=0.550 Sum_probs=151.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.+++.......... ......+++..++.++.|++.||.|||+.+++|+||||.||+++.++.+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~ 169 (296)
T cd05051 94 LCMIMEYMENGDLNQFLQKHVAETSGL----ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTI 169 (296)
T ss_pred cEEEEecCCCCCHHHHHHhcccccccc----cccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCce
Confidence 457899999999999998754211110 1122468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFN-KGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~-~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++......... ......++..|++||.+....++.++|+||||+++|++++ .+..||........+..+...
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~ 249 (296)
T cd05051 170 KIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHF 249 (296)
T ss_pred EEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhc
Confidence 99999998754332211 1223345678999999888888999999999999999984 267788877766665554332
Q ss_pred ------cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 175 ------KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 175 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
......+..++.++.+++.+||+.+|.+||++.++++.|+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 250 FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1122334456789999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=212.69 Aligned_cols=180 Identities=18% Similarity=0.261 Sum_probs=144.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++|||+.+|+|.+++..... ..+++..++.++.|+++|+.|||+.+++|+|++|.||+++.++.++
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKG-------------NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 488999999999999986543 4588999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
++|||++....... .......++..|+|||.+. ...++.++|+||+|+++|+++ +|..||...........+.
T Consensus 162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~-~g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA-EGAPPLCDMHPMRALFLIP 239 (282)
T ss_pred EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHH-hCCCCccccCHHhhhhhHh
Confidence 99999876432211 1123345677899999875 345778999999999999999 7999998776655444443
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...........++.++.+++.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 240 RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 3322222334578899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=209.15 Aligned_cols=180 Identities=20% Similarity=0.279 Sum_probs=150.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+++|+|.+++..... ..++++.++.++.|+++|+.+||+.|++|+||+|.||+++.++.+
T Consensus 73 ~~lv~e~~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~ 139 (255)
T cd08219 73 LYIVMEYCDGGDLMQKIKLQRG-------------KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKV 139 (255)
T ss_pred EEEEEeeCCCCcHHHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcE
Confidence 3488999999999999976433 458999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+........ ......++..|++||.+.+..++.++|+||+|+++|+|+ +|..||...+.......+.....
T Consensus 140 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 217 (255)
T cd08219 140 KLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELC-TLKHPFQANSWKNLILKVCQGSY 217 (255)
T ss_pred EEcccCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehh-hccCCCCCCCHHHHHHHHhcCCC
Confidence 9999998865432221 112345677899999998888899999999999999999 79999998877776666655533
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+.+..++..+.+++.+||+.+|++||++++++..
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 33456678889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=218.55 Aligned_cols=177 Identities=16% Similarity=0.230 Sum_probs=142.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.||+.|+.|||+.|++||||||+||+++.++.+
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~---------------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~ 135 (327)
T cd05617 71 LFLVIEYVNGGDLMFHMQRQR---------------KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHI 135 (327)
T ss_pred EEEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCE
Confidence 348899999999999997653 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC------CHH-HHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL------SDD-QVLS 169 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~------~~~-~~~~ 169 (223)
+++|||++....... .......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||... ... ....
T Consensus 136 kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell-~g~~pf~~~~~~~~~~~~~~~~~ 213 (327)
T cd05617 136 KLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM-AGRSPFDIITDNPDMNTEDYLFQ 213 (327)
T ss_pred EEeccccceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHH-hCCCCCCccCCCcccccHHHHHH
Confidence 999999886422111 1123356788999999998888999999999999999999 799999532 112 2223
Q ss_pred HHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q psy15108 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF------PSIVTQ 212 (223)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~ 212 (223)
.+... ....+...+..+.+++.+||+.||.+|+++ ++++.|
T Consensus 214 ~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 214 VILEK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 33332 233456678899999999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=221.59 Aligned_cols=179 Identities=16% Similarity=0.183 Sum_probs=147.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++... .+++..+..++.||+.||.|||+.+++||||||+||+++.++.+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~----------------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~ 181 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY----------------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCE
Confidence 44899999999999999642 47899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE----FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
+++|||++...............+++.|+|||.+.... ++.++|+||+||++|+|+ +|..||...+.......+.
T Consensus 182 kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell-~G~~Pf~~~~~~~~~~~i~ 260 (370)
T cd05621 182 KLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML-VGDTPFYADSLVGTYSKIM 260 (370)
T ss_pred EEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH-hCCCCCCCCCHHHHHHHHH
Confidence 99999998765333222223456889999999986543 678999999999999999 7999999888877777776
Q ss_pred hCcccC--CCCCCChHHHHHHHHHhcCCCCC--CCCCHHHHHHH
Q psy15108 173 SKKLCW--KHSSKTPEYITSLHEKCIHPHPH--QRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~--~~~~~~~~~~~~li~~~l~~dp~--~Rps~~~ll~~ 212 (223)
...... +.....+..+++++..|+..++. .|++++++++|
T Consensus 261 ~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 543333 22335688899999999985554 38899999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=221.79 Aligned_cols=179 Identities=14% Similarity=0.186 Sum_probs=147.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||.||+++.++.+
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~ 140 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD---------------TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHI 140 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCE
Confidence 448899999999999998643 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-------------------------------------hhhcCCcccccccccccccCCCCccc
Q psy15108 97 KISLSGLSKDTYQKEYY-------------------------------------KYRNAILPLRWLPYEAVFDDEFSTKS 139 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~ 139 (223)
+++|||++......... ......+++.|+|||.+....++.++
T Consensus 141 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 220 (364)
T cd05599 141 KLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220 (364)
T ss_pred EEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCee
Confidence 99999988643211000 00123578899999999888899999
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCC--CCCChHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q psy15108 140 DVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKH--SSKTPEYITSLHEKCIHPHPHQRPT---FPSIVTQ 212 (223)
Q Consensus 140 Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~ 212 (223)
|+||+||++|+|+ +|..||...+..+....+......... ...+++++++++.+|+. +|.+|++ +++++.|
T Consensus 221 DiwSlG~il~el~-~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 221 DWWSLGVIMYEML-VGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred eeecchhHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999999999999 899999988887776666543332222 23568899999999997 9999998 8888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=218.85 Aligned_cols=177 Identities=18% Similarity=0.256 Sum_probs=141.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+++||||||+||+++.++.+
T Consensus 71 ~~lv~E~~~~~~L~~~~~~~~---------------~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~ 135 (329)
T cd05618 71 LFFVIEYVNGGDLMFHMQRQR---------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI 135 (329)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCE
Confidence 348899999999999987643 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---------HHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS---------DDQV 167 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~---------~~~~ 167 (223)
+++|||++....... .......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||.... ....
T Consensus 136 kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05618 136 KLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-AGRSPFDIVGSSDNPDQNTEDYL 213 (329)
T ss_pred EEeeCCccccccCCC-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHh-hCCCCCccCCCcCCcccccHHHH
Confidence 999999986432111 1123346788999999999888999999999999999999 7999995211 1122
Q ss_pred HHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCC------HHHHHHH
Q psy15108 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT------FPSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~~ 212 (223)
...+... ....+...+..+.+++.+||+.||++||+ +.++++|
T Consensus 214 ~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 214 FQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 2223332 23345677889999999999999999998 4676655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=213.66 Aligned_cols=180 Identities=21% Similarity=0.301 Sum_probs=146.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||+++|+|.+++..... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 141 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMGN-------------PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHI 141 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcCc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCE
Confidence 4488999999999999975432 468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC--
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK-- 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~-- 174 (223)
+++|||++....... ......++..|++||.+.+..++.++|+||+|+++|+++ +|..||.+.......+.+...
T Consensus 142 ~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~-~g~~pf~~~~~~~~~~~~~~~~~ 218 (285)
T cd05605 142 RISDLGLAVEIPEGE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI-EGKSPFRQRKEKVKREEVERRVK 218 (285)
T ss_pred EEeeCCCceecCCCC--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHH-HCCCCCCCCchhhHHHHHHHHhh
Confidence 999999986543221 112346778899999998888999999999999999999 799999876554333332221
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
......+...+..+.+++.+||+.||.+|| ++++++++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 219 EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 122233456788999999999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=198.04 Aligned_cols=189 Identities=23% Similarity=0.252 Sum_probs=166.3
Q ss_pred HHHHHhhc--CCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCC
Q psy15108 5 QFLLATRK--DSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKD 82 (223)
Q Consensus 5 ~~~~~~~~--~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 82 (223)
||++-+.. ++...-+++||..+|+|+..|...+. ..+++.....++.|++.|+.|+|..+++|||
T Consensus 83 nilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~-------------~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRd 149 (281)
T KOG0580|consen 83 NILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRM-------------KRFDEQRAATYIKQLANALLYCHLKRVIHRD 149 (281)
T ss_pred cHHhhhhheeccceeEEEEEecCCchHHHHHHhccc-------------ccccccchhHHHHHHHHHHHHhccCCcccCC
Confidence 46666665 44445589999999999999985443 5699999999999999999999999999999
Q ss_pred CCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q psy15108 83 IAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL 162 (223)
Q Consensus 83 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~ 162 (223)
|||.|+|++..+.+|+.|||++.....+ ...+..+|..|++||...+..++..+|+|++|++.||++ .|..||...
T Consensus 150 iKpenlLlg~~~~lkiAdfGwsV~~p~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl-vg~ppFes~ 225 (281)
T KOG0580|consen 150 IKPENLLLGSAGELKIADFGWSVHAPSN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL-VGLPPFESQ 225 (281)
T ss_pred CCHHHhccCCCCCeeccCCCceeecCCC---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH-hcCCchhhh
Confidence 9999999999999999999999765432 345678999999999999999999999999999999999 899999999
Q ss_pred CHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 163 SDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+++..+.+-.... +..++.++.++|.+|+..+|.+|....|+++|
T Consensus 226 ~~~etYkrI~k~~~~~--p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 226 SHSETYKRIRKVDLKF--PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred hhHHHHHHHHHccccC--CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 9999999887754443 47789999999999999999999999999876
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=208.69 Aligned_cols=175 Identities=21% Similarity=0.348 Sum_probs=141.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
..+++||+.+|+|.+++...+. .+++..++.++.||+.||.|||+.+++|+||||.||+++..+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~ 140 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN--------------NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN 140 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc
Confidence 4578999999999999986542 589999999999999999999999999999999999999887
Q ss_pred -----CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy15108 95 -----SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD--EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167 (223)
Q Consensus 95 -----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~ 167 (223)
.++++|||++..... .....++..|++||.+... .++.++|+||+|++++++++.+..||......+.
T Consensus 141 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~ 215 (259)
T cd05037 141 EGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215 (259)
T ss_pred cCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence 799999999875433 1223455679999998766 6888999999999999999557888877754443
Q ss_pred HHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
....... ... +......+.+++.+||..+|.+||++.++++.|
T Consensus 216 ~~~~~~~-~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 216 ERFYQDQ-HRL--PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHhcC-CCC--CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 3333322 111 222237789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=210.47 Aligned_cols=177 Identities=20% Similarity=0.249 Sum_probs=141.4
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|+|.+ +.+|.+.|++... ++++.+..+++||+.||+|+|+.+++|||+||.|++++.+..+|+
T Consensus 103 iV~elM-etDL~~iik~~~~---------------L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQQD---------------LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred EehhHH-hhHHHHHHHcCcc---------------ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEe
Confidence 555555 8899999987543 999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhh-hhhcCCcccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---
Q psy15108 99 SLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVF-DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES--- 173 (223)
Q Consensus 99 ~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~--- 173 (223)
+|||+|+........ .....+.|.+|.|||.+. ...|+...||||+|||+.||+ +|+.-|++.+...-+..+..
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL-~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEML-TGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHH-cCCCCCCCCchHHHHHHHHHhcC
Confidence 999999876432111 124567899999999975 456999999999999999999 89988887765433322211
Q ss_pred ---------------------CcccCC-----CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 ---------------------KKLCWK-----HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ---------------------~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
-...+. ..+..++...+++.+||..||.+|+|++|.++|
T Consensus 246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 101111 114566888999999999999999999999977
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=206.35 Aligned_cols=183 Identities=30% Similarity=0.512 Sum_probs=150.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+++|.+++.... ..+++..+..++.+++.|+.|||+++++|+||+|+||+++.++.+
T Consensus 67 ~~~v~e~~~~~~l~~~l~~~~--------------~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~ 132 (251)
T cd05041 67 IYIVMELVPGGSLLTFLRKKK--------------NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVL 132 (251)
T ss_pred eEEEEEcCCCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcE
Confidence 347899999999999997643 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhh-hhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYK-YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++.......... ......+..|++||.+.+..++.++|+||+|++++++++.+..||...........+...
T Consensus 133 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~- 211 (251)
T cd05041 133 KISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG- 211 (251)
T ss_pred EEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-
Confidence 999999886543211111 112233566999999888888999999999999999995588999887776666555543
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.....+...+.++.+++.+||..+|.+||++.++++.|.
T Consensus 212 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 212 YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 334445677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=207.34 Aligned_cols=188 Identities=21% Similarity=0.315 Sum_probs=149.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++..... ....+++.+++.++.++++|+.|||+.|++|+||+|+||+++.++.+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~ 145 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKK-----------QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVV 145 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcc-----------cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcE
Confidence 4478999999999999975422 23468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS--DDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~--~~~~~~~~~~~ 174 (223)
+++|||++........ ......++..|.+||.+.+..++.++|+||+|+++|+++ +|..||.... .......+...
T Consensus 146 ~l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 223 (267)
T cd08224 146 KLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA-ALQSPFYGDKMNLYSLCKKIEKC 223 (267)
T ss_pred EEeccceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH-HCCCCcccCCccHHHHHhhhhcC
Confidence 9999998864432211 112235677799999998888999999999999999999 7888986443 23334444443
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
..........+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 2222222367788999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=224.74 Aligned_cols=179 Identities=17% Similarity=0.206 Sum_probs=139.3
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC-CeE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-SVK 97 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-~~~ 97 (223)
+||||+. ++|.+++..... ....+++..+..++.||+.||.|||+.+++||||||+||+++.++ .++
T Consensus 144 lvmE~~~-~~l~~~~~~~~~-----------~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 144 VVMEFIP-QTVHKYMKHYAR-----------NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred EEEecCC-ccHHHHHHHHhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCcee
Confidence 6888887 578888765322 234689999999999999999999999999999999999998665 699
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc-
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK- 175 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~- 175 (223)
|+|||++....... ......+++.|+|||.+.+. .++.++||||+||++|+|+ +|..||.+......+..+....
T Consensus 212 L~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell-tG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 212 LCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI-LGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred eeccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhC
Confidence 99999997543221 11234568889999997654 5889999999999999999 7999998876554443332200
Q ss_pred --------------------------ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 --------------------------LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 --------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+...++++.+++.+||+.||.+|||+.++++|
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0011123467889999999999999999999999866
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=208.20 Aligned_cols=176 Identities=23% Similarity=0.374 Sum_probs=139.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
..+||||+++|+|..++.... +.+++..++.++.|+++||.|||+++++||||||+||+++..+
T Consensus 91 ~~lv~ey~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 91 NIMVEEFVEHGPLDVCLRKEK--------------GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eEEEEecCCCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 348899999999999997532 3589999999999999999999999999999999999997643
Q ss_pred -----CeEEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy15108 95 -----SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168 (223)
Q Consensus 95 -----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~ 168 (223)
.++++|||++...... ....++..|++||.+.. ..++.++|+||||+++|++++.|..||......+..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 3799999987543221 22345677999998765 457899999999999999975799999877655443
Q ss_pred HHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
...... . ..+...+..+.+++.+||+.+|++||+++++++.|+
T Consensus 232 ~~~~~~-~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 RFYEKK-H--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHhc-c--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 332222 1 223334567999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=211.98 Aligned_cols=185 Identities=22% Similarity=0.357 Sum_probs=143.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|.||+++.++.+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~ 148 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK--------------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 148 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCE
Confidence 458999999999999997543 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC------------
Q psy15108 97 KISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL------------ 162 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~------------ 162 (223)
+++|||++........ .......++..|++||.+.+..++.++|+||||+++|+++ ++..|....
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ell-t~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd05079 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL-TYCDSESSPMTLFLKMIGPTH 227 (284)
T ss_pred EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhh-cCCCCCccccchhhhhccccc
Confidence 9999999875433221 1112334566799999988888899999999999999999 454433211
Q ss_pred ---CHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 163 ---SDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 163 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
........+... ...+.+..++..+.+++.+||+.+|++||+++++++.++.++
T Consensus 228 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 228 GQMTVTRLVRVLEEG-KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred ccccHHHHHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 011111222222 233445668899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=219.18 Aligned_cols=172 Identities=17% Similarity=0.152 Sum_probs=145.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||.||+++.++.+
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~ 135 (325)
T cd05604 71 LYFVLDFVNGGELFFHLQRER---------------SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHV 135 (325)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCE
Confidence 348899999999999997543 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||...+..+....+.....
T Consensus 136 kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~-~G~~pf~~~~~~~~~~~~~~~~~ 213 (325)
T cd05604 136 VLTDFGLCKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNILHKPL 213 (325)
T ss_pred EEeecCCcccCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhh-cCCCCCCCCCHHHHHHHHHcCCc
Confidence 999999986432211 1123345788999999998888999999999999999999 89999998887777776665432
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFP 207 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 207 (223)
......+..+.+++.+|++.+|.+||+++
T Consensus 214 --~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 214 --VLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred --cCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 23446788899999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=219.99 Aligned_cols=180 Identities=16% Similarity=0.203 Sum_probs=147.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++.. .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~----------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~i 181 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY----------------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 181 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCE
Confidence 33889999999999999642 47899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE----FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
+++|||++...............+++.|+|||.+.... ++.++|+||+||++|+|+ +|..||...+.......+.
T Consensus 182 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell-~G~~Pf~~~~~~~~~~~i~ 260 (371)
T cd05622 182 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYADSLVGTYSKIM 260 (371)
T ss_pred EEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHH-hCCCCCCCCCHHHHHHHHH
Confidence 99999998755433222233456889999999986543 778999999999999999 7999999888877777776
Q ss_pred hCcc--cCCCCCCChHHHHHHHHHhcCCCCCC--CCCHHHHHHHH
Q psy15108 173 SKKL--CWKHSSKTPEYITSLHEKCIHPHPHQ--RPTFPSIVTQL 213 (223)
Q Consensus 173 ~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~L 213 (223)
.... ..+.....+.++++++..|+..++.+ |++++++++|.
T Consensus 261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 5432 23334468899999999999844432 78999998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-33 Score=226.45 Aligned_cols=175 Identities=19% Similarity=0.293 Sum_probs=153.3
Q ss_pred cCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee
Q psy15108 12 KDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS 91 (223)
Q Consensus 12 ~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~ 91 (223)
+..+....||||..||++..+.+. ..|++..+..++.+++.||.|||++||++||+|-+|||+|
T Consensus 439 QT~~~l~fvmey~~Ggdm~~~~~~----------------~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD 502 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGDLMHHIHT----------------DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD 502 (694)
T ss_pred ccCCeEEEEEEecCCCcEEEEEec----------------ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc
Confidence 345555689999999994444432 3599999999999999999999999999999999999999
Q ss_pred cCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 92 SDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 92 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
..|.+||.|||+++.....+ ....+..||+.|+|||++....|+.++|.|+|||++|||+ .|..||.+.+..++...|
T Consensus 503 ~eGh~kiADFGlcKe~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML-~Gq~PF~gddEee~FdsI 580 (694)
T KOG0694|consen 503 TEGHVKIADFGLCKEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEML-VGESPFPGDDEEEVFDSI 580 (694)
T ss_pred ccCcEEecccccccccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHH
Confidence 99999999999998654222 2456789999999999999999999999999999999999 899999999999999999
Q ss_pred HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCH
Q psy15108 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206 (223)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 206 (223)
.... ...|..++.+..+++++++..+|++|...
T Consensus 581 ~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 8754 44567789999999999999999999765
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=212.45 Aligned_cols=178 Identities=19% Similarity=0.295 Sum_probs=140.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+. |+|.+++...+. .+++..+..++.||++||.|||++|++||||||+||+++.++.++
T Consensus 79 ~lv~e~~~-~~l~~~l~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~k 143 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDNCGN--------------LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELK 143 (288)
T ss_pred EEEEeCCC-cCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEE
Confidence 37889987 599999975432 578999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++....... .......++..|+|||.+.+ ..++.++|+||+||++|+|+ +|..||.+.+..+....+.....
T Consensus 144 l~DfG~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~ 221 (288)
T cd07871 144 LADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMA-TGRPMFPGSTVKEELHLIFRLLG 221 (288)
T ss_pred ECcCcceeeccCCC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999986532211 11233456788999998865 45789999999999999999 79999988776555444322100
Q ss_pred -------------------cC---------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 -------------------CW---------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 -------------------~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. ......+.++.+++.+|++.||.+|||++|+++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 222 TPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0012456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=210.09 Aligned_cols=194 Identities=30% Similarity=0.574 Sum_probs=150.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++.......... ......+++..+..++.|++.|+.|||+.|++|+||||.||+++.++.+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~ 169 (296)
T cd05095 94 LCMITEYMENGDLNQFLSRHEPQEAAE----KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTI 169 (296)
T ss_pred cEEEEEeCCCCcHHHHHHhcCcccccc----cccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCE
Confidence 448899999999999998754321110 1123458899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHh-
Q psy15108 97 KISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFN-KGEMPFPDLSDDQVLSQLES- 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~-~~~~p~~~~~~~~~~~~~~~- 173 (223)
+++|||++........ ........+..|++||......++.++|+|||||++|++++ .+..||...+..+.......
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~ 249 (296)
T cd05095 170 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEF 249 (296)
T ss_pred EeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHH
Confidence 9999999875432221 11122334567999998888889999999999999999984 27789987766555443321
Q ss_pred -----CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 174 -----KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 174 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.....+.+..++..+.+++.+||+.||.+||++.++++.|+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 250 FRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11122334567889999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=208.13 Aligned_cols=187 Identities=32% Similarity=0.490 Sum_probs=143.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||+.+|+|.+++..... ......++..+..++.||+.|+.|||+.+++||||||.||+++.++.+
T Consensus 70 ~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~ 139 (269)
T cd05042 70 YLLVLEFCPLGDLKNYLRSNRG----------MVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSV 139 (269)
T ss_pred eEEEEEeCCCCcHHHHHHhccc----------cccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcE
Confidence 4478999999999999987543 011235788899999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-hhhcCCccccccccccccc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFD-------DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~ 168 (223)
+++|||++......... .......+..|++||.... ..++.++|+||+||++|+|++.+..||......+..
T Consensus 140 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 219 (269)
T cd05042 140 KIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL 219 (269)
T ss_pred EEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence 99999988643322211 1123344667999998642 346789999999999999996588999887766655
Q ss_pred HHHHhCc-cc---CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 169 SQLESKK-LC---WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 169 ~~~~~~~-~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
....... .. ...+..++..+.+++..|| .||++||+++++++.|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 220 KQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 5543321 11 2223467888899999999 49999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=198.12 Aligned_cols=179 Identities=22% Similarity=0.223 Sum_probs=143.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+ ..||+..|+++.. .++..++..++.++++|++|||++.|+|||+||.|++++.+|.+
T Consensus 76 l~lVfEfm-~tdLe~vIkd~~i--------------~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~l 140 (318)
T KOG0659|consen 76 LSLVFEFM-PTDLEVVIKDKNI--------------ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQL 140 (318)
T ss_pred eEEEEEec-cccHHHHhccccc--------------ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcE
Confidence 34667766 4789999997654 79999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
|+.|||+++.+++.... ....+.|.+|.|||.+++. .|...+|+||.|||+.||+ .+..-|++.+..+.+..+-+.-
T Consensus 141 KiADFGLAr~f~~p~~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELl-lr~P~fpG~sDidQL~~If~~L 218 (318)
T KOG0659|consen 141 KIADFGLARFFGSPNRI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELL-LRVPFFPGDSDIDQLSKIFRAL 218 (318)
T ss_pred EeecccchhccCCCCcc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHH-ccCCCCCCCchHHHHHHHHHHc
Confidence 99999999977654321 2233788999999999875 5899999999999999999 7887777776655444432200
Q ss_pred -----ccCC---------------------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 -----LCWK---------------------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 -----~~~~---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..|+ .....++...+++.+|+.+||.+|+++.|++++
T Consensus 219 GTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0111 123445677899999999999999999999876
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=208.04 Aligned_cols=179 Identities=21% Similarity=0.316 Sum_probs=148.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++...+ .+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~ 145 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---------------AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGI 145 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---------------CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCE
Confidence 448899999999999997643 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-----hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYY-----KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||.+......... ......++..|++||.+.+..++.++|+||+|+++|+++ +|..||...........+
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~ 224 (267)
T cd06628 146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML-TGKHPFPDCTQLQAIFKI 224 (267)
T ss_pred EecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHh-hCCCCCCCccHHHHHHHH
Confidence 99999988765422110 111234567899999998888889999999999999999 799999877665555544
Q ss_pred HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
... ..+..+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 225 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GEN-ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hcc-CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 443 3344556788999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=219.98 Aligned_cols=180 Identities=17% Similarity=0.210 Sum_probs=144.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||.||+++.++.+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------------~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~ 140 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRME---------------VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHI 140 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCE
Confidence 448899999999999998653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh---h-------------------------------------------hhhhcCCccccccccccc
Q psy15108 97 KISLSGLSKDTYQKE---Y-------------------------------------------YKYRNAILPLRWLPYEAV 130 (223)
Q Consensus 97 ~l~df~~~~~~~~~~---~-------------------------------------------~~~~~~~~~~~~~~pe~~ 130 (223)
+++|||++....... . .......++..|+|||.+
T Consensus 141 kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 220 (381)
T cd05626 141 KLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220 (381)
T ss_pred EEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHH
Confidence 999999875321000 0 001124688999999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc--ccCCCCCCChHHHHHHHHH--hcCCCCCCCCCH
Q psy15108 131 FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK--LCWKHSSKTPEYITSLHEK--CIHPHPHQRPTF 206 (223)
Q Consensus 131 ~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~--~l~~dp~~Rps~ 206 (223)
.+..++.++||||+||++|+|+ +|..||......+....+.... ...+....+++++.+++.+ |+..++..||++
T Consensus 221 ~~~~~~~~~DiwSlG~il~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 221 LRKGYTQLCDWWSVGVILFEML-VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred cCCCCCCccceeehhhHHHHHH-hCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 8888999999999999999999 8999998877666555554321 2233334578899999998 445666679999
Q ss_pred HHHHHH
Q psy15108 207 PSIVTQ 212 (223)
Q Consensus 207 ~~ll~~ 212 (223)
++++.|
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=205.66 Aligned_cols=181 Identities=15% Similarity=0.204 Sum_probs=152.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++..... ..+++..+..++.|+++|+.|||+.+++|+||+|.||+++.++.+
T Consensus 74 ~~~~~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~ 140 (256)
T cd08221 74 LLIEMEYANGGTLYDKIVRQKG-------------QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLI 140 (256)
T ss_pred EEEEEEecCCCcHHHHHHhccc-------------cCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCE
Confidence 3377999999999999986532 458999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|.+||...+..++.++|+||+|+++++|+ +|..||......+....+..+..
T Consensus 141 kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~-~g~~~~~~~~~~~~~~~~~~~~~ 218 (256)
T cd08221 141 KLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL-TLKRTFDATNPLNLVVKIVQGNY 218 (256)
T ss_pred EECcCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999998865433221 123345778899999988888889999999999999999 78899988877777777665533
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
. +.+..++.++.+++.+||..+|.+||+++++++++
T Consensus 219 ~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 T-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred C-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 3 33466788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=205.62 Aligned_cols=175 Identities=24% Similarity=0.433 Sum_probs=139.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC-
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS- 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~- 95 (223)
..+|+||+.+|+|.++++..+. .+++..++.++.||+.|+.|||+.+++|+||||.||+++.++.
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~ 139 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKN--------------LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDR 139 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEeccccc
Confidence 4588999999999999986432 5899999999999999999999999999999999999987654
Q ss_pred -------eEEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy15108 96 -------VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167 (223)
Q Consensus 96 -------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~ 167 (223)
++++|||++...... ....++..|++||.+.+. .++.++|+||+|+++|++++.+..|+........
T Consensus 140 ~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~ 214 (258)
T cd05078 140 KTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214 (258)
T ss_pred ccCCCceEEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence 689999987644322 223456779999998763 4788999999999999999434677766655544
Q ss_pred HHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
...... ....+...+.++.+++.+||+.+|++||+++++++.|
T Consensus 215 ~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 215 LQFYED---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHc---cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 332222 2233445667899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=210.27 Aligned_cols=178 Identities=18% Similarity=0.250 Sum_probs=141.5
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+. ++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||.||+++.++.++
T Consensus 83 ~lv~e~~~-~~l~~~~~~~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 83 TLVFEHVD-QDLRTYLDKVPP-------------PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred EEEEcccc-cCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 47788887 589999976432 3589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc--
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK-- 175 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~-- 175 (223)
++|||++....... ......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||...........+....
T Consensus 149 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~-~g~~~f~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07863 149 LADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKPLFCGNSEADQLGKIFDLIGL 225 (288)
T ss_pred ECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHH-hCCcCcCCCCHHHHHHHHHHHhCC
Confidence 99999986543221 122345678899999998888999999999999999999 8999998776554443332200
Q ss_pred ---ccC--------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ---LCW--------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ---~~~--------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+ ...+.++..+.+++.+|++.||++||++.+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0113457788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=209.54 Aligned_cols=195 Identities=30% Similarity=0.546 Sum_probs=148.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.+++........-. .......+++..++.++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~ 168 (295)
T cd05097 92 LCMITEYMENGDLNQFLSQREIESTFT---HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTI 168 (295)
T ss_pred cEEEEecCCCCcHHHHHHhcccccccc---ccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcE
Confidence 347899999999999997643210000 00112347899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHh-
Q psy15108 97 KISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFN-KGEMPFPDLSDDQVLSQLES- 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~-~~~~p~~~~~~~~~~~~~~~- 173 (223)
+++|||++........ .......++..|++||......++.++|+||||++++++++ .+..||......+....+..
T Consensus 169 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~ 248 (295)
T cd05097 169 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248 (295)
T ss_pred EecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHh
Confidence 9999999865432221 11222344678999999888889999999999999999984 26778887766655544322
Q ss_pred -----CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 174 -----KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 174 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.......+...+..+.+++.+||+.+|++||+++++++.|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 249 FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11112334557889999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=208.65 Aligned_cols=179 Identities=20% Similarity=0.276 Sum_probs=145.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+.+|+|.+++.... .++++..+..++.|+++||.|||+.|++|+||+|+||+++.++.++
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~--------------~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~k 143 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELE--------------RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIK 143 (282)
T ss_pred EEEEEecCCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEE
Confidence 37899999999999887532 3589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
++|||++....... .......++..|++||.+. ...++.++|+||+||++|+++ +|..||...+..+....+.
T Consensus 144 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~-~g~~p~~~~~~~~~~~~~~ 221 (282)
T cd06643 144 LADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMRVLLKIA 221 (282)
T ss_pred Eccccccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc-cCCCCccccCHHHHHHHHh
Confidence 99999986543221 1123345678899999874 344678999999999999999 7999998877666555554
Q ss_pred hCcc-cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKL-CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... ....+..++.++.+++.+||+.+|.+||++.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 222 KSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred hcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4322 223345678899999999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=216.14 Aligned_cols=181 Identities=15% Similarity=0.206 Sum_probs=147.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++..+. .+++..+..++.|++.|+.|||+.+++||||||+||+++.++.+
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~--------------~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~ 141 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED--------------RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHI 141 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCE
Confidence 4489999999999999986432 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++...............++..|+|||.+. ...++.++|+|||||++|+|+ +|..||...+..+....+
T Consensus 142 kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell-~g~~Pf~~~~~~~~~~~i 220 (332)
T cd05623 142 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI 220 (332)
T ss_pred EEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHh-cCCCCCCCCCHHHHHHHH
Confidence 99999998654332222223356788999999975 345788999999999999999 799999988887777777
Q ss_pred HhCcccCCC---CCCChHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q psy15108 172 ESKKLCWKH---SSKTPEYITSLHEKCIHPHPHQ--RPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~ 212 (223)
......... ...+++++++++.+|+..++.. |++++++++|
T Consensus 221 ~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 221 MNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred hCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 654333222 2357889999999988654443 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=205.22 Aligned_cols=187 Identities=32% Similarity=0.518 Sum_probs=142.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++|+|.++++.... ......++..+..++.|++.|+.|||+.+++|+||||.||+++..+.+
T Consensus 70 ~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~ 139 (269)
T cd05087 70 YLLVMEFCPLGDLKGYLRSCRK----------AELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTV 139 (269)
T ss_pred cEEEEECCCCCcHHHHHHHhhh----------cccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcE
Confidence 4488999999999999986543 012346778888999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh-hhhhcCCcccccccccccccC-------CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy15108 97 KISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDD-------EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-------~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~ 168 (223)
+++|||++........ .......++..|++||.+... .++.++|+||||+++|++++.|..||......+..
T Consensus 140 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 219 (269)
T cd05087 140 KIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219 (269)
T ss_pred EECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence 9999998864332221 112233456779999987532 35779999999999999985599999877665544
Q ss_pred HHHHhC-cccC---CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 169 SQLESK-KLCW---KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 169 ~~~~~~-~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
...... .... ......++.+.+++..|| .+|++||++++|+..|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 220 TYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 332221 1111 122346788999999999 58999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=226.65 Aligned_cols=173 Identities=15% Similarity=0.212 Sum_probs=134.2
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCC---
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDL--- 94 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~--- 94 (223)
+|++++ +++|.+++...+ .+++..+..++.||+.||.|||+ .||+||||||.||+++..+
T Consensus 209 iv~~~~-g~~l~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHG---------------PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEEecc-CCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccc
Confidence 455554 889999997653 49999999999999999999998 5999999999999998664
Q ss_pred -------------CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q psy15108 95 -------------SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPD 161 (223)
Q Consensus 95 -------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~ 161 (223)
.+||+|||.+..... ......++..|+|||.+.+..++.++|||||||++|||+ +|+.||.+
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell-tG~~pf~~ 347 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY-TGKLLYDT 347 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH-hCCCCCCC
Confidence 489999998753221 123456788999999999989999999999999999999 79999987
Q ss_pred CCHHHHHHHHHhCcc-------------------------cCCC---------------CCCChHHHHHHHHHhcCCCCC
Q psy15108 162 LSDDQVLSQLESKKL-------------------------CWKH---------------SSKTPEYITSLHEKCIHPHPH 201 (223)
Q Consensus 162 ~~~~~~~~~~~~~~~-------------------------~~~~---------------~~~~~~~~~~li~~~l~~dp~ 201 (223)
.+..+.+..+..... .+.. .....+.+.+||.+||+.||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 765544333221100 0000 000134567999999999999
Q ss_pred CCCCHHHHHHH
Q psy15108 202 QRPTFPSIVTQ 212 (223)
Q Consensus 202 ~Rps~~~ll~~ 212 (223)
+|||++|+++|
T Consensus 428 ~R~ta~e~L~H 438 (467)
T PTZ00284 428 KRLNARQMTTH 438 (467)
T ss_pred hCCCHHHHhcC
Confidence 99999999975
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=221.52 Aligned_cols=179 Identities=15% Similarity=0.153 Sum_probs=144.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||.||+++.++.+
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~---------------~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~i 140 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG---------------IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHI 140 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCE
Confidence 348899999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh------------------------------------------hhhhhcCCcccccccccccccCC
Q psy15108 97 KISLSGLSKDTYQKE------------------------------------------YYKYRNAILPLRWLPYEAVFDDE 134 (223)
Q Consensus 97 ~l~df~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~pe~~~~~~ 134 (223)
+++|||++....... ........+++.|+|||.+.+..
T Consensus 141 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 220 (376)
T cd05598 141 KLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220 (376)
T ss_pred EEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC
Confidence 999999874221000 00011246788999999999888
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc--CCCCCCChHHHHHHHHHhcCCCCCCCC---CHHHH
Q psy15108 135 FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC--WKHSSKTPEYITSLHEKCIHPHPHQRP---TFPSI 209 (223)
Q Consensus 135 ~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~l 209 (223)
++.++||||+||++|+|+ +|..||.+....+....+...... .+....++.++.+++.+|+ .+|.+|+ ++.++
T Consensus 221 ~~~~~DiwSlGvilyell-~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 221 YTQLCDWWSVGVILYEML-VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred CCcceeeeeccceeeehh-hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999999999999 799999988876666555443222 2223457888999999976 5999999 89999
Q ss_pred HHH
Q psy15108 210 VTQ 212 (223)
Q Consensus 210 l~~ 212 (223)
++|
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=205.55 Aligned_cols=188 Identities=30% Similarity=0.547 Sum_probs=151.3
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++++|+.+|+|.+++...... .+...+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++.+++
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~---------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIG---------EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred EEEecCCCCcHHHHHHHhccc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEE
Confidence 557899999999998754320 01135899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 99 SLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 99 ~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
+|||++........ ........+..|++||......++.++|+||||+++|++++.|..||.+.+..+....+... ..
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~ 233 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NR 233 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence 99998875432221 11122334567899999888888999999999999999995589999888777666665544 22
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 333456788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=209.13 Aligned_cols=180 Identities=19% Similarity=0.221 Sum_probs=141.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+++|.++++..+ ++++..+..++.|+++|+.|||+.+++|+|++|.||+++.++.+
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~ 145 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTG---------------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDV 145 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCE
Confidence 347899999999999997543 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+++|||++....... .......++..|++||.+. ...++.++|+||+|+++++|+ +|..||...........+..
T Consensus 146 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~-~g~~p~~~~~~~~~~~~~~~ 223 (267)
T cd06646 146 KLADFGVAAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA-ELQPPMFDLHPMRALFLMSK 223 (267)
T ss_pred EECcCccceeecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH-hCCCCccccchhhhheeeec
Confidence 999999987543221 1112345667899999874 344678999999999999999 78889876554433332222
Q ss_pred CcccCC---CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 174 KKLCWK---HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 174 ~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
.....+ .....+..+.+++.+||..+|++||+++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 224 SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 222221 1234678899999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=223.72 Aligned_cols=201 Identities=23% Similarity=0.413 Sum_probs=176.3
Q ss_pred chHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccC
Q psy15108 2 DLKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHK 81 (223)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 81 (223)
||+.++..+..+. ..+|..+++.|+|.++++.++. ++.....+.+.+||++|+.|||+++++||
T Consensus 759 nl~RLLgvc~~s~--~qlvtq~mP~G~LlDyvr~hr~--------------~igsq~lLnw~~QIAkgM~YLe~qrlVHr 822 (1177)
T KOG1025|consen 759 NLLRLLGVCMLST--LQLVTQLMPLGCLLDYVREHRD--------------NIGSQDLLNWCYQIAKGMKYLEEQRLVHR 822 (1177)
T ss_pred hHHHHhhhcccch--HHHHHHhcccchHHHHHHHhhc--------------cccHHHHHHHHHHHHHHHHHHHhcchhhh
Confidence 3566666666544 6688999999999999998765 69999999999999999999999999999
Q ss_pred CCCCCCeeeecCCCeEEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q psy15108 82 DIAARNCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFP 160 (223)
Q Consensus 82 di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~ 160 (223)
||-++|+|+.....+|+.|||+++...... .........++.|++-|.+....|+.++|||||||++||++|.|..|+.
T Consensus 823 dLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~ 902 (1177)
T KOG1025|consen 823 DLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD 902 (1177)
T ss_pred hhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC
Confidence 999999999999999999999998654433 2223345567889999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 161 DLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
+....++...+..+ .+++.|+.++..++.++.+||..|+..||+|+++...+.+...+
T Consensus 903 gi~~~eI~dlle~g-eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 903 GIPAEEIPDLLEKG-ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCHHHhhHHHhcc-ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 99999998888887 55888999999999999999999999999999999998886543
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=204.34 Aligned_cols=179 Identities=20% Similarity=0.277 Sum_probs=148.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC-C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-S 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-~ 95 (223)
..+|+||+++++|.+++..... ..+++..++.++.++++|+.|||++|++|+||+|.||+++.++ .
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~ 140 (256)
T cd08220 74 LMIVMEYAPGGTLAEYIQKRCN-------------SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMV 140 (256)
T ss_pred EEEEEecCCCCCHHHHHHHhcc-------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE
Confidence 4488999999999999987543 4589999999999999999999999999999999999998654 5
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++++|||++....... ......++..|++||.+....++.++|+||+|+++++++ ++..||...+.......+....
T Consensus 141 ~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~ 217 (256)
T cd08220 141 VKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA-SLKRAFEAANLPALVLKIMSGT 217 (256)
T ss_pred EEEccCCCceecCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHH-hCCCCcccCchHHHHHHHHhcC
Confidence 7999999987543322 112345677899999998888889999999999999999 7899998877666665555542
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+.+..++.++.+++..||+.+|.+||++++++++
T Consensus 218 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 -FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 233455678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=207.96 Aligned_cols=185 Identities=25% Similarity=0.381 Sum_probs=142.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++|+|.+++...+. .+++..++.++.|++.||.|||+.|++|+||+|.||+++.++.+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~--------------~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~ 147 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRE--------------RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRV 147 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCc--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeE
Confidence 4478999999999999975432 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh--hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------
Q psy15108 97 KISLSGLSKDTYQKEYY--KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ-------- 166 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~-------- 166 (223)
+++|||++......... .......+..|++||...+..++.++|+||+|+++++++ ++..++.......
T Consensus 148 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~-~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05081 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF-TYSDKSCSPPAEFMRMMGNDK 226 (284)
T ss_pred EECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHh-hcCCcCCCcchhhhhhccccc
Confidence 99999998754322110 111122345589999998888899999999999999999 5554543221110
Q ss_pred -------HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 167 -------VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 167 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
............+.+..++.++.+++.+||..+|++|||+.++++.|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 227 QGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01111222233444567788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=217.79 Aligned_cols=178 Identities=18% Similarity=0.268 Sum_probs=139.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++
T Consensus 80 ~lv~e~~~-~~l~~~~~~~---------------~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~k 143 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP---------------QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLK 143 (372)
T ss_pred EEEeeccc-cCHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEE
Confidence 36777775 6888888643 3499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES--- 173 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~--- 173 (223)
++|||++...............++..|+|||.+.+. .++.++|+||+||++|+|+ +|+.||.+.+.......+..
T Consensus 144 L~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~i~~~~g 222 (372)
T cd07853 144 ICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL-GRRILFQAQSPIQQLDLITDLLG 222 (372)
T ss_pred eccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHH-cCCCCCCCCCHHHHHHHHHHHcC
Confidence 999999875432221122334567889999998764 4788999999999999999 79999987765544433321
Q ss_pred --------------------CcccC-------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 --------------------KKLCW-------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 --------------------~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ......++++.+++.+||+.||++|||+.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 1123457789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=219.43 Aligned_cols=179 Identities=16% Similarity=0.181 Sum_probs=144.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~ 140 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD---------------TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHI 140 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCE
Confidence 448899999999999998643 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-------------hh---------------------------------hhhcCCccccccccccc
Q psy15108 97 KISLSGLSKDTYQKE-------------YY---------------------------------KYRNAILPLRWLPYEAV 130 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-------------~~---------------------------------~~~~~~~~~~~~~pe~~ 130 (223)
+++|||++....... .. ......+++.|+|||.+
T Consensus 141 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 220 (377)
T cd05629 141 KLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF 220 (377)
T ss_pred EEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH
Confidence 999999985321100 00 00123578899999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC--CCCCCChHHHHHHHHHhcCCCCCCC---CC
Q psy15108 131 FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW--KHSSKTPEYITSLHEKCIHPHPHQR---PT 205 (223)
Q Consensus 131 ~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R---ps 205 (223)
.+..++.++|+||+||++|+|+ +|..||......+....+....... +....++.++.+++.+|+. +|.+| ++
T Consensus 221 ~~~~~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 221 LQQGYGQECDWWSLGAIMFECL-IGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred ccCCCCCceeeEecchhhhhhh-cCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 8888999999999999999999 8999998887777666665432222 2223568889999999997 67665 59
Q ss_pred HHHHHHH
Q psy15108 206 FPSIVTQ 212 (223)
Q Consensus 206 ~~~ll~~ 212 (223)
+.+++.|
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=205.27 Aligned_cols=184 Identities=17% Similarity=0.291 Sum_probs=152.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+++++|.+++..... ....+++..++.++.|++.|+.|||+ .+++|+||+|.||+++..+.
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~-----------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~ 152 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKE-----------KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK 152 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc
Confidence 4488999999999999865332 22468999999999999999999996 78999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++++|||.+....... ......++..|++||...+..++.++|+||||+++|+++ +|..||...........+....
T Consensus 153 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~-~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 153 VTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC-TLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred EEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHH-hCCCcccccCHHHHHHHHhhcc
Confidence 9999999987544332 223455677899999998888899999999999999999 7899998777666666655553
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.........+.++.+++.+||+.||++||++.|+..++.
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 333333367889999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=206.00 Aligned_cols=180 Identities=14% Similarity=0.236 Sum_probs=147.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++.+.+ ++++..+..++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~ 141 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFG---------------PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGII 141 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeE
Confidence 448899999999999997643 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-----hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKE-----YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++....... ........++..|++||...+..++.++|+||+|+++++++ +|..||...+.......+
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~-~g~~p~~~~~~~~~~~~~ 220 (265)
T cd06631 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMA-TGKPPLASMDRLAAMFYI 220 (265)
T ss_pred EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHH-hCCCccccCChHHHHHHh
Confidence 999999886532111 11112345677899999998888899999999999999999 799999877665544443
Q ss_pred HhC-cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESK-KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
... ...+..+...+.++.+++++||+.+|.+||++.+++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 221 GAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred hhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 332 22334556788999999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=206.94 Aligned_cols=179 Identities=20% Similarity=0.208 Sum_probs=142.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.++++..+ .+++.+++.++.|++.|+.|||+.|++|+||+|.||+++.++.+
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~ 145 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVTG---------------PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHV 145 (267)
T ss_pred EEEEEeccCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence 448899999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+++|||++....... .......++..|+|||.+. ...++.++|+||+||++|+++ ++..||..............
T Consensus 146 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~-~~~~p~~~~~~~~~~~~~~~ 223 (267)
T cd06645 146 KLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA-ELQPPMFDLHPMRALFLMTK 223 (267)
T ss_pred EECcceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHh-cCCCCcccccchhhHHhhhc
Confidence 999999876443221 1123346778899999874 445788999999999999999 78889876554443333322
Q ss_pred CcccCCC---CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWKH---SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....++. ...++..+.+++.+||+.+|++||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 224 SNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 2222211 22467889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=219.19 Aligned_cols=179 Identities=16% Similarity=0.166 Sum_probs=143.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+++||||||+||+++.++.+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------------~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~ 140 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMG---------------IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHI 140 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 348999999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh----------------------------------------------hhhhhcCCccccccccccc
Q psy15108 97 KISLSGLSKDTYQKE----------------------------------------------YYKYRNAILPLRWLPYEAV 130 (223)
Q Consensus 97 ~l~df~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~~pe~~ 130 (223)
+++|||++....... ........+++.|+|||.+
T Consensus 141 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 220 (382)
T cd05625 141 KLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL 220 (382)
T ss_pred EEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh
Confidence 999999874221000 0001123578899999999
Q ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc--cCCCCCCChHHHHHHHHHhcCCCCCCCCC---
Q psy15108 131 FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL--CWKHSSKTPEYITSLHEKCIHPHPHQRPT--- 205 (223)
Q Consensus 131 ~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps--- 205 (223)
.+..++.++|+||+||++|+|+ +|..||...+..+....+..... ..+.....++++.+++.+|+ .+|.+|++
T Consensus 221 ~~~~~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 221 LRTGYTQLCDWWSVGVILYEML-VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred cCCCCCCeeeEEechHHHHHHH-hCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 8888999999999999999999 79999998877666655544222 22223457888999998876 49999987
Q ss_pred HHHHHHH
Q psy15108 206 FPSIVTQ 212 (223)
Q Consensus 206 ~~~ll~~ 212 (223)
+.+++.|
T Consensus 299 ~~ei~~h 305 (382)
T cd05625 299 ADEIKAH 305 (382)
T ss_pred HHHHhcC
Confidence 8888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=206.86 Aligned_cols=178 Identities=19% Similarity=0.260 Sum_probs=144.5
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+++++|.+++...+ .+++..++.++.|++.|+.|||+.+++|+|++|+||+++.++.++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~ 146 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---------------ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVK 146 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEE
Confidence 36889999999999997643 489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 98 ISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 98 l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++|||++....... ........++..|+|||.+.+..++.++|+||+||++|+++ +|..||......+.........
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~-~g~~pf~~~~~~~~~~~~~~~~ 225 (266)
T cd06651 147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML-TEKPPWAEYEAMAAIFKIATQP 225 (266)
T ss_pred EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH-HCCCCccccchHHHHHHHhcCC
Confidence 99999886542211 01112234677899999998888899999999999999999 7999998777666555544433
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+..+...++.+.+++ .||..+|++||++++++.|
T Consensus 226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 34444556678888888 6777899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=208.88 Aligned_cols=178 Identities=17% Similarity=0.280 Sum_probs=145.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++++|.++++. ..+++.++..++.|++.|+.|||+.|++|+||+|+||+++.++.+
T Consensus 92 ~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~ 155 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV 155 (296)
T ss_pred EEEeecccCCCCHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence 4489999999999999964 247899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-c
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK-K 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~-~ 175 (223)
+++|||++........ ......++..|++||.+....++.++|+|||||++|+++ +|..||............... .
T Consensus 156 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~-~g~~pf~~~~~~~~~~~~~~~~~ 233 (296)
T cd06654 156 KLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENPLRALYLIATNGT 233 (296)
T ss_pred EECccccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHH-hCCCCCCCCCHHHhHHHHhcCCC
Confidence 9999998765332211 112345677899999998888899999999999999999 799999877654443333222 1
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+...+..+.+++.+||..+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 2223345677889999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=209.66 Aligned_cols=179 Identities=20% Similarity=0.307 Sum_probs=144.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++...+. ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.+
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~ 141 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGE-------------AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHI 141 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcc-------------cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCE
Confidence 3388999999999999976433 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD---QVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~---~~~~~~~~ 173 (223)
+++|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|+ +|..||...... ........
T Consensus 142 ~l~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~-~g~~Pf~~~~~~~~~~~~~~~~~ 218 (285)
T cd05630 142 RISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI-AGQSPFQQRKKKIKREEVERLVK 218 (285)
T ss_pred EEeeccceeecCCCc--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHH-hCCCCCCCCCccchHHHHHhhhh
Confidence 999999886433221 112346788899999998888999999999999999999 799999865432 22222212
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
. .....+..+++++.+++.+||+.||++||+ ++++++|
T Consensus 219 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 219 E-VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred h-hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1 122334567888999999999999999999 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=218.78 Aligned_cols=179 Identities=16% Similarity=0.186 Sum_probs=145.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||.||+++.++.+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~v 140 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD---------------TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHV 140 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCE
Confidence 448899999999999998653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh----------------------------------hhhhcCCcccccccccccccCCCCcccchH
Q psy15108 97 KISLSGLSKDTYQKEY----------------------------------YKYRNAILPLRWLPYEAVFDDEFSTKSDVY 142 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~ 142 (223)
+++|||++........ .......+++.|+|||.+.+..++.++|+|
T Consensus 141 kL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw 220 (360)
T cd05627 141 KLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWW 220 (360)
T ss_pred EEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceec
Confidence 9999998764321100 001124678899999999888899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC--CCCCCChHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q psy15108 143 AYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW--KHSSKTPEYITSLHEKCIHPHPHQRPT---FPSIVTQ 212 (223)
Q Consensus 143 slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~ 212 (223)
|+||++|+|+ +|..||...........+....... +.....++++++++.+++. +|.+|++ +.++++|
T Consensus 221 SlGvilyel~-tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 221 SLGVIMYEML-IGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred cccceeeecc-cCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 9999999999 8999999888877777666432222 2223467889999998774 9999985 6777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=203.24 Aligned_cols=180 Identities=21% Similarity=0.283 Sum_probs=150.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+++|.+++..... ..+++.+++.++.|++.|+.|||+.+++|+||+|+||+++.++.+
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~ 140 (256)
T cd08218 74 LYIVMDYCEGGDLYKKINAQRG-------------VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTI 140 (256)
T ss_pred EEEEEecCCCCcHHHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCE
Confidence 3488999999999999976432 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|++||...+..++.++|+||||+++++++ +|..||...........+..+ .
T Consensus 141 ~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~-~g~~~~~~~~~~~~~~~~~~~-~ 217 (256)
T cd08218 141 KLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC-TLKHAFEAGNMKNLVLKIIRG-S 217 (256)
T ss_pred EEeeccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHH-cCCCCccCCCHHHHHHHHhcC-C
Confidence 9999998865433221 122345677899999998888889999999999999999 799999877777666666554 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+.+...+.++.+++.+||+.+|.+||++++++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 334456778899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=208.16 Aligned_cols=179 Identities=19% Similarity=0.276 Sum_probs=146.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+.+|+|.+++...+. ..+++..+..++.|++.||.|||+.+++|+||+|.||+++.++.++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~k 142 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGN-------------PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIR 142 (285)
T ss_pred EEEEEeccCccHHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEE
Confidence 378999999999999976433 4699999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc--
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK-- 175 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~-- 175 (223)
++|||++....... ......++..|++||.+.+..++.++|+||+|+++|+++ +|..||...........+....
T Consensus 143 l~Dfg~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~P~~~~~~~~~~~~~~~~~~~ 219 (285)
T cd05632 143 ISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMI-EGQSPFRGRKEKVKREEVDRRVLE 219 (285)
T ss_pred EecCCcceecCCCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhhhc
Confidence 99999886432221 123346788999999998888999999999999999999 7999998776554433332211
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
.........+.++.+++..||+.+|++||+ +++++.+
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 220 TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 122334567888999999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=203.55 Aligned_cols=181 Identities=17% Similarity=0.264 Sum_probs=152.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCcccCCCCCCCeeeec
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHIS-----DKRLIHKDIAARNCLISS 92 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~i~H~di~~~nil~~~ 92 (223)
.+++||+.+++|.+++..... ...++++..++.++.|++.|+.+|| +.+++|+||+|.||+++.
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~ 145 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCKK-----------ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA 145 (265)
T ss_pred EEEehhccCCCHHHHHHHHhh-----------cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec
Confidence 478999999999999986532 2356999999999999999999999 899999999999999999
Q ss_pred CCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 93 DLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 93 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
++.++++|||++......... .....++..|++||.+....++.++|+||||+++++++ +|..||...+.......+.
T Consensus 146 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~~ 223 (265)
T cd08217 146 NNNVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELC-ALSPPFTARNQLQLASKIK 223 (265)
T ss_pred CCCEEEecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHH-HCCCcccCcCHHHHHHHHh
Confidence 999999999988765433211 22345678899999998888899999999999999999 7999998887666666655
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .....+...+..+.+++.+|++.+|++||++++++++
T Consensus 224 ~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 EG-KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cC-CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 54 3334456778999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=208.35 Aligned_cols=179 Identities=18% Similarity=0.273 Sum_probs=146.0
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
...+++||+++++|.+++.. ..+++..+..++.||+.|+.|||+.+++|+||+|.||+++.++.
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~----------------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~ 156 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH----------------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR 156 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC
Confidence 35589999999999999853 24899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++++|||++....... .......++..|+|||......++.++|+||+|+++++++ +|..||...........+....
T Consensus 157 ~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~-~g~~p~~~~~~~~~~~~~~~~~ 234 (292)
T cd06658 157 IKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI-DGEPPYFNEPPLQAMRRIRDNL 234 (292)
T ss_pred EEEccCcchhhccccc-ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcC
Confidence 9999999886432211 1122345678899999998888899999999999999999 7999998877666555544321
Q ss_pred -ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 -LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.........+..+.+++.+||..+|.+||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 235 PPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1112223567889999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=205.23 Aligned_cols=177 Identities=21% Similarity=0.275 Sum_probs=146.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+++|.+++.. ..+++..+..++.|+++|+.|||+++++|+||+|+||+++.++.+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~ 140 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKP----------------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDV 140 (277)
T ss_pred eEEEEEccCCCcHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCE
Confidence 5589999999999999853 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|++||.+.+..++.++|+||||+++++++ +|..|+...........+... .
T Consensus 141 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~-tg~~p~~~~~~~~~~~~~~~~-~ 217 (277)
T cd06642 141 KLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELA-KGEPPNSDLHPMRVLFLIPKN-S 217 (277)
T ss_pred EEccccccccccCcc-hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHH-hCCCCCcccchhhHHhhhhcC-C
Confidence 999999886543221 1122345677899999998888899999999999999999 799999876665555444333 2
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........+.++.+++.+||+.+|.+||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 233345678889999999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=205.99 Aligned_cols=180 Identities=19% Similarity=0.290 Sum_probs=144.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+++|..++.+... .+++..+..++.|++.|+.|||+.+++|+|++|.||+++.++.+
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~--------------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 149 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDR--------------GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDI 149 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCE
Confidence 4488999999999998875432 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++....... .......++..|++||.+. ...++.++|+||||+++|+|+ +|..||...........+
T Consensus 150 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~-~g~~p~~~~~~~~~~~~~ 227 (292)
T cd06644 150 KLADFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKI 227 (292)
T ss_pred EEccCccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHh-cCCCCCccccHHHHHHHH
Confidence 999999876432211 1122345677899999874 344678899999999999999 799999877765555554
Q ss_pred HhCcc-cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKL-CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ....+..++.++.+++.+||+.+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 228 AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred hcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 43322 223345677889999999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=210.50 Aligned_cols=182 Identities=19% Similarity=0.231 Sum_probs=149.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.+++..... ..+++..+..++.|+++||.|||+.|++|+||||+||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 142 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPG-------------KCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHI 142 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCC-------------CccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCE
Confidence 3478999999999999975432 468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh----------------------------hhhhcCCcccccccccccccCCCCcccchHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEY----------------------------YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLI 148 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il 148 (223)
+++|||++........ ...+...++..|++||.+.+..++.++|+||||+++
T Consensus 143 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll 222 (316)
T cd05574 143 MLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222 (316)
T ss_pred EEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHH
Confidence 9999998764321110 011123567789999999888889999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Q psy15108 149 WEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT----FPSIVTQ 212 (223)
Q Consensus 149 ~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~~ 212 (223)
|+++ +|..||.+.+.......+.......+.....+..+.+++.+||..+|++||+ +++++.+
T Consensus 223 ~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 223 YEML-YGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHh-hCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 9999 7999998888777666666554444444447899999999999999999999 7777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=212.49 Aligned_cols=181 Identities=15% Similarity=0.193 Sum_probs=144.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ ..+++..+..++.||+.||.|||+++++||||||.||+++.++.+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~ 141 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE--------------DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHI 141 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCE
Confidence 348899999999999997643 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-----DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++...............+++.|+|||.+.. ..++.++|+||+||++|+|+ +|..||......+....+
T Consensus 142 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~-~g~~Pf~~~~~~~~~~~i 220 (331)
T cd05597 142 RLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI 220 (331)
T ss_pred EEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHh-hCCCCCCCCCHHHHHHHH
Confidence 999999986543322212223457889999999863 34678999999999999999 799999888777766666
Q ss_pred HhCcccCCC---CCCChHHHHHHHHHhcCCCCC--CCCCHHHHHHH
Q psy15108 172 ESKKLCWKH---SSKTPEYITSLHEKCIHPHPH--QRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~--~Rps~~~ll~~ 212 (223)
......... ....++.+++++.+|+..+++ .|+++++++.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 221 MNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 543322222 234688999999998865333 37899999877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=203.15 Aligned_cols=180 Identities=22% Similarity=0.260 Sum_probs=145.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.++++... .++++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.+
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~--------------~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~ 140 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTR--------------GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDV 140 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhc--------------cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCE
Confidence 347899999999999998652 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD---EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+++|||++....... .......++..|++||.+... .++.++|+||+|+++++|+ +|..||...........+..
T Consensus 141 ~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~-tg~~p~~~~~~~~~~~~~~~ 218 (262)
T cd06613 141 KLADFGVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA-ELQPPMFDLHPMRALFLISK 218 (262)
T ss_pred EECccccchhhhhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHh
Confidence 999999886543221 112334567789999998766 7888999999999999999 79999988776655544443
Q ss_pred CcccC---CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCW---KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ......+.++.+++.+||..+|.+||++.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 219 SNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 32222 1233456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=204.12 Aligned_cols=178 Identities=16% Similarity=0.196 Sum_probs=149.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++.... .+++..+..++.|+++|+.|||+.+++|+||+|+||+++.++.+
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~ 132 (262)
T cd05572 68 IYMLMEYCLGGELWTILRDRG---------------LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYV 132 (262)
T ss_pred cEEEEecCCCCcHHHHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCE
Confidence 448899999999999997643 38999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS--DDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~--~~~~~~~~~~~ 174 (223)
+++|||.+....... ......++..|++||.+....++.++|+|++|+++|+++ +|..||.... .......+...
T Consensus 133 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 209 (262)
T cd05572 133 KLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELL-TGRPPFGEDDEDPMEIYNDILKG 209 (262)
T ss_pred EEeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHH-hCCCCcCCCCCCHHHHHHHHhcc
Confidence 999999887654332 122345677899999988888899999999999999999 7999998776 55556655543
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
......+...+.++.+++.+||+.+|.+||+ ++|++++
T Consensus 210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 3445555666889999999999999999999 7887764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=210.21 Aligned_cols=179 Identities=21% Similarity=0.333 Sum_probs=135.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+ +++|.+++..+. ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+
T Consensus 78 ~~lv~e~~-~~~l~~~~~~~~--------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 142 (303)
T cd07869 78 LTLVFEYV-HTDLCQYMDKHP--------------GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGEL 142 (303)
T ss_pred EEEEEECC-CcCHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence 33788988 478888887643 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~~~~~~ 174 (223)
+++|||++....... .......++..|+|||.+.+. .++.++|+||+||++|+|+ +|..||.+.... .....+...
T Consensus 143 kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~ 220 (303)
T cd07869 143 KLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI-QGVAAFPGMKDIQDQLERIFLV 220 (303)
T ss_pred EECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCccHHHHHHHHHHH
Confidence 999999886432211 112334567889999987653 4788999999999999999 799999875432 222221110
Q ss_pred --cc---cC----------------CC---------CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 --KL---CW----------------KH---------SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 --~~---~~----------------~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .+ .. ....++.+.+++.+||+.||++|||++++++|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 221 LGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 00 00 01234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=202.84 Aligned_cols=180 Identities=21% Similarity=0.290 Sum_probs=144.8
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
++.+|||||++ +|..+|..-+. +|+..++..++.|+++|++|||.+.|+|||+|++|+|+...|.
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~q--------------~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~ 215 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMKQ--------------PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI 215 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhccC--------------CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc
Confidence 35588888875 78888876543 6999999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+|++|||+|+..++. .......+.|.+|.|||.+.+.+ |+.+.|+||+|||+.|++ .++.-|.+......+..|..-
T Consensus 216 lKiaDFGLAR~ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l-~~kPlf~G~sE~dQl~~If~l 293 (419)
T KOG0663|consen 216 LKIADFGLAREYGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELL-TQKPLFPGKSEIDQLDKIFKL 293 (419)
T ss_pred EEecccchhhhhcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHH-hcCCCCCCCchHHHHHHHHHH
Confidence 999999999976654 23345667899999999988765 899999999999999999 788888877765544443320
Q ss_pred c-----ccCC------------------------CC-CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 K-----LCWK------------------------HS-SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~-----~~~~------------------------~~-~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
- -.|+ .. ...++.-.+++..++.+||.+|.|+++.++|
T Consensus 294 lGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 294 LGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 0000 00 1134677899999999999999999999875
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=204.37 Aligned_cols=182 Identities=18% Similarity=0.259 Sum_probs=145.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+.+++|.+++..... .+..+++..+..++.|+++|+.|||+.+++|+||+|+||+++.++.++
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~ 153 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRK-----------KGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVK 153 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhh-----------cCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEE
Confidence 488999999999999976441 124689999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-----DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
++|||++....... .......++..|+|||.+.. ..++.++|+||+|+++++++ +|..||...........+.
T Consensus 154 l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~~ 231 (275)
T cd06608 154 LVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA-DGKPPLCDMHPMRALFKIP 231 (275)
T ss_pred ECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH-hCCCCccccchHHHHHHhh
Confidence 99999886543222 12233456778999998753 34677899999999999999 7999998766655555544
Q ss_pred hCcc-cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKL-CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... ....+...+.++.+++.+||..||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 4322 222233467889999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=214.80 Aligned_cols=177 Identities=18% Similarity=0.221 Sum_probs=133.8
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++++++ +++|.+++...+ .+++..++.++.||+.||.|||+.|++||||||.||+++.++.++|
T Consensus 160 lv~e~~-~~~L~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL 223 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAKR---------------NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCL 223 (391)
T ss_pred EEEecC-CCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEE
Confidence 667776 579999987643 4899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHH
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-------DQVLSQL 171 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-------~~~~~~~ 171 (223)
+|||++...............+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||..... ...+..+
T Consensus 224 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~l~~i 302 (391)
T PHA03212 224 GDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA-TCHDSLFEKDGLDGDCDSDRQIKLI 302 (391)
T ss_pred EeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHH-HCCCCcCCcccccccCchhHHHHHH
Confidence 999998643322211223456889999999998888999999999999999999 67766543210 0001000
Q ss_pred --------------------------HhCccc-------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 --------------------------ESKKLC-------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 --------------------------~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... +......+.++.+++.+||+.||.+|||++|++++
T Consensus 303 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 303 IRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00011345678999999999999999999999875
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=204.42 Aligned_cols=177 Identities=15% Similarity=0.222 Sum_probs=144.6
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+++||+++++|.+++...+ .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.+++
T Consensus 83 ~v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l 147 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYG---------------ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKL 147 (265)
T ss_pred EEEEecCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEE
Confidence 6889999999999998643 4899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 99 SLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 99 ~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+|||++........ .......++..|++||...+..++.++|+||||+++|+++ +|..||.................
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~-~g~~p~~~~~~~~~~~~~~~~~~ 226 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML-TEKPPWAEFEAMAAIFKIATQPT 226 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh-hCCCCCCccchHHHHHHHhcCCC
Confidence 99998865322110 0112234677899999988888899999999999999999 79999987766555555444433
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+..+...+..+.+++.+|+. +|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 444455667888999999995 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=204.88 Aligned_cols=180 Identities=22% Similarity=0.296 Sum_probs=147.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+++|.+++...+. .+++..+..++.|++.|+.|||+.+++|+|++|.||+++.++.+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~--------------~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~ 142 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELER--------------GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDV 142 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCE
Confidence 4488999999999999986533 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++........ ......++..|++||.+. ...++.++|+||+|+++|+++ +|..||...........+
T Consensus 143 ~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~-~g~~p~~~~~~~~~~~~~ 220 (280)
T cd06611 143 KLADFGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA-QMEPPHHELNPMRVLLKI 220 (280)
T ss_pred EEccCccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH-hCCCCcccCCHHHHHHHH
Confidence 9999998764332211 122345677899999874 334677899999999999999 799999888776666555
Q ss_pred HhCcc-cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKL-CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ....+..++.++.+++..||+.+|.+||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 221 LKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred hcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 44322 223345678899999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=203.59 Aligned_cols=174 Identities=21% Similarity=0.289 Sum_probs=145.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.++++..+ ++++..+..++.|+++||.|||+.+++|+||+|.||+++.++.+
T Consensus 72 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~ 136 (260)
T cd05611 72 LYLVMEYLNGGDCASLIKTLG---------------GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHL 136 (260)
T ss_pred EEEEEeccCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcE
Confidence 348899999999999997643 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++..... .....++..|++||...+..++.++|+||+|+++|+++ +|..||...........+.....
T Consensus 137 ~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 210 (260)
T cd05611 137 KLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL-FGYPPFHAETPDAVFDNILSRRI 210 (260)
T ss_pred EEeecccceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHHhccc
Confidence 9999998864322 22345677899999988877899999999999999999 79999988887777666655433
Q ss_pred cCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15108 177 CWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVT 211 (223)
Q Consensus 177 ~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 211 (223)
.++ ....++.++.+++.+||+.+|++||++.++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 211 NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 332 23357899999999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=206.98 Aligned_cols=182 Identities=18% Similarity=0.255 Sum_probs=146.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
-+++||+++++|.++++..+ .+++..+..++.|+++|+.|||+.+++|+||+|.||+++.++.++
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~ 141 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIG---------------ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIK 141 (305)
T ss_pred EEEEecCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEE
Confidence 38899999999999997653 489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchh--------------hhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q psy15108 98 ISLSGLSKDTYQK--------------EYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS 163 (223)
Q Consensus 98 l~df~~~~~~~~~--------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~ 163 (223)
++|||+++..... .........++..|++||.+....++.++|+||||+++|+++ +|..||.+..
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~-~g~~pf~~~~ 220 (305)
T cd05609 142 LTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL-VGCVPFFGDT 220 (305)
T ss_pred EeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCC
Confidence 9999987631100 000111234567899999988888899999999999999999 7999998887
Q ss_pred HHHHHHHHHhCcccCCC-CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 164 DDQVLSQLESKKLCWKH-SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 164 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..+............+. ...++.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 221 PEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 77777766654333322 23578899999999999999999996555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=206.40 Aligned_cols=178 Identities=17% Similarity=0.280 Sum_probs=147.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+++|.+++.. ..+++.++..++.+++.|+.|||+.|++|+||+|+||+++.++.+
T Consensus 91 ~~lv~e~~~~~~L~~~~~~----------------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~ 154 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE----------------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSV 154 (296)
T ss_pred EEEEEEecCCCcHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 4478999999999999964 248999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-c
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK-K 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~-~ 175 (223)
+++|||++........ ......++..|++||.+....++.++|+||||+++|+++ +|..||...+.......+... .
T Consensus 155 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~ll-tg~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T cd06655 155 KLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV-EGEPPYLNENPLRALYLIATNGT 232 (296)
T ss_pred EEccCccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcCC
Confidence 9999998765432221 122345677899999998888899999999999999999 799999887765555444332 2
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+..++..+.+++.+||..+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 233 PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 2333455678899999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=205.30 Aligned_cols=184 Identities=16% Similarity=0.269 Sum_probs=144.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++..... ....+++..+..++.|+++|+.|||+.+++|+|++|.||+++.++.+
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLK-----------RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhc-----------cCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence 4588999999999999875322 22468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-----DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++....... .......++..|++||.+.. ..++.++|+||+||++|+++ +|..||...........+
T Consensus 164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~-~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG-DGDPPLADLHPMRALFKI 241 (286)
T ss_pred EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHh-cCCCCCCCCchhHHHhhc
Confidence 999999986543221 11223457788999998742 34788999999999999999 799999876654443333
Q ss_pred HhCc-ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 172 ESKK-LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 172 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
.... .....+..++..+.+++.+||+.+|++||++.+++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 2221 12222344677899999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=213.41 Aligned_cols=181 Identities=15% Similarity=0.200 Sum_probs=145.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++..+. .+++..+..++.|++.||.|||+.+++||||||.||+++.++.+
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~--------------~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~ 141 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED--------------RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHI 141 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCE
Confidence 4489999999999999986432 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-----DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++...............++..|+|||.+.. ..++.++|+||+|+++|+|+ +|..||...+..+....+
T Consensus 142 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell-~g~~Pf~~~~~~~~~~~i 220 (331)
T cd05624 142 RLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI 220 (331)
T ss_pred EEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhh-hCCCCccCCCHHHHHHHH
Confidence 999999986543332222223467889999998865 45778999999999999999 799999988877777776
Q ss_pred HhCcccCCCC---CCChHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q psy15108 172 ESKKLCWKHS---SKTPEYITSLHEKCIHPHPHQ--RPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~ 212 (223)
.....+.+.+ ..+++++.+++.+|+..+++. |++++++++|
T Consensus 221 ~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 221 MNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 6543333222 346889999999999865544 4688888766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=206.08 Aligned_cols=183 Identities=17% Similarity=0.276 Sum_probs=145.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.++++.... ....+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++.+
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLI-----------CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCE
Confidence 4488999999999999975322 22468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-----EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++........ ......++..|++||.+... .++.++|+||+|+++|+++ +|+.||...........+
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~-~g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG-DGDPPLFDMHPVKTLFKI 245 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh-hCCCCCCCCcHHHHHHHH
Confidence 9999998875432221 12234567789999987533 2578999999999999999 799999887765555544
Q ss_pred HhCcc-cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKL-CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 43321 222234566789999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=204.87 Aligned_cols=175 Identities=22% Similarity=0.291 Sum_probs=146.3
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+++||+.+++|.+++... .+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.+++
T Consensus 76 ~v~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l 139 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG----------------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKL 139 (274)
T ss_pred EEEEeeCCCcHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEE
Confidence 788999999999999753 4899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW 178 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 178 (223)
+|||++....... .......++..|++||.+.+..++.++|+||||+++|+++ +|..||...+.......+.... ..
T Consensus 140 ~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~-tg~~p~~~~~~~~~~~~~~~~~-~~ 216 (274)
T cd06609 140 ADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELA-KGEPPLSDLHPMRVLFLIPKNN-PP 216 (274)
T ss_pred cccccceeecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHH-hCCCCcccCchHHHHHHhhhcC-CC
Confidence 9999987654321 1123345667899999998888999999999999999999 7999998777666555554442 22
Q ss_pred CCCCC-ChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 179 KHSSK-TPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 179 ~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ++.++.+++.+||..+|++||++++++++
T Consensus 217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 22333 78889999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=205.82 Aligned_cols=176 Identities=18% Similarity=0.273 Sum_probs=142.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++..++ .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~---------------~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~ 136 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHG---------------VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHV 136 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCE
Confidence 448899999999999997653 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD--QVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~--~~~~~~~~ 173 (223)
+++|||++....... .....++..|++||... +..++.++|+||+||++++++ +|..||...... ........
T Consensus 137 ~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~ 212 (279)
T cd05633 137 RISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL-RGHSPFRQHKTKDKHEIDRMTL 212 (279)
T ss_pred EEccCCcceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHH-hCCCCcCCCCCcCHHHHHHHhh
Confidence 999999886443221 12345778899999876 355788999999999999999 799999754321 12222111
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
. .....+..++.++.+++.+||..||.+|| +++++++|
T Consensus 213 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 T-VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred c-CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1 23344567889999999999999999999 59998876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=204.89 Aligned_cols=177 Identities=21% Similarity=0.277 Sum_probs=147.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++.. .++++.++..++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 77 ~~lv~e~~~~~~L~~~i~~----------------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~ 140 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA----------------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDV 140 (277)
T ss_pred EEEEEecCCCCcHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCE
Confidence 4488999999999999964 248899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|++||.+.+..++.++|+||||+++|+|+ +|..||...........+... .
T Consensus 141 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~-tg~~p~~~~~~~~~~~~~~~~-~ 217 (277)
T cd06640 141 KLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELA-KGEPPNSDMHPMRVLFLIPKN-N 217 (277)
T ss_pred EEcccccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHH-HCCCCCCCcChHhHhhhhhcC-C
Confidence 9999998865432221 122335677899999998888899999999999999999 799999887766655544333 2
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+.....++..+.+++.+||+.+|++||++++++.+
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 334445678889999999999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=205.26 Aligned_cols=185 Identities=24% Similarity=0.383 Sum_probs=146.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++..... .+++..++.++.|++.||.|||+.|++|+||+|.||+++.++.+
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~--------------~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~ 148 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD--------------QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLV 148 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc--------------ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCE
Confidence 4488999999999999986532 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------
Q psy15108 97 KISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ-------- 166 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~-------- 166 (223)
+++|||++........ ........+..|.+||......++.++|+||||+++++++ +|..|+.......
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~-tg~~p~~~~~~~~~~~~~~~~ 227 (284)
T cd05038 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF-TYGDPSQSPPAEFLRMIGIAQ 227 (284)
T ss_pred EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheee-ccCCCcccccchhcccccccc
Confidence 9999999876542211 1111234456689999988888899999999999999999 6877875432211
Q ss_pred ------HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 167 ------VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 167 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
..............+..++.++.+++.+||+.+|++||++.++++.|.++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 228 GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11122222234444566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=211.82 Aligned_cols=174 Identities=16% Similarity=0.267 Sum_probs=135.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+.+ +|.+.+.. .+++..+..++.|+++||.|||+.|++||||||+||+++.++.++
T Consensus 102 ~lv~e~~~~-~l~~~~~~-----------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~k 163 (359)
T cd07876 102 YLVMELMDA-NLCQVIHM-----------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 163 (359)
T ss_pred EEEEeCCCc-CHHHHHhc-----------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEE
Confidence 477888864 67666642 488999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES---- 173 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~---- 173 (223)
++|||++....... ......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.+....+..+..
T Consensus 164 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~-tg~~pf~~~~~~~~~~~~~~~~~~ 240 (359)
T cd07876 164 ILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKVIEQLGT 240 (359)
T ss_pred EecCCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999986533221 123346678899999998888999999999999999999 79999987654332221111
Q ss_pred ------------------CcccC------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 ------------------KKLCW------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ------------------~~~~~------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ......++++++++.+||..||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0011235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=202.12 Aligned_cols=178 Identities=20% Similarity=0.324 Sum_probs=145.4
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+++||+.+++|.+++...+ ..+++..+..++.|+++|+.|||+.+++|+|++|.||+++.++.+++
T Consensus 75 l~~e~~~~~~L~~~l~~~~--------------~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l 140 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN--------------KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKL 140 (256)
T ss_pred EEEecCCCCcHHHHHHhCc--------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEE
Confidence 7899999999999997643 36899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc-cc
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK-LC 177 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~ 177 (223)
+|||++........ ......++..|++||.+.+..++.++|+||+|+++++|+ +|..||...........+.... ..
T Consensus 141 ~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~ 218 (256)
T cd06612 141 ADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMA-EGKPPYSDIHPMRAIFMIPNKPPPT 218 (256)
T ss_pred cccccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHH-hCCCCCCCcchhhhhhhhccCCCCC
Confidence 99998875433221 122334667899999998888899999999999999999 7999998776655444433221 12
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+..++.++.+++.+||+.+|++||++++++.+
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 22334567889999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=212.58 Aligned_cols=174 Identities=17% Similarity=0.250 Sum_probs=138.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+. ++|.+++.. .+++..+..++.|++.||.|||++|++||||||.||+++.++.++
T Consensus 105 ~lv~e~~~-~~l~~~~~~-----------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 105 YIVMELMD-ANLCQVIQM-----------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred EEEEeCCC-CCHHHHHHh-----------------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEE
Confidence 37888886 577777752 378999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++....... ......++..|+|||.+.+..++.++|+||+||++|+|+ +|+.||.+.+.......+......
T Consensus 167 L~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 167 ILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred EEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999987543321 123346788899999998888999999999999999999 799999877765544433221000
Q ss_pred ----------------------------------------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 ----------------------------------------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ----------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.......+..+.+++.+|++.||.+|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00001124568899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=211.52 Aligned_cols=174 Identities=16% Similarity=0.250 Sum_probs=136.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++|||+.+ +|.+.+.. .+++..+..++.|+++||.|||+.|++||||||+||+++.++.++
T Consensus 98 ~lv~e~~~~-~l~~~~~~-----------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~k 159 (355)
T cd07874 98 YLVMELMDA-NLCQVIQM-----------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_pred EEEhhhhcc-cHHHHHhh-----------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEE
Confidence 378888864 67777742 488999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC---
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK--- 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~--- 174 (223)
++|||++....... ......++..|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.+.......+...
T Consensus 160 l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~~~~~~~~ 236 (355)
T cd07874 160 ILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_pred EeeCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999987543321 123346788899999998888999999999999999999 799999877644332221110
Q ss_pred -------------------ccc------------------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 -------------------KLC------------------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 -------------------~~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
... .......+.++++++.+||+.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 00011234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=211.11 Aligned_cols=178 Identities=14% Similarity=0.181 Sum_probs=157.8
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC--
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD-- 93 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~-- 93 (223)
...+|||+|.||+|.+.|... .+++..+..++.|++.++.|||+.|++|||+||+|+++...
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~----------------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK----------------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDE 173 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc----------------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccC
Confidence 356999999999999999763 28999999999999999999999999999999999998644
Q ss_pred --CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 94 --LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 94 --~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+.++++|||++..... ........|++.|+|||++....|+..+|+||+|+++|.|+ +|..||.+....+....+
T Consensus 174 ~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL-~G~~PF~~~~~~~~~~~i 250 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILL-SGVPPFWGETEFEIFLAI 250 (382)
T ss_pred CCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHh-hCCCCCcCCChhHHHHHH
Confidence 4699999999987655 33456789999999999999999999999999999999999 899999999988888888
Q ss_pred HhCcccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+.+.... ...++..++++++.|+..||..|+++.++++|
T Consensus 251 ~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 251 LRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 877654332 35678999999999999999999999999987
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=212.77 Aligned_cols=174 Identities=17% Similarity=0.200 Sum_probs=135.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+.. ..++..+..++.||+.||.|||+.|++|||||++||+++.++.+
T Consensus 147 ~~lv~e~~~~~~L~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 207 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH-------------------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNV 207 (353)
T ss_pred EEEEEecCCCCcccccc-------------------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCE
Confidence 34789999999986532 35788889999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-----EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ---VL 168 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~---~~ 168 (223)
+|+|||++....... .......++..|++||.+... ..+.++|||||||++|+|+ +|+.||....... ..
T Consensus 208 kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~-~g~~pf~~~~~~~~~~~~ 285 (353)
T PLN00034 208 KIADFGVSRILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFY-LGRFPFGVGRQGDWASLM 285 (353)
T ss_pred EEcccccceeccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCccHHHHH
Confidence 999999987543211 112345678899999987432 2346899999999999999 8999997433222 22
Q ss_pred HHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+... .....+..++.++++++.+||+.||++||++.|+++|
T Consensus 286 ~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 286 CAICMS-QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHhcc-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 222222 2334456778999999999999999999999999987
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=202.20 Aligned_cols=182 Identities=21% Similarity=0.313 Sum_probs=149.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+++|.++++..+ .+++..+..++.|+++||.|||+.+++|+||+|+||+++.++.+
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~ 132 (265)
T cd05579 68 LYLVMEYLPGGDLASLLENVG---------------SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHL 132 (265)
T ss_pred EEEEEecCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCE
Confidence 448899999999999998643 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh-------hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEY-------YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~ 169 (223)
+++|||++........ .......++..|++||.......+.++|+||+|+++++++ +|..||......+...
T Consensus 133 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~-~g~~p~~~~~~~~~~~ 211 (265)
T cd05579 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFL-VGIPPFHGETPEEIFQ 211 (265)
T ss_pred EEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHH
Confidence 9999998765432211 0122345667899999988888889999999999999999 7999998888877777
Q ss_pred HHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.+......++.....+..+.+++.+||+.+|.+||++..+.+.|.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 212 NILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 776654444433345889999999999999999999955554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=201.39 Aligned_cols=178 Identities=19% Similarity=0.294 Sum_probs=147.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++...+ .+++..+..++.|+++|+.|||+.|++|+||+|+||+++.++.+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~ 141 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKYG---------------SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVV 141 (258)
T ss_pred EEEEEEecCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 448899999999999997643 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||.+....... ......++..|++||.+.... ++.++|+||+|+++|+++ +|..||...........+....
T Consensus 142 kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~ 218 (258)
T cd06632 142 KLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA-TGKPPWSQLEGVAAVFKIGRSK 218 (258)
T ss_pred EEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHH-hCCCCcccCcHHHHHHHHHhcc
Confidence 999999876543222 123455678899999987666 889999999999999999 7999998776555554444422
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+..++..+.+++.+||+.+|.+||++.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 3344456678899999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=214.36 Aligned_cols=185 Identities=30% Similarity=0.601 Sum_probs=158.6
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+++||++.|+|.+++..+.. ..+.-....+++.||++|++||.+.+++|||+.++|+|+++++++|+
T Consensus 612 mI~EYmEnGDLnqFl~ahea-------------pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKi 678 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHEL-------------PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKI 678 (807)
T ss_pred HHHHHHhcCcHHHHHHhccC-------------cccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEe
Confidence 68999999999999998754 23566777889999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHhC--
Q psy15108 99 SLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFN-KGEMPFPDLSDDQVLSQLESK-- 174 (223)
Q Consensus 99 ~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~-~~~~p~~~~~~~~~~~~~~~~-- 174 (223)
+|||+++...+..+. ..+..+.+..|+|+|.+...+++.++|+|+||+++||+++ +...||......++.+....-
T Consensus 679 adfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~ 758 (807)
T KOG1094|consen 679 ADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFR 758 (807)
T ss_pred cCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcC
Confidence 999999876655533 3456677899999999999999999999999999999842 578899999888887775432
Q ss_pred ----cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 175 ----KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 175 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
..-+..|+-||.+++++|..||..|..+||+|+++..+|++.
T Consensus 759 ~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 759 DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112345678999999999999999999999999999999764
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=199.00 Aligned_cols=180 Identities=19% Similarity=0.273 Sum_probs=151.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+++++|.+++..... ....+++..++.++.|++.|+.|||+.|++|+||+|.||+++.++.+
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~ 142 (256)
T cd08530 74 LCIVMEYAPFGDLSKAISKRKK-----------KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLV 142 (256)
T ss_pred EEEEehhcCCCCHHHHHHHHHh-----------hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcE
Confidence 4488999999999999976433 22468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...... ......++..|++||...+..++.++|+||+|+++++++ +|..||...+..+....+....
T Consensus 143 kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~-~g~~p~~~~~~~~~~~~~~~~~- 217 (256)
T cd08530 143 KIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA-TFAPPFEARSMQDLRYKVQRGK- 217 (256)
T ss_pred EEeeccchhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcCC-
Confidence 99999988654332 122345677899999998888889999999999999999 7999999888766666655542
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+...+.++.+++.+|++.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 233445778899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=204.16 Aligned_cols=178 Identities=19% Similarity=0.273 Sum_probs=146.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+++|.+++.. .++++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.+
T Consensus 91 ~~~v~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 154 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH----------------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRV 154 (285)
T ss_pred EEEEEeccCCCCHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcE
Confidence 4478999999999999975 248999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|++||...+..++.++|+||+|+++++++ +|..||...+.......+.....
T Consensus 155 ~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell-~g~~p~~~~~~~~~~~~~~~~~~ 232 (285)
T cd06648 155 KLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV-DGEPPYFNEPPLQAMKRIRDNLP 232 (285)
T ss_pred EEcccccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHH-hCCCCCcCCCHHHHHHHHHhcCC
Confidence 9999998754322111 112345678899999998888899999999999999999 79999987776666666554422
Q ss_pred c-CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 C-WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ......++..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 233 PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1 12223477899999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=233.54 Aligned_cols=178 Identities=15% Similarity=0.220 Sum_probs=153.4
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+.||||.+|+|.+++...+. .++.....+..|++.|+.|||+.||+||||||.||+++.+|.+|+
T Consensus 1311 IFMEyC~~GsLa~ll~~gri---------------~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~ 1375 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI---------------EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKY 1375 (1509)
T ss_pred HHHHHhccCcHHHHHHhcch---------------hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEe
Confidence 56999999999999986544 788888899999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhh---hhhhhcCCcccccccccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH
Q psy15108 99 SLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFDDE---FSTKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLSQL 171 (223)
Q Consensus 99 ~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~---~~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~~~ 171 (223)
+|||.++....+. ....+...||+.|||||++.+.. ...++||||+||++.||+ +|+.||...+.. +++..+
T Consensus 1376 ~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~-tGkrPW~~~dne~aIMy~V 1454 (1509)
T KOG4645|consen 1376 GDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMA-TGKRPWAELDNEWAIMYHV 1454 (1509)
T ss_pred ecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEee-cCCCchhhccchhHHHhHH
Confidence 9999998765432 23456789999999999987654 457899999999999999 899999888764 455555
Q ss_pred HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
..+ ..++.|..++.+-++++..|++.||+.|.++.|++++-
T Consensus 1455 ~~g-h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1455 AAG-HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred hcc-CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 554 66777888999999999999999999999999998874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=203.43 Aligned_cols=175 Identities=18% Similarity=0.234 Sum_probs=141.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC-C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-S 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-~ 95 (223)
..+||||+++|+|.++++... .+++..+..++.|+++|+.|||+.|++|+||+|.||+++.++ .
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~ 148 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG---------------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDR 148 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCe
Confidence 448899999999999998643 489999999999999999999999999999999999999988 8
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHh-
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV-LSQLES- 173 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~-~~~~~~- 173 (223)
++++|||++...... ....++..|+|||.+.+..++.++|+||+|+++++++ +|..||........ ...+..
T Consensus 149 ~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~ 222 (267)
T PHA03390 149 IYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL-TGKHPFKEDEDEELDLESLLKR 222 (267)
T ss_pred EEEecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHH-HCCCCCCCCCcchhhHHHHHHh
Confidence 999999988654322 2235678899999998888899999999999999999 79999975543221 111111
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT-FPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~~ 212 (223)
...........+..+.+++.+||+.+|.+||+ ++++++|
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 223 QQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred hcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 11222334467899999999999999999996 6998864
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=217.56 Aligned_cols=176 Identities=20% Similarity=0.280 Sum_probs=141.0
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC--CCe
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD--LSV 96 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~--~~~ 96 (223)
-+..++-..||+++|+.++. .+|+...+..++.||++||.+||+.+|+|+||||+|||+... ..+
T Consensus 264 ciVfELL~~NLYellK~n~f-------------~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 264 CIVFELLSTNLYELLKNNKF-------------RGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred eeeehhhhhhHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCce
Confidence 34556778899999999877 789999999999999999999999999999999999999755 458
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES--- 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~--- 173 (223)
||+|||.++.....-+ .......|.|||++.+.+|+.+.|+||||||++||+ +|..-|++.+....+..|..
T Consensus 331 KVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~-tG~PLfpG~ne~DQl~~I~e~lG 405 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELF-TGEPLFPGDNEYDQLARIIEVLG 405 (586)
T ss_pred eEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHh-cCccccCCCCHHHHHHHHHHHhC
Confidence 9999999976543321 566778899999999999999999999999999999 78777777766554443322
Q ss_pred ------------------C-----------------------------cccCCCC-----------CCChHHHHHHHHHh
Q psy15108 174 ------------------K-----------------------------KLCWKHS-----------SKTPEYITSLHEKC 195 (223)
Q Consensus 174 ------------------~-----------------------------~~~~~~~-----------~~~~~~~~~li~~~ 195 (223)
. ......+ ......+.+++.+|
T Consensus 406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 0 0000001 01125678999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q psy15108 196 IHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 196 l~~dp~~Rps~~~ll~~ 212 (223)
+..||.+|+|..+.++|
T Consensus 486 L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNH 502 (586)
T ss_pred hccCchhcCCHHHHhcC
Confidence 99999999999999876
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=208.75 Aligned_cols=182 Identities=19% Similarity=0.248 Sum_probs=137.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++|+|.+++..+.. ..+++..++.++.|++.||.|||+.+++|+||||.||+++.++.+
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~ 140 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFM-------------DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 140 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcE
Confidence 3478999999999999976533 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh------hhhcCCccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYY------KYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~ 168 (223)
++.||+........... ......++..|++||.+.+ ..++.++|+||+||++++++ +|..||.........
T Consensus 141 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~ 219 (327)
T cd08227 141 YLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA-NGHVPFKDMPATQML 219 (327)
T ss_pred EEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHH-HCCCCCCCcchhHHH
Confidence 99998754332211100 0112244567999999875 35889999999999999999 799999765543322
Q ss_pred HHHHhCccc--------------------------------------------CCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy15108 169 SQLESKKLC--------------------------------------------WKHSSKTPEYITSLHEKCIHPHPHQRP 204 (223)
Q Consensus 169 ~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp 204 (223)
......... .+.....++.+.+++.+||+.||++||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 299 (327)
T cd08227 220 LEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP 299 (327)
T ss_pred HHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC
Confidence 221111000 001123456789999999999999999
Q ss_pred CHHHHHHH
Q psy15108 205 TFPSIVTQ 212 (223)
Q Consensus 205 s~~~ll~~ 212 (223)
|+++++++
T Consensus 300 t~~ell~~ 307 (327)
T cd08227 300 SASTLLNH 307 (327)
T ss_pred CHHHHhcC
Confidence 99999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=206.04 Aligned_cols=177 Identities=16% Similarity=0.254 Sum_probs=140.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+++++|.++++..+ .+++..+..++.|+++||.|||+ .+++|+||+|.||+++.++.
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~ 138 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKAG---------------RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE 138 (308)
T ss_pred EEEEeeccCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc
Confidence 348899999999999998653 48999999999999999999997 58999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++++|||++....... .....++..|++||.+.+..++.++|+||||+++++++ +|..||...+.......+....
T Consensus 139 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~ 214 (308)
T cd06615 139 IKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMA-IGRYPIPPPDAKELEAMFGRPV 214 (308)
T ss_pred EEEccCCCcccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHH-hCCCCCCCcchhhHHHhhcCcc
Confidence 9999999886432211 23345678899999988888899999999999999999 7998987554333222211100
Q ss_pred -----------------------------------ccCCCC-CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 -----------------------------------LCWKHS-SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 -----------------------------------~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+..+ ..++.++.+++.+||..+|++||++++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 215 SEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111 1356789999999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=202.42 Aligned_cols=177 Identities=18% Similarity=0.291 Sum_probs=143.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~ 95 (223)
..++++|+.+++|.+++.... ..+++..+..++.|+++|+.|||+ .+++|+||+|.||+++.++.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~ 139 (265)
T cd06605 74 ISICMEYMDGGSLDKILKEVQ--------------GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ 139 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcc--------------CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC
Confidence 448889999999999998642 258999999999999999999999 99999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS-----DDQVLSQ 170 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~-----~~~~~~~ 170 (223)
++++|||.+....... .....++..|++||...+..++.++|+||+|+++++++ +|..||.... .......
T Consensus 140 ~~l~d~g~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~ 215 (265)
T cd06605 140 IKLCDFGVSGQLVNSL---AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELA-TGRFPYPPENDPPDGIFELLQY 215 (265)
T ss_pred EEEeecccchhhHHHH---hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHH-hCCCCCCccccccccHHHHHHH
Confidence 9999999886543221 11256677899999998888999999999999999999 7898986542 2223333
Q ss_pred HHhCcccCCCCCC-ChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKKLCWKHSSK-TPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+... ..+..+.. ++.++.++|.+||..+|++||++.+++.+
T Consensus 216 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 216 IVNE-PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HhcC-CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 3332 22222333 78889999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=206.66 Aligned_cols=178 Identities=20% Similarity=0.376 Sum_probs=142.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++|+.+++|.+++...+ .+++..++.++.|+++||.+||+.+++|+||+|.||+++.++.++
T Consensus 74 ~~v~~~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~ 138 (260)
T PF00069_consen 74 YIVMEYCPGGSLQDYLQKNK---------------PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVK 138 (260)
T ss_dssp EEEEEEETTEBHHHHHHHHS---------------SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEE
T ss_pred cccccccccccccccccccc---------------ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 37899999999999998443 589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHh
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS---DDQVLSQLES 173 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~---~~~~~~~~~~ 173 (223)
++|||.+..... .........++..|.|||.+. ...++.++|+||+|+++++|+ +|..||.... ..........
T Consensus 139 l~Dfg~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~~~~p~~~~~~~~~~~~~~~~~~ 216 (260)
T PF00069_consen 139 LIDFGSSVKLSE-NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELL-TGKLPFEESNSDDQLEIIEKILK 216 (260)
T ss_dssp ESSGTTTEESTS-TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHH-HSSSSSTTSSHHHHHHHHHHHHH
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-ccccccccccchhhhhhhhhccc
Confidence 999999864311 111234456778899999987 777899999999999999999 7889998873 3333333322
Q ss_pred CcccC--CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCW--KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ......+.++.+++..||+.||++||++++++++
T Consensus 217 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 217 RPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp THHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 21111 1112235889999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=210.85 Aligned_cols=178 Identities=19% Similarity=0.232 Sum_probs=133.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|++++ .|+|.+++.... ..+++..++.++.||+.||.|||+.|++||||||.||+++..+.++
T Consensus 133 ~lv~e~~-~~~l~~~l~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~k 197 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTKRS--------------RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVC 197 (357)
T ss_pred EEEEEcc-CCcHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence 3677777 578999987543 3689999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----------HH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD----------QV 167 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~----------~~ 167 (223)
++|||++....... ......++..|++||.+.+..++.++|+|||||++|+|++.+..+|...... ..
T Consensus 198 l~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l 275 (357)
T PHA03209 198 IGDLGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275 (357)
T ss_pred EecCccccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHH
Confidence 99999986432211 1123457888999999988889999999999999999996566555432211 01
Q ss_pred HHHHHhCc---ccCC----------------------------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 168 LSQLESKK---LCWK----------------------------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~---~~~~----------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+.... ...+ .....+..+.++|.+||+.||.+|||+.|+++|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 276 LKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 11111000 0000 011345566779999999999999999999876
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=207.98 Aligned_cols=172 Identities=17% Similarity=0.265 Sum_probs=135.0
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+++++ .+++|.++++. ..+++..+..++.|+++||.|||+.|++||||||.||+++.++.+++
T Consensus 97 ~~~~~-~~~~l~~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl 159 (343)
T cd07878 97 LVTNL-MGADLNNIVKC----------------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI 159 (343)
T ss_pred EEeec-CCCCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEE
Confidence 44454 48999988853 35899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc-
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL- 176 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~- 176 (223)
+|||++...... .....++..|+|||.+.+ ..++.++||||+||++|+|+ +|..||.+.+.......+.....
T Consensus 160 ~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 160 LDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred cCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHH-HCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998754322 123467888999999876 45788999999999999999 79999987665444333221000
Q ss_pred ----------------------cCC------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 ----------------------CWK------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ----------------------~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+ .....++.+.+++.+|++.||.+|||+.+++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 012345668899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=212.34 Aligned_cols=178 Identities=20% Similarity=0.322 Sum_probs=154.8
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+..|||.||-...++-.-+. ++++.++..+++|++.||.|||+++|+|||+|+.|||++.+|.+++
T Consensus 106 iliEFC~GGAVDaimlEL~r--------------~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirL 171 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGR--------------VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRL 171 (1187)
T ss_pred EEEeecCCchHhHHHHHhcc--------------ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEee
Confidence 56799999999999876554 7999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
.|||.+...... ....-...||++|+|||++. ..+|+.++|||||||++.+|. .+.+|....++..++-.+..
T Consensus 172 ADFGVSAKn~~t-~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMA-qiEPPHhelnpMRVllKiaK 249 (1187)
T KOG0579|consen 172 ADFGVSAKNKST-RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 249 (1187)
T ss_pred ecccccccchhH-HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHh-ccCCCccccchHHHHHHHhh
Confidence 999988654332 23345689999999999853 678999999999999999999 89999999998877766654
Q ss_pred -CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 -KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.++.+..|...+..+.+++..||..||..||+++++++|
T Consensus 250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 444556677889999999999999999999999999876
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=202.43 Aligned_cols=182 Identities=15% Similarity=0.229 Sum_probs=158.3
Q ss_pred cCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee
Q psy15108 12 KDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS 91 (223)
Q Consensus 12 ~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~ 91 (223)
+..+..-+||||..||.|.-.|...+. |+++....+..+|+.||.|||+++|++||+|..|.+++
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsrer~---------------FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD 302 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRERV---------------FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD 302 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhhhc---------------ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec
Confidence 344445589999999999999987655 99999999999999999999999999999999999999
Q ss_pred cCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 92 SDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 92 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
++|++|+.|||+++..... ........|++.|+|||++....|..++|.|.+|+++|||+ +|++||...+.....+.|
T Consensus 303 kDGHIKitDFGLCKE~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMm-CGRLPFyn~dh~kLFeLI 380 (516)
T KOG0690|consen 303 KDGHIKITDFGLCKEEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMM-CGRLPFYNKDHEKLFELI 380 (516)
T ss_pred cCCceEeeecccchhcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHH-hccCcccccchhHHHHHH
Confidence 9999999999999754332 22346688999999999999999999999999999999999 999999999999888887
Q ss_pred HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
.....+. |..++++.+.++..+|..||.+|. +++||.++
T Consensus 381 l~ed~kF--Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 381 LMEDLKF--PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HhhhccC--CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 7654444 677899999999999999999994 35666655
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=202.35 Aligned_cols=180 Identities=19% Similarity=0.248 Sum_probs=142.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC-CCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD-LSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~-~~~ 96 (223)
.+||||++ .||++.++.--. .+..++.-.+.-+.+||++|+.|||+.||+||||||+|+|+|.. +.+
T Consensus 98 nlVleymP-~tL~~~~r~~~~-----------~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~L 165 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTR-----------ANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVL 165 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhh-----------cCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeE
Confidence 37777775 589999985311 12468889999999999999999999999999999999999977 889
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-- 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~-- 173 (223)
|++|||-|+.....+ .......+..|.|||.+.+.. |+.+.||||.||++.||+ .|+.-|++.+....+..+.+
T Consensus 166 KicDFGSAK~L~~~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl-~g~plFpG~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 166 KICDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELL-KGQPLFPGDSSVDQLVEIIKVL 242 (364)
T ss_pred EeccCCcceeeccCC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHh-cCCcccCCCCHHHHHHHHHHHh
Confidence 999999998765544 224556788899999998765 899999999999999999 89999988765443332221
Q ss_pred ----------Ccc-------------cC--CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 ----------KKL-------------CW--KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ----------~~~-------------~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
... .| ......+++..+++.++++++|.+|.++.+++.|
T Consensus 243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 000 01 1234567889999999999999999999999876
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=203.69 Aligned_cols=174 Identities=21% Similarity=0.203 Sum_probs=147.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.+++...+ .+++..+..++.|+++||.|||+.|++|+||+|.||+++.++.+
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~---------------~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~ 140 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG---------------RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYI 140 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCE
Confidence 337899999999999998653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...... .....+++.|++||.+.....+.++|+||||+++++|+ +|..||...........+....
T Consensus 141 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~- 214 (290)
T cd05580 141 KITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEML-AGYPPFFDDNPIQIYEKILEGK- 214 (290)
T ss_pred EEeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcCC-
Confidence 99999998754332 23345678899999988778889999999999999999 7999998877666666655432
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
...+...+..+.+++.+||..+|.+|+ ++++++.+
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 344566788999999999999999999 77888755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=201.45 Aligned_cols=180 Identities=22% Similarity=0.292 Sum_probs=143.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++|+|.+++...+ .+++..+..++.|++.|+.+||+.+++|+||+|.||+++.++.+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYG---------------RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC 147 (272)
T ss_pred eEEEEecCCCCcHHHHHhhcc---------------CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeE
Confidence 458899999999999997653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDE--FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+++|||++....... ........++..|++||...... ++.++|+||+|+++++++ +|..||......+....+..
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~ 226 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF-AGRRPWSDEEAIAAMFKLGN 226 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH-hCCCCCcCcchHHHHHHhhc
Confidence 999999886543211 11122345677899999987654 788999999999999999 79999976665544443322
Q ss_pred CcccCC----CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWK----HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... ....++.++.+++.+||+.+|.+||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 212221 123467899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=229.71 Aligned_cols=180 Identities=19% Similarity=0.256 Sum_probs=140.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CcccCCCCCCCee
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-------RLIHKDIAARNCL 89 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~i~H~di~~~nil 89 (223)
..+||||+.+|+|.++|..... ....+++..++.++.||+.||.|||+. +|+|+||||.|||
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~-----------~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYK-----------MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhh-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 4488999999999999986432 124699999999999999999999984 4999999999999
Q ss_pred eecC-----------------CCeEEcCCCCCcccchhhhhhhhcCCccccccccccccc--CCCCcccchHHHHHHHHH
Q psy15108 90 ISSD-----------------LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWE 150 (223)
Q Consensus 90 ~~~~-----------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~~ 150 (223)
++.. ..++|+|||++....... ......+++.|+|||.+.. ..++.++|||||||++|+
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE 235 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence 9642 348999999987543222 1234467899999999854 347889999999999999
Q ss_pred HHhCCCCCCCCCCHHH-HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 151 IFNKGEMPFPDLSDDQ-VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 151 l~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
|+ +|..||....... ....+... ...+ ....+.++.+||..||..+|.+||++.+++.+
T Consensus 236 LL-TGk~PF~~~~~~~qli~~lk~~-p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 236 LC-SGKTPFHKANNFSQLISELKRG-PDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HH-HCCCCCCcCCcHHHHHHHHhcC-CCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 99 7999997665443 33333332 2222 23568889999999999999999999999854
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=202.20 Aligned_cols=180 Identities=21% Similarity=0.308 Sum_probs=147.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.+++..... .+++..+..++.|++.|+.|||+.|++|+|++|.||+++.++.+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~--------------~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~ 155 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNFV--------------RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSV 155 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhcc--------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCE
Confidence 4478899999999999987541 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++........ ......++..|++||.+.+..++.++|+||||+++|+++ +|..||...........+.....
T Consensus 156 ~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06614 156 KLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA-EGEPPYLREPPLRALFLITTKGI 233 (286)
T ss_pred EECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcCC
Confidence 9999998754332211 122334667899999988888899999999999999999 79999988776665555444322
Q ss_pred cC-CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CW-KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .....++.++.+++.+||+.+|.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 22 2223478899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=204.59 Aligned_cols=178 Identities=20% Similarity=0.272 Sum_probs=146.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++.. ..+++..++.++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 93 ~~iv~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~ 156 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ----------------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRV 156 (297)
T ss_pred EEEEEecCCCCCHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcE
Confidence 4488999999999998854 248999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|++||.+....++.++|+||+|+++++++ +|..||......+....+.....
T Consensus 157 kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~-~g~~p~~~~~~~~~~~~~~~~~~ 234 (297)
T cd06659 157 KLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV-DGEPPYFSDSPVQAMKRLRDSPP 234 (297)
T ss_pred EEeechhHhhccccc-ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhccCC
Confidence 999999875432211 1122345678899999998888899999999999999999 79999987776666555544322
Q ss_pred -cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 -CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+......+..+.+++.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 235 PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 222334678889999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=199.70 Aligned_cols=180 Identities=21% Similarity=0.300 Sum_probs=147.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC-
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS- 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~- 95 (223)
..+++||+.+++|.+++..... ..+++..+..++.|+++|+.|||+.+++|+|++|.||+++.++.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~ 140 (257)
T cd08225 74 LFIVMEYCDGGDLMKRINRQRG-------------VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMV 140 (257)
T ss_pred EEEEEecCCCCcHHHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCe
Confidence 4588999999999999976433 35899999999999999999999999999999999999988754
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++++|||.+....... .......++..|++||......++.++|+||+|+++++++ +|..||......+....+....
T Consensus 141 ~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~ 218 (257)
T cd08225 141 AKLGDFGIARQLNDSM-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELC-TLKHPFEGNNLHQLVLKICQGY 218 (257)
T ss_pred EEecccccchhccCCc-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCccHHHHHHHHhccc
Confidence 6999999886543321 1112335677899999988888899999999999999999 7999998777666665555442
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........+.++.+++.+||..+|++||++.+++++
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 219 -FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 233345678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=218.07 Aligned_cols=191 Identities=18% Similarity=0.268 Sum_probs=152.3
Q ss_pred HHHHHhhcCCC-C-CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCccc
Q psy15108 5 QFLLATRKDSK-D-KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSL--STSQAVTMAYQVALGLEHISDKRLIH 80 (223)
Q Consensus 5 ~~~~~~~~~~~-~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~i~H 80 (223)
||.++-...++ + ....||..+||+|.++|+..= +++ ++...-.+..||++||.|||++.|+|
T Consensus 633 NIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW--------------GPlKDNEstm~fYtkQILeGLkYLHen~IVH 698 (1226)
T KOG4279|consen 633 NIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW--------------GPLKDNESTMNFYTKQILEGLKYLHENKIVH 698 (1226)
T ss_pred hHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc--------------CCCccchhHHHHHHHHHHHHhhhhhhcceee
Confidence 44444445333 3 447899999999999998532 245 78889999999999999999999999
Q ss_pred CCCCCCCeeeecC-CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCC--CCcccchHHHHHHHHHHHhCCCC
Q psy15108 81 KDIAARNCLISSD-LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE--FSTKSDVYAYACLIWEIFNKGEM 157 (223)
Q Consensus 81 ~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slG~il~~l~~~~~~ 157 (223)
||||..|+++... |.+|++|||-+++...-... ..+..||..|+|||++..++ |..++|||||||++.||. +|++
T Consensus 699 RDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMA-TGrP 776 (1226)
T KOG4279|consen 699 RDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMA-TGRP 776 (1226)
T ss_pred ccccCCcEEEeeccceEEecccccchhhccCCcc-ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeec-cCCC
Confidence 9999999999765 78999999998765433322 24567899999999998654 889999999999999999 8999
Q ss_pred CCCCCC-HHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15108 158 PFPDLS-DDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVT 211 (223)
Q Consensus 158 p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 211 (223)
||.... +...+.++.-.+.-++.|...+.+.+.+|.+|+.+||.+||++++++.
T Consensus 777 PF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 777 PFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 997654 344444433333345667788899999999999999999999999875
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=208.79 Aligned_cols=174 Identities=17% Similarity=0.280 Sum_probs=154.4
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCee-eecCCCeE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCL-ISSDLSVK 97 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil-~~~~~~~~ 97 (223)
+|.|.-.+|+|++||-++.. .++++.+.+++.||+.|+.|+|+..++|||+||+|++ +.+-|-+|
T Consensus 94 LiLELGD~GDl~DyImKHe~--------------Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVK 159 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEE--------------GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVK 159 (864)
T ss_pred EEEEecCCchHHHHHHhhhc--------------cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceE
Confidence 77888899999999987654 6999999999999999999999999999999999986 45668899
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFS-TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++..+.+.. ...+..|...|-|||.+.+..|+ +++||||||||+|-+. +|+.||...+..+.+-.|+..++
T Consensus 160 LTDFGFSNkf~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLV-CGq~PFqeANDSETLTmImDCKY 236 (864)
T KOG4717|consen 160 LTDFGFSNKFQPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLV-CGQPPFQEANDSETLTMIMDCKY 236 (864)
T ss_pred eeeccccccCCCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHH-hCCCccccccchhhhhhhhcccc
Confidence 99999998765544 44667788899999999999987 5699999999999888 99999999999999999988765
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVT 211 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 211 (223)
. +|...+.+++++|..||..||++|.+.++|..
T Consensus 237 t--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 T--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 4 46778999999999999999999999999874
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=199.28 Aligned_cols=179 Identities=15% Similarity=0.266 Sum_probs=142.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.+++.... .+++..+..++.++++|+.|||+.+++|+||+|.||+++.++.+
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~ 138 (264)
T cd06626 74 VYIFMEYCSGGTLEELLEHGR---------------ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVI 138 (264)
T ss_pred EEEEEecCCCCcHHHHHhhcC---------------CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 458899999999999997543 38899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhh---hhcCCcccccccccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHH
Q psy15108 97 KISLSGLSKDTYQKEYYK---YRNAILPLRWLPYEAVFDDE---FSTKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLS 169 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~---~~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~ 169 (223)
+++|||.+.......... .....++..|++||.+.... .+.++|+|+||+++++++ +|..||...... ....
T Consensus 139 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~-~g~~pf~~~~~~~~~~~ 217 (264)
T cd06626 139 KLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA-TGKRPWSELDNEFQIMF 217 (264)
T ss_pred EEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHH-hCCCCccCCcchHHHHH
Confidence 999999887543322111 12345677899999987665 788999999999999999 799999766432 2222
Q ss_pred HHHhCcccCCCCC--CChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 170 QLESKKLCWKHSS--KTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 170 ~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+... ..+..+. ..+..+.+++.+||+.+|.+||++++++.+
T Consensus 218 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 218 HVGAG-HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHhcC-CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 22222 2222233 347889999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=201.75 Aligned_cols=175 Identities=18% Similarity=0.275 Sum_probs=142.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++...+ .+++..+..++.|+++|+.|||+.+++|+||+|+||+++.++.+
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~~---------------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~ 136 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQHG---------------VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHV 136 (278)
T ss_pred EEEEEecCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCE
Confidence 347899999999999997543 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLS---DDQVLSQLE 172 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~---~~~~~~~~~ 172 (223)
+++|||++....... .....++..|++||.+... .++.++|+||+|+++|+++ +|..||.... .........
T Consensus 137 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~ 212 (278)
T cd05606 137 RISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-RGHSPFRQHKTKDKHEIDRMTL 212 (278)
T ss_pred EEccCcCccccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHH-hCCCCCCCCCccchHHHHHHhh
Confidence 999999886443221 1234677889999998744 5788999999999999999 7999997663 222222222
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
. .....+...+.++.+++.+|+..+|.+|| ++.+++++
T Consensus 213 ~--~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 213 T--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred c--cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 2 22344556788999999999999999999 89999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=205.35 Aligned_cols=179 Identities=20% Similarity=0.310 Sum_probs=139.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+ +|.+++...+. .+++..+..++.|+++||.|||+.|++||||+|+||+++.++.+
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~ 143 (309)
T cd07872 79 LTLVFEYLDK-DLKQYMDDCGN--------------IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGEL 143 (309)
T ss_pred EEEEEeCCCC-CHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence 3378898874 89888876433 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......++..|+|||.+.+ ..++.++|+||+|+++|+|+ +|..||.+.+..+....+....
T Consensus 144 kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-tg~~pf~~~~~~~~~~~~~~~~ 221 (309)
T cd07872 144 KLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMA-SGRPLFPGSTVEDELHLIFRLL 221 (309)
T ss_pred EECccccceecCCCc-cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHh
Confidence 999999986532221 11223456788999998765 45788999999999999999 7999998776554433332100
Q ss_pred ---------------------cc-------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ---------------------LC-------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ---------------------~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. ......++.++.+++.+|++.||.+|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 222 GTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00 00112457789999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=200.95 Aligned_cols=179 Identities=19% Similarity=0.307 Sum_probs=142.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+++++|.+++..... ...+++..+..++.|+++|+.|||+ .+++|+||+|+||+++.++.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~ 141 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVA------------TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ 141 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC
Confidence 4588999999999999975311 1358999999999999999999996 59999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCC------CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE------FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~------~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~ 169 (223)
++++|||++....... .....++..|++||.+.... ++.++|+||+||++|+++ +|..||..........
T Consensus 142 ~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~ 217 (286)
T cd06622 142 VKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA-LGRYPYPPETYANIFA 217 (286)
T ss_pred EEEeecCCcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH-hCCCCCCCcchhhHHH
Confidence 9999999886442221 12234667899999875433 478899999999999999 7999997665544433
Q ss_pred HH---HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 170 QL---ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 170 ~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+ ... .....+..++.++.+++.+||+.+|.+||++++++.+
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 218 QLSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 32 222 2334455688999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=197.52 Aligned_cols=182 Identities=19% Similarity=0.267 Sum_probs=152.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++..... ....+++..+..++.++++|+.+||+.|++|+|++|+||+++.++.+
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~ 142 (258)
T cd08215 74 LCIVMEYADGGDLSQKIKKQKK-----------EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLV 142 (258)
T ss_pred EEEEEEecCCCcHHHHHHHhhc-----------cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcE
Confidence 3478999999999999987531 12469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|++||......++.++|+|++|+++++++ +|..||............... .
T Consensus 143 ~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~-~g~~p~~~~~~~~~~~~~~~~-~ 219 (258)
T cd08215 143 KLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELC-TLKHPFEGENLLELALKILKG-Q 219 (258)
T ss_pred EECCccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHH-cCCCCCCCCcHHHHHHHHhcC-C
Confidence 999999886543322 1122345677899999988888899999999999999999 899999888776666666554 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+.+..++..+.+++.+||..+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 344455788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=200.70 Aligned_cols=179 Identities=20% Similarity=0.312 Sum_probs=149.6
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
...++||++.+++|.+++.+.+ .+++..++.++.|++.|+.+||+.|++|+|++|.||+++.++.
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~ 140 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG---------------SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH 140 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC
Confidence 3558999999999999998653 4999999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhh-------------------hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCC
Q psy15108 96 VKISLSGLSKDTYQKEY-------------------YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGE 156 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~-------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~ 156 (223)
++++|||++........ .......++..|++||......++.++|+|++|+++++++ +|.
T Consensus 141 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~-~g~ 219 (280)
T cd05581 141 IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML-TGK 219 (280)
T ss_pred EEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHH-hCC
Confidence 99999998875433221 1222345678899999988888889999999999999999 799
Q ss_pred CCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Q psy15108 157 MPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF----PSIVTQ 212 (223)
Q Consensus 157 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~ 212 (223)
.||...........+.. ..+..+...++.+.+++.+||+.+|.+||++ ++++++
T Consensus 220 ~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 220 PPFRGSNEYLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CCCCCccHHHHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 99998876666555543 3344556778899999999999999999999 787764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=198.90 Aligned_cols=178 Identities=19% Similarity=0.244 Sum_probs=147.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+++++|.+++.... ++++..++.++.|+++|+.|||+ .+++|+||+|.||+++.++.
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~ 138 (264)
T cd06623 74 ISIVLEYMDGGSLADLLKKVG---------------KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE 138 (264)
T ss_pred EEEEEEecCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC
Confidence 447899999999999998653 48999999999999999999999 99999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS---DDQVLSQLE 172 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~---~~~~~~~~~ 172 (223)
++++|||.+......... .....++..|++||.+....++.++|+|+||+++|+++ +|..||.... ..+....+.
T Consensus 139 ~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~-tg~~p~~~~~~~~~~~~~~~~~ 216 (264)
T cd06623 139 VKIADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECA-LGKFPFLPPGQPSFFELMQAIC 216 (264)
T ss_pred EEEccCccceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHH-hCCCCCccccccCHHHHHHHHh
Confidence 999999988754332211 12345677899999998888899999999999999999 7999997773 444455555
Q ss_pred hCcccCCCCCC-ChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKLCWKHSSK-TPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .....+.. ++..+.+++.+||+.+|++||++.+++++
T Consensus 217 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 DG-PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cC-CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 43 33334445 78899999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=199.66 Aligned_cols=175 Identities=17% Similarity=0.197 Sum_probs=144.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+++|.+++.... ++++..+..++.|+++|+.|||+.+++|+||+|.||+++.++.+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~ 139 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQKV---------------KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHV 139 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhcC---------------CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCE
Confidence 558899999999999997642 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD---DQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~---~~~~~~~~~ 173 (223)
+++|||.+....... ......++..|++||.+....++.++|+||+|+++|+++ +|..||..... ...... ..
T Consensus 140 ~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~-~~ 215 (258)
T cd05578 140 HITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL-RGKRPYRGHSRTIRDQIRAK-QE 215 (258)
T ss_pred EEeecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHH-hCCCCCCCCCccHHHHHHHH-hc
Confidence 999999886543322 123345677899999998888899999999999999999 79999987764 232222 22
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCH--HHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF--PSIVT 211 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~~ll~ 211 (223)
. .....+...+..+.+++.+||+.||.+||++ +++++
T Consensus 216 ~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 216 T-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred c-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1 3344556788999999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=199.38 Aligned_cols=183 Identities=20% Similarity=0.253 Sum_probs=146.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++++.+++|.+++..... ...+++..+..++.|++.|+.+||+.|++|+|++|+||+++.++.+
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~------------~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~ 141 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYP------------RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSV 141 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCE
Confidence 3388999999999999986422 1358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh---hhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYY---KYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
+++|||++......... ......++..|++||.+... .++.++|+||+|+++++|+ +|..||...+..+......
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~-~g~~p~~~~~~~~~~~~~~ 220 (267)
T cd06610 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA-TGAAPYSKYPPMKVLMLTL 220 (267)
T ss_pred EEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH-hCCCCccccChhhhHHHHh
Confidence 99999988654432211 12233567789999998766 6788999999999999999 7999998777655554443
Q ss_pred hCcc-cCCCC---CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKL-CWKHS---SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~-~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... ..... ..++..+.+++.+||..+|++||++++++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 221 QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 3321 11111 2567889999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=202.11 Aligned_cols=178 Identities=15% Similarity=0.202 Sum_probs=139.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+++++|..++... ..+++..++.++.|++.||.|||+.+++|+||+|.||+++.++.++
T Consensus 76 ~~v~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~ 140 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNP---------------RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIK 140 (286)
T ss_pred EEEEeccCccHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEE
Confidence 3789999999998887643 3489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++........ ......++..|++||.+.+ ..++.++|+||+|+++++|+ +|..||.+....+....+.....
T Consensus 141 l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07847 141 LCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQLYLIRKTLG 218 (286)
T ss_pred ECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhC
Confidence 999999875433221 1123346678999999765 45788999999999999999 79999987765444333221000
Q ss_pred ---------------------cCC--------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 ---------------------CWK--------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ---------------------~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+ .....+..+.+++.+||+.+|++||++.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 012456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=202.27 Aligned_cols=181 Identities=20% Similarity=0.260 Sum_probs=142.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++..... ....+++..+..++.|++.||.|||+.+++|+|++|.||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~ 144 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKK-----------RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQV 144 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeE
Confidence 4478999999999999875432 23468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL-----SDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~-----~~~~~~~~~ 171 (223)
+++|||++....... .....++..|++||.+....++.++|+|++|+++|+|+ +|..||... ...+....+
T Consensus 145 ~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 220 (287)
T cd06621 145 KLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA-QNRFPFPPEGEPPLGPIELLSYI 220 (287)
T ss_pred EEeeccccccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCcccCCCCChHHHHHHH
Confidence 999999876443221 11234567799999998888899999999999999999 799999765 223444443
Q ss_pred HhCcc-cCCC----CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKL-CWKH----SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~-~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... .... ....++.+.+++.+||+.+|.+||++.|++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 221 VNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 33111 1111 12346789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=204.53 Aligned_cols=178 Identities=16% Similarity=0.271 Sum_probs=144.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++++|.+++.. ..+++.++..++.|++.|+.|||+.+++|+||+|+||+++.++.+
T Consensus 91 ~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~ 154 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSV 154 (297)
T ss_pred EEEeecccCCCCHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 3488999999999999964 247899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-Cc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-KK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~-~~ 175 (223)
+++|||++........ ......++..|++||...+..++.++|+||+|+++|+++ +|..||...+.......+.. ..
T Consensus 155 ~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~-tg~~pf~~~~~~~~~~~~~~~~~ 232 (297)
T cd06656 155 KLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV-EGEPPYLNENPLRALYLIATNGT 232 (297)
T ss_pred EECcCccceEccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCcchheeeeccCCC
Confidence 9999998865432211 122345677899999998888899999999999999999 79999977655333322222 21
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+...+..+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2223345678889999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=210.11 Aligned_cols=178 Identities=14% Similarity=0.101 Sum_probs=136.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++|+++. ++|.+++... ..+++..++.++.||+.||.|||+.|++||||||.||+++..+.++
T Consensus 162 ~lv~e~~~-~~l~~~l~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~ 225 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRS---------------GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV 225 (392)
T ss_pred EEEehhcC-CCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEE
Confidence 36677764 7899999543 3599999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh
Q psy15108 98 ISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD---QVLSQLES 173 (223)
Q Consensus 98 l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~---~~~~~~~~ 173 (223)
++|||++........ .......++..|++||.+....++.++|+||+||++|+|+ +|..||.+.... ..+..+..
T Consensus 226 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~-~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS-VKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred EccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHH-HCCCCCCCCCCCCcHHHHHHHHH
Confidence 999999865433221 1122356789999999998888999999999999999999 788888654321 11111100
Q ss_pred ----Cc---------------------ccC--CC-----CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 ----KK---------------------LCW--KH-----SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ----~~---------------------~~~--~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .++ .. ....+.++.++|.+||..||++||++.+++.+
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 305 CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000 00 01345678889999999999999999999876
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=201.00 Aligned_cols=180 Identities=18% Similarity=0.235 Sum_probs=141.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+ +++|.+++.... .++++..++.++.||++||.|||+.+++|+||+|.||+++.++.+
T Consensus 74 ~~~v~e~~-~~~L~~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~ 138 (286)
T cd07832 74 FVLVMEYM-PSDLSEVLRDEE--------------RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVL 138 (286)
T ss_pred eEEEeccc-CCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcE
Confidence 34889999 999999997643 359999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++...............++..|++||.+... .++.++|+||+|+++++++ +|..+|.+.........+....
T Consensus 139 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~-tg~~~~~~~~~~~~~~~~~~~~ 217 (286)
T cd07832 139 KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRTL 217 (286)
T ss_pred EEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHH-cCCcCcCCCCHHHHHHHHHHHc
Confidence 9999998875543322122345677889999987654 3688999999999999999 6888887666544433332210
Q ss_pred c-------------------cC---------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 L-------------------CW---------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~-------------------~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .. ......+.++.+++.+|+..+|++||++++++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 218 GTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00 0112456889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=200.25 Aligned_cols=176 Identities=18% Similarity=0.288 Sum_probs=142.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+.+++|.++++. ..+++..++.++.|+++|+.|||+.|++|+||+|+||+++..+.++
T Consensus 78 ~lv~e~~~~~~L~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~ 141 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA----------------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVK 141 (277)
T ss_pred EEEEecCCCCcHHHHHHc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEE
Confidence 378999999999999864 2589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++........ ......++..|++||.+.. ..++.++|+||+|+++|+|+ +|..||...........+.....
T Consensus 142 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll-~g~~p~~~~~~~~~~~~~~~~~~ 219 (277)
T cd06917 142 LCDFGVAALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA-TGNPPYSDVDAFRAMMLIPKSKP 219 (277)
T ss_pred EccCCceeecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH-hCCCCCCCCChhhhhhccccCCC
Confidence 999998875543321 1223456778999998764 34688999999999999999 79999987766554443333211
Q ss_pred cCCCCC-CChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSS-KTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+..+. ..+.++.+++..||+.+|++||++.+++.+
T Consensus 220 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 220 -PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 22222 377889999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=196.81 Aligned_cols=180 Identities=21% Similarity=0.289 Sum_probs=141.0
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|+|| ..-+|.+++...+. .+..++...+..+++||++|+.|||+++|+||||||+||+++..|.+|+
T Consensus 94 lvfe~-~d~DL~~ymd~~~~-----------~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKl 161 (323)
T KOG0594|consen 94 LVFEF-LDRDLKKYMDSLPK-----------KPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKL 161 (323)
T ss_pred EEEEe-ecccHHHHHHhccc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEee
Confidence 44444 45789999987653 1135777999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC---
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK--- 174 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~--- 174 (223)
+|||+++...... ......+.|.+|.|||++.+. .|+...|+||+|||++||+ +++.-|++......+..+-.-
T Consensus 162 aDFGlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~-~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 162 ADFGLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMF-TRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred eccchHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHH-hCCCCCCCCcHHHHHHHHHHHcCC
Confidence 9999998554221 224556778899999999887 5899999999999999999 788889888775554443320
Q ss_pred ------------------cccCCCC-------CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 ------------------KLCWKHS-------SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ------------------~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+.+..+ +.......+++.+|++.+|.+|.|++.++.|
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0011101 1112467889999999999999999999987
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=201.67 Aligned_cols=156 Identities=12% Similarity=0.157 Sum_probs=126.4
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhh------hhhhcCCcccccccc
Q psy15108 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEY------YKYRNAILPLRWLPY 127 (223)
Q Consensus 54 l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~p 127 (223)
.++..+..++.|+++|+.|||+.+++||||||+||+++.++.++++|||+++....... .......+++.|+||
T Consensus 123 ~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap 202 (294)
T PHA02882 123 KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL 202 (294)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCH
Confidence 67888999999999999999999999999999999999999999999999876532210 011224578899999
Q ss_pred cccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHH--------HHHHHhCcccCCCCCCChHHHHHHHHHhcCC
Q psy15108 128 EAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQV--------LSQLESKKLCWKHSSKTPEYITSLHEKCIHP 198 (223)
Q Consensus 128 e~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-~~~--------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 198 (223)
|...+..++.++||||+||++++++ +|..||.+... ... ...+..+.. ....+++++.+++..||+.
T Consensus 203 e~~~~~~~~~~~DiwSlG~~l~el~-~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 278 (294)
T PHA02882 203 DAHNGACVTRRGDLESLGYCMLKWA-GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKL 278 (294)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCccccchHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhC
Confidence 9998888999999999999999999 79999987732 221 122222211 2345688899999999999
Q ss_pred CCCCCCCHHHHHHHH
Q psy15108 199 HPHQRPTFPSIVTQL 213 (223)
Q Consensus 199 dp~~Rps~~~ll~~L 213 (223)
+|++||+++++++.+
T Consensus 279 ~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 279 SYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCCCCHHHHHHhh
Confidence 999999999999876
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=202.15 Aligned_cols=177 Identities=19% Similarity=0.278 Sum_probs=138.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+. |+|.+++.... ..+++.+++.++.|++.||.|||+.+++|+||+|.||+++. +.+
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~--------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~ 138 (282)
T cd07831 75 LALVFELMD-MNLYELIKGRK--------------RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DIL 138 (282)
T ss_pred EEEEEecCC-ccHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCe
Confidence 457888886 68888887543 25899999999999999999999999999999999999999 999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ......++..|++||.+.. ..++.++|+||+||++|+|+ +|..||...+..+....+....
T Consensus 139 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~-~~~~p~~~~~~~~~~~~~~~~~ 215 (282)
T cd07831 139 KLADFGSCRGIYSKP--PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL-SLFPLFPGTNELDQIAKIHDVL 215 (282)
T ss_pred EEEecccccccccCC--CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHH-cCCcCCCCCCHHHHHHHHHHHc
Confidence 999999887543222 1122346778999997654 44688999999999999999 7999998776554443332100
Q ss_pred ----------------ccCC-----------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ----------------LCWK-----------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ----------------~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... .....+.++.+++.+||+.+|++||++++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 216 GTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 012457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=201.06 Aligned_cols=173 Identities=17% Similarity=0.284 Sum_probs=138.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|..+. .+++..+..++.|++.|+.|||+.|++|+||+|.||+++.++.+
T Consensus 74 ~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~ 134 (279)
T cd06619 74 ISICTEFMDGGSLDVYR-------------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQV 134 (279)
T ss_pred EEEEEecCCCCChHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCE
Confidence 34789999999997553 37899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-------DQVLS 169 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-------~~~~~ 169 (223)
+++|||++...... ......++..|++||.+....++.++|+||+|+++|+++ +|..||..... .+...
T Consensus 135 ~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~ 210 (279)
T cd06619 135 KLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELA-LGRFPYPQIQKNQGSLMPLQLLQ 210 (279)
T ss_pred EEeeCCcceecccc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHH-hCCCCchhhcccccccchHHHHH
Confidence 99999998654322 123346778899999998888999999999999999999 79999865322 12222
Q ss_pred HHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+.............+.++.+++.+||+.+|++||++++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 211 CIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2222211111123467889999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=186.09 Aligned_cols=166 Identities=13% Similarity=0.228 Sum_probs=130.9
Q ss_pred CChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 27 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
|||.++++.++. ++++.+++.++.|+++||.|||+++ ||.||+++.++.+++ ||.+..
T Consensus 1 GsL~~~l~~~~~--------------~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~ 58 (176)
T smart00750 1 VSLADILEVRGR--------------PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAF 58 (176)
T ss_pred CcHHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEe
Confidence 799999986533 6999999999999999999999998 999999999999998 998765
Q ss_pred cchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhCcccC-----CC
Q psy15108 107 TYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQVLSQLESKKLCW-----KH 180 (223)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-~~~~~~~~~~~~~~-----~~ 180 (223)
.... ...++..|+|||.+.+..++.++||||+||++|+|+ +|..||..... ......+....... ..
T Consensus 59 ~~~~------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (176)
T smart00750 59 KTPE------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL-DYELPYNEERELSAILEILLNGMPADDPRDRSN 131 (176)
T ss_pred eccc------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHH-hCCCCccccchhcHHHHHHHHHhccCCcccccc
Confidence 4322 125678999999999889999999999999999999 79999975543 23333332221111 01
Q ss_pred CCCChH--HHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhcc
Q psy15108 181 SSKTPE--YITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDV 221 (223)
Q Consensus 181 ~~~~~~--~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 221 (223)
....+. ++++++..||..+|.+||++.++++++.....+.+
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~~ 174 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAETL 174 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHHh
Confidence 112233 68999999999999999999999999988876654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=211.18 Aligned_cols=170 Identities=15% Similarity=0.259 Sum_probs=142.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee-ecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI-SSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~-~~~~~~ 96 (223)
..|||.+.||.|.+.+...+. +. ..+..|+.+|+.|+.|||++|++|||+||.|||+ +..+++
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~---------------~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~l 455 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPE---------------FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHL 455 (612)
T ss_pred eeeehhccccHHHHHHHhcch---------------hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcE
Confidence 389999999999998876433 44 7888899999999999999999999999999999 588999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~~~~~~~ 175 (223)
+++|||.+...... .-...-+..|.|||++....|+.++|+||||+++|+|+ +|..||...... ++..++..+.
T Consensus 456 rltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML-~G~tp~~~~P~~~ei~~~i~~~~ 530 (612)
T KOG0603|consen 456 RLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEML-TGRTLFAAHPAGIEIHTRIQMPK 530 (612)
T ss_pred EEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHH-hCCCccccCCchHHHHHhhcCCc
Confidence 99999999765443 11234467799999999999999999999999999999 899999877665 4444444332
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+++.++|+.+||+.||.+|+++.++..+
T Consensus 531 ----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 ----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 236789999999999999999999999999765
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=201.18 Aligned_cols=179 Identities=18% Similarity=0.259 Sum_probs=135.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+. ++|.+++...+ ..+++..++.++.||++||.|||+.+++|+||+|+||+++.++.+
T Consensus 74 ~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~ 138 (284)
T cd07839 74 LTLVFEYCD-QDLKKYFDSCN--------------GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGEL 138 (284)
T ss_pred eEEEEecCC-CCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcE
Confidence 447888886 68888887543 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCC-CCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMP-FPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p-~~~~~~~~~~~~~~~~ 174 (223)
+++|||++....... .......++..|++||.+.+.. ++.++|+||+||++|+|+ +|..| |.+.+..+....+...
T Consensus 139 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-tg~~p~~~~~~~~~~~~~~~~~ 216 (284)
T cd07839 139 KLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA-NAGRPLFPGNDVDDQLKRIFRL 216 (284)
T ss_pred EECccchhhccCCCC-CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHH-hcCCCCcCCCCHHHHHHHHHHH
Confidence 999999886543211 1122345577899999876644 688999999999999999 56656 4444433333222110
Q ss_pred c------------------cc---------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 K------------------LC---------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~------------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .. .+.....++++.+++.+||+.||.+|||+++++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 217 LGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 00 01113467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=199.82 Aligned_cols=181 Identities=18% Similarity=0.230 Sum_probs=139.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~ 95 (223)
..+++||++ |+|.+++..... ....+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~ 142 (283)
T cd06617 75 VWICMEVMD-TSLDKFYKKVYD-----------KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ 142 (283)
T ss_pred EEEEhhhhc-ccHHHHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC
Confidence 337788886 789999876432 224689999999999999999999997 9999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCccccccccccccc----CCCCcccchHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD----DEFSTKSDVYAYACLIWEIFNKGEMPFPDLS-DDQVLSQ 170 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Di~slG~il~~l~~~~~~p~~~~~-~~~~~~~ 170 (223)
++++|||++....... ......++..|++||.+.+ ..++.++|+||+|+++|+|+ +|..||.... ..+....
T Consensus 143 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~ 219 (283)
T cd06617 143 VKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELA-TGRFPYDSWKTPFQQLKQ 219 (283)
T ss_pred EEEeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHH-hCCCCCCccccCHHHHHH
Confidence 9999999987543221 1122456778999998754 34678999999999999999 7999996532 2233333
Q ss_pred HHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.............++.++.+++.+||+.+|.+||++++++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 220 VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 333322222223578899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=195.29 Aligned_cols=182 Identities=18% Similarity=0.215 Sum_probs=147.9
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
...+++||+.+++|.+++..... ....+++..++.++.|+++|+.|||+.|++|+|++|+||+++. +.
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~ 143 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKH-----------TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NL 143 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhh-----------cccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CC
Confidence 35589999999999999975332 2246999999999999999999999999999999999999975 56
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++++|||++....... .......++..|++||......++.++|+||+|+++++++ ++..||...........+...
T Consensus 144 ~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~-~~~~~~~~~~~~~~~~~~~~~- 220 (260)
T cd08222 144 LKIGDFGVSRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC-CLAHAFEGQNFLSVVLRIVEG- 220 (260)
T ss_pred EeecccCceeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHH-hCCCCCCCccHHHHHHHHHcC-
Confidence 9999999886543221 1122345667899999988778888999999999999999 799999877666666555444
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+..+..++.++.+++.+||..+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 3334455678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=198.26 Aligned_cols=181 Identities=15% Similarity=0.247 Sum_probs=143.7
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC-
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL- 94 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~- 94 (223)
...++++|+++++|.++++..+ ++++..+..++.|++.|+.|||+.|++|+||+|.||+++.++
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~ 141 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKYG---------------AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ 141 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 3558899999999999997643 489999999999999999999999999999999999998775
Q ss_pred CeEEcCCCCCcccchhhh---hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHH
Q psy15108 95 SVKISLSGLSKDTYQKEY---YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD---QVL 168 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~---~~~ 168 (223)
.++++|||.+........ .......++..|++||.+.+..++.++|+|++|+++++++ +|..||...... ...
T Consensus 142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~~~~~~~~ 220 (268)
T cd06630 142 RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA-TAKPPWNAEKHSNHLALI 220 (268)
T ss_pred EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHH-hCCCCCCCCCCcchHHHH
Confidence 589999998865433211 0112335677899999988888899999999999999999 799999654432 222
Q ss_pred HHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
............+...+.++.+++.+||..+|.+||++.+++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 22222223344455678889999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=202.60 Aligned_cols=182 Identities=20% Similarity=0.294 Sum_probs=139.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.++++.... ..+++..+..++.|+++||.|||+.+++|+||+|+||+++.++.+
T Consensus 74 ~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~ 140 (314)
T cd08216 74 LYVVSPLMAYGSCEDLLKTHFP-------------EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKV 140 (314)
T ss_pred EEEEEeccCCCCHHHHHHHhcc-------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCce
Confidence 4578999999999999986533 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh------hhhhcCCccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy15108 97 KISLSGLSKDTYQKEY------YKYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~ 168 (223)
++.||+.+........ .......++..|++||.+.. ..++.++|+||+|+++++++ +|..||.........
T Consensus 141 kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~-~g~~pf~~~~~~~~~ 219 (314)
T cd08216 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA-NGHVPFKDMPATQML 219 (314)
T ss_pred EEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCHHHHH
Confidence 9999998764432211 01122345567999999865 34788999999999999999 799999876544332
Q ss_pred -HHHHhCc-------------------------------ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 169 -SQLESKK-------------------------------LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 169 -~~~~~~~-------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+.+.... .........+.++.+++.+||+.+|++||++++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 220 LEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred HHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 2211100 0000011224678899999999999999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=195.28 Aligned_cols=179 Identities=23% Similarity=0.353 Sum_probs=145.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+++|.+++.... .++++..+..++.|+++|+.+||+.|++|+||+|.||+++.++.+
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~ 137 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN--------------QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEV 137 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeE
Confidence 447899999999999997642 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+........ .....++..|++||.+....++.++|+||+|+++++++ +|..||...+.............
T Consensus 138 ~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 214 (253)
T cd05122 138 KLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA-EGKPPYSELPPMKALFKIATNGP 214 (253)
T ss_pred EEeecccccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHH-hCCCCCCCCchHHHHHHHHhcCC
Confidence 9999998865543321 23445677899999998878889999999999999999 79999987755544444433211
Q ss_pred c-CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 C-WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ......++..+.+++..||+.||++||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 215 PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 11122337889999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=197.30 Aligned_cols=178 Identities=17% Similarity=0.218 Sum_probs=147.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+++++|.+++...+ .+++..+..++.|+++|+.|||+.+++|+|++|+||+++.++.++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---------------~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---------------ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEE
Confidence 36889999999999997643 389999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 98 ISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 98 l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++|||++....... ........++..|++||.+.+..++.++|+||||+++++++ +|..||......+...++....
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~ 225 (264)
T cd06653 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML-TEKPPWAEYEAMAAIFKIATQP 225 (264)
T ss_pred ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH-hCCCCCCccCHHHHHHHHHcCC
Confidence 99999987542211 01112345677899999998888889999999999999999 7999998877666555555443
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+...++++.+++.+||. +|..||++.+++.|
T Consensus 226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 4455677788999999999999 57999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=199.27 Aligned_cols=178 Identities=21% Similarity=0.280 Sum_probs=142.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~ 95 (223)
..+|+||+++|+|.+++...+ .+++..+..++.+++.|+.|||+ .+++|+||+|.||+++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~ 142 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGG---------------PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ 142 (284)
T ss_pred EEEEEecCCCCCHHHHHHhcc---------------CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc
Confidence 348999999999999997643 48999999999999999999997 58999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----------
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD---------- 165 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~---------- 165 (223)
++++|||++...... ......++..|++||.+....++.++|+||+||++++++ +|..||......
T Consensus 143 ~~l~d~gl~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~-tg~~p~~~~~~~~~~~~~~~~~ 218 (284)
T cd06620 143 IKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA-LGKFPFAFSNIDDDGQDDPMGI 218 (284)
T ss_pred EEEccCCcccchhhh---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHH-hCCCCCcccchhhhhhhhhhHH
Confidence 999999987643221 112345778899999988888899999999999999999 799999765432
Q ss_pred -HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 166 -QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 166 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
.....+............++.++.+++.+||+.||.+||+++|++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 222222222111111123678899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=199.35 Aligned_cols=180 Identities=19% Similarity=0.313 Sum_probs=142.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.-+++||+++++|.+++...+. ..+++..+..++.|++.|+.|||+.|++|+||+|.||+++.++.+
T Consensus 68 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~ 134 (277)
T cd05577 68 LCLVMTLMNGGDLKYHIYNVGE-------------PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNV 134 (277)
T ss_pred EEEEEecCCCCcHHHHHHHcCc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE
Confidence 3488999999999999986542 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC--
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK-- 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~-- 174 (223)
+++|||.+....... ......++..|++||.+.+..++.++|+||+|+++++++ +|..||...........+...
T Consensus 135 ~l~dfg~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 211 (277)
T cd05577 135 RISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI-AGRSPFRQRKEKVEKEELKRRTL 211 (277)
T ss_pred EEccCcchhhhccCC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHh-hCCCCCCCCcccccHHHHHhccc
Confidence 999999876432211 112345567899999988888899999999999999999 799999765442222222111
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
......+...++.+.+++.+||+.+|.+|| ++.+++.+
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 212 EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 122334456788999999999999999999 66667653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=206.00 Aligned_cols=178 Identities=17% Similarity=0.173 Sum_probs=162.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.-+.||-|.||+|...|++++. |++..+..++.-+++|++|||++||++||+||+|.+++.+|.+
T Consensus 495 vYmLmEaClGGElWTiLrdRg~---------------Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~ 559 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGS---------------FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYL 559 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCC---------------cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCce
Confidence 3367899999999999998755 9999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
|+.|||+++...... ...+..||+.|.|||.+.++..+.++|.|+||+++||++ +|.+||.+.++..++..|.++-.
T Consensus 560 KLVDFGFAKki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL-~G~pPFs~~dpmktYn~ILkGid 636 (732)
T KOG0614|consen 560 KLVDFGFAKKIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELL-TGSPPFSGVDPMKTYNLILKGID 636 (732)
T ss_pred EEeehhhHHHhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHH-cCCCCCCCCchHHHHHHHHhhhh
Confidence 999999998776554 457789999999999999999999999999999999999 89999999999999999999888
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
.+..|..++....++|+++-..+|.+|.. +.+|.+|
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 88888899999999999999999999965 5666555
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=211.79 Aligned_cols=178 Identities=17% Similarity=0.170 Sum_probs=133.6
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++++++ .++|.+++.... ..+++.+++.++.|++.||.|||+.|++||||||.||+++.++.++|
T Consensus 237 lv~e~~-~~~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL 301 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARL--------------RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICL 301 (461)
T ss_pred EEEEcc-CCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEE
Confidence 667777 579999987542 25999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--------CHHHHHH
Q psy15108 99 SLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL--------SDDQVLS 169 (223)
Q Consensus 99 ~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~--------~~~~~~~ 169 (223)
+|||+++........ ......++..|++||.+.+..++.++|||||||++||++ .+..++... ...++..
T Consensus 302 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~-~g~~~lf~~~~~~~~~~~~~~l~~ 380 (461)
T PHA03211 302 GDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA-VHTASLFSASRGDERRPYDAQILR 380 (461)
T ss_pred cccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHH-HcCCCcccCCcccccCCcHHHHHH
Confidence 999998754322111 112346789999999998888999999999999999998 444333211 1222222
Q ss_pred HHHhCccc--------------------------------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 170 QLESKKLC--------------------------------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 170 ~~~~~~~~--------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+...... |......+..+.+++.+||+.||.+|||+.|+++|
T Consensus 381 ~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 381 IIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 22211100 00111334578899999999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=199.15 Aligned_cols=177 Identities=17% Similarity=0.282 Sum_probs=144.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+. |+|.+++..++ .++++.++..++.+++.|+.|||+.+++|+||+|.||+++.++.++
T Consensus 101 ~lv~e~~~-g~l~~~~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~k 165 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVHK--------------KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVK 165 (317)
T ss_pred EEEEeCCC-CCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEE
Confidence 37888886 58888886543 3589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++|||++..... .....++..|++||.+. ...++.++|+||+|+++|+++ +|..||...........+...
T Consensus 166 l~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~-~g~~p~~~~~~~~~~~~~~~~ 239 (317)
T cd06635 166 LADFGSASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALYHIAQN 239 (317)
T ss_pred EecCCCccccCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHH-hCCCCCCCccHHHHHHHHHhc
Confidence 999998764322 12345677899999874 345788999999999999999 799999877766666665554
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..........+..+.+++.+||+.+|.+||++.+++++...
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 34333445678889999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=201.31 Aligned_cols=179 Identities=19% Similarity=0.294 Sum_probs=139.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+. ++|.+++...+. .+++..+..++.|+++||.|||+.+++|+||+|+||+++.++.+
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~--------------~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~ 143 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCGN--------------SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGEL 143 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcE
Confidence 337889987 699999976433 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......++..|++||.+.+. .++.++|+||+|+++|+|+ +|..||...+..+....+....
T Consensus 144 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~-tg~~~f~~~~~~~~~~~~~~~~ 221 (301)
T cd07873 144 KLADFGLARAKSIPT-KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS-TGRPLFPGSTVEEQLHFIFRIL 221 (301)
T ss_pred EECcCcchhccCCCC-CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHc
Confidence 999999886432211 111233457789999987653 4788999999999999999 7999998776654443322110
Q ss_pred c-------------------cCC---------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 L-------------------CWK---------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~-------------------~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ..+ ....+++.+++++.+|++.||.+|||++++++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 222 GTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 000 012467789999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=199.51 Aligned_cols=174 Identities=17% Similarity=0.278 Sum_probs=140.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+. |+|.+++.... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~--------------~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~k 155 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK--------------KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVK 155 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc--------------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEE
Confidence 37788886 68888876432 2589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++|||++...... ....++..|++||.+. ...++.++|+||||+++|+++ +|..||...+.......+...
T Consensus 156 L~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~-tg~~p~~~~~~~~~~~~~~~~ 229 (307)
T cd06607 156 LADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALYHIAQN 229 (307)
T ss_pred EeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHH-cCCCCCCCccHHHHHHHHhcC
Confidence 9999988643221 2345667899999874 345788999999999999999 799999887766655544433
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.........++..+.+++.+||+.+|++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 22222233467889999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=199.26 Aligned_cols=181 Identities=18% Similarity=0.181 Sum_probs=137.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|++|+. ++|.+++..... ...+++..+..++.|+++||.|||+.+++|+||+|+||+++.++.+
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~ 140 (285)
T cd07861 74 LYLIFEFLS-MDLKKYLDSLPK------------GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVI 140 (285)
T ss_pred EEEEEecCC-CCHHHHHhcCCC------------CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcE
Confidence 447889987 799999875422 2468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK- 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~- 174 (223)
+++|||++....... .......++..|+|||.+.+. .++.++|+||+|+++++++ +|..||.+.............
T Consensus 141 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~-tg~~~~~~~~~~~~~~~~~~~~ 218 (285)
T cd07861 141 KLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA-TKKPLFHGDSEIDQLFRIFRIL 218 (285)
T ss_pred EECcccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHHHHh
Confidence 999999886543221 112233457789999987654 4688999999999999999 789899766543222111100
Q ss_pred --------------------c------ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 --------------------K------LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 --------------------~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ........+++++.+++.+||..||.+|||+++++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 219 GTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred CCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 0000123467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=199.33 Aligned_cols=178 Identities=20% Similarity=0.297 Sum_probs=153.3
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
.|||||-.|+..++++.++. +++++.+..++...++||+|||...-+|||||+.||++..+|..|+
T Consensus 105 IVMEYCGAGSiSDI~R~R~K--------------~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKL 170 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRK--------------PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKL 170 (502)
T ss_pred eehhhcCCCcHHHHHHHhcC--------------CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhh
Confidence 89999999999999998765 8999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc-cc
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK-LC 177 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~ 177 (223)
.|||.+....... ...++..+++.|++||++..-.|..++||||+|++..||. .|+.||.+..+...+..+-... +.
T Consensus 171 ADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMA-EG~PPYsDIHPMRAIFMIPT~PPPT 248 (502)
T KOG0574|consen 171 ADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMA-EGRPPYSDIHPMRAIFMIPTKPPPT 248 (502)
T ss_pred hhccccchhhhhH-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhh-cCCCCcccccccceeEeccCCCCCC
Confidence 9999987654432 2357789999999999999889999999999999999999 8999999887755444333321 22
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+..+...+.++-++++.||...|++|.++.++++|
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 22344567889999999999999999999999876
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=220.46 Aligned_cols=183 Identities=17% Similarity=0.199 Sum_probs=157.4
Q ss_pred CCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec
Q psy15108 13 DSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS 92 (223)
Q Consensus 13 ~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~ 92 (223)
+..---+||+|++||+|..+|.+.. .+++.-+..++.+|+-||..+|+.|++||||||.|||++.
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~---------------~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD---------------RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC---------------CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc
Confidence 4444448999999999999998653 4999999999999999999999999999999999999999
Q ss_pred CCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccc----c-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy15108 93 DLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF----D-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167 (223)
Q Consensus 93 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~----~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~ 167 (223)
.|++++.|||-+......+.......+|||.|.+||++. + ..|....|.||+||++|||+ +|..||...+..++
T Consensus 211 ~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMl-yG~TPFYadslveT 289 (1317)
T KOG0612|consen 211 SGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEML-YGETPFYADSLVET 289 (1317)
T ss_pred cCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHH-cCCCcchHHHHHHH
Confidence 999999999988777655555567789999999999986 2 45889999999999999999 99999999999999
Q ss_pred HHHHHhCcccCCCC--CCChHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q psy15108 168 LSQLESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPT---FPSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~ 212 (223)
+..|+...-.+..| ...+++.++||.+.+. +|+.|.. ++++..|
T Consensus 290 Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 290 YGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 99998874444434 6789999999998776 6667766 8888766
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=194.64 Aligned_cols=178 Identities=21% Similarity=0.293 Sum_probs=148.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+++|.+++...+ .+++..+..++.|++.|+.+||+.|++|+||+|.||+++.++.+
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~---------------~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~ 138 (254)
T cd06627 74 LYIILEYAENGSLRQIIKKFG---------------PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVV 138 (254)
T ss_pred EEEEEecCCCCcHHHHHHhcc---------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCE
Confidence 447889999999999998653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+......... .....++..|++||......++.++|+|++|+++++++ +|..||............... .
T Consensus 139 ~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~-~ 215 (254)
T cd06627 139 KLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELL-TGNPPYYDLNPMAALFRIVQD-D 215 (254)
T ss_pred EEeccccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHH-hCCCCCCCccHHHHHHHHhcc-C
Confidence 99999988755433211 12345677899999988777889999999999999999 799999877765555554433 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+...+..+.+++.+||..+|++||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 344556778999999999999999999999998753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=203.20 Aligned_cols=186 Identities=17% Similarity=0.239 Sum_probs=132.1
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee----cCC
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS----SDL 94 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~----~~~ 94 (223)
++++|+ +++|.+++....... ...+...+++..+..++.|++.||.|||++|++||||||+||++. ..+
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~ 149 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASK------ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 149 (317)
T ss_pred EEEecc-CCCHHHHHHhccccc------ccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcC
Confidence 566765 468999987543210 001223589999999999999999999999999999999999994 457
Q ss_pred CeEEcCCCCCcccchhh--hhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------
Q psy15108 95 SVKISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD------ 165 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~------ 165 (223)
.++++|||++....... ........++..|+|||.+.+. .++.++|+||+||++++|+ +|..||......
T Consensus 150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~~f~~~~~~~~~~~~ 228 (317)
T cd07868 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNP 228 (317)
T ss_pred cEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHH-hCCCCccCCccccccccc
Confidence 89999999987543221 1122345678889999998764 5788999999999999999 799898643211
Q ss_pred ---HHHHHHHh---------------Cc--------cc---C----------CCCCCChHHHHHHHHHhcCCCCCCCCCH
Q psy15108 166 ---QVLSQLES---------------KK--------LC---W----------KHSSKTPEYITSLHEKCIHPHPHQRPTF 206 (223)
Q Consensus 166 ---~~~~~~~~---------------~~--------~~---~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~ 206 (223)
.....+.. .. .. . ......+.++.+++.+||+.||.+|||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~ 308 (317)
T cd07868 229 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 308 (317)
T ss_pred ccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCH
Confidence 00111000 00 00 0 0001224567899999999999999999
Q ss_pred HHHHHH
Q psy15108 207 PSIVTQ 212 (223)
Q Consensus 207 ~~ll~~ 212 (223)
+|+++|
T Consensus 309 ~e~l~h 314 (317)
T cd07868 309 EQAMQD 314 (317)
T ss_pred HHHhcC
Confidence 999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=196.40 Aligned_cols=177 Identities=21% Similarity=0.285 Sum_probs=147.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+++|.+++.. ..+++..+..++.|++.|+.+||+.+++|+||+|.||+++.++.+
T Consensus 77 ~~lv~e~~~~~~l~~~i~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~ 140 (277)
T cd06641 77 LWIIMEYLGGGSALDLLEP----------------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV 140 (277)
T ss_pred EEEEEEeCCCCcHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCE
Confidence 4488999999999999963 248999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|++||.+....++.++|+||+|+++++++ +|..||...........+... .
T Consensus 141 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~-~ 217 (277)
T cd06641 141 KLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPHSELHPMKVLFLIPKN-N 217 (277)
T ss_pred EEeecccceecccch-hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHH-cCCCCCCccchHHHHHHHhcC-C
Confidence 999999886543322 1122345677899999988888889999999999999999 799999877766655554433 2
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.......++.++.+++.+||+.+|.+||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 333455678899999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=193.02 Aligned_cols=176 Identities=17% Similarity=0.220 Sum_probs=147.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+++|.+++...+ .+++..+..++.|+++|+.+||+.+++|+||+|.||+++.++.+
T Consensus 68 ~~~v~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~ 132 (250)
T cd05123 68 LYLVLEYAPGGELFSHLSKEG---------------RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHI 132 (250)
T ss_pred eEEEEecCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcE
Confidence 568899999999999998643 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+....... .......++..|++||...+...+.++|+|+||+++++++ +|..||...+..+....+...
T Consensus 133 ~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~-~g~~p~~~~~~~~~~~~~~~~-- 208 (250)
T cd05123 133 KLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML-TGKPPFYAEDRKEIYEKILKD-- 208 (250)
T ss_pred EEeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHhcC--
Confidence 999999886543321 1123345667899999998888888999999999999999 799999888776666665553
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCH---HHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTF---PSIVT 211 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~ll~ 211 (223)
....+...+..+.+++.+||..||++||++ ++++.
T Consensus 209 ~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 209 PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 344566678999999999999999999999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=200.63 Aligned_cols=178 Identities=17% Similarity=0.283 Sum_probs=144.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++++|.+++.+. .+++..+..++.|++.|+.|||+.|++|+|++|+||+++.++.+
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~----------------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~ 154 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET----------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV 154 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCE
Confidence 44889999999999999642 47899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-c
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK-K 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~-~ 175 (223)
+++|||++........ ......++..|++||.+....++.++|+||||+++|+++ +|..||...........+... .
T Consensus 155 kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll-~g~~pf~~~~~~~~~~~~~~~~~ 232 (293)
T cd06647 155 KLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV-EGEPPYLNENPLRALYLIATNGT 232 (293)
T ss_pred EEccCcceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChhhheeehhcCCC
Confidence 9999998764433221 122345677899999998888899999999999999999 799999876654433333222 1
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+...+..+.+++.+||..+|++||++++++.+
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222334567889999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=208.89 Aligned_cols=173 Identities=18% Similarity=0.272 Sum_probs=149.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|||||-| |-.|++..++. ++.+..+..|..+.+.||.|||+.+.+|||||+.||+++..|.||+
T Consensus 103 LVMEYClG-SAsDlleVhkK--------------plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKL 167 (948)
T KOG0577|consen 103 LVMEYCLG-SASDLLEVHKK--------------PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKL 167 (948)
T ss_pred HHHHHHhc-cHHHHHHHHhc--------------cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeee
Confidence 89999875 55666665554 7999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
.|||-+.... +.+..+||++|+|||++. .+.|+.++||||+||+..|+. .+++|+.+++....+..|.+..
T Consensus 168 aDFGSAsi~~-----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELA-ERkPPlFnMNAMSALYHIAQNe 241 (948)
T KOG0577|consen 168 ADFGSASIMA-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALYHIAQNE 241 (948)
T ss_pred ccccchhhcC-----chhcccCCccccchhHheeccccccCCccceeeccchhhhhh-hcCCCccCchHHHHHHHHHhcC
Confidence 9999775332 346789999999999975 567999999999999999999 8999999998887777787764
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+.......+..+..|+..||+.-|.+|||.++++.|
T Consensus 242 sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 4444456789999999999999999999999999876
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=195.98 Aligned_cols=180 Identities=20% Similarity=0.294 Sum_probs=139.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSL--STSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS-D 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~-~ 93 (223)
..+++||+.+++|.+++..... ++ ++..+..++.|++.|+.|||+.+++|+||+|.||+++. .
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~ 145 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWG--------------PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS 145 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcc--------------cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC
Confidence 4488899999999999986422 34 88899999999999999999999999999999999976 5
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE--FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ-VLSQ 170 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~-~~~~ 170 (223)
+.++++|||.+........ ......++..|++||.+.... ++.++|+||+|+++|+++ +|..||....... ....
T Consensus 146 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~-~g~~p~~~~~~~~~~~~~ 223 (268)
T cd06624 146 GVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMA-TGKPPFIELGEPQAAMFK 223 (268)
T ss_pred CeEEEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHH-hCCCCCccccChhhhHhh
Confidence 7899999998865432211 112234677899999976543 778999999999999999 7999997654322 1111
Q ss_pred HHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..........+..+++++.+++.+||+.+|.+||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 224 VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 111112333456678899999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=200.24 Aligned_cols=180 Identities=17% Similarity=0.252 Sum_probs=139.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.++.+..++.+. ..+++..+..++.|++.|+.|||+.+++|+|++|.||+++.++.+
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~ 139 (288)
T cd07833 75 LYLVFEYVERTLLELLEASP---------------GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVL 139 (288)
T ss_pred EEEEEecCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCE
Confidence 44889999987777766543 348999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++...............++..|+|||..... .++.++|+||+|+++|+++ +|..||...........+....
T Consensus 140 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~-~g~~~~~~~~~~~~~~~~~~~~ 218 (288)
T cd07833 140 KLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL-DGEPLFPGDSDIDQLYLIQKCL 218 (288)
T ss_pred EEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHh
Confidence 9999998865433321122234556779999998877 7889999999999999999 7998997665443322221100
Q ss_pred ----------------c---cC-----------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ----------------L---CW-----------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ----------------~---~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .. ..+..++.++.+++++||..+|++||++++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 219 GPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 00 0122347889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=187.69 Aligned_cols=158 Identities=15% Similarity=0.268 Sum_probs=130.9
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCccccccccccc
Q psy15108 52 RSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAV 130 (223)
Q Consensus 52 ~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 130 (223)
.+++|..+-++...+++||.||-+ ++++|||+||+|||+|..|++|++|||++....++. ......|-+.|++||-+
T Consensus 186 ~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--AhtrsAGC~~YMaPERi 263 (391)
T KOG0983|consen 186 GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHTRSAGCAAYMAPERI 263 (391)
T ss_pred CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc--ccccccCCccccCcccc
Confidence 369999999999999999999975 589999999999999999999999999997765544 33445666789999988
Q ss_pred cc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhCcc-cCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy15108 131 FD---DEFSTKSDVYAYACLIWEIFNKGEMPFPDLS-DDQVLSQLESKKL-CWKHSSKTPEYITSLHEKCIHPHPHQRPT 205 (223)
Q Consensus 131 ~~---~~~~~~~Di~slG~il~~l~~~~~~p~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps 205 (223)
.. ..|+..+||||||+.++|+. +|+.||.+-+ ..+++..+....+ .++...++++.+.+++..||+.|+.+||.
T Consensus 264 dp~~~~kYDiRaDVWSlGITlveLa-Tg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~ 342 (391)
T KOG0983|consen 264 DPPDKPKYDIRADVWSLGITLVELA-TGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPK 342 (391)
T ss_pred CCCCCCccchhhhhhhhccchhhhh-cccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcc
Confidence 63 35889999999999999999 8999998743 4556655555433 23333458999999999999999999999
Q ss_pred HHHHHHH
Q psy15108 206 FPSIVTQ 212 (223)
Q Consensus 206 ~~~ll~~ 212 (223)
+.++++|
T Consensus 343 Y~~Ll~h 349 (391)
T KOG0983|consen 343 YNKLLEH 349 (391)
T ss_pred hHHHhcC
Confidence 9999876
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=201.85 Aligned_cols=178 Identities=18% Similarity=0.227 Sum_probs=142.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++|+. ++|.++++.. ..+++..++.++.|+++|+.+||+.|++|+||+|.||+++.++.++
T Consensus 80 ~lv~e~~~-~~l~~~l~~~---------------~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~ 143 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP---------------QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLK 143 (330)
T ss_pred EEEecchh-hhHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 47788877 5899999753 2599999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhh--hhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 98 ISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++|||++........ .......++..|++||.+.+. .++.++|+||+|+++++++ +|..||.+.+..+....+...
T Consensus 144 L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~-~g~~pf~~~~~~~~~~~i~~~ 222 (330)
T cd07834 144 ICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFPGRDYIDQLNLIVEV 222 (330)
T ss_pred EcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHH-cCCCCcCCCCHHHHHHHHHHh
Confidence 999998875533221 112234567789999998877 7889999999999999999 799999877765554443331
Q ss_pred cccC-----------------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCW-----------------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+ ......+.++.+++.+||+.+|.+||++++++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1000 0113357788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=194.55 Aligned_cols=164 Identities=10% Similarity=0.098 Sum_probs=132.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++.... .+++..+..++.|+++|+.|||+.+++|+||+|+||+++.++.+
T Consensus 60 ~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 124 (237)
T cd05576 60 VFLVLQHAEGGKLWSHISKFL---------------NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHI 124 (237)
T ss_pred EEEEEecCCCCCHHHHHHHhc---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCE
Confidence 458999999999999997643 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||.+....... .....+..|++||......++.++|+||+|+++|+++ +|..|+...... + ....
T Consensus 125 ~l~df~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~-~g~~~~~~~~~~-----~-~~~~ 193 (237)
T cd05576 125 QLTYFSRWSEVEDSC----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELL-TGKTLVECHPSG-----I-NTHT 193 (237)
T ss_pred EEecccchhcccccc----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHH-HCcchhhcCchh-----c-cccc
Confidence 999999775433211 1223456699999988788889999999999999999 688776533211 0 1111
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 206 (223)
....+..++..+++++.+|++.||++||++
T Consensus 194 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 194 TLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 223445678889999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=198.52 Aligned_cols=179 Identities=21% Similarity=0.286 Sum_probs=138.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.++.... ..+++..++.++.|+++|+.|||+.+++|+|++|+||+++.++.+
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~ 139 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYP---------------NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVV 139 (286)
T ss_pred EEEEEecCCccHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcE
Confidence 45889999999999887643 248999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......++..|++||...+. .++.++|+||||+++++++ +|..||...........+....
T Consensus 140 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~-~g~~~~~~~~~~~~~~~~~~~~ 217 (286)
T cd07846 140 KLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML-TGEPLFPGDSDIDQLYHIIKCL 217 (286)
T ss_pred EEEeeeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHH-cCCCCCCCCchHHHHHHHHHHh
Confidence 999999886543222 112234567789999987653 4678899999999999999 7888887655433322222100
Q ss_pred --------------------ccC---------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 --------------------LCW---------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 --------------------~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+ ...+.++..+.+++.+||+.+|++||++++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred CCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000 0123567889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=194.20 Aligned_cols=180 Identities=21% Similarity=0.281 Sum_probs=148.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.+++.+.. .+++..+..++.|++.|+.|||+.+++|+|++|.||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~ 140 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG---------------KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVV 140 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCE
Confidence 458899999999999998653 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS-DDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~-~~~~~~~~~~~ 174 (223)
+++|||.+......... ......++..|.+||.......+.++|+|++|+++++++ +|..||.... .......+...
T Consensus 141 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~ 219 (260)
T cd06606 141 KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA-TGKPPWSELGNPMAALYKIGSS 219 (260)
T ss_pred EEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHhcccc
Confidence 99999988765443210 123456678899999998888899999999999999999 7999998766 33333333332
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
......+...+..+.+++.+|++.+|.+||++.+++.+
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 23344556678999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=198.82 Aligned_cols=176 Identities=18% Similarity=0.272 Sum_probs=142.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+. |+|.+++...+ ..+++..+..++.|++.|+.|||+.+++|+||+|.||+++.++.+
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~--------------~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~ 154 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHK--------------KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV 154 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcE
Confidence 337889986 68888886543 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+++|||++...... ....++..|++||.+. ...++.++|+||+|+++|+++ +|..||...........+..
T Consensus 155 kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~~~~~~~~~~ 228 (308)
T cd06634 155 KLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALYHIAQ 228 (308)
T ss_pred EECCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHH-cCCCCCccccHHHHHHHHhh
Confidence 99999988644321 2345677899999874 345788999999999999999 79999887766555555444
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
...........+.++.+++.+||..+|.+||++.+++.+-
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 4333333456788899999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=199.68 Aligned_cols=179 Identities=17% Similarity=0.203 Sum_probs=138.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+ +|+|.+++.... ..+++..++.++.||++||.|||+.|++|+||+|+||+++.++.+
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~--------------~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~ 141 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKS--------------IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVL 141 (298)
T ss_pred EEEEEccc-CCCHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCE
Confidence 45889999 999999997543 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ........+..|++||.+.+ ..++.++|+||+||++++++ +|..+|...........+....
T Consensus 142 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~-~g~~~~~~~~~~~~~~~~~~~~ 219 (298)
T cd07841 142 KLADFGLARSFGSPN-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELL-LRVPFLPGDSDIDQLGKIFEAL 219 (298)
T ss_pred EEccceeeeeccCCC-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHH-cCCccccCCccHHHHHHHHHHc
Confidence 999999987543321 11122345677999998754 45788999999999999999 6777777665544333332110
Q ss_pred cc---------------------C-----CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LC---------------------W-----KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~---------------------~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. . ......+.++.+++.+||+.+|++||++++++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 220 GTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 0 0012346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=193.89 Aligned_cols=192 Identities=21% Similarity=0.327 Sum_probs=143.9
Q ss_pred hHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCC
Q psy15108 3 LKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKD 82 (223)
Q Consensus 3 ~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 82 (223)
+.+++..... .....+|+||+ +|+|.+++..... ..+++..+..++.|++.++.|||+.+++|+|
T Consensus 60 i~~~~~~~~~-~~~~~lv~e~~-~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~d 124 (283)
T cd07830 60 IVKLKEVFRE-NDELYFVFEYM-EGNLYQLMKDRKG-------------KPFSESVIRSIIYQILQGLAHIHKHGFFHRD 124 (283)
T ss_pred chhHHHHhhc-CCcEEEEEecC-CCCHHHHHHhccc-------------ccCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 3444444333 23355889999 8999999986542 3589999999999999999999999999999
Q ss_pred CCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCC
Q psy15108 83 IAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPD 161 (223)
Q Consensus 83 i~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~ 161 (223)
|+|.||+++.++.++++|||++....... ......++..|++||.+.. ..++.++|+||||+++++++ +|..||..
T Consensus 125 l~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~-~g~~~~~~ 201 (283)
T cd07830 125 LKPENLLVSGPEVVKIADFGLAREIRSRP--PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELY-TLRPLFPG 201 (283)
T ss_pred CChhhEEEcCCCCEEEeecccceeccCCC--CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHH-hCCCccCC
Confidence 99999999999999999999886543322 1123456778999998743 45788999999999999999 78889976
Q ss_pred CCHHHHHHHHHhCc-----------------ccCC-----------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 162 LSDDQVLSQLESKK-----------------LCWK-----------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 162 ~~~~~~~~~~~~~~-----------------~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.........+.... .... .....+..+.+++.+||+.+|++||+++|++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 202 SSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred CChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 65543332221100 0000 011235779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=204.57 Aligned_cols=173 Identities=21% Similarity=0.314 Sum_probs=145.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
-+|+.-+.||+|.=.|.+.+. +.|++..+..++.+|+.||++||+.+|++||+||.|||+|..|+++
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~-------------~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGN-------------PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred EEEEEeecCCceeEEeeccCC-------------CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeE
Confidence 378889999999999988764 5799999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc--
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK-- 175 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~-- 175 (223)
|+|+|+|....... .....+||..|||||++....|+.++|.|++||++|+|+ .|..||...-...-.+.+.+..
T Consensus 328 ISDLGLAvei~~g~--~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi-~G~sPFr~~KeKvk~eEvdrr~~~ 404 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGK--PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMI-AGHSPFRQRKEKVKREEVDRRTLE 404 (591)
T ss_pred eeccceEEecCCCC--ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHH-cccCchhhhhhhhhHHHHHHHHhc
Confidence 99999998765544 334558999999999999999999999999999999999 8999997554322222222111
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 206 (223)
..-..+.+++++.+++.+.+|+.||.+|...
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 2234467889999999999999999999654
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=196.84 Aligned_cols=180 Identities=20% Similarity=0.280 Sum_probs=138.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+. ++|.+++..... ..+++..+..++.|+++|+.|||+.+++|+||+|.||+++.++.+
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~~-------------~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~ 139 (284)
T cd07860 74 LYLVFEFLH-QDLKKFMDASPL-------------SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI 139 (284)
T ss_pred EEEEeeccc-cCHHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence 458899985 689999976433 468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......++..|++||...+.. ++.++|+||||+++|+++ +|..||...+......++....
T Consensus 140 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~-tg~~p~~~~~~~~~~~~~~~~~ 217 (284)
T cd07860 140 KLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV-TRRALFPGDSEIDQLFRIFRTL 217 (284)
T ss_pred EEeeccchhhcccCc-cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHHHHh
Confidence 999999876432211 1112234567799999876544 578899999999999999 7899997766543333222110
Q ss_pred c---------------------cC------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 L---------------------CW------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~---------------------~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .+ ......+.++++++.+||+.||.+||++++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 218 GTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred CCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 00 0012456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=204.43 Aligned_cols=175 Identities=17% Similarity=0.264 Sum_probs=135.1
Q ss_pred CCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCC
Q psy15108 22 KPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLS 101 (223)
Q Consensus 22 ~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df 101 (223)
.+|-..+|..+|++... ....-.++.+..|++.|+.++|..||+|.|+||.|+++- .|.+|++||
T Consensus 439 mE~Gd~DL~kiL~k~~~--------------~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDF 503 (677)
T KOG0596|consen 439 MECGDIDLNKILKKKKS--------------IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDF 503 (677)
T ss_pred eecccccHHHHHHhccC--------------CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeee
Confidence 34567889999997654 233338889999999999999999999999999999875 468999999
Q ss_pred CCCcccchhh-hhhhhcCCcccccccccccccCC-----------CCcccchHHHHHHHHHHHhCCCCCCCCCC-HHHHH
Q psy15108 102 GLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDE-----------FSTKSDVYAYACLIWEIFNKGEMPFPDLS-DDQVL 168 (223)
Q Consensus 102 ~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~-----------~~~~~Di~slG~il~~l~~~~~~p~~~~~-~~~~~ 168 (223)
|++....... ........||+.|++||++.... .+.++||||+|||+|+|+ +|+.||.... ....+
T Consensus 504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv-YgktPf~~~~n~~aKl 582 (677)
T KOG0596|consen 504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV-YGKTPFGQIINQIAKL 582 (677)
T ss_pred chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH-hcCCchHHHHHHHHHH
Confidence 9998765443 22334568999999999975322 567899999999999999 8999997665 33444
Q ss_pred HHHHhCcccCCCCCC-ChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 169 SQLESKKLCWKHSSK-TPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 169 ~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..|....-..+.+.- -..++.++|+.||+.||++||++.+++++
T Consensus 583 ~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 445544332232221 13348999999999999999999999976
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=196.58 Aligned_cols=178 Identities=16% Similarity=0.243 Sum_probs=145.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++++|.+++.. ..+++..+..++.|++.|++|||+.|++|+||+|.||+++.++.+
T Consensus 92 ~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~ 155 (292)
T cd06657 92 LWVVMEFLEGGALTDIVTH----------------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV 155 (292)
T ss_pred EEEEEecCCCCcHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence 4588999999999998853 247999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|++||.+....++.++|+||+|+++|+++ +|..||......+....+.....
T Consensus 156 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~-tg~~p~~~~~~~~~~~~~~~~~~ 233 (292)
T cd06657 156 KLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV-DGEPPYFNEPPLKAMKMIRDNLP 233 (292)
T ss_pred EEcccccceeccccc-ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhhCC
Confidence 999999876443221 1122345677899999988778889999999999999999 79999987776655554443311
Q ss_pred -cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 -CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........+..+.+++.+||..+|.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 234 PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 222334568889999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=198.07 Aligned_cols=181 Identities=16% Similarity=0.187 Sum_probs=142.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++.... .+++..+..++.|+++||.|||+.+++|+||+|.||+++.++.+
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~ 144 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQRE---------------HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHV 144 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcC---------------CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCE
Confidence 338899999999999997543 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE--FSTKSDVYAYACLIWEIFNKGEMPFPDLSD----DQVLSQ 170 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slG~il~~l~~~~~~p~~~~~~----~~~~~~ 170 (223)
+++|||++...............++..|++||...+.. .+.++|+||+|+++++|+ +|..||..... .+....
T Consensus 145 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~-tg~~p~~~~~~~~~~~~~~~~ 223 (288)
T cd05583 145 VLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL-TGASPFTVDGEQNSQSEISRR 223 (288)
T ss_pred EEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHH-hCCCCcccCcccchHHHHHHH
Confidence 99999988654333222222345678899999986654 678999999999999999 79999864322 222222
Q ss_pred HHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 171 LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
+... ..+.+..++..+.+++.+||+.+|++|||+.++.+.|..
T Consensus 224 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 ILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 2222 234455678889999999999999999998777655543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=207.31 Aligned_cols=187 Identities=17% Similarity=0.253 Sum_probs=156.6
Q ss_pred HHHHHhhc--CCC-C-CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC--Cc
Q psy15108 5 QFLLATRK--DSK-D-KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK--RL 78 (223)
Q Consensus 5 ~~~~~~~~--~~~-~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i 78 (223)
||++.+.+ +.. + ..+|.|-+..|+|..|++..+. ++...+..|++||++||.|||++ .|
T Consensus 102 NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~---------------vn~kaik~W~RQILkGL~yLHs~~PPI 166 (632)
T KOG0584|consen 102 NIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR---------------VNIKAIKSWCRQILKGLVYLHSQDPPI 166 (632)
T ss_pred ceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc---------------CCHHHHHHHHHHHHHHhhhhhcCCCCc
Confidence 45555554 222 2 5588999999999999998866 99999999999999999999987 69
Q ss_pred ccCCCCCCCeeeecC-CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCC
Q psy15108 79 IHKDIAARNCLISSD-LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEM 157 (223)
Q Consensus 79 ~H~di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~ 157 (223)
+|||||=.||+++++ |.|||+|+|+|....... ....+||+.|||||... ..|+..+||||||..+.||+ ++.+
T Consensus 167 IHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMv-T~eY 241 (632)
T KOG0584|consen 167 IHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMV-TSEY 241 (632)
T ss_pred cccccccceEEEcCCcCceeecchhHHHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHH-hccC
Confidence 999999999999877 889999999997543332 23368999999999975 67999999999999999999 7888
Q ss_pred CCC-CCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 158 PFP-DLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 158 p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
||. ..+..++++.+..+..+-....--.+++++||.+|+.. ...|+++.|++.+
T Consensus 242 PYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 242 PYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 985 56778899998888544444444578899999999999 8999999999876
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=196.82 Aligned_cols=174 Identities=16% Similarity=0.276 Sum_probs=141.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+. |+|.+++...+ .++++..+..++.|++.|+.|||+.|++|+||+|.||+++.++.++
T Consensus 97 ~lv~e~~~-~~l~~~l~~~~--------------~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~k 161 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVHK--------------KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVK 161 (313)
T ss_pred EEEEecCC-CCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEE
Confidence 37888885 68888886543 3589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++|||++..... .....++..|++||.+. ...++.++|+||+|+++|+++ +|..||...+.......+...
T Consensus 162 L~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~-~g~~p~~~~~~~~~~~~~~~~ 235 (313)
T cd06633 162 LADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALYHIAQN 235 (313)
T ss_pred EeecCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhc
Confidence 999998754321 12345677899999974 345788999999999999999 799999887766655555444
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..........+..+.+++.+||+.+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33333334567789999999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=195.97 Aligned_cols=179 Identities=20% Similarity=0.252 Sum_probs=139.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+. ++|.+++.... ..+++..++.++.|+++|+.|||+.+++|+||+|+||+++.++.+
T Consensus 73 ~~~v~e~~~-~~l~~~l~~~~--------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~ 137 (283)
T cd05118 73 LYLVFEFMD-TDLYKLIKDRQ--------------RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVL 137 (283)
T ss_pred EEEEEeccC-CCHHHHHHhhc--------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcE
Confidence 447888886 48998887643 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||.+....... .......++..|.+||.+... .++.++|+||+|+++++++ +|+.||...+..+....+....
T Consensus 138 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~-tg~~~~~~~~~~~~~~~~~~~~ 215 (283)
T cd05118 138 KLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELL-SRRPLFPGKSEIDQLFKIFRTL 215 (283)
T ss_pred EEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHc
Confidence 999999886543322 112234566779999998766 6788999999999999999 7899998776544333322110
Q ss_pred cc----------------------------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LC----------------------------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .......+.++.+++.+||+.||.+||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 216 GTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred CCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 00112357789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=218.38 Aligned_cols=174 Identities=22% Similarity=0.318 Sum_probs=138.2
Q ss_pred CCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEc
Q psy15108 20 SGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS 99 (223)
Q Consensus 20 v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~ 99 (223)
=||||+..+|++++..+.. .-..+..++++.||++||.|+|++|++||||||.||+++..+.+||+
T Consensus 674 QMEyCE~~ll~~iI~~N~~--------------~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIG 739 (1351)
T KOG1035|consen 674 QMEYCEKTLLRDIIRRNHF--------------NSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIG 739 (1351)
T ss_pred EHhhhhhhHHHHHHHhccc--------------chhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeec
Confidence 3899999999999987654 11578999999999999999999999999999999999999999999
Q ss_pred CCCCCcccc----hh-------------hhhhhhcCCcccccccccccccCC---CCcccchHHHHHHHHHHHhCCCCCC
Q psy15108 100 LSGLSKDTY----QK-------------EYYKYRNAILPLRWLPYEAVFDDE---FSTKSDVYAYACLIWEIFNKGEMPF 159 (223)
Q Consensus 100 df~~~~~~~----~~-------------~~~~~~~~~~~~~~~~pe~~~~~~---~~~~~Di~slG~il~~l~~~~~~p~ 159 (223)
|||++.... .. ........+||.-|+|||.+.+.. |+.++|+||+||+++||+ + ||
T Consensus 740 DFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~-y---PF 815 (1351)
T KOG1035|consen 740 DFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML-Y---PF 815 (1351)
T ss_pred ccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh-c---cC
Confidence 999997621 00 011234568889999999987655 899999999999999999 3 45
Q ss_pred C-CCCHHHHHHHHHhCcccCC---CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 160 P-DLSDDQVLSQLESKKLCWK---HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 160 ~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .+....++..+..+..+.+ ..+..+. -.++|++|++.||.+|||+.|++..
T Consensus 816 ~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~-e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 816 GTSMERASILTNLRKGSIPEPADFFDPEHPE-EASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred CchHHHHHHHHhcccCCCCCCcccccccchH-HHHHHHHHhcCCCccCCCHHHHhhc
Confidence 4 3345566666666544444 2234444 4679999999999999999999853
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=216.12 Aligned_cols=196 Identities=13% Similarity=0.145 Sum_probs=147.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++|||+++|+|.++++...... .........++...++.++.||++||.|||+.|++||||||+||+++.++.++
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~----~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKE----SLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhcc----ccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEE
Confidence 37899999999999997532200 00011123567888999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh-----------------hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q psy15108 98 ISLSGLSKDTYQKE-----------------YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFP 160 (223)
Q Consensus 98 l~df~~~~~~~~~~-----------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~ 160 (223)
++|||++....... ........+++.|+|||.+.+..++.++|+||+||++++|+ +|..||.
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELL-TG~~PF~ 232 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML-TLSFPYR 232 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHH-HCCCCCC
Confidence 99999987541110 00112246789999999998888999999999999999999 7999998
Q ss_pred CCCHHHHHHHH-HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHhh
Q psy15108 161 DLSDDQVLSQL-ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP-TFPSIVTQLSDAMC 218 (223)
Q Consensus 161 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~~ 218 (223)
........... ............+++.+.+++.+|++.||++|+ +++++++.|+..+.
T Consensus 233 ~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 233 RKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred CcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 75544332221 111111112246788899999999999999996 56777787777654
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=196.15 Aligned_cols=180 Identities=19% Similarity=0.230 Sum_probs=138.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+ +++|.+++..... ..+++..++.++.|+++||.|||+.+++|+||+|.||+++.++.+
T Consensus 73 ~~iv~e~~-~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~ 138 (283)
T cd07835 73 LYLVFEFL-DLDLKKYMDSSPL-------------TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGAL 138 (283)
T ss_pred EEEEEecc-CcCHHHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcE
Confidence 44788888 4799999976542 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......++..|++||.+.+. .++.++|+||+|+++|+++ +|..||...........+....
T Consensus 139 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~ 216 (283)
T cd07835 139 KLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV-NRRPLFPGDSEIDQLFRIFRTL 216 (283)
T ss_pred EEeecccccccCCCc-cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHh
Confidence 999999986442211 111223446779999987654 4688999999999999999 7999998766543332221100
Q ss_pred ---------------------cc------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ---------------------LC------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ---------------------~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .......+..+.+++.+||+.+|.+||++++++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred CCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 01124566889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=195.43 Aligned_cols=180 Identities=18% Similarity=0.258 Sum_probs=159.0
Q ss_pred HHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCC
Q psy15108 7 LLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86 (223)
Q Consensus 7 ~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~ 86 (223)
++-|-+.-++...||||+.||+|-=.|++-+. |-+..+..++.+|+-||-+||++||++||+|..
T Consensus 415 lHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk---------------FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLD 479 (683)
T KOG0696|consen 415 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---------------FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLD 479 (683)
T ss_pred HHHHhhhhhheeeEEEEecCchhhhHHHHhcc---------------cCCchhhhhhHHHHHHhhhhhcCCeeeeecccc
Confidence 44555666677799999999999999988755 999999999999999999999999999999999
Q ss_pred CeeeecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy15108 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166 (223)
Q Consensus 87 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~ 166 (223)
||+++..|++|+.|||+++...-. .....+..+|+.|+|||.+.+.+|..++|.|++|+++|||+ -|+.||.+.+..+
T Consensus 480 NvmLd~eGHiKi~DFGmcKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEml-aGQpPFdGeDE~e 557 (683)
T KOG0696|consen 480 NVMLDSEGHIKIADFGMCKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQPPFDGEDEDE 557 (683)
T ss_pred ceEeccCCceEeeecccccccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHH-cCCCCCCCCCHHH
Confidence 999999999999999998753222 22346678999999999999999999999999999999999 7999999999999
Q ss_pred HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy15108 167 VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205 (223)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 205 (223)
....|+.... ..+..++.+..++....+...|.+|..
T Consensus 558 lF~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 558 LFQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 9999988653 457788999999999999999999954
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=195.25 Aligned_cols=182 Identities=21% Similarity=0.286 Sum_probs=138.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-CCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS-DLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~-~~~~ 96 (223)
.+++||+.+ +|.+++..... .....+++..++.++.||++||.|||+.+++|+||+|+||+++. ++.+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~----------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~ 150 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGR----------GPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLL 150 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcc----------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeE
Confidence 478899885 89999876543 01246899999999999999999999999999999999999998 7899
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|+ +|..||.+.+..+....+....
T Consensus 151 kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~~~~~~~~~~~~~~~~~~~ 228 (295)
T cd07837 151 KIADLGLGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFKLL 228 (295)
T ss_pred EEeecccceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHHHh
Confidence 999999886542211 11122345677999998764 45788999999999999999 7999998776554433322110
Q ss_pred c-----cC---------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 L-----CW---------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~-----~~---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .+ ......+.++.++|.+||..+|.+||++++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00 0013467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=200.35 Aligned_cols=178 Identities=17% Similarity=0.225 Sum_probs=137.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|++|+. |+|.+++... ..+++..+..++.|+++||.|||+.+++|+||+|+||+++.++.++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~k 147 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD---------------QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELR 147 (334)
T ss_pred EEEEehhh-hhHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEE
Confidence 47888885 6899998654 3489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhh---hhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 98 ISLSGLSKDTYQKEYY---KYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 98 l~df~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
++|||++......... ......++..|++||.+.. ..++.++|+||+|+++|+|+ +|..||.+.+.......+..
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~-~g~~pf~~~~~~~~~~~~~~ 226 (334)
T cd07855 148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILS 226 (334)
T ss_pred ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHH-cCCCccCCCChHHHHHHHHH
Confidence 9999998654322211 1123456788999998765 45788999999999999999 89999977654332221111
Q ss_pred ------------------------CcccCCC-----CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 ------------------------KKLCWKH-----SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ------------------------~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....... ....+.++.+++.+||+.+|.+||++++++.+
T Consensus 227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000 13457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=201.30 Aligned_cols=174 Identities=17% Similarity=0.287 Sum_probs=136.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+. ++|.+.+.. .+++..+..++.|++.||.|||+.|++|+||||.||+++.++.++
T Consensus 97 ~lv~e~~~-~~l~~~~~~-----------------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 97 YLVMELMD-ANLCQVIQM-----------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred EEEEeccC-CCHHHHHhh-----------------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEE
Confidence 37788885 588888853 388999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC---
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK--- 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~--- 174 (223)
++|||++....... ......++..|++||.+.+..++.++|+||+||++++|+ +|..||...+.......+...
T Consensus 159 L~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~~ 235 (353)
T cd07850 159 ILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-RGTVLFPGTDHIDQWNKIIEQLGT 235 (353)
T ss_pred EccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHH-HCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999987543321 122335677899999998888999999999999999999 799999866543332222110
Q ss_pred -------------------ccc--------------CC-----CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 -------------------KLC--------------WK-----HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 -------------------~~~--------------~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
... .+ .....++.+.+++.+||+.||++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00 011345678999999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=199.75 Aligned_cols=181 Identities=20% Similarity=0.273 Sum_probs=140.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++|+. ++|.++++.. +.+++..+..++.|+++|+.|||+.+++|+||+|+||+++.++.++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS---------------QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEE
Confidence 47788875 7899999754 3599999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC--
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK-- 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~-- 174 (223)
++|||++....... .......++..|++||.+.. ..++.++|+||+|+++|+|+ +|..||.+.+.......+...
T Consensus 149 L~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~ 226 (337)
T cd07858 149 ICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLITELLG 226 (337)
T ss_pred ECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHHHhC
Confidence 99999987543321 11123355778999998764 45889999999999999999 899999766543322221110
Q ss_pred ---------------------ccc------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHH
Q psy15108 175 ---------------------KLC------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ--LSDA 216 (223)
Q Consensus 175 ---------------------~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~--L~~~ 216 (223)
... ......++.++.+++.+||+.+|++||++++++++ +..+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 00123567889999999999999999999999988 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=195.97 Aligned_cols=177 Identities=16% Similarity=0.207 Sum_probs=139.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+++++|.+++..++ .+++..+..++.|+++||.|||+.|++|+||+|+||+++.++.++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~k 145 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---------------RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 145 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEE
Confidence 38899999999999998653 489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD--EFSTKSDVYAYACLIWEIFNKGEMPFPDLSD----DQVLSQL 171 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~~l~~~~~~p~~~~~~----~~~~~~~ 171 (223)
++|||++...............++..|++||.+... .++.++|+||+|+++|+++ +|..||..... ......+
T Consensus 146 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll-~g~~p~~~~~~~~~~~~~~~~~ 224 (290)
T cd05613 146 LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL-TGASPFTVDGEKNSQAEISRRI 224 (290)
T ss_pred EeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHh-cCCCCCCcCCccccHHHHHHHh
Confidence 999998875433222222234567789999998643 3678899999999999999 79999864332 2223333
Q ss_pred HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
... ..+.+..++..+.+++.+||+.+|.+|| ++++++.+
T Consensus 225 ~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 225 LKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred hcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 222 2333556788899999999999999997 67777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=195.14 Aligned_cols=179 Identities=18% Similarity=0.261 Sum_probs=139.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+. ++|.+++..... .+++..++.++.|+++||.|||+.+++|+||+|+||+++.++.+
T Consensus 81 ~~lv~e~~~-~~L~~~~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~ 145 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMETMKQ--------------PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGIL 145 (293)
T ss_pred EEEEehhcC-cCHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcE
Confidence 447888887 599999976432 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||.+....... .......++..|++||.+.+.. ++.++|+||+|+++++|+ +|..||...........+....
T Consensus 146 ~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~~f~~~~~~~~~~~~~~~~ 223 (293)
T cd07843 146 KICDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFKLL 223 (293)
T ss_pred EEeecCceeeccCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHh
Confidence 999999887554321 1122345577899999886544 688999999999999999 7999998776554443332110
Q ss_pred -----------------------------ccCCCCCC-ChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 -----------------------------LCWKHSSK-TPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 -----------------------------~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+.. .++.+.+++.+||+.+|++||+++|++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred CCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00001111 47788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=197.03 Aligned_cols=179 Identities=18% Similarity=0.186 Sum_probs=140.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+. ++|.+++.... ..+++..+..++.|+++|+.|||+.|++|+||+|+||+++.++.+
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~--------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~ 147 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMP--------------TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCL 147 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcc--------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 347788886 58999987542 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ........+..|++||.+.+ ..++.++|+||+|+++|+++ +|..||...+..+....+....
T Consensus 148 kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~-~g~~~f~~~~~~~~~~~~~~~~ 225 (309)
T cd07845 148 KIADFGLARTYGLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELL-AHKPLLPGKSEIEQLDLIIQLL 225 (309)
T ss_pred EECccceeeecCCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhc
Confidence 999999887543321 11122234667999999865 45788999999999999999 7999998887766655543310
Q ss_pred c-------------------cCC-C--------CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 L-------------------CWK-H--------SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~-------------------~~~-~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ... . ....++++.+++.+|++.||++||++++++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000 0 01246778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=193.99 Aligned_cols=178 Identities=20% Similarity=0.297 Sum_probs=139.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+. ++|.+++..... ..+++..++.++.|+++||.|||+.+++|+|++|.||+++.++.++
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~~-------------~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCPK-------------PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred EEEehhcc-cCHHHHHHHccC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEE
Confidence 36677776 589999876432 3589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc--
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK-- 175 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~-- 175 (223)
++|||++....... ......++..|++||.+.+..++.++|+||+|+++|+|+ +|..||......+....+....
T Consensus 148 l~dfg~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07838 148 IADFGLARIYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDKIFDVIGL 224 (287)
T ss_pred EeccCcceeccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHH-hCCCcccCCChHHHHHHHHHHcCC
Confidence 99999886543222 112234567799999998888899999999999999999 7898998777655544443210
Q ss_pred ---ccCC--------------------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ---LCWK--------------------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ---~~~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..++ .....+..+.+++.+||+.||.+||++++++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000 001235677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=198.57 Aligned_cols=181 Identities=22% Similarity=0.258 Sum_probs=136.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++|+.+|+|.+++..... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~ 141 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFP-------------EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVS 141 (328)
T ss_pred EEEEecccCCCHHHHHHhhcc-------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEE
Confidence 368899999999999987533 3589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhh------hhhhcCCcccccccccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEY------YKYRNAILPLRWLPYEAVFDD--EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169 (223)
Q Consensus 98 l~df~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~ 169 (223)
+.||+.+........ .......++..|++||.+.+. .++.++|+||+||++++++ +|..||..........
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~-~g~~p~~~~~~~~~~~ 220 (328)
T cd08226 142 LSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA-TGRVPFQDMLRTQMLL 220 (328)
T ss_pred EechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCcChHHHHH
Confidence 999875432211100 000112234569999998653 4678999999999999999 7999998766544332
Q ss_pred HHHhCcc---------------------------------------------cCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy15108 170 QLESKKL---------------------------------------------CWKHSSKTPEYITSLHEKCIHPHPHQRP 204 (223)
Q Consensus 170 ~~~~~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rp 204 (223)
....... ..+....++..+.+++++||+.||++||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 300 (328)
T cd08226 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP 300 (328)
T ss_pred HHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC
Confidence 2211100 0111223567789999999999999999
Q ss_pred CHHHHHHH
Q psy15108 205 TFPSIVTQ 212 (223)
Q Consensus 205 s~~~ll~~ 212 (223)
|+++++++
T Consensus 301 ta~e~l~~ 308 (328)
T cd08226 301 SASSLLSH 308 (328)
T ss_pred CHHHHhhC
Confidence 99999866
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=193.92 Aligned_cols=178 Identities=14% Similarity=0.238 Sum_probs=137.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~ 95 (223)
..++++|+ +++|.+++.... ..+++..+..++.|+++|+.|||+ .+++|+||+|.||+++.++.
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~ 153 (296)
T cd06618 89 VFICMELM-STCLDKLLKRIQ--------------GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN 153 (296)
T ss_pred EEEEeecc-CcCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC
Confidence 33677776 568888876532 268999999999999999999997 59999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE----FSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQVLSQ 170 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slG~il~~l~~~~~~p~~~~~~-~~~~~~ 170 (223)
++++|||++....... ......++..|++||.+.... ++.++|+||||+++|+++ +|+.||..... .+....
T Consensus 154 ~kL~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~~~~~~~~ 230 (296)
T cd06618 154 VKLCDFGISGRLVDSK--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA-TGQFPYKNCKTEFEVLTK 230 (296)
T ss_pred EEECccccchhccCCC--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHH-hCCCCCCcchhHHHHHHH
Confidence 9999999886543221 112234567799999986543 778999999999999999 79999976433 233333
Q ss_pred HHhCc-ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKK-LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+.... ...+....++.++.+++.+||+.+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 231 ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 33322 2222223478899999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=182.38 Aligned_cols=195 Identities=19% Similarity=0.267 Sum_probs=147.4
Q ss_pred chHHHHHHhhcCCCC----CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q psy15108 2 DLKQFLLATRKDSKD----KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR 77 (223)
Q Consensus 2 ~~~~~~~~~~~~~~~----~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 77 (223)
|++++++.+.....+ ..+||.+|+ .+|.-+|..... .++...+.+++.++++||.|+|...
T Consensus 80 nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~v--------------r~sls~Ikk~Mk~Lm~GL~~iHr~k 144 (376)
T KOG0669|consen 80 NLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKV--------------RFSLSEIKKVMKGLMNGLYYIHRNK 144 (376)
T ss_pred HHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCccc--------------cccHHHHHHHHHHHHHHHHHHHHhh
Confidence 344555554444444 337777776 478888875543 6999999999999999999999999
Q ss_pred cccCCCCCCCeeeecCCCeEEcCCCCCcccchhh---hhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHh
Q psy15108 78 LIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFN 153 (223)
Q Consensus 78 i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~ 153 (223)
|+|||+|+.|++++.++.+++.|||+++.+.... ...+...+.|.+|++||.+.+ +.|+.+.|+|..||++.+|+
T Consensus 145 ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMw- 223 (376)
T KOG0669|consen 145 ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMW- 223 (376)
T ss_pred HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHH-
Confidence 9999999999999999999999999997664432 112345677899999999875 45899999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHh-----CcccCCC---------------C-------------CCChHHHHHHHHHhcCCCC
Q psy15108 154 KGEMPFPDLSDDQVLSQLES-----KKLCWKH---------------S-------------SKTPEYITSLHEKCIHPHP 200 (223)
Q Consensus 154 ~~~~p~~~~~~~~~~~~~~~-----~~~~~~~---------------~-------------~~~~~~~~~li~~~l~~dp 200 (223)
++..-+.+....+.+..|.. .+..|+. + -.-.++..+++.+++..||
T Consensus 224 trspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP 303 (376)
T KOG0669|consen 224 TRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDP 303 (376)
T ss_pred ccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCc
Confidence 78877777766555444322 0011111 0 0113467789999999999
Q ss_pred CCCCCHHHHHHH
Q psy15108 201 HQRPTFPSIVTQ 212 (223)
Q Consensus 201 ~~Rps~~~ll~~ 212 (223)
.+|+++++++.|
T Consensus 304 ~kR~~ad~alnh 315 (376)
T KOG0669|consen 304 TKRIDADQALNH 315 (376)
T ss_pred ccCcchHhhhch
Confidence 999999999866
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=190.08 Aligned_cols=181 Identities=21% Similarity=0.269 Sum_probs=140.6
Q ss_pred CCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC
Q psy15108 15 KDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL 94 (223)
Q Consensus 15 ~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~ 94 (223)
....+++||+. ++|.+++..... .+++..+..++.+++.|+.+||+.|++|+||+|.||+++.++
T Consensus 71 ~~~~~v~e~~~-~~l~~~i~~~~~--------------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~ 135 (282)
T cd07829 71 RKLYLVFEYCD-MDLKKYLDKRPG--------------PLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG 135 (282)
T ss_pred CceEEEecCcC-cCHHHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC
Confidence 34558889887 599999987532 589999999999999999999999999999999999999999
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
.++++|||.+........ .......+..|++||.+... .++.++|+|++|+++++++ +|..||......+....+..
T Consensus 136 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 136 VLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred CEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHH-hCCCCCCCccHHHHHHHHHH
Confidence 999999998865432211 12223445679999998766 6888999999999999999 78999987765544333321
Q ss_pred Cc------------------ccC---------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KK------------------LCW---------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~------------------~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. ... ...+..+..+.+++..||..+|++||++.+++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 214 ILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 000 0112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=197.63 Aligned_cols=186 Identities=18% Similarity=0.235 Sum_probs=131.6
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee----ecCC
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI----SSDL 94 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~----~~~~ 94 (223)
++++|+. ++|.+++....... .......+++..+..++.|++.||.|||+.+++|+||||+||++ +.++
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 149 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASK------ANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 149 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccc------cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCC
Confidence 6677765 58888887543210 00122358999999999999999999999999999999999999 4557
Q ss_pred CeEEcCCCCCcccchhh--hhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------
Q psy15108 95 SVKISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD------ 165 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~------ 165 (223)
.++++|||+++...... ........++..|+|||.+.+. .++.++|+||+||++|+|+ +|..||......
T Consensus 150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~-tg~~~f~~~~~~~~~~~~ 228 (317)
T cd07867 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNP 228 (317)
T ss_pred cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHH-hCCCCccccccccccccc
Confidence 89999999987543321 1112334667889999998764 4788999999999999999 799898643211
Q ss_pred ---HHHHHHHh---------------Cc--------c-c------------CCCCCCChHHHHHHHHHhcCCCCCCCCCH
Q psy15108 166 ---QVLSQLES---------------KK--------L-C------------WKHSSKTPEYITSLHEKCIHPHPHQRPTF 206 (223)
Q Consensus 166 ---~~~~~~~~---------------~~--------~-~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 206 (223)
.....+.. .. . . .......+..+.+++.+|++.||.+|||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 308 (317)
T cd07867 229 FHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITS 308 (317)
T ss_pred ccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCH
Confidence 00000000 00 0 0 00011224567889999999999999999
Q ss_pred HHHHHH
Q psy15108 207 PSIVTQ 212 (223)
Q Consensus 207 ~~ll~~ 212 (223)
+|+++|
T Consensus 309 ~e~l~h 314 (317)
T cd07867 309 EQALQD 314 (317)
T ss_pred HHHhcC
Confidence 999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=194.97 Aligned_cols=180 Identities=19% Similarity=0.285 Sum_probs=139.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+. ++|.+++.... ..+++..++.++.|+++|+.+||+.|++|+||+|.||+++.++.+
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~ 139 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPE--------------VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVL 139 (287)
T ss_pred EEEEecccc-ccHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCE
Confidence 447888887 58999987542 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++...............++..|++||.+.+ ..++.++|+||||+++++++ +|..||...+.......+....
T Consensus 140 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~-t~~~p~~~~~~~~~~~~~~~~~ 218 (287)
T cd07840 140 KLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF-LGKPIFQGSTELEQLEKIFELC 218 (287)
T ss_pred EEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHh
Confidence 999999887554332111223455677999998764 35788999999999999999 7899998777655444432210
Q ss_pred c-----cCC-----------------------CCCC-ChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 L-----CWK-----------------------HSSK-TPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~-----~~~-----------------------~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .++ .... ++..+.+++.+||..+|.+||++++++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred CCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 000 0011 37788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=197.24 Aligned_cols=172 Identities=20% Similarity=0.284 Sum_probs=137.2
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|++|+ +++|.+++.. .++++..+..++.|+++|+.|||+.|++|+||+|.||+++.++.+++
T Consensus 97 lv~e~~-~~~L~~~~~~----------------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL 159 (343)
T cd07851 97 LVTHLM-GADLNNIVKC----------------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 159 (343)
T ss_pred EEEecC-CCCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEE
Confidence 666666 7899999964 25899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
+|||++...... .....++..|++||.+.. ..++.++|+||+|+++++++ +|..||........+..+......
T Consensus 160 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ell-tg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 160 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCC
Confidence 999998754322 223456778999998764 35788999999999999999 799999877665554443221100
Q ss_pred C-----------------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 W-----------------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ......+..+.+++.+||+.+|++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 0012357889999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=218.09 Aligned_cols=176 Identities=18% Similarity=0.139 Sum_probs=126.0
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC-----
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD----- 93 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~----- 93 (223)
+.+.++.+++|.++|.... ..+++..++.++.||++||.|||++||+||||||.|||++..
T Consensus 56 ~~~~e~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~ 121 (793)
T PLN00181 56 VRALECEDVSLRQWLDNPD--------------RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSF 121 (793)
T ss_pred hhhhccCCccHHHHHhccc--------------ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEE
Confidence 3444466889999997422 359999999999999999999999999999999999999643
Q ss_pred --------------CCeEEcCCCCCcccchhh---h------------hhhhcCCcccccccccccccCCCCcccchHHH
Q psy15108 94 --------------LSVKISLSGLSKDTYQKE---Y------------YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144 (223)
Q Consensus 94 --------------~~~~l~df~~~~~~~~~~---~------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 144 (223)
+.++++|||+++...... . .......+++.|+|||.+.+..++.++|||||
T Consensus 122 ~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSl 201 (793)
T PLN00181 122 IESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRL 201 (793)
T ss_pred eeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhH
Confidence 445666666665321100 0 00011356788999999988899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 145 G~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
||++|||+ ++..|+.... .....+..... ++...........++.+||+.+|.+||++.+++++
T Consensus 202 GviL~ELl-~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 202 GVLLFELF-CPVSSREEKS--RTMSSLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHh-hCCCchhhHH--HHHHHHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 99999999 6777664321 12222222211 11111223446788899999999999999999865
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=207.24 Aligned_cols=183 Identities=17% Similarity=0.149 Sum_probs=131.0
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++++++ +++|.+++...... .........+..++.|++.||.|||+.|++||||||.||+++.++.++|
T Consensus 240 lv~e~~-~~~l~~~l~~~~~~----------~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL 308 (501)
T PHA03210 240 MITQKY-DFDLYSFMYDEAFD----------WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVL 308 (501)
T ss_pred EEEecc-ccCHHHHHhhcccc----------ccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence 445555 57888888653320 0122456778899999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--H-HHHHHHHHhCc
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS--D-DQVLSQLESKK 175 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~--~-~~~~~~~~~~~ 175 (223)
+|||++...............++..|++||.+.+..++.++|||||||++|+|++.+..|+.... . ....+.+..-.
T Consensus 309 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~ 388 (501)
T PHA03210 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLS 388 (501)
T ss_pred EeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcc
Confidence 99999975543222222335678999999999988899999999999999999954445554332 1 11111111000
Q ss_pred ---ccC--------------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ---LCW--------------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ---~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+ ......+..+.+++.+||+.||++||++.|++.+
T Consensus 389 ~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 389 VCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred cChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0011345567788999999999999999999876
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=193.92 Aligned_cols=179 Identities=20% Similarity=0.237 Sum_probs=138.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|.||+++.++.++
T Consensus 92 ~lv~e~~~~-~l~~~l~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 92 YLVFEYMDH-DLMGLLESGL--------------VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred EEEEcccCc-cHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEE
Confidence 378888875 7777776432 3589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++................+..|++||.+... .++.++|+||+|+++++++ +|+.||...+..+....+.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~-~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF-TKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhC
Confidence 999998875433221112223446779999987643 4688999999999999999 78999987665554444332100
Q ss_pred cC----------------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CW----------------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .....++..+.+++..||+.+|.+||++++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0112467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=193.51 Aligned_cols=158 Identities=15% Similarity=0.287 Sum_probs=123.3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCccccccccccc
Q psy15108 52 RSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAV 130 (223)
Q Consensus 52 ~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 130 (223)
..+++..+..++.++++|++|||+. +++|+||+|+||+++.++.++++|||++....... ......++..|++||.+
T Consensus 102 ~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~ 179 (288)
T cd06616 102 SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERI 179 (288)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC--ccccccCccCccCHHHh
Confidence 4699999999999999999999975 99999999999999999999999999886433221 11223567789999998
Q ss_pred ccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhCcc-c--CCCCCCChHHHHHHHHHhcCCCCCCC
Q psy15108 131 FDD---EFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQVLSQLESKKL-C--WKHSSKTPEYITSLHEKCIHPHPHQR 203 (223)
Q Consensus 131 ~~~---~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~~~l~~dp~~R 203 (223)
... .++.++|+||+|+++|+++ +|..||..... .+....+..... . ......++.++.+++.+||+.+|.+|
T Consensus 180 ~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 258 (288)
T cd06616 180 DPSARDGYDVRSDVWSLGITLYEVA-TGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKR 258 (288)
T ss_pred ccccccCCcchhhhhHHHHHHHHHH-hCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhC
Confidence 765 5788999999999999999 79999976542 122222222111 1 11123478889999999999999999
Q ss_pred CCHHHHHHH
Q psy15108 204 PTFPSIVTQ 212 (223)
Q Consensus 204 ps~~~ll~~ 212 (223)
|++++++.+
T Consensus 259 pt~~~i~~~ 267 (288)
T cd06616 259 PKYKELLEH 267 (288)
T ss_pred cCHHHHhcC
Confidence 999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=197.28 Aligned_cols=178 Identities=20% Similarity=0.226 Sum_probs=137.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+. ++|.++++.. .+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN----------------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred EEEEecccc-cCHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcE
Confidence 347889987 5999998642 47899999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh----hhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEY----YKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++........ .......++..|++||.+.+ ..++.++|+||+|+++|+++ +|+.||.+.........+
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~-tg~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML-LGKPLFPGTSTLNQLEKI 225 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHH
Confidence 9999998875432211 11223356778999998754 44778999999999999999 799999766544332222
Q ss_pred HhCc-----------------------------ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKK-----------------------------LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~-----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... .........+.++.+++.+||+.+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 226 IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 1110 0011123467889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=193.17 Aligned_cols=179 Identities=17% Similarity=0.230 Sum_probs=135.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+. ++|.+++...+ ..+++..++.++.|+++|+.|||+.|++|+||+|+||+++.++.++
T Consensus 95 ~lv~e~~~-~~l~~~l~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~k 159 (310)
T cd07865 95 YLVFEFCE-HDLAGLLSNKN--------------VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILK 159 (310)
T ss_pred EEEEcCCC-cCHHHHHHhcc--------------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEE
Confidence 47788876 58888886543 2589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhh---hhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 98 ISLSGLSKDTYQKEY---YKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 98 l~df~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
++|||++........ .......++..|+|||.+.+. .++.++|+||+|+++|+++ +|..||.+.+.......+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~-t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW-TRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHH
Confidence 999998865432211 111233456779999987654 3678999999999999999 78999987765444333222
Q ss_pred Cc--ccC---------------CC-------------CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KK--LCW---------------KH-------------SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~--~~~---------------~~-------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
-. ... .. ....+..+.+++.+||..||.+||++++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 000 00 01124567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=184.57 Aligned_cols=178 Identities=20% Similarity=0.254 Sum_probs=146.2
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
...++++|+.+++|.+++...+ .+++..++.++.++++++.+||+.+++|+||+|.||+++.++.
T Consensus 61 ~~~l~~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~ 125 (244)
T smart00220 61 KLYLVMEYCDGGDLFDLLKKRG---------------RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH 125 (244)
T ss_pred EEEEEEeCCCCCCHHHHHHhcc---------------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc
Confidence 3558899999999999997643 2899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPD-LSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~-~~~~~~~~~~~~~ 174 (223)
++++|||.+....... ......+...|++||......++.++|+|++|+++++++ ++..||.. .........+...
T Consensus 126 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~-~~~~p~~~~~~~~~~~~~~~~~ 202 (244)
T smart00220 126 VKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELL-TGKPPFPGDDQLLELFKKIGKP 202 (244)
T ss_pred EEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHhcc
Confidence 9999999987654332 223445667899999998788889999999999999999 78899987 4455555555444
Q ss_pred cccCCCCCC-ChHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15108 175 KLCWKHSSK-TPEYITSLHEKCIHPHPHQRPTFPSIVT 211 (223)
Q Consensus 175 ~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~ 211 (223)
......... ++.++.+++.+||..+|++||++.++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 203 KPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 333222222 7889999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=191.87 Aligned_cols=179 Identities=21% Similarity=0.328 Sum_probs=134.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+. ++|.+++...+. .+++..+..++.|+++||.|||+.+++|+||+|.||+++.++.+
T Consensus 78 ~~lv~e~~~-~~L~~~~~~~~~--------------~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~ 142 (291)
T cd07844 78 LTLVFEYLD-TDLKQYMDDCGG--------------GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGEL 142 (291)
T ss_pred EEEEEecCC-CCHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCE
Confidence 448899998 499999976432 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLS-DDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~-~~~~~~~~~~~ 174 (223)
+++|||++....... .......++..|+|||.+.+ ..++.++|+||+|+++|+|+ +|..||.... ..+....+...
T Consensus 143 kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~-~g~~~~~~~~~~~~~~~~~~~~ 220 (291)
T cd07844 143 KLADFGLARAKSVPS-KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVEDQLHKIFRV 220 (291)
T ss_pred EECccccccccCCCC-ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHH-hCCCCCCCCccHHHHHHHHHHh
Confidence 999999886432111 11122345677999998765 45788999999999999999 7999997654 22222111100
Q ss_pred c-------------------c--cC-------CCCCCCh--HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 K-------------------L--CW-------KHSSKTP--EYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~-------------------~--~~-------~~~~~~~--~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. . .. ....... .++.+++.+|++.+|++||++.+++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 221 LGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0 00 0001223 678899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=194.90 Aligned_cols=176 Identities=18% Similarity=0.212 Sum_probs=133.1
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-CCCeE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS-DLSVK 97 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~-~~~~~ 97 (223)
+++||+. ++|.+++.. ..+++..++.++.||++|+.|||+.|++|+||+|+||+++. ++.++
T Consensus 93 lv~e~~~-~~L~~~~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 93 IVQEYME-TDLANVLEQ----------------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred EEeeccc-ccHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEE
Confidence 7788886 699988853 25899999999999999999999999999999999999975 45689
Q ss_pred EcCCCCCcccchhhh--hhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 98 ISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++|||.+........ .......++..|+|||.+.. ..++.++|+|||||++|+++ +|..||......+....+...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~-~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHh
Confidence 999998865422110 01122345678999998654 45788999999999999999 799999876654433332211
Q ss_pred c-----------------------ccC-----CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 K-----------------------LCW-----KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~-----------------------~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ... ......+.++.+++.+||+.||.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 000 0012466788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=194.08 Aligned_cols=176 Identities=18% Similarity=0.248 Sum_probs=134.3
Q ss_pred CCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEc
Q psy15108 20 SGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS 99 (223)
Q Consensus 20 v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~ 99 (223)
++++ .+++|.+++... .++++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++++
T Consensus 84 ~~e~-~~~~L~~~l~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 84 YEEL-MEADLHQIIRSG---------------QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred EEec-ccCCHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeC
Confidence 3444 457999999754 359999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccchhhhh---hhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 100 LSGLSKDTYQKEYY---KYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 100 df~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
|||++......... ......++..|++||.+.+ ..++.++|+||+|+++++++ +|..||...+.......+....
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~-~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHH-hCCcCCCCCCHHHHHHHHHHHh
Confidence 99998754322111 1123456788999998755 45788999999999999999 7999997665433332221100
Q ss_pred ----------------------------cc-CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ----------------------------LC-WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ----------------------------~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .......+..+.+++.+|++.+|.+||++++++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 00112356789999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=195.29 Aligned_cols=181 Identities=18% Similarity=0.251 Sum_probs=136.5
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++++|+. ++|.++++. ..+++..+..++.|+++||.+||+.|++|+||+|+||+++.++.+++
T Consensus 85 lv~e~~~-~~l~~~~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl 147 (336)
T cd07849 85 IVQELME-TDLYKLIKT----------------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKI 147 (336)
T ss_pred EEehhcc-cCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEE
Confidence 6677775 588888853 35899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhh--hhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--
Q psy15108 99 SLSGLSKDTYQKEYY--KYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-- 173 (223)
Q Consensus 99 ~df~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~-- 173 (223)
+|||++......... ......++..|+|||.+.+ ..++.++|+||+|+++++|+ +|+.||.+.+.......+..
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~-~G~~~f~~~~~~~~~~~~~~~~ 226 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML-SNRPLFPGKDYLHQLNLILGVL 226 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHc
Confidence 999988654322111 1122456788999998654 45788999999999999999 79999976654332221110
Q ss_pred -------------Cc---------ccCC-----CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHHh
Q psy15108 174 -------------KK---------LCWK-----HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ--LSDAM 217 (223)
Q Consensus 174 -------------~~---------~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~--L~~~~ 217 (223)
.. .... ..+..+.++.+++.+||+.+|++||++.+++++ +....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00 0000 012346778999999999999999999999987 44443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=194.00 Aligned_cols=177 Identities=18% Similarity=0.237 Sum_probs=137.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+++||+. |+|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.+++
T Consensus 97 lv~e~~~-~~l~~~l~~~~---------------~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 97 LVMDIMA-SDLKKVVDRKI---------------RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEEeccc-cCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence 7788886 79999997543 4899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhh-------------hhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Q psy15108 99 SLSGLSKDTYQKE-------------YYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSD 164 (223)
Q Consensus 99 ~df~~~~~~~~~~-------------~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~ 164 (223)
+|||++....... ........++..|++||.+.+. .++.++|+||+|+++++++ +|..||...+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~-tg~~p~~~~~~ 239 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL-TGKPLFPGENE 239 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCH
Confidence 9999886543111 0011123446779999998654 3688999999999999999 69999988776
Q ss_pred HHHHHHHHhCcc---c--C---------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 165 DQVLSQLESKKL---C--W---------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 165 ~~~~~~~~~~~~---~--~---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+....+..... . + ......+.++.+++.+||+.+|.+||++++++.+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 555443322100 0 0 0012346788999999999999999999999875
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=189.36 Aligned_cols=180 Identities=18% Similarity=0.222 Sum_probs=136.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-CCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS-DLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~-~~~ 95 (223)
..+|+||+. ++|.+++..... ..+++..+..++.||+.||.|||+++++|+||+|+||+++. ++.
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~ 141 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSSPD-------------FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA 141 (294)
T ss_pred EEEEEeccc-ccHHHHHHhCCC-------------CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCE
Confidence 447889985 688888865433 34688999999999999999999999999999999999985 456
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||++....... .......++..|++||.+.+. .++.++|+||+|+++|+++ +|..||......+....+...
T Consensus 142 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~-tg~~pf~~~~~~~~~~~~~~~ 219 (294)
T PLN00009 142 LKLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV-NQKPLFPGDSEIDELFKIFRI 219 (294)
T ss_pred EEEcccccccccCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHH
Confidence 8999999886432211 111223456789999987653 4788999999999999999 799999877655444332210
Q ss_pred c---------------------ccCC------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 K---------------------LCWK------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~---------------------~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ..+. .....++++.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 220 LGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 113467789999999999999999999999875
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-29 Score=202.60 Aligned_cols=176 Identities=15% Similarity=0.209 Sum_probs=154.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.-+||||+.+|.+++++.+++. ..+..+..++.|+.+|++|||+++|+|||||+.||+++.+-++
T Consensus 130 lylV~eya~~ge~~~yl~~~gr---------------~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGR---------------MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNI 194 (596)
T ss_pred eEEEEEeccCchhHHHHHhccc---------------chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccce
Confidence 3389999999999999998866 7779999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
||+|||++..+.... ......+.+.|.|||...+.+| ...+|+|++|+++|.+. .|.+||.+.+..+..+....++
T Consensus 195 kIaDfgfS~~~~~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV-~GsLPFDG~~lk~Lr~rvl~gk 271 (596)
T KOG0586|consen 195 KIADFGFSTFFDYGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALV-EGSLPFDGQNLKELRPRVLRGK 271 (596)
T ss_pred eeeccccceeecccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeee-ecccccCCcccccccchheeee
Confidence 999999998765433 3466788899999999998886 46799999999999999 8999999998877777766665
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
++.+ -..+.++.+++++++..+|.+|++.++++.+
T Consensus 272 ~rIp--~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 YRIP--FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eccc--ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 5543 4456778999999999999999999999876
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=194.51 Aligned_cols=184 Identities=17% Similarity=0.169 Sum_probs=135.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec----
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---- 92 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~---- 92 (223)
..+|+||+. ++|.+++..... .....+++..++.++.|++.|+.|||+.+++|+||+|+||+++.
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~----------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~ 147 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQ----------AKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPE 147 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhcc----------CCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCc
Confidence 447888886 478888765433 11236899999999999999999999999999999999999999
Q ss_pred CCCeEEcCCCCCcccchhhh--hhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---
Q psy15108 93 DLSVKISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ--- 166 (223)
Q Consensus 93 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~--- 166 (223)
++.++++|||++........ .......++..|+|||.+.+. .++.++|+||+|+++++++ +|..||.+.....
T Consensus 148 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-~~~~~~~~~~~~~~~~ 226 (316)
T cd07842 148 RGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKS 226 (316)
T ss_pred cceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH-hcCCCCcCCccccccc
Confidence 89999999998875432211 112234567789999987654 4788999999999999999 7899987554321
Q ss_pred ------HHHHHHh------------------------CcccCCCC-----------CCChHHHHHHHHHhcCCCCCCCCC
Q psy15108 167 ------VLSQLES------------------------KKLCWKHS-----------SKTPEYITSLHEKCIHPHPHQRPT 205 (223)
Q Consensus 167 ------~~~~~~~------------------------~~~~~~~~-----------~~~~~~~~~li~~~l~~dp~~Rps 205 (223)
.+..+.. .......+ ...+..+.+++.+|++.||++|||
T Consensus 227 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 306 (316)
T cd07842 227 NPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306 (316)
T ss_pred chhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC
Confidence 0000000 00000001 145567889999999999999999
Q ss_pred HHHHHHH
Q psy15108 206 FPSIVTQ 212 (223)
Q Consensus 206 ~~~ll~~ 212 (223)
+.+++.+
T Consensus 307 ~~eil~~ 313 (316)
T cd07842 307 AEEALEH 313 (316)
T ss_pred HHHHhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=184.53 Aligned_cols=200 Identities=17% Similarity=0.213 Sum_probs=143.4
Q ss_pred chHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccC
Q psy15108 2 DLKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHK 81 (223)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 81 (223)
|++.+.+...+......++++|.+ .+|.+.|+-++. ++...++...+..+++||+.|+.|||++-++||
T Consensus 88 nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~----------~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHR 156 (438)
T KOG0666|consen 88 NVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRA----------SKAKQLPRSMVKSILWQILDGVHYLHSNWVLHR 156 (438)
T ss_pred cchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhcc----------chhccCCHHHHHHHHHHHHhhhHHHhhhheeec
Confidence 455566666665333556777765 589999987655 233578999999999999999999999999999
Q ss_pred CCCCCCeeeecC----CCeEEcCCCCCcccchhh--hhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhC
Q psy15108 82 DIAARNCLISSD----LSVKISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNK 154 (223)
Q Consensus 82 di~~~nil~~~~----~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~ 154 (223)
|+||.||++..+ |.+|+.|+|+++.+...- .......+.|++|.|||.+.+.. |+.+.|+|++|||+.||+ +
T Consensus 157 DLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL-t 235 (438)
T KOG0666|consen 157 DLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL-T 235 (438)
T ss_pred cCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH-c
Confidence 999999999887 889999999998664432 22334567789999999988765 889999999999999998 4
Q ss_pred CCCCCCCCCHH---------HHHHHHHh---C--cccCCC------------------------------CCCChHHHHH
Q psy15108 155 GEMPFPDLSDD---------QVLSQLES---K--KLCWKH------------------------------SSKTPEYITS 190 (223)
Q Consensus 155 ~~~p~~~~~~~---------~~~~~~~~---~--~~~~~~------------------------------~~~~~~~~~~ 190 (223)
...-|.+.... .-+..|.. . ...|+. ...-++...+
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~ 315 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALD 315 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHH
Confidence 44434222100 00000000 0 000100 0112344678
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 191 LHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 191 li~~~l~~dp~~Rps~~~ll~~L 213 (223)
++.++|+.||.+|.|+++.+++.
T Consensus 316 LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHhccCchhhccHHHHhccc
Confidence 99999999999999999999874
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=188.58 Aligned_cols=178 Identities=19% Similarity=0.328 Sum_probs=132.5
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+. ++|.+++.... ..+++..+..++.|+++||.|||+.+++|+||+|.||+++.++.++
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~ 143 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHP--------------GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELK 143 (291)
T ss_pred EEEEeccc-CCHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEE
Confidence 37889985 78888776432 2478899999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhC-
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLSQLESK- 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~~~~~~- 174 (223)
++|||++....... .......++..|++||.+.+. .++.++|+||+|+++|+++ +|..||...... +.+..+...
T Consensus 144 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-~g~~~f~~~~~~~~~~~~~~~~~ 221 (291)
T cd07870 144 LADFGLARAKSIPS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML-QGQPAFPGVSDVFEQLEKIWTVL 221 (291)
T ss_pred EeccccccccCCCC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCchhHHHHHHHHHHHc
Confidence 99999886432211 111233457789999998654 4788899999999999999 799999765432 211111100
Q ss_pred ---------------cccCC--------------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 ---------------KLCWK--------------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ---------------~~~~~--------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... .....+.++.+++.+|++.||.+|||+++++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 222 GVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred CCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000 001125678899999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=188.52 Aligned_cols=181 Identities=17% Similarity=0.258 Sum_probs=138.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+. |+|.+++..... ...+++..+..++.|+++|+.|||+.|++|+||+|.||+++.++.+
T Consensus 73 ~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~ 139 (284)
T cd07836 73 LMLVFEYMD-KDLKKYMDTHGV------------RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGEL 139 (284)
T ss_pred EEEEEecCC-ccHHHHHHhcCC------------CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcE
Confidence 458899998 489999876432 1358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......++..|++||.+.+. .++.++|+|++|+++++++ +|..||.+.+..+....+....
T Consensus 140 ~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~-~g~~~~~~~~~~~~~~~~~~~~ 217 (284)
T cd07836 140 KLADFGLARAFGIPV-NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI-TGRPLFPGTNNEDQLLKIFRIM 217 (284)
T ss_pred EEeecchhhhhcCCc-cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHh
Confidence 999999886432211 111233456779999987654 4688999999999999999 7999998776554433322110
Q ss_pred ----------------ccCC-----------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ----------------LCWK-----------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ----------------~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... ..+..+..+.+++.+|++.+|.+||++++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 218 GTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 012346778899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=193.63 Aligned_cols=174 Identities=18% Similarity=0.256 Sum_probs=134.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+ +++|.++++. .++++..+..++.|+++||.|||+.+++|+||+|.||+++.++.+
T Consensus 85 ~~lv~e~~-~~~L~~~~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~ 147 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS----------------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDL 147 (328)
T ss_pred EEEEeehh-ccCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCE
Confidence 33677876 6789988863 247889999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-- 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~-- 173 (223)
+++|||.+...... .....++..|++||.+.+ ..++.++|+||+|+++++++ +|..||...........+..
T Consensus 148 ~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~-tg~~~f~~~~~~~~~~~~~~~~ 222 (328)
T cd07856 148 KICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML-EGKPLFPGKDHVNQFSIITDLL 222 (328)
T ss_pred EeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHh
Confidence 99999988643221 122345677999998765 56788999999999999999 79999977654322111110
Q ss_pred ----------------------CcccCC-----CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 ----------------------KKLCWK-----HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ----------------------~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... ....++.++.+++.+||+.+|++||++++++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 223 GTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 113467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=189.18 Aligned_cols=178 Identities=22% Similarity=0.257 Sum_probs=133.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++++|+. ++|.+.+...+ ..+++..+..++.|+++||.|||+.|++|+|++|.||+++.++.+++
T Consensus 92 lv~~~~~-~~l~~~~~~~~--------------~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 92 MVTPYMD-HDLSGLLENPS--------------VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred EEEecCC-cCHHHHHhccc--------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence 5667765 46777776432 35999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhh----------hhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy15108 99 SLSGLSKDTYQKEYY----------KYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167 (223)
Q Consensus 99 ~df~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~ 167 (223)
+|||++......... ......++..|+|||.+.+. .++.++|+||+|+++|+|+ +|..||.+.+....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~-~g~~~~~~~~~~~~ 235 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF-TRRPILQGKSDIDQ 235 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHH-hCCCCCCCCCHHHH
Confidence 999988754322110 01122446779999987654 4788999999999999999 79999987766554
Q ss_pred HHHHHhCccc-----C----------------C-------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 168 LSQLESKKLC-----W----------------K-------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~~~-----~----------------~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+...... + . ......+.+.+++.+|++.+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 4433221000 0 0 002234678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=191.57 Aligned_cols=172 Identities=19% Similarity=0.257 Sum_probs=132.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++|+. ++|.+++. ..++++.+..++.|++.|+.|||+.+++||||+|+||+++.++.++
T Consensus 96 ~lv~e~~~-~~l~~~~~-----------------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 96 YLVMPYMQ-TDLQKIMG-----------------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred EEEecccc-cCHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 36667665 46766552 2589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc-
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK- 175 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~- 175 (223)
++|||++...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|+ +|+.||.+.+.......+....
T Consensus 158 L~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~-~g~~pf~~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 158 ILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML-TGKTLFKGKDYLDQLTQILKVTG 232 (342)
T ss_pred EeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998653221 122345677999999865 45788999999999999999 7999998776544433322210
Q ss_pred ----------------------ccCC------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ----------------------LCWK------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ----------------------~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+ ..+..+..+.+++.+||+.||.+||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 012456778999999999999999999999866
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=190.83 Aligned_cols=173 Identities=17% Similarity=0.236 Sum_probs=135.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|++|+ +++|.++++. ..+++..++.++.|+++|+.|||+.|++|+||+|.||+++.++.++
T Consensus 96 ~lv~e~~-~~~l~~~~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKH----------------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred EEEEecC-CCCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 3677777 7899988863 2489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++...... .....++..|++||.+.. ..++.++|+||+|+++++++ +|..||...+.......+.....
T Consensus 159 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 159 ILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML-TGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred EeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999998754322 122345678999998765 34788999999999999999 79999987665433333221100
Q ss_pred c-----------------------------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 C-----------------------------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .......+..+.+++.+|++.||++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00113467778999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=197.22 Aligned_cols=189 Identities=14% Similarity=0.269 Sum_probs=146.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC--CC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD--LS 95 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~--~~ 95 (223)
-++||||.+|||+..|.+ +.+..++++.+++.++..+..|+.|||++||+||||||.||++-.. |.
T Consensus 93 vlvmEyC~gGsL~~~L~~------------PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq 160 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNS------------PENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQ 160 (732)
T ss_pred eEEEeecCCCcHHHHhcC------------cccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc
Confidence 388999999999999973 2234579999999999999999999999999999999999987433 33
Q ss_pred --eEEcCCCCCcccchhhhhhhhcCCcccccccccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHH
Q psy15108 96 --VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD----QVL 168 (223)
Q Consensus 96 --~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~----~~~ 168 (223)
.|++|||.|+...... .....+||..|++||... +..|+..+|.|||||++|+++ +|..||...... ++.
T Consensus 161 ~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~ca-TG~lPF~p~~~pk~~~~~~ 237 (732)
T KOG4250|consen 161 SIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECA-TGELPFIPFGGPKNNKEIM 237 (732)
T ss_pred eEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHh-ccCCCCCcCCCccccchhh
Confidence 5999999999776665 556789999999999988 478999999999999999999 899999644332 222
Q ss_pred HHHHhC---------------ccc----CCCCCCCh----HHHHHHHHHhcCCCCCCCC--CHHHHHHHHHHHhhhcc
Q psy15108 169 SQLESK---------------KLC----WKHSSKTP----EYITSLHEKCIHPHPHQRP--TFPSIVTQLSDAMCNDV 221 (223)
Q Consensus 169 ~~~~~~---------------~~~----~~~~~~~~----~~~~~li~~~l~~dp~~Rp--s~~~ll~~L~~~~~~~~ 221 (223)
..+..+ +.. ++.+...+ ..+-..+..++..+|++|. .+.+....+..++...|
T Consensus 238 ~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 238 WHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred hhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 222211 111 12222222 2345677788999999999 88999888888876654
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=185.07 Aligned_cols=183 Identities=20% Similarity=0.294 Sum_probs=144.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc--------CCcccCCCCCCCeee
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD--------KRLIHKDIAARNCLI 90 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--------~~i~H~di~~~nil~ 90 (223)
+|.+|++.|||+|||..+ +++.+..++++..+++||++||. -.|+|||||+.||++
T Consensus 286 LvTdYHe~GSL~DyL~r~----------------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV 349 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN----------------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 349 (513)
T ss_pred EeeecccCCcHHHHHhhc----------------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence 889999999999999863 69999999999999999999994 369999999999999
Q ss_pred ecCCCeEEcCCCCCcccchhh---hhhhhcCCcccccccccccccCCC------CcccchHHHHHHHHHHHhCC------
Q psy15108 91 SSDLSVKISLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFDDEF------STKSDVYAYACLIWEIFNKG------ 155 (223)
Q Consensus 91 ~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~------~~~~Di~slG~il~~l~~~~------ 155 (223)
+.++.+.|.|+|++....... ....+..+||..|+|||++..... -..+||||||.++||++ .+
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia-rRc~~ggi 428 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA-RRCESGGI 428 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH-HHhhcCCE
Confidence 999999999999998765442 234678899999999999864431 23599999999999986 22
Q ss_pred ----CCCCCCC-----CHHHHHHHHHhCcccCCCCCCC-----hHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 156 ----EMPFPDL-----SDDQVLSQLESKKLCWKHSSKT-----PEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 156 ----~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
+.||.+. +..++.+-+...+.++..+... -..+.++|+.||..+|.-|-|+-.+.+.|.++.+
T Consensus 429 ~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 5677543 2233333344444555444322 2456789999999999999999999999988764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=190.18 Aligned_cols=171 Identities=19% Similarity=0.264 Sum_probs=133.5
Q ss_pred CCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcC
Q psy15108 21 GKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISL 100 (223)
Q Consensus 21 ~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~d 100 (223)
.+++.+++|.++++. ..+++..+..++.|+++|+.|||+.|++|+||+|+||+++.++.++++|
T Consensus 100 v~~~~~~~L~~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 100 VTHLMGADLNNIVKC----------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred EehhcccCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEec
Confidence 344568999988863 2489999999999999999999999999999999999999999999999
Q ss_pred CCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc---
Q psy15108 101 SGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL--- 176 (223)
Q Consensus 101 f~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~--- 176 (223)
||++...... .....++..|++||.+.+ ..++.++|+||+||++++++ +|..||...+.......+.....
T Consensus 164 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~-~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 164 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred cccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9988654221 123456778999998765 45788999999999999999 79999977665443333211000
Q ss_pred --------------------c-CC-----CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 --------------------C-WK-----HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 --------------------~-~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .. .....+.++.+++..|++.||.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 00 011356778999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=188.58 Aligned_cols=173 Identities=17% Similarity=0.277 Sum_probs=135.9
Q ss_pred CCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec----------
Q psy15108 23 PRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---------- 92 (223)
Q Consensus 23 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~---------- 92 (223)
...|-|++++|+.++. .+++...+..+++|+++++++||+.+++|-|+||+||++..
T Consensus 171 ellG~S~~dFlk~N~y-------------~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 171 ELLGLSTFDFLKENNY-------------IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred eccChhHHHHhccCCc-------------cccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 3456699999998877 68999999999999999999999999999999999999842
Q ss_pred ----------CCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q psy15108 93 ----------DLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL 162 (223)
Q Consensus 93 ----------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~ 162 (223)
+..++++|||-+...... ....+.|..|.|||++.+..++.+.||||+|||+.|++ +|..-|+..
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely-tG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY-TGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEee-ccceecccC
Confidence 234789999988643222 25678899999999999999999999999999999999 788888777
Q ss_pred CHHH---HHHHHHhC------------------cccCCC-------------C----------CCChHHHHHHHHHhcCC
Q psy15108 163 SDDQ---VLSQLESK------------------KLCWKH-------------S----------SKTPEYITSLHEKCIHP 198 (223)
Q Consensus 163 ~~~~---~~~~~~~~------------------~~~~~~-------------~----------~~~~~~~~~li~~~l~~ 198 (223)
++.+ +++.+... ...|+. + .....++.+|+++||.+
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 6544 33322211 111110 0 11124578899999999
Q ss_pred CCCCCCCHHHHHHHH
Q psy15108 199 HPHQRPTFPSIVTQL 213 (223)
Q Consensus 199 dp~~Rps~~~ll~~L 213 (223)
||.+|+|++|++.|=
T Consensus 393 DP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 393 DPARRITLREALSHP 407 (415)
T ss_pred CccccccHHHHhcCH
Confidence 999999999999873
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=200.70 Aligned_cols=194 Identities=13% Similarity=0.071 Sum_probs=127.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhcccc-----CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKD-----KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS 91 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~-----~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~ 91 (223)
..+|++|+.+++|.++++........ ......+.........+..++.|++.||.|||+++|+||||||+|||++
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~ 289 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS 289 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEe
Confidence 55889999999999999864321000 0000111122234556778999999999999999999999999999998
Q ss_pred c-CCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCC----------------------CCcccchHHHHHHH
Q psy15108 92 S-DLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE----------------------FSTKSDVYAYACLI 148 (223)
Q Consensus 92 ~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~----------------------~~~~~Di~slG~il 148 (223)
. ++.+|++|||++...............+++.|++||.+.... +..++||||+||++
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 6 578999999999754322211223456678899999653221 23456999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhCcc---------cCCC----------CCCChHHHHHHHHHhcCCCCCCCCCHHHH
Q psy15108 149 WEIFNKGEMPFPDLSDDQVLSQLESKKL---------CWKH----------SSKTPEYITSLHEKCIHPHPHQRPTFPSI 209 (223)
Q Consensus 149 ~~l~~~~~~p~~~~~~~~~~~~~~~~~~---------~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~l 209 (223)
|+|+ ++..++... .......+..... .... .........+|+.+|++.||++|||++++
T Consensus 370 ~el~-~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~ 447 (566)
T PLN03225 370 LQMA-FPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAA 447 (566)
T ss_pred HHHH-hCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHH
Confidence 9999 565554321 1111111111100 0000 01112334589999999999999999999
Q ss_pred HHH
Q psy15108 210 VTQ 212 (223)
Q Consensus 210 l~~ 212 (223)
++|
T Consensus 448 L~H 450 (566)
T PLN03225 448 LAH 450 (566)
T ss_pred hCC
Confidence 986
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=199.85 Aligned_cols=179 Identities=18% Similarity=0.265 Sum_probs=155.1
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|||||.+||.-|+++.... ..+.|+.+.-|+++++.|+.+||.+.++|||||..||+++.++.+|+
T Consensus 98 LVMEfC~gGSVTDLVKn~~g-------------~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKG-------------NRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred EEeeccCCccHHHHHhhhcc-------------cchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEE
Confidence 99999999999999998765 67999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCccccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-----DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+|||.+....+.. ...++..+++.|+|||++.- ..|+..+|+||||++..||. -|.+|+.++.+...+-.+-.
T Consensus 165 vDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEla-dG~PPl~DmHPmraLF~IpR 242 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMA-EGAPPLCDMHPMRALFLIPR 242 (953)
T ss_pred eeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhc-CCCCCccCcchhhhhccCCC
Confidence 9999988665433 23577899999999999752 23678899999999999998 89999999988777666544
Q ss_pred Cc-ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KK-LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+ +.+..+.+.++++.++|..||..|..+||+..++++|
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 42 2334466788999999999999999999999998865
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=176.09 Aligned_cols=193 Identities=14% Similarity=0.206 Sum_probs=151.0
Q ss_pred chHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccC
Q psy15108 2 DLKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHK 81 (223)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 81 (223)
|++++|....++ ..+-+|||-+.||.|...|++++. |++..+.++..+|+.||.+||.+||+||
T Consensus 137 nilqLiefFEdd-~~FYLVfEKm~GGplLshI~~~~~---------------F~E~EAs~vvkdia~aLdFlH~kgIAHR 200 (463)
T KOG0607|consen 137 NILQLIEFFEDD-TRFYLVFEKMRGGPLLSHIQKRKH---------------FNEREASRVVKDIASALDFLHTKGIAHR 200 (463)
T ss_pred cHHHHHHHhccc-ceEEEEEecccCchHHHHHHHhhh---------------ccHHHHHHHHHHHHHHHHHHhhcCcccc
Confidence 456666554433 334589999999999999998866 9999999999999999999999999999
Q ss_pred CCCCCCeeeecCC---CeEEcCCCCCcccchhh------hhhhhcCCcccccccccccc-----cCCCCcccchHHHHHH
Q psy15108 82 DIAARNCLISSDL---SVKISLSGLSKDTYQKE------YYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACL 147 (223)
Q Consensus 82 di~~~nil~~~~~---~~~l~df~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~i 147 (223)
|+||+|||-.... .+|++||.+.....-+. --...+..|...|||||++. ...|+.+.|.||||++
T Consensus 201 DlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvI 280 (463)
T KOG0607|consen 201 DLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVI 280 (463)
T ss_pred cCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHH
Confidence 9999999976554 37999998764321111 00123456778899999864 2347889999999999
Q ss_pred HHHHHhCCCCCCCCCC---------------HHHHHHHHHhCcccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy15108 148 IWEIFNKGEMPFPDLS---------------DDQVLSQLESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIV 210 (223)
Q Consensus 148 l~~l~~~~~~p~~~~~---------------~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll 210 (223)
+|-|+ .|..||.+.= +....+.|..+.+.++.. ..++.+.++++..++..|+.+|-++.+++
T Consensus 281 lYImL-sGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vl 359 (463)
T KOG0607|consen 281 LYIML-SGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVL 359 (463)
T ss_pred HHHHH-hCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence 99999 8999995441 234566777777666543 35688999999999999999999998887
Q ss_pred H
Q psy15108 211 T 211 (223)
Q Consensus 211 ~ 211 (223)
+
T Consensus 360 n 360 (463)
T KOG0607|consen 360 N 360 (463)
T ss_pred C
Confidence 6
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=208.76 Aligned_cols=178 Identities=14% Similarity=0.165 Sum_probs=133.8
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCCCCCeeeec
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHIS---DKRLIHKDIAARNCLISS 92 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~~~nil~~~ 92 (223)
...+||||+++|+|.++++ .+++..+..++.|+++|+.||| +.+++|||+||.||+++.
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~ 818 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC
Confidence 3558999999999999995 2789999999999999999999 669999999999999998
Q ss_pred CCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----HHH
Q psy15108 93 DLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-----DQV 167 (223)
Q Consensus 93 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-----~~~ 167 (223)
+...++. ++...... ......++..|+|||.+.+..++.++|||||||++||++ +|+.||..... .+.
T Consensus 819 ~~~~~~~-~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~-tg~~p~~~~~~~~~~~~~~ 891 (968)
T PLN00113 819 KDEPHLR-LSLPGLLC-----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL-TGKSPADAEFGVHGSIVEW 891 (968)
T ss_pred CCceEEE-eccccccc-----cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHH-hCCCCCCcccCCCCcHHHH
Confidence 8777664 44432211 112235678899999998888999999999999999999 79999853211 111
Q ss_pred HHHHHh---------CcccC--CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 168 LSQLES---------KKLCW--KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 168 ~~~~~~---------~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
...... ..... ........++.+++.+||+.+|++||+++++++.|+++..
T Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 111000 00000 0011223457789999999999999999999999998865
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=167.39 Aligned_cols=189 Identities=15% Similarity=0.228 Sum_probs=141.7
Q ss_pred hHHHHHHhhc-CCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccC
Q psy15108 3 LKQFLLATRK-DSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHK 81 (223)
Q Consensus 3 ~~~~~~~~~~-~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 81 (223)
+..+++.-.+ .+....+++||..+.+...+-. +++.-++..++.|+++||.|+|++||.||
T Consensus 95 Ii~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~------------------tl~d~dIryY~~elLkALdyCHS~GImHR 156 (338)
T KOG0668|consen 95 IIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP------------------TLTDYDIRYYIYELLKALDYCHSMGIMHR 156 (338)
T ss_pred eeehhhhhcCccccCchhHhhhhccccHHHHhh------------------hhchhhHHHHHHHHHHHHhHHHhcCcccc
Confidence 4455555455 5555779999999999888874 58999999999999999999999999999
Q ss_pred CCCCCCeeeecC-CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCC
Q psy15108 82 DIAARNCLISSD-LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPF 159 (223)
Q Consensus 82 di~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~ 159 (223)
|+||.|++++.. ..++++|+|++...-... ..+..+....|..||.+... .|+.+-|+|||||++..|+ ..+.||
T Consensus 157 DVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~--eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~mi-FrkepF 233 (338)
T KOG0668|consen 157 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI-FRKEPF 233 (338)
T ss_pred cCCcceeeechhhceeeeeecchHhhcCCCc--eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHH-hccCcc
Confidence 999999999866 458999999996543222 34455666778899998754 4889999999999999999 566665
Q ss_pred -CCCCHHHHHHHHHh-----------------------------CcccCC------CCCCChHHHHHHHHHhcCCCCCCC
Q psy15108 160 -PDLSDDQVLSQLES-----------------------------KKLCWK------HSSKTPEYITSLHEKCIHPHPHQR 203 (223)
Q Consensus 160 -~~~~~~~~~~~~~~-----------------------------~~~~~~------~~~~~~~~~~~li~~~l~~dp~~R 203 (223)
.+.++...+-.+.. ...+|. ...-.+++..+++.++|..|.++|
T Consensus 234 FhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeR 313 (338)
T KOG0668|consen 234 FHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQER 313 (338)
T ss_pred cCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccc
Confidence 44443222111111 000111 112235889999999999999999
Q ss_pred CCHHHHHHH
Q psy15108 204 PTFPSIVTQ 212 (223)
Q Consensus 204 ps~~~ll~~ 212 (223)
+|++|.+.|
T Consensus 314 lTakEam~H 322 (338)
T KOG0668|consen 314 LTAKEAMAH 322 (338)
T ss_pred cchHHHhcC
Confidence 999999876
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=178.71 Aligned_cols=201 Identities=21% Similarity=0.299 Sum_probs=151.2
Q ss_pred chHHHHHHhhcCCC---CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc---
Q psy15108 2 DLKQFLLATRKDSK---DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD--- 75 (223)
Q Consensus 2 ~~~~~~~~~~~~~~---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--- 75 (223)
|+++|+.+-+.... .+-+|++|+++|+|.+||+.+ .+++....+++..+++||+|||+
T Consensus 265 nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n----------------tisw~~~cria~SmarGLa~LHee~p 328 (534)
T KOG3653|consen 265 NILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN----------------TISWNSLCRIAESMARGLAHLHEELP 328 (534)
T ss_pred hHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc----------------cccHHHHHHHHHHHHHHHHHhcccCC
Confidence 56777776655332 255999999999999999874 68999999999999999999995
Q ss_pred ------CCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCC-CC-----cccchH
Q psy15108 76 ------KRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDE-FS-----TKSDVY 142 (223)
Q Consensus 76 ------~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~-~~-----~~~Di~ 142 (223)
.+|+|||||++|||+..++++.|+|||++........ ...-..+||..|||||++.+.. +. .+.|||
T Consensus 329 ~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvY 408 (534)
T KOG3653|consen 329 RGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVY 408 (534)
T ss_pred cCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHH
Confidence 3799999999999999999999999999987654321 1122378999999999986543 22 369999
Q ss_pred HHHHHHHHHHhCCC-----------CCCC-----CCCHHHHHHHHHhCcccCCCCC-----CChHHHHHHHHHhcCCCCC
Q psy15108 143 AYACLIWEIFNKGE-----------MPFP-----DLSDDQVLSQLESKKLCWKHSS-----KTPEYITSLHEKCIHPHPH 201 (223)
Q Consensus 143 slG~il~~l~~~~~-----------~p~~-----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~ 201 (223)
|+|.++||+++... .||. ...-.++...+...+.++..+. .....+++.+..||..|++
T Consensus 409 amgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDae 488 (534)
T KOG3653|consen 409 AMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAE 488 (534)
T ss_pred HHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchh
Confidence 99999999973321 2222 1112233334444444444332 2356688999999999999
Q ss_pred CCCCHHHHHHHHHHHhh
Q psy15108 202 QRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 202 ~Rps~~~ll~~L~~~~~ 218 (223)
-|.|+.-+-+.+.++..
T Consensus 489 ARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 489 ARLTAGCVEERMAELMM 505 (534)
T ss_pred hhhhhHHHHHHHHHHhc
Confidence 99999999888887653
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=183.98 Aligned_cols=183 Identities=19% Similarity=0.283 Sum_probs=143.8
Q ss_pred CCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC--CcccCCCCCCCeee
Q psy15108 13 DSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK--RLIHKDIAARNCLI 90 (223)
Q Consensus 13 ~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~di~~~nil~ 90 (223)
+.+.+-.|.|||+|-+|.=||++++- +++..+..|+.||+.||.||... .|+|-|+||.|||+
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhkl---------------mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL 603 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKL---------------MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL 603 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhh---------------hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE
Confidence 33444578999999999999998865 99999999999999999999864 79999999999998
Q ss_pred ecC---CCeEEcCCCCCcccchhhhh------hhhcCCcccccccccccccC----CCCcccchHHHHHHHHHHHhCCCC
Q psy15108 91 SSD---LSVKISLSGLSKDTYQKEYY------KYRNAILPLRWLPYEAVFDD----EFSTKSDVYAYACLIWEIFNKGEM 157 (223)
Q Consensus 91 ~~~---~~~~l~df~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~----~~~~~~Di~slG~il~~l~~~~~~ 157 (223)
... |.+|++|||+++......+. ......||.+|++||++.-. +.+.++||||+|||+|.++ +|+.
T Consensus 604 v~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQCl-YGrK 682 (775)
T KOG1151|consen 604 VNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCL-YGRK 682 (775)
T ss_pred ecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhh-ccCC
Confidence 644 66899999999865443221 23346789999999997633 3688999999999999999 8999
Q ss_pred CCCCCC-HHHHHHH---HHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15108 158 PFPDLS-DDQVLSQ---LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVT 211 (223)
Q Consensus 158 p~~~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 211 (223)
||-..- ...+++. +......++.-+..+.+.+.+|++||++.-++|.++.++..
T Consensus 683 PFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 683 PFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred CCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 996543 3333322 23333444445567888999999999999999988877643
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=195.27 Aligned_cols=93 Identities=17% Similarity=0.291 Sum_probs=78.1
Q ss_pred cccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCC-CCCChHHHHHHHHHhcCC
Q psy15108 120 LPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKH-SSKTPEYITSLHEKCIHP 198 (223)
Q Consensus 120 ~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~ 198 (223)
+++.|++||++.+..++.++|||||||++|||+ +|..||.+.........+......++. ...++..+.+++..||..
T Consensus 542 GT~~Y~APE~l~~~~~~~~~DiwSlG~il~Ell-tG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~ 620 (669)
T cd05610 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFL-TGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTM 620 (669)
T ss_pred eCccccCHHHcCCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence 467899999998888999999999999999999 799999988887777776554443332 235678899999999999
Q ss_pred CCCCCCCHHHHHHHH
Q psy15108 199 HPHQRPTFPSIVTQL 213 (223)
Q Consensus 199 dp~~Rps~~~ll~~L 213 (223)
||.+||++.++++|-
T Consensus 621 dP~~R~ta~e~l~h~ 635 (669)
T cd05610 621 DPTKRAGLKELKQHP 635 (669)
T ss_pred ChhHCcCHHHHHhCH
Confidence 999999999999873
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=170.98 Aligned_cols=163 Identities=17% Similarity=0.309 Sum_probs=128.8
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccc
Q psy15108 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEA 129 (223)
Q Consensus 50 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~ 129 (223)
++..++.+.+.-+++||++||+|||+.+|+||||||.|.+++.+..+|++|||+++.............+.+..|.+||.
T Consensus 149 SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEi 228 (449)
T KOG0664|consen 149 SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPEL 228 (449)
T ss_pred cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHH
Confidence 44579999999999999999999999999999999999999999999999999999876665555555667888999999
Q ss_pred cccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----------------------CcccCCC-----
Q psy15108 130 VFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-----------------------KKLCWKH----- 180 (223)
Q Consensus 130 ~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~-----------------------~~~~~~~----- 180 (223)
+.+. .|+...||||+|||+.|++ .++.-|...++.+.++.+.. +..+.+.
T Consensus 229 LMGaRhYs~AvDiWSVGCIFaELL-gRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLY 307 (449)
T KOG0664|consen 229 LMGARRYTGAVDIWSVGCIFAELL-QRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLY 307 (449)
T ss_pred hhcchhhcCccceehhhHHHHHHH-hhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCcccee
Confidence 8765 5899999999999999999 78888876665544333221 1111110
Q ss_pred ----CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 181 ----SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 181 ----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
+..-..+...+..+++.+||.+|.+..+.+.++
T Consensus 308 tlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 308 KIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred eecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 011234566788899999999999999888764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=182.87 Aligned_cols=195 Identities=17% Similarity=0.139 Sum_probs=134.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhcccc------CCCC---CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKD------KSGS---GKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARN 87 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~------~~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~n 87 (223)
.-+|+||+.+|+|.++|+........ ..+. .......+++..+..++.|+++||.|||+.+++||||||.|
T Consensus 260 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~N 339 (507)
T PLN03224 260 QWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPEN 339 (507)
T ss_pred eEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHh
Confidence 34899999999999999864321110 0000 00112346788999999999999999999999999999999
Q ss_pred eeeecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCC--------------------C--CcccchHHHH
Q psy15108 88 CLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE--------------------F--STKSDVYAYA 145 (223)
Q Consensus 88 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--------------------~--~~~~Di~slG 145 (223)
|+++.++.++++|||++................++.|++||.+.... + ....|+||+|
T Consensus 340 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlG 419 (507)
T PLN03224 340 LLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAG 419 (507)
T ss_pred EEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHH
Confidence 99999999999999998654322111111233467899999875322 1 1246999999
Q ss_pred HHHHHHHhCCC-CCCCCCCHH-----------HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCC---CCCCCHHHHH
Q psy15108 146 CLIWEIFNKGE-MPFPDLSDD-----------QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHP---HQRPTFPSIV 210 (223)
Q Consensus 146 ~il~~l~~~~~-~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rps~~~ll 210 (223)
|++++|+ .+. .|+.+.... ..+................++..++++.+|+..+| .+|+|++|++
T Consensus 420 vil~em~-~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 420 VLLMQMC-VPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred HHHHHHH-hCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 9999999 554 366532211 11111122223333345567889999999999766 6899999999
Q ss_pred HH
Q psy15108 211 TQ 212 (223)
Q Consensus 211 ~~ 212 (223)
+|
T Consensus 499 ~H 500 (507)
T PLN03224 499 SH 500 (507)
T ss_pred CC
Confidence 76
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=169.99 Aligned_cols=173 Identities=17% Similarity=0.306 Sum_probs=133.7
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|||+ ..+||-+.+.- .++-..+..+++|++.|++|||+.||+|||+||+||++..+...|+
T Consensus 98 ~v~e~-m~~nl~~vi~~-----------------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 98 LVMEL-MDANLCQVILM-----------------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred HHHHh-hhhHHHHHHHH-----------------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheee
Confidence 34444 45677777762 3788999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES----- 173 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~----- 173 (223)
.|||+++..... ......+.+..|.|||++.+..+...+||||+||++.||+ .|..-|.+.+...-+.++..
T Consensus 160 ~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli-~~~Vlf~g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 160 LDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELI-LGTVLFPGKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred ccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHh-hceEEecCchHHHHHHHHHHHhcCC
Confidence 999999865444 2345567788899999999999999999999999999999 78877776553322111111
Q ss_pred -----------------Ccc------------------cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 -----------------KKL------------------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 -----------------~~~------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
... ..+.++.....+++++.+||..+|++|.+++++++|
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 000111223557889999999999999999999876
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=171.07 Aligned_cols=174 Identities=17% Similarity=0.254 Sum_probs=140.6
Q ss_pred cCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee
Q psy15108 12 KDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS 91 (223)
Q Consensus 12 ~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~ 91 (223)
+......+|.||.+||+|-=.+++.+ +++++.+..+..+|+-||.|||++||++||+|..|++++
T Consensus 321 qtesrlffvieyv~ggdlmfhmqrqr---------------klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld 385 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMFHMQRQR---------------KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD 385 (593)
T ss_pred cccceEEEEEEEecCcceeeehhhhh---------------cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc
Confidence 34444558899999999988887664 499999999999999999999999999999999999999
Q ss_pred cCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCC-------CCCH
Q psy15108 92 SDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFP-------DLSD 164 (223)
Q Consensus 92 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~-------~~~~ 164 (223)
..|.+|++|+|+++..... .....+..+|+.|.|||.+.+..|..++|.|++|++++||+ -|+.||. ..+.
T Consensus 386 aeghikltdygmcke~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemm-agrspfdivgm~n~d~nt 463 (593)
T KOG0695|consen 386 AEGHIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM-AGRSPFDIVGMDNPDMNT 463 (593)
T ss_pred cCCceeecccchhhcCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHH-cCCCCcceecCCCcccch
Confidence 9999999999998754322 23346688999999999999999999999999999999999 7999994 1222
Q ss_pred HHHHHH-HHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy15108 165 DQVLSQ-LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204 (223)
Q Consensus 165 ~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 204 (223)
...+.+ +.....+ ++...+-....+++..++.||.+|.
T Consensus 464 edylfqvilekqir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 464 EDYLFQVILEKQIR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hHHHHHHHhhhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 223333 3333233 3556666677889999999999984
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-26 Score=186.04 Aligned_cols=181 Identities=16% Similarity=0.269 Sum_probs=144.9
Q ss_pred CCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec
Q psy15108 13 DSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS 92 (223)
Q Consensus 13 ~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~ 92 (223)
..++..+|||-+ +|+..++|-.+.. +.+++.....++.||+.||+|||.++|+|+|+||+||++..
T Consensus 634 T~ervFVVMEKl-~GDMLEMILSsEk-------------gRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas 699 (888)
T KOG4236|consen 634 TPERVFVVMEKL-HGDMLEMILSSEK-------------GRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLAS 699 (888)
T ss_pred CCceEEEEehhh-cchHHHHHHHhhc-------------ccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeecc
Confidence 334455677665 4555555554433 57999999999999999999999999999999999999965
Q ss_pred C---CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy15108 93 D---LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169 (223)
Q Consensus 93 ~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~ 169 (223)
. ..+|++|||+++..+....+ +..+||+.|+|||++..+.|..+-|+||+|+|+|.-+ .|..||... +.+-.
T Consensus 700 ~~~FPQvKlCDFGfARiIgEksFR--rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsL-SGTFPFNEd--EdInd 774 (888)
T KOG4236|consen 700 ASPFPQVKLCDFGFARIIGEKSFR--RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSL-SGTFPFNED--EDIND 774 (888)
T ss_pred CCCCCceeeccccceeecchhhhh--hhhcCCccccCHHHHhhccccccccceeeeEEEEEEe-cccccCCCc--cchhH
Confidence 4 56899999999987766543 5678999999999999999999999999999999888 799999654 34555
Q ss_pred HHHhCcccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 170 QLESKKLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 170 ~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+|....+..+. -..++++..++|..+|+..-.+|-+.+..+.|
T Consensus 775 QIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 775 QIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 66555443332 24678889999999999999999998877644
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-26 Score=193.52 Aligned_cols=177 Identities=22% Similarity=0.384 Sum_probs=134.9
Q ss_pred CCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC-----CCeE
Q psy15108 23 PRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD-----LSVK 97 (223)
Q Consensus 23 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~-----~~~~ 97 (223)
+.+..||+++++..+.+ .........+.++.|+++||++||+.+|+|||+||+|||+... ..++
T Consensus 583 ELC~~sL~dlie~~~~d-----------~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~ 651 (903)
T KOG1027|consen 583 ELCACSLQDLIESSGLD-----------VEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAK 651 (903)
T ss_pred hHhhhhHHHHHhccccc-----------hhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEE
Confidence 34678999999975221 0111224567889999999999999999999999999999863 4579
Q ss_pred EcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 98 ISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 98 l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
|+|||++++..... .....+..|+..|.|||.+.......++||+|+||++|+.++.|..||......+ ..|..+.
T Consensus 652 iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~ 729 (903)
T KOG1027|consen 652 ISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGN 729 (903)
T ss_pred ecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCc
Confidence 99999998765432 4445677889999999999888888899999999999999988899997554332 2334433
Q ss_pred ccCCCCC-CChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSS-KTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....... ....+..++|.+|++++|..||++.+|+.|
T Consensus 730 ~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 730 YTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred cceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 3332211 112278999999999999999999999855
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-26 Score=166.90 Aligned_cols=184 Identities=13% Similarity=0.193 Sum_probs=137.9
Q ss_pred CCCCCCCCCCCCCCCChHHH---HHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCe
Q psy15108 13 DSKDKSGSGKPRVKGDLKQF---LLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNC 88 (223)
Q Consensus 13 ~~~~~~~v~~~~~~g~L~~~---l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~ni 88 (223)
++++.--+..++..-||..+ +..-.. ..++|+-+-.|..-.+.||.||-. ..|+|||+||+||
T Consensus 133 F~EGdcWiCMELMd~SlDklYk~vy~vq~-------------~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNI 199 (361)
T KOG1006|consen 133 FSEGDCWICMELMDISLDKLYKRVYSVQK-------------SRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNI 199 (361)
T ss_pred hcCCceeeeHHHHhhhHHHHHHHHHHHHh-------------ccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhhe
Confidence 56664444444455555444 333322 468999999999999999999975 4899999999999
Q ss_pred eeecCCCeEEcCCCCCcccchhhhhhhhcCCccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-H
Q psy15108 89 LISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-D 165 (223)
Q Consensus 89 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-~ 165 (223)
|++..|.+|++|||++.....+- ....-.|-..|+|||-+.. ..|+.++|+||||++++|++ +|..|+...+. .
T Consensus 200 Lldr~G~vKLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvA-tG~fPyr~w~svf 276 (361)
T KOG1006|consen 200 LLDRHGDVKLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVA-TGNFPYRKWDSVF 276 (361)
T ss_pred EEecCCCEeeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeee-cCCCCcchHHHHH
Confidence 99999999999999986543332 3334456677999998863 34889999999999999999 89999987654 3
Q ss_pred HHHHHHHhCcc-cCCCCC---CChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 166 QVLSQLESKKL-CWKHSS---KTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 166 ~~~~~~~~~~~-~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+.+.++..+.+ ....+. ..+..+..++..|+..|-..||.+.+++.+
T Consensus 277 eql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 277 EQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 44444444422 222222 367889999999999999999999998754
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=180.70 Aligned_cols=161 Identities=16% Similarity=0.180 Sum_probs=130.6
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+||+|.+||++-.+|-+-+. |.|+.+..++.++..|+++.|+.|++||||||.|||||.+|++||
T Consensus 706 FVMdYIPGGDmMSLLIrmgI---------------FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGI---------------FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred EEEeccCCccHHHHHHHhcc---------------CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceee
Confidence 89999999999999987765 999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccch---------h------------------------hhh--------hhhcCCcccccccccccccCCCCc
Q psy15108 99 SLSGLSKDTYQ---------K------------------------EYY--------KYRNAILPLRWLPYEAVFDDEFST 137 (223)
Q Consensus 99 ~df~~~~~~~~---------~------------------------~~~--------~~~~~~~~~~~~~pe~~~~~~~~~ 137 (223)
+|||++.-+.- . +.+ .....+|+..|++||++....++.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 99999742210 0 000 011347888999999999999999
Q ss_pred ccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--CcccCCCCCCChHHHHHHHHHh
Q psy15108 138 KSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES--KKLCWKHSSKTPEYITSLHEKC 195 (223)
Q Consensus 138 ~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~ 195 (223)
..|.|+.|||+|||+ .|+.||....+.+.-..+.. ..+-.+...+++.++.++|.++
T Consensus 851 ~cdwws~gvil~em~-~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL 909 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEML-VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL 909 (1034)
T ss_pred cchhhHhhHHHHHHh-hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH
Confidence 999999999999999 89999987766554433322 2233344567889998888763
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=154.71 Aligned_cols=178 Identities=21% Similarity=0.302 Sum_probs=140.3
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|+||| ..+|..+..+.+ +.++.+.+..++.|+++|+.++|+++++|||+||+|.++..+|..|+
T Consensus 78 lvfe~c-dqdlkkyfdsln--------------g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkl 142 (292)
T KOG0662|consen 78 LVFEFC-DQDLKKYFDSLN--------------GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKL 142 (292)
T ss_pred EeHHHh-hHHHHHHHHhcC--------------CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEe
Confidence 667766 467888776544 36999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES---- 173 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~---- 173 (223)
.|||+++.++..- .-+...+.+.+|.+|.++++.+ |+.+.|+||.|||+.|+..-|..-|++.+....+..+..
T Consensus 143 adfglarafgipv-rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~ 221 (292)
T KOG0662|consen 143 ADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_pred cccchhhhcCCce-EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCC
Confidence 9999998765432 2234557789999999998876 789999999999999999777877888876655544422
Q ss_pred -CcccCCCC----------------------CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 -KKLCWKHS----------------------SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 -~~~~~~~~----------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....|+-. ++....-++++++++.-+|.+|.++++.+++
T Consensus 222 p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 222 PTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11122211 1122334689999999999999999998875
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=152.18 Aligned_cols=122 Identities=23% Similarity=0.247 Sum_probs=101.2
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCccccccccc
Q psy15108 50 RVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYE 128 (223)
Q Consensus 50 ~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe 128 (223)
.+..++|..+-+++..+++|+.|||++ .++|||+||+|||++..|++|+||||.+....++- ......|-..|+|||
T Consensus 141 ~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--Akt~daGCkpYmaPE 218 (282)
T KOG0984|consen 141 KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--AKTMDAGCKPYMAPE 218 (282)
T ss_pred cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh--HHHHhcCCCccCChh
Confidence 346799999999999999999999986 89999999999999999999999999987654443 222234556699999
Q ss_pred ccc----cCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhC
Q psy15108 129 AVF----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDL-SDDQVLSQLESK 174 (223)
Q Consensus 129 ~~~----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~-~~~~~~~~~~~~ 174 (223)
.+. +..|+.++||||||+++.||+ .++.||... .+.+.+.++...
T Consensus 219 ri~~e~n~~gY~vksDvWSLGItmiElA-~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 219 RINPELNQKGYSVKSDVWSLGITMIEMA-ILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hcCcccCcccceeehhhhhhhhhhhhhh-hccccccccCCHHHHHHHHhcC
Confidence 875 346899999999999999999 799998644 567777777665
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=156.18 Aligned_cols=179 Identities=18% Similarity=0.196 Sum_probs=129.2
Q ss_pred CCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec
Q psy15108 13 DSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS 92 (223)
Q Consensus 13 ~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~ 92 (223)
..+-+-+++||++.|+|.+-+..+ .+.+....+++.|+++|+.|||+.+++|||||.+|||+-.
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~~----------------GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~ 156 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEAA----------------GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD 156 (378)
T ss_pred cCceEEEeeccCccchhhhhcCcc----------------cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec
Confidence 455567899999999999998653 5789999999999999999999999999999999999743
Q ss_pred C--CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCC--
Q psy15108 93 D--LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-----EFSTKSDVYAYACLIWEIFNKGEMPFPDLS-- 163 (223)
Q Consensus 93 ~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----~~~~~~Di~slG~il~~l~~~~~~p~~~~~-- 163 (223)
. .++|++|||++...+..-.. ......|.+||..... .....+|+|.||++++.++ +|..||....
T Consensus 157 ~df~rvKlcDFG~t~k~g~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl-tG~~PWQka~~~ 231 (378)
T KOG1345|consen 157 ADFYRVKLCDFGLTRKVGTTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL-TGKFPWQKASIM 231 (378)
T ss_pred CCccEEEeeecccccccCceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeee-cCCCcchhhhcc
Confidence 3 57999999998765443211 1223346677765432 2467899999999999999 8999997332
Q ss_pred ---HHHHHHHHHhCccc-CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 164 ---DDQVLSQLESKKLC-WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 164 ---~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.-+........... +.....+++.+.+++++-+..++++|=...+..+.
T Consensus 232 d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 232 DKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred CchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 11222222221111 11234567778889999999999999444444433
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-24 Score=170.91 Aligned_cols=191 Identities=18% Similarity=0.240 Sum_probs=145.6
Q ss_pred HHHHHhhcCCCCCC--CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCC
Q psy15108 5 QFLLATRKDSKDKS--GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKD 82 (223)
Q Consensus 5 ~~~~~~~~~~~~~~--~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 82 (223)
+.++..+.|....+ +|+|.+ .-+|.++|++-+. +-.|....+..++.|+.-||..|-..|++|.|
T Consensus 495 Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~------------nvGL~ikaVRsYaqQLflALklLK~c~vlHaD 561 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR------------NVGLHIKAVRSYAQQLFLALKLLKKCGVLHAD 561 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc------------ccceeehHHHHHHHHHHHHHHHHHhcCeeecc
Confidence 34555555555544 555543 5789999998776 34689999999999999999999999999999
Q ss_pred CCCCCeeeecC-CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q psy15108 83 IAARNCLISSD-LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPD 161 (223)
Q Consensus 83 i~~~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~ 161 (223)
|||.|||+... ..+||||||-|-....++..+ ......|.|||.+.+.+|+..-|+||+||++||+. +|+.-|++
T Consensus 562 IKPDNiLVNE~k~iLKLCDfGSA~~~~eneitP---YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElY-tGkIlFpG 637 (752)
T KOG0670|consen 562 IKPDNILVNESKNILKLCDFGSASFASENEITP---YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELY-TGKILFPG 637 (752)
T ss_pred cCccceEeccCcceeeeccCccccccccccccH---HHHHHhccCcceeecCcccCCccceeeceeeEEee-ccceecCC
Confidence 99999999876 457999999886655554222 23345699999999999999999999999999999 89999988
Q ss_pred CCHHHHHHHHHhCcccCC-------------------------------------------------------CC---CC
Q psy15108 162 LSDDQVLSQLESKKLCWK-------------------------------------------------------HS---SK 183 (223)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~-------------------------------------------------------~~---~~ 183 (223)
..+..++...+.-....+ .+ ..
T Consensus 638 ~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~ 717 (752)
T KOG0670|consen 638 RTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPK 717 (752)
T ss_pred CCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHH
Confidence 877666554332000000 00 01
Q ss_pred ChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 184 TPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 184 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.-..+.+|+.+|+..||++|.+..+.+.|
T Consensus 718 ~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 718 IVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 12457889999999999999999999876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=150.71 Aligned_cols=148 Identities=24% Similarity=0.362 Sum_probs=125.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-CCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS-DLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~-~~~ 95 (223)
..++++++.+++|.+++.... ..++...+..++.++++++.+||+.+++|+|++|.||+++. .+.
T Consensus 66 ~~~~~e~~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~ 131 (215)
T cd00180 66 LYLVMEYCEGGSLKDLLKENE--------------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK 131 (215)
T ss_pred EEEEEecCCCCcHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc
Confidence 447889999999999998642 24899999999999999999999999999999999999999 889
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++||+.+........ ..........|.+||..... ..+.++|+|++|++++++
T Consensus 132 ~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------- 187 (215)
T cd00180 132 VKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------- 187 (215)
T ss_pred EEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------
Confidence 99999998875433211 12234456778999998776 778899999999999998
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
..+.+++..|+..+|.+||+++++++++
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5689999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=164.41 Aligned_cols=177 Identities=20% Similarity=0.243 Sum_probs=146.2
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
..||||.+|+|++.-+.++. +++.++..+.++.++|++|||++|-+|||||..||+++..+.+++
T Consensus 89 icMEycgggslQdiy~~Tgp---------------lselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvkl 153 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGP---------------LSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKL 153 (829)
T ss_pred EEEEecCCCcccceeeeccc---------------chhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceee
Confidence 67999999999999987654 999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
.|||.+...+.. ........|++.|++||+.. ...|....|+|++|+...|+. .-+.|.....+...........
T Consensus 154 aDfgvsaqitat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~-eLqpplfdlhpmr~l~LmTkS~ 231 (829)
T KOG0576|consen 154 ADFGVSAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELG-ELQPPLFDLHPMRALFLMTKSG 231 (829)
T ss_pred cccCchhhhhhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhh-hcCCcccccchHHHHHHhhccC
Confidence 999988654432 22345689999999999853 445888999999999988987 6777777776666665554443
Q ss_pred ccCC---CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWK---HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+.++ .....++.+-+|++.++..+|++||+++-++.|
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 4333 234567889999999999999999999887653
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-22 Score=170.26 Aligned_cols=179 Identities=16% Similarity=0.123 Sum_probs=140.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
+..+||||++ +|..++.... .++..++..++.|++.|+.|+|+.|+.|||+|++|+++..++.+
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~---------------~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~l 459 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNG---------------KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGIL 459 (601)
T ss_pred chhhhhcccH-HHHHHHhccc---------------ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCce
Confidence 3345999999 9999998653 38999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh---hhhhhcCCcccccccccccccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHH
Q psy15108 97 KISLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFDDEFST-KSDVYAYACLIWEIFNKGEMPFPDLSDDQVL-SQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Di~slG~il~~l~~~~~~p~~~~~~~~~~-~~~ 171 (223)
|++|||.+..+.... ........+...|+|||++.+.+|+. ..||||.|+++..|. .++.||.-....... ...
T Consensus 460 ki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~-~~~~~Wk~a~~~~~~~~~~ 538 (601)
T KOG0590|consen 460 KIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMI-LGRFPWKVAKKSDNSFKTN 538 (601)
T ss_pred EEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEe-cCCCccccccccccchhhh
Confidence 999999886543221 23445677888899999999999864 599999999999998 789999755433221 110
Q ss_pred Hh------CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ES------KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. ..........++...+.+|..||+.+|.+|.++++|++.
T Consensus 539 ~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 539 NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00 001111224567788899999999999999999999853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=140.29 Aligned_cols=144 Identities=18% Similarity=0.169 Sum_probs=115.5
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
...++++++.+++|.+++..... .+++..+..++.+++.++.+||+.+++|+|+++.||+++.++.
T Consensus 71 ~~~~v~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~ 136 (225)
T smart00221 71 PLYLVMEYCEGGDLFDYLRKKGG--------------KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL 136 (225)
T ss_pred ceEEEEeccCCCCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 35578999999999999986432 1789999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCccccccccccc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHH-HHHHHHH
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAV-FDDEFSTKSDVYAYACLIWEIFNKGEMPFPD-LSDD-QVLSQLE 172 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slG~il~~l~~~~~~p~~~-~~~~-~~~~~~~ 172 (223)
++++|||.+...............+...|++||.. ....++.++|+|++|+++++++ +|+.||.. .+.. ...+.+.
T Consensus 137 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~-~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 137 VKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELL-WGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred EEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHH-HCCCCccccchhHHHHHHHHh
Confidence 99999998876543321111234456679999998 5566778999999999999999 69999987 4544 5555555
Q ss_pred hC
Q psy15108 173 SK 174 (223)
Q Consensus 173 ~~ 174 (223)
.+
T Consensus 216 ~~ 217 (225)
T smart00221 216 FG 217 (225)
T ss_pred cC
Confidence 54
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=157.29 Aligned_cols=126 Identities=20% Similarity=0.284 Sum_probs=107.7
Q ss_pred CCCCCCCC-CCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPR-VKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
+-+++|-. ++-+|.++|.-.. .++|..+..|+.|++-|+++||++||+|||||-+|++++.+|.
T Consensus 644 yyl~te~hg~gIDLFd~IE~kp---------------~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFIEFKP---------------RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF 708 (772)
T ss_pred eEEEecCCCCCcchhhhhhccC---------------ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe
Confidence 44556655 6678999998654 4999999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCC
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPD 161 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~ 161 (223)
+|++|||-+....+.. +-...||..|.|||++.+.+| ....|||++|+++|.+. +..-||.+
T Consensus 709 ~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytiv-ykenpyyn 771 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIV-YKENPYYN 771 (772)
T ss_pred EEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEE-eccCCCcC
Confidence 9999999886554443 445678999999999998887 45699999999999998 77778764
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=152.88 Aligned_cols=202 Identities=18% Similarity=0.265 Sum_probs=150.0
Q ss_pred chHHHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCc-cc
Q psy15108 2 DLKQFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRL-IH 80 (223)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i-~H 80 (223)
|+..|+..+.+. +...+|.+||..|+|+|.+..... .+++.....+++.|+.|+.|+|+..+ .|
T Consensus 8 n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~~~--------------~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h 72 (484)
T KOG1023|consen 8 NLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNEDI--------------KLDYFFILSFIRDISKGLAYLHNSPIGYH 72 (484)
T ss_pred hhhhheeeEecC-CceEEEEeeecCccHHhHHhcccc--------------CccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence 345555555555 445578899999999999987443 68899999999999999999999866 89
Q ss_pred CCCCCCCeeeecCCCeEEcCCCCCcccchh-hhhhhhcCCcccccccccccccCC-------CCcccchHHHHHHHHHHH
Q psy15108 81 KDIAARNCLISSDLSVKISLSGLSKDTYQK-EYYKYRNAILPLRWLPYEAVFDDE-------FSTKSDVYAYACLIWEIF 152 (223)
Q Consensus 81 ~di~~~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~-------~~~~~Di~slG~il~~l~ 152 (223)
+.+++.|++++..+.+|++|||+....... .............|.+||.+.... .+.+.|+||||++++|++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 999999999999999999999987654321 111111112235588999986532 356799999999999999
Q ss_pred hCCCCCCCCC----CHHHHHHHHHhCcccCCCC-----CCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 153 NKGEMPFPDL----SDDQVLSQLESKKLCWKHS-----SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 153 ~~~~~p~~~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.+..||... +..++...+.........| ...++++..++..||..+|.+||+++++...+..+...
T Consensus 153 -~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 153 -FRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred -hccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 789899753 2345555555522221111 13455788999999999999999999999888776653
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-19 Score=144.28 Aligned_cols=191 Identities=17% Similarity=0.198 Sum_probs=147.0
Q ss_pred CCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC-
Q psy15108 15 KDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD- 93 (223)
Q Consensus 15 ~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~- 93 (223)
+++..++....|.||.++.+.... +.|+...++.++.|++.+|+++|+.|++||||||.|+++...
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~-------------~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~ 159 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPP-------------GRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSS 159 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCC-------------CCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCC
Confidence 334555567889999998876542 579999999999999999999999999999999999999765
Q ss_pred ----CCeEEcCCCCCc--ccchhh---hhh----hhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q psy15108 94 ----LSVKISLSGLSK--DTYQKE---YYK----YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFP 160 (223)
Q Consensus 94 ----~~~~l~df~~~~--~~~~~~---~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~ 160 (223)
..+.+.|||+++ ...... ... .....+|..|.++.+..+.+.+.+.|+||++.++.++. .|..||.
T Consensus 160 ~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~-~g~LPW~ 238 (322)
T KOG1164|consen 160 RSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELL-KGSLPWE 238 (322)
T ss_pred CcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHh-cCCCCCc
Confidence 358999999998 322111 011 12345889999999999999999999999999999998 8889998
Q ss_pred CCCHHHHHHHHHhCcccCC---CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 161 DLSDDQVLSQLESKKLCWK---HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..........+........ .....+.++.++...+-..+...+|.+..+...+...+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 239 ALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred cccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 7764333333322211111 2234567788888888889999999999999998887654
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=145.97 Aligned_cols=180 Identities=17% Similarity=0.218 Sum_probs=131.2
Q ss_pred CCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC
Q psy15108 14 SKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD 93 (223)
Q Consensus 14 ~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~ 93 (223)
.+....|++|+++.+..++.. .++..++..+++.++.||.++|.+||+||||||.|++.+..
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~------------------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~ 168 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR------------------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRR 168 (418)
T ss_pred CCeeEEEecccCccCHHHHHh------------------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccc
Confidence 334568999999999999996 48899999999999999999999999999999999999865
Q ss_pred -CCeEEcCCCCCcccc-hh---------------------------------hh---------hhhhcCCcccccccccc
Q psy15108 94 -LSVKISLSGLSKDTY-QK---------------------------------EY---------YKYRNAILPLRWLPYEA 129 (223)
Q Consensus 94 -~~~~l~df~~~~~~~-~~---------------------------------~~---------~~~~~~~~~~~~~~pe~ 129 (223)
+.-.|+|||++.... .. .+ .......||+.|.|||+
T Consensus 169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv 248 (418)
T KOG1167|consen 169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV 248 (418)
T ss_pred cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence 557899999986210 00 00 00113467888999999
Q ss_pred cccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHH------------HHHh--Cc------------------
Q psy15108 130 VFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQVLS------------QLES--KK------------------ 175 (223)
Q Consensus 130 ~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~-~~~~~------------~~~~--~~------------------ 175 (223)
+...+ .+.+.|+||.|+|+..++ ++..||..... ...+. +... +.
T Consensus 249 L~k~~~QttaiDiws~GVI~Lsll-s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~ 327 (418)
T KOG1167|consen 249 LFRCPRQTTAIDIWSAGVILLSLL-SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVN 327 (418)
T ss_pred HhhccCcCCccceeeccceeehhh-ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhc
Confidence 87655 578899999999999999 78888732211 10000 0000 00
Q ss_pred -ccC---------------CC-CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 -LCW---------------KH-SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 -~~~---------------~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
... .. ....+..+.+++.+|++.||.+|.++++.++|
T Consensus 328 f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 328 FETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000 00 01224478899999999999999999999876
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=135.56 Aligned_cols=190 Identities=22% Similarity=0.309 Sum_probs=146.9
Q ss_pred HHHHHhhcCCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-C-cccCC
Q psy15108 5 QFLLATRKDSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-R-LIHKD 82 (223)
Q Consensus 5 ~~~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~-i~H~d 82 (223)
-++.+|-+. +..-.+.-|++.|+|+..++.... -.++..++.+++..+++|+.|||+. . +.--.
T Consensus 251 pvlgacnsp-pnlv~isq~mp~gslynvlhe~t~-------------vvvd~sqav~faldiargmaflhslep~ipr~~ 316 (448)
T KOG0195|consen 251 PVLGACNSP-PNLVIISQYMPFGSLYNVLHEQTS-------------VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFY 316 (448)
T ss_pred hhhhhccCC-CCceEeeeeccchHHHHHHhcCcc-------------EEEecchHHHHHHHHHhhHHHHhhcchhhhhhh
Confidence 344444333 223356789999999999986433 3568889999999999999999985 2 33456
Q ss_pred CCCCCeeeecCCCeEE--cCCCCCcccchhhhhhhhcCCcccccccccccccCCC---CcccchHHHHHHHHHHHhCCCC
Q psy15108 83 IAARNCLISSDLSVKI--SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEF---STKSDVYAYACLIWEIFNKGEM 157 (223)
Q Consensus 83 i~~~nil~~~~~~~~l--~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~---~~~~Di~slG~il~~l~~~~~~ 157 (223)
+.+..++++.+...++ .|--++- ......-.+.|++||.+...+- -.++|.|||.+++||+- ++..
T Consensus 317 lns~hvmidedltarismad~kfsf--------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~-trev 387 (448)
T KOG0195|consen 317 LNSKHVMIDEDLTARISMADTKFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELN-TREV 387 (448)
T ss_pred cccceEEecchhhhheecccceeee--------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhh-cccc
Confidence 7888999998865544 3322221 1122344567999999987663 35799999999999998 8999
Q ss_pred CCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 158 PFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
||.+..+.+.--++.-...+..+++..+..+.++|.-|++.||.+||.|+.++..|+++.
T Consensus 388 pfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 388 PFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 999999888777777776888899999999999999999999999999999999988764
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-20 Score=146.08 Aligned_cols=75 Identities=20% Similarity=0.268 Sum_probs=59.6
Q ss_pred hHHHHHHhhc-CCCCCC--CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-Cc
Q psy15108 3 LKQFLLATRK-DSKDKS--GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RL 78 (223)
Q Consensus 3 ~~~~~~~~~~-~~~~~~--~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i 78 (223)
++++++.+.. ..++.+ +|+| +-|.+|..+|+.... +.++...+.+|++|++.||.|||.. ||
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfE-vLGdnLLklI~~s~Y-------------rGlpl~~VK~I~~qvL~GLdYLH~ecgI 209 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFE-VLGDNLLKLIKYSNY-------------RGLPLSCVKEICRQVLTGLDYLHRECGI 209 (590)
T ss_pred eeeeeccceecCCCCcEEEEEeh-hhhhHHHHHHHHhCC-------------CCCcHHHHHHHHHHHHHHHHHHHHhcCc
Confidence 3445554444 444444 4444 457889999998877 7899999999999999999999976 99
Q ss_pred ccCCCCCCCeeee
Q psy15108 79 IHKDIAARNCLIS 91 (223)
Q Consensus 79 ~H~di~~~nil~~ 91 (223)
+|-||||.|||+.
T Consensus 210 IHTDlKPENvLl~ 222 (590)
T KOG1290|consen 210 IHTDLKPENVLLC 222 (590)
T ss_pred cccCCCcceeeee
Confidence 9999999999984
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.8e-18 Score=128.07 Aligned_cols=184 Identities=16% Similarity=0.220 Sum_probs=149.7
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC----
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL---- 94 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~---- 94 (223)
+|++ +-|-||+|+..-.+. .|+...+..++.|++.-++++|++.++.|||||+|+||...+
T Consensus 101 LVid-LLGPSLEDLFD~CgR--------------~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~ 165 (449)
T KOG1165|consen 101 LVID-LLGPSLEDLFDLCGR--------------RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDA 165 (449)
T ss_pred hhhh-hhCcCHHHHHHHhcC--------------cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCC
Confidence 3443 456788888876654 799999999999999999999999999999999999997553
Q ss_pred -CeEEcCCCCCcccchhh------hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---H
Q psy15108 95 -SVKISLSGLSKDTYQKE------YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS---D 164 (223)
Q Consensus 95 -~~~l~df~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~---~ 164 (223)
.+.++|||+++...+.. ++......||..||+-....+++.+...|+-++|.++.+.+ .|.+||.+.. .
T Consensus 166 n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL-RGsLPWQGLKA~tn 244 (449)
T KOG1165|consen 166 NVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL-RGSLPWQGLKADTN 244 (449)
T ss_pred ceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc-cCCCccccccCcch
Confidence 47899999998765432 44455678899999999999999999999999999999888 8999998764 4
Q ss_pred HHHHHHHHhCcccCC---CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 165 DQVLSQLESKKLCWK---HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 165 ~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.+.++.|...+...+ ...++|.++...+.-.-..+-.+-|+++-+...+.+++.
T Consensus 245 K~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 245 KEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 455666655433322 246789999999998889999999999999888888774
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-19 Score=142.97 Aligned_cols=171 Identities=23% Similarity=0.271 Sum_probs=130.7
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
..|..|...+|.++|..+.. ....+....+.++.|++.|+.| ++.+|+|++|.||++..+..+++
T Consensus 333 I~Mn~c~~~tledWl~rr~~------------~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 333 IQMNLCEKETLEDWLRRRRT------------GEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred hhhhhhhhhhHHHHhhCCCc------------ccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence 56788999999999975443 2456788899999999999999 99999999999999999989999
Q ss_pred cCCCCCcccchhh-----hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 99 SLSGLSKDTYQKE-----YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 99 ~df~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
.|||+........ ........++..|++||.+.+..|+.++|||+||++++|++..-...+ ........+..
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~ 474 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRD 474 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhc
Confidence 9999876543322 233456688999999999999999999999999999999984122222 22344444555
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPS 208 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 208 (223)
+.+++..-.+.|.+ +.|+.+++...|.+||++.+
T Consensus 475 g~ip~~~~~d~p~e-~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 475 GIIPPEFLQDYPEE-YTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred CCCChHHhhcCcHH-HHHHHHhcCCCcccCchHHH
Confidence 43332233344444 67999999999999995543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-19 Score=138.95 Aligned_cols=162 Identities=18% Similarity=0.272 Sum_probs=106.0
Q ss_pred CCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCC
Q psy15108 23 PRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSG 102 (223)
Q Consensus 23 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~ 102 (223)
+-..+||.+++..-..... ....+.....+.+..|+++.+++||+.|++|+||+|+|++++.+|.+.++||+
T Consensus 119 P~~~~dL~~~~~~l~~~~~--------~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~ 190 (288)
T PF14531_consen 119 PRAQGDLQDLVEALFSRAQ--------THSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFS 190 (288)
T ss_dssp E--SEEHHHHHHHHHHHTT--------TSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GG
T ss_pred chhhhcHHHHHHHHhhccc--------ccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChH
Confidence 3456788888653221000 11234555667777999999999999999999999999999999999999998
Q ss_pred CCcccchhhhhhhhcCCccccccccccccc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 103 LSKDTYQKEYYKYRNAILPLRWLPYEAVFD--------DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.....+..... ...+..|.|||.... ..++.+.|.|++|+++|.++ ++..||..........
T Consensus 191 ~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW-C~~lPf~~~~~~~~~~----- 260 (288)
T PF14531_consen 191 SLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW-CGRLPFGLSSPEADPE----- 260 (288)
T ss_dssp GEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH-HSS-STCCCGGGSTSG-----
T ss_pred HHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH-HccCCCCCCCcccccc-----
Confidence 76554432211 233456788887533 24678899999999999999 8999998664432221
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCC
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQR 203 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R 203 (223)
..+..+...|+.++.+|..+|+.+|.+|
T Consensus 261 -~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 261 -WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred -ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 1344455889999999999999999887
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-18 Score=148.74 Aligned_cols=175 Identities=19% Similarity=0.154 Sum_probs=125.3
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
..+..+...+|+|.|..+.. +...+.+-|+.|++.|+..+|+.|++|||||.+|||++.-+++.+
T Consensus 97 ylvRqyvkhnLyDRlSTRPF---------------L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~L 161 (1431)
T KOG1240|consen 97 YLVRQYVKHNLYDRLSTRPF---------------LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYL 161 (1431)
T ss_pred HHHHHHHhhhhhhhhccchH---------------HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhh
Confidence 34555677899999987655 788889999999999999999999999999999999999999999
Q ss_pred cCCCCCcccch--hhhhh----hhcCCcccccccccccccC----------C-CCcccchHHHHHHHHHHHhCCCCCCCC
Q psy15108 99 SLSGLSKDTYQ--KEYYK----YRNAILPLRWLPYEAVFDD----------E-FSTKSDVYAYACLIWEIFNKGEMPFPD 161 (223)
Q Consensus 99 ~df~~~~~~~~--~~~~~----~~~~~~~~~~~~pe~~~~~----------~-~~~~~Di~slG~il~~l~~~~~~p~~~ 161 (223)
+||.-.+...- ...-. +-+.....+|+|||-+... . .+.+.||||+||+++|+++.|+.+|.-
T Consensus 162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 99986543211 11111 1123334679999976431 1 467899999999999999788888841
Q ss_pred CCHHHHHHHHHhC-ccc--CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 162 LSDDQVLSQLESK-KLC--WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 162 ~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. +.... +.+ ... .....-.+..++.++..|++.||.+|.++++.++.
T Consensus 242 S---QL~aY-r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 242 S---QLLAY-RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred H---HHHhH-hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1 11100 000 000 00001112358899999999999999999999876
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=120.75 Aligned_cols=183 Identities=16% Similarity=0.193 Sum_probs=141.6
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC---CC
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD---LS 95 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~---~~ 95 (223)
+|| ..-|-||.++..-... .|+...++-++.|++.-++|+|.++++||||||+|+++.-. ..
T Consensus 88 lVM-dLLGPsLEdLfnfC~R--------------~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~k 152 (341)
T KOG1163|consen 88 LVM-DLLGPSLEDLFNFCSR--------------RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNK 152 (341)
T ss_pred eee-eccCccHHHHHHHHhh--------------hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccce
Confidence 444 4567788888874433 59999999999999999999999999999999999998654 45
Q ss_pred eEEcCCCCCcccchhh------hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---H
Q psy15108 96 VKISLSGLSKDTYQKE------YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD---Q 166 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~---~ 166 (223)
+-++|||+++...+.. ++......+|..|.+-.+..+.+.+...|.-|+|.++.+.. .|.+||.+.... +
T Consensus 153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfn-rG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFN-RGSLPWQGLKAATKKQ 231 (341)
T ss_pred EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeee-cCCCcccccchhhHHH
Confidence 7899999998765432 33445567888898887777777888999999999888777 899999887543 3
Q ss_pred HHHHHHhCccc---CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 167 VLSQLESKKLC---WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 167 ~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
..+.|...+.. ...+...|.++...+.-|-...-++-|+..-+.+.+.-++
T Consensus 232 KyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 232 KYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 34444333222 2335788999999999999999999999877666554443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8e-17 Score=127.13 Aligned_cols=182 Identities=21% Similarity=0.232 Sum_probs=141.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC-Ce
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-SV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-~~ 96 (223)
.++++++.++++.+++...... ..++......++.|++.++.++|+.+++|||+||.||+++..+ .+
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~ 141 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK------------GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVV 141 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeE
Confidence 5789999999999888764320 2589999999999999999999999999999999999999988 69
Q ss_pred EEcCCCCCcccchhhhh-----hhhcCCccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----
Q psy15108 97 KISLSGLSKDTYQKEYY-----KYRNAILPLRWLPYEAVFD---DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD---- 164 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~---- 164 (223)
+++|||.+......... ......++..|.+||.... .......|+|++|+++++++ .+..||.....
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~-~~~~p~~~~~~~~~~ 220 (384)
T COG0515 142 KLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL-TGLPPFEGEKNSSAT 220 (384)
T ss_pred EEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCCccccH
Confidence 99999998744332211 2356678899999999887 46788999999999999988 78888876653
Q ss_pred HHHHHHHHhCccc-CC--CCCCC----hHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 165 DQVLSQLESKKLC-WK--HSSKT----PEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 165 ~~~~~~~~~~~~~-~~--~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
......+...... .. ..... ...+.+++..++..+|..|.+..+....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 221 SQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 4444444443222 11 11111 2568899999999999999998877654
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.2e-17 Score=126.98 Aligned_cols=172 Identities=16% Similarity=0.136 Sum_probs=121.8
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee--cC--C
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS--SD--L 94 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~--~~--~ 94 (223)
+||..+ ..+|.+++-.+ ..+.....-++.|+++|+.|||++|+.|||+|++||++. .+ .
T Consensus 320 lvMkrY-~~tLr~yl~~~----------------~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P 382 (598)
T KOG4158|consen 320 LVMKRY-RQTLREYLWTR----------------HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIP 382 (598)
T ss_pred Eehhcc-hhhHHHHHhcC----------------CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCc
Confidence 445443 56899999754 357777888899999999999999999999999999974 33 3
Q ss_pred CeEEcCCCCCcccchhhhh-----hhhcCCcccccccccccccCC------CCcccchHHHHHHHHHHHhCCCCCCCCCC
Q psy15108 95 SVKISLSGLSKDTYQKEYY-----KYRNAILPLRWLPYEAVFDDE------FSTKSDVYAYACLIWEIFNKGEMPFPDLS 163 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~------~~~~~Di~slG~il~~l~~~~~~p~~~~~ 163 (223)
.+.+.|||++..-...... ..-..-+.-..++||+....+ ...++|.|+.|-+-||++ +..-||....
T Consensus 383 ~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIf-g~~NPFY~rG 461 (598)
T KOG4158|consen 383 QLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIF-GRSNPFYKRG 461 (598)
T ss_pred EEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHh-ccCCcccccc
Confidence 4689999987543221110 011234455678999875432 235899999999999999 7888998743
Q ss_pred HHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHH
Q psy15108 164 DDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPS 208 (223)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 208 (223)
....-...-+....+..+..+++.+.+++...++.||.+|++.+-
T Consensus 462 em~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 462 EMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred hheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 322111111111234456788999999999999999999998643
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-18 Score=138.27 Aligned_cols=165 Identities=17% Similarity=0.200 Sum_probs=137.7
Q ss_pred CCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec
Q psy15108 13 DSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS 92 (223)
Q Consensus 13 ~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~ 92 (223)
+..+..+++++..+|+|...+.+.. .+++.....+..+++-++.++|+.+++|+|+|+.||+++.
T Consensus 68 t~~kl~l~ld~~rgg~lft~l~~~~---------------~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~ 132 (612)
T KOG0603|consen 68 TDGKLYLILDFLRGGDLFTRLSKEV---------------MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL 132 (612)
T ss_pred cccchhHhhhhcccchhhhccccCC---------------chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc
Confidence 4444568889999999999887654 4899999999999999999999999999999999999999
Q ss_pred CCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 93 DLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 93 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
.|.+++.|||+++.....+ ...++..|++||++. .....+|.|++|++.++++ +|..||.. ++...|.
T Consensus 133 ~Ghi~~tdfglske~v~~~-----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~fell-tg~~pf~~----~~~~~Il 200 (612)
T KOG0603|consen 133 EGHIKLTDFGLSKEAVKEK-----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELL-TGTLPFGG----DTMKRIL 200 (612)
T ss_pred cCccccCCchhhhHhHhhh-----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHh-hCCCCCch----HHHHHHh
Confidence 9999999999987543332 227789999999987 5677899999999999999 89999987 4555554
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCH
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 206 (223)
.. .+..+...+..+.+++..++..+|.+|...
T Consensus 201 ~~--~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 201 KA--ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hh--ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 43 244466778889999999999999999654
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.5e-17 Score=139.16 Aligned_cols=137 Identities=20% Similarity=0.366 Sum_probs=117.5
Q ss_pred HHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchh--------------hhhhhhcCCccccccccccccc
Q psy15108 67 ALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQK--------------EYYKYRNAILPLRWLPYEAVFD 132 (223)
Q Consensus 67 ~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~--------------~~~~~~~~~~~~~~~~pe~~~~ 132 (223)
+-+++|||+.||+|||+||.|.+++.-|.+|++|||+++..... .........+++.|.+||++..
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr 232 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR 232 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence 67899999999999999999999999999999999998753211 0111234578999999999999
Q ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCC-CCCChHHHHHHHHHhcCCCCCCCC
Q psy15108 133 DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKH-SSKTPEYITSLHEKCIHPHPHQRP 204 (223)
Q Consensus 133 ~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rp 204 (223)
+.|...+|.|++|+|+|+.+ .|..||.+..+++.+.++......|+. ....+.+..+++..+|+.+|..|-
T Consensus 233 qgygkpvdwwamGiIlyeFL-VgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 233 QGYGKPVDWWAMGIILYEFL-VGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hccCCCccHHHHHHHHHHHh-eeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 99999999999999999999 899999999999999988776666654 346788999999999999999984
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=132.86 Aligned_cols=179 Identities=14% Similarity=0.182 Sum_probs=137.2
Q ss_pred CCCCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec
Q psy15108 13 DSKDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS 92 (223)
Q Consensus 13 ~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~ 92 (223)
+.+...+|++|.+-|||.+++..++ .+++.-++.+..|++..++.||..+|+|+||||+|+++..
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~~---------------~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~ 829 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTNK---------------VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRR 829 (974)
T ss_pred cCCcceeeeeccccccHHHhhccCC---------------CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeec
Confidence 6667779999999999999998554 4899999999999999999999999999999999999853
Q ss_pred -------CCCeEEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Q psy15108 93 -------DLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD 164 (223)
Q Consensus 93 -------~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~ 164 (223)
...++|+|||-+....-.. ...+.....+-.+.++|...++++++..|.|.+.-+++.|+ .|+.
T Consensus 830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mL-FG~y------- 901 (974)
T KOG1166|consen 830 EICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVML-FGKY------- 901 (974)
T ss_pred ccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHH-HHHH-------
Confidence 2458999999887543221 23455566677788999999999999999999999999998 4442
Q ss_pred HHHHHHHHhCcccCCCCCCChH-----HHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 165 DQVLSQLESKKLCWKHSSKTPE-----YITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
++ ...+ ..|....+++. -..+++..+|+.|...=|.+.++...+++.+.+
T Consensus 902 ---~q-~~~g-~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 902 ---ME-VKNG-SSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred ---HH-hcCC-cceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 11 1222 33433333332 244688888887777778888888888877643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.6e-14 Score=106.24 Aligned_cols=73 Identities=23% Similarity=0.109 Sum_probs=63.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCcccCCCCCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHI-SDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~i~H~di~~~nil~~~~~~~ 96 (223)
.+||||+.++++...+... .++++..+..++.|++.+|.++ |+.|++||||||.||+++ ++.+
T Consensus 93 ~iVmE~i~g~~l~~~~~~~---------------~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKD---------------APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred EEEEEEeCCCCCcchhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 4899999998887654332 3589999999999999999999 799999999999999998 4789
Q ss_pred EEcCCCCCcc
Q psy15108 97 KISLSGLSKD 106 (223)
Q Consensus 97 ~l~df~~~~~ 106 (223)
+++|||++..
T Consensus 157 ~LiDFG~a~~ 166 (190)
T cd05147 157 YIIDVSQSVE 166 (190)
T ss_pred EEEEcccccc
Confidence 9999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-14 Score=108.50 Aligned_cols=98 Identities=10% Similarity=0.080 Sum_probs=73.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||++|.+|.++.. ++++ ...+++.++..+|+.|++|+|++|.||+++.++ +
T Consensus 118 ~~lvmEyi~G~tL~~~~~-------------------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 118 YIMLIEYIEGVELNDMPE-------------------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred eEEEEEEECCccHHHhhh-------------------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence 347999999999988742 4443 356999999999999999999999999999888 9
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEI 151 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l 151 (223)
+++|||............ .....+.+..++|+|+||+++...
T Consensus 174 ~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHH
Confidence 999999876443222110 022234456789999999886644
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.6e-14 Score=112.85 Aligned_cols=94 Identities=13% Similarity=0.039 Sum_probs=70.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCC-CCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDI-AARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di-~~~nil~~~~~~ 95 (223)
..+||||+++++|.. +. . ... ..++.++++||.|||+.|++|||| ||.||+++.++.
T Consensus 93 ~~LVmE~~~G~~L~~-~~---~---------------~~~---~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-AR---P---------------HGD---PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred cEEEEEccCCCCHHH-hC---c---------------cch---HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC
Confidence 448899999999962 21 1 111 467889999999999999999999 999999998899
Q ss_pred eEEcCCCCCcccchhh--hh-----hhhcCCccccccccccccc
Q psy15108 96 VKISLSGLSKDTYQKE--YY-----KYRNAILPLRWLPYEAVFD 132 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~--~~-----~~~~~~~~~~~~~pe~~~~ 132 (223)
++++|||+++...... .. ......+++.|.+||.+..
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999998654322 00 1124456677888888753
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.1e-14 Score=102.32 Aligned_cols=75 Identities=16% Similarity=0.010 Sum_probs=63.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~~ 96 (223)
-+||||+.++++....... ..++...+..++.|++.++.++|+ .|++|+||||.||+++ ++.+
T Consensus 93 ~lVmE~~~g~~~~~~~l~~---------------~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 93 VLVMEFIGDDGSPAPRLKD---------------VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred EEEEEEecCCCchhhhhhh---------------ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 3799999998654432222 247889999999999999999999 9999999999999998 7899
Q ss_pred EEcCCCCCcccc
Q psy15108 97 KISLSGLSKDTY 108 (223)
Q Consensus 97 ~l~df~~~~~~~ 108 (223)
+++|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.4e-13 Score=99.07 Aligned_cols=121 Identities=10% Similarity=-0.032 Sum_probs=81.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCC-CCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDI-AARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di-~~~nil~~~~~~~ 96 (223)
.++|+|+.|.+|.+.+. .. ...++.|++.++.++|+.|++|+|| ||.||+++.++.+
T Consensus 74 ~lvmeyI~G~~L~~~~~-------------------~~---~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i 131 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPP-------------------RG---DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSP 131 (218)
T ss_pred EEEEeeecCccHHhhhh-------------------hh---hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCE
Confidence 47899999999875431 11 1346789999999999999999999 7999999999999
Q ss_pred EEcCCCCCcccchhhh----hh--------hhcCCcccccccccccccC-CCC-cccchHHHHHHHHHHHhCCCCCCC
Q psy15108 97 KISLSGLSKDTYQKEY----YK--------YRNAILPLRWLPYEAVFDD-EFS-TKSDVYAYACLIWEIFNKGEMPFP 160 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~----~~--------~~~~~~~~~~~~pe~~~~~-~~~-~~~Di~slG~il~~l~~~~~~p~~ 160 (223)
+++|||++........ .. ..-...++.++.|+...-. ..+ ...+.++.|..+|.++|.+-..|.
T Consensus 132 ~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 132 AVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred EEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 9999999975433221 00 0011233445555432211 223 345566889999999954444443
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.8e-12 Score=98.51 Aligned_cols=181 Identities=15% Similarity=0.110 Sum_probs=121.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC--CcccCCCCCCCeeeecCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK--RLIHKDIAARNCLISSDL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~di~~~nil~~~~~ 94 (223)
..++.+|+.-|+|.++|+..++ .+..+......+++-||++||.|||+. .++|+++.-+.|++..++
T Consensus 147 viFiteymssgs~~~fLkrt~~-----------~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng 215 (458)
T KOG1266|consen 147 VIFITEYMSSGSLKQFLKRTKK-----------NQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG 215 (458)
T ss_pred eEEEEecccchhHHHHHHHHHH-----------hhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc
Confidence 4477899999999999998876 445788999999999999999999985 699999999999999888
Q ss_pred CeEEcCCCCCcccchhh---hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 95 SVKISLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
-+|+.--........-. ........+.+.|.+|+.=.....+.++|||+||....+|....-.|-.+......-..+
T Consensus 216 LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~i 295 (458)
T KOG1266|consen 216 LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENI 295 (458)
T ss_pred eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhh
Confidence 88875432221111111 111122234466777776544556788999999988888862222233322222222222
Q ss_pred HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
.....-.. . .--+.++.+|++..|..||++++++.|.
T Consensus 296 a~~i~~le--n---~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 296 ANVIIGLE--N---GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred hhheeecc--C---ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 22111111 1 1124688899999999999999988663
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.6e-13 Score=116.56 Aligned_cols=180 Identities=17% Similarity=0.172 Sum_probs=136.6
Q ss_pred CCCCCCCCCCCChHHHH-HHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCcccCCCCCCCeeeecCC
Q psy15108 17 KSGSGKPRVKGDLKQFL-LATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHIS-DKRLIHKDIAARNCLISSDL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l-~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~di~~~nil~~~~~ 94 (223)
+-.+.+|..+|++.+.+ +... ...+....-.++.|+..++.|+| ..++.|+|++|+|.+++..+
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~--------------~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~ 161 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDS--------------TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESG 161 (601)
T ss_pred cccccCcccccccccccccCCc--------------cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCC
Confidence 34778889999999988 4322 14667778888999999999999 99999999999999999999
Q ss_pred -CeEEcCCCCCcccch-hh-hhhhhcCCc-ccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH-
Q psy15108 95 -SVKISLSGLSKDTYQ-KE-YYKYRNAIL-PLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL- 168 (223)
Q Consensus 95 -~~~l~df~~~~~~~~-~~-~~~~~~~~~-~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~- 168 (223)
..+..|||++..... .+ ........+ ++.|.+||...+..+ ....|+||.|+++..++ .|..||.........
T Consensus 162 ~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~-~g~~p~~~~~~~~~~~ 240 (601)
T KOG0590|consen 162 SALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAML-TGELPWDFPSRKDGRY 240 (601)
T ss_pred CcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccc-cCCCCccccccccccc
Confidence 899999999876654 22 333344556 888999999887544 56799999999999999 899999766543321
Q ss_pred H-HHHhC-cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15108 169 S-QLESK-KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVT 211 (223)
Q Consensus 169 ~-~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 211 (223)
. ..... ...............+++.+++..+|..|.+.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 241 SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred eeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1 11111 1123334566777889999999999999999988753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.7e-12 Score=97.57 Aligned_cols=74 Identities=15% Similarity=0.059 Sum_probs=63.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-cccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR-LIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H~di~~~nil~~~~~~ 95 (223)
..+||||+.+++|...+... ..+....+..++.|++.++.+||+.| ++|+|++|.||+++ ++.
T Consensus 123 ~~lV~E~~~g~~L~~~~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~ 186 (237)
T smart00090 123 NVLVMEFIGGDGLPAPRLKD---------------VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGK 186 (237)
T ss_pred ceEEEEEecCCccccccccc---------------CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCC
Confidence 34899999999987765322 23667778899999999999999999 99999999999999 788
Q ss_pred eEEcCCCCCcc
Q psy15108 96 VKISLSGLSKD 106 (223)
Q Consensus 96 ~~l~df~~~~~ 106 (223)
++++|||.+..
T Consensus 187 i~LiDFg~a~~ 197 (237)
T smart00090 187 VVIIDVSQSVE 197 (237)
T ss_pred EEEEEChhhhc
Confidence 99999998763
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.1e-11 Score=104.16 Aligned_cols=173 Identities=17% Similarity=0.219 Sum_probs=143.4
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++++|..+|+|...|+..+ ..+++-+...+..+..+.++||...+.|+|++|.|++....+..++
T Consensus 881 L~~~~~~~~~~~Skl~~~~---------------~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l 945 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---------------CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPL 945 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---------------CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCccc
Confidence 7889999999999998754 3777888888899999999999999999999999999999999999
Q ss_pred cCCCCCcccch---------------------h---------hhhhhhcCCcccccccccccccCCCCcccchHHHHHHH
Q psy15108 99 SLSGLSKDTYQ---------------------K---------EYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLI 148 (223)
Q Consensus 99 ~df~~~~~~~~---------------------~---------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il 148 (223)
.+|+......- . +........+++.|++||...+......+|.|++|+.+
T Consensus 946 ~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 946 TDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCL 1025 (1205)
T ss_pred CccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhh
Confidence 88873221100 0 01223345778899999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCC-CCChHHHHHHHHHhcCCCCCCCCCHH
Q psy15108 149 WEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHS-SKTPEYITSLHEKCIHPHPHQRPTFP 207 (223)
Q Consensus 149 ~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~ 207 (223)
++.+ +|..||.......+.+.+..+...|+.. ...+.+..+++...+..+|.+|..+.
T Consensus 1026 ~e~l-~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1026 FEVL-TGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhh-cCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999 8999999999999998888877777654 45678899999999999999997765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.5e-11 Score=88.94 Aligned_cols=68 Identities=13% Similarity=0.057 Sum_probs=54.2
Q ss_pred CCCCC--CCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCcccCCCCCCCeeeecC--
Q psy15108 19 GSGKP--RVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGL-EHISDKRLIHKDIAARNCLISSD-- 93 (223)
Q Consensus 19 ~v~~~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~i~H~di~~~nil~~~~-- 93 (223)
.|++| +.+|||.+++++. .+++. ..++.+++.++ .|||+++|+||||||.||+++..
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~----------------~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~ 143 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC----------------RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISE 143 (210)
T ss_pred EEecCCCCcchhHHHHHHcc----------------cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCC
Confidence 46898 6689999999652 25665 35678888887 89999999999999999999743
Q ss_pred --CCeEEcCCCCC
Q psy15108 94 --LSVKISLSGLS 104 (223)
Q Consensus 94 --~~~~l~df~~~ 104 (223)
..++++|++.+
T Consensus 144 ~~~~~~LiDg~G~ 156 (210)
T PRK10345 144 SEVIPVVCDNIGE 156 (210)
T ss_pred CCCcEEEEECCCC
Confidence 37999995434
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.5e-11 Score=90.99 Aligned_cols=68 Identities=19% Similarity=0.083 Sum_probs=57.9
Q ss_pred CCCCCCCC-CChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 19 GSGKPRVK-GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 19 ~v~~~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
+|++++++ .+|.+++.. ..+++.. +.+++.++.+||+.|++|+|++|.||+++.++.++
T Consensus 123 lV~e~l~G~~~L~~~l~~----------------~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 123 ILIERIEGARDLVALLQE----------------APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred EEEEecCCCCCHHHHHhc----------------CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEE
Confidence 78899997 689999853 2355543 56899999999999999999999999999888999
Q ss_pred EcCCCCCcc
Q psy15108 98 ISLSGLSKD 106 (223)
Q Consensus 98 l~df~~~~~ 106 (223)
++|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=1e-10 Score=87.38 Aligned_cols=70 Identities=13% Similarity=0.110 Sum_probs=61.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||++|++|.+++.. ... ....++.+++.++.++|+.+++|+|++|.||+++ .+.+
T Consensus 74 ~~lv~e~~~G~~L~~~~~~------------------~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~ 133 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINS------------------NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKI 133 (211)
T ss_pred CEEEEEEeCCcCHHHHHHh------------------ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCE
Confidence 3478999999999999863 122 8889999999999999999999999999999999 7889
Q ss_pred EEcCCCCCcc
Q psy15108 97 KISLSGLSKD 106 (223)
Q Consensus 97 ~l~df~~~~~ 106 (223)
+++|||.+..
T Consensus 134 ~liDf~~a~~ 143 (211)
T PRK14879 134 YLIDFGLAEF 143 (211)
T ss_pred EEEECCcccC
Confidence 9999998863
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.8e-11 Score=88.01 Aligned_cols=71 Identities=13% Similarity=0.014 Sum_probs=60.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||+.+++|.++.. ......++.++++++.++|+.|++|+|++|.||+++.++.+
T Consensus 106 ~~lv~e~~~g~~L~~~~~---------------------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 106 HAVVMEYIDGVELYRVRV---------------------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred ceEEEEEeCCcchhhccc---------------------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 347899999999876542 02345788999999999999999999999999999999999
Q ss_pred EEcCCCCCcccc
Q psy15108 97 KISLSGLSKDTY 108 (223)
Q Consensus 97 ~l~df~~~~~~~ 108 (223)
+++|||.+....
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.2e-09 Score=83.19 Aligned_cols=163 Identities=17% Similarity=0.164 Sum_probs=116.9
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccc
Q psy15108 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF 131 (223)
Q Consensus 52 ~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 131 (223)
....++.+++++.+++.+..-||..|..-+|+.++|+|+..++.+.+.|-.-.... .......+.++...|++||...
T Consensus 112 P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~--~ng~~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 112 PHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN--ANGTLHLCPVGVSEFTPPELQT 189 (637)
T ss_pred CccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec--cCCceEecccCccccCCHHHhc
Confidence 35789999999999999999999999999999999999999999998875432211 1122345667788999999865
Q ss_pred -----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----HHH-HHHh---------Cc-ccC-CC---CCCChHH
Q psy15108 132 -----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ----VLS-QLES---------KK-LCW-KH---SSKTPEY 187 (223)
Q Consensus 132 -----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~----~~~-~~~~---------~~-~~~-~~---~~~~~~~ 187 (223)
+..-+...|.|.+|+++++++..|+.||.+..... -.+ .|.. +. +.+ +. ..-+++.
T Consensus 190 ~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~ 269 (637)
T COG4248 190 LPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPD 269 (637)
T ss_pred cccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHH
Confidence 22346779999999999999878899997653110 000 1111 10 111 11 1234677
Q ss_pred HHHHHHHhcCC--CCCCCCCHHHHHHHHHHH
Q psy15108 188 ITSLHEKCIHP--HPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 188 ~~~li~~~l~~--dp~~Rps~~~ll~~L~~~ 216 (223)
+..++.+|+.. .+.-||+.+..+..|..+
T Consensus 270 vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 270 VQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 88899999875 467899998887777654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.6e-10 Score=84.47 Aligned_cols=67 Identities=15% Similarity=0.131 Sum_probs=58.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||++|++|.+++... . . .++.++++++.++|+.|++|+|++|.||+++ ++.+
T Consensus 72 ~~lv~e~~~g~~l~~~~~~~-~---------------~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~ 128 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEEG-N---------------D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKL 128 (199)
T ss_pred CEEEEEEECCccHHHHHhhc-H---------------H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcE
Confidence 34889999999999988531 1 1 7889999999999999999999999999999 7899
Q ss_pred EEcCCCCCcc
Q psy15108 97 KISLSGLSKD 106 (223)
Q Consensus 97 ~l~df~~~~~ 106 (223)
+++|||++..
T Consensus 129 ~liDfg~a~~ 138 (199)
T TIGR03724 129 YLIDFGLGKY 138 (199)
T ss_pred EEEECCCCcC
Confidence 9999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.2e-10 Score=96.28 Aligned_cols=66 Identities=20% Similarity=0.173 Sum_probs=58.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++++|.+++. ....++.++++++.+||+.+++|||+||.||++ .++.+
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcE
Confidence 448899999999999884 235688999999999999999999999999999 57789
Q ss_pred EEcCCCCCcc
Q psy15108 97 KISLSGLSKD 106 (223)
Q Consensus 97 ~l~df~~~~~ 106 (223)
+++|||+++.
T Consensus 467 ~liDFGla~~ 476 (535)
T PRK09605 467 YLIDFGLGKY 476 (535)
T ss_pred EEEeCccccc
Confidence 9999999864
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.8e-10 Score=94.54 Aligned_cols=150 Identities=17% Similarity=0.214 Sum_probs=105.4
Q ss_pred HHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhh--------cCCcccccccccccc
Q psy15108 61 TMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYR--------NAILPLRWLPYEAVF 131 (223)
Q Consensus 61 ~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~--------~~~~~~~~~~pe~~~ 131 (223)
.=+.+.+.|+.++|.. +++|++|.|++|.++.++..|+..|+++........+... .......|.+||.+.
T Consensus 103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3345666899999976 8999999999999999999999999987654332111110 112224589999998
Q ss_pred cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--HHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHH
Q psy15108 132 DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ--LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209 (223)
Q Consensus 132 ~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 209 (223)
....+.++|++|+|+++|.+...|+.-+........... ............++|.++++-+.+++..++..||++.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 877889999999999999887455544433322211111 111112233346789999999999999999999977665
Q ss_pred H
Q psy15108 210 V 210 (223)
Q Consensus 210 l 210 (223)
.
T Consensus 263 ~ 263 (700)
T KOG2137|consen 263 L 263 (700)
T ss_pred h
Confidence 4
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.1e-10 Score=80.98 Aligned_cols=72 Identities=15% Similarity=0.048 Sum_probs=57.3
Q ss_pred CCCCCCCCCCChHH-HHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC
Q psy15108 18 SGSGKPRVKGDLKQ-FLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 18 ~~v~~~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~ 95 (223)
.++++|+.++++.. .+... . .. ..+..++.+++.++.++|. .+++|+|++|.||+++ ++.
T Consensus 91 ~lv~e~~~g~~~~~~~l~~~-~---------------~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 91 VLVMEFIGGDGIPAPRLKDV-R---------------LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred EEEEEEeCCCCccChhhhhh-h---------------hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 37889999865432 22211 0 11 6778999999999999999 9999999999999999 889
Q ss_pred eEEcCCCCCccc
Q psy15108 96 VKISLSGLSKDT 107 (223)
Q Consensus 96 ~~l~df~~~~~~ 107 (223)
++++|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.91 E-value=9e-10 Score=90.74 Aligned_cols=176 Identities=15% Similarity=0.125 Sum_probs=124.7
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCcccCCCCCCCeeeecC-
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVAL----GLEHISDKRLIHKDIAARNCLISSD- 93 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~i~H~di~~~nil~~~~- 93 (223)
.+....++.+|+++.+.... -+++..++..+.+... |+.++|..+++|.|++|.||++..+
T Consensus 194 fiqtE~~~~sl~~~~~~~~~--------------~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 194 FIQTELCGESLQSYCHTPCN--------------FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW 259 (524)
T ss_pred eeeeccccchhHHhhhcccc--------------cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc
Confidence 55666777899999886433 4777888888888888 9999999999999999999999999
Q ss_pred CCeEEcCCCCCcccchhhhh----hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCC-CCCCHHHHH
Q psy15108 94 LSVKISLSGLSKDTYQKEYY----KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF-PDLSDDQVL 168 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~-~~~~~~~~~ 168 (223)
..++++||++.........- ......+...|++||... .-++...|++++|.++.+.. .+..+. .+.+. .+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~-l~~~~~~~g~~~--~W 335 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAI-LGSHLPSVGKNS--SW 335 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhH-hhcccccCCCCC--Cc
Confidence 78899999988765544311 111225567799999874 44578899999999988876 343332 22111 11
Q ss_pred HHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.++.......+.....+.++...+..|+..++..|++.+.+..+
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 11222212333344455666778889999999999999887654
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.9e-09 Score=86.47 Aligned_cols=171 Identities=15% Similarity=0.105 Sum_probs=117.3
Q ss_pred CCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC-CCeEE
Q psy15108 20 SGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD-LSVKI 98 (223)
Q Consensus 20 v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~-~~~~l 98 (223)
--|||.++++...+... ..+++...+++..|++.++.++|+..++|+|++|.||++..+ +..++
T Consensus 344 p~e~~~~~s~~l~~~~~---------------~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~ 408 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTS---------------QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKL 408 (524)
T ss_pred chhhhcCcchhhhhHHH---------------HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhc
Confidence 34788898877666332 358999999999999999999999999999999999999876 67789
Q ss_pred cCCCCCcccchhhhhhhhcCCccccc-ccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRW-LPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~-~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
.||+.+....-.. .........| .++.......+..++|++++|..+.+.++....++....... +..+ .
T Consensus 409 ~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~----i~~~--~ 479 (524)
T KOG0601|consen 409 GDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT----IRSG--D 479 (524)
T ss_pred cccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCccccccee----eecc--c
Confidence 9998775321110 0011112223 345555566678899999999999998844444444322211 1121 1
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
.+.......++..+.+.+...++..||.+.++..+..
T Consensus 480 ~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 480 TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 2223344466777888889999999999888766543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.76 E-value=1e-08 Score=75.16 Aligned_cols=74 Identities=18% Similarity=0.092 Sum_probs=57.9
Q ss_pred CCCCCCCCCCCChH-HHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCcccCCCCCCCeeeecCC
Q psy15108 17 KSGSGKPRVKGDLK-QFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHI-SDKRLIHKDIAARNCLISSDL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~-~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~i~H~di~~~nil~~~~~ 94 (223)
..+||||..++.+. ..+++ ..++.++...+..+++.++..+ |+.|++|+|+++.||++. ++
T Consensus 99 ~~lvME~Ig~~~~~~~~Lkd----------------~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~ 161 (197)
T cd05146 99 HVLVMSFIGDDQVPAPKLKD----------------AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DG 161 (197)
T ss_pred CEEEEEEcCCCCccchhhhc----------------cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CC
Confidence 33889999876542 23322 1356667788899999999998 899999999999999997 46
Q ss_pred CeEEcCCCCCccc
Q psy15108 95 SVKISLSGLSKDT 107 (223)
Q Consensus 95 ~~~l~df~~~~~~ 107 (223)
.+.++||+.+...
T Consensus 162 ~v~iIDF~qav~~ 174 (197)
T cd05146 162 KVWFIDVSQSVEP 174 (197)
T ss_pred cEEEEECCCceeC
Confidence 7999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=4e-08 Score=75.87 Aligned_cols=74 Identities=11% Similarity=0.051 Sum_probs=62.2
Q ss_pred CCCCCCCCC-ChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-----
Q psy15108 19 GSGKPRVKG-DLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS----- 92 (223)
Q Consensus 19 ~v~~~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~----- 92 (223)
+|+|++++. +|.+++..... .+.+......++.+++..+.-||..|++|+|+++.||+++.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~-------------~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWAT-------------NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcc-------------cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCC
Confidence 788999886 89999864321 23567788899999999999999999999999999999985
Q ss_pred --CCCeEEcCCCCCc
Q psy15108 93 --DLSVKISLSGLSK 105 (223)
Q Consensus 93 --~~~~~l~df~~~~ 105 (223)
...+.++||+.+.
T Consensus 179 ~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 179 EEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCceEEEEECCccc
Confidence 3568999999774
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.6e-08 Score=69.56 Aligned_cols=81 Identities=21% Similarity=0.201 Sum_probs=63.8
Q ss_pred CCCCCCCCCCCCCC-CChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee
Q psy15108 13 DSKDKSGSGKPRVK-GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS 91 (223)
Q Consensus 13 ~~~~~~~v~~~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~ 91 (223)
+.+...++|||.++ .++.+++..... ..........++..|-+.+.-||..+++|+|+.++||++.
T Consensus 81 D~~~~~i~ME~~~g~~~vk~~i~~~~~-------------~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~ 147 (229)
T KOG3087|consen 81 DTYGGQIYMEFIDGASTVKDFILSTME-------------DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLR 147 (229)
T ss_pred ecCCCeEEEEeccchhHHHHHHHHHcc-------------CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEe
Confidence 34555688999987 579999987654 2233444478889999999999999999999999999987
Q ss_pred cCCC---eEEcCCCCCcc
Q psy15108 92 SDLS---VKISLSGLSKD 106 (223)
Q Consensus 92 ~~~~---~~l~df~~~~~ 106 (223)
..+. +.++|||++..
T Consensus 148 ~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 148 SDGNQITPILIDFGLSSV 165 (229)
T ss_pred cCCCcCceEEEeecchhc
Confidence 6643 58999999853
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.1e-08 Score=81.94 Aligned_cols=75 Identities=13% Similarity=0.032 Sum_probs=59.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHH-HHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVAL-GLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
-+||||++|++|.++...... .++ ...++..++. .+..+|..|++|+|++|.||+++.++.+
T Consensus 234 vLvmE~i~G~~L~~~~~~~~~--------------~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i 296 (437)
T TIGR01982 234 VLTMEWIDGIPLSDIAALDEA--------------GLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKI 296 (437)
T ss_pred eEEEEeECCcccccHHHHHhc--------------CCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcE
Confidence 389999999999998764321 122 3445666665 4678899999999999999999999999
Q ss_pred EEcCCCCCcccch
Q psy15108 97 KISLSGLSKDTYQ 109 (223)
Q Consensus 97 ~l~df~~~~~~~~ 109 (223)
+++|||++.....
T Consensus 297 ~liDfG~~~~l~~ 309 (437)
T TIGR01982 297 IALDFGIVGRLSE 309 (437)
T ss_pred EEEeCCCeeECCH
Confidence 9999999876654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.65 E-value=7.5e-07 Score=73.11 Aligned_cols=171 Identities=11% Similarity=0.063 Sum_probs=123.0
Q ss_pred CCCCCCCCCC-CChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVK-GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
.-+|++|++. ++|.++--.+.......+..-...+...+++.+|.++.|+..||.++|+.|+.-+-+.+.+|+++++-+
T Consensus 352 lvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~R 431 (655)
T KOG3741|consen 352 LVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMR 431 (655)
T ss_pred EEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcce
Confidence 3378899987 789999887776665555555667778999999999999999999999999999999999999999888
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCC-CCCCCCHHHH-HHHHHh
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEM-PFPDLSDDQV-LSQLES 173 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~-p~~~~~~~~~-~~~~~~ 173 (223)
+++...|+........ .+| +. -..+.|.-.||.++..+. +|.. .+......+. ...+
T Consensus 432 IriS~C~i~Dvl~~d~-------------~~~--le---~~Qq~D~~~lG~ll~aLA-t~~~ns~~~d~~~~s~~~~I-- 490 (655)
T KOG3741|consen 432 IRISGCGIMDVLQEDP-------------TEP--LE---SQQQNDLRDLGLLLLALA-TGTENSNRTDSTQSSHLTRI-- 490 (655)
T ss_pred EEEecccceeeecCCC-------------Ccc--hh---HHhhhhHHHHHHHHHHHh-hcccccccccchHHHHHHHh--
Confidence 8888777654322111 111 11 123578889999999998 5543 3333332222 2222
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
....+.++++++.......+++ -++.+++.++-.-
T Consensus 491 -------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ 525 (655)
T KOG3741|consen 491 -------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSR 525 (655)
T ss_pred -------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHH
Confidence 2245677888888888888876 7888888776543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.9e-08 Score=69.18 Aligned_cols=67 Identities=15% Similarity=0.073 Sum_probs=55.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++|||.+|-.|.+++... ...++..+-.-+.-||..||+|+|+.++||++... .+
T Consensus 74 ~~I~me~I~G~~lkd~l~~~----------------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i 130 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEA----------------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RI 130 (204)
T ss_pred CEEEEEEeCChhHHHHHHhc----------------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cE
Confidence 44889999999999999641 24555666667778999999999999999999766 49
Q ss_pred EEcCCCCCcc
Q psy15108 97 KISLSGLSKD 106 (223)
Q Consensus 97 ~l~df~~~~~ 106 (223)
.++|||++..
T Consensus 131 ~~IDfGLg~~ 140 (204)
T COG3642 131 YFIDFGLGEF 140 (204)
T ss_pred EEEECCcccc
Confidence 9999999863
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=1e-07 Score=71.06 Aligned_cols=73 Identities=18% Similarity=0.136 Sum_probs=62.8
Q ss_pred CCCCCCCC-CChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC---
Q psy15108 19 GSGKPRVK-GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL--- 94 (223)
Q Consensus 19 ~v~~~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~--- 94 (223)
+++|++++ .+|.+++..... .+......++.+++..+.-||+.|++|+|+++.|||++...
T Consensus 94 lite~l~~~~~L~~~~~~~~~---------------~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~ 158 (206)
T PF06293_consen 94 LITEALPGAQDLRDLLQQWEQ---------------LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQY 158 (206)
T ss_pred EEEEeCCCcccHHHHHHhhcc---------------cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCce
Confidence 56788887 489999986432 67778889999999999999999999999999999999887
Q ss_pred CeEEcCCCCCcc
Q psy15108 95 SVKISLSGLSKD 106 (223)
Q Consensus 95 ~~~l~df~~~~~ 106 (223)
.+.++||+-+..
T Consensus 159 ~~~lIDld~~~~ 170 (206)
T PF06293_consen 159 RFYLIDLDRMRF 170 (206)
T ss_pred eEEEEcchhcee
Confidence 789999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.1e-07 Score=66.69 Aligned_cols=51 Identities=20% Similarity=0.121 Sum_probs=44.9
Q ss_pred HHHHHHHHHHHHHHHHHhhcC---CcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 56 TSQAVTMAYQVALGLEHISDK---RLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 56 ~~~~~~i~~~i~~~l~~LH~~---~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
......++.++++++..+|.. +++|+|++|.||+++..+.+++.||+.+..
T Consensus 85 ~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 85 EEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 456677889999999999985 699999999999999988999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.7e-06 Score=70.36 Aligned_cols=98 Identities=18% Similarity=0.245 Sum_probs=68.9
Q ss_pred CCHHHHHHHHHHHHHHHHHhh-cCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCccccccccccccc
Q psy15108 54 LSTSQAVTMAYQVALGLEHIS-DKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD 132 (223)
Q Consensus 54 l~~~~~~~i~~~i~~~l~~LH-~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 132 (223)
++...+.--++||+.||.+|| +.+++|++|+...|+++..|..++++|..+........ .......-..|..|+.+..
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 446677777899999999997 56899999999999999999999999987654322211 0011111122445544322
Q ss_pred CCCCcccchHHHHHHHHHHHhCC
Q psy15108 133 DEFSTKSDVYAYACLIWEIFNKG 155 (223)
Q Consensus 133 ~~~~~~~Di~slG~il~~l~~~~ 155 (223)
.. -..|.|.|||++++++ .|
T Consensus 180 s~--~s~D~~~Lg~li~el~-ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELF-NG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHh-Cc
Confidence 22 2469999999999998 66
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.6e-07 Score=67.53 Aligned_cols=71 Identities=15% Similarity=0.113 Sum_probs=49.4
Q ss_pred CCCCCCC--CCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCcccCCCCCCCeeeecCCC
Q psy15108 19 GSGKPRV--KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEH-ISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 19 ~v~~~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~i~H~di~~~nil~~~~~~ 95 (223)
+||||.. |..+..+.. . .++.+....++.+++..+.. +|..|++|+|+++.||+++.+ .
T Consensus 83 ivME~I~~~G~~~~~l~~-~----------------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 83 IVMEYIGEDGVPLPRLKD-V----------------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp EEEE--EETTEEGGCHHH-C----------------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C
T ss_pred EEEEecCCCccchhhHHh-c----------------cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e
Confidence 8899999 555655443 2 12345666777888886555 579999999999999999887 9
Q ss_pred eEEcCCCCCccc
Q psy15108 96 VKISLSGLSKDT 107 (223)
Q Consensus 96 ~~l~df~~~~~~ 107 (223)
+.++||+.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.5e-07 Score=75.85 Aligned_cols=73 Identities=14% Similarity=0.034 Sum_probs=52.4
Q ss_pred CCCCCCCCCChHHHH--HHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 19 GSGKPRVKGDLKQFL--LATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l--~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
+||||+.|+.+.++- ...+. ....+.+..+..++.|+ ...|++|+|++|.||+++.++
T Consensus 238 LvmE~i~G~~l~d~~~l~~~g~-----------d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~ 299 (537)
T PRK04750 238 MVMERMYGIPVSDVAALRAAGT-----------DMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPE 299 (537)
T ss_pred EEEeeecCccHHhHHHHHhcCC-----------CHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCC
Confidence 899999999998753 32221 00124444444444444 458999999999999999887
Q ss_pred --CeEEcCCCCCcccch
Q psy15108 95 --SVKISLSGLSKDTYQ 109 (223)
Q Consensus 95 --~~~l~df~~~~~~~~ 109 (223)
.++++|||+......
T Consensus 300 ~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 300 NPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCeEEEEecceEEECCH
Confidence 899999999876544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.6e-06 Score=64.34 Aligned_cols=64 Identities=13% Similarity=0.112 Sum_probs=51.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++|||++|-.|.++.. +++. +...+.+++.-+|+.|++|+|..|.|+++..+ .+++
T Consensus 120 ll~EYIeG~~l~d~~~-------------------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 120 LLMEYIEGVELNDIED-------------------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred EEEEEecCeecccchh-------------------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEE
Confidence 6899999999887753 4442 44567788999999999999999999998854 5999
Q ss_pred cCCCCCcc
Q psy15108 99 SLSGLSKD 106 (223)
Q Consensus 99 ~df~~~~~ 106 (223)
+|++..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.15 E-value=6.3e-06 Score=60.95 Aligned_cols=75 Identities=11% Similarity=0.011 Sum_probs=60.4
Q ss_pred CCCCCCCC-CChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC--
Q psy15108 19 GSGKPRVK-GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS-- 95 (223)
Q Consensus 19 ~v~~~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~-- 95 (223)
+|.|-+.+ .||.+++.+... .+.+......++.++++.+.-||+.|+.|+|+.+.||+++..+.
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~-------------~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~ 168 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAV-------------SPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAE 168 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCc-------------CCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCee
Confidence 34454544 678888865322 34678888899999999999999999999999999999986666
Q ss_pred eEEcCCCCCcc
Q psy15108 96 VKISLSGLSKD 106 (223)
Q Consensus 96 ~~l~df~~~~~ 106 (223)
+.++||.-++.
T Consensus 169 v~lIDlEk~r~ 179 (216)
T PRK09902 169 AGFLDLEKSRR 179 (216)
T ss_pred EEEEEhhccch
Confidence 89999987654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.1e-06 Score=59.28 Aligned_cols=45 Identities=18% Similarity=0.123 Sum_probs=39.0
Q ss_pred HHHHHHHHHHHHhhcCCc-----ccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 61 TMAYQVALGLEHISDKRL-----IHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 61 ~i~~~i~~~l~~LH~~~i-----~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
.++.++++++..||+.++ +|+|+++.||+++ ++.++++||+.+..
T Consensus 87 ~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 87 ENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 346789999999999885 9999999999998 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.83 E-value=1.9e-05 Score=60.22 Aligned_cols=70 Identities=10% Similarity=0.057 Sum_probs=55.1
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
...+|||+.+|-.|...- ++.+....++..|++-+...-..|++|+|+++-||+++.+|.
T Consensus 181 RHaVvMe~ieG~eL~~~r--------------------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 181 RHAVVMEYIEGVELYRLR--------------------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred cceeeeehcccceeeccc--------------------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 344899999986665433 345566667777777777777999999999999999999999
Q ss_pred eEEcCCCCCc
Q psy15108 96 VKISLSGLSK 105 (223)
Q Consensus 96 ~~l~df~~~~ 105 (223)
+.++||=-+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999985443
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00058 Score=61.72 Aligned_cols=167 Identities=14% Similarity=0.107 Sum_probs=104.6
Q ss_pred CCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCC---CeeeecCCCeE
Q psy15108 21 GKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR---NCLISSDLSVK 97 (223)
Q Consensus 21 ~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~---nil~~~~~~~~ 97 (223)
.++|.+-++...+..-+ .++.+.++.+..++.+|+.++|+....|.-+... +-..+..+.+.
T Consensus 265 ~~~~s~~~~~~~~q~v~---------------~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~ 329 (1351)
T KOG1035|consen 265 QEICSKVELRSLLQSVG---------------SIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVA 329 (1351)
T ss_pred HhhcCccchHHHHhhcc---------------ccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceee
Confidence 46777777777776543 4899999999999999999999986655555444 33334445555
Q ss_pred Ec--CCCCCcccchhhhhhhhcCCcccccccccccccCCCC--cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 98 IS--LSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFS--TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 98 l~--df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~--~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
.. ||+.+......... .....+..+.+++........ ...|+|.+|.....+..+...+-....... +.
T Consensus 330 ~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~----~l- 402 (1351)
T KOG1035|consen 330 ISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVS----LL- 402 (1351)
T ss_pred cchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchhh----hh-
Confidence 55 77766654433211 112223335566665544443 447999999988877632222222111111 10
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
+.....+..+...+|+..++++|++..+++.+...-
T Consensus 403 -------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 403 -------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLR 438 (1351)
T ss_pred -------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence 111222577788899999999999999999876543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.47 E-value=6.6e-05 Score=56.20 Aligned_cols=31 Identities=23% Similarity=0.150 Sum_probs=26.1
Q ss_pred CCcccCCCCCCCeeeec--CCCeEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLISS--DLSVKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~--~~~~~l~df~~~~~ 106 (223)
..++|+|+.+.||+++. .+.+.++||+.+..
T Consensus 174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 46799999999999998 56678999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.002 Score=54.50 Aligned_cols=75 Identities=13% Similarity=0.058 Sum_probs=54.2
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHH-HHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALG-LEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~-l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
++|||..|-.+.+....... .++.. .++..++++ +..+-..|+.|.|.+|.||++..++.+.
T Consensus 243 LtmE~i~Gi~i~d~~~l~~~--------------g~d~k---~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~ 305 (517)
T COG0661 243 LTMEWIDGIKISDIAALKSA--------------GIDRK---ELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIV 305 (517)
T ss_pred EEEEeeCCEecccHHHHHhc--------------CCCHH---HHHHHHHHHHHHHHHhcCccccCCCccceEEecCCcEE
Confidence 88999999999988532211 24432 333333333 3445558999999999999999999999
Q ss_pred EcCCCCCcccchh
Q psy15108 98 ISLSGLSKDTYQK 110 (223)
Q Consensus 98 l~df~~~~~~~~~ 110 (223)
+.|||+.......
T Consensus 306 ~lDfGi~g~l~~~ 318 (517)
T COG0661 306 LLDFGIVGRLDPK 318 (517)
T ss_pred EEcCcceecCCHH
Confidence 9999998765543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0011 Score=48.59 Aligned_cols=53 Identities=17% Similarity=0.023 Sum_probs=47.3
Q ss_pred CCHHHHHHHHHHHHHHHHHhhc---CCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 54 LSTSQAVTMAYQVALGLEHISD---KRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 54 l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
-++..+.+++.++++.+.+++. ..+.-+|++++|+-++.++.++++|......
T Consensus 56 ~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 56 SPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 6899999999999999999987 4567799999999999999999999986643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0062 Score=51.57 Aligned_cols=75 Identities=16% Similarity=0.118 Sum_probs=52.3
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec----CC
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS----DL 94 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~----~~ 94 (223)
++|||++|.-+.|.-.-.. ..++...+..-+.+.. .+.+-..|++|+|-.|.||++.+ +.
T Consensus 279 LtME~~~G~~i~Dl~~i~~--------------~gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~ 342 (538)
T KOG1235|consen 279 LTMEYVDGIKINDLDAIDK--------------RGISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDE 342 (538)
T ss_pred EEEEecCCccCCCHHHHHH--------------cCCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCc
Confidence 8899999988776643222 2466665444433332 23445678999999999999984 56
Q ss_pred CeEEcCCCCCcccch
Q psy15108 95 SVKISLSGLSKDTYQ 109 (223)
Q Consensus 95 ~~~l~df~~~~~~~~ 109 (223)
.+.+.|+|+......
T Consensus 343 ~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 343 EIVLLDHGLYAVISH 357 (538)
T ss_pred cEEEEcccccccccH
Confidence 789999999875543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.0077 Score=45.80 Aligned_cols=53 Identities=19% Similarity=0.149 Sum_probs=45.0
Q ss_pred CCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCCeEEcCCCCCccc
Q psy15108 54 LSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLSVKISLSGLSKDT 107 (223)
Q Consensus 54 l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~~~l~df~~~~~~ 107 (223)
+...+...+..++++.+.-|-. .+++|+|++.-|||+. .+.+.++|++-+...
T Consensus 163 ~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 163 LELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 4444688888999999998877 8999999999999999 779999999977643
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.00077 Score=62.91 Aligned_cols=128 Identities=14% Similarity=0.074 Sum_probs=91.8
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CcccCCCCCCCeeeecC
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-----RLIHKDIAARNCLISSD 93 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~i~H~di~~~nil~~~~ 93 (223)
..++|+.+|++.+.|-+--. +...+...-+.....+.+.+..-+|+. -.+|+++++.|.++..+
T Consensus 1308 ~r~~~~~~g~~f~iIikg~e-----------e~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn 1376 (2724)
T KOG1826|consen 1308 IRSLYVEFGKLFSIIIKGLE-----------ESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN 1376 (2724)
T ss_pred HHHHHHHHhHHHHHHHhccc-----------cCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecC
Confidence 56788999999998865322 344555555555444446665665543 35899999999999999
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCC
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~ 159 (223)
-.+++.++|+.+.... .....+...+++.|+.++..+.-+++.++|+|..|+.+|... .+..+|
T Consensus 1377 y~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs-~~n~~f 1440 (2724)
T KOG1826|consen 1377 YNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS-DGNAYF 1440 (2724)
T ss_pred CcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh-cccHHH
Confidence 9999999999972211 122345567778888888887777888899999999999876 555444
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.032 Score=42.25 Aligned_cols=28 Identities=18% Similarity=0.000 Sum_probs=24.9
Q ss_pred CcccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 77 RLIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 77 ~i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
.++|+|+.|.||+++..+ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 568999999999999877 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.05 Score=41.17 Aligned_cols=30 Identities=20% Similarity=0.165 Sum_probs=26.2
Q ss_pred CCcccCCCCCCCeeeec-CCCeEEcCCCCCc
Q psy15108 76 KRLIHKDIAARNCLISS-DLSVKISLSGLSK 105 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~-~~~~~l~df~~~~ 105 (223)
.+++|+|+.+.||+++. ++.+.++||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 46899999999999998 5779999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.07 Score=42.29 Aligned_cols=30 Identities=20% Similarity=0.197 Sum_probs=26.8
Q ss_pred CCcccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 76 KRLIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
.+++|+|+.+.|++++.++.+.++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999988767899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.045 Score=41.54 Aligned_cols=31 Identities=19% Similarity=0.131 Sum_probs=25.6
Q ss_pred cCCcccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 75 DKRLIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 75 ~~~i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
..+++|+|+.+.|++++.....-++||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 3468999999999999876555799999774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.13 Score=40.84 Aligned_cols=31 Identities=19% Similarity=0.174 Sum_probs=26.3
Q ss_pred CCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
.+++|+|+.+.||+++.+...-++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999999765568999998753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.12 Score=40.97 Aligned_cols=29 Identities=21% Similarity=0.212 Sum_probs=25.2
Q ss_pred CCcccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 76 KRLIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
.+++|+|+.+.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 678899999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.05 E-value=0.052 Score=40.66 Aligned_cols=31 Identities=29% Similarity=0.225 Sum_probs=21.0
Q ss_pred cCCcccCCCCCCCeeee-cCCCeEEcCCCCCc
Q psy15108 75 DKRLIHKDIAARNCLIS-SDLSVKISLSGLSK 105 (223)
Q Consensus 75 ~~~i~H~di~~~nil~~-~~~~~~l~df~~~~ 105 (223)
...++|+|+.+.||+++ .++.+-++||+.+.
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred CcEEEEeccccccceeeeccceeEEEecccce
Confidence 35799999999999999 55556799998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.11 Score=40.92 Aligned_cols=30 Identities=13% Similarity=0.120 Sum_probs=26.3
Q ss_pred CCcccCCCCCCCeeeecC----CCeEEcCCCCCc
Q psy15108 76 KRLIHKDIAARNCLISSD----LSVKISLSGLSK 105 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~----~~~~l~df~~~~ 105 (223)
.+++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 368999999999999874 789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.099 Score=41.08 Aligned_cols=31 Identities=19% Similarity=0.170 Sum_probs=26.9
Q ss_pred CCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
.+++|+|+.|.|++++.++.+.++||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999877778999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=93.88 E-value=0.04 Score=43.92 Aligned_cols=63 Identities=14% Similarity=0.032 Sum_probs=46.2
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+||+...+-.|.+.-+- ..+-.+...++.-+--|..+|++|+|..--||+++.+..+++
T Consensus 185 Vvmelv~g~Pl~~v~~v---------------------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 185 VVMELVDGYPLRQVRHV---------------------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred eHHHhhcccceeeeeec---------------------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 66777766666554431 222334455555666788899999999999999999999999
Q ss_pred cCCC
Q psy15108 99 SLSG 102 (223)
Q Consensus 99 ~df~ 102 (223)
+||=
T Consensus 244 IDFP 247 (465)
T KOG2268|consen 244 IDFP 247 (465)
T ss_pred eech
Confidence 9994
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.82 E-value=0.058 Score=40.60 Aligned_cols=37 Identities=14% Similarity=0.048 Sum_probs=32.0
Q ss_pred HHHHHHhhc--CCcccCCCCCCCeeeecCCCeEEcCCCC
Q psy15108 67 ALGLEHISD--KRLIHKDIAARNCLISSDLSVKISLSGL 103 (223)
Q Consensus 67 ~~~l~~LH~--~~i~H~di~~~nil~~~~~~~~l~df~~ 103 (223)
+++|...|+ .+.+|+|..|+|||-++.|.+|+.|.+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 566778884 4789999999999999999999999763
|
The function of this family is unknown. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.38 E-value=0.24 Score=38.60 Aligned_cols=52 Identities=12% Similarity=0.054 Sum_probs=40.6
Q ss_pred CHHHHHHHHHHHHHHHHHhhcC--CcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 55 STSQAVTMAYQVALGLEHISDK--RLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 55 ~~~~~~~i~~~i~~~l~~LH~~--~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
+...+.+.+..+-.++.-.+.. -++|+|+.+.|++.+..+.+.++||.-|..
T Consensus 130 ~~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 130 DNHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred hhHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 4444555666666677666665 689999999999999989999999987753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.17 Score=41.05 Aligned_cols=52 Identities=17% Similarity=0.213 Sum_probs=45.1
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 54 LSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 54 l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
-..+++..++++.+..+.-+... .+-||++.-.||+++ .|++.++||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 46788899999988877777654 678999999999999 99999999999974
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.88 E-value=0.28 Score=36.17 Aligned_cols=30 Identities=30% Similarity=0.228 Sum_probs=25.1
Q ss_pred CCcccCCCCCCCeeeecCC-----CeEEcCCCCCc
Q psy15108 76 KRLIHKDIAARNCLISSDL-----SVKISLSGLSK 105 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~-----~~~l~df~~~~ 105 (223)
..++|||+.+.|+++..++ .+.++||+.+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4689999999999997543 58899999875
|
subfamily of choline kinases |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=92.73 E-value=0.1 Score=39.81 Aligned_cols=30 Identities=13% Similarity=0.016 Sum_probs=26.2
Q ss_pred CCcccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 76 KRLIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
..++|+|+.+.||+++....+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 468999999999999987777899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=92.62 E-value=0.066 Score=46.22 Aligned_cols=94 Identities=20% Similarity=0.094 Sum_probs=66.7
Q ss_pred HHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCc
Q psy15108 58 QAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFST 137 (223)
Q Consensus 58 ~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~ 137 (223)
+...+...-.++++++|+.--+|+| ||+... +..+..+|+......... ..+...++..|++||+.....+..
T Consensus 337 ~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~ 409 (829)
T KOG0576|consen 337 QFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDG 409 (829)
T ss_pred hhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhccccccc
Confidence 3344455556678899988778887 665544 577888888765443322 345678889999999998889999
Q ss_pred ccchHHHHHHHHHHHhCCCCCC
Q psy15108 138 KSDVYAYACLIWEIFNKGEMPF 159 (223)
Q Consensus 138 ~~Di~slG~il~~l~~~~~~p~ 159 (223)
..|.|+++.--.++. -+..|-
T Consensus 410 ~p~~~~~~~~~~~~a-p~~pPr 430 (829)
T KOG0576|consen 410 CPDSGSLAVSAIQMA-PGLPPR 430 (829)
T ss_pred CCCccCCCcchhhcC-CCCCCC
Confidence 999999997555554 454443
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.42 E-value=0.13 Score=37.64 Aligned_cols=29 Identities=21% Similarity=0.189 Sum_probs=25.0
Q ss_pred CcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 77 RLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 77 ~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
..+|+|+.|.|+++..++ ++++|++.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 468999999999988776 88999998754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=91.98 E-value=0.27 Score=39.79 Aligned_cols=31 Identities=16% Similarity=0.162 Sum_probs=26.4
Q ss_pred CCcccCCCCCCCeeeec-CCCeEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLISS-DLSVKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~-~~~~~l~df~~~~~ 106 (223)
..++|+|+++.||+++. ++.+.++||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 46899999999999986 46799999998753
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=91.88 E-value=0.11 Score=43.93 Aligned_cols=74 Identities=22% Similarity=0.220 Sum_probs=45.4
Q ss_pred CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC----------CCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy15108 136 STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW----------KHSSKTPEYITSLHEKCIHPHPHQRPT 205 (223)
Q Consensus 136 ~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps 205 (223)
..++|||++|.++.++. .|..-+......+....+..-.... ...-.++..+.++..+|+-..|..||.
T Consensus 109 ~pKsdVwsl~~i~~el~-L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l 187 (725)
T KOG1093|consen 109 GPKSDVWSLGFIILELY-LGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL 187 (725)
T ss_pred CcchhhhhHHHHHHHHH-HhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc
Confidence 35899999999999987 6765555444444333332210000 001123455677888899999988886
Q ss_pred HHHHH
Q psy15108 206 FPSIV 210 (223)
Q Consensus 206 ~~~ll 210 (223)
..++.
T Consensus 188 ~~~~~ 192 (725)
T KOG1093|consen 188 PMELS 192 (725)
T ss_pred hhHHh
Confidence 65544
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=91.73 E-value=0.14 Score=39.38 Aligned_cols=29 Identities=21% Similarity=0.249 Sum_probs=25.3
Q ss_pred CcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 77 RLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 77 ~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
.++|+|+.+.||+++.++ +.++||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999998876 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=91.63 E-value=0.29 Score=36.45 Aligned_cols=31 Identities=26% Similarity=0.212 Sum_probs=21.5
Q ss_pred CCcccCCCCCCCeee-ecCCCeEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLI-SSDLSVKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~-~~~~~~~l~df~~~~~ 106 (223)
..++|+|+.+.||++ ..++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 367899999999999 7888999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=91.09 E-value=0.84 Score=33.82 Aligned_cols=58 Identities=12% Similarity=0.159 Sum_probs=38.8
Q ss_pred CChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC----CeEEcC-C
Q psy15108 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL----SVKISL-S 101 (223)
Q Consensus 27 g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~----~~~l~d-f 101 (223)
-||.++++. ..+++ ...+ .+-+-..+|-+.+|+.+|++|.||++.... .+.++| |
T Consensus 108 ~TL~~~l~~----------------~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~ 167 (199)
T PF10707_consen 108 PTLEDYLKE----------------GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGL 167 (199)
T ss_pred ccHHHHHHc----------------CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCC
Confidence 458888854 23566 4433 334445677889999999999999987542 356666 5
Q ss_pred CCC
Q psy15108 102 GLS 104 (223)
Q Consensus 102 ~~~ 104 (223)
|-.
T Consensus 168 G~~ 170 (199)
T PF10707_consen 168 GEK 170 (199)
T ss_pred CCc
Confidence 543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.00 E-value=0.41 Score=38.46 Aligned_cols=29 Identities=21% Similarity=0.182 Sum_probs=25.8
Q ss_pred cccCCCCCCCeeeecCCC-eEEcCCCCCcc
Q psy15108 78 LIHKDIAARNCLISSDLS-VKISLSGLSKD 106 (223)
Q Consensus 78 i~H~di~~~nil~~~~~~-~~l~df~~~~~ 106 (223)
++|+|+.+.||+++.... +-++||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999998875 88999998753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=90.94 E-value=0.31 Score=38.67 Aligned_cols=29 Identities=10% Similarity=0.024 Sum_probs=26.6
Q ss_pred CcccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 77 RLIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 77 ~i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
+++|+|+.+.|+++++++.+-++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999998889999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=89.96 E-value=0.48 Score=38.99 Aligned_cols=32 Identities=22% Similarity=0.332 Sum_probs=27.0
Q ss_pred hcCCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 74 SDKRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 74 H~~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
..+.++|||+.|.||+++.+ .++++|..++-.
T Consensus 225 ~~~aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy 256 (409)
T PRK12396 225 NAQALIHGDLHTGSVFVKND-STKVIDPEFAFY 256 (409)
T ss_pred cchhhccCcCCCCCEEecCC-ceEEEccccccc
Confidence 45689999999999999875 689999888753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.95 E-value=0.26 Score=39.29 Aligned_cols=35 Identities=17% Similarity=0.084 Sum_probs=29.9
Q ss_pred cCCcccCCCCCCCeeeecCCCeEEcCCCCCcccch
Q psy15108 75 DKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109 (223)
Q Consensus 75 ~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~ 109 (223)
...++|+|+.+.|++++..+.+-|+||+++.....
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 34789999999999999998899999999875433
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=89.03 E-value=0.63 Score=36.53 Aligned_cols=46 Identities=17% Similarity=0.105 Sum_probs=31.5
Q ss_pred HHHHHHHHHHHHHhh------cCCcccCCCCCCCeeeecC--C---CeEEcCCCCCc
Q psy15108 60 VTMAYQVALGLEHIS------DKRLIHKDIAARNCLISSD--L---SVKISLSGLSK 105 (223)
Q Consensus 60 ~~i~~~i~~~l~~LH------~~~i~H~di~~~nil~~~~--~---~~~l~df~~~~ 105 (223)
..+...+.+.+..+. -.-++|||++..||++..+ + .+++.||.+++
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 193 EALLDKFFERMQELVDPSKEPFNVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred HHHHHHHHHHHHHHhccccCCceEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 334444444444444 1358999999999999655 2 58999999875
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=88.73 E-value=0.6 Score=37.63 Aligned_cols=38 Identities=24% Similarity=0.221 Sum_probs=24.6
Q ss_pred HHHHHHHHHHHHHHHHHhh----cCCcccCCCCCCCeeeecC
Q psy15108 56 TSQAVTMAYQVALGLEHIS----DKRLIHKDIAARNCLISSD 93 (223)
Q Consensus 56 ~~~~~~i~~~i~~~l~~LH----~~~i~H~di~~~nil~~~~ 93 (223)
.+.+..++.|++--.--.. -.+++|.||||.|||+-++
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 315 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDS 315 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecC
Confidence 4556666777654331122 2468999999999997543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=88.32 E-value=0.34 Score=37.88 Aligned_cols=31 Identities=23% Similarity=0.199 Sum_probs=25.3
Q ss_pred CCcccCCCCCCCeeeecCCC-eEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLISSDLS-VKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~-~~l~df~~~~~ 106 (223)
..++|+|+++.||+++..+. .-++||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999987555 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=87.35 E-value=1 Score=37.25 Aligned_cols=31 Identities=13% Similarity=0.269 Sum_probs=26.2
Q ss_pred cCCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 75 DKRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 75 ~~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
...++|||+.+.||++..+ .++++|+.++..
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 4579999999999999766 689999987753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.02 E-value=1.2 Score=35.65 Aligned_cols=29 Identities=17% Similarity=0.034 Sum_probs=24.2
Q ss_pred CCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
.+++|+|+.+.||+++ + .+.++||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4789999999999995 3 578999997753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=86.75 E-value=1.6 Score=35.16 Aligned_cols=30 Identities=10% Similarity=0.100 Sum_probs=25.4
Q ss_pred CcccCCCCCCCeeeec-CCCeEEcCCCCCcc
Q psy15108 77 RLIHKDIAARNCLISS-DLSVKISLSGLSKD 106 (223)
Q Consensus 77 ~i~H~di~~~nil~~~-~~~~~l~df~~~~~ 106 (223)
-++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3789999999999975 46899999998753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=85.25 E-value=1 Score=36.71 Aligned_cols=32 Identities=19% Similarity=0.277 Sum_probs=26.2
Q ss_pred hcCCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 74 SDKRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 74 H~~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
....++|||+.+.||++..+ .++++|+.++..
T Consensus 190 ~~~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~ 221 (370)
T TIGR01767 190 SAETLLHGDLHSGSIFVSEH-ETKVIDPEFAFY 221 (370)
T ss_pred CcceeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence 45689999999999999765 477999987753
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=85.16 E-value=1.6 Score=40.68 Aligned_cols=32 Identities=22% Similarity=0.288 Sum_probs=26.3
Q ss_pred CCcccCCCCCCCeeeecCC--CeE-EcCCCCCccc
Q psy15108 76 KRLIHKDIAARNCLISSDL--SVK-ISLSGLSKDT 107 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~--~~~-l~df~~~~~~ 107 (223)
.+++|+|+.+.||+++.++ .+. ++|||.+...
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 4799999999999999775 454 9999987643
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.61 E-value=2.2 Score=34.43 Aligned_cols=38 Identities=24% Similarity=0.268 Sum_probs=26.8
Q ss_pred HHHHHHHHHHHHHHHHHhhc----CCcccCCCCCCCeeeecC
Q psy15108 56 TSQAVTMAYQVALGLEHISD----KRLIHKDIAARNCLISSD 93 (223)
Q Consensus 56 ~~~~~~i~~~i~~~l~~LH~----~~i~H~di~~~nil~~~~ 93 (223)
.+.+..++.||+--.-...+ .+++|.||||.|||+-++
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 45677777787765433322 468999999999997544
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=83.93 E-value=1.6 Score=40.48 Aligned_cols=32 Identities=22% Similarity=0.092 Sum_probs=25.6
Q ss_pred cCCcccCCCCCCCeeeecCC--C---eEEcCCCCCcc
Q psy15108 75 DKRLIHKDIAARNCLISSDL--S---VKISLSGLSKD 106 (223)
Q Consensus 75 ~~~i~H~di~~~nil~~~~~--~---~~l~df~~~~~ 106 (223)
..+++|+|+.+.||+++.+. . .-++|||.+..
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 45899999999999998652 2 36999997754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=81.63 E-value=2.2 Score=35.46 Aligned_cols=30 Identities=13% Similarity=0.317 Sum_probs=25.1
Q ss_pred cCCcccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 75 DKRLIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 75 ~~~i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
...++|||+.+.||++..++ .+++|..++-
T Consensus 229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred ccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 46799999999999998864 8888887664
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=80.31 E-value=2.4 Score=31.59 Aligned_cols=37 Identities=19% Similarity=0.154 Sum_probs=29.9
Q ss_pred HHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCC
Q psy15108 63 AYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLS 104 (223)
Q Consensus 63 ~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~ 104 (223)
+.+|.+-+..+|..||+-+|+++.|.. .-+++|||.+
T Consensus 170 ~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 456777788899999999999999986 3477888753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 223 | ||||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-29 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-29 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-29 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-29 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-29 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-29 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-29 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-29 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-29 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-29 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-29 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-29 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-29 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-29 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-29 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-28 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-28 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-28 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-28 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-28 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-28 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-28 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-28 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-28 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-28 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-28 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-28 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-28 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-28 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-28 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-28 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-28 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-27 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-27 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-27 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-27 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-27 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-27 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-27 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-26 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-26 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-26 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-26 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-26 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-26 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-26 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-26 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-26 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-26 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-26 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-26 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-26 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-26 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-26 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-26 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-26 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-26 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-26 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-26 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-26 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-26 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-26 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-26 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-26 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-26 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-26 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-25 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-25 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-25 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-25 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-25 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-25 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-25 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-25 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-24 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-24 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-24 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-24 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-24 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-24 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-24 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-24 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-24 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-24 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-24 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-24 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-24 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-24 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-24 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-24 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-24 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-24 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-24 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-24 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-24 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-24 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-24 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-24 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-24 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-23 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-23 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-23 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-23 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-23 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-22 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-22 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-22 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-22 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-22 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-22 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-22 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-22 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-22 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-22 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-22 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-22 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-22 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-22 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-22 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-22 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-22 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-22 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-22 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-22 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-21 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-21 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-20 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-20 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-20 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-20 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-20 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-18 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-18 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-18 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-17 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-10 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-04 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-04 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-04 |
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 223 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-58 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-57 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-57 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-57 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-56 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-55 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-55 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-55 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-55 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-54 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-54 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-54 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 7e-54 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-53 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-52 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-52 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-52 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-52 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-52 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-52 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 5e-52 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-51 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-51 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-51 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-51 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-50 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-50 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-49 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-49 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-49 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 7e-49 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-48 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-48 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-47 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-47 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-47 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 8e-47 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-46 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-46 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-46 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-46 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-46 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 9e-46 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-45 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-45 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 8e-45 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-43 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-42 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-42 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 8e-42 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 8e-42 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-41 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-40 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-34 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-33 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-29 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 6e-29 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-28 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-28 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-27 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-24 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-21 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-18 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-18 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-17 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-17 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-16 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 8e-16 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-11 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 6e-11 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-10 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-10 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 5e-10 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-09 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-08 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-08 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-08 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-08 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-08 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-08 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-08 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-07 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-07 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 9e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 9e-06 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 9e-06 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-05 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-05 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-05 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-05 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-05 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-04 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-04 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-04 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-04 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-04 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-04 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 7e-04 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 7e-04 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-58
Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL +FL + D+K +G L Q + +A QVA G+ +++ +H+D+A
Sbjct: 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLAT 186
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RNCL+ L VKI G+S+D Y +YY+ +LP+RW+P E++ +F+T+SDV+++
Sbjct: 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 246
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL------CWKHSSKTPEYITSLHEKCIHP 198
++WEIF G+ P+ LS+ + + + + C P + ++ C
Sbjct: 247 GVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRAC-------PPEVYAIMRGCWQR 299
Query: 199 HPHQRPTFPSIVTQLSDAMCND 220
P QR + + +L A+
Sbjct: 300 EPQQRHSIKDVHARL-QALAQA 320
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-57
Identities = 63/198 (31%), Positives = 108/198 (54%), Gaps = 15/198 (7%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRS-LSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDL +FL+ S S V+S L V + Q+A G+E++S ++HKD+A
Sbjct: 96 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA 155
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L+ L+VKIS GL ++ Y +YYK N++LP+RW+ EA+ +FS SD+++
Sbjct: 156 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 215
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL------CWKHSSKTPEYITSLHEKCIH 197
Y ++WE+F+ G P+ S+ V+ + ++++ C P ++ +L +C +
Sbjct: 216 YGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDC-------PAWVYALMIECWN 268
Query: 198 PHPHQRPTFPSIVTQLSD 215
P +RP F I ++L
Sbjct: 269 EFPSRRPRFKDIHSRLRA 286
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-57
Identities = 60/198 (30%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 26 KGDLKQFLLATRKDSKD-KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
GDL +FL A D+ G + L SQ + +A Q+A G+ +++ + +H+D+A
Sbjct: 101 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLA 160
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYA 143
RNCL+ ++L VKI G+S+D Y +YY+ + +LP+RW+P E++ +F+T+SDV++
Sbjct: 161 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 220
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIH 197
+ ++WEIF G+ P+ LS+ +V+ + ++C P+ + + C
Sbjct: 221 FGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVC-------PKEVYDVMLGCWQ 273
Query: 198 PHPHQRPTFPSIVTQLSD 215
P QR I L
Sbjct: 274 REPQQRLNIKEIYKILHA 291
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-57
Identities = 59/193 (30%), Positives = 108/193 (55%), Gaps = 7/193 (3%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
+GDLK +L + R + P + + + MA ++A G+ +++ + +H+D+AA
Sbjct: 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKM-----IQMAGEIADGMAYLNANKFVHRDLAA 166
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RNC+++ D +VKI G+++D Y+ +YY K +LP+RW+ E++ D F+T SDV+++
Sbjct: 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
++WEI E P+ LS++QVL + L P+ + L C +P RP
Sbjct: 227 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRP 285
Query: 205 TFPSIVTQLSDAM 217
+F I++ + + M
Sbjct: 286 SFLEIISSIKEEM 298
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-56
Identities = 60/198 (30%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 26 KGDLKQFLLATRKDSKDKS-GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
KG+L+++L A R + S + ++ V+ YQ+A G+E+++ ++ IH+D+A
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYA 143
ARN L++ + +KI+ GL++D +YY K N LP++W+ EA+FD ++ +SDV++
Sbjct: 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIH 197
+ L+WEIF G P+P + +++ L+ C + + C H
Sbjct: 245 FGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANC-------TNELYMMMRDCWH 297
Query: 198 PHPHQRPTFPSIVTQLSD 215
P QRPTF +V L
Sbjct: 298 AVPSQRPTFKQLVEDLDR 315
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-55
Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 23/211 (10%)
Query: 26 KGDLKQFLLATRKDSKDKSGSG---------KPRVRSLSTSQAVTMAYQVALGLEHISDK 76
G L+ FL +RK GSG P R+L+ ++ A+Q++ G++++++
Sbjct: 110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM 169
Query: 77 RLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEF 135
+L+H+D+AARN L++ +KIS GLS+D Y+++ Y K +P++W+ E++FD +
Sbjct: 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229
Query: 136 STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYIT 189
+T+SDV+++ L+WEI G P+P + +++ + L++ C E +
Sbjct: 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNC-------SEEMY 282
Query: 190 SLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220
L +C P +RP F I L M
Sbjct: 283 RLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-55
Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 15/205 (7%)
Query: 26 KGDLKQFLLATRKDSKDKS-GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
KG+L+++L A R + S + ++ V+ YQ+A G+E+++ ++ IH+D+A
Sbjct: 171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 230
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYA 143
ARN L++ + +KI+ GL++D +YYK N LP++W+ EA+FD ++ +SDV++
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIH 197
+ L+WEIF G P+P + +++ L+ C + + C H
Sbjct: 291 FGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANC-------TNELYMMMRDCWH 343
Query: 198 PHPHQRPTFPSIVTQLSDAMCNDVN 222
P QRPTF +V L + N
Sbjct: 344 AVPSQRPTFKQLVEDLDRILTLTTN 368
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-55
Identities = 64/211 (30%), Positives = 113/211 (53%), Gaps = 24/211 (11%)
Query: 26 KGDLKQFLLATRKDSKD---------KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK 76
GDL +FL + + ++ P LS ++ + +A QVA G+ ++S++
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193
Query: 77 RLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEF 135
+ +H+D+A RNCL+ ++ VKI+ GLS++ Y +YYK N +P+RW+P E++F + +
Sbjct: 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 253
Query: 136 STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL------CWKHSSKTPEYIT 189
+T+SDV+AY ++WEIF+ G P+ ++ ++V+ + + C P +
Sbjct: 254 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENC-------PLELY 306
Query: 190 SLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220
+L C P RP+F SI L MC
Sbjct: 307 NLMRLCWSKLPADRPSFCSIHRIL-QRMCER 336
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-55
Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL FLLA+R +L V +A G+E++S + IH+D+AA
Sbjct: 115 HGDLHAFLLASRIGENP---------FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAA 165
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RNC+++ D++V ++ GLS+ Y +YY + + LP++WL E++ D+ ++ SDV+A+
Sbjct: 166 RNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHP 198
+WEI +G+ P+ + + ++ + L C E + L +C
Sbjct: 226 GVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPEC-------MEEVYDLMYQCWSA 278
Query: 199 HPHQRPTFPSIVTQLSD 215
P QRP+F + +L +
Sbjct: 279 DPKQRPSFTCLRMELEN 295
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-54
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 26 KGDLKQFLLATRKD---SKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKD 82
GDL FL R SK + +L ++ +YQVA G+ ++ K IH+D
Sbjct: 111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170
Query: 83 IAARNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDV 141
+AARN L++ KI GL++D Y + NA LP++W+ E++F+ ++ +SDV
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230
Query: 142 YAYACLIWEIFNKGEMPFPDLS-DDQVLSQLESK------KLCWKHSSKTPEYITSLHEK 194
++Y +WE+F+ G P+P + D + ++ + P + + +
Sbjct: 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHA-------PAEMYDIMKT 283
Query: 195 CIHPHPHQRPTFPSIVTQLSDAMCNDVN 222
C P +RPTF IV + + N
Sbjct: 284 CWDADPLKRPTFKQIVQLIEKQISESTN 311
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-54
Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 23/197 (11%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL +LL +R ++ + + + +ALG+E++S++ +H+D+AA
Sbjct: 125 YGDLHTYLLYSRLETGP---------KHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAA 175
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RNC++ D++V ++ GLSK Y +YY + R A +P++W+ E++ D +++KSDV+A+
Sbjct: 176 RNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 235
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHP 198
+WEI +G P+P + + ++ L + C + + + C
Sbjct: 236 GVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDC-------LDELYEIMYSCWRT 288
Query: 199 HPHQRPTFPSIVTQLSD 215
P RPTF + QL
Sbjct: 289 DPLDRPTFSVLRLQLEK 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-54
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 26 KGDLKQFLLATRKDSKDKS-GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
G+L +L + R + L+ + ++QVA G+E ++ ++ IH+D+A
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 175
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYA 143
ARN L+S VKI GL++D Y+ Y + +A LPL+W+ E +FD ++ +SDV++
Sbjct: 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 144 YACLIWEIFNKGEMPFPDLS-DDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCI 196
+ L+WEIF+ G P+P + D++ +L+ + C
Sbjct: 236 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT-------TPEMYQTMLDCW 288
Query: 197 HPHPHQRPTFPSIVTQLSDAMCNDVNS 223
H P QRPTF +V L + + +
Sbjct: 289 HGEPSQRPTFSELVEHLGNLLQANAQQ 315
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 7e-54
Identities = 67/206 (32%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVR-SLSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
KG+L+++L A R + S + LS+ V+ AYQVA G+E+++ K+ IH+D+A
Sbjct: 159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYA 143
ARN L++ D +KI+ GL++D + +YY K N LP++W+ EA+FD ++ +SDV++
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL------CWKHSSKTPEYITSLHEKCIH 197
+ L+WEIF G P+P + +++ L+ C + + C H
Sbjct: 279 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC-------TNELYMMMRDCWH 331
Query: 198 PHPHQRPTFPSIVTQLSDAMCNDVNS 223
P QRPTF +V L + N
Sbjct: 332 AVPSQRPTFKQLVEDLDRIVALTSNQ 357
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-53
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL FL + + + ST + + QVA G+ ++ K IH+D+AA
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIAN-STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA 192
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RN L+++ KI GL++D Y + NA LP++W+ E++FD ++ +SDV++Y
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252
Query: 145 ACLIWEIFNKGEMPFP-DLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIH 197
L+WEIF+ G P+P L + + ++ P+ I S+ + C
Sbjct: 253 GILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA-------PKNIYSIMQACWA 305
Query: 198 PHPHQRPTFPSIVTQLSDAMCNDVN 222
P RPTF I + L + D
Sbjct: 306 LEPTHRPTFQQICSFLQEQAQEDRR 330
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-52
Identities = 52/199 (26%), Positives = 102/199 (51%), Gaps = 30/199 (15%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL QF+ + + R+ + ++ QVA G+E++++++ +H+D+AA
Sbjct: 107 HGDLLQFIRSPQ--------------RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAA 152
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYR---NAILPLRWLPYEAVFDDEFSTKSDVY 142
RNC++ +VK++ GL++D +EYY + +A LP++W E++ F+TKSDV+
Sbjct: 153 RNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVW 212
Query: 143 AYACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCI 196
++ L+WE+ +G P+ + + L + C P+ + + ++C
Sbjct: 213 SFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYC-------PDSLYQVMQQCW 265
Query: 197 HPHPHQRPTFPSIVTQLSD 215
P RPTF +V ++
Sbjct: 266 EADPAVRPTFRVLVGEVEQ 284
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-52
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRS-LSTSQAVTMAYQVALGLEHISDKRLIHKDIA 84
G+L FL +R D + + S LS+ Q + A VA G++++S K+ IH+D+A
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 169
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
ARN L+ + KI+ GLS+ + Y K LP+RW+ E++ ++T SDV++Y
Sbjct: 170 ARNILVGENYVAKIADFGLSRGQ--EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHP 198
L+WEI + G P+ ++ ++ +L C + + L +C
Sbjct: 228 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC-------DDEVYDLMRQCWRE 280
Query: 199 HPHQRPTFPSIVTQLSDAMCNDVNS 223
P++RP+F I+ L + M + +
Sbjct: 281 KPYERPSFAQILVSL-NRMLEERKT 304
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-52
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L+ FL + SL + + AYQ++ L ++ KR +H+DIAA
Sbjct: 99 LGELRSFLQVRK--------------YSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 144
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L+SS+ VK+ GLS+ YYK LP++W+ E++ F++ SDV+ +
Sbjct: 145 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 204
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
+WEI G PF + ++ V+ ++E+ C P + SL KC
Sbjct: 205 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-------PPTLYSLMTKCWAYD 257
Query: 200 PHQRPTFPSIVTQLSD 215
P +RP F + QLS
Sbjct: 258 PSRRPRFTELKAQLST 273
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-52
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGK--------PRVRSLSTSQAVTMAYQVALGLEHISDKR 77
GDL +L + R+ + + + L+ + AYQVA G+E + K
Sbjct: 133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192
Query: 78 LIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFS 136
+H+D+AARN L++ VKI GL++D Y NA LP++W+ E++F+ ++
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 252
Query: 137 TKSDVYAYACLIWEIFNKGEMPFPDLS-DDQVLSQLESK------KLCWKHSSKTPEYIT 189
KSDV++Y L+WEIF+ G P+P + D +++ E I
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA-------TEEIY 305
Query: 190 SLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDVNS 223
+ + C +RP+FP++ + L + + +
Sbjct: 306 IIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-52
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDLK FL TR S SL+ + +A +A G +++ + IH+DIAA
Sbjct: 117 GGDLKSFLRETRPRPSQPS--------SLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 168
Query: 86 RNCLIS---SDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDV 141
RNCL++ KI G+++D Y+ YY K A+LP++W+P EA + F++K+D
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 228
Query: 142 YAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPH 201
+++ L+WEIF+ G MP+P S+ +VL + S P + + +C P
Sbjct: 229 WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPE 287
Query: 202 QRPTFPSIVTQLSDAMCND 220
RP F I+ ++ + D
Sbjct: 288 DRPNFAIILERI-EYCTQD 305
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-52
Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 30/199 (15%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL+ F+ + + + QVA G+++++ K+ +H+D+AA
Sbjct: 111 HGDLRNFIRNET--------------HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAA 156
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKY---RNAILPLRWLPYEAVFDDEFSTKSDVY 142
RNC++ +VK++ GL++D Y KEYY A LP++W+ E++ +F+TKSDV+
Sbjct: 157 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 216
Query: 143 AYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL------CWKHSSKTPEYITSLHEKCI 196
++ L+WE+ +G P+PD++ + L + C P+ + + KC
Sbjct: 217 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC-------PDPLYEVMLKCW 269
Query: 197 HPHPHQRPTFPSIVTQLSD 215
HP RP+F +V+++S
Sbjct: 270 HPKAEMRPSFSELVSRISA 288
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-52
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 27/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L +L + + L SQ + M Y V G+ + + IH+D+AA
Sbjct: 87 NGCLLNYL--------------RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAA 132
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNCL+ DL VK+S G+++ +Y P++W E ++S+KSDV+A+
Sbjct: 133 RNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFG 192
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
L+WE+F+ G+MP+ ++ +V+ ++ L + I + C H
Sbjct: 193 ILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLA-------SDTIYQIMYSCWHEL 245
Query: 200 PHQRPTFPSIVTQLSD 215
P +RPTF +++ +
Sbjct: 246 PEKRPTFQQLLSSIEP 261
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-51
Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 27/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L +L + +V +L V + Q+ + ++ +H+DIA
Sbjct: 96 YGELGHYL---------ERNKNSLKVLTL-----VLYSLQICKAMAYLESINCVHRDIAV 141
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L++S VK+ GLS+ ++YYK LP++W+ E++ F+T SDV+ +A
Sbjct: 142 RNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFA 201
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
+WEI + G+ PF L + V+ LE LC P + +L +C
Sbjct: 202 VCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC-------PPVLYTLMTRCWDYD 254
Query: 200 PHQRPTFPSIVTQLSD 215
P RP F +V LSD
Sbjct: 255 PSDRPRFTELVCSLSD 270
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-51
Identities = 54/199 (27%), Positives = 101/199 (50%), Gaps = 30/199 (15%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDL+ F+ + + + QVA G++ ++ K+ +H+D+AA
Sbjct: 175 HGDLRNFIRNET--------------HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA 220
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYR---NAILPLRWLPYEAVFDDEFSTKSDVY 142
RNC++ +VK++ GL++D Y KE+ A LP++W+ E++ +F+TKSDV+
Sbjct: 221 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 280
Query: 143 AYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL------CWKHSSKTPEYITSLHEKCI 196
++ L+WE+ +G P+PD++ + L + C P+ + + KC
Sbjct: 281 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC-------PDPLYEVMLKCW 333
Query: 197 HPHPHQRPTFPSIVTQLSD 215
HP RP+F +V+++S
Sbjct: 334 HPKAEMRPSFSELVSRISA 352
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-51
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GDLK FL TR S SL+ + +A +A G +++ + IH+DIAA
Sbjct: 158 GGDLKSFLRETRPRPSQPS--------SLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 209
Query: 86 RNCLIS---SDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDV 141
RNCL++ KI G+++D Y+ YY K A+LP++W+P EA + F++K+D
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 269
Query: 142 YAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPH 201
+++ L+WEIF+ G MP+P S+ +VL + S P + + +C P
Sbjct: 270 WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPE 328
Query: 202 QRPTFPSIVTQLSDAMCND 220
RP F I+ ++ + D
Sbjct: 329 DRPNFAIILERI-EYCTQD 346
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-51
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 26/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L FL K+ SG L+ ++ + MA Q+A G+ I ++ IH+D+ A
Sbjct: 91 NGSLVDFL---------KTPSGI----KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA 137
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
N L+S LS KI+ GL++ EY A P++W EA+ F+ KSDV+++
Sbjct: 138 ANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
L+ EI G +P+P +++ +V+ LE C PE + L C
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-------PEELYQLMRLCWKER 250
Query: 200 PHQRPTFPSIVTQLSD 215
P RPTF + + L D
Sbjct: 251 PEDRPTFDYLRSVLED 266
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-50
Identities = 44/196 (22%), Positives = 92/196 (46%), Gaps = 27/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L +L ++ G + + M V G+ ++ + +IH+D+AA
Sbjct: 87 HGCLSDYL---------RTQRGL-----FAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 132
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNCL+ + +K+S G+++ +Y P++W E +S+KSDV+++
Sbjct: 133 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG 192
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
L+WE+F++G++P+ + S+ +V+ + + +L ++ + C
Sbjct: 193 VLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA-------STHVYQIMNHCWRER 245
Query: 200 PHQRPTFPSIVTQLSD 215
P RP F ++ QL++
Sbjct: 246 PEDRPAFSRLLRQLAE 261
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-50
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 27/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L +L + + T Q + M V +E++ K+ +H+D+AA
Sbjct: 103 NGCLLNYL---------REMRHR-----FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 148
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNCL++ VK+S GLS+ EY + P+RW P E + +FS+KSD++A+
Sbjct: 149 RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 208
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
L+WEI++ G+MP+ ++ + + L E + ++ C H
Sbjct: 209 VLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA-------SEKVYTIMYSCWHEK 261
Query: 200 PHQRPTFPSIVTQLSD 215
+RPTF +++ + D
Sbjct: 262 ADERPTFKILLSNILD 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-49
Identities = 46/197 (23%), Positives = 89/197 (45%), Gaps = 28/197 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L ++ ++ KD + + + Q+A G+ ++ D+RL+H+D+AA
Sbjct: 100 FGCLLDYV----REHKDN----------IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RN L+ + VKI+ GL+K +E Y +P++W+ E++ ++ +SDV++Y
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHP 198
+WE+ G P+ + ++ S LE +C + + KC
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-------TIDVYMIMRKCWMI 258
Query: 199 HPHQRPTFPSIVTQLSD 215
RP F ++ + S
Sbjct: 259 DADSRPKFRELIIEFSK 275
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-49
Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 26/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L +L + + +S + MA Q++ +E++ K IH+D+AA
Sbjct: 93 YGNLLDYLRECNR-------------QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 139
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNCL+ + VK++ GLS+ Y + A P++W E++ ++FS KSDV+A+
Sbjct: 140 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
L+WEI G P+P + QV LE + C PE + L C +
Sbjct: 200 VLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC-------PEKVYELMRACWQWN 252
Query: 200 PHQRPTFPSIVTQLSD 215
P RP+F I
Sbjct: 253 PSDRPSFAEIHQAFET 268
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-49
Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 30/196 (15%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
KG L +L +S L + + V +E++ +H+D+AA
Sbjct: 99 KGSLVDYL---------RSRGRSV----LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 145
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L+S D K+S GL+K+ LP++W EA+ + +FSTKSDV+++
Sbjct: 146 RNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 201
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
L+WEI++ G +P+P + V+ ++E C P + + + C H
Sbjct: 202 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-------PPAVYEVMKNCWHLD 254
Query: 200 PHQRPTFPSIVTQLSD 215
RP+F + QL
Sbjct: 255 AAMRPSFLQLREQLEH 270
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-49
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 28/197 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
GD FL + L + M A G+E++ K IH+D+AA
Sbjct: 196 GGDFLTFL--------------RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNA-ILPLRWLPYEAVFDDEFSTKSDVYAY 144
RNCL++ +KIS G+S++ Y +P++W EA+ +S++SDV+++
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHP 198
L+WE F+ G P+P+LS+ Q +E +LC P+ + L E+C
Sbjct: 302 GILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELC-------PDAVFRLMEQCWAY 354
Query: 199 HPHQRPTFPSIVTQLSD 215
P QRP+F +I +L
Sbjct: 355 EPGQRPSFSTIYQELQS 371
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-48
Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 29/198 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L FL + + Q V M V G+ ++SD +H+D+AA
Sbjct: 134 NGSLDTFL--------------RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAA 179
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKY--RNAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L+ S+L K+S GLS+ Y +P+RW EA+ FS+ SDV++
Sbjct: 180 RNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWS 239
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIH 197
+ ++WE+ GE P+ ++++ V+S +E C P + L C H
Sbjct: 240 FGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGC-------PHALHQLMLDCWH 292
Query: 198 PHPHQRPTFPSIVTQLSD 215
QRP F IV+ L
Sbjct: 293 KDRAQRPRFSQIVSVLDA 310
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-48
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L+ FL + SL + + AYQ++ L ++ KR +H+DIAA
Sbjct: 474 LGELRSFLQVRK--------------FSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 519
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L+SS+ VK+ GLS+ YYK LP++W+ E++ F++ SDV+ +
Sbjct: 520 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG 579
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
+WEI G PF + ++ V+ ++E+ C P + SL KC
Sbjct: 580 VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-------PPTLYSLMTKCWAYD 632
Query: 200 PHQRPTFPSIVTQLSD 215
P +RP F + QLS
Sbjct: 633 PSRRPRFTELKAQLST 648
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-47
Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 26/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
KG L FL K +GK L Q V MA Q+A G+ ++ +H+D+ A
Sbjct: 262 KGSLLDFL---------KGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 308
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
N L+ +L K++ GL++ EY + A P++W EA F+ KSDV+++
Sbjct: 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 368
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
L+ E+ KG +P+P + + +VL Q+E C PE + L +C
Sbjct: 369 ILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-------PESLHDLMCQCWRKE 421
Query: 200 PHQRPTFPSIVTQLSD 215
P +RPTF + L D
Sbjct: 422 PEERPTFEYLQAFLED 437
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-47
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L +FL + G+ S Q V M +A G++++++ +H+D+AA
Sbjct: 130 NGALDKFL---------REKDGE-----FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKY--RNAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L++S+L K+S GLS+ Y +P+RW EA+ +F++ SDV++
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 235
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIH 197
+ ++WE+ GE P+ +LS+ +V+ + C P I L +C
Sbjct: 236 FGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-------PSAIYQLMMQCWQ 288
Query: 198 PHPHQRPTFPSIVTQLSD 215
+RP F IV+ L
Sbjct: 289 QERARRPKFADIVSILDK 306
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-47
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 29/198 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L FL + + + Q V M +A G++++SD +H+D+AA
Sbjct: 130 NGSLDSFL---------RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 175
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKY--RNAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN LI+S+L K+S GL + Y R +P+RW EA+ +F++ SDV++
Sbjct: 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWS 235
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIH 197
Y ++WE+ + GE P+ ++S+ V+ ++ C P + L C
Sbjct: 236 YGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC-------PAALYQLMLDCWQ 288
Query: 198 PHPHQRPTFPSIVTQLSD 215
+ RP F IV+ L
Sbjct: 289 KDRNNRPKFEQIVSILDK 306
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-47
Identities = 44/197 (22%), Positives = 87/197 (44%), Gaps = 28/197 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L ++ + ++ + + Q+A G+ ++ D+RL+H+D+AA
Sbjct: 100 FGCLLDYVREHKD--------------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RN L+ + VKI+ GL+K +E Y +P++W+ E++ ++ +SDV++Y
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 205
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHP 198
+WE+ G P+ + ++ S LE +C + + KC
Sbjct: 206 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-------TIDVYMIMVKCWMI 258
Query: 199 HPHQRPTFPSIVTQLSD 215
RP F ++ + S
Sbjct: 259 DADSRPKFRELIIEFSK 275
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-46
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 30/207 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L L + A QVA G+ ++ KR IH+D+AA
Sbjct: 104 LGSLLDRLRKHQ--------------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAA 149
Query: 86 RNCLISSDLSVKISLSGLSKDTYQ--KEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L+++ VKI GL + Q Y + +P W E++ FS SD +
Sbjct: 150 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 209
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESK-------KLCWKHSSKTPEYITSLHEKCI 196
+ +WE+F G+ P+ L+ Q+L +++ + + C P+ I ++ +C
Sbjct: 210 FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC-------PQDIYNVMVQCW 262
Query: 197 HPHPHQRPTFPSIVTQLSDAMCNDVNS 223
P RPTF ++ L +A D+ +
Sbjct: 263 AHKPEDRPTFVALRDFLLEAQPTDMRA 289
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-46
Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 26/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
KG L FL K +GK L Q V MA Q+A G+ ++ +H+D+ A
Sbjct: 345 KGSLLDFL---------KGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 391
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
N L+ +L K++ GL++ EY + A P++W EA F+ KSDV+++
Sbjct: 392 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 451
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
L+ E+ KG +P+P + + +VL Q+E C PE + L +C
Sbjct: 452 ILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-------PESLHDLMCQCWRKE 504
Query: 200 PHQRPTFPSIVTQLSD 215
P +RPTF + L D
Sbjct: 505 PEERPTFEYLQAFLED 520
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-46
Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 26/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
KG L FL KS G + + + Q+A G+ I + IH+D+ A
Sbjct: 266 KGSLLDFL---------KSDEGSK----QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 312
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
N L+S+ L KI+ GL++ EY A P++W EA+ F+ KSDV+++
Sbjct: 313 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 372
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
L+ EI G +P+P +S+ +V+ LE + C PE + ++ +C
Sbjct: 373 ILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC-------PEELYNIMMRCWKNR 425
Query: 200 PHQRPTFPSIVTQLSD 215
P +RPTF I + L D
Sbjct: 426 PEERPTFEYIQSVLDD 441
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-46
Identities = 40/197 (20%), Positives = 83/197 (42%), Gaps = 28/197 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L + R +L + Q+A G+ ++ + ++H+++AA
Sbjct: 98 LGSLLDHVRQHR--------------GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAA 143
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RN L+ S V+++ G++ + Y A P++W+ E++ +++ +SDV++Y
Sbjct: 144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY 203
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHP 198
+WE+ G P+ L +V LE ++C + + KC
Sbjct: 204 GVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQIC-------TIDVYMVMVKCWMI 256
Query: 199 HPHQRPTFPSIVTQLSD 215
+ RPTF + + +
Sbjct: 257 DENIRPTFKELANEFTR 273
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-46
Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 29/198 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L +FL+ R + S + +QV++G++++ +K +H+D+AA
Sbjct: 93 GGPLHKFLVGKR--------------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 138
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L+ + KIS GLSK + Y PL+W E + +FS++SDV++
Sbjct: 139 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 198
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIH 197
Y +WE + G+ P+ + +V++ +E C P + +L C
Sbjct: 199 YGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-------PPELYALMSDCWI 251
Query: 198 PHPHQRPTFPSIVTQLSD 215
RP F ++ ++
Sbjct: 252 YKWEDRPDFLTVEQRMRA 269
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-46
Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 30/198 (15%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L ++L +++ R + + + +QV++G++++ + +H+D+AA
Sbjct: 101 LGPLNKYL---QQN------------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAA 145
Query: 86 RNCLISSDLSVKISLSGLSKDTY--QKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L+ + KIS GLSK + Y + P++W E + +FS+KSDV++
Sbjct: 146 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 205
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLES------KKLCWKHSSKTPEYITSLHEKCIH 197
+ L+WE F+ G+ P+ + +V + LE C P + L C
Sbjct: 206 FGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-------PREMYDLMNLCWT 258
Query: 198 PHPHQRPTFPSIVTQLSD 215
RP F ++ +L +
Sbjct: 259 YDVENRPGFAAVELRLRN 276
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 26/196 (13%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L +L + + +S + MA Q++ +E++ K IH+++AA
Sbjct: 300 YGNLLDYLRECNR-------------QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAA 346
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RNCL+ + VK++ GLS+ Y + A P++W E++ ++FS KSDV+A+
Sbjct: 347 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 406
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
L+WEI G P+P + QV LE + C PE + L C +
Sbjct: 407 VLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC-------PEKVYELMRACWQWN 459
Query: 200 PHQRPTFPSIVTQLSD 215
P RP+F I
Sbjct: 460 PSDRPSFAEIHQAFET 475
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-45
Identities = 38/211 (18%), Positives = 78/211 (36%), Gaps = 39/211 (18%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L +L + ++ + +A Q+A + + + LIH ++ A
Sbjct: 96 FGSLDTYLKKNK--------------NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCA 141
Query: 86 RNCLISSD--------LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFS 136
+N L+ + +K+S G+S K+ + + W+P E + + +
Sbjct: 142 KNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ-----ERIPWVPPECIENPKNLN 196
Query: 137 TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES----KKLCWKHSSKTPEYITSLH 192
+D +++ +WEI + G+ P L + L E +L
Sbjct: 197 LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKA-----AELA--NLI 249
Query: 193 EKCIHPHPHQRPTFPSIVTQLSDAMCNDVNS 223
C+ P RP+F +I+ L+ D+
Sbjct: 250 NNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 8e-45
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 30/201 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
KG L +L R + L + + V +E++ +H+D+AA
Sbjct: 271 KGSLVDYL---RSRGR----------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 317
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L+S D K+S GL+K+ LP++W EA+ + +FSTKSDV+++
Sbjct: 318 RNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 373
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPH 199
L+WEI++ G +P+P + V+ ++E C P + + + C H
Sbjct: 374 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-------PPAVYDVMKNCWHLD 426
Query: 200 PHQRPTFPSIVTQLSDAMCND 220
RPTF + QL ++
Sbjct: 427 AATRPTFLQLREQLEHIRTHE 447
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-43
Identities = 54/177 (30%), Positives = 92/177 (51%), Gaps = 15/177 (8%)
Query: 49 PRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY 108
L+ + ++QVA G+E ++ ++ IH+D+AARN L+S VKI GL++D Y
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 109 QKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS-DDQ 166
+ Y + +A LPL+W+ E +FD ++ +SDV+++ L+WEIF+ G P+P + D++
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304
Query: 167 VLSQLESK------KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217
+L+ + C H P QRPTF +V L + +
Sbjct: 305 FCRRLKEGTRMRAPDYT-------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-42
Identities = 46/212 (21%), Positives = 86/212 (40%), Gaps = 45/212 (21%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L+ +L S+ +Q + A Q+ G+ ++ + IH+D+AA
Sbjct: 119 LGSLRDYL----------------PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAA 162
Query: 86 RNCLISSDLSVKISLSGLSKDTYQ-KEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L+ +D VKI GL+K + EYY+ R + P+ W E + + +F SDV++
Sbjct: 163 RNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWS 222
Query: 144 YACLIWEIFNKGE--------------MPFPDLSDDQVLSQLESKK------LCWKHSSK 183
+ ++E+ + + ++ ++ LE + C
Sbjct: 223 FGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKC------ 276
Query: 184 TPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
P + L + C RPTF +++ L
Sbjct: 277 -PAEVYHLMKNCWETEASFRPTFENLIPILKT 307
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-42
Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 29/198 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L +FL+ R + S + +QV++G++++ +K +H+++AA
Sbjct: 419 GGPLHKFLVGKR--------------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAA 464
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L+ + KIS GLSK + Y PL+W E + +FS++SDV++
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 524
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESKK------LCWKHSSKTPEYITSLHEKCIH 197
Y +WE + G+ P+ + +V++ +E K C P + +L C
Sbjct: 525 YGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-------PPELYALMSDCWI 577
Query: 198 PHPHQRPTFPSIVTQLSD 215
RP F ++ ++
Sbjct: 578 YKWEDRPDFLTVEQRMRA 595
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-42
Identities = 44/213 (20%), Positives = 91/213 (42%), Gaps = 44/213 (20%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L+ +L ++ + + + Q+ G+E++ KR IH+D+A
Sbjct: 97 YGSLRDYLQKHKE--------------RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 142
Query: 86 RNCLISSDLSVKISLSGLSKD-TYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L+ ++ VKI GL+K KE++K + P+ W E++ + +FS SDV++
Sbjct: 143 RNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWS 202
Query: 144 YACLIWEIF---------------NKGEMPFPDLSDDQVLSQLESKK------LCWKHSS 182
+ +++E+F G + ++ L++ C
Sbjct: 203 FGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC----- 257
Query: 183 KTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
P+ I + +C + + +QRP+F + ++
Sbjct: 258 --PDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-42
Identities = 46/213 (21%), Positives = 91/213 (42%), Gaps = 44/213 (20%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L+ +L ++ + + + Q+ G+E++ KR IH+D+A
Sbjct: 128 YGSLRDYLQKHKE--------------RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 173
Query: 86 RNCLISSDLSVKISLSGLSKD-TYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L+ ++ VKI GL+K KEYYK + P+ W E++ + +FS SDV++
Sbjct: 174 RNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWS 233
Query: 144 YACLIWEIF---------------NKGEMPFPDLSDDQVLSQLESKK------LCWKHSS 182
+ +++E+F G + ++ L++ C
Sbjct: 234 FGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC----- 288
Query: 183 KTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
P+ I + +C + + +QRP+F + ++
Sbjct: 289 --PDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-41
Identities = 44/212 (20%), Positives = 87/212 (41%), Gaps = 43/212 (20%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G LK++L + ++ Q + A Q+ G++++ ++ +H+D+AA
Sbjct: 109 SGSLKEYLPKNKN--------------KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAA 154
Query: 86 RNCLISSDLSVKISLSGLSKDTYQ-KEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L+ S+ VKI GL+K KEYY + + P+ W E + +F SDV++
Sbjct: 155 RNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWS 214
Query: 144 YACLIWEIFNKGEM--------------PFPDLSDDQVLSQLESKK------LCWKHSSK 183
+ + E+ + ++ ++++ L+ K C
Sbjct: 215 FGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNC------ 268
Query: 184 TPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
P+ + L KC P R +F +++
Sbjct: 269 -PDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-40
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 43/212 (20%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L+ FL R L S+ + + Q+ G+E++ +R +H+D+AA
Sbjct: 110 SGCLRDFLQRHRA--------------RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA 155
Query: 86 RNCLISSDLSVKISLSGLSKD-TYQKEYYKYR-NAILPLRWLPYEAVFDDEFSTKSDVYA 143
RN L+ S+ VKI+ GL+K K+YY R P+ W E++ D+ FS +SDV++
Sbjct: 156 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 215
Query: 144 YACLIWEIFNKGEMPF--------------PDLSDDQVLSQLESKK------LCWKHSSK 183
+ +++E+F + + ++L LE + C
Sbjct: 216 FGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPAC------ 269
Query: 184 TPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
P + L + C P P RP+F ++ QL
Sbjct: 270 -PAEVHELMKLCWAPSPQDRPSFSALGPQLDM 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-33
Identities = 39/172 (22%), Positives = 87/172 (50%), Gaps = 9/172 (5%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
+ + +A Q A G++++ K +IH+D+ + N + D +VKI GL+ + +
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
Query: 112 YYKYRNAIL-PLRWLPYEAVFDDE---FSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQ 166
+ + W+ E + + +S +SDVYA+ +++E+ G++P+ ++++ DQ
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQ 233
Query: 167 VLSQLESKKL---CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
++ + L K S P+ + L +C+ +RP+FP I+ ++ +
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-29
Identities = 41/192 (21%), Positives = 81/192 (42%), Gaps = 25/192 (13%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLE--HISDKRLIHKDIA 84
G L L + + SQAV A +A G+ H + + +
Sbjct: 94 GSLYNVLH-------------EGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN 140
Query: 85 ARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD---DEFSTKSDV 141
+R+ +I D++ +IS++ + + W+ EA+ D +D+
Sbjct: 141 SRSVMIDEDMTARISMADVKFSFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADM 194
Query: 142 YAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPH 201
+++A L+WE+ E+PF DLS+ ++ ++ + L +++ L + C++ P
Sbjct: 195 WSFAVLLWELVT-REVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPA 253
Query: 202 QRPTFPSIVTQL 213
+RP F IV L
Sbjct: 254 KRPKFDMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-29
Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHI---SDKRLIHKDIAARNCLIS--------SDLSVKI 98
+ + V A Q+A G+ ++ + +IH+D+ + N LI S+ +KI
Sbjct: 98 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157
Query: 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMP 158
+ GL+++ ++ +A W+ E + FS SDV++Y L+WE+ GE+P
Sbjct: 158 TDFGLAREWHRTTKM---SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVP 213
Query: 159 FPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
F + V + KL S PE L E C +P PH RP+F +I+ QL+
Sbjct: 214 FRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 36/204 (17%), Positives = 74/204 (36%), Gaps = 29/204 (14%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G L+ + K SQ V+ A +A G+ ++ +IH+D+ +
Sbjct: 91 GGTLRGII-------KSMDSQ-------YPWSQRVSFAKDIASGMAYLHSMNIIHRDLNS 136
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPL-------------RWLPYEAVFD 132
NCL+ + +V ++ GL++ ++ L W+ E +
Sbjct: 137 HNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING 196
Query: 133 DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKH-SSKTPEYITSL 191
+ K DV+++ ++ EI + PD + L + ++ P +
Sbjct: 197 RSYDEKVDVFSFGIVLCEIIGRVN-ADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPI 255
Query: 192 HEKCIHPHPHQRPTFPSIVTQLSD 215
+C P +RP+F + L
Sbjct: 256 TVRCCDLDPEKRPSFVKLEHWLET 279
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-28
Identities = 43/190 (22%), Positives = 87/190 (45%), Gaps = 16/190 (8%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLE--HISDKRLIHKDI 83
+G L + L L + ++MAY VA G+ H + ++H+++
Sbjct: 118 RGSLYRLLH------------KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNL 165
Query: 84 AARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYA 143
+ N L+ +VK+ GLS+ + ++A W+ E + D+ + KSDVY+
Sbjct: 166 KSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYS 224
Query: 144 YACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
+ ++WE+ + P+ +L+ QV++ + K + + ++ E C P +R
Sbjct: 225 FGVILWELAT-LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
Query: 204 PTFPSIVTQL 213
P+F +I+ L
Sbjct: 284 PSFATIMDLL 293
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-27
Identities = 33/177 (18%), Positives = 66/177 (37%), Gaps = 15/177 (8%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS---LSGLSKDTY 108
L ++ +A ++ G+ ++ K ++HKD+ ++N + V I+ L +S
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQ 183
Query: 109 QKEYYKYRNAIL---------PLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMP 158
+R L + D FS SDV+A + +E+ E P
Sbjct: 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWP 242
Query: 159 FPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
F + ++ Q+ + + I+ + C +RPTF ++ L
Sbjct: 243 FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-24
Identities = 38/178 (21%), Positives = 80/178 (44%), Gaps = 18/178 (10%)
Query: 50 RVRSLSTSQAVTMAYQVALGLE--HISDKRLIHKDIAARNCLISS-----DLSVKISLSG 102
+ + S + + +ALG+E + ++H+D+ + N + S + K++ G
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 103 LSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE---FSTKSDVYAYACLIWEIFNKGEMPF 159
LS+ + + +W+ E E ++ K+D Y++A +++ I GE PF
Sbjct: 175 LSQQ----SVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILT-GEGPF 228
Query: 160 PDLSDDQV--LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ S ++ ++ + + L P + ++ E C P +RP F IV +LS+
Sbjct: 229 DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-21
Identities = 41/197 (20%), Positives = 71/197 (36%), Gaps = 22/197 (11%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHI---SDKRLIHKD 82
G L L + + A++ Q + G+ ++ K LIH+D
Sbjct: 83 GGSLYNVLHGAEPLPY------------YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 83 IAARNCLISSDLSV-KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDV 141
+ N L+ + +V KI G + D N W+ E +S K DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 142 YAYACLIWEIFNKGEMPFPDLSD-DQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHP 200
+++ ++WE+ PF ++ + P+ I SL +C P
Sbjct: 187 FSWGIILWEVI-TRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDP 245
Query: 201 HQRPTFPSIVTQLSDAM 217
QRP+ IV ++ M
Sbjct: 246 SQRPSMEEIVKIMTHLM 262
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-18
Identities = 34/201 (16%), Positives = 72/201 (35%), Gaps = 38/201 (18%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRL--------IHKDIAARNCLISSDLSVKISLSGL 103
+L + +AY GL H+ + H+D+ ++N L+ + + I+ GL
Sbjct: 129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188
Query: 104 SKDTYQKEYYKYRNAILP---LRWLPYEAVFDD-------EFSTKSDVYAYACLIWEIF- 152
+ R++P E V D+ + +D+Y++ ++WE+
Sbjct: 189 AVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
Query: 153 --------NKGEMPFPDLSDDQVLSQLESKKLCWK----------HSSKTPEYITSLHEK 194
+ ++P+ DL + + +C K S + + L +
Sbjct: 248 RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE 307
Query: 195 CIHPHPHQRPTFPSIVTQLSD 215
C +P R T + L+
Sbjct: 308 CWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-18
Identities = 34/203 (16%), Positives = 76/203 (37%), Gaps = 38/203 (18%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHI--------SDKRLIHKDIAARNCLISSDLSVKIS-- 99
++ +L T + + +A GL H+ + H+D+ ++N L+ + I+
Sbjct: 98 QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157
Query: 100 -LSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-------EFSTKSDVYAYACLIWEI 151
L+ + + + + R++ E V D+ + + D++A+ ++WE+
Sbjct: 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
Query: 152 F---------NKGEMPFPDLSDDQVLSQLESKKLCWKH----------SSKTPEYITSLH 192
+ PF D+ + + K +C S T + L
Sbjct: 217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLM 276
Query: 193 EKCIHPHPHQRPTFPSIVTQLSD 215
++C + +P R T I L+
Sbjct: 277 KECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 41/231 (17%), Positives = 80/231 (34%), Gaps = 62/231 (26%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHI--------SDKR 77
G L +L +++ + +A A GL H+
Sbjct: 124 HGSLFDYL----------------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167
Query: 78 LIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILP------LRWLPYEAVF 131
+ H+D+ ++N L+ + + I+ GL+ + + I P R++ E V
Sbjct: 168 IAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYMAPE-VL 223
Query: 132 DD-------EFSTKSDVYAYACLIWEIFNK--------------GEMPFPDLSDDQVLSQ 170
DD E ++D+YA + WEI + ++ D S +++
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283
Query: 171 LESKKL------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ +KL W S + + + +C + + R T I LS
Sbjct: 284 VCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-16
Identities = 30/203 (14%), Positives = 72/203 (35%), Gaps = 38/203 (18%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHI----------SDKRLIHKDIAARNCLISSDLSVKIS 99
+ +S ++ +A +A GL ++ + H+DI ++N L+ ++L+ I+
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 100 LSGLSKDTYQKEYYKYRNAILP-LRWLP-----YEAVFDDEFSTKSDVYAYACLIWEIFN 153
GL+ + + + R++ F + + D+YA ++WE+ +
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 154 ----------KGEMPF-----PDLSDDQVLSQLESKKL------CWKHSSKTPEYITSLH 192
+ +PF S + + + KK W +
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW-QKHAGMAMLCETI 292
Query: 193 EKCIHPHPHQRPTFPSIVTQLSD 215
E+C R + + +++
Sbjct: 293 EECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 8e-16
Identities = 35/213 (16%), Positives = 70/213 (32%), Gaps = 48/213 (22%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHI---------SDKRLIHKDIAARNCLISSDLSVKISL 100
+ + + +A+ V GL ++ + H+D+ +RN L+ +D + IS
Sbjct: 104 SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 101 SGLSKDTYQKEYYKYRNAILP-------LRWLPYEAVFDDEFST--------KSDVYAYA 145
GLS + +R++ E V + + + D+YA
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALG 222
Query: 146 CLIWEIFNKGE------------MPFPDL-----SDDQVLSQLESKKL------CWKHSS 182
+ WEIF + M F + + + + +K WK +S
Sbjct: 223 LIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282
Query: 183 KTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ E C R T ++++
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 4e-11
Identities = 29/153 (18%), Positives = 62/153 (40%), Gaps = 17/153 (11%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRW 124
Q+A +E + K L+H+D+ N + D VK+ GL Q E + +P
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 125 L-------PY----EAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQVLSQLE 172
E + + +S K D+++ +++E+ F + ++++ +
Sbjct: 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL----YSFSTQMERVRIITDVR 287
Query: 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
+ K + K P+ + + + P P +RP
Sbjct: 288 NLKFPLLFTQKYPQ-EHMMVQDMLSPSPTERPE 319
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-11
Identities = 36/192 (18%), Positives = 74/192 (38%), Gaps = 29/192 (15%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
K +LK ++ +G+ + S + + Q+A +E + K L+H+D+
Sbjct: 99 KENLKDWM------------NGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKP 146
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWL-------PY----EAVFDDE 134
N + D VK+ GL Q E + +P E + +
Sbjct: 147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206
Query: 135 FSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQVLSQLESKKLCWKHSSKTPEYITSLHE 193
+S K D+++ +++E+ PF + + L+ + + K + K P + +
Sbjct: 207 YSHKVDIFSLGLILFELL----YPFSTQMERVRTLTDVRNLKFPPLFTQKYPC-EYVMVQ 261
Query: 194 KCIHPHPHQRPT 205
+ P P +RP
Sbjct: 262 DMLSPSPMERPE 273
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-10
Identities = 35/184 (19%), Positives = 75/184 (40%), Gaps = 22/184 (11%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
KG L+Q++ + + G L A+ + Q+ G+++I K+LI++D+
Sbjct: 104 KGTLEQWI-------EKRRG------EKLDKVLALELFEQITKGVDYIHSKKLINRDLKP 150
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
N + VKI GL + + + + R+ ++ E + ++ + D+YA
Sbjct: 151 SNIFLVDTKQVKIGDFGLVT-SLKNDGKRTRSKGTLR-YMSPEQISSQDYGKEVDLYALG 208
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
++ E+ + + F + + L + S + +L +K + P RP
Sbjct: 209 LILAELLHVCDTAF---ETSKFFTDLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPN 261
Query: 206 FPSI 209
I
Sbjct: 262 TSEI 265
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-10
Identities = 31/160 (19%), Positives = 57/160 (35%), Gaps = 11/160 (6%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
SL +Q L L H+ + L+H D+ N + K+ GL +
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211
Query: 112 YYKYRNAIL--PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169
P R++ E + + T +DV++ I E+ E+P +
Sbjct: 212 ---AGEVQEGDP-RYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPH----GGEGWQ 262
Query: 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
QL L + ++ + S+ + P P R T ++
Sbjct: 263 QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 5e-10
Identities = 25/192 (13%), Positives = 60/192 (31%), Gaps = 22/192 (11%)
Query: 23 PRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKD 82
P DL+ + G + L Q+ ++ K L+H
Sbjct: 168 PAASVDLELLFSTLDFVYVFRGDEGILALHIL--------TAQLIRLAANLQSKGLVHGH 219
Query: 83 IAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE--FSTKSD 140
N I D + + K + + +P+ + P E + F+ +
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALN 275
Query: 141 VYAYACLIWEIFNKGEMPFPDLSDDQ-------VLSQLESKKLCWKHSSKTPEYITSLHE 193
+ I+ ++ +PF ++ L + L + + P+++ +L
Sbjct: 276 AWQLGLSIYRVWC-LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG 334
Query: 194 KCIHPHPHQRPT 205
+ ++ +R
Sbjct: 335 RFLNFDRRRRLL 346
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-09
Identities = 42/207 (20%), Positives = 80/207 (38%), Gaps = 36/207 (17%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
+G L + KD + L+ Q + + + GLE I K H+D+
Sbjct: 114 RGTLWNEI-ERLKDKGNF----------LTEDQILWLLLGICRGLEAIHAKGYAHRDLKP 162
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRW------LPYEA--VFDDE--- 134
N L+ + + G R A+ W + Y A +F +
Sbjct: 163 TNILLGDEGQPVLMDLGSMN-QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC 221
Query: 135 -FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPE---YITS 190
++DV++ C+++ + GE P+ D V + +S L ++ P+ + ++
Sbjct: 222 VIDERTDVWSLGCVLYAMMF-GEGPY-----DMVFQKGDSVALAVQNQLSIPQSPRHSSA 275
Query: 191 LHE---KCIHPHPHQRPTFPSIVTQLS 214
L + + PHQRP P +++QL
Sbjct: 276 LWQLLNSMMTVDPHQRPHIPLLLSQLE 302
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 1e-08
Identities = 19/165 (11%), Positives = 50/165 (30%), Gaps = 13/165 (7%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS------LSGLSK 105
+SL + + QV L + L+H + + ++ V ++ G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV 260
Query: 106 DTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD 165
+ ++ + Y + D +A +I+ I+ ++P +
Sbjct: 261 VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW-CADLPITKDAAL 319
Query: 166 QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210
+ ++ P+ + +L E + R +
Sbjct: 320 GGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 30/164 (18%), Positives = 65/164 (39%), Gaps = 17/164 (10%)
Query: 50 RVRSLSTSQAVTMAYQVALGLE--HISDKRLIHKDIAARNCLISSDL-SVKISLSGLSKD 106
R + + + Q+ GL+ H +IH+D+ N I+ SVKI GL+
Sbjct: 122 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT- 180
Query: 107 TYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166
K + I ++ E ++++++ DVYA+ + E+ E P+ + +
Sbjct: 181 --LKRASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMA-TSEYPYSECQNAA 236
Query: 167 VLSQLESKKLCWKHSSKTPEYITSLH-----EKCIHPHPHQRPT 205
+ +++ + + + E CI + +R +
Sbjct: 237 QI----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-08
Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 17/170 (10%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---DLSVKISLS--GLS 104
+ + + +T+ Q GL H+ ++H+D+ N LIS +K +S GL
Sbjct: 111 KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 105 K--DTYQKEYYKYRNAILPLRWLPYEAVFDDEF---STKSDVYAYACLIWEIFNKGEMPF 159
K + + + W+ E + +D + D+++ C+ + + ++G PF
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230
Query: 160 PDLSDDQVLSQLESKKL----CWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
Q L + L KH L EK I P +RP+
Sbjct: 231 GKSLQRQANILLGACSLDCLHPEKHEDVIAR---ELIEKMIAMDPQKRPS 277
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-08
Identities = 24/194 (12%), Positives = 58/194 (29%), Gaps = 22/194 (11%)
Query: 23 PRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKD 82
PR++ +L+ F + S +SL + + QV L + L+H
Sbjct: 185 PRMQSNLQTFG--------EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236
Query: 83 IAARNCLISSDLSVKIS------LSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFS 136
+ + ++ V ++ G S + + + +
Sbjct: 237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHH-PTLMT 295
Query: 137 TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCI 196
D + I+ I+ ++P D + + ++ P+ + +L E +
Sbjct: 296 FAFDTWTLGLAIYWIWC-ADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFL 348
Query: 197 HPHPHQRPTFPSIV 210
R +
Sbjct: 349 RYPKEDRLLPLQAM 362
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-08
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 21/184 (11%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL + + +K + + Q+ LEH+ +R++H+DI
Sbjct: 117 GDLSRMIKHFKKQKR-----------LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPA 165
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
N I++ VK+ GL + K + P ++ E + ++ ++ KSD+++ C
Sbjct: 166 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPERIHENGYNFKSDIWSLGC 224
Query: 147 LIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITS-----LHEKCIHPHPH 201
L++E+ + PF D L L KK+ P S L CI+P P
Sbjct: 225 LLYEMAA-LQSPF--YGDKMNLYSL-CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPE 280
Query: 202 QRPT 205
+RP
Sbjct: 281 KRPD 284
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-08
Identities = 37/183 (20%), Positives = 78/183 (42%), Gaps = 16/183 (8%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
GDL + + A + Q + Q+ L L+H+ D++++H+DI ++
Sbjct: 108 GDLFKRINAQKG-------------VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYAC 146
N ++ D +V++ G+++ P +L E + ++ KSD++A C
Sbjct: 155 NIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY-YLSPEICENKPYNNKSDIWALGC 213
Query: 147 LIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
+++E+ + F S ++ ++ S S + SL + +P RP+
Sbjct: 214 VLYELCT-LKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSV 271
Query: 207 PSI 209
SI
Sbjct: 272 NSI 274
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-08
Identities = 35/198 (17%), Positives = 64/198 (32%), Gaps = 39/198 (19%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
G L + + ++ + QV GL +I L+H DI
Sbjct: 96 GSLADAISENYRIM-----------SYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPS 144
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPL--------------RWLPYEAVFD 132
N IS + +D + ++ L R+L E + +
Sbjct: 145 NIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQE 204
Query: 133 DE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYIT-- 189
+ K+D++A A + G P P D ++ + P+ ++
Sbjct: 205 NYTHLPKADIFALALTVVCAA--GAEPLPRNGDQW-------HEIRQGRLPRIPQVLSQE 255
Query: 190 --SLHEKCIHPHPHQRPT 205
L + IHP P +RP+
Sbjct: 256 FTELLKVMIHPDPERRPS 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-07
Identities = 27/180 (15%), Positives = 54/180 (30%), Gaps = 31/180 (17%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS---LSGLS 104
+ + + Q+ L +I + +IH+D+ N I +VKI L+
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 105 KDTYQKEYYKYRNAILPLRWL------PY--------EAVFDDEFSTKSDVYAYACLIWE 150
+ +N L +E K D+Y+ + +E
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE---KIDMYSLGIIFFE 223
Query: 151 IFNKGEMPFPDLSDDQVLSQLESKKLC-----WKHSSKTPEYITSLHEKCIHPHPHQRPT 205
+ + +L +L S + + K + I P++RP
Sbjct: 224 MIYP---FSTGMERVNILKKLRSVSIEFPPDFDDNKMKV---EKKIIRLLIDHDPNKRPG 277
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-07
Identities = 32/176 (18%), Positives = 68/176 (38%), Gaps = 21/176 (11%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKR--LIHKDIAARNCLISSDLSVKI----SLSGLSKDT 107
LS + + YQ ++H+ ++ +IH+D+ N L+S+ ++K+ S + +S
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 108 YQKEYYKYRNAILPLRW----LPYEA--VFD----DEFSTKSDVYAYACLIWEIFNKGEM 157
+ R + Y + D K D++A C+++ + +
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF-RQH 251
Query: 158 PFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
PF +D ++ + K SL + +P +R + +V QL
Sbjct: 252 PF----EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-07
Identities = 31/190 (16%), Positives = 72/190 (37%), Gaps = 23/190 (12%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRL-----IHK 81
GDL + K+ + L + + Q+ L L+ + +H+
Sbjct: 92 GDLASVITKGTKER-----------QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 140
Query: 82 DIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAIL--PLRWLPYEAVFDDEFSTKS 139
D+ N + +VK+ GL++ + + P P E + ++ KS
Sbjct: 141 DLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKTFVGTPYYMSP-EQMNRMSYNEKS 197
Query: 140 DVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPH 199
D+++ CL++E+ PF S ++ ++ K + + + + + + ++
Sbjct: 198 DIWSLGCLLYELCA-LMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLK 255
Query: 200 PHQRPTFPSI 209
+ RP+ I
Sbjct: 256 DYHRPSVEEI 265
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 9e-06
Identities = 38/229 (16%), Positives = 70/229 (30%), Gaps = 61/229 (26%)
Query: 28 DLK-QFLLATR-KDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHK---- 81
+L + LL TR K D + SL ++ L K L+ K
Sbjct: 263 NLSCKILLTTRFKQVTDFLSAATTTHISLD---------HHSMTLTPDEVKSLLLKYLDC 313
Query: 82 ---DIAARNCLISSDLSVKISLSG--LSKDTYQKEYYKYRN------AI-LPLRWL-PYE 128
D+ + ++S+ + + +K+ N I L L P E
Sbjct: 314 RPQDLPREVLTTNP---RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE 370
Query: 129 --------AVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKH 180
+VF + + LIW ++ D V+++L L K
Sbjct: 371 YRKMFDRLSVFPPSAHIPTILL---SLIW-----FDVIKSD--VMVVVNKLHKYSLVEKQ 420
Query: 181 SSKTPEYITSLHEKCIHPHP------HQRPTFPSIVTQLSDAMCNDVNS 223
++ I S++ + + H+ IV + D +
Sbjct: 421 PKESTISIPSIYLE-LKVKLENEYALHRS-----IVDHYNIPKTFDSDD 463
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-06
Identities = 28/150 (18%), Positives = 54/150 (36%), Gaps = 13/150 (8%)
Query: 65 QVALGLEHISDKRLIHKDIAARNCLISSD-LSVKISLSGLSKDTYQKEYYKYRNAILPLR 123
Q GLE++ +R++H D+ A N L+SSD + G + K +
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 124 WLPY----EAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWK 179
E V K D+++ C++ + N G P+ + ++ S+
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFRGPLCLKIASEP---P 273
Query: 180 HSSKTPEYITSLH----EKCIHPHPHQRPT 205
+ P L ++ + P R +
Sbjct: 274 PIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-05
Identities = 25/114 (21%), Positives = 49/114 (42%), Gaps = 15/114 (13%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
++ +A+ + L +IH+D+ N +IS+ +VK+ G+++
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 114 KYR-NAIL-------PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159
+ A++ P E D +SDVY+ C+++E+ GE PF
Sbjct: 173 VTQTAAVIGTAQYLSP------EQARGDSVDARSDVYSLGCVLYEVLT-GEPPF 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-05
Identities = 29/174 (16%), Positives = 65/174 (37%), Gaps = 21/174 (12%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
+S+ + + + + I ++H D+ N LI +K+ G++
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180
Query: 112 YYKYRN------------AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159
++ AI + + S KSDV++ C+++ + G+ PF
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPF 239
Query: 160 PDLSDDQVLSQLESKKLCWKHSSKTPEYIT----SLHEKCIHPHPHQRPTFPSI 209
+ + +S+L + H + P+ + + C+ P QR + P +
Sbjct: 240 QQIINQ--ISKLH-AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-05
Identities = 29/174 (16%), Positives = 65/174 (37%), Gaps = 21/174 (12%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
+S+ + + + + I ++H D+ N LI +K+ G++
Sbjct: 103 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 161
Query: 112 YYKYRN------------AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159
++ AI + + S KSDV++ C+++ + G+ PF
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPF 220
Query: 160 PDLSDDQVLSQLESKKLCWKHSSKTPEYITS----LHEKCIHPHPHQRPTFPSI 209
+ + +S+L + H + P+ + + C+ P QR + P +
Sbjct: 221 QQIINQ--ISKLH-AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 5e-05
Identities = 30/113 (26%), Positives = 53/113 (46%), Gaps = 15/113 (13%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
LS A+ Q+ G++H D R++H+DI +N LI S+ ++KI G++K +
Sbjct: 108 LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSL 166
Query: 114 KYRNAIL-------PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159
N +L P E + +D+Y+ +++E+ GE PF
Sbjct: 167 TQTNHVLGTVQYFSP------EQAKGEATDECTDIYSIGIVLYEMLV-GEPPF 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 8e-05
Identities = 37/192 (19%), Positives = 66/192 (34%), Gaps = 32/192 (16%)
Query: 43 KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---------- 92
++ +++ Q+A G+ H+ ++IH+D+ +N L+S+
Sbjct: 101 SKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160
Query: 93 ---DLSVKISLSGLSKDTYQKEYYKYRNAILPL---RWLPYEAVFDDEFSTKSDVYAYAC 146
+L + IS GL K + N P W E + + +
Sbjct: 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI 220
Query: 147 LIW-------EIFNKGEMPFPDLSDDQ------VLSQLESKKLCWKHSSKTPEYITSLHE 193
I+ I +KG+ PF D + + S E K L + L
Sbjct: 221 DIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEAT---DLIS 277
Query: 194 KCIHPHPHQRPT 205
+ I P +RPT
Sbjct: 278 QMIDHDPLKRPT 289
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 29/174 (16%), Positives = 65/174 (37%), Gaps = 21/174 (12%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
+S+ + + + + I ++H D+ N LI +K+ G++
Sbjct: 150 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 208
Query: 112 YYKYRN------------AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159
++ AI + + S KSDV++ C+++ + G+ PF
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPF 267
Query: 160 PDLSDDQVLSQLESKKLCWKHSSKTPEYIT----SLHEKCIHPHPHQRPTFPSI 209
+ + +S+L + H + P+ + + C+ P QR + P +
Sbjct: 268 QQIINQ--ISKLH-AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 1e-04
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS---LSGLSKD 106
L +Q T+ ++ GL+++ ++ IH+DI A N L+S VK++ ++G D
Sbjct: 112 EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171
Query: 107 TYQKEYYKYRNAIL--PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD 164
T K RN + P W+ E + + +K+D+++ E+ GE P +L
Sbjct: 172 TQIK-----RNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELAR-GEPPHSELHP 224
Query: 165 DQVL---SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
+VL + L +S E++ E C++ P RPT
Sbjct: 225 MKVLFLIPKNNPPTLEGNYSKPLKEFV----EACLNKEPSFRPT 264
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 1e-04
Identities = 21/123 (17%), Positives = 44/123 (35%), Gaps = 33/123 (26%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI---------SLSGLS 104
L+ +AV + Q+ L+ H+D+ N L+S+D + + L+
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190
Query: 105 KDTYQKEYYKYRNAIL-------PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEM 157
+ + P E + + ++D+YA C+++E G
Sbjct: 191 QL----------GNTVGTLYYMAP------ERFSESHATYRADIYALTCVLYECLT-GSP 233
Query: 158 PFP 160
P+
Sbjct: 234 PYQ 236
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 35/173 (20%), Positives = 65/173 (37%), Gaps = 32/173 (18%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
++ + T ++A L + KR+IH+DI N L+ S +KI+ G S
Sbjct: 102 KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161
Query: 110 K---------EYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFP 160
+Y LP E + K D+++ L +E F G+ PF
Sbjct: 162 SRRTDLCGTLDY------------LPPEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFE 208
Query: 161 DLSDDQVLSQLESKKLCWKHSSKTPEYITS----LHEKCIHPHPHQRPTFPSI 209
+ + ++ + P+++T L + + +P QRP +
Sbjct: 209 ANTYQETYKRISRVEF------TFPDFVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 2e-04
Identities = 17/66 (25%), Positives = 33/66 (50%), Gaps = 3/66 (4%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS---LSGLS 104
R L+ Q + Q+ L + KR+IH+D+ A N L++ + ++++ +S +
Sbjct: 108 LELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167
Query: 105 KDTYQK 110
T QK
Sbjct: 168 LKTLQK 173
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 3e-04
Identities = 19/58 (32%), Positives = 29/58 (50%)
Query: 41 KDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98
K G+ + L S T+ +V GLE++ IH+D+ A N L+ D SV+I
Sbjct: 105 KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 7e-04
Identities = 41/176 (23%), Positives = 72/176 (40%), Gaps = 37/176 (21%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKIS---LSGLSKD 106
+ +L + ++ GL H+ ++IH+DI +N L++ + VK+ +S
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 107 TYQKEYYKYRNAIL--PLRWLPYEAVFDDEFSTKSDVYAYACLIW-------EIFNKGEM 157
T + RN + P W+ E + DE + Y + +W E+ +G
Sbjct: 182 TVGR-----RNTFIGTPY-WMAPEVIACDENPDAT--YDFKSDLWSLGITAIEMA-EGAP 232
Query: 158 PFPDLSDDQVL--------SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
P D+ + L +L+SKK W S K +I E C+ + QRP
Sbjct: 233 PLCDMHPMRALFLIPRNPAPRLKSKK--W--SKKFQSFI----ESCLVKNHSQRPA 280
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 7e-04
Identities = 35/165 (21%), Positives = 73/165 (44%), Gaps = 27/165 (16%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLS---KDTYQK 110
L+ Q T+ V L ++ + +IH+DI + + L++ D VK+S G K
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197
Query: 111 EYYKYRNAIL--PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168
R +++ P W+ E + ++T+ D+++ ++ E+ + GE P+ S Q +
Sbjct: 198 -----RKSLVGTPY-WMAPEVISRSLYATEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAM 250
Query: 169 --------SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
+L++ K S +++ E+ + P +R T
Sbjct: 251 KRLRDSPPPKLKNSH---KVSPVLRDFL----ERMLVRDPQERAT 288
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 223 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.98 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.98 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.98 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.98 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.98 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.98 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.98 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.89 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.7 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.51 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.27 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.43 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.84 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.77 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.3 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.25 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.58 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 93.05 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 92.94 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.8 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 91.32 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 91.16 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 91.16 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 90.64 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.87 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 89.45 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 88.71 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 86.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 86.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.1 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.88 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=297.83 Aligned_cols=201 Identities=28% Similarity=0.505 Sum_probs=161.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|||.++|+..+...............++++.+++.++.||++||.|||+++|+||||||+|||++.++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 44899999999999999876543222222222234679999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
||+|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||+|.|+.||.+....+....+..+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g- 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG- 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999998654433 222345678999999999999999999999999999999995599999999998888888776
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.+++.+..+++++.+++.+||+.||++|||++||+++|+.+.+
T Consensus 277 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 277 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 4566778899999999999999999999999999999998765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=308.16 Aligned_cols=205 Identities=29% Similarity=0.499 Sum_probs=166.8
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCC-CCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSG-SGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL 94 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~ 94 (223)
...+|||||++|||.++|+..+........ ........+++.+++.++.||++||.|||+++++||||||+|||++.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 355899999999999999876542211100 0011234689999999999999999999999999999999999999999
Q ss_pred CeEEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH
Q psy15108 95 SVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ-VLSQLE 172 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~-~~~~~~ 172 (223)
.+||+|||+++...... ........+|+.|+|||.+.+..|+.++|||||||++|||+|.|..||.+....+ ....+.
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~ 302 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 99999999998654332 2223445678999999999999999999999999999999966999999876544 444454
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhcc
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDV 221 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 221 (223)
.+ .+++.+..+++++.++|..||+.||++|||+++++++|+++++.+.
T Consensus 303 ~g-~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 303 EG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp HT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred cC-CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 44 5667778899999999999999999999999999999999987543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=293.56 Aligned_cols=200 Identities=30% Similarity=0.534 Sum_probs=167.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|||.++|+..+....... .......+++.+++.++.||++||.|||+++|+||||||+|||++.++.+
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~--~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMA--EGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC------CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEEcCCCCcHHHHHHhcCccccccc--ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 4489999999999999987643111000 00123469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
||+|||+++........ ......+|+.|+|||.+.+..|+.++|||||||++|||+|.|+.||.+.+..++...+..+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~- 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG- 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT-
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 99999999755433321 2233467899999999999999999999999999999995599999999999998888877
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..++.+..+|+++.+++.+||+.||++|||++++++.|+++.+.
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 44566788999999999999999999999999999999887653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=291.86 Aligned_cols=199 Identities=30% Similarity=0.540 Sum_probs=167.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCC-CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKS-GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+|||||++|||.++|+.++....... .........+++.+++.++.||++||.|||+++++||||||+|||++.++.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 4589999999999999986543211100 011122356999999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+||+|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||+|.|..||.+.+..++...+..+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~ 263 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 263 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999998654433 222345678899999999999999999999999999999996689999999999888888776
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
...+.+..+|+++.+++..||+.||++|||+++|+++|+..
T Consensus 264 -~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 264 -QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 45566788999999999999999999999999999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=290.98 Aligned_cols=187 Identities=16% Similarity=0.179 Sum_probs=159.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC-C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-S 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-~ 95 (223)
..+|||||++|+|.++|++.+. +++..+..++.||+.||.|||+++|+||||||+|||++.++ .
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~---------------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~ 189 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGC---------------LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSR 189 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCC
T ss_pred EEEEEeccCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCE
Confidence 4489999999999999987644 99999999999999999999999999999999999999887 5
Q ss_pred eEEcCCCCCcccchhhh----hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 96 VKISLSGLSKDTYQKEY----YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+||+|||+++....... .......||+.|+|||.+.+..|+.++||||+||++|+|+ +|..||.+.+..++...+
T Consensus 190 vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml-tG~~Pf~~~~~~~~~~~i 268 (336)
T 4g3f_A 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML-NGCHPWTQYFRGPLCLKI 268 (336)
T ss_dssp EEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSSTTTCCSCCHHHH
T ss_pred EEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH-HCcCCCCCCCHHHHHHHH
Confidence 99999999986543321 1223457999999999999999999999999999999999 799999988777777777
Q ss_pred HhCcccC-CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 172 ESKKLCW-KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 172 ~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
....... ..+..+++++.+++.+||+.||.+|||+.|++++|.+++.+
T Consensus 269 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 269 ASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp HHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 6654332 35678899999999999999999999999999999988754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=285.24 Aligned_cols=186 Identities=22% Similarity=0.361 Sum_probs=150.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|||.++|+..+ .++++.+++.++.||++||.|||+++|+||||||+|||++.++.+
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~--------------~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~ 171 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQE--------------TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTV 171 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEE
T ss_pred EEEEEEcCCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcE
Confidence 458999999999999998643 369999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFD---DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ-L 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~-~ 171 (223)
||+|||+|+...... ........||+.|+|||.+.. .+|+.++|||||||++|||+ +|+.||.+.+....... +
T Consensus 172 Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ell-tg~~Pf~~~~~~~~~~~~~ 250 (307)
T 3omv_A 172 KIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM-TGELPYSHINNRDQIIFMV 250 (307)
T ss_dssp EECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHH-HSSCTTTTCCCHHHHHHHH
T ss_pred EEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHH-HCCCCCCCCChHHHHHHHH
Confidence 999999997654322 222345678999999999863 35899999999999999999 69999988766544444 3
Q ss_pred HhCcccC---CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 172 ESKKLCW---KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 172 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
..+...+ ..+..+++++.+++.+||+.||++|||+++++++|+.+.
T Consensus 251 ~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 251 GRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp HTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred hcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 3332221 234578999999999999999999999999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=289.88 Aligned_cols=180 Identities=21% Similarity=0.285 Sum_probs=159.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|||.++|+..+. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~-------------~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~v 164 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKG-------------VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTV 164 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCE
T ss_pred EEEEEeCCCCCcHHHHHHHcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCE
Confidence 3489999999999999987654 468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++....... ......||+.|+|||.+.+..|+.++||||+||++|+|+ +|..||.+.+..+++.++.....
T Consensus 165 Kl~DFGla~~~~~~~~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml-tG~~PF~~~~~~~~~~~i~~~~~ 242 (350)
T 4b9d_A 165 QLGDFGIARVLNSTVE-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC-TLKHAFEAGSMKNLVLKIISGSF 242 (350)
T ss_dssp EECSTTEESCCCHHHH-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHTCC
T ss_pred EEcccccceeecCCcc-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCcCHHHHHHHHHcCCC
Confidence 9999999986644321 234457899999999999999999999999999999999 79999999999888888877643
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
++.+..+++++++||.+||+.||++|||++|+++|
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 34566789999999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=282.66 Aligned_cols=176 Identities=16% Similarity=0.230 Sum_probs=156.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||.+|+|.++|++.+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~---------------l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~v 171 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGS---------------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI 171 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCCHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCE
Confidence 3489999999999999987644 9999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
||+|||+++...... ........||+.|+|||.+.+..|+.++|+||+||++|+|+ +|..||.+.+..++...+....
T Consensus 172 Kl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml-~G~~PF~~~~~~~~~~~i~~~~ 250 (311)
T 4aw0_A 172 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEGLIFAKIIKLE 250 (311)
T ss_dssp EECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHTC
T ss_pred EEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998654322 22234568999999999999999999999999999999999 7999999999999988888765
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 210 (223)
+. .+..+++++++|+.+||+.||++|||++|++
T Consensus 251 ~~--~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 YD--FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CC--CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CC--CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 43 4567899999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=283.34 Aligned_cols=178 Identities=16% Similarity=0.245 Sum_probs=155.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.-+|||||++|+|.++++. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 146 ~~ivmEy~~gg~L~~~l~~----------------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~v 209 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH----------------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRV 209 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCE
T ss_pred EEEEEeCCCCCcHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCE
Confidence 3489999999999999975 248999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++...... .......||+.|+|||++.+..|+.++||||+||++|+|+ +|..||.+.+..+.+..+.....
T Consensus 210 Kl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml-~G~~PF~~~~~~~~~~~i~~~~~ 287 (346)
T 4fih_A 210 KLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV-DGEPPYFNEPPLKAMKMIRDNLP 287 (346)
T ss_dssp EECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHHHHSSC
T ss_pred EEecCcCceecCCCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCcCHHHHHHHHHcCCC
Confidence 999999997653322 1234568999999999999899999999999999999999 79999999998888888776532
Q ss_pred -cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 -CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.......+++++++|+.+||+.||++|||++|+++|
T Consensus 288 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 288 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 223345688999999999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=279.01 Aligned_cols=177 Identities=19% Similarity=0.239 Sum_probs=154.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|||.++|++.+. +++.++..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~---------------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVM---------------FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCC---------------CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCE
T ss_pred EEEEEEcCCCCCHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCE
Confidence 4489999999999999987644 9999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
|++|||+++...... .......||+.|+|||.+.+..|+.++||||+||++|+|+ +|..||.+.+..+....+.....
T Consensus 166 Kl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml-tG~~PF~~~~~~~~~~~i~~~~~ 243 (304)
T 3ubd_A 166 KLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML-TGTLPFQGKDRKETMTMILKAKL 243 (304)
T ss_dssp EEESSEEEEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EecccccceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHH-hCCCCCCCcCHHHHHHHHHcCCC
Confidence 999999997543322 1234567999999999999999999999999999999999 79999999999998888877644
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTF-----PSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~ 212 (223)
..+..+++++++++.+||+.||++|||+ +|+++|
T Consensus 244 --~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 --GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 3466789999999999999999999984 677764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=275.55 Aligned_cols=175 Identities=19% Similarity=0.285 Sum_probs=148.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCCCCCeeeec-CC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR--LIHKDIAARNCLISS-DL 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~~~nil~~~-~~ 94 (223)
.+|||||.+|+|.++|+..+ .+++..+..++.||++||.|||+++ |+||||||.|||++. ++
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g 169 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFK---------------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS
T ss_pred EEEEeCCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC
Confidence 47899999999999998764 4999999999999999999999998 999999999999974 78
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHh
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQVLSQLES 173 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-~~~~~~~~~ 173 (223)
.+||+|||+|+..... ......||+.|+|||.+. ..|+.++|||||||++|+|+ +|..||.+... ..+...+..
T Consensus 170 ~vKl~DFGla~~~~~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyell-tg~~Pf~~~~~~~~~~~~i~~ 244 (290)
T 3fpq_A 170 SVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMA-TSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp CEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHH-HSSCTTTTCSSHHHHHHHHTT
T ss_pred CEEEEeCcCCEeCCCC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHH-HCCCCCCCCCcHHHHHHHHHc
Confidence 9999999999743322 234568999999999875 46999999999999999999 79999976554 455555655
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.......+...++++++++.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 533334455678899999999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=272.78 Aligned_cols=175 Identities=15% Similarity=0.223 Sum_probs=146.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||| +|+|.++|.+++ .+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~---------------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~v 151 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRD---------------KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNV 151 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSC---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCE
T ss_pred EEEEEeCC-CCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCE
Confidence 34889998 789999998754 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
|++|||+++...... ......||+.|+|||.+.+..+ +.++||||+||++|+|+ +|..||.+.+..+....+....
T Consensus 152 kl~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~ll-tg~~PF~~~~~~~~~~~i~~~~ 228 (275)
T 3hyh_A 152 KIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML-CRRLPFDDESIPVLFKNISNGV 228 (275)
T ss_dssp EECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHTC
T ss_pred EEeecCCCeecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHHcCC
Confidence 999999997654332 2345679999999999988876 57899999999999999 7999999988888888887765
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .+..+++++++++.+||+.||++|||++|+++|
T Consensus 229 ~~--~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 YT--LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CC--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 43 456789999999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=284.20 Aligned_cols=178 Identities=16% Similarity=0.245 Sum_probs=156.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.-+|||||.+|+|.++++. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 223 ~~iVmEy~~gG~L~~~i~~----------------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~v 286 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH----------------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRV 286 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCE
T ss_pred EEEEEeCCCCCcHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCE
Confidence 3489999999999999964 248999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++...... .......||+.|+|||++.+..|+.++||||+||++|+|+ +|..||.+.+..+.+..+.....
T Consensus 287 Kl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml-~G~~PF~~~~~~~~~~~i~~~~~ 364 (423)
T 4fie_A 287 KLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV-DGEPPYFNEPPLKAMKMIRDNLP 364 (423)
T ss_dssp EECCCTTCEECCSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHHHHSCC
T ss_pred EEecCccceECCCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCcCHHHHHHHHHcCCC
Confidence 999999997653322 1234568999999999999999999999999999999999 79999999998888888776532
Q ss_pred -cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 -CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.......+++++++||.+||+.||++|||++|+++|
T Consensus 365 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 365 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 233456789999999999999999999999999876
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=265.84 Aligned_cols=185 Identities=19% Similarity=0.243 Sum_probs=143.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CcccCCCCCCCee
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK--------RLIHKDIAARNCL 89 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~i~H~di~~~nil 89 (223)
.+|||||++|||.++|+.. +++++.+.+++.|+++||.|||++ +|+||||||+|||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~----------------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NIL 140 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY----------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC----------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEE
T ss_pred EEEecCCCCCcHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEE
Confidence 4899999999999999752 589999999999999999999987 9999999999999
Q ss_pred eecCCCeEEcCCCCCcccchhhh---hhhhcCCcccccccccccccC------CCCcccchHHHHHHHHHHHhCCCCC--
Q psy15108 90 ISSDLSVKISLSGLSKDTYQKEY---YKYRNAILPLRWLPYEAVFDD------EFSTKSDVYAYACLIWEIFNKGEMP-- 158 (223)
Q Consensus 90 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~------~~~~~~Di~slG~il~~l~~~~~~p-- 158 (223)
++.++.+||+|||+++....... .......+|+.|+|||.+.+. .++.++|||||||++|||+ +|..|
T Consensus 141 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~-tg~~~~~ 219 (303)
T 3hmm_A 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA-RRCSIGG 219 (303)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH-HTBCBTT
T ss_pred ECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH-HCCCCCC
Confidence 99999999999999976543321 112345789999999998654 3567899999999999999 56544
Q ss_pred --------CCCC-----CHHHHHHHHHhCcccCCCCC-----CChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 159 --------FPDL-----SDDQVLSQLESKKLCWKHSS-----KTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 159 --------~~~~-----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
|.+. ........+.....++..+. .+++.+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 220 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 3322 22334444444444443332 2345788999999999999999999999999988654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=260.96 Aligned_cols=177 Identities=19% Similarity=0.288 Sum_probs=132.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|||||.+|+|.++++..+. ....++..++.++.||++||.|||++||+||||||+|||++.++.+||
T Consensus 92 ivmE~~~gg~L~~~l~~~~~------------~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 92 IQMQLCRKENLKDWMNGRCT------------IEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp EEEECCCSCCHHHHHHTCCS------------GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred EEEecCCCCcHHHHHHhcCC------------CChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 78999999999999986533 124567788999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhh-----------hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HH
Q psy15108 99 SLSGLSKDTYQKEY-----------YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQ 166 (223)
Q Consensus 99 ~df~~~~~~~~~~~-----------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-~~ 166 (223)
+|||+++....... .......||+.|+|||.+.+..|+.++||||+||++|||+ + ||..... ..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell-~---Pf~~~~~~~~ 235 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-Y---PFSTQMERVR 235 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH-S---CCSSHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHc-c---CCCCccHHHH
Confidence 99999986543221 1123457899999999999999999999999999999999 4 7754322 22
Q ss_pred HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 167 VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+..... ++.....++...+++.+||+.||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 TLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2333333211 11112234567889999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=263.76 Aligned_cols=178 Identities=16% Similarity=0.210 Sum_probs=146.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
-+|||||. |+|.++|... +.+++..+..++.||+.||.|||++||+||||||.|||++.++.+|
T Consensus 135 ~ivmE~~~-g~L~~~i~~~---------------~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSS---------------QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp EEEEECCS-EEHHHHHTSS---------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEE
T ss_pred EEEEeCCC-CCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEE
Confidence 38899995 7899999754 3599999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh---hhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 98 ISLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 98 l~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
++|||+++...... ........||+.|+|||++.+.. ++.++||||+||++|+|+ +|..||.+.+....+..+..
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell-~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML-ARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH-HTSCSSCCSSHHHHHHHHHH
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH-HCCCCCCCCCHHHHHHHHHH
Confidence 99999998654332 11234568999999999987654 688999999999999999 79999999888777766643
Q ss_pred CcccCC-----------------------------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWK-----------------------------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+. ..+..++++++|+.+||+.||.+|||++|+++|
T Consensus 278 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 278 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 211110 013457889999999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=255.46 Aligned_cols=175 Identities=17% Similarity=0.161 Sum_probs=136.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC-CCeE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD-LSVK 97 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~-~~~~ 97 (223)
+||||+++|+|.++++ .+++.++..++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 97 lvmE~~~g~~L~~~~~------------------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~k 158 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------------------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYA 158 (361)
T ss_dssp EEEECCCCCCHHHHHT------------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred EEEeCCCcccHHHHHc------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEE
Confidence 8899999999999993 48999999999999999999999999999999999999877 7899
Q ss_pred EcCCCCCcccchhh---------------------------hhhhhcCCcccccccccccccCC-CCcccchHHHHHHHH
Q psy15108 98 ISLSGLSKDTYQKE---------------------------YYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIW 149 (223)
Q Consensus 98 l~df~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~ 149 (223)
++|||+|+...... ........||+.|+|||++.+.. ++.++|+||+||++|
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 99999997432211 01123457899999999987754 889999999999999
Q ss_pred HHHhCCCCCCCCCC-HHHHHHHHHhC----------------------------------------------------cc
Q psy15108 150 EIFNKGEMPFPDLS-DDQVLSQLESK----------------------------------------------------KL 176 (223)
Q Consensus 150 ~l~~~~~~p~~~~~-~~~~~~~~~~~----------------------------------------------------~~ 176 (223)
+|+ +|+.||.... ....+..+..- ..
T Consensus 239 ell-~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 317 (361)
T 4f9c_A 239 SLL-SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHAT 317 (361)
T ss_dssp HHH-HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------------
T ss_pred HHH-HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccc
Confidence 999 7999985443 33322222110 00
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........++++++|+.+||+.||++|||++|+++|
T Consensus 318 ~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 318 NLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp ----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 011123567889999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=270.17 Aligned_cols=174 Identities=18% Similarity=0.262 Sum_probs=148.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
-+|||||.||+|.++|+..+. +++..+..++.||+.||.|||++||+||||||.|||++.+|.+|
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~---------------l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vK 332 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGV---------------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 332 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCC---------------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEE
Confidence 388999999999999987644 99999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHh
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDL---SDDQVLSQLES 173 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~---~~~~~~~~~~~ 173 (223)
|+|||+++...... .....||+.|+|||++.. ..|+.++|+||+||++|+|+ +|..||.+. +..++...+..
T Consensus 333 L~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmL-tG~~PF~~~~~~~~~~i~~~i~~ 408 (689)
T 3v5w_A 333 ISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-RGHSPFRQHKTKDKHEIDRMTLT 408 (689)
T ss_dssp ECCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH-HSSCTTCGGGCCCHHHHHHHHHH
T ss_pred ecccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhhcC
Confidence 99999997654322 345689999999999864 57999999999999999999 799999754 33344444444
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
.. ...+..+++++++||.+||+.||.+|++ ++|+++|
T Consensus 409 ~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 409 MA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 43 3446678999999999999999999998 6888765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=270.77 Aligned_cols=179 Identities=18% Similarity=0.214 Sum_probs=156.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC--C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD--L 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~--~ 94 (223)
..+|||||.+|+|.++|.... ..+++.++..++.||++||.|||+++|+||||||.||+++.+ +
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~--------------~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~ 294 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEH--------------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN 294 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTT--------------SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC
T ss_pred EEEEEeecCCCcHHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCC
Confidence 348899999999999996432 359999999999999999999999999999999999999854 7
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.+||+|||+++...... ......||+.|+|||++.+..|+.++|+||+||++|+|+ +|..||.+.+..+.+..+...
T Consensus 295 ~vKl~DFG~a~~~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml-~G~~Pf~~~~~~~~~~~i~~~ 371 (573)
T 3uto_A 295 ELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL-SGLSPFGGENDDETLRNVKSC 371 (573)
T ss_dssp CEEECCCSSCEECCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH-HSCCSSCCSSHHHHHHHHHTT
T ss_pred CEEEeeccceeEccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCcCHHHHHHHHHhC
Confidence 89999999998654432 224457899999999999999999999999999999999 799999999999988888776
Q ss_pred cccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+ ....+++++++||.+||+.||.+||++.|+++|
T Consensus 372 ~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 372 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 54432 235688999999999999999999999999885
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=244.88 Aligned_cols=189 Identities=31% Similarity=0.519 Sum_probs=152.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+. .+++..++.++.|+++||.|||+.|++|+||||.||+++.++.+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 155 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKY--------------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 155 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTT--------------TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred cEEEEecCCCCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCE
Confidence 4488999999999999986543 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............+++.|+|||.+....++.++|+||+|+++|++++.|..||.+.........+... .
T Consensus 156 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-~ 234 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-E 234 (281)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-C
T ss_pred EECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-C
Confidence 999999997654433323334455678999999988889999999999999999995699999988887777777665 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
..+.+..+++++.+++.+||+.||.+||++.+++++|++++++.
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 44556788999999999999999999999999999999988653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=241.36 Aligned_cols=189 Identities=23% Similarity=0.483 Sum_probs=164.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++.... .+++..++.++.|+++||.|||+.|++|+||||.||+++.++.+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 145 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRG--------------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 145 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTT--------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCE
T ss_pred eEEEEEeCCCCcHHHHHHhcCc--------------ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCE
Confidence 3488999999999999976433 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|+|||.+....++.++|+||+|+++++|++.|..||......+....+... .
T Consensus 146 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~ 224 (269)
T 4hcu_A 146 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-F 224 (269)
T ss_dssp EECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-C
T ss_pred EeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-c
Confidence 999999997665544444445566778999999988889999999999999999994499999999988888887766 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
....+...++.+.+++.+||+.||.+||++++++++|+++.+..
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 45556678999999999999999999999999999999988754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=259.59 Aligned_cols=189 Identities=29% Similarity=0.472 Sum_probs=165.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++..+. ..+++..++.++.||+.||.|||+++++||||||+||+++.++.+
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 323 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEG-------------SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVC 323 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHH-------------HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCE
T ss_pred cEEEEeecCCCcHHHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcE
Confidence 4488999999999999986543 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++..............++..|+|||.+....++.++||||||+++|+|++.|..||.+....+....+..+ .
T Consensus 324 kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~ 402 (454)
T 1qcf_A 324 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-Y 402 (454)
T ss_dssp EECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-C
T ss_pred EEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999998665444333444556788999999988889999999999999999995599999999988888887766 5
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..+.+..+++++.++|.+||+.||++|||++++++.|++++..
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 5666778999999999999999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=241.58 Aligned_cols=189 Identities=29% Similarity=0.529 Sum_probs=165.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.|++|+||||.||+++.++.+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~ 159 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRH--------------RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 159 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGG--------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCE
T ss_pred eEEEEeccCCCcHHHHHHHhcc--------------CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCE
Confidence 3488999999999999986433 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|+|||.+.+..++.++|+||+|+++|++++.|..||...........+... .
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~ 238 (283)
T 3gen_A 160 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-L 238 (283)
T ss_dssp EECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-C
T ss_pred EEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-c
Confidence 999999997665544444445566778999999988889999999999999999994499999999888888877766 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
....+...++.+.+++.+||+.||.+||++++++++|.++++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 44556677899999999999999999999999999999998753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=261.90 Aligned_cols=187 Identities=27% Similarity=0.495 Sum_probs=162.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++..+. ..+++..++.++.|+++||.|||+++++||||||+||+++.++.+
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 328 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGR-------------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA 328 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCT-------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCE
T ss_pred eEEEEEecCCCcHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCE
Confidence 4588999999999999987644 347999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++...... ....++..|+|||.+.+..++.++||||||+++|+|++.|..||......+....+..+ .
T Consensus 329 kl~DfG~a~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~ 403 (450)
T 1k9a_A 329 KVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-Y 403 (450)
T ss_dssp EECCCTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-C
T ss_pred EEeeCCCcccccccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999987543221 22356788999999998899999999999999999995599999988887777777665 5
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhcc
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDV 221 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 221 (223)
+.+.+..+++++.++|.+||+.||.+||++.++++.|+.+...++
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l 448 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence 566778899999999999999999999999999999999887654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=250.62 Aligned_cols=202 Identities=28% Similarity=0.531 Sum_probs=163.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhcccc-CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKD-KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+||||+.+|+|.++++..+..... ...........+++..++.++.||+.||.|||++|++||||||.||+++.++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 241 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV 241 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCC
Confidence 44889999999999999876431000 00000012245899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++.|..||.+....+....+...
T Consensus 242 ~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 321 (370)
T 2psq_A 242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321 (370)
T ss_dssp EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 99999999975433221 12233455778999999988889999999999999999995599999998888777776665
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.....+..++.++.+++.+||+.||.+||++.+++++|++++..
T Consensus 322 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 322 -HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 44556778899999999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=244.03 Aligned_cols=190 Identities=23% Similarity=0.407 Sum_probs=155.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCCCCCeeeecCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR--LIHKDIAARNCLISSDL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~~~nil~~~~~ 94 (223)
..+|+||+.+|+|.++++..+. ...+++..++.++.|+++||.|||+.| ++||||||+||+++.++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~ 176 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGA------------REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY 176 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTH------------HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC
T ss_pred eEEEEecCCCCcHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC
Confidence 4588999999999999986432 124899999999999999999999999 99999999999999999
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++++|||++...... ........++..|+|||.+.+..++.++||||+|+++|+|+ +|..||......+....+...
T Consensus 177 ~~kL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-tg~~Pf~~~~~~~~~~~~~~~ 254 (309)
T 3p86_A 177 TVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA-TLQQPWGNLNPAQVVAAVGFK 254 (309)
T ss_dssp CEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHH-HCCCTTTTSCHHHHHHHHHHS
T ss_pred cEEECCCCCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhc
Confidence 9999999998743322 12233456789999999999888999999999999999999 799999999888887777655
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
......+..+++++.+++.+||+.||.+||+++++++.|+.+++..
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 5666677889999999999999999999999999999999988653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=256.91 Aligned_cols=189 Identities=29% Similarity=0.475 Sum_probs=158.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++.... ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 319 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETG-------------KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHH-------------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred eEEEehhhcCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCE
Confidence 4588999999999999986543 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+|+|||+++..............++..|+|||.+....++.++||||||+++|+|++.|..||.+....+....+..+ .
T Consensus 320 kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~ 398 (452)
T 1fmk_A 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 398 (452)
T ss_dssp EECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-C
T ss_pred EECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999997654433333344556788999999988889999999999999999995599999999988888887766 5
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
+.+.+..+++.+.++|.+||+.||++|||++++++.|++++..
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 5666778999999999999999999999999999999988754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=236.87 Aligned_cols=189 Identities=23% Similarity=0.490 Sum_probs=163.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+++|+|.+++...+. .+++..++.++.|+++||.|||+.|++|+||+|+||+++.++.+
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~ 143 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRG--------------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 143 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCE
T ss_pred eEEEEeCCCCCcHHHHHhhCcc--------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCE
Confidence 4488999999999999986533 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|+|||.+....++.++|+||+|+++|+|++.|..||......+....+... .
T Consensus 144 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-~ 222 (267)
T 3t9t_A 144 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-F 222 (267)
T ss_dssp EECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-C
T ss_pred EEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-C
Confidence 999999987655444333344566778999999988889999999999999999994489999998888888777665 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
....+...+..+.+++.+||+.||.+||++++++++|+++.++.
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (267)
T 3t9t_A 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266 (267)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 44456678899999999999999999999999999999988764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=246.02 Aligned_cols=189 Identities=29% Similarity=0.448 Sum_probs=160.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++... ..+++..++.++.|++.||.|||+.|++||||||.||+++.++.+
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHD--------------GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVC 190 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTT--------------TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred cEEEeeCCCCCcHHHHHHhcc--------------cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCE
Confidence 348899999999999997543 359999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh--hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEYY--KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++.|..||.+.........+...
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 270 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 99999999765433211 1122344667999999988889999999999999999995599999999988888877766
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
...+.+..+++++.+++..||+.||.+||+++++++.|+.++...
T Consensus 271 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 271 -YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 555667788999999999999999999999999999999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=254.08 Aligned_cols=188 Identities=28% Similarity=0.588 Sum_probs=150.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.++++..+. .+++..++.++.||++||.|||+.|++||||||+||+++.++.+
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 231 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETH--------------NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 231 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTC--------------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred eEEEEECCCCCCHHHHHhhccc--------------CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCE
Confidence 4478999999999999975433 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhh---hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKEYY---KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+++|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++.+..||......+....+..
T Consensus 232 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~ 311 (373)
T 3c1x_A 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311 (373)
T ss_dssp EECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT
T ss_pred EEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc
Confidence 99999999755332211 123345677899999998889999999999999999999558889987776666666655
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
. .....+..++..+.+++.+||+.||++||+++++++.|++++..
T Consensus 312 ~-~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 312 G-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 5 34455667899999999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=239.67 Aligned_cols=188 Identities=28% Similarity=0.509 Sum_probs=161.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.++++..+. .+++..++.++.|+++||.|||+.|++|+||||.||+++.++.+
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 143 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGK--------------GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCV 143 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG--------------GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCE
T ss_pred eEEEEEccCCCcHHHHHHHcCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCE
Confidence 3488999999999999987644 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|+|||.+.+..++.++|+||+|++++++++.|..||...........+... .
T Consensus 144 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~ 222 (268)
T 3sxs_A 144 KVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-H 222 (268)
T ss_dssp EECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-C
T ss_pred EEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC-C
Confidence 999999987654433222334455677999999988888999999999999999994499999998888877777665 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
....+...++.+.+++..||+.||.+|||+++++++|+.+.++
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 4445667789999999999999999999999999999988654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=251.93 Aligned_cols=188 Identities=29% Similarity=0.459 Sum_probs=160.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.++++..+. .+++..++.++.|+++||.|||+.|++||||||+||+++.++.+
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~ 252 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGA--------------RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG--------------GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred cEEEEEcCCCCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcE
Confidence 4488999999999999987643 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhh-hcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKY-RNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||+++.......... ....++..|+|||.+....++.++||||||+++|++++.|..||.+....+....+..+
T Consensus 253 kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~- 331 (377)
T 3cbl_A 253 KISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG- 331 (377)
T ss_dssp EECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-
T ss_pred EECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999875433221111 12234677999999988889999999999999999995599999999888877776665
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
...+.+..+++++.+++.+||+.||++|||++++++.|+++.+.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 45566778899999999999999999999999999999988653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=253.97 Aligned_cols=168 Identities=32% Similarity=0.613 Sum_probs=140.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhh-hhhhhcCCcccccccccccc
Q psy15108 53 SLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVF 131 (223)
Q Consensus 53 ~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~ 131 (223)
.+++..++.++.|+++||.|||++|++|+||||.||+++.++.++++|||++....... ........++..|+|||.+.
T Consensus 189 ~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 268 (359)
T 3vhe_A 189 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 268 (359)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhc
Confidence 38999999999999999999999999999999999999999999999999987543322 12233455678899999998
Q ss_pred cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15108 132 DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVT 211 (223)
Q Consensus 132 ~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 211 (223)
+..++.++||||||+++|+|++.|..||.+...................+..+++++.+++.+||+.||.+||+++++++
T Consensus 269 ~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 348 (359)
T 3vhe_A 269 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348 (359)
T ss_dssp HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 88899999999999999999944999998876544444433333455666778999999999999999999999999999
Q ss_pred HHHHHhhhc
Q psy15108 212 QLSDAMCND 220 (223)
Q Consensus 212 ~L~~~~~~~ 220 (223)
+|++++..+
T Consensus 349 ~L~~~~~~~ 357 (359)
T 3vhe_A 349 HLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=247.37 Aligned_cols=188 Identities=29% Similarity=0.479 Sum_probs=151.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.++++..+. .+++..++.++.||++||.|||+.|++||||||.||+++.++.+
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDA--------------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVC 186 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTT--------------CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred eEEEEeCCCCCcHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCE
Confidence 4488999999999999986433 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++........ .......++..|+|||.+.+..++.++||||||+++|++++.|..||...........+...
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~ 266 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999876543321 11122334677999999988899999999999999999995599999998888887777665
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
...+.+..++.++.+++..||+.||.+||+++++++.|++++.+
T Consensus 267 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 -YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 45555678899999999999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=237.11 Aligned_cols=188 Identities=29% Similarity=0.448 Sum_probs=157.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++...+. .+++..+..++.|+++||.|||+.|++|+||||.||+++.++.+
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 152 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKN--------------SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECV 152 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTT--------------TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEE
T ss_pred CEEEEecCCCCCHHHHHHhccc--------------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcE
Confidence 3488999999999999987543 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|+|||.+....++.++|+||||+++|+|++.|..||...........+... .
T Consensus 153 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~ 231 (281)
T 3cc6_A 153 KLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-D 231 (281)
T ss_dssp EECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-C
T ss_pred EeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-C
Confidence 999999987654443333344556778999999988889999999999999999994499999887777776666655 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..+.+..+++.+.+++.+||+.||.+||++.+++++|+++...
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 4455667899999999999999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=248.34 Aligned_cols=193 Identities=31% Similarity=0.557 Sum_probs=161.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
..+||||+.+|+|.++++..+.. ......+++..++.++.||++||.|||++|++||||||.||+++.++
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPR--------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCC--------SSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred CEEEEEeCCCCCHHHHHHhhccc--------cCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC
Confidence 34889999999999999986531 11224699999999999999999999999999999999999998554
Q ss_pred -CeEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 95 -SVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 95 -~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
.++++|||+++....... .......+++.|+|||.+.+..++.++|||||||++|+|++.|..||......+....+.
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 499999999875433221 122334567889999999888999999999999999999955999999999888888777
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.. .....+..++..+.+++.+||+.||.+||++++++++|+.+..
T Consensus 301 ~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 301 SG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cC-CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 66 3455567789999999999999999999999999999988754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=242.58 Aligned_cols=176 Identities=17% Similarity=0.261 Sum_probs=154.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+. +++..+..++.|+++||.|||+.|++||||||+||+++.++.+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~---------------l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~ 153 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGR---------------MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNI 153 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCC---------------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred EEEEEECCCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCE
Confidence 3488999999999999987644 9999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFS-TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ......+++.|+|||.+.+..+. .++||||+||++|+|+ +|..||.+.+..+....+..+.
T Consensus 154 kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~ 230 (328)
T 3fe3_A 154 KIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV-SGSLPFDGQNLKELRERVLRGK 230 (328)
T ss_dssp EECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEeeccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCC
Confidence 999999987543322 23456788999999999887765 7899999999999999 7999999999888888877764
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .+...++++.+++.+||+.||.+|||++++++|
T Consensus 231 ~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 YR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CC--CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC--CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 43 355678999999999999999999999999876
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=245.86 Aligned_cols=202 Identities=32% Similarity=0.553 Sum_probs=165.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhcccc-CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKD-KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+||||+.+|+|.++++..+..... ...........+++..++.++.|++.||.|||+.|++||||||.||+++.++.
T Consensus 150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 229 (382)
T 3tt0_A 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 229 (382)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCc
Confidence 44889999999999999976531110 00111112346999999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++++|++.|..||.+....+....+...
T Consensus 230 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 309 (382)
T 3tt0_A 230 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 309 (382)
T ss_dssp EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999975543221 12233456778999999998889999999999999999994499999999888888777665
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.....+..+++++.+++.+||+.||++||++++++++|++++..
T Consensus 310 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 310 -HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp -CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 45556678899999999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=243.57 Aligned_cols=187 Identities=23% Similarity=0.426 Sum_probs=158.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+|+|.+++...+. .+++..++.++.|+++||.|||+.|++||||||.||+++.++.+
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~ 156 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKD--------------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTT--------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEE
T ss_pred eEEEEEecCCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCE
Confidence 3478999999999999987543 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||+++...... ........++..|+|||.+.+..++.++||||||+++|++++.|..||.+.........+...
T Consensus 157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~- 235 (327)
T 3poz_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 235 (327)
T ss_dssp EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred EEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-
Confidence 999999987543322 112223455778999999999999999999999999999994499999988887777666655
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
...+.+..++.++.+++.+||+.||.+||++++++++|+++..
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 4455567789999999999999999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=258.38 Aligned_cols=189 Identities=29% Similarity=0.475 Sum_probs=165.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++|+.... ..+++..++.++.||++||.|||+++++||||||+||+++.++.+
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~ 402 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETG-------------KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 402 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHH-------------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred ceEeeehhcCCcHHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcE
Confidence 4588999999999999986543 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++..............++..|+|||.+....++.++||||||+++|+|++.|..||.+....+....+..+ .
T Consensus 403 kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-~ 481 (535)
T 2h8h_A 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 481 (535)
T ss_dssp EECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-C
T ss_pred EEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999998665444333344566788999999988889999999999999999995599999999988888887765 5
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
+.+.+..+++++.++|.+||+.||++||+++++++.|+.++..
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 5666778999999999999999999999999999999987653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=242.38 Aligned_cols=189 Identities=29% Similarity=0.580 Sum_probs=158.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.++++... ..+++..++.++.|++.||.|||+.|++|+||||.||+++.++.+
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 167 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNET--------------HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 167 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTT--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCE
T ss_pred eEEEEeCCCCCCHHHHHHhcc--------------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCE
Confidence 447899999999999997543 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh---hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKEY---YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+++|||++........ .......++..|+|||.+.+..++.++|+||+|++++++++.+..||...........+..
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3f66_A 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247 (298)
T ss_dssp EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT
T ss_pred EECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc
Confidence 9999999876543321 1223445677899999998888999999999999999999557888887777666666665
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
. .....+..+++.+.+++.+||+.||.+||+++++++.|++++.+-
T Consensus 248 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 248 G-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred C-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 5 344446678999999999999999999999999999999988653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=258.19 Aligned_cols=189 Identities=29% Similarity=0.474 Sum_probs=163.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++..+. ..+++..++.++.||+.||.|||+++++||||||.||+++.++.+
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~ 357 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNR-------------QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV 357 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCT-------------TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEEccCCCCHHHHHHhcCc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcE
Confidence 4488999999999999987543 468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++..............++..|+|||.+....++.++||||||+++|+|++.|..||.+.+..+....+... .
T Consensus 358 kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~ 436 (495)
T 1opk_A 358 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-Y 436 (495)
T ss_dssp EECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-C
T ss_pred EEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999997654333223334456778999999988889999999999999999995599999998887777776655 5
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
+...+..+++++.++|.+||+.||.+||+++++++.|+.++.+
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 5666778999999999999999999999999999999887643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=240.79 Aligned_cols=192 Identities=29% Similarity=0.546 Sum_probs=155.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++|+.+|+|.+++...... .....+++..++.++.|+++||.|||+.|++||||||.||+++.++.++
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIG---------ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred EEEEEeccCCcHHHHHHhhhcc---------ccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 4789999999999999876531 0112589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++........ .......++..|+|||.+.+..++.++||||+|+++|+|++.|..||.+....+....+... .
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG-N 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-C
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC-C
Confidence 999999976543332 12233455678999999988889999999999999999994499999998888887777665 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
....+..+++++.+++.+||+.||.+||++.++++.|++++..
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 4555678899999999999999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=244.19 Aligned_cols=188 Identities=21% Similarity=0.359 Sum_probs=157.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|++|+.+|+|.+++...+. .+++..++.++.|+++||.|||+.|++||||||.||+++.++.+
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~ 154 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRG--------------ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQV 154 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGG--------------GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCE
T ss_pred cEEEEEeCCCCCHHHHHHHccc--------------cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeE
Confidence 3478999999999999986533 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ........++..|+|||.+.+..++.++||||+|+++|++++.|..||.+....+....+...
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 233 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG- 233 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-
Confidence 999999997653322 112234456678999999988889999999999999999994499999988877777776665
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.....+..++.++.+++.+||+.||.+||++++++++|+++..+
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 44555666788899999999999999999999999999988643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=240.91 Aligned_cols=188 Identities=23% Similarity=0.431 Sum_probs=155.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+|+|.+++...+. .+++..++.++.|++.||.|||+.|++||||||.||+++.++.+
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~ 156 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKD--------------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEE
T ss_pred ceEEEEecCCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCE
Confidence 3378899999999999987543 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ........++..|+|||.+.+..++.++||||+|+++|+|++.|..||.+.........+...
T Consensus 157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~- 235 (327)
T 3lzb_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 235 (327)
T ss_dssp EECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred EEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999997654322 112233455778999999998899999999999999999994499999988887777766665
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
...+.+..++.++.+++.+||+.||.+||++.++++.|+++..+
T Consensus 236 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 236 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 44556677899999999999999999999999999999988643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=239.10 Aligned_cols=188 Identities=27% Similarity=0.554 Sum_probs=160.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++|+.+|+|.++++..+ ..+++..++.++.|+++||.|||+.|++|+||||.||+++.++.++
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~k 164 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQ--------------RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVK 164 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTT--------------CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEE
T ss_pred EEEEecccCCCHHHHHhccc--------------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 47899999999999997633 3689999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhh---hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 98 ISLSGLSKDTYQKEY---YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++|||++........ .......++..|++||.+.+..++.++|+||+|+++|+|++.+..||...........+...
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3pls_A 165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244 (298)
T ss_dssp ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT
T ss_pred eCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC
Confidence 999999975543321 12233456788999999998889999999999999999996577778777777776666655
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
.....+..+++.+.+++.+||+.||.+|||++++++.|+++++.-
T Consensus 245 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 245 -RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 445556778999999999999999999999999999999987654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=260.89 Aligned_cols=190 Identities=26% Similarity=0.443 Sum_probs=161.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++..+ .+++..++.++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~---------------~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~ 508 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNR---------------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 508 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCT---------------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred EEEEEEccCCCCHHHHHhhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCE
Confidence 348899999999999997653 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
||+|||+++...... ........++..|+|||.+....++.++|||||||++|+|++.|..||.+....+....+..+
T Consensus 509 kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~ 588 (635)
T 4fl3_A 509 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 588 (635)
T ss_dssp EECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred EEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999987543322 112233445678999999998899999999999999999995599999999988888877776
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhccC
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDVN 222 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 222 (223)
.....+..+++++.++|..||+.||++||+++++++.|++++.+-+|
T Consensus 589 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~n 635 (635)
T 4fl3_A 589 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 635 (635)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHCC
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhcC
Confidence 45566778999999999999999999999999999999999876654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=239.72 Aligned_cols=187 Identities=27% Similarity=0.492 Sum_probs=156.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++...+. ..+++..++.++.|+++||.|||+.|++|+||+|.||+++.++.+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 156 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGR-------------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA 156 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHH-------------HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred eEEEEecCCCCCHHHHHHhccc-------------ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcE
Confidence 4588999999999999987654 348999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... ....++..|+|||.+.+..++.++|+||+|+++++|++.|..||...........+... .
T Consensus 157 ~l~Dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~ 231 (278)
T 1byg_A 157 KVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-Y 231 (278)
T ss_dssp EECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-C
T ss_pred EEeeccccccccccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-C
Confidence 999999987543322 22345778999999988889999999999999999994499999988877777766655 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhcc
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDV 221 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 221 (223)
....+..+++++.+++.+||+.||.+||++.++++.|+++....+
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~ 276 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 276 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence 455567889999999999999999999999999999999876654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=239.27 Aligned_cols=188 Identities=28% Similarity=0.469 Sum_probs=155.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+. .+++..++.++.|+++||.|||+.|++|+||||.||+++.++.+
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~ 186 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDG--------------EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC 186 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTT--------------CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred cEEEEeCCCCCcHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcE
Confidence 3488999999999999986533 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++........ .......++..|+|||.+....++.++||||||+++|++++.|..||......+....+...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 266 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence 9999999876543321 11222345678999999988889999999999999999994499999988888887777665
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
...+.+..++..+.+++.+||+.||.+||+++++++.|++++..
T Consensus 267 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 267 -FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp -CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 44555678899999999999999999999999999999988753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=240.37 Aligned_cols=206 Identities=26% Similarity=0.462 Sum_probs=161.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCC---CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKS---GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~---~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~ 93 (223)
..+|+||+++|+|.+++...+....... .........+++..++.++.|+++||.|||+.|++|+||||.||+++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence 4488999999999999987643100000 0000112358999999999999999999999999999999999999999
Q ss_pred CCeEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 94 LSVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
+.++++|||++........ .......++..|+|||.+.+..++.++||||||+++++|++.|..||.+...........
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 261 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence 9999999999876543321 112234456789999999888899999999999999999944999998877554444443
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhccC
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDVN 222 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 222 (223)
........+..++.++.+++.+||+.||.+||++++++++|++++.+..+
T Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 33345555677899999999999999999999999999999999987655
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=236.96 Aligned_cols=189 Identities=30% Similarity=0.482 Sum_probs=162.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++..... ..+++..++.++.|+++||.|||+.|++|+||+|.||+++.++.+
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 148 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSG-------------IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC 148 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHH-------------HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE
T ss_pred cEEEEecCCCCCHHHHHhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCE
Confidence 4488999999999999976532 359999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|+|||.+.+..++.++|+||||+++++|++.|..||.+....+....+... .
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~ 227 (279)
T 1qpc_A 149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-Y 227 (279)
T ss_dssp EECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-C
T ss_pred EECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-c
Confidence 999999987654433222234455678999999988888999999999999999994499999998888877777665 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
....+..+++++.+++.+||+.||++||+++++++.|++++..
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 4555678899999999999999999999999999999998765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=241.96 Aligned_cols=202 Identities=29% Similarity=0.548 Sum_probs=160.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccc---------cCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSK---------DKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARN 87 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~---------~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~n 87 (223)
..+||||+.+|+|.+++........ ............+++..++.++.||++||.|||+.|++|+||||.|
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 204 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 204 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence 4488999999999999987532100 0000001112579999999999999999999999999999999999
Q ss_pred eeeecCCCeEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy15108 88 CLISSDLSVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166 (223)
Q Consensus 88 il~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~ 166 (223)
|+++.++.++++|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++.|..||.+....+
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 284 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence 9999999999999999875433321 122345667889999999888899999999999999999944999999998888
Q ss_pred HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 167 VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
....+.... ....+..++.++.+++.+||+.||.+||++.+++++|+++...
T Consensus 285 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 285 VIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHHHHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 887777663 3445677899999999999999999999999999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=236.88 Aligned_cols=187 Identities=22% Similarity=0.363 Sum_probs=150.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+. .+++..++.++.|++.||.|||+.|++|+||||.||+++.++.+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~ 153 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKE--------------RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGG--------------GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred eEEEEEeCCCCCHHHHHHhccc--------------ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeE
Confidence 3478999999999999987543 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---------
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD--------- 165 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~--------- 165 (223)
+++|||++....... ........++..|+|||.+.+..++.++||||+|+++|+++ +|..|+......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~~~~~~~~~~~~~~~~~~ 232 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF-TYIEKSKSPPAEFMRMIGNDK 232 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH-HTTCTTCSHHHHHHHHHCTTC
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHH-hcccccCCChHHHHhhhcCcc
Confidence 999999997654332 11223345667799999999889999999999999999999 677777543211
Q ss_pred -------HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 166 -------QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 166 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.....+... ...+.+..+++++.+++..||+.||++|||++++++.|+++.++
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 233 QGQMIVFHLIELLKNN-GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp CTHHHHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccchhHHHHHHHHhcc-CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 122222222 44556778899999999999999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=257.51 Aligned_cols=188 Identities=24% Similarity=0.435 Sum_probs=158.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ ..+++..+..++.||+.||.|||+++++||||||+||+++.++.+
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~v 475 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKR--------------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYA 475 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCT--------------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred eEEEEEeCCCCcHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcE
Confidence 448899999999999997532 369999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
||+|||+++...... ........++..|+|||.+....++.++|||||||++|||++.|..||.+....+....+..+
T Consensus 476 kL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~ 555 (613)
T 2ozo_A 476 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555 (613)
T ss_dssp EECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT
T ss_pred EEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 999999997654322 111223345678999999988899999999999999999995599999999888888887776
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.+...+..+++++.++|..||+.||++||+++++++.|+.++..
T Consensus 556 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 556 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 45566778999999999999999999999999999999987644
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=242.84 Aligned_cols=203 Identities=28% Similarity=0.464 Sum_probs=158.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCC--------CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKS--------GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNC 88 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~--------~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~ni 88 (223)
..+||||+++|+|.+++...+....... .........+++..++.++.||+.||.|||+.|++|+||||.||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 4488999999999999987543110000 00001123589999999999999999999999999999999999
Q ss_pred eeecCCCeEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy15108 89 LISSDLSVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167 (223)
Q Consensus 89 l~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~ 167 (223)
+++.++.++++|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++.|..||.+......
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 283 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence 999999999999999875543321 1123345567899999998888999999999999999999449999988776555
Q ss_pred HHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.............+..+++++.+++.+||+.||.+||++.+++++|+.++..
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 284 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 5555554456666777899999999999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=239.47 Aligned_cols=176 Identities=16% Similarity=0.254 Sum_probs=153.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++|++||||||.||+++.++.++
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vk 145 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRER---------------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHS---------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEE
Confidence 38899999999999998754 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
|+|||++....... .......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.+.......+......
T Consensus 146 L~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~~~~~~~i~~~~~~ 223 (337)
T 1o6l_A 146 ITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHERLFELILMEEIR 223 (337)
T ss_dssp ECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EeeccchhhcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHh-cCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999987533221 1223456789999999999888999999999999999999 799999998888888777765433
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
.+..+++++.+++.+||+.||.+|| +++++++|
T Consensus 224 --~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 3567899999999999999999999 89999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=235.64 Aligned_cols=188 Identities=25% Similarity=0.418 Sum_probs=159.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.++++..+ .+++..++.++.|+++||.|||+.|++|+||+|.||+++.++.+
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~ 156 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR---------------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 156 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT---------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cEEEEEeCCCCCHHHHHHhCc---------------CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcE
Confidence 348899999999999998753 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++.|..||......+....+...
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 236 (291)
T 1xbb_A 157 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236 (291)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred EEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999875533221 11122345678999999988888999999999999999994499999998888877777665
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
.....+..+++++.+++.+||+.||.+||++.++++.|++++.+.
T Consensus 237 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 237 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 345556788999999999999999999999999999999988764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=236.43 Aligned_cols=185 Identities=17% Similarity=0.177 Sum_probs=152.1
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC---
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS--- 95 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~--- 95 (223)
+|+||+ +++|.++++..+. ++++..+..++.|+++||.|||+.|++||||||+||+++.++.
T Consensus 83 lv~e~~-~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~ 147 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGR--------------KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNA 147 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTT
T ss_pred EEEEec-CCCHHHHHHHhcc--------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCC
Confidence 788999 9999999986533 5999999999999999999999999999999999999987765
Q ss_pred --eEEcCCCCCcccchhhh------hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---H
Q psy15108 96 --VKISLSGLSKDTYQKEY------YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS---D 164 (223)
Q Consensus 96 --~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~---~ 164 (223)
++++|||++........ .......++..|+|||.+.+..++.++||||||+++|+|+ +|..||.+.. .
T Consensus 148 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~~~~ 226 (298)
T 1csn_A 148 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL-RGSLPWQGLKAATN 226 (298)
T ss_dssp TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTSSCCSCCH
T ss_pred CeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH-cCCCCcchhhcccc
Confidence 99999999976543321 1223456889999999998888999999999999999999 7999998743 3
Q ss_pred HHHHHHHHhCcccC---CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 165 DQVLSQLESKKLCW---KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 165 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
......+....... .....+++++.+++..||+.||.+||+++++++.|++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 227 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 34444433322211 12346789999999999999999999999999999998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=235.30 Aligned_cols=191 Identities=27% Similarity=0.415 Sum_probs=160.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++..... .+++..+..++.|+++||.|||+.|++|+||+|.||+++.++.+
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~ 160 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQG--------------HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV 160 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG--------------GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE
T ss_pred ceeeEecccCCCHHHHHHhccC--------------CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCE
Confidence 4478999999999999987643 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++....... ........++..|+|||.+....++.++|+||||+++++|++.|..||......+....+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 240 (291)
T 1u46_A 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240 (291)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred EEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc
Confidence 999999987653322 111223455678999999988888999999999999999994499999999988888888776
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhcc
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDV 221 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 221 (223)
....+.+..++.++.+++.+||+.||.+||++.++++.|+++...+.
T Consensus 241 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 56666677889999999999999999999999999999999877654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=237.43 Aligned_cols=202 Identities=29% Similarity=0.572 Sum_probs=162.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhcccc---------CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKD---------KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARN 87 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~---------~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~n 87 (223)
..+|+||+.+|+|.+++...+..... ...........+++..++.++.|+++||.|||+.|++|+||||.|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 44889999999999999876431000 000001122458999999999999999999999999999999999
Q ss_pred eeeecCCCeEEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy15108 88 CLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166 (223)
Q Consensus 88 il~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~ 166 (223)
|+++.++.++++|||++....... ........++..|+|||.+.+..++.++||||+|+++|+|++.|..||.+.....
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987553322 1122334556789999999888889999999999999999944999999888877
Q ss_pred HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 167 VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
....+... .....+..+++++.+++.+||+.||.+||++.+++++|++++.+
T Consensus 261 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 261 LFNLLKTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHhhcC-CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 77766665 44555678899999999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=236.53 Aligned_cols=189 Identities=29% Similarity=0.478 Sum_probs=162.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.++++..+. ..+++..++.++.|++.||.|||+.|++|+||+|.||+++.++.+
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 150 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNR-------------QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCT-------------TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEEcCCCCcHHHHHHhccc-------------CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCE
Confidence 3478999999999999987543 469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............++..|+|||.+.+..++.++|+||+|+++|+|++.|..||...+.......+... .
T Consensus 151 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~ 229 (288)
T 3kfa_A 151 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-Y 229 (288)
T ss_dssp EECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-C
T ss_pred EEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-C
Confidence 999999987654333222333455678999999988889999999999999999994499999988887777766655 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
....+..+++.+.+++.+||+.||.+||+++++++.|+.++.+
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 5566778899999999999999999999999999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=235.21 Aligned_cols=186 Identities=18% Similarity=0.273 Sum_probs=151.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.+++...+ ++++..++.++.|+++||.|||+.|++||||||.||+++.++.++
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHG---------------PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 38899999999999998764 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++...............+++.|+|||.+.+..++.++|+||+|+++|+|+ +|..||.+................
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll-~g~~pf~~~~~~~~~~~~~~~~~~ 230 (294)
T 4eqm_A 152 IFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML-VGEPPFNGETAVSIAIKHIQDSVP 230 (294)
T ss_dssp ECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHH-HSSCSSCSSCHHHHHHHHHSSCCC
T ss_pred EEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHhhccCC
Confidence 9999999765444333334456889999999998888999999999999999999 699999988876655444333221
Q ss_pred ---CCCCCCChHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHhhh
Q psy15108 178 ---WKHSSKTPEYITSLHEKCIHPHPHQRP-TFPSIVTQLSDAMCN 219 (223)
Q Consensus 178 ---~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~~~ 219 (223)
......+++.+.+++.+||+.||.+|| +++++.+.|+.++.+
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 123456889999999999999999998 899999999887654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=234.68 Aligned_cols=192 Identities=28% Similarity=0.532 Sum_probs=155.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++|+.+|+|.+++...... .....+++..++.++.|+++||.|||+.|++|+||||.||+++.++.++
T Consensus 117 ~~v~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 117 MVILPFMKYGDLHTYLLYSRLE---------TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp EEEEECCTTCBHHHHHHHTTBT---------TSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred EEEEecccCCCHHHHHHHhhhh---------cCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 4789999999999999764320 1234699999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++.|..||...........+... .
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~ 266 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-H 266 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-C
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC-C
Confidence 999999876543321 12233456778999999988889999999999999999994489999988887777776665 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
....+..+++++.+++.+||+.||.+||++++++++|++++..
T Consensus 267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 4555677899999999999999999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=243.43 Aligned_cols=176 Identities=17% Similarity=0.224 Sum_probs=150.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.++++..+. +++..+..++.||+.||.|||++|++||||||+||+++.++.++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ik 164 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRR---------------FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEE
Confidence 388999999999999987644 99999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
|+|||++....... .......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.+..+....+......
T Consensus 165 L~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~G~~Pf~~~~~~~~~~~i~~~~~~ 242 (353)
T 3txo_A 165 LADFGMCKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML-CGHAPFEAENEDDLFEAILNDEVV 242 (353)
T ss_dssp ECCCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EccccceeecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999987533222 1234457899999999998888999999999999999999 799999999998888888776443
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTF------PSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~ 212 (223)
.+..+++.+.+++.+||+.||.+||++ +++++|
T Consensus 243 --~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 --YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred --CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 356688999999999999999999998 777764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=244.09 Aligned_cols=203 Identities=29% Similarity=0.505 Sum_probs=158.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCC-CCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSG-SGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+++||+.+|+|.+++............ ........+++..++.++.|+++||.|||+.|++|+||||.||+++.++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence 45789999999999999865431110000 00001123899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh
Q psy15108 96 VKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ-VLSQLES 173 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~-~~~~~~~ 173 (223)
++++|||++....... ........++..|+|||.+.+..++.++||||+|+++|+|++.|..||.+..... ....+..
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~ 266 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhcc
Confidence 9999999987543322 1122334557789999999888899999999999999999944999998776443 3333433
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
. .....+..+++++.+++..||+.||.+||++.+++++|+.++...
T Consensus 267 ~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 267 G-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C-ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 3 444556678899999999999999999999999999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=235.73 Aligned_cols=197 Identities=30% Similarity=0.577 Sum_probs=162.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++..+...... .....+++..++.++.|++.||.|||+.|++||||||.||+++.++.+
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANN-----PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHC-----TTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccC-----CCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 447899999999999998764311000 011357999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++........ .......++..|+|||.+.+..++.++||||+|+++|+|++.|..||.+.........+....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 9999999876543321 122334557789999999888899999999999999999955899999988888777776653
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
....+..++..+.+++.+||+.||.+||++.+++++|++.+.+
T Consensus 258 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 258 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 3445667899999999999999999999999999999887653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=244.68 Aligned_cols=186 Identities=16% Similarity=0.141 Sum_probs=149.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee--cCCC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS--SDLS 95 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~--~~~~ 95 (223)
.+||||+ +|+|.++++..+. .+++..++.++.||+.||.|||+.|++||||||.||+++ .++.
T Consensus 128 ~lv~e~~-g~~L~~~~~~~~~--------------~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 128 FMIMDRF-GSDLQKIYEANAK--------------RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEECE-EEEHHHHHHHTTS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EEEEeCC-CCCHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 4789999 9999999987533 599999999999999999999999999999999999999 8899
Q ss_pred eEEcCCCCCcccchhhhh------hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHH
Q psy15108 96 VKISLSGLSKDTYQKEYY------KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVL 168 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~ 168 (223)
++|+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|+|+ +|..||.+.... ...
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~-~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL-TGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH-hCCCCccccccCHHHH
Confidence 999999999765433211 112345889999999999888999999999999999999 699999854322 211
Q ss_pred HHHHh----Cc----ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 169 SQLES----KK----LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 169 ~~~~~----~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..... .. ........+++++.+++..||+.+|.+||+++++++.|++++.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 11111 00 00111256789999999999999999999999999999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=256.28 Aligned_cols=188 Identities=31% Similarity=0.515 Sum_probs=160.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++..+. .+++..++.++.|+++||.|||+.|++||||||+||+++.++.+
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~v 530 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKF--------------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 530 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTT--------------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred eEEEEEcCCCCcHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCE
Confidence 4488999999999999986543 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++...............+++.|+|||.+....++.++||||||+++|+|++.|..||.+....+....+... .
T Consensus 531 kL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-~ 609 (656)
T 2j0j_A 531 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-E 609 (656)
T ss_dssp EECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-C
T ss_pred EEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999998654443333334456678999999988889999999999999999996699999999888888777766 3
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..+.+..+++.+.+++.+||+.||.+||++.++++.|++++++
T Consensus 610 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 4556678899999999999999999999999999999998765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=230.72 Aligned_cols=182 Identities=22% Similarity=0.353 Sum_probs=157.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCCCCCeeeecCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR--LIHKDIAARNCLISSDL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~~~nil~~~~~ 94 (223)
..+|+||+++|+|.++++..+. ..+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~ 150 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTN-------------FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM 150 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSS-------------CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS
T ss_pred eEeeecccCCCcHHHHHhhccc-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc
Confidence 4588999999999999986432 35899999999999999999999999 99999999999999999
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCc---ccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFST---KSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~---~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
.+++.||+++.... .....+++.|+|||.+.+..++. ++||||+|+++|+++ +|..||...........+
T Consensus 151 ~~~l~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~~~~~~~~ 223 (271)
T 3kmu_A 151 TARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV-TREVPFADLSNMEIGMKV 223 (271)
T ss_dssp CEEEEGGGSCCTTS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHH-HCSCTTTTSCHHHHHHHH
T ss_pred ceeEEeccceeeec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHH-hCCCCccccChHHHHHHH
Confidence 99998888765422 23356788999999987665444 799999999999999 699999998888877777
Q ss_pred HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
......+..+..+++++.+++.+||+.||++|||++++++.|+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 76666677778899999999999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=235.29 Aligned_cols=188 Identities=24% Similarity=0.422 Sum_probs=160.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++...+ ..+++..++.++.|+++||.|||+.|++|+||+|.||+++.++.+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 149 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKR--------------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 149 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCT--------------TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEE
T ss_pred cEEEEEeCCCCCHHHHHHhCC--------------ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCE
Confidence 347899999999999997432 359999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||++........ .......++..|+|||.+.+..++.++|+||+|+++|+|++.|..||......+....+...
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~ 229 (287)
T 1u59_A 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229 (287)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT
T ss_pred EECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC
Confidence 9999999876533221 11223345788999999988888999999999999999994499999988887777777665
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.....+..+++++.+++..||+.||.+||++.+++++|+.++.+
T Consensus 230 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 230 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 34555678899999999999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=244.59 Aligned_cols=179 Identities=17% Similarity=0.221 Sum_probs=155.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec---C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---D 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~---~ 93 (223)
..+||||+.+|+|.+++...+ .+++..+..++.||++||.|||++|++||||||+||+++. +
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~---------------~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~ 149 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVARE---------------YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKG 149 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCS---------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTT
T ss_pred EEEEEEeCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCC
Confidence 348899999999999998754 4999999999999999999999999999999999999984 5
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+.++++|||++....... .......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+.......+..
T Consensus 150 ~~vkL~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell-~G~~Pf~~~~~~~~~~~i~~ 227 (444)
T 3soa_A 150 AAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL-VGYPPFWDEDQHRLYQQIKA 227 (444)
T ss_dssp CCEEECCCSSCBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHH
T ss_pred CcEEEccCceeEEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHH-hCCCCCCCccHHHHHHHHHh
Confidence 789999999997554322 1123457889999999998888999999999999999999 79999999998888888877
Q ss_pred CcccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+....+.+ ..+++++++++.+||+.||.+||++.++++|
T Consensus 228 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 228 GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 65544333 4678999999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=236.22 Aligned_cols=178 Identities=17% Similarity=0.281 Sum_probs=151.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++.. .+++..+..++.|++.||.|||+.|++||||||.||+++.++.+
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~ 155 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTET----------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV 155 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHS----------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCE
T ss_pred EEEEEECCCCCCHHHHHhhc----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCE
Confidence 34889999999999999753 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-Cc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-KK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~-~~ 175 (223)
+++|||++....... .......+++.|+|||.+.+..++.++||||+|+++|+|+ +|..||.+.+.......+.. ..
T Consensus 156 kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~ 233 (297)
T 3fxz_A 156 KLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENPLRALYLIATNGT 233 (297)
T ss_dssp EECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHHHHHCS
T ss_pred EEeeCCCceecCCcc-cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCC
Confidence 999999987544322 1233457889999999999889999999999999999999 79999998887665555443 32
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+..+++.+.+++.+||+.||.+||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3344456788999999999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=242.23 Aligned_cols=178 Identities=17% Similarity=0.265 Sum_probs=153.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
..+||||+.+|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||.||+++.++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~ 154 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---------------ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---------------SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSS
T ss_pred EEEEEEcCCCCcHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCC
Confidence 34889999999999999653 3599999999999999999999999999999999999998776
Q ss_pred --CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 95 --SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 95 --~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
.++++|||++....... ......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.+..+....+.
T Consensus 155 ~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll-~g~~Pf~~~~~~~~~~~i~ 231 (361)
T 2yab_A 155 IPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL-SGASPFLGDTKQETLANIT 231 (361)
T ss_dssp SCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSCCSSCCSSHHHHHHHHH
T ss_pred ccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHH
Confidence 79999999997654322 224457899999999998888999999999999999999 7999999998888888877
Q ss_pred hCcccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........ ....++++++++.+||..||.+|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 232 AVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 65443321 24678899999999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=239.47 Aligned_cols=175 Identities=18% Similarity=0.282 Sum_probs=152.8
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+||||+.+|+|.++++..+ .+++..++.++.||+.||.|||+.|++||||||.||+++.++.++|
T Consensus 98 lv~E~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---------------RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEeCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEE
Confidence 7899999999999998764 4999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW 178 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 178 (223)
+|||++....... .......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.+..+....+......
T Consensus 163 ~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~G~~Pf~~~~~~~~~~~i~~~~~~- 239 (353)
T 2i0e_A 163 ADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQAPFEGEDEDELFQSIMEHNVA- 239 (353)
T ss_dssp CCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCCCC-
T ss_pred EeCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHH-cCCCCCCCCCHHHHHHHHHhCCCC-
Confidence 9999987532221 1234457899999999999888999999999999999999 799999999988888888776443
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 179 KHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 179 ~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
.+..++.++.+++.+||+.||.+||+ ++++++|
T Consensus 240 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 45678999999999999999999995 5777765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=234.85 Aligned_cols=173 Identities=20% Similarity=0.232 Sum_probs=153.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.++++..+ .+++..+..++.||+.||.|||+.|++||||||+||+++.++.++
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~k 146 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQ---------------RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIK 146 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTS---------------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEE
Confidence 38899999999999998653 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++...... .....+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.+.......+.....
T Consensus 147 L~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~- 220 (318)
T 1fot_A 147 ITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML-AGYTPFYDSNTMKTYEKILNAEL- 220 (318)
T ss_dssp ECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHHHCCC-
T ss_pred EeecCcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCCC-
Confidence 9999999754322 23457889999999999888999999999999999999 79999999888888888777643
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
..+...++++.+++.+||+.||.+|| +++++++|
T Consensus 221 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 33567889999999999999999999 88998865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=240.08 Aligned_cols=202 Identities=29% Similarity=0.464 Sum_probs=159.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+....... ........+++..++.++.|++.||.|||+.|++|+||||.||+++.++.+
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDP-AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence 4478999999999999987653111100 000012468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++.|..||.+.........+....
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 283 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC
Confidence 999999987543322 1112334456789999999888899999999999999999955999998876655554444443
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.....+..+++.+.+++..||+.||.+||++.+++++|+++..+
T Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 284 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 55555677899999999999999999999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=240.65 Aligned_cols=177 Identities=18% Similarity=0.257 Sum_probs=153.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~v 157 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH---------------KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI 157 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE
T ss_pred EEEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCE
Confidence 338899999999999998754 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.+..+....+.....
T Consensus 158 kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~~~~~~~i~~~~~ 235 (345)
T 1xjd_A 158 KIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML-IGQSPFHGQDEEELFHSIRMDNP 235 (345)
T ss_dssp EECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEeEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHh-cCCCCCCCCCHHHHHHHHHhCCC
Confidence 999999987532221 1234567889999999999888999999999999999999 79999999998888888776643
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFP-SIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~~ 212 (223)
..+..+++++.+++.+||+.||.+||++. ++++|
T Consensus 236 --~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 236 --FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 33566889999999999999999999997 77643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=237.26 Aligned_cols=200 Identities=27% Similarity=0.454 Sum_probs=159.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCC-CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKS-GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.+||||+++|+|.+++...+....+.. .........+++..++.++.|+++||.|||+.|++|+||||.||+++.++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence 378999999999999986541000000 0000012469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... ......++..|+|||.+....++.++|+||+|+++|+|++.|..||.+....+....+... .
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~ 258 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-Y 258 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-C
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-C
Confidence 999999986432211 1122345678999999988888999999999999999994499999998888877776655 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
....+..+++++.+++.+||+.||.+||++++++++|.+++.+.
T Consensus 259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 45556778999999999999999999999999999999987654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=234.05 Aligned_cols=186 Identities=17% Similarity=0.200 Sum_probs=151.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee---ecCC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI---SSDL 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~---~~~~ 94 (223)
.+||||+ +|+|.+++..... .+++..++.++.|++.||.|||+.|++|+||||+||++ +.++
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~--------------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~ 145 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR--------------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN 145 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT
T ss_pred EEEEEcc-CCCHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC
Confidence 3788999 9999999986433 59999999999999999999999999999999999999 7888
Q ss_pred CeEEcCCCCCcccchhhh------hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---
Q psy15108 95 SVKISLSGLSKDTYQKEY------YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD--- 165 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~--- 165 (223)
.++++|||++........ .......++..|+|||.+.+..++.++||||+|+++|+++ +|..||.+....
T Consensus 146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~ 224 (296)
T 4hgt_A 146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN-LGSLPWQGLKAATKR 224 (296)
T ss_dssp CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTSSCCCSSSS
T ss_pred eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHh-cCCCCCcccchhhhh
Confidence 999999999976543321 1223457789999999999888999999999999999999 799999764322
Q ss_pred HHHHHHHhCcccCC---CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 166 QVLSQLESKKLCWK---HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 166 ~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.....+.......+ ....+++++.+++..||+.||++||+++++++.|++++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 225 QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp SHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 22222222212111 2256789999999999999999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=238.59 Aligned_cols=173 Identities=19% Similarity=0.195 Sum_probs=153.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||.||+++.++.++
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~k 181 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIG---------------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHC---------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEcCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEE
Confidence 38899999999999998764 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
|+|||++...... .....+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.+..+....+.....
T Consensus 182 L~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~~~~~~~i~~~~~- 255 (350)
T 1rdq_E 182 VTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA-AGYPPFFADQPIQIYEKIVSGKV- 255 (350)
T ss_dssp ECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCCC-
T ss_pred EcccccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHh-hCCCCCCCCCHHHHHHHHHcCCC-
Confidence 9999999755332 23456789999999999888999999999999999999 79999999988888888877643
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
..+..++.++.+++.+||+.||.+||+ ++++++|
T Consensus 256 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 -RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 345678999999999999999999998 8888765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=236.78 Aligned_cols=202 Identities=29% Similarity=0.534 Sum_probs=161.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCC-CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKS-GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+|+||+.+|+|.+++...+....... .........+++..++.++.||++||.|||+.|++|+||||.||+++.++.
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 195 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV 195 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCC
Confidence 4478999999999999986543100000 000011235899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++.|..||.+....+....+...
T Consensus 196 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 275 (334)
T 2pvf_A 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275 (334)
T ss_dssp EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcC
Confidence 99999999875543221 11223445678999999988888999999999999999994499999998888877777665
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.....+..++.++.+++.+||+.||.+||++++++++|++++..
T Consensus 276 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 276 -HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 34555677899999999999999999999999999999998753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=232.52 Aligned_cols=186 Identities=17% Similarity=0.200 Sum_probs=151.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee---ecCC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI---SSDL 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~---~~~~ 94 (223)
.+|+||+ +++|.+++...+. .+++..++.++.|++.||.|||++|++|+||||.||++ +.++
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~ 145 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSR--------------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN 145 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT
T ss_pred EEEEEec-CCCHHHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC
Confidence 3788999 9999999985433 59999999999999999999999999999999999999 4788
Q ss_pred CeEEcCCCCCcccchhhh------hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---H
Q psy15108 95 SVKISLSGLSKDTYQKEY------YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD---D 165 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~---~ 165 (223)
.++++|||++........ .......++..|+|||.+.+..++.++||||||+++|+|+ +|..||..... .
T Consensus 146 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~ 224 (296)
T 3uzp_A 146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN-LGSLPWQGLKAATKR 224 (296)
T ss_dssp CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTSSCCCSSSS
T ss_pred eEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHH-hCCCCCCCcCchhhh
Confidence 999999999876543321 1123456788999999999888999999999999999999 79999976432 2
Q ss_pred HHHHHHHhCcccCC---CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 166 QVLSQLESKKLCWK---HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 166 ~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
+....+.......+ ....+++++.+++..||+.||.+||+++++++.|++++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 225 QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp SHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 22233222212111 2356789999999999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=229.16 Aligned_cols=180 Identities=29% Similarity=0.485 Sum_probs=151.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCCCCCeeeec-
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR---LIHKDIAARNCLISS- 92 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~~~nil~~~- 92 (223)
..+|+||+.+|+|.++++. ..+++..++.++.|+++|+.|||+.| ++|+||||+||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~ 144 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG----------------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS----------------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSC
T ss_pred eEEEEEcCCCCCHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecc
Confidence 4488999999999999952 35899999999999999999999999 889999999999986
Q ss_pred -------CCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH
Q psy15108 93 -------DLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD 165 (223)
Q Consensus 93 -------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~ 165 (223)
++.++++|||++....... .....++..|+|||.+.+..++.++|+||+|+++++++ +|..||.+....
T Consensus 145 ~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~ 220 (271)
T 3dtc_A 145 VENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL-TGEVPFRGIDGL 220 (271)
T ss_dssp CSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHH-HCCCTTTTSCHH
T ss_pred cccccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHH
Confidence 6779999999987544332 22346788999999998888999999999999999999 799999998888
Q ss_pred HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 166 QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
.....+.......+.+..+++++.+++.+||+.||.+||++.+++++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 877777776666677788999999999999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=243.53 Aligned_cols=179 Identities=13% Similarity=0.224 Sum_probs=142.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec---CC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---DL 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~---~~ 94 (223)
.+||||+.+|+|.+++...+. ..+++..+..++.||+.||.|||+.|++||||||.||+++. ++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD-------------QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----------------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCc
Confidence 378999999999999986432 35999999999999999999999999999999999999987 68
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ----VLSQ 170 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~----~~~~ 170 (223)
.+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|+ +|..||.+..... ....
T Consensus 202 ~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~ 278 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAISPGMKTR 278 (400)
T ss_dssp CEEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHH-HSSCSCCCCTTCSSCCSHHHH
T ss_pred cEEEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCccccccHHHHHH
Confidence 89999999997554322 223456788999999998888999999999999999999 7999997654321 3334
Q ss_pred HHhCcccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKKLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+..+....+. ...++.++.+++.+||+.||.+|||++++++|
T Consensus 279 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 279 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 4444333322 24678999999999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=230.74 Aligned_cols=179 Identities=23% Similarity=0.432 Sum_probs=150.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCCCCCeeeecCCC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR--LIHKDIAARNCLISSDLS 95 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~~~nil~~~~~~ 95 (223)
.+||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA--------------HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT--------------SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT
T ss_pred eEEEEecCCCCHHHHHhccc--------------CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC
Confidence 37899999999999997543 36999999999999999999999999 999999999999987766
Q ss_pred -----eEEcCCCCCcccchhhhhhhhcCCcccccccccccc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--
Q psy15108 96 -----VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF--DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ-- 166 (223)
Q Consensus 96 -----~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~-- 166 (223)
++++|||++...... .....++..|+|||.+. ...++.++|+||+|+++|+|+ +|..||.......
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~ 237 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL-TGEGPFDEYSYGKIK 237 (287)
T ss_dssp TCSCCEEECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH-HSSCTTTTCCCCHHH
T ss_pred CCceeEEeCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH-cCCCCCccccccHHH
Confidence 999999998754332 23456788999999984 344688999999999999999 7999998665433
Q ss_pred HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 167 VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
....+.........+..+++++.+++.+||+.||.+||+++++++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 238 FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 3444555555666677889999999999999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=238.50 Aligned_cols=179 Identities=15% Similarity=0.184 Sum_probs=153.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec--CC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS--DL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~--~~ 94 (223)
..+||||+.+|+|.+++...+ ..+++..+..++.|++.||.|||+.|++||||||+||+++. ++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~ 141 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSA--------------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS 141 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS--------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCC
Confidence 348899999999999996532 35999999999999999999999999999999999999987 78
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++++|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|+ +|..||.+....+....+...
T Consensus 142 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~ 218 (321)
T 1tki_A 142 TIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL-SGINPFLAETNQQIIENIMNA 218 (321)
T ss_dssp CEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHHHT
T ss_pred CEEEEECCCCeECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH-hCCCCCcCCCHHHHHHHHHcC
Confidence 89999999997654322 223456788999999998888899999999999999999 799999999888888887776
Q ss_pred cccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... ...++.++.+++.+||..||.+|||+.|+++|
T Consensus 219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 443322 24678999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=232.95 Aligned_cols=187 Identities=21% Similarity=0.430 Sum_probs=143.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|++|+.+++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||.||+++.++.+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~ 159 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASE--------------TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTV 159 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC-----------------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred cEEEEEecCCCcHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCE
Confidence 448899999999999996543 359999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ-VLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~-~~~~~ 171 (223)
+++|||++....... ........++..|+|||.+. ...++.++||||+|+++++|+ +|..||....... ....+
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~~~~~~~~~ 238 (289)
T 3og7_A 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM-TGQLPYSNINNRDQIIEMV 238 (289)
T ss_dssp EECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHH-HSSCTTSSCCCHHHHHHHH
T ss_pred EEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHH-HCCCCccccchHHHHHHHh
Confidence 999999987543221 12233456789999999986 556788999999999999999 6999998765543 44444
Q ss_pred HhCcccCC---CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 172 ESKKLCWK---HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 172 ~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
........ ....+++++.+++.+||+.||.+||+++++++.|+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 44322221 234678999999999999999999999999999998765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=239.22 Aligned_cols=177 Identities=18% Similarity=0.243 Sum_probs=152.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC---
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL--- 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~--- 94 (223)
.+||||+.+|+|.+++... ..+++..+..++.||++||.|||+.|++||||||+||+++.++
T Consensus 104 ~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~ 168 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAR---------------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 168 (362)
T ss_dssp EEEECCCCSCBHHHHHTTC---------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTC
T ss_pred EEEEecCCCCCHHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCC
Confidence 4889999999999999754 3489999999999999999999999999999999999998653
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++++|||++....... ......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+.......+..+
T Consensus 169 ~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~Pf~~~~~~~~~~~i~~~ 245 (362)
T 2bdw_A 169 AVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL-VGYPPFWDEDQHRLYAQIKAG 245 (362)
T ss_dssp CEEECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHT
T ss_pred CEEEeecCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHHhC
Confidence 59999999997654322 223457889999999998888999999999999999999 799999998888888888776
Q ss_pred cccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+.+ ..+++++.+++.+||+.||.+||++.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 246 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 5444332 3578999999999999999999999999876
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=236.47 Aligned_cols=178 Identities=16% Similarity=0.245 Sum_probs=151.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
..+||||+.+|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||.||+++.++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~ 153 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK---------------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVP 153 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS---------------SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSS
T ss_pred EEEEEEcCCCCCHHHHHHhc---------------CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCC
Confidence 34889999999999999653 3599999999999999999999999999999999999998877
Q ss_pred --CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 95 --SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 95 --~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
.++++|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|+ +|..||.+....+....+.
T Consensus 154 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~ 230 (326)
T 2y0a_A 154 KPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL-SGASPFLGDTKQETLANVS 230 (326)
T ss_dssp SCCEEECCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSCCSSCCSSHHHHHHHHH
T ss_pred CCCEEEEECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHH-HCcCCCCCCCHHHHHHHHH
Confidence 79999999997653322 223456889999999998888999999999999999999 7999999888887777766
Q ss_pred hCcccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........ ....+..+.+++.+||+.||.+|||+.++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 231 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 54333221 24678899999999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=230.26 Aligned_cols=182 Identities=21% Similarity=0.424 Sum_probs=148.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC-
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS- 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~- 95 (223)
..+||||+.+|+|.++++..+. .+++..++.++.|+++||.|||+++++||||||+||+++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 152 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--------------CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR 152 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--------------GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBG
T ss_pred CEEEEECCCCCCHHHHHHhCCC--------------CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcc
Confidence 4488999999999999987543 4899999999999999999999999999999999999998877
Q ss_pred -------eEEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy15108 96 -------VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167 (223)
Q Consensus 96 -------~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~ 167 (223)
++++|||++....... ...++..|+|||.+.+ ..++.++||||+|+++|+|++.+..||........
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~ 227 (289)
T 4fvq_A 153 KTGNPPFIKLSDPGISITVLPKD-----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227 (289)
T ss_dssp GGTBCCEEEECCCCSCTTTSCHH-----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred cccccceeeeccCcccccccCcc-----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH
Confidence 9999999987554332 1234667999999877 66899999999999999999546777776666555
Q ss_pred HHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
....... ...+...++++.+++.+||+.||.+|||+++++++|++++.+.
T Consensus 228 ~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 228 LQFYEDR---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHHHHTT---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred HHHhhcc---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 4443332 2334456778999999999999999999999999999987653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=241.98 Aligned_cols=176 Identities=17% Similarity=0.255 Sum_probs=153.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~~ 96 (223)
.+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+ .|++||||||.||+++.++.+
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRER---------------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHS---------------CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCE
T ss_pred EEEEeeCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCE
Confidence 37899999999999998754 49999999999999999999998 999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+|+|||++....... .......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+.......+.....
T Consensus 289 kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~~~~~~~i~~~~~ 366 (446)
T 4ejn_A 289 KITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHEKLFELILMEEI 366 (446)
T ss_dssp EECCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEccCCCceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHh-hCCCCCCCCCHHHHHHHHHhCCC
Confidence 999999987533222 1234567899999999999889999999999999999999 79999999988888887776543
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
. .+..+++++.+++.+||+.||.+|| +++++++|
T Consensus 367 ~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 R--FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp C--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C--CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 3 4567889999999999999999999 99999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=244.72 Aligned_cols=181 Identities=15% Similarity=0.208 Sum_probs=152.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~v 214 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFE--------------DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHI 214 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTT--------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHHHcc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCE
Confidence 348999999999999998632 359999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
||+|||+++..............+++.|+|||.+. ...++.++|+||+||++|+|+ +|..||.+.+..+....+
T Consensus 215 kL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ell-tG~~Pf~~~~~~~~~~~i 293 (437)
T 4aw2_A 215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKI 293 (437)
T ss_dssp EECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHH
T ss_pred EEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHH-hCCCCCCCCChhHHHHhh
Confidence 99999999765443322233457899999999986 456889999999999999999 799999999988888877
Q ss_pred HhCcccCCCC---CCChHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q psy15108 172 ESKKLCWKHS---SKTPEYITSLHEKCIHPHPHQ--RPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~ 212 (223)
.........+ ..+++++++++.+||..+|+. ||+++|+++|
T Consensus 294 ~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 MNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 6543222222 458999999999999988887 9999999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=242.26 Aligned_cols=178 Identities=16% Similarity=0.202 Sum_probs=153.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+++|+|.++++. ..+++..+..++.||+.||.|||+.|++||||||.||+++.++.++
T Consensus 145 ~lV~E~~~gg~L~~~l~~----------------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ik 208 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN----------------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 208 (410)
T ss_dssp EEEECCCTTEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEeCCCCCcHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEE
Confidence 389999999999999974 2489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE----FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
|+|||++...............+++.|+|||.+.... ++.++|+||+||++|+|+ +|..||.+.+.......+..
T Consensus 209 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell-~G~~Pf~~~~~~~~~~~i~~ 287 (410)
T 3v8s_A 209 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYADSLVGTYSKIMN 287 (410)
T ss_dssp ECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHHT
T ss_pred EeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHH-hCCCCCCCCChhhHHHHHHh
Confidence 9999999765443322334567899999999987655 778999999999999999 79999999998888888776
Q ss_pred Ccc--cCCCCCCChHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q psy15108 174 KKL--CWKHSSKTPEYITSLHEKCIHPHPHQ--RPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~--~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~ 212 (223)
... ..+....+++++++++.+||..+|.+ ||+++|+++|
T Consensus 288 ~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 432 33334578999999999999998888 9999999976
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=237.95 Aligned_cols=177 Identities=17% Similarity=0.250 Sum_probs=147.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~i 192 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQR---------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI 192 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE
T ss_pred EEEEEEcCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCE
Confidence 348899999999999998764 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC---------CHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL---------SDDQV 167 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~---------~~~~~ 167 (223)
+|+|||+++...... .......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||... .....
T Consensus 193 kL~DFGla~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell-~G~~Pf~~~~~~~~~~~~~~~~~ 270 (396)
T 4dc2_A 193 KLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-AGRSPFDIVGSSDNPDQNTEDYL 270 (396)
T ss_dssp EECCCTTCBCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSTTTTC------CCHHHH
T ss_pred EEeecceeeecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH-hCCCCCcccccccccchhhHHHH
Confidence 999999997532221 1234567899999999999999999999999999999999 799999643 22234
Q ss_pred HHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q psy15108 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF------PSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~ 212 (223)
...+.... ...+..++.++.+++.+||+.||.+||++ +++++|
T Consensus 271 ~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 271 FQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 44444443 34456789999999999999999999985 677654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=235.68 Aligned_cols=182 Identities=19% Similarity=0.299 Sum_probs=146.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+.+|+|.++++.... .+++..+..++.|+++||.|||+.|++|+||||.||+++.++.++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~k 148 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDS--------------QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVV 148 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCT--------------TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEE
T ss_pred EEEEEecCCCcHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEE
Confidence 378999999999999987433 599999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhh-------------hhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Q psy15108 98 ISLSGLSKDTYQKEYYK-------------YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD 164 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~-------------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~ 164 (223)
++|||++.......... .....+++.|+|||.+.+..++.++||||+|+++|+++ +|..|+.....
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~-~g~~~~~~~~~ 227 (310)
T 3s95_A 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLP 227 (310)
T ss_dssp ECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HTCCSSTTTSC
T ss_pred EeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHh-cCCCCCcchhh
Confidence 99999997653322111 11456889999999999989999999999999999999 68877764322
Q ss_pred HH-----HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 165 DQ-----VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 165 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.. ..... .....+..+++++.+++.+||+.||++||+++++++.|+.+..
T Consensus 228 ~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 228 RTMDFGLNVRGF----LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp BCTTSSBCHHHH----HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHhhhhhcc----ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11 01111 1122345678889999999999999999999999999988754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=231.10 Aligned_cols=186 Identities=20% Similarity=0.330 Sum_probs=152.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.|++|+||||.||+++.++.+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN--------------KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT--------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred EEEEEEeCCCCcHHHHHHhccc--------------cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCE
Confidence 3478999999999999976543 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC------------
Q psy15108 97 KISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL------------ 162 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~------------ 162 (223)
+++|||++........ .......++..|+|||.+.+..++.++|+||+|+++|+|+ +|..|+...
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~ 244 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL-TYCDSDSSPMALFLKMIGPTH 244 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH-TTTCGGGSHHHHHHHHHCSCC
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHH-HccCCCcchhhHHhhccCCcc
Confidence 9999999876543321 1223456677899999998888899999999999999999 677765321
Q ss_pred --CHH-HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 163 --SDD-QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 163 --~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
... .....+... ...+.+..+++++.+++.+||+.||.+|||++++++.|+++++
T Consensus 245 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 245 GQMTVTRLVNTLKEG-KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp GGGHHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred cccCHHHHHHHHhcc-CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 111 222223333 4555667889999999999999999999999999999998863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=235.54 Aligned_cols=178 Identities=18% Similarity=0.275 Sum_probs=139.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC-
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS- 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~- 95 (223)
..+||||+.+|+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||.||+++.++.
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~ 155 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAG---------------RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAP 155 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSC
T ss_pred EEEEEEeCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCc
Confidence 338899999999999998754 4999999999999999999999999999999999999987765
Q ss_pred -eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Q psy15108 96 -VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTK-SDVYAYACLIWEIFNKGEMPFPDLSD----DQVLS 169 (223)
Q Consensus 96 -~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~~l~~~~~~p~~~~~~----~~~~~ 169 (223)
++++|||++....... ......+++.|+|||.+.+..+..+ +||||+||++|+|+ +|..||.+... .....
T Consensus 156 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~~~~~~~~~~ 232 (361)
T 3uc3_A 156 RLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPRDYRKTIQ 232 (361)
T ss_dssp CEEECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHH-HSSCSCC----CCCHHHHHH
T ss_pred eEEEeecCccccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHH-hCCCCCCCCccHHHHHHHHH
Confidence 9999999987432221 2234568899999999988777655 89999999999999 79999986543 34445
Q ss_pred HHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+.......+....+++++.+++.+||+.||.+|||+.++++|
T Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 5555444555555688999999999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=241.88 Aligned_cols=180 Identities=16% Similarity=0.192 Sum_probs=150.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+. .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~v 201 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGE--------------RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHI 201 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEcCCCCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCE
Confidence 3489999999999999987542 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc-------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-------DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~ 169 (223)
||+|||++...............+++.|+|||.+. ...++.++|+|||||++|+|+ +|..||.+.+..+...
T Consensus 202 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell-tG~~Pf~~~~~~~~~~ 280 (412)
T 2vd5_A 202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF-YGQTPFYADSTAETYG 280 (412)
T ss_dssp EECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHH
T ss_pred EEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH-hCCCCCCCCCHHHHHH
Confidence 99999999765433222223457899999999986 346889999999999999999 7999999998888877
Q ss_pred HHHhCcccCC---CCCCChHHHHHHHHHhcCCCCCCC---CCHHHHHHH
Q psy15108 170 QLESKKLCWK---HSSKTPEYITSLHEKCIHPHPHQR---PTFPSIVTQ 212 (223)
Q Consensus 170 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~R---ps~~~ll~~ 212 (223)
.+........ ....++++++++|.+||. +|.+| |+++++++|
T Consensus 281 ~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 KIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 7765332222 235789999999999999 99998 589998865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=234.09 Aligned_cols=185 Identities=16% Similarity=0.204 Sum_probs=150.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC--
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS-- 95 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~-- 95 (223)
.+||||+ +|+|.+++...+ ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~ 145 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCD--------------RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKT 145 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTT--------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTC
T ss_pred EEEEEeC-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCC
Confidence 3789999 999999998753 36999999999999999999999999999999999999998876
Q ss_pred ---eEEcCCCCCcccchhhhh------hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---
Q psy15108 96 ---VKISLSGLSKDTYQKEYY------KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS--- 163 (223)
Q Consensus 96 ---~~l~df~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~--- 163 (223)
++++|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|+ +|..||.+..
T Consensus 146 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell-~g~~Pf~~~~~~~ 224 (330)
T 2izr_A 146 QQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFL-RGSLPWQGLKADT 224 (330)
T ss_dssp TTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTTTCCCSS
T ss_pred CceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHh-cCCCCcccccccc
Confidence 999999999765432211 123567889999999999988999999999999999999 7999998754
Q ss_pred HHHHHHHHHhCcccCC---CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 164 DDQVLSQLESKKLCWK---HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 164 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..+....+.......+ ....+| ++.+++..||+.||.+||+++++.+.|++++.+
T Consensus 225 ~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 225 LKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 3334444433222211 123456 899999999999999999999999999987654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=233.05 Aligned_cols=193 Identities=31% Similarity=0.565 Sum_probs=158.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec---C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---D 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~---~ 93 (223)
..+||||+++|+|.+++...+.. ......+++..++.++.|++.||.|||+.|++|+||+|.||+++. .
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPR--------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCC--------SSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred cEEEEecCCCCcHHHHHHhhccc--------ccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 34889999999999999876431 112245899999999999999999999999999999999999984 4
Q ss_pred CCeEEcCCCCCcccchhhh-hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 94 LSVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
..++++|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++.|..||...........+.
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 4699999998864432221 122334567889999999888899999999999999999955999999888887777776
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.. .....+..++..+.+++.+||+.||.+||++.+++++|..+..
T Consensus 260 ~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 260 SG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 65 3445566789999999999999999999999999999988754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=229.54 Aligned_cols=177 Identities=18% Similarity=0.255 Sum_probs=147.4
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+++||+. |+|.+++..... ..+++..+..++.|++.||.|||+.|++||||||.||+++.++.+++
T Consensus 96 lv~e~~~-~~L~~~~~~~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 96 LVFEHVD-QDLRTYLDKAPP-------------PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp EEEECCC-CBHHHHHHTCCT-------------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEE
T ss_pred EEehhhh-cCHHHHHhhccC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEE
Confidence 6778886 699999986543 45999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc-
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC- 177 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~- 177 (223)
+|||++....... ......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.........+......
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTT-TSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999987543222 223456788999999998888999999999999999999 899999988887776665432110
Q ss_pred ----CC--------------------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 ----WK--------------------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ----~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
++ ....+++++.+++.+||+.||++|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 013567889999999999999999999999876
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=231.44 Aligned_cols=177 Identities=15% Similarity=0.204 Sum_probs=149.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||.||+++.++.+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~ 160 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---------------IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHV 160 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCE
T ss_pred EEEEEeCCCCCcHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcE
Confidence 348899999999999998754 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......+++.|+|||.+.+..++.++|+||+|+++|+|+ +|..||.+.+.......+.....
T Consensus 161 kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~i~~~~~ 238 (327)
T 3a62_A 161 KLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML-TGAPPFTGENRKKTIDKILKCKL 238 (327)
T ss_dssp EECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHTCC
T ss_pred EEEeCCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHH-HCCCCCCCCCHHHHHHHHHhCCC
Confidence 999999987533221 1223456889999999998888999999999999999999 79999999888888777766543
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
..+..++.++.+++.+||+.||.+|| ++.++++|
T Consensus 239 --~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 --NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 34567889999999999999999999 77888765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=236.54 Aligned_cols=170 Identities=16% Similarity=0.194 Sum_probs=149.1
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+||||+.+|+|.++++..+ .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|
T Consensus 116 lv~E~~~gg~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL 180 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER---------------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEeCCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEE
Confidence 7899999999999998754 4999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW 178 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 178 (223)
+|||+++...... .......+++.|+|||.+.+..++.++|+|||||++|+|+ +|..||.+.+..+....+.....
T Consensus 181 ~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~G~~Pf~~~~~~~~~~~i~~~~~-- 256 (373)
T 2r5t_A 181 TDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILNKPL-- 256 (373)
T ss_dssp CCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCTTCCSBHHHHHHHHHHSCC--
T ss_pred eeCccccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHhccc--
Confidence 9999987532221 1223457889999999999889999999999999999999 79999999988888888877643
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCHH
Q psy15108 179 KHSSKTPEYITSLHEKCIHPHPHQRPTFP 207 (223)
Q Consensus 179 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 207 (223)
..+..++.++.+++.+||+.||.+||++.
T Consensus 257 ~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 257 QLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 34567899999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=230.25 Aligned_cols=186 Identities=17% Similarity=0.233 Sum_probs=144.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+.+++|.++++..+ .+++..++.++.|+++||.|||+.|++|+||+|.||+++.++.++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~k 174 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQG---------------PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAY 174 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred EEEEEecCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEE
Confidence 37899999999999998754 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++...............++..|+|||.+.+..++.++|+||||+++|+++ +|..||...........+......
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~ 253 (309)
T 2h34_A 175 LVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL-TGSPPYQGDQLSVMGAHINQAIPR 253 (309)
T ss_dssp ECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHH-HSSCSSCSCHHHHHHHHHHSCCCC
T ss_pred EecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHH-HCCCCCCCchHHHHHHHhccCCCC
Confidence 9999998765443333334556788999999998888999999999999999999 699999887665444444433221
Q ss_pred -CCCCCCChHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHhhh
Q psy15108 178 -WKHSSKTPEYITSLHEKCIHPHPHQRP-TFPSIVTQLSDAMCN 219 (223)
Q Consensus 178 -~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~~~ 219 (223)
...+..++.++.+++.+||+.||++|| +++++++.|++++..
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 223467889999999999999999999 999999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=251.92 Aligned_cols=176 Identities=18% Similarity=0.287 Sum_probs=155.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.++++..+. +++..+..++.||+.||.|||+.||+||||||+|||++.++.++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~---------------~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ik 482 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGR---------------FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEE
T ss_pred EEEEeCcCCCcHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEE
Confidence 388999999999999987644 99999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
|+|||+++...... .......+++.|+|||.+.+..++.++|+|||||++|||+ +|..||.+.+..+....+.....
T Consensus 483 L~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyell-tG~~Pf~~~~~~~~~~~i~~~~~- 559 (674)
T 3pfq_A 483 IADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQAPFEGEDEDELFQSIMEHNV- 559 (674)
T ss_dssp ECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHSSCC-
T ss_pred EeecceeeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHH-cCCCCCCCCCHHHHHHHHHhCCC-
Confidence 99999997532221 1234567899999999999899999999999999999999 79999999999998888887654
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTF-----PSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~ 212 (223)
..+..+++++.+++.+||+.||.+||++ +++++|
T Consensus 560 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred -CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 3456789999999999999999999997 777654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=232.90 Aligned_cols=176 Identities=17% Similarity=0.256 Sum_probs=146.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+.|++||||||+||+++.++.++
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~k 150 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQR---------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 150 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEE
Confidence 37899999999999998754 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC---------CHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL---------SDDQVL 168 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~---------~~~~~~ 168 (223)
++|||+++...... .......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||... ......
T Consensus 151 L~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~ 228 (345)
T 3a8x_A 151 LTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-AGRSPFDIVGSSDNPDQNTEDYLF 228 (345)
T ss_dssp ECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCTTTTTTC-------CHHHHH
T ss_pred EEeccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHH-hCCCCcCCcccccccccccHHHHH
Confidence 99999987532221 1234457889999999999888999999999999999999 799999652 233344
Q ss_pred HHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCH------HHHHHH
Q psy15108 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF------PSIVTQ 212 (223)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~ 212 (223)
..+.... ...+..++.++.+++.+||+.||.+||++ +++++|
T Consensus 229 ~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 229 QVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 4444443 33456789999999999999999999995 677654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=225.58 Aligned_cols=175 Identities=20% Similarity=0.256 Sum_probs=150.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.+
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~ 148 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLS---------------KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGEL 148 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCE
Confidence 348899999999999998754 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .....++..|+|||.+.+..++.++|+||+|+++++|+ +|..||...........+....
T Consensus 149 ~l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~- 223 (279)
T 3fdn_A 149 KIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVE- 223 (279)
T ss_dssp EECSCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHHHTC-
T ss_pred EEEeccccccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHH-HCCCCCCCCcHHHHHHHHHhCC-
Confidence 999999886443322 23456788999999998888999999999999999999 7999999888887777766643
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+...++.+.+++.+||+.||.+||+++++++|
T Consensus 224 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 33456688999999999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=233.73 Aligned_cols=188 Identities=13% Similarity=0.153 Sum_probs=151.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
..+||||+ +|+|.+++..... ..+++..++.++.||+.||.|||+.|++||||||.||+++.++
T Consensus 133 ~~lv~e~~-~~~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~ 198 (352)
T 2jii_A 133 RFLVLPSL-GRSLQSALDVSPK-------------HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS 198 (352)
T ss_dssp EEEEEECC-CEEHHHHHHHSGG-------------GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEE
T ss_pred EEEEecCC-CcCHHHHHHhCCc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCc
Confidence 45889999 9999999987522 4699999999999999999999999999999999999999988
Q ss_pred CeEEcCCCCCcccchhhhh------hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHH
Q psy15108 95 SVKISLSGLSKDTYQKEYY------KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS--DDQ 166 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~--~~~ 166 (223)
.++++|||++......... ......++..|+|||.+.+..++.++||||||+++|+|+ +|..||.... ...
T Consensus 199 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~~~~~ 277 (352)
T 2jii_A 199 QVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL-YGFLPWTNCLPNTED 277 (352)
T ss_dssp EEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSCCTTGGGTTCHHH
T ss_pred eEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH-hCCCCcccCCcCHHH
Confidence 8999999999765433210 112347788999999998888999999999999999999 7999998653 222
Q ss_pred HHHHHH---hCcccCCC----CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 167 VLSQLE---SKKLCWKH----SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 167 ~~~~~~---~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
...... ........ ...+++++.+++.+||+.||.+||+++++++.|++++.+
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 278 IMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp HHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 222221 11111110 124689999999999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=229.25 Aligned_cols=187 Identities=19% Similarity=0.310 Sum_probs=146.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CcccCCCCCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK--------RLIHKDIAARNC 88 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~i~H~di~~~ni 88 (223)
..+||||+.+|+|.++++.. .+++..++.++.|++.||.|||+. |++||||||+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Ni 173 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----------------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----------------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGE
T ss_pred eEEEEeccCCCcHHHHhhcc----------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHE
Confidence 34889999999999999652 489999999999999999999998 999999999999
Q ss_pred eeecCCCeEEcCCCCCcccchhhhh---hhhcCCcccccccccccccCCCCcc------cchHHHHHHHHHHHhCC----
Q psy15108 89 LISSDLSVKISLSGLSKDTYQKEYY---KYRNAILPLRWLPYEAVFDDEFSTK------SDVYAYACLIWEIFNKG---- 155 (223)
Q Consensus 89 l~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~------~Di~slG~il~~l~~~~---- 155 (223)
+++.++.++|+|||++......... ......++..|+|||.+.+...... +|||||||++|+|+ +|
T Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~-tg~~~~ 252 (337)
T 3mdy_A 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA-RRCVSG 252 (337)
T ss_dssp EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHH-TTBCBT
T ss_pred EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHH-hccCcc
Confidence 9999999999999999755433211 1234578899999999877666554 99999999999999 67
Q ss_pred ------CCCCCCCC-----HHHHHHHHHhCcccCCCC-----CCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 156 ------EMPFPDLS-----DDQVLSQLESKKLCWKHS-----SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 156 ------~~p~~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..||.... .......+.........+ ..+++++.+++.+||+.||.+||++.+++++|+++.++
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 67775432 222222232222222222 24567899999999999999999999999999998765
Q ss_pred c
Q psy15108 220 D 220 (223)
Q Consensus 220 ~ 220 (223)
.
T Consensus 333 ~ 333 (337)
T 3mdy_A 333 Q 333 (337)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=233.79 Aligned_cols=184 Identities=17% Similarity=0.184 Sum_probs=145.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------CcccCCCCCCC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK----------RLIHKDIAARN 87 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~i~H~di~~~n 87 (223)
.+||||+++|+|.++++.. .+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 98 ~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~N 161 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN----------------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC----------------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGG
T ss_pred EEEEecCCCCCHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHh
Confidence 4789999999999999752 489999999999999999999999 99999999999
Q ss_pred eeeecCCCeEEcCCCCCcccchhhh-hhhhcCCcccccccccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCC
Q psy15108 88 CLISSDLSVKISLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFDD-----EFSTKSDVYAYACLIWEIFNKGEMPFPD 161 (223)
Q Consensus 88 il~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-----~~~~~~Di~slG~il~~l~~~~~~p~~~ 161 (223)
|+++.++.++|+|||++........ .......+++.|+|||.+.+. .++.++|||||||++|+|+ +|..||.+
T Consensus 162 ill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~-tg~~pf~~ 240 (322)
T 3soc_A 162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA-SRCTAADG 240 (322)
T ss_dssp EEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTBTTSSS
T ss_pred EEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHH-hCCCCCCC
Confidence 9999999999999999975543321 112335678999999998763 3556789999999999999 79888865
Q ss_pred CC----------------HHHHHHHHHhCcccCCCCC-----CChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 162 LS----------------DDQVLSQLESKKLCWKHSS-----KTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 162 ~~----------------~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.. .......+......+..+. ..++++.+++.+||+.||++|||++++++.|+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 32 1222222322222222111 234569999999999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=225.68 Aligned_cols=177 Identities=18% Similarity=0.241 Sum_probs=152.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC--
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS-- 95 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~-- 95 (223)
.+++||+.+|+|.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~ 145 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVARE---------------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 145 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTC
T ss_pred EEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCC
Confidence 37899999999999998764 4999999999999999999999999999999999999986655
Q ss_pred -eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 -VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 -~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||++....... ......+++.|+|||.+.+..++.++|+||+|+++++|+ +|..||.+.........+...
T Consensus 146 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~ 222 (284)
T 3kk8_A 146 AVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL-VGYPPFWDEDQHRLYAQIKAG 222 (284)
T ss_dssp CEEECCCTTCEECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHT
T ss_pred cEEEeeceeeEEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHH-HCCCCCCCCchhHHHHHHHhc
Confidence 9999999986554322 223456788999999999888999999999999999999 799999998888888877766
Q ss_pred cccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+.+ ..+++++.+++.+||+.||.+||++++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 223 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 5443332 4678999999999999999999999999876
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=236.80 Aligned_cols=179 Identities=17% Similarity=0.193 Sum_probs=152.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee--cCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS--SDL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~--~~~ 94 (223)
..+||||+++|+|.+++...+. .+++..++.++.||++||.|||+.|++||||||.||++. ..+
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 226 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESY--------------NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK 226 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGG--------------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCC
Confidence 3488999999999999986543 589999999999999999999999999999999999984 557
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++|+|||++....... ......+++.|+|||.+....++.++|||||||++|+|+ +|..||.+.+..+....+...
T Consensus 227 ~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~ 303 (373)
T 2x4f_A 227 QIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL-SGLSPFLGDNDAETLNNILAC 303 (373)
T ss_dssp EEEECCCSSCEECCTTC--BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHHHT
T ss_pred cEEEEeCCCceecCCcc--ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhc
Confidence 89999999997654332 223456889999999998888999999999999999999 799999998888877777665
Q ss_pred cccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... ...+++++.+++.+||+.||.+||++.+++++
T Consensus 304 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 304 RWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 433322 24678999999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=234.67 Aligned_cols=187 Identities=27% Similarity=0.401 Sum_probs=152.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.++++..+. .+++..++.++.|++.||.|||+.|++|+||||.||+++.++.+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~ 166 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA--------------RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHV 166 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG--------------GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred EEEEEeecCCCCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCE
Confidence 3388999999999999987543 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---------
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD--------- 165 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~--------- 165 (223)
+++|||++....... ........++..|+|||.+.+..++.++||||+|+++++|+ +|..||......
T Consensus 167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll-~g~~p~~~~~~~~~~~~~~~~ 245 (327)
T 3lxl_A 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF-TYCDKSCSPSAEFLRMMGCER 245 (327)
T ss_dssp EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH-TTTCGGGSHHHHHHHHCC---
T ss_pred EEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHH-hCCCCCccccchhhhhccccc
Confidence 999999987553322 11223345677899999998888899999999999999999 788887543321
Q ss_pred ------HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 166 ------QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 166 ------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.....+... ...+.+..+++++.+++.+||+.||.+||++++++++|+.+...
T Consensus 246 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 246 DVPALSRLLELLEEG-QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp -CCHHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred ccccHHHHHHHhhcc-cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 222222233 45556778899999999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=229.58 Aligned_cols=182 Identities=19% Similarity=0.270 Sum_probs=143.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCcccCCCCCCCee
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHIS--------DKRLIHKDIAARNCL 89 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~i~H~di~~~nil 89 (223)
.+|+||+.+|+|.++++. ..+++..++.++.|+++||.||| +.+++||||||+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nil 145 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL----------------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL 145 (301)
T ss_dssp EEEECCCTTCBHHHHHTT----------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEE
T ss_pred EEehhhccCCCHHHHHhh----------------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEE
Confidence 388999999999999953 35899999999999999999999 999999999999999
Q ss_pred eecCCCeEEcCCCCCcccchhhhh---hhhcCCcccccccccccccC------CCCcccchHHHHHHHHHHHhCC-----
Q psy15108 90 ISSDLSVKISLSGLSKDTYQKEYY---KYRNAILPLRWLPYEAVFDD------EFSTKSDVYAYACLIWEIFNKG----- 155 (223)
Q Consensus 90 ~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~------~~~~~~Di~slG~il~~l~~~~----- 155 (223)
++.++.++++|||++......... ......+++.|+|||.+.+. .++.++||||||+++|+|+ +|
T Consensus 146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~-tg~~~~~ 224 (301)
T 3q4u_A 146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA-RRMVSNG 224 (301)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH-TTBCBTT
T ss_pred EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHH-hhhcCcc
Confidence 999999999999998754433211 12334788999999998766 3446899999999999999 67
Q ss_pred -----CCCCCCCC-----HHHHHHHHHhCcccCCCC-----CCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 156 -----EMPFPDLS-----DDQVLSQLESKKLCWKHS-----SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 156 -----~~p~~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
..||.... .......+.........+ ..+++++.+++.+||+.||++|||++++++.|+++
T Consensus 225 ~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 77885432 122222222222222222 22457899999999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=238.21 Aligned_cols=184 Identities=16% Similarity=0.125 Sum_probs=146.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
..+||||+ +++|.+++...+ .+++..++.++.||+.||.|||+.|++||||||+||+++.++
T Consensus 127 ~~lv~e~~-~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 127 RFMVMERL-GIDLQKISGQNG---------------TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEECE-EEEHHHHCBGGG---------------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred EEEEEecc-CCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 34889999 999999997653 499999999999999999999999999999999999999877
Q ss_pred CeEEcCCCCCcccchhhh------hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--CHHH
Q psy15108 95 SVKISLSGLSKDTYQKEY------YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL--SDDQ 166 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~--~~~~ 166 (223)
.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|+|+ +|..||... ....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell-~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL-CGKLPWEQNLKDPVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH-HSSCTTGGGTTCHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH-hCCCCccccccccHH
Confidence 999999999976533221 1124457889999999998888999999999999999999 799999643 2222
Q ss_pred HHHHHHhCcc-------cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 167 VLSQLESKKL-------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 167 ~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
.......... .......+++++.+++..||+.||++||+++++++.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 2111111000 01112268889999999999999999999999999998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=226.50 Aligned_cols=184 Identities=22% Similarity=0.352 Sum_probs=146.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCCCCCeeeecC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD---KRLIHKDIAARNCLISSD 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~~~nil~~~~ 93 (223)
..+||||+++|+|.++++.... ...+++..++.++.|+++||.|||+ +|++||||||+||+++.+
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 141 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEP------------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAG 141 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSS------------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETT
T ss_pred cEEEEEcCCCCCHHHHHhccCC------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCC
Confidence 4488999999999999985432 1347899999999999999999999 899999999999999988
Q ss_pred CC-eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH
Q psy15108 94 LS-VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD--DQVLSQ 170 (223)
Q Consensus 94 ~~-~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~--~~~~~~ 170 (223)
+. ++++|||++...... .....++..|+|||.+.+..++.++||||||+++|+|+ +|..||..... ......
T Consensus 142 ~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~~~~~~~~~ 216 (307)
T 2eva_A 142 GTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI-TRRKPFDEIGGPAFRIMWA 216 (307)
T ss_dssp TTEEEECCCCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHH-HTCCTTTTTCSSHHHHHHH
T ss_pred CCEEEEcccccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHH-HCCCCchhhCccHHHHHHH
Confidence 76 799999998654322 12345788999999998888999999999999999999 79999975532 233333
Q ss_pred HHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 171 LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
+... ........++..+.+++.+||+.||.+||+++++++.|+.+..
T Consensus 217 ~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 217 VHNG-TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHTT-CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HhcC-CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 3333 3445566789999999999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=231.53 Aligned_cols=183 Identities=18% Similarity=0.234 Sum_probs=144.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.++++..+ .+++..++.++.|+++||.|||+++++|+||||.||+++.++.++
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG---------------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEE
T ss_pred EEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEE
Confidence 47899999999999998754 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 98 ISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 98 l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++|||++....... ........++..|+|||.+.+..++.++||||+|+++|+|+ +|..||.+..............
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll-~g~~pf~~~~~~~~~~~~~~~~ 235 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL-TGEPPFTGDSPVSVAYQHVRED 235 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHCC
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHhcCC
Confidence 99999987554322 12223456789999999998888999999999999999999 6999999888777665555442
Q ss_pred ccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHHH
Q psy15108 176 LCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ-LSDA 216 (223)
Q Consensus 176 ~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~-L~~~ 216 (223)
.... ....++.++.+++.+||+.||.+||+..+++.+ +.+.
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 2221 134578999999999999999999987666544 4443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=230.41 Aligned_cols=177 Identities=20% Similarity=0.274 Sum_probs=150.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.++++. ..+++..+..++.|+++||.|||+.|++||||||.||+++.++.++
T Consensus 118 ~lv~e~~~~~~L~~~l~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 181 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ----------------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVK 181 (321)
T ss_dssp EEEECCCCSCBHHHHHTT----------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred EEEEecCCCCCHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEE
Confidence 378999999999999853 3589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++....... .......++..|+|||.+.+..++.++||||||+++|+|+ +|..||...........+......
T Consensus 182 l~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~-~g~~pf~~~~~~~~~~~~~~~~~~ 259 (321)
T 2c30_A 182 LSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV-DGEPPYFSDSPVQAMKRLRDSPPP 259 (321)
T ss_dssp ECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHHHHSSCC
T ss_pred EeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcCCCC
Confidence 99999987543321 1123457889999999998888999999999999999999 799999988887777766654322
Q ss_pred -CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 -WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
......+++++.+++.+||+.||++||++++++++
T Consensus 260 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 260 KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22234578899999999999999999999999876
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=229.89 Aligned_cols=178 Identities=20% Similarity=0.258 Sum_probs=150.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++. ...+++..+..++.|+++||.|||+.|++|+||||.||+++.++.+
T Consensus 113 ~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 176 (298)
T 2zv2_A 113 LYMVFELVNQGPVMEVPT----------------LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHI 176 (298)
T ss_dssp EEEEEECCTTCBSCCSSC----------------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCE
Confidence 347899999999987653 2469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE---FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~---~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+++|||++........ ......+++.|+|||.+.+.. ++.++|+||+|+++|+|+ +|..||...........+..
T Consensus 177 kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~ 254 (298)
T 2zv2_A 177 KIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV-FGQCPFMDERIMCLHSKIKS 254 (298)
T ss_dssp EECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHH
T ss_pred EEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH-HCCCCCCCccHHHHHHHHhc
Confidence 9999999875433221 123456889999999987655 367899999999999999 79999998888777777766
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+....+++++.+++.+||+.||++||+++++++|
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 255 QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 655555556789999999999999999999999999865
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=230.52 Aligned_cols=178 Identities=18% Similarity=0.264 Sum_probs=151.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
..+|+||+.+|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|.||+++.++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK---------------ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC---------------SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSS
T ss_pred EEEEEEcCCCCcHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCC
Confidence 34789999999999999754 3489999999999999999999999999999999999999887
Q ss_pred --CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 95 --SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 95 --~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
.++++|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|+ +|..||.+....+....+.
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~i~ 231 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL-SGASPFLGDTKQETLANIT 231 (321)
T ss_dssp SCCEEECCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSCCSSCCSSHHHHHHHHH
T ss_pred cCCEEEccCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHH
Confidence 79999999987554322 223456788999999998888999999999999999999 7999999888888777776
Q ss_pred hCcccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....... .....+..+.+++.+||+.||.+||++.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 232 SVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 6533222 124678899999999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=232.65 Aligned_cols=178 Identities=17% Similarity=0.190 Sum_probs=140.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec---C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---D 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~---~ 93 (223)
..+|+||+.+|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||.||+++. +
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~ 187 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEK---------------GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPD 187 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTC---------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTT
T ss_pred EEEEEEeCCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCC
Confidence 34889999999999999754 34899999999999999999999999999999999999975 7
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ-VLSQLE 172 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~-~~~~~~ 172 (223)
+.++++|||++....... ......+++.|+|||.+.+..++.++|||||||++|+|+ +|..||....... ....+.
T Consensus 188 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~i~ 264 (349)
T 2w4o_A 188 APLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL-CGFEPFYDERGDQFMFRRIL 264 (349)
T ss_dssp CCEEECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCTTCCTTCHHHHHHHHH
T ss_pred CCEEEccCccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHH-hCCCCCCCCcccHHHHHHHH
Confidence 889999999987543322 123456788999999999888999999999999999999 7999997665543 455555
Q ss_pred hCcccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....... ....++.++.+++.+||+.||++||++.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 265 NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4433222 235678999999999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=232.70 Aligned_cols=181 Identities=16% Similarity=0.170 Sum_probs=148.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC--
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS-- 95 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~-- 95 (223)
.+||||+.+|+|.+++..... ....+++..+..++.||++||.|||++|++||||||+||+++.++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRAD-----------AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHH-----------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTC
T ss_pred EEEEeCCCCCCHHHHHHHhcc-----------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCC
Confidence 488999999999999876543 2235899999999999999999999999999999999999986654
Q ss_pred -eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 -VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 -~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||++........ ......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.. ......+...
T Consensus 171 ~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~-~~~~~~i~~~ 247 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL-SGCLPFYGTK-ERLFEGIIKG 247 (351)
T ss_dssp CEEECCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCSSH-HHHHHHHHHT
T ss_pred cEEEecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHH-HCCCCCCCcH-HHHHHHHHcC
Confidence 99999999976543321 123457889999999998888999999999999999999 7999998753 4455555544
Q ss_pred cccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... ...+++++.+++.+||+.||++||++.++++|
T Consensus 248 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 248 KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 332211 14678899999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=237.79 Aligned_cols=179 Identities=18% Similarity=0.220 Sum_probs=151.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec--CC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS--DL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~--~~ 94 (223)
..+||||+.+|+|.+++...+ ..+++..+..++.||+.||.|||+.|++||||||+||+++. .+
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~ 188 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED--------------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS 188 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT--------------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCC
T ss_pred EEEEEEcCCCCcHHHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCC
Confidence 348899999999999997543 25999999999999999999999999999999999999974 46
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++|+|||++....... ......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+..+....+...
T Consensus 189 ~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-tg~~Pf~~~~~~~~~~~i~~~ 265 (387)
T 1kob_A 189 SVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL-SGLSPFAGEDDLETLQNVKRC 265 (387)
T ss_dssp CEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH-HSCCSSCCSSHHHHHHHHHHC
T ss_pred ceEEEecccceecCCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH-hCCCCCCCCCHHHHHHHHHhC
Confidence 79999999997654332 123346789999999998888999999999999999999 799999998888777777665
Q ss_pred cccC--CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCW--KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... .....+++++.+++.+||+.||.+||++.+++++
T Consensus 266 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 266 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 4332 2234678999999999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=236.60 Aligned_cols=175 Identities=18% Similarity=0.269 Sum_probs=145.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+ +|+|.+++...+ .+++..+..++.|+++||.|||+.|++||||||+||+++.++.+
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~ 147 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKK---------------RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNV 147 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCE
T ss_pred EEEEEECC-CCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCE
Confidence 34788998 899999998764 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ......+++.|+|||.+.+..+ +.++||||+|+++|+|+ +|..||.+.........+...
T Consensus 148 kl~DFG~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~Pf~~~~~~~~~~~i~~~- 223 (336)
T 3h4j_B 148 KIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVML-VGRLPFDDEFIPNLFKKVNSC- 223 (336)
T ss_dssp EECCSSCTBTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHH-HSSCSSBCSSSTTCBCCCCSS-
T ss_pred EEEEeccceeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHH-hCCCCCCCccHHHHHHHHHcC-
Confidence 999999987544332 2344568899999999987776 67899999999999999 799999876544333222222
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+..+++++.+++.+||+.||.+|||++|++++
T Consensus 224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 233456678999999999999999999999999876
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=241.76 Aligned_cols=176 Identities=16% Similarity=0.253 Sum_probs=152.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++... +.+++..+..++.||+.||.|||+.|++||||||+||+++.++.+
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~v 155 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKN---------------GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNA 155 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSS---------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCE
T ss_pred EEEEEeCCCCCcHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCe
Confidence 33889999999999999753 359999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ......+++.|+|||.+.+..+ +.++||||+||++|+|+ +|..||.+.........+..+.
T Consensus 156 kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~ 232 (476)
T 2y94_A 156 KIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALL-CGTLPFDDDHVPTLFKKICDGI 232 (476)
T ss_dssp EECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHH-HSSCSSCCSSSHHHHHHHHTTC
T ss_pred EEEeccchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHh-hCCCCCCCCCHHHHHHHHhcCC
Confidence 999999997654322 2234578899999999987765 67899999999999999 7999999888888877777654
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ..+..+++++.+++.+||+.||.+|||++++++|
T Consensus 233 ~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 3 3355678999999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=225.05 Aligned_cols=189 Identities=21% Similarity=0.297 Sum_probs=145.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+.+|+|.+++..... ....+++..++.++.|++.||.|||+.|++|+||+|.||+++.++.++
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKK-----------QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHH-----------TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEecCCCCCHHHHHHHhcc-----------cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEE
Confidence 378999999999999986543 234689999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhCc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS--DDQVLSQLESKK 175 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~--~~~~~~~~~~~~ 175 (223)
++|||++........ ......++..|+|||.+....++.++|+||||+++|+|+ +|..||.+.. .......+....
T Consensus 177 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~~ 254 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA-ALQSPFYGDKMNLYSLCKKIEQCD 254 (310)
T ss_dssp ECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTC---CCHHHHHHHHHTTC
T ss_pred EEeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHH-hCCCCCcccchhHHHHHHHhhccc
Confidence 999999875433221 123346788899999998888999999999999999999 7888986543 334444555443
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
........+++++.+++.+||+.||.+||+++++++.|+++...
T Consensus 255 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 33333456889999999999999999999999999999988654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=230.51 Aligned_cols=184 Identities=20% Similarity=0.234 Sum_probs=140.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------CcccCCCCCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK---------RLIHKDIAARNC 88 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~i~H~di~~~ni 88 (223)
.+||||+++|+|.++++.. ..++..+..++.|+++||.|||+. |++||||||.||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Ni 151 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----------------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----------------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGE
T ss_pred EEEEecCCCCcHHHHHhhc----------------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceE
Confidence 3889999999999999753 358999999999999999999999 999999999999
Q ss_pred eeecCCCeEEcCCCCCcccchhh-------hhhhhcCCccccccccccccc-------CCCCcccchHHHHHHHHHHHhC
Q psy15108 89 LISSDLSVKISLSGLSKDTYQKE-------YYKYRNAILPLRWLPYEAVFD-------DEFSTKSDVYAYACLIWEIFNK 154 (223)
Q Consensus 89 l~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~slG~il~~l~~~ 154 (223)
+++.++.++|+|||++....... ........++..|+|||.+.+ ..++.++|||||||++|+|+ +
T Consensus 152 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell-~ 230 (336)
T 3g2f_A 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF-M 230 (336)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH-T
T ss_pred EEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH-h
Confidence 99999999999999997543221 112234568899999999876 34567899999999999999 5
Q ss_pred CCCCC-CCCC-----------------HHHHHHHHHhCcccCCCCCC------ChHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy15108 155 GEMPF-PDLS-----------------DDQVLSQLESKKLCWKHSSK------TPEYITSLHEKCIHPHPHQRPTFPSIV 210 (223)
Q Consensus 155 ~~~p~-~~~~-----------------~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~~l~~dp~~Rps~~~ll 210 (223)
|..|| .+.. .......+.........+.. +++++.+++.+||+.||++|||+++++
T Consensus 231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l 310 (336)
T 3g2f_A 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310 (336)
T ss_dssp TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence 65554 2211 11111122222222222222 345799999999999999999999999
Q ss_pred HHHHHHhh
Q psy15108 211 TQLSDAMC 218 (223)
Q Consensus 211 ~~L~~~~~ 218 (223)
+.|++++.
T Consensus 311 ~~L~~ll~ 318 (336)
T 3g2f_A 311 ERMAELMM 318 (336)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=228.59 Aligned_cols=181 Identities=20% Similarity=0.280 Sum_probs=146.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++..... ..+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKG-------------NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGG-------------GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCE
T ss_pred EEEEEEcCCCCcHHHHHHhccc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCE
Confidence 4488999999999999987543 469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++....... .......++..|+|||.+. ...++.++|+||||+++|+|+ +|..||...........+
T Consensus 169 kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~ 246 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA-EGAPPLCDMHPMRALFLI 246 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHH
T ss_pred EEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHh
Confidence 999999987543221 1223456788999999986 456888999999999999999 799999888877666666
Q ss_pred HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
............++..+.+++.+||..||.+||++++++++
T Consensus 247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 55544334456788999999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=230.54 Aligned_cols=177 Identities=18% Similarity=0.298 Sum_probs=141.1
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+||| +.+|+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||.||+++ ++.++|
T Consensus 86 lv~e-~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl 148 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKK---------------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL 148 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSC---------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred EEEe-CCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEE
Confidence 6778 78899999998753 499999999999999999999999999999999999997 578999
Q ss_pred cCCCCCcccchhhh-hhhhcCCccccccccccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-H
Q psy15108 99 SLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFD-----------DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-D 165 (223)
Q Consensus 99 ~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-----------~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-~ 165 (223)
+|||++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|+ +|..||..... .
T Consensus 149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~ 227 (343)
T 3dbq_A 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIINQI 227 (343)
T ss_dssp CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHH-HSSCTTTTCCSHH
T ss_pred eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHH-hCCCcchhhhhHH
Confidence 99999976543321 12334578999999999864 56788999999999999999 79999987543 3
Q ss_pred HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 166 QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
.....+.........+...+.++.+++.+||+.||.+|||+.++++|-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 444444444455555667788999999999999999999999998763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=229.24 Aligned_cols=187 Identities=19% Similarity=0.182 Sum_probs=150.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+++|.+++...+ ..+++..++.++.|++.||.|||+.|++|+||+|+||+++ ++.+
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~ 168 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK--------------IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKV 168 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC--------------CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CC
T ss_pred eEEEeecccCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCE
Confidence 448899999999999997543 2589999999999999999999999999999999999998 6799
Q ss_pred EEcCCCCCcccchhh----hhhhhcCCccccccccccccc---------CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q psy15108 97 KISLSGLSKDTYQKE----YYKYRNAILPLRWLPYEAVFD---------DEFSTKSDVYAYACLIWEIFNKGEMPFPDLS 163 (223)
Q Consensus 97 ~l~df~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~---------~~~~~~~Di~slG~il~~l~~~~~~p~~~~~ 163 (223)
+++|||++....... ........++..|+|||.+.. ..++.++||||||+++|+|+ +|..||....
T Consensus 169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~ 247 (319)
T 2y4i_B 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH-AREWPFKTQP 247 (319)
T ss_dssp EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH-HSSCSSSSCC
T ss_pred EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH-hCCCCCCCCC
Confidence 999999876543211 111223457788999999864 34788999999999999999 7999999988
Q ss_pred HHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 164 DDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.......+............++.++.+++.+||+.||.+||+++++++.|+++.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 248 AEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 88887777666444444446788899999999999999999999999999887654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=239.52 Aligned_cols=186 Identities=18% Similarity=0.230 Sum_probs=152.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee---ecCC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI---SSDL 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~---~~~~ 94 (223)
.+||||+ +++|.++++.... .+++..++.++.||+.||.|||+.|++||||||.||++ +..+
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~--------------~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~ 143 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSR--------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT
T ss_pred EEEEECC-CCCHHHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC
Confidence 3788998 9999999986433 59999999999999999999999999999999999999 5788
Q ss_pred CeEEcCCCCCcccchhhh------hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---H
Q psy15108 95 SVKISLSGLSKDTYQKEY------YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD---D 165 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~---~ 165 (223)
.++|+|||++........ .......++..|++||.+.+..++.++|||||||++|+|+ +|..||.+... .
T Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ell-tG~~Pf~~~~~~~~~ 222 (483)
T 3sv0_A 144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKK 222 (483)
T ss_dssp CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTSSCCCSSHH
T ss_pred eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHH-hCCCCCccccchhHH
Confidence 999999999976543321 1122567889999999999999999999999999999999 79999987543 3
Q ss_pred HHHHHHHhCcccC---CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 166 QVLSQLESKKLCW---KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 166 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..+..+....... .....++.++.+++..||+.+|++||++++|++.|++++..
T Consensus 223 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 223 QKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 3333332221111 11256789999999999999999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=222.56 Aligned_cols=180 Identities=18% Similarity=0.258 Sum_probs=144.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee---cCC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS---SDL 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~---~~~ 94 (223)
.+|+||+.+|+|.+++..... ....+++..+..++.|+++||.|||+.|++|+||||.||+++ ..+
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~ 164 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQA-----------RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS 164 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHH-----------HTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTC
T ss_pred EEEEEeCCCCcHHHHHHhhhh-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCC
Confidence 488999999999999976543 224699999999999999999999999999999999999994 457
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++++|||++....... ......++..|+|||.+. ..++.++|+||+|+++++|+ +|..||.+.............
T Consensus 165 ~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll-~g~~pf~~~~~~~~~~~~~~~ 240 (285)
T 3is5_A 165 PIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLL-TGCLPFTGTSLEEVQQKATYK 240 (285)
T ss_dssp CEEECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHC
T ss_pred CEEEEeeecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHH-hCCCCCCCCCHHHHHhhhccC
Confidence 89999999997544332 223456788999999875 56889999999999999999 799999988877776665544
Q ss_pred cccCCC-CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKH-SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... ....++++.+++.+||+.||.+||+++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 241 EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 333222 24578899999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=231.49 Aligned_cols=177 Identities=16% Similarity=0.243 Sum_probs=150.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++
T Consensus 176 ~lv~e~~~g~~L~~~l~~~~---------------~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTEKV---------------ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEECCCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEeCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 37899999999999998653 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD------DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
++|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|+ +|..||...........+
T Consensus 241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell-~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL-AGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHH
T ss_pred EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHH-HCCCCCCCCCHHHHHHHH
Confidence 99999987554322 2234578899999998753 35788999999999999999 799999988887777777
Q ss_pred HhCcccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
......... ....+..+.+++.+||+.||.+||++++++++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 665443322 14678889999999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=225.06 Aligned_cols=177 Identities=15% Similarity=0.203 Sum_probs=151.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee---ecC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI---SSD 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~---~~~ 93 (223)
..+|+||+.+|+|.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|+||++ +.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~ 145 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERG---------------VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN 145 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT
T ss_pred EEEEEEcCCCccHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC
Confidence 347899999999999998754 49999999999999999999999999999999999999 677
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+.++++|||++....... .....++..|+|||.+.+..++.++|+||+|+++|+|+ +|..||...........+..
T Consensus 146 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~i~~ 221 (304)
T 2jam_A 146 SKIMITDFGLSKMEQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL-CGYPPFYEETESKLFEKIKE 221 (304)
T ss_dssp CCEEBCSCSTTCCCCCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHHHH
T ss_pred CCEEEccCCcceecCCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHHc
Confidence 889999999986543221 12235678899999998888999999999999999999 79999999888888877777
Q ss_pred CcccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+ ....+++++.+++.+||+.||.+||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 222 GYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 644332 235678999999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=230.84 Aligned_cols=173 Identities=18% Similarity=0.291 Sum_probs=148.7
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|+||+. |+|.+++...+. .+++..+..++.|+++||.|||+.|++||||||+||+++.++.+++
T Consensus 131 lv~e~~~-g~l~~~l~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL 195 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKK--------------PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 195 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTS--------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEE
T ss_pred EEEecCC-CCHHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEE
Confidence 7889997 789999876543 6999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+|||++...... ....+++.|+|||.+. ...++.++||||||+++|+|+ +|..||.+.........+....
T Consensus 196 ~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell-~g~~p~~~~~~~~~~~~~~~~~ 269 (348)
T 1u5q_A 196 GDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALYHIAQNE 269 (348)
T ss_dssp CCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHHHHSC
T ss_pred eeccCceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcC
Confidence 999998754322 3456889999999974 456889999999999999999 7999999888777766666654
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........+++.+.+++.+||+.||++||++++++++
T Consensus 270 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 4444456789999999999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=238.22 Aligned_cols=177 Identities=21% Similarity=0.322 Sum_probs=150.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee---cC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS---SD 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~---~~ 93 (223)
..+|+|||.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||.||+++ .+
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~ 160 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRK---------------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD 160 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTT
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCC
Confidence 347899999999999998764 499999999999999999999999999999999999995 44
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+.++++|||++....... ......+++.|+|||.+.+ .++.++||||+||++|+|+ +|..||.+....+....+..
T Consensus 161 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~ 236 (486)
T 3mwu_A 161 CDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL-SGTPPFYGKNEYDILKRVET 236 (486)
T ss_dssp CCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHH
T ss_pred CCEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHh
Confidence 679999999987554332 2344578899999999865 5899999999999999999 79999999998888888877
Q ss_pred CcccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.......+ ..+++++++++.+||+.||.+|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp TCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 65444332 4678999999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=226.85 Aligned_cols=184 Identities=16% Similarity=0.262 Sum_probs=153.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----cccCCCCCCCeeee
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR-----LIHKDIAARNCLIS 91 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----i~H~di~~~nil~~ 91 (223)
..+|+||+.+|+|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~ 150 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTK-----------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 150 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHH-----------TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC
T ss_pred EEEEEeCCCCCCHHHHHHhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc
Confidence 4488999999999999987654 2345999999999999999999999999 99999999999999
Q ss_pred cCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 92 SDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 92 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
.++.++++|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|+ +|..||...........+
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~i 228 (279)
T 2w5a_A 151 GKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC-ALMPPFTAFSQKELAGKI 228 (279)
T ss_dssp SSSCEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHH
T ss_pred CCCCEEEecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHH-HCCCCCcccCHHHHHHHH
Confidence 999999999998865433221 112345678899999998888999999999999999999 799999988888777777
Q ss_pred HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15108 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214 (223)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~ 214 (223)
..... ...+..++.++.+++.+||+.||.+||+++++++++.
T Consensus 229 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 229 REGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred hhccc-ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 76633 3445678999999999999999999999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=224.41 Aligned_cols=176 Identities=16% Similarity=0.218 Sum_probs=150.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee---ecCC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI---SSDL 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~---~~~~ 94 (223)
.+|+||+.+++|.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|.||++ +.++
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 146 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKR---------------VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS 146 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC
T ss_pred EEEEeccCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC
Confidence 47899999999999998754 49999999999999999999999999999999999999 7778
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++++|||++....... ......+++.|+|||.+.+ .++.++|+||+|+++++|+ +|..||......+....+...
T Consensus 147 ~~~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~ 222 (277)
T 3f3z_A 147 PLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLL-CGYPPFSAPTDSEVMLKIREG 222 (277)
T ss_dssp CEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHC
T ss_pred cEEEEecccceeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHH-HCCCCCCCCCHHHHHHHHHhC
Confidence 99999999987544322 2244567889999999865 4889999999999999999 799999998888888777766
Q ss_pred cccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+.. ..+++.+.+++.+||+.||.+||++.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 223 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4433221 2578899999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=232.55 Aligned_cols=176 Identities=16% Similarity=0.253 Sum_probs=145.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.++++..+ .+++..+..++.||+.||.|||+.|++||||||.||+++.++.+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~v 154 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNV---------------HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHV 154 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTC---------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCE
Confidence 348899999999999998643 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD---DEFSTKSDVYAYACLIWEIFNKGEMPFPDLS---DDQVLSQ 170 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slG~il~~l~~~~~~p~~~~~---~~~~~~~ 170 (223)
+|+|||++....... ......+++.|+|||.+.. ..++.++|+||+||++|+|+ +|..||.... ..+....
T Consensus 155 kL~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ell-tG~~Pf~~~~~~~~~~~~~~ 231 (384)
T 4fr4_A 155 HITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL-RGRRPYHIRSSTSSKEIVHT 231 (384)
T ss_dssp EECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHH-HSSCSSCCCTTSCHHHHHHH
T ss_pred EEeccceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHH-hCCCCCCCCCCccHHHHHHH
Confidence 999999997543322 2345678999999999864 34788999999999999999 7999997443 3444444
Q ss_pred HHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q psy15108 171 LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT-FPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~~ 212 (223)
+... ....+..++.++.+++.+||+.||.+||+ ++++++|
T Consensus 232 ~~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 232 FETT--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred Hhhc--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 4443 23445678999999999999999999998 7777653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=229.99 Aligned_cols=179 Identities=17% Similarity=0.208 Sum_probs=146.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.+++||||||.||+++.++.+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 198 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE---------------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV 198 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE
T ss_pred EEEEeecCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcE
Confidence 348999999999999998754 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCC----HHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWEIFNKGEMPFPDLS----DDQVLSQ 170 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~~l~~~~~~p~~~~~----~~~~~~~ 170 (223)
+|+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||.... ...+...
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~ 277 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL-TGASPFTVDGEKNSQAEISRR 277 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH-HSSCTTSCTTSCCCHHHHHHH
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHH-HCCCCCccCCccchHHHHHHH
Confidence 999999987654433333344568899999999875 34688999999999999999 7999996432 3333333
Q ss_pred HHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH
Q psy15108 171 LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQL 213 (223)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~L 213 (223)
+... ....+..++..+.+++.+||+.||.+|| ++++++++.
T Consensus 278 ~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 278 ILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred Hhcc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 3333 2344567889999999999999999999 999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=232.04 Aligned_cols=178 Identities=12% Similarity=0.284 Sum_probs=128.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC---
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL--- 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~--- 94 (223)
.+||||+.+|+|.++++..+ .+++..+..++.|+++||.|||+.|++||||||.||+++.++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~ 146 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKK---------------HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNL 146 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCS---------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----C
T ss_pred EEEEEccCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcc
Confidence 38899999999999998653 499999999999999999999999999999999999998765
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------HHH
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-------DQV 167 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-------~~~ 167 (223)
.++++|||++....... .......++..|+|||.+.+..++.++||||+|+++|+|+ +|..||..... .+.
T Consensus 147 ~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~ 224 (325)
T 3kn6_A 147 EIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML-SGQVPFQSHDRSLTCTSAVEI 224 (325)
T ss_dssp EEEECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHH-HSSCTTC-------CCCHHHH
T ss_pred cEEEeccccceecCCCC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHH-hCCCCCCCCccccccccHHHH
Confidence 79999999997543322 1223456688999999999888999999999999999999 79999976433 345
Q ss_pred HHHHHhCcccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 168 LSQLESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+..+....... ..+++++++++.+||+.||.+||++++++++
T Consensus 225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 225 MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 55555543332211 3578899999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=234.40 Aligned_cols=179 Identities=21% Similarity=0.216 Sum_probs=146.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.++++.. ..+++..+..++.|++.||.|||+.|++||||||.||+++.++.++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~k 145 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPD---------------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLK 145 (323)
T ss_dssp EEEEECCTTEEGGGGSBTT---------------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEcCCCCcHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEE
Confidence 3889999999999999654 3499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh-hhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhC
Q psy15108 98 ISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLSQLESK 174 (223)
Q Consensus 98 l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~~~~~~ 174 (223)
|+|||++....... ........+++.|+|||.+.+..+ +.++||||+|+++|+|+ +|..||...... .........
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~ 224 (323)
T 3tki_A 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML-AGELPWDQPSDSCQEYSDWKEK 224 (323)
T ss_dssp ECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHH-HSSCSCSSSCTTSHHHHHHHTT
T ss_pred EEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCchHHHHHHHHhcc
Confidence 99999997543222 112234578899999999987765 67899999999999999 799999866543 333333333
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.........++..+.+++.+||+.||.+|||++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 23333335678999999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=223.25 Aligned_cols=174 Identities=21% Similarity=0.255 Sum_probs=151.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+.+|+|.+++...+ .+++..+..++.|+++||.|||+.|++|+||+|+||+++.++.++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 154 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHG---------------RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELK 154 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEE
T ss_pred EEEEEeCCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEE
Confidence 37899999999999998754 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++...... ......++..|+|||.+.+..++.++|+||+|+++|+++ +|..||...........+....
T Consensus 155 l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~-- 228 (284)
T 2vgo_A 155 IADFGWSVHAPSL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL-VGMPPFDSPSHTETHRRIVNVD-- 228 (284)
T ss_dssp ECCCTTCEECSSS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHHTTC--
T ss_pred EecccccccCccc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHH-HCCCCCCCCCHhHHHHHHhccc--
Confidence 9999988654322 123456788999999998888999999999999999999 7999999888877776666543
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+..++.++.+++.+||+.||.+||+++++++|
T Consensus 229 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 33456788999999999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=233.01 Aligned_cols=176 Identities=18% Similarity=0.302 Sum_probs=142.3
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+||| +.+++|.++++..+ .+++..+..++.||+.||.|||+.+++||||||.||+++ ++.++|
T Consensus 133 lv~E-~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl 195 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKK---------------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL 195 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCS---------------SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEE
T ss_pred EEEe-cCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEE
Confidence 6777 78899999998653 489999999999999999999999999999999999995 578999
Q ss_pred cCCCCCcccchhh-hhhhhcCCccccccccccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCC-HH
Q psy15108 99 SLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFD-----------DEFSTKSDVYAYACLIWEIFNKGEMPFPDLS-DD 165 (223)
Q Consensus 99 ~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~-----------~~~~~~~Di~slG~il~~l~~~~~~p~~~~~-~~ 165 (223)
+|||++....... ........+++.|+|||.+.. ..++.++|||||||++|+|+ +|..||.... ..
T Consensus 196 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell-~G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIINQI 274 (390)
T ss_dssp CCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH-HSSCTTTTCCCHH
T ss_pred EecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH-HCCCcchhhhHHH
Confidence 9999997654332 112345678999999999864 35788999999999999999 7999998754 33
Q ss_pred HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 166 QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+.........+...+.++.+++.+||+.||.+||++.+++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 45555555545555566678899999999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=236.18 Aligned_cols=187 Identities=20% Similarity=0.272 Sum_probs=146.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCCCCCeeeecC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK---RLIHKDIAARNCLISSD 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~~~nil~~~~ 93 (223)
..+|+||+.+|+|.++++.... ...++++..+..++.|++.||.|||+. |++|+||||.||+++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPE-----------SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCST-----------TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred eEEEEEeccCCCHHHHHHhccc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence 3478999999999999986543 334699999999999999999999999 99999999999999999
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-----CHHHHH
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL-----SDDQVL 168 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~-----~~~~~~ 168 (223)
+.++++|||++...............+++.|+|||.+.+..++.++||||+|+++|+|+ +|..||... ......
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI-TGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHH-HCCCSBCHHHHTTTSCSBHH
T ss_pred CCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHH-hCCCcccccccccccchhHH
Confidence 99999999999755433322233455889999999998888999999999999999999 799999521 111111
Q ss_pred HHHHh---Cc---------ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 169 SQLES---KK---------LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 169 ~~~~~---~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
..+.. .. .....+...+..+.+++.+||+.||.+|||+++++++|+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 11111 00 0011112234778999999999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=227.31 Aligned_cols=172 Identities=18% Similarity=0.129 Sum_probs=137.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|+||+ +|+|.+++...+. .+++..++.++.|++.||.|||+.+++|+||||+||+++.++.+++
T Consensus 134 lv~e~~-~~~L~~~~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl 198 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGA--------------SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKL 198 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEE
T ss_pred EEEecc-CCCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEE
Confidence 678888 7899999987643 6999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW 178 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 178 (223)
+|||++....... ......+++.|+|||.+.+ .++.++||||||+++|+|+ +|..|+... .....+.......
T Consensus 199 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~-~g~~~~~~~---~~~~~~~~~~~~~ 271 (311)
T 3p1a_A 199 GDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVA-CNMELPHGG---EGWQQLRQGYLPP 271 (311)
T ss_dssp CCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHH-HTCCCCSSH---HHHHHHTTTCCCH
T ss_pred ccceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHH-hCCCCCCCc---cHHHHHhccCCCc
Confidence 9999987654332 2234568899999998865 7899999999999999999 454444332 2233344433333
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 179 KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 179 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+..+++++.+++.+||+.||++||++++++++
T Consensus 272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 3345678999999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=231.96 Aligned_cols=179 Identities=17% Similarity=0.308 Sum_probs=147.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC---
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD--- 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~--- 93 (223)
..+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+||++...
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~---------------~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~ 155 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK---------------FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGN 155 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT---------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCS
T ss_pred EEEEEeCCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCC
Confidence 348999999999999998653 49999999999999999999999999999999999998543
Q ss_pred -CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC---CCHHHHHH
Q psy15108 94 -LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPD---LSDDQVLS 169 (223)
Q Consensus 94 -~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~---~~~~~~~~ 169 (223)
+.++++|||++........ ......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||.+ ....++..
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~~~~~~~~~ 233 (342)
T 2qr7_A 156 PESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML-TGYTPFANGPDDTPEEILA 233 (342)
T ss_dssp GGGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHH-HSSCSSCSSTTSCHHHHHH
T ss_pred cCeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHh-cCCCCCCCCCcCCHHHHHH
Confidence 3499999999975433221 123456788999999998777889999999999999999 79999975 34556666
Q ss_pred HHHhCcccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 170 QLESKKLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 170 ~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+..+..... ....+++++.+++.+||+.||++||++.++++|
T Consensus 234 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 234 RIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 6666544432 235688999999999999999999999999876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=223.44 Aligned_cols=175 Identities=19% Similarity=0.285 Sum_probs=145.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCCCCCeeee-cCC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR--LIHKDIAARNCLIS-SDL 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~~~nil~~-~~~ 94 (223)
.+|+||+.+|+|.++++..+ .+++..++.++.|++.||.|||+.+ ++|+||+|.||+++ .++
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~ 169 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFK---------------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS
T ss_pred EEEEEecCCCCHHHHHHHcc---------------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC
Confidence 47899999999999998654 4899999999999999999999999 99999999999997 778
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHh
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-DQVLSQLES 173 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~-~~~~~~~~~ 173 (223)
.++++|||++...... ......++..|+|||.+. ..++.++|+||+|+++++|+ +|..||..... ......+..
T Consensus 170 ~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~ 244 (290)
T 1t4h_A 170 SVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMA-TSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp CEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHH-HSSCTTTTCSSHHHHHHHHTT
T ss_pred CEEEeeCCCccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHH-hCCCCCCCcCcHHHHHHHHhc
Confidence 9999999998643322 123456788999999875 45899999999999999999 79999987544 444555544
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.......+...++++.+++.+||+.||.+||+++++++|
T Consensus 245 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 433333445667889999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=221.34 Aligned_cols=179 Identities=21% Similarity=0.256 Sum_probs=148.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.+++..... ..+++..++.++.|++.||.|||+.|++|+||+|.||+++.++.++
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 96 FIQMEFCDKGTLEQWIEKRRG-------------EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp EEEECCCCSCBHHHHHHHGGG-------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred EEEEeccCCCCHHHHHhhccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 478999999999999987643 4699999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|+ ++..|+.. .......+...
T Consensus 163 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~~~~~~~~--~~~~~~~~~~~--- 234 (284)
T 2a19_B 163 IGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL-HVCDTAFE--TSKFFTDLRDG--- 234 (284)
T ss_dssp ECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHH-SCCSSHHH--HHHHHHHHHTT---
T ss_pred ECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHH-hcCCcchh--HHHHHHHhhcc---
Confidence 99999987543322 123446788999999998888999999999999999999 67777642 12223333322
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
..+..++..+.+++.+||+.||.+||++.+++++|..+..
T Consensus 235 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 235 -IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred -cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 2345678899999999999999999999999999988754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=234.37 Aligned_cols=190 Identities=19% Similarity=0.254 Sum_probs=147.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++..... ....+++..++.++.|+++||.|||+.|++|+||||.||+++.++.+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 178 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDL-----------PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVP 178 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCC-----------CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCE
T ss_pred EEEEEEcCCCCcHHHHHhccCC-----------CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCE
Confidence 4488999999999999965432 22358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---H----
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV---L---- 168 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~---~---- 168 (223)
+++|||++....... ........++..|+|||.+.+..++.++||||||+++|+|+ +|..||........ .
T Consensus 179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell-~g~~p~~~~~~~~~~~~~~~~~ 257 (321)
T 2qkw_B 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL-CARSAIVQSLPREMVNLAEWAV 257 (321)
T ss_dssp EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHH-HCCTTCSCSSSSSCCCHHHHTH
T ss_pred EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHH-hCCCcccccCcHHHHHHHHHhh
Confidence 999999987543221 11122345688899999998888999999999999999999 78888865432211 1
Q ss_pred HHHHhCcc--------cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 169 SQLESKKL--------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 169 ~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
........ ........+..+.+++.+||+.||++||++++++++|+.++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 11111101 111122346778999999999999999999999999998864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=229.29 Aligned_cols=186 Identities=23% Similarity=0.332 Sum_probs=151.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++.. ..+++..++.++.|++.||.|||+.|++|+||||.||+++.++.+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~ 173 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----------------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLV 173 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred EEEEEecccCCcHHHHHhh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCE
Confidence 3488999999999999964 248999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---------
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD--------- 165 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~--------- 165 (223)
+++|||++....... ........++..|+|||.+.+..++.++||||+|+++++|+ +|..||......
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll-~g~~p~~~~~~~~~~~~~~~~ 252 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL-THCDSSQSPPTKFLELIGIAQ 252 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH-TTTCGGGSHHHHHHHHHCSCC
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHH-hCCCcccccchhhhhhhcccc
Confidence 999999987654322 11223445677899999998888899999999999999999 788888653221
Q ss_pred -----HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 166 -----QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 166 -----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.............+.+..++.++.+++.+||+.||.+||+++++++.|+++.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 253 GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 011122223345556778899999999999999999999999999999988654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=238.59 Aligned_cols=177 Identities=18% Similarity=0.275 Sum_probs=152.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC---
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD--- 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~--- 93 (223)
..+|||||.+|+|.+++.... .+++..+..++.||++||.|||+.|++||||||.||+++..
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 175 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRM---------------KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKD 175 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTT
T ss_pred EEEEEecCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCC
Confidence 347899999999999998764 49999999999999999999999999999999999999764
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+.++++|||++....... ......+++.|+|||.+. ..++.++||||+||++|+|+ +|..||.+....+....+..
T Consensus 176 ~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~ 251 (494)
T 3lij_A 176 ALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILL-AGYPPFGGQTDQEILRKVEK 251 (494)
T ss_dssp CCEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHH
T ss_pred CcEEEEECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHh
Confidence 459999999987654332 234457889999999875 56899999999999999999 79999999999888888877
Q ss_pred CcccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.......+ ..+++++++++.+||+.||.+|||+.++++|
T Consensus 252 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 252 GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 65544332 4678999999999999999999999999876
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=231.58 Aligned_cols=179 Identities=16% Similarity=0.240 Sum_probs=148.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec---CC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---DL 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~---~~ 94 (223)
.+|+||+.+|+|.+++..... ..+++..++.++.|++.||.|||+.|++||||||.||+++. .+
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELA-------------EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC
T ss_pred EEEEEecCCCcHHHHHHHhcc-------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC
Confidence 388999999999999864322 46999999999999999999999999999999999999987 68
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++++|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|+ +|..||...........+...
T Consensus 172 ~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~ 248 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL-THTSPFVGEDNQETYLNISQV 248 (327)
T ss_dssp CEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHT
T ss_pred cEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHhc
Confidence 99999999997654332 223456889999999999889999999999999999999 799999998887777666554
Q ss_pred cccC--CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCW--KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... .....+++.+.+++.+||+.||.+||++++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 3322 3335688999999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=231.18 Aligned_cols=176 Identities=15% Similarity=0.242 Sum_probs=143.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-----
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS----- 92 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~----- 92 (223)
.+||||+ +++|.+++...+. ..+++..+..++.||+.||.|||+.|++||||||.||+++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNY-------------NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred EEEEcCC-CCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 3789999 9999999987654 45999999999999999999999999999999999999974
Q ss_pred --------------------CCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHH
Q psy15108 93 --------------------DLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIF 152 (223)
Q Consensus 93 --------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~ 152 (223)
.+.++++|||++...... .....+++.|+|||.+.+..++.++||||+||++|+|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 778999999999753322 23456789999999999999999999999999999999
Q ss_pred hCCCCCCCCCCHHHHHHHHHhCccc--------------------------CCCC------------------CCChHHH
Q psy15108 153 NKGEMPFPDLSDDQVLSQLESKKLC--------------------------WKHS------------------SKTPEYI 188 (223)
Q Consensus 153 ~~~~~p~~~~~~~~~~~~~~~~~~~--------------------------~~~~------------------~~~~~~~ 188 (223)
+|..||......+....+...... ++.. ...++.+
T Consensus 254 -~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 254 -TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp -HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred -HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 799999888776655554331110 0000 0112667
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 189 TSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 189 ~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+++.+||+.||.+|||++|+++|
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhcCChhhCCCHHHHhcC
Confidence 899999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=234.91 Aligned_cols=181 Identities=18% Similarity=0.252 Sum_probs=142.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~k 168 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFM-------------DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 168 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCT-------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred EEEEEccCCCCHHHHHhhhcc-------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 378999999999999987533 4599999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhh------hhhhcCCccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEY------YKYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169 (223)
Q Consensus 98 l~df~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~ 169 (223)
++|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|+|+ +|..||.+.+......
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA-NGHVPFKDMPATQMLL 247 (389)
T ss_dssp ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHH-HSSCTTTTCCSTTHHH
T ss_pred EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHH-HCCCCCCCCCHHHHHH
Confidence 999998765432210 11123467788999999987 56899999999999999999 7999998765443332
Q ss_pred HHHhCcc--------------------------------------------cCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy15108 170 QLESKKL--------------------------------------------CWKHSSKTPEYITSLHEKCIHPHPHQRPT 205 (223)
Q Consensus 170 ~~~~~~~--------------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps 205 (223)
.+..... ..+.+..+++++.+++.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 327 (389)
T 3gni_B 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327 (389)
T ss_dssp HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence 2211100 01123456788999999999999999999
Q ss_pred HHHHHHH
Q psy15108 206 FPSIVTQ 212 (223)
Q Consensus 206 ~~~ll~~ 212 (223)
++++++|
T Consensus 328 a~ell~h 334 (389)
T 3gni_B 328 ASTLLNH 334 (389)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999876
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=226.47 Aligned_cols=179 Identities=15% Similarity=0.201 Sum_probs=140.5
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC--
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS-- 95 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~-- 95 (223)
.+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+||+++.++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~ 151 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRR---------------HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVS 151 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSC
T ss_pred EEEEEcCCCCcHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcC
Confidence 38899999999999998764 4999999999999999999999999999999999999987765
Q ss_pred -eEEcCCCCCcccchhh------hhhhhcCCccccccccccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q psy15108 96 -VKISLSGLSKDTYQKE------YYKYRNAILPLRWLPYEAVFD-----DEFSTKSDVYAYACLIWEIFNKGEMPFPDLS 163 (223)
Q Consensus 96 -~~l~df~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slG~il~~l~~~~~~p~~~~~ 163 (223)
++++|||++....... ........++..|+|||.+.. ..++.++||||+|+++|+|+ +|..||.+..
T Consensus 152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~ 230 (316)
T 2ac3_A 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL-SGYPPFVGRC 230 (316)
T ss_dssp SEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH-HSSCSCCCCC
T ss_pred ceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH-HCCCCCcccc
Confidence 9999999987543221 111223458899999999864 44788999999999999999 7999997654
Q ss_pred H---------------HHHHHHHHhCcccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 164 D---------------DQVLSQLESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 164 ~---------------~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ......+.......+.. ..++.++.+++.+||+.||.+||+++++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 231 GSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2 23444455443332211 3578899999999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=221.94 Aligned_cols=178 Identities=17% Similarity=0.272 Sum_probs=148.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC--
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-- 94 (223)
..+|+||+.+++|.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|.||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 147 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKE---------------SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVP 147 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSS
T ss_pred EEEEEeecCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCC
Confidence 347899999999999998653 499999999999999999999999999999999999998776
Q ss_pred --CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 95 --SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 95 --~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
.++++|||++....... ......++..|+|||.+....++.++|+||+|+++++++ +|..||.+....+....+.
T Consensus 148 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~ 224 (283)
T 3bhy_A 148 NPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL-SGASPFLGETKQETLTNIS 224 (283)
T ss_dssp SCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHH
T ss_pred CCceEEEecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHH-HCCCCCCCcchHHHHHHhH
Confidence 79999999987654332 223456788999999998888999999999999999999 7999999888877777665
Q ss_pred hCcccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....... .....++.+.+++.+||+.||.+||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 225 AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp TTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred hcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 5433221 124678889999999999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=228.10 Aligned_cols=184 Identities=14% Similarity=0.211 Sum_probs=145.5
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee----ecC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI----SSD 93 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~----~~~ 93 (223)
.+||||+.+|+|.++++.... ...+++..++.++.|+++||.|||+.|++|+||||.||++ +..
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~ 152 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSN------------AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ 152 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGG------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSC
T ss_pred EEEEeCCCCCCHHHHHHHhcc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCC
Confidence 488999999999999986543 1349999999999999999999999999999999999998 666
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccc--------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF--------DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD- 164 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~- 164 (223)
+.++++|||++....... ......++..|+|||.+. +..++.++||||+||++|+|+ +|..||.....
T Consensus 153 ~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~ 229 (319)
T 4euu_A 153 SVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA-TGSLPFRPFEGP 229 (319)
T ss_dssp EEEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH-HSSCSEECTTCG
T ss_pred ceEEEccCCCceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCcc
Confidence 779999999997654332 223456889999999875 466889999999999999999 79999964432
Q ss_pred ---HHHHHHHHhCccc-------------------C----CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 165 ---DQVLSQLESKKLC-------------------W----KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 165 ---~~~~~~~~~~~~~-------------------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
.+....+..+.+. . ......+..+.+++.+||+.||++||+++|++++.++.
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 3333333332110 0 11123456788999999999999999999999998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=240.94 Aligned_cols=176 Identities=20% Similarity=0.343 Sum_probs=151.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee---ecCC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI---SSDL 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~---~~~~ 94 (223)
.+|+||+.+|+|.+++...+ .+++..+..++.||+.||.|||++|++||||||.||++ +.++
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 166 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRK---------------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA 166 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCS---------------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC
T ss_pred EEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCC
Confidence 37899999999999997643 49999999999999999999999999999999999999 4568
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++++|||++....... ......+++.|+|||.+.+ .++.++||||+||++|+|+ +|..||.+.+..+....+...
T Consensus 167 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~ 242 (484)
T 3nyv_A 167 NIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILL-SGCPPFNGANEYDILKKVEKG 242 (484)
T ss_dssp CEEECCTTHHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHC
T ss_pred cEEEEeeeeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHHcC
Confidence 89999999886543322 1233468899999999865 6899999999999999999 799999999998888888776
Q ss_pred cccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
......+ ..+++++++++.+||+.||.+|||++++++|
T Consensus 243 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 243 KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 5544332 4678999999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=227.75 Aligned_cols=187 Identities=19% Similarity=0.260 Sum_probs=148.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCcccCCCCCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHIS--------DKRLIHKDIAARNC 88 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~i~H~di~~~ni 88 (223)
..+|+||+.+|+|.++++.. .+++..++.++.|++.||.||| +.+++|+||||+||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI 178 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY----------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC----------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred eEEEEeecCCCcHHHHHhcc----------------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence 34889999999999999752 4899999999999999999999 89999999999999
Q ss_pred eeecCCCeEEcCCCCCcccchhhhh---hhhcCCcccccccccccccCC------CCcccchHHHHHHHHHHHhCC----
Q psy15108 89 LISSDLSVKISLSGLSKDTYQKEYY---KYRNAILPLRWLPYEAVFDDE------FSTKSDVYAYACLIWEIFNKG---- 155 (223)
Q Consensus 89 l~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~------~~~~~Di~slG~il~~l~~~~---- 155 (223)
+++.++.++++|||++......... ......++..|+|||.+.... ++.++||||||+++|+|+ +|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~-tg~~~~ 257 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA-RRCSIG 257 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH-TTBCBT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH-hccCcC
Confidence 9999999999999999765433211 123456889999999987653 236899999999999999 67
Q ss_pred ------CCCCCCCC-----HHHHHHHHHhCcccCCCCC-----CChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 156 ------EMPFPDLS-----DDQVLSQLESKKLCWKHSS-----KTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 156 ------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..||.... .......+.........+. .+++.+.+++.+||+.||.+||++.+++++|+++.++
T Consensus 258 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 77886542 3344444444333333222 3456799999999999999999999999999998765
Q ss_pred c
Q psy15108 220 D 220 (223)
Q Consensus 220 ~ 220 (223)
.
T Consensus 338 ~ 338 (342)
T 1b6c_B 338 E 338 (342)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=220.62 Aligned_cols=175 Identities=15% Similarity=0.244 Sum_probs=143.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+.+++|.+++...+ .+++..+..++.|+++||.|||+.|++|+||+|.||+++.++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHG---------------RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEE
T ss_pred EEEEeccCCCcHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEE
Confidence 37899999999999998754 489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++....... ......++..|+|||.+.+..+ +.++|+||+|+++++|+ +|..||...........+.....
T Consensus 152 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 228 (276)
T 2h6d_A 152 IADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL-CGTLPFDDEHVPTLFKKIRGGVF 228 (276)
T ss_dssp ECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EeecccccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHhhcCcc
Confidence 99999987654332 1233467788999999887765 57899999999999999 69999998888777777766532
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+..++.++.+++.+||+.||.+||++++++++
T Consensus 229 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 --YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 3356678999999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=227.96 Aligned_cols=176 Identities=17% Similarity=0.241 Sum_probs=144.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~~ 96 (223)
.+||||+.+|+|.++++..+ .+++..+..++.|++.||.|||+. |++|+||||.||+++.++.+
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~ 171 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAG---------------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCE
T ss_pred EEEEECCCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCE
Confidence 38899999999999998764 499999999999999999999996 99999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS------- 169 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~------- 169 (223)
+++|||++...... ......++..|+|||.+.+..++.++||||+|+++|+|+ +|..||..........
T Consensus 172 kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~ 247 (360)
T 3eqc_A 172 KLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA-VGRYPIPPPDAKELELMFGCQVE 247 (360)
T ss_dssp EECCCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHH-HTSCCSSCCCHHHHHHHHC----
T ss_pred EEEECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHhccccc
Confidence 99999998644322 223457789999999999888999999999999999999 7999998766543321
Q ss_pred -----------------------------------HHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 170 -----------------------------------QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 170 -----------------------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+............++.++.+++.+||+.||.+|||++++++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1222212222234568899999999999999999999999976
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=238.93 Aligned_cols=173 Identities=12% Similarity=0.080 Sum_probs=136.5
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++|||+ +|+|.++++..+.- ......+++..++.++.||++||.|||+.|++||||||.||+++.++.+||
T Consensus 177 lv~E~~-~g~L~~~l~~~~~~--------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL 247 (377)
T 3byv_A 177 FLYPRM-QSNLQTFGEVLLSH--------SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 247 (377)
T ss_dssp EEEECC-SEEHHHHHHHHHHT--------TTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE
T ss_pred EEEecc-CCCHHHHHHhcccc--------ccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEE
Confidence 778888 68999999976540 011123455889999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccC-----------CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-----------EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-----------~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~ 167 (223)
+|||+++.... ......+ ..|+|||.+.+. .++.++|||||||++|+|+ +|..||.+......
T Consensus 248 ~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell-tg~~Pf~~~~~~~~ 321 (377)
T 3byv_A 248 TGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW-CADLPITKDAALGG 321 (377)
T ss_dssp CCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH-HSSCCC------CC
T ss_pred EechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH-HCCCCCcccccccc
Confidence 99999975332 1233455 889999999877 7899999999999999999 69999976554332
Q ss_pred HHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+ ......+++++.+++.+||+.||.+||++.+++++
T Consensus 322 ~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 322 SEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp SGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred hhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 2221 12235788999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=233.34 Aligned_cols=178 Identities=17% Similarity=0.216 Sum_probs=143.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+. |+|.++++.. .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~ 148 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----------------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHV 148 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred EEEEecccC-cCHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCE
Confidence 347889987 6999999752 48999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchh--------------------hhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCC
Q psy15108 97 KISLSGLSKDTYQK--------------------EYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKG 155 (223)
Q Consensus 97 ~l~df~~~~~~~~~--------------------~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~ 155 (223)
+++|||+++..... .........+++.|+|||.+.+ ..++.++||||+||++|+|+ +|
T Consensus 149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g 227 (388)
T 3oz6_A 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CG 227 (388)
T ss_dssp EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HS
T ss_pred EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH-hC
Confidence 99999999754210 1112234578899999999876 56899999999999999999 79
Q ss_pred CCCCCCCCHHHHHHHHHhCcccC---------------------------------------------CCCCCChHHHHH
Q psy15108 156 EMPFPDLSDDQVLSQLESKKLCW---------------------------------------------KHSSKTPEYITS 190 (223)
Q Consensus 156 ~~p~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~ 190 (223)
..||.+.+....+..+......+ .....+++++.+
T Consensus 228 ~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 307 (388)
T 3oz6_A 228 KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307 (388)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHH
Confidence 99999888766655543210000 011256788999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHH
Q psy15108 191 LHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 191 li~~~l~~dp~~Rps~~~ll~~ 212 (223)
++.+||+.||.+|||++|+++|
T Consensus 308 ll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 308 LLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHhhccCcccCCCHHHHhCC
Confidence 9999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=227.72 Aligned_cols=187 Identities=21% Similarity=0.340 Sum_probs=150.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+++|+|.++++..+. .+++..++.++.|+++||.|||+.|++|+||||.||+++.++.+
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 184 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE--------------RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 184 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT--------------SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE
T ss_pred eEEEEECCCCCCHHHHHHhccc--------------CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcE
Confidence 4478999999999999987533 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----------
Q psy15108 97 KISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD---------- 164 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~---------- 164 (223)
+++|||++........ .......++..|+|||.+.+..++.++||||||+++++|+ +|..|+.....
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~-tg~~~~~~~~~~~~~~~~~~~ 263 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF-TYIEKSKSPPAEFMRMIGNDK 263 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH-HTTCGGGSHHHHHHHHHCTTC
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHH-hcCCCCCCCHHHHHHhhcccc
Confidence 9999999876543221 1122345567799999998888899999999999999999 67777753211
Q ss_pred --H----HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 165 --D----QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 165 --~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
. .....+... ...+.+..++.++.+++.+||+.||.+||++.++++.|+.+.+.
T Consensus 264 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 264 QGQMIVFHLIELLKNN-GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp CTHHHHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhHHHHHHHhhcC-CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0 112222222 34455678899999999999999999999999999999987643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=238.57 Aligned_cols=176 Identities=17% Similarity=0.262 Sum_probs=152.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC---
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL--- 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~--- 94 (223)
.+|||||.+|+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||.||+++.++
T Consensus 122 ~lv~e~~~gg~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 122 YLVTEFYEGGELFEQIINRH---------------KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEEECCTTCBHHHHHHHHS---------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred EEEEecCCCCcHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence 37899999999999998764 499999999999999999999999999999999999998775
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++++|||++....... ......+++.|+|||.+. ..++.++||||+||++|+|+ +|..||.+.+..+....+...
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILL-CGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHC
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcC
Confidence 69999999997554322 234457889999999976 56899999999999999999 799999999998888888776
Q ss_pred cccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... ...+++++++++.+||+.||.+|||++++++|
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 543322 25678999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=224.66 Aligned_cols=178 Identities=22% Similarity=0.302 Sum_probs=141.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+. |+|.+++...+. .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++
T Consensus 95 ~lv~e~~~-~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~k 159 (311)
T 3niz_A 95 TLVFEFME-KDLKKVLDENKT--------------GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALK 159 (311)
T ss_dssp EEEEECCS-EEHHHHHHTCTT--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred EEEEcCCC-CCHHHHHHhccC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEE
Confidence 37889988 589988876433 599999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++....... .......++..|+|||.+.+ ..++.++||||+||++|+|+ +|..||.+.........+.....
T Consensus 160 l~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~ 237 (311)
T 3niz_A 160 LADFGLARAFGIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI-TGKPLFPGVTDDDQLPKIFSILG 237 (311)
T ss_dssp ECCCTTCEETTSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH-HSSCSCCCSSTTTHHHHHHHHHC
T ss_pred EccCcCceecCCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHHC
Confidence 99999997543221 12234567889999999876 45899999999999999999 79999987766555444432100
Q ss_pred cC----------------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CW----------------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .....+++++.+++.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 0013456789999999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=237.73 Aligned_cols=176 Identities=11% Similarity=0.114 Sum_probs=139.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCcccCCCCCCCeee
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQA------VTMAYQVALGLEHISDKRLIHKDIAARNCLI 90 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~i~H~di~~~nil~ 90 (223)
..+||||+. |+|.++++..+. .+++..+ ..++.||++||.|||++|++||||||+||++
T Consensus 163 ~~lv~e~~~-~~L~~~l~~~~~--------------~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll 227 (371)
T 3q60_A 163 YLLLMPAAS-VDLELLFSTLDF--------------VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI 227 (371)
T ss_dssp EEEEECCCS-EEHHHHHHHHHH--------------SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE
T ss_pred EEEEecCCC-CCHHHHHHHhcc--------------ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE
Confidence 357899999 999999998654 3455555 6778999999999999999999999999999
Q ss_pred ecCCCeEEcCCCCCcccchhhhhhhhcCCccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH-
Q psy15108 91 SSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV- 167 (223)
Q Consensus 91 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~- 167 (223)
+.++.++|+|||++....... ....+++.|+|||.+.+ ..++.++|||||||++|+|+ +|..||.+......
T Consensus 228 ~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell-tg~~Pf~~~~~~~~~ 302 (371)
T 3q60_A 228 MPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW-CLFLPFGLVTPGIKG 302 (371)
T ss_dssp CTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH-HSSCSTTBCCTTCTT
T ss_pred CCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH-hCCCCCCCcCccccc
Confidence 999999999999987553322 13445688999999987 67899999999999999999 69999976643210
Q ss_pred -HH-----HHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 168 -LS-----QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 168 -~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .........+....+++.+.+++.+||+.||++||++.++++|
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0001112233335789999999999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=240.36 Aligned_cols=178 Identities=19% Similarity=0.309 Sum_probs=149.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++...+. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~-------------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~v 325 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQ-------------AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHI 325 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSS-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE
T ss_pred EEEEEEcCCCCcHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCe
Confidence 3489999999999999986433 459999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS----DDQVLSQLE 172 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~----~~~~~~~~~ 172 (223)
+|+|||++....... ......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||.... ...+...+.
T Consensus 326 KL~DFGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLl-tG~~PF~~~~~~~~~~~i~~~i~ 402 (576)
T 2acx_A 326 RISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI-AGQSPFQQRKKKIKREEVERLVK 402 (576)
T ss_dssp EECCCTTCEECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHH-HSSCSSSCSSSCCCHHHHHHHHH
T ss_pred EEEecccceecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHH-hCCCCCcccccchhHHHHHHHhh
Confidence 999999997654322 223457899999999998888999999999999999999 7999998653 334444444
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
... ...+..+++++.+++.+||+.||.+|| +++|+++|
T Consensus 403 ~~~--~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 403 EVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccc--ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 432 334567899999999999999999999 78888865
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=226.56 Aligned_cols=177 Identities=19% Similarity=0.290 Sum_probs=152.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+++|.+++...+ .+++..++.++.|+++||.|||+.|++|+||+|.||+++.++.+
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~~---------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 180 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRRK---------------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 180 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCE
T ss_pred EEEEEecCCCCCHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCE
Confidence 348899999999999998754 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+++|||++....... .......++..|++||.+.+..++.++|+||||+++|+|+ +|..||......+....+.....
T Consensus 181 kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~ 258 (335)
T 2owb_A 181 KIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPFETSCLKETYLRIKKNEY 258 (335)
T ss_dssp EECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHHHTCC
T ss_pred EEeeccCceecccCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHH-HCcCCCCCCCHHHHHHHHhcCCC
Confidence 999999987543221 1123456788899999998888899999999999999999 79999998887777766665433
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+..++.++.+++.+||+.||++||++++++++
T Consensus 259 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 --SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3456788999999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=222.45 Aligned_cols=177 Identities=16% Similarity=0.250 Sum_probs=150.5
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+.+|+|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.++
T Consensus 100 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 164 (298)
T 1phk_A 100 FLVFDLMKKGELFDYLTEKV---------------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 164 (298)
T ss_dssp EEEEECCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEeccCCCcHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEE
Confidence 37899999999999998653 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF------DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~------~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
++|||++....... ......++..|+|||.+. ...++.++|+||+|+++++|+ +|..||...........+
T Consensus 165 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~ 241 (298)
T 1phk_A 165 LTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPFWHRKQMLMLRMI 241 (298)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHH
T ss_pred EecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHH-HCCCCCcCccHHHHHHHH
Confidence 99999987543322 223456788999999874 345788999999999999999 799999988887777777
Q ss_pred HhCcccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.........+ ..++..+.+++.+||+.||.+||++++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 242 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 6654443322 3578899999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=228.42 Aligned_cols=194 Identities=20% Similarity=0.282 Sum_probs=148.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhcccc-------------------------CCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKD-------------------------KSGSGKPRVRSLSTSQAVTMAYQVALGLEH 72 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~-------------------------~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 72 (223)
.+||||+.+|+|.+++......... ..+........+++..+..++.|+++||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 4889999999999999532110000 000000012245788899999999999999
Q ss_pred hhcCCcccCCCCCCCeeeecCC--CeEEcCCCCCcccchhh---hhhhhcCCccccccccccccc--CCCCcccchHHHH
Q psy15108 73 ISDKRLIHKDIAARNCLISSDL--SVKISLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYA 145 (223)
Q Consensus 73 LH~~~i~H~di~~~nil~~~~~--~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG 145 (223)
||+.+++|+||||.||+++.++ .++|+|||++....... ........+++.|+|||.+.. ..++.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998766 79999999997543321 222345678899999999865 5688999999999
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 146 ~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+++|+|+ +|..||.+.........+.........+ ..+++++.+++.+||+.||.+||++.+++++
T Consensus 264 ~il~el~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 264 VLLHLLL-MGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHH-HSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHH-HCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 9999999 7999999998888887777665443332 2478899999999999999999999999886
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=221.80 Aligned_cols=180 Identities=18% Similarity=0.239 Sum_probs=137.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~~ 96 (223)
.+|+||+. |+|.++++.... ....+++..++.++.|++.||.|||++ |++|+||||.||+++.++.+
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~ 149 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVID-----------KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQV 149 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHH-----------TTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCE
T ss_pred EEEEehhc-cchHHHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCE
Confidence 37889987 599998876433 235699999999999999999999998 99999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccc----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAV----FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL-SDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~-~~~~~~~~~ 171 (223)
+++|||++....... ......+++.|+|||.+ ....++.++|+||+|+++++|+ +|..||... .........
T Consensus 150 kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~ 226 (290)
T 3fme_A 150 KMCDFGISGYLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA-ILRFPYDSWGTPFQQLKQV 226 (290)
T ss_dssp EBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHH-HTSCSSCCCSCHHHHHHHH
T ss_pred EEeecCCcccccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHH-HCCCCccccCchHHHHHHH
Confidence 999999987554332 22334678889999996 4556889999999999999999 799999863 344444444
Q ss_pred HhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
............+++++.+++.+||+.||++|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 44433333345688999999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=221.70 Aligned_cols=179 Identities=20% Similarity=0.271 Sum_probs=140.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+ +|.+++...+ +.+++..+..++.|+++||.|||+.|++||||||+||+++.++.++
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~--------------~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~k 141 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCN--------------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTT--------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEecCCC-CHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 378899875 6666665533 3599999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++....... .......++..|+|||.+.+.. ++.++|+||+|+++++|++.+..+|.+.+.......+.....
T Consensus 142 l~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~ 220 (292)
T 3o0g_A 142 LANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220 (292)
T ss_dssp ECCCTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred EeecccceecCCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence 99999997543221 1223456788999999987765 799999999999999999444444666666665555433110
Q ss_pred c---------------------------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 C---------------------------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ......+++++.+++.+||+.||++|||++|+++|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 01123467889999999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=221.67 Aligned_cols=176 Identities=19% Similarity=0.303 Sum_probs=151.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+.+++|.+++...+ .+++..++.++.|+++||.|||+.|++|+||+|+||+++.++.++
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 155 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRK---------------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVK 155 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred EEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEE
Confidence 48899999999999998654 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++....... .......++..|+|||.+.+..++.++|+||+|+++++|+ +|..||......+....+....
T Consensus 156 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~-- 231 (294)
T 2rku_A 156 IGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPFETSCLKETYLRIKKNE-- 231 (294)
T ss_dssp ECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHHTTC--
T ss_pred EEeccCceecccCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhhcc--
Confidence 99999987543221 1123456788899999998888899999999999999999 7999999888777766665543
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+..++..+.+++.+||+.||++||++++++++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 33456788999999999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=237.06 Aligned_cols=180 Identities=18% Similarity=0.280 Sum_probs=149.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+|+|.+++...+. ....+++..+..++.||+.||.|||+.|++||||||.||+++.++.++
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~-----------~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vk 329 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDE-----------DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSST-----------TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEeccCCCHHHHHHHhhc-----------ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEE
Confidence 388999999999999986432 224699999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHh
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS----DDQVLSQLES 173 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~----~~~~~~~~~~ 173 (223)
|+|||++........ ......+++.|+|||.+.+..++.++|+||+||++|+|+ +|..||.+.. ..++...+..
T Consensus 330 L~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyell-tG~~PF~~~~~~~~~~~~~~~i~~ 407 (543)
T 3c4z_A 330 ISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI-AARGPFRARGEKVENKELKQRVLE 407 (543)
T ss_dssp ECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCTTCCCCHHHHHHHHHH
T ss_pred EeecceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHH-hCCCCCCCCccchhHHHHHHHHhh
Confidence 999999976433221 123347899999999999888999999999999999999 7999997653 3455555554
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF-----PSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~ 212 (223)
.. ...+..++.++.+++.+||+.||.+||++ +++++|
T Consensus 408 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 408 QA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred cc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 43 33456789999999999999999999975 666654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=231.35 Aligned_cols=175 Identities=15% Similarity=0.168 Sum_probs=143.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC--e
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS--V 96 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~--~ 96 (223)
+|+||+. ++|.+++..... ..+++..+..++.||++||.|||+.+++||||||.||+++.++. +
T Consensus 176 lv~e~~~-~~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF-------------QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT-------------CCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCE
T ss_pred EEEeccC-CCHHHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcce
Confidence 6788885 799999987654 45999999999999999999999999999999999999998877 9
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+|+|||++...... .....+++.|+|||.+.+..++.++|||||||++|+|+ +|..||.+.+....+..+.....
T Consensus 242 kL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-tG~~pf~~~~~~~~l~~i~~~~~ 316 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL-TGYPLLPGEDEGDQLACMIELLG 316 (429)
T ss_dssp EECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHcC
Confidence 99999998643322 23457788999999999989999999999999999999 79999998887666554432100
Q ss_pred cC-------------------------------------------------C--------CCCCChHHHHHHHHHhcCCC
Q psy15108 177 CW-------------------------------------------------K--------HSSKTPEYITSLHEKCIHPH 199 (223)
Q Consensus 177 ~~-------------------------------------------------~--------~~~~~~~~~~~li~~~l~~d 199 (223)
.+ + .....++.+.+|+.+||+.|
T Consensus 317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 00 0 01123677899999999999
Q ss_pred CCCCCCHHHHHHH
Q psy15108 200 PHQRPTFPSIVTQ 212 (223)
Q Consensus 200 p~~Rps~~~ll~~ 212 (223)
|++|||++|+++|
T Consensus 397 P~~Rpta~e~L~H 409 (429)
T 3kvw_A 397 PAVRMTPGQALRH 409 (429)
T ss_dssp TTTSCCHHHHHTS
T ss_pred hhhCCCHHHHhCC
Confidence 9999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=221.17 Aligned_cols=179 Identities=23% Similarity=0.319 Sum_probs=141.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+ +|.+++.... ..+++..+..++.|+++||.|||+.|++||||||+||+++.++.+
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 139 (288)
T 1ob3_A 75 LVLVFEHLDQ-DLKKLLDVCE--------------GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139 (288)
T ss_dssp EEEEEECCSE-EHHHHHHTST--------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred EEEEEEecCC-CHHHHHHhcc--------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCE
Confidence 3478888875 9999997643 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......++..|+|||.+.+. .++.++|+||+|+++|+|+ +|..||.+.........+....
T Consensus 140 kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~ 217 (288)
T 1ob3_A 140 KIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRIL 217 (288)
T ss_dssp EECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEeECccccccCccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHH
Confidence 999999886543221 122334678899999998754 4889999999999999999 7999999887766655543210
Q ss_pred cc-----C----------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LC-----W----------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~-----~----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. + .....+++++.+++.+||+.||++|||++++++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 0 0123468899999999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=223.09 Aligned_cols=177 Identities=20% Similarity=0.284 Sum_probs=152.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+.+++|.++++. .++++..+..++.|++.||.|||+.|++|+||+|.||+++.++.++
T Consensus 96 ~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 159 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP----------------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVK 159 (303)
T ss_dssp EEEEECCTTEEHHHHHTT----------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEeCCCCcHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEE
Confidence 378999999999999953 3589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++....... .......++..|+|||.+.+..++.++|+||||+++++|+ +|..||...........+... ..
T Consensus 160 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~-~~ 236 (303)
T 3a7i_A 160 LADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA-RGEPPHSELHPMKVLFLIPKN-NP 236 (303)
T ss_dssp ECCCTTCEECBTTB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHHHHS-CC
T ss_pred EeecccceecCccc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHc-cCCCCCCCcCHHHHHHHhhcC-CC
Confidence 99999987554322 1123456788899999998888999999999999999999 799999988877776666554 33
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
...+..++..+.+++.+||+.||.+||++.+++++.
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 444567899999999999999999999999998763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=223.89 Aligned_cols=187 Identities=18% Similarity=0.263 Sum_probs=147.7
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|+||+.+|+|.+++..... ....+++..++.++.|+++||.|||+.+++|+||+|.||+++.++.+++
T Consensus 107 lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKD-----------KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHT-----------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred EEEEeCCCCcHHHHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEE
Confidence 78999999999999987533 2346999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchh--------hhhhhhcCCcccccccccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCH--H
Q psy15108 99 SLSGLSKDTYQK--------EYYKYRNAILPLRWLPYEAVFDDE---FSTKSDVYAYACLIWEIFNKGEMPFPDLSD--D 165 (223)
Q Consensus 99 ~df~~~~~~~~~--------~~~~~~~~~~~~~~~~pe~~~~~~---~~~~~Di~slG~il~~l~~~~~~p~~~~~~--~ 165 (223)
+|||++...... .........++..|+|||.+.... ++.++||||||+++|+|+ +|..||..... .
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~~~~ 254 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM-FGEGPYDMVFQKGD 254 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH-HSSCTTHHHHHTTS
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH-hCCCChhhhhcccc
Confidence 999987653211 011122345688899999987544 688999999999999999 79999853211 1
Q ss_pred HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 166 QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.....+.. ....+....++.++.+++.+||+.||.+||++++++++|+.+..
T Consensus 255 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 255 SVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp CHHHHHHC-C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhhHHhhc-cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 11122222 24444456788999999999999999999999999999988754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=220.38 Aligned_cols=178 Identities=21% Similarity=0.328 Sum_probs=148.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+. |+|.+++..... ..+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.++
T Consensus 95 ~lv~e~~~-~~L~~~l~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 95 TLVFEHVD-QDLTTYLDKVPE-------------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp EEEEECCS-CBHHHHHHHSCT-------------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred EEEEecCC-CCHHHHHHhccc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEE
Confidence 37788887 799999987543 4589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc-
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL- 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~- 176 (223)
++|||++....... ......++..|+|||.+.+..++.++||||||+++|+|+ +|..||.+.........+.....
T Consensus 161 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 161 LADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp ECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999987654332 234466788999999998888999999999999999999 79999998887766655543100
Q ss_pred ----cC--------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 ----CW--------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ----~~--------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+ .....++..+.+++.+||+.||.+||++.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 1124578899999999999999999999999865
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=222.99 Aligned_cols=177 Identities=16% Similarity=0.272 Sum_probs=126.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+.+++|.+++.... .++++..++.++.|+++||.|||+.|++|+||+|.||+++.++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~k 152 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRV--------------KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIK 152 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCS--------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEE
T ss_pred EEEEecCCCCcHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEE
Confidence 38899999999999998642 3689999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++........ ......++..|+|||.+.+..++.++|+||+|+++++|+ +|..||...........+... .
T Consensus 153 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~--~ 228 (278)
T 3cok_A 153 IADFGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL-IGRPPFDTDTVKNTLNKVVLA--D 228 (278)
T ss_dssp ECCCTTCEECC-----------------------------CTHHHHHHHHHHHHH-HSSCSSCCCSCC-----CCSS--C
T ss_pred EEeecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCChhHHHHHHHHhhc--c
Confidence 999999875432221 122345788899999998888899999999999999999 799999876655444433322 2
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+..++.++.+++.+||+.||++||++++++++
T Consensus 229 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 23455678999999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=224.95 Aligned_cols=176 Identities=16% Similarity=0.208 Sum_probs=143.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-----
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS----- 92 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~----- 92 (223)
.+||||+ +++|.+++...+. .++++..+..++.|+++||.|||+.|++||||||.||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF-------------LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEE
T ss_pred EEEEcCC-CCCHHHHHHhcCC-------------CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccc
Confidence 3788999 9999999987643 46899999999999999999999999999999999999987
Q ss_pred --------------CCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q psy15108 93 --------------DLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMP 158 (223)
Q Consensus 93 --------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p 158 (223)
++.++++|||++...... .....++..|+|||.+.+..++.++||||+|+++|+++ +|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~p 233 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY-LGFTV 233 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHH-HSSCS
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHH-hCCCC
Confidence 567999999998753322 23456789999999999888999999999999999999 79999
Q ss_pred CCCCCHHHHHHHHHhCccc------------------------------------------CCCCCCChHHHHHHHHHhc
Q psy15108 159 FPDLSDDQVLSQLESKKLC------------------------------------------WKHSSKTPEYITSLHEKCI 196 (223)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~~l 196 (223)
|...+..+....+...... .......++++.+++.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 9888766554433221000 0011223577899999999
Q ss_pred CCCCCCCCCHHHHHHH
Q psy15108 197 HPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 197 ~~dp~~Rps~~~ll~~ 212 (223)
+.||.+|||++|++++
T Consensus 314 ~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 314 EYDPAKRITLREALKH 329 (339)
T ss_dssp CSSTTTSCCHHHHTTS
T ss_pred CcCcccccCHHHHhcC
Confidence 9999999999999876
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=228.30 Aligned_cols=180 Identities=17% Similarity=0.174 Sum_probs=145.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee-cCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS-SDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~-~~~~~ 96 (223)
.+||||+. |+|.+.++.... ....+++..+..++.||++||.|||+.|++||||||+||+++ .++.+
T Consensus 114 ~lv~e~~~-~~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~ 181 (383)
T 3eb0_A 114 NVIMEYVP-DTLHKVLKSFIR-----------SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181 (383)
T ss_dssp EEEECCCS-EEHHHHHHHHHH-----------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEE
T ss_pred EEEEecCC-ccHHHHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcE
Confidence 37899998 588888876433 235699999999999999999999999999999999999998 57889
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ......++..|+|||.+.+.. ++.++||||+||++|+|+ +|..||.+.........+....
T Consensus 182 kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~ 258 (383)
T 3eb0_A 182 KLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI-LGKPLFSGETSIDQLVRIIQIM 258 (383)
T ss_dssp EECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHh
Confidence 999999997543332 223456788899999987654 899999999999999999 7999999887766555543210
Q ss_pred c---------------------------cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 L---------------------------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ....+...++++.+++.+||+.||.+|||+.|+++|
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 259 GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 001234578889999999999999999999999865
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=222.46 Aligned_cols=184 Identities=16% Similarity=0.250 Sum_probs=146.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+. |+|.+++...... .....+++..+..++.||++||.|||+.|++||||||+||+++.++.+
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~---------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~ 147 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVG---------NTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQL 147 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSS---------SCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred EEEEEEecC-CCHHHHHHhcccc---------ccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCE
Confidence 347889998 6999999876431 112358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......++..|+|||.+.+. .++.++||||+||++|+|+ +|..||.+....+....+....
T Consensus 148 kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~i~~~~ 225 (317)
T 2pmi_A 148 KLGDFGLARAFGIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTNDEEQLKLIFDIM 225 (317)
T ss_dssp EECCCSSCEETTSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHH
T ss_pred EECcCccceecCCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHh
Confidence 999999987543221 112345678899999998764 5899999999999999999 7999999888776666553310
Q ss_pred c--------------------------------cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 L--------------------------------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~--------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ........+.++.+++.+||+.||++|||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 001122567889999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=225.23 Aligned_cols=173 Identities=17% Similarity=0.238 Sum_probs=144.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+ +++|.++++. ..+++..+..++.||++||.|||+.|++||||||.||+++.++.++
T Consensus 106 ~lv~e~~-~~~L~~~~~~----------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH----------------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp EEEEECC-SEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred EEEEecC-CCCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEE
Confidence 4778888 8999999975 2489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||+++..... .....++..|+|||.+.+ ..++.++|+||+||++++|+ +|..||.+.+....+..+.....
T Consensus 169 l~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 169 ILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp ECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999754322 234567899999999876 67899999999999999999 79999998877665554432100
Q ss_pred c-----------------------------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 C-----------------------------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .......++.+.+++.+||+.||.+|||++++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 01124568889999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=224.20 Aligned_cols=187 Identities=21% Similarity=0.288 Sum_probs=146.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+++|+|.+++..... ..++++..++.++.|+++||.|||+.|++|+||+|.||+++.++.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 172 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCLDG------------TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTA 172 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTGGG------------CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCE
T ss_pred eEEEEEecCCCcHHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcE
Confidence 4488999999999999986433 2468999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ----VLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~----~~~~~ 171 (223)
+++|||++....... ........++..|+|||.+.+ .++.++|+||||+++|+|+ +|..||....... ....+
T Consensus 173 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~ 250 (307)
T 2nru_A 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEII-TGLPAVDEHREPQLLLDIKEEI 250 (307)
T ss_dssp EECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHH-HCCCSBCTTBSSSBTTHHHHHH
T ss_pred EEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHH-HCCCCcccCcchHHHHHHHHHh
Confidence 999999987543221 111233467889999998754 4788999999999999999 7999997654322 22222
Q ss_pred HhCc---------ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHh
Q psy15108 172 ESKK---------LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 172 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 217 (223)
.... .....+...++.+.+++.+||+.||.+||++++++++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 251 EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1110 011112334677899999999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=222.70 Aligned_cols=178 Identities=16% Similarity=0.208 Sum_probs=140.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+.+++|.++++..+ .+++..+..++.|+++||.|||+.|++|+||||.||+++.++.++
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~---------------~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k 142 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQR---------------GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIK 142 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSS---------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEeCCCchHHHHHhhhc---------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEE
Confidence 47899999999999987543 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++....... .......++..|+|||.+.+ ..++.++|+||+|+++++++ +|..||.+.........+.....
T Consensus 143 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 220 (311)
T 4agu_A 143 LCDFGFARLLTGPS-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLG 220 (311)
T ss_dssp ECCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EeeCCCchhccCcc-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhc
Confidence 99999997544322 12234567888999999875 56799999999999999999 79999998877665544332100
Q ss_pred -------------------cCCC----------CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 -------------------CWKH----------SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 -------------------~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+. ...++.++.+++.+||+.||.+|||++++++|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp SCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 13567889999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=221.22 Aligned_cols=179 Identities=17% Similarity=0.274 Sum_probs=149.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+.+|+|.+++...+ ..+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.++
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 165 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRN--------------KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAK 165 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHT--------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred EEEeecCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEE
Confidence 47899999999999998543 3699999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc-
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL- 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~- 176 (223)
++|||++....... .......++..|+|||.+.+..++.++|+||||+++|+|+ +|..||...........+.....
T Consensus 166 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~~ 243 (314)
T 3com_A 166 LADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA-EGKPPYADIHPMRAIFMIPTNPPP 243 (314)
T ss_dssp ECCCTTCEECBTTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred Eeecccchhhhhhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHhcCCCc
Confidence 99999987543321 1223456788899999998888999999999999999999 79999988877665555444322
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+..++..+.+++.+||+.||.+||++.+++++
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 222344578899999999999999999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=221.26 Aligned_cols=178 Identities=21% Similarity=0.220 Sum_probs=144.5
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|+||+.+|+|.+++... ..+++..+..++.|+++||.|||+.|++|+||+|.||+++.++.+++
T Consensus 82 lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 146 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPD---------------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKI 146 (276)
T ss_dssp EEEECCTTEEGGGGSBTT---------------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCcHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEE
Confidence 789999999999998643 34999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhh-hhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhCc
Q psy15108 99 SLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLSQLESKK 175 (223)
Q Consensus 99 ~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~~~~~~~ 175 (223)
+|||.+....... ........++..|+|||.+.+..+ +.++|+||+|+++++++ +|..||...... ..........
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~ 225 (276)
T 2yex_A 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML-AGELPWDQPSDSCQEYSDWKEKK 225 (276)
T ss_dssp CCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHH-HSSCCCSCSCTTSHHHHHHHTTC
T ss_pred eeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCchHHHHHHHhhhcc
Confidence 9999987543222 111234567888999999987665 67899999999999999 799999876543 2333333332
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........++..+.+++.+||+.||.+||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 2233334678999999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=217.57 Aligned_cols=174 Identities=20% Similarity=0.193 Sum_probs=140.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC----
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD---- 93 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~---- 93 (223)
.+|+||+++|+|.+++..... ....+++..++.++.|+++||.|||++|++|+||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~ 155 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYR-----------IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPN 155 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHH-----------HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------
T ss_pred EEEEEecCCCcHHHHHHhhcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCc
Confidence 378999999999999987643 22458999999999999999999999999999999999999843
Q ss_pred ---------------CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCC
Q psy15108 94 ---------------LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEM 157 (223)
Q Consensus 94 ---------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~ 157 (223)
..++++|||.+...... ....++..|+|||.+.+. .++.++||||||+++++++ ++..
T Consensus 156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~~~~ 229 (289)
T 1x8b_A 156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA-GAEP 229 (289)
T ss_dssp --------------CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHT-TCCC
T ss_pred ccccccccccccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHh-cCCC
Confidence 47899999998754332 234578899999998765 4567999999999999998 6765
Q ss_pred CCCCCCHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 158 PFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 158 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
++.... ....+... .....+..+++++.+++.+||+.||.+||++.++++|
T Consensus 230 ~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 230 LPRNGD---QWHEIRQG-RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CCSSSH---HHHHHHTT-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCcchh---HHHHHHcC-CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 554332 23333343 3344566789999999999999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=223.64 Aligned_cols=179 Identities=18% Similarity=0.269 Sum_probs=141.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+. |+|.+++...+. .+++..+..++.|++.||.|||+.|++||||||.||+++.++.+
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~ 139 (324)
T 3mtl_A 75 LTLVFEYLD-KDLKQYLDDCGN--------------IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGEL 139 (324)
T ss_dssp EEEEEECCS-EEHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCE
T ss_pred EEEEecccc-cCHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCE
Confidence 347889987 699999987543 58999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......++..|+|||.+.+ ..++.++||||+|+++|+|+ +|..||.+....+....+....
T Consensus 140 kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~i~~~~ 217 (324)
T 3mtl_A 140 KLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA-TGRPLFPGSTVEEQLHFIFRIL 217 (324)
T ss_dssp EECSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEccCcccccccCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHh
Confidence 999999987543222 12234567889999999876 56899999999999999999 7999999888776666554311
Q ss_pred ccC----------------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCW----------------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+ .....+++++.+++.+||+.||.+|||++|+++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 100 0012457889999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=224.68 Aligned_cols=187 Identities=11% Similarity=0.113 Sum_probs=147.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec----
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---- 92 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~---- 92 (223)
..+||||+.+|+|.++++..+. .....+++..++.++.||+.||.|||+.|++||||||+||+++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKN----------TPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHT----------STTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred cEEEEeccCCCcHHHHHHHhhc----------ccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 3489999999999999986543 12346999999999999999999999999999999999999998
Q ss_pred -------CCCeEEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Q psy15108 93 -------DLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD 164 (223)
Q Consensus 93 -------~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~ 164 (223)
.+.++|+|||+++...... ........++..|+|||.+.+..++.++|||||||++|+|+ +|..||.....
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~ 290 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML-FGTYMKVKNEG 290 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHH-HSSCCCEEEET
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHH-hCCCccccCCC
Confidence 8999999999996543211 11234567899999999999988999999999999999999 78888854322
Q ss_pred HHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHHHhhhc
Q psy15108 165 DQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQR-PTFPSIVTQLSDAMCND 220 (223)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R-ps~~~ll~~L~~~~~~~ 220 (223)
... ...........++.+.+++..|++.+|.+| |+++++.+.|++.+...
T Consensus 291 ~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 291 GEC------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp TEE------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred Cce------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 100 000011112347788999999999999998 57888888888877653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=227.50 Aligned_cols=178 Identities=13% Similarity=0.230 Sum_probs=123.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC---C
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD---L 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~---~ 94 (223)
.+||||+.+|+|.+++...+. ..+++..++.++.|++.||.|||+.|++|+||||.||+++.+ +
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~-------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD-------------QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C-------------CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTC
T ss_pred EEEEeccCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCc
Confidence 478999999999999986533 469999999999999999999999999999999999999764 4
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH----H
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS----Q 170 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~----~ 170 (223)
.++++|||++....... .....+++.|+|||.+....++.++||||+|+++|+|+ +|..||.......... .
T Consensus 169 ~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~~ 244 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL-CGFPPFYSNTGQAISPGMKRR 244 (336)
T ss_dssp CEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHH-HSSCCC---------------
T ss_pred eEEEeccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHH-HCCCCCCCccchhhhhhHHHh
Confidence 59999999987544322 23456688899999998888889999999999999999 7999997665443321 1
Q ss_pred HHhCcc--cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKKL--CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+..... ..+....+++++.+++.+||+.||.+|||+++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 245 IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 211111 122235678999999999999999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=224.85 Aligned_cols=169 Identities=18% Similarity=0.261 Sum_probs=141.7
Q ss_pred CCCCCCCCCC-ChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKG-DLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.+|+||+.+| +|.+++...+ .+++..+..++.|++.||.|||+.|++||||||.||+++.++.+
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~---------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 169 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHP---------------RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTI 169 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCC---------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE
T ss_pred EEEEEeCCCCccHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcE
Confidence 3789999777 9999998643 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... ......+++.|+|||.+.+..+ +.++||||+|+++|+|+ +|..||...... ..
T Consensus 170 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~------~~-- 238 (335)
T 3dls_A 170 KLIDFGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV-FEENPFCELEET------VE-- 238 (335)
T ss_dssp EECCCTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHH-HSSCSCSSGGGG------TT--
T ss_pred EEeecccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHH-hCCCchhhHHHH------Hh--
Confidence 999999987554332 1234567899999999987776 78899999999999999 799999763321 11
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+..+++++.+++.+||+.||++||++++++++
T Consensus 239 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223345678999999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=220.58 Aligned_cols=180 Identities=19% Similarity=0.271 Sum_probs=146.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++..... .+++..+..++.|+++||.|||+.|++|+||+|.||+++.++.+
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 156 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDR--------------GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDI 156 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTS--------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCE
T ss_pred EEEEEEeCCCCcHHHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCE
Confidence 3478999999999999986533 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccc-----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAV-----FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-----~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++...... ........++..|+|||.+ ....++.++|+||||+++|+|+ +|..||...+.......+
T Consensus 157 kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~ 234 (302)
T 2j7t_A 157 RLADFGVSAKNLKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKI 234 (302)
T ss_dssp EECCCHHHHHHHHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHH
T ss_pred EEEECCCCcccccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHh-cCCCCCccCCHHHHHHHH
Confidence 99999987533221 1122345678899999997 3566889999999999999999 799999988877766665
Q ss_pred HhCccc-CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKLC-WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... ...+..++.++.+++.+||+.||.+||+++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 235 AKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred hccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 554322 23345678899999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=222.83 Aligned_cols=182 Identities=19% Similarity=0.285 Sum_probs=129.7
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCCCCCeeeecCCCe
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR--LIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~~~nil~~~~~~~ 96 (223)
+++||+. |+|.++++.... ...+++..++.++.||+.||.|||+.+ ++|+||||.||+++.++.+
T Consensus 111 lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 111 LLTELCK-GQLVEFLKKMES------------RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp EEEECCS-EEHHHHHHHHHT------------TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred EEEEecC-CCHHHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 6677775 899999986432 246999999999999999999999999 9999999999999999999
Q ss_pred EEcCCCCCcccchhhhh-----------hhhcCCccccccccccc---ccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q psy15108 97 KISLSGLSKDTYQKEYY-----------KYRNAILPLRWLPYEAV---FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL 162 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~-----------~~~~~~~~~~~~~pe~~---~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~ 162 (223)
+|+|||++......... ......++..|+|||.+ ....++.++||||||+++|+|+ +|..||...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~-~g~~p~~~~ 256 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC-FRQHPFEDG 256 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHH-HSSCCC---
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH-hCCCCCcch
Confidence 99999998765432110 11234578889999998 4566888999999999999999 799999765
Q ss_pred CHHHHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 163 SDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
....... .....+.....+..+.+++.+||+.||.+||++.+++++|+.+..
T Consensus 257 ~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 257 AKLRIVN----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHhhc----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5433322 223334455667789999999999999999999999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=217.12 Aligned_cols=176 Identities=21% Similarity=0.319 Sum_probs=147.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC---C
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD---L 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~---~ 94 (223)
.+++||+.+++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||+|.||+++.+ +
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~ 161 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRK---------------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDC 161 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEEEEccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcc
Confidence 37899999999999998654 49999999999999999999999999999999999999754 4
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++++|||++....... ......++..|+|||.+.+ .++.++|+||+|+++++|+ +|..||.+.........+...
T Consensus 162 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~ 237 (287)
T 2wei_A 162 DIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL-SGTPPFYGKNEYDILKRVETG 237 (287)
T ss_dssp CEEECSTTGGGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHC
T ss_pred cEEEeccCcceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcC
Confidence 69999999886543321 1122345778999999865 4889999999999999999 799999998888887777766
Q ss_pred cccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... ...+++++.+++.+||+.||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 443332 25678999999999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=223.23 Aligned_cols=175 Identities=18% Similarity=0.285 Sum_probs=141.4
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee--------
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI-------- 90 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~-------- 90 (223)
+||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.|++||||||.||++
T Consensus 99 lv~e~~-~~~l~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNF-------------QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTT-------------CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EEEecc-CCChHHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 778888 7888888876543 469999999999999999999999999999999999999
Q ss_pred -----------ecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCC
Q psy15108 91 -----------SSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPF 159 (223)
Q Consensus 91 -----------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~ 159 (223)
+..+.++++|||++...... .....++..|+|||.+.+..++.++|+||+|+++|+|+ +|..||
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~pf 239 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY-RGFTLF 239 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSC
T ss_pred ccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH-hCCCCC
Confidence 66788999999998753222 23457789999999999889999999999999999999 799999
Q ss_pred CCCCHHHHHHHHHhCccc---------------------C---------------------CCCCCChHHHHHHHHHhcC
Q psy15108 160 PDLSDDQVLSQLESKKLC---------------------W---------------------KHSSKTPEYITSLHEKCIH 197 (223)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~---------------------~---------------------~~~~~~~~~~~~li~~~l~ 197 (223)
...........+...... + ......+.++.+++.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 988766554443221000 0 0111224578899999999
Q ss_pred CCCCCCCCHHHHHHH
Q psy15108 198 PHPHQRPTFPSIVTQ 212 (223)
Q Consensus 198 ~dp~~Rps~~~ll~~ 212 (223)
.||.+|||++++++|
T Consensus 320 ~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 320 FDPAQRITLAEALLH 334 (355)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999999865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=222.89 Aligned_cols=177 Identities=19% Similarity=0.238 Sum_probs=137.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee-----c
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS-----S 92 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~-----~ 92 (223)
.+||||+. |+|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+||+++ .
T Consensus 109 ~lv~e~~~-~~L~~~~~~~~---------------~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~ 172 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKNP---------------DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASE 172 (329)
T ss_dssp EEEEECCS-EEHHHHHHHCT---------------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----
T ss_pred EEEEecCC-CCHHHHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCc
Confidence 37889988 59999998754 499999999999999999999999999999999999995 4
Q ss_pred CCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 93 DLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 93 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
.+.++|+|||++....... .......++..|+|||.+.+.. ++.++||||+||++|+|+ +|..||.+.........+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~ 250 (329)
T 3gbz_A 173 TPVLKIGDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKI 250 (329)
T ss_dssp CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHH
T ss_pred cceEEECcCCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH-HCCCCcCCCCHHHHHHHH
Confidence 4559999999986543221 1223446688999999987644 799999999999999999 799999988877666555
Q ss_pred HhCcccCCC----------------------------CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKLCWKH----------------------------SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~----------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
......+.. ...+++++.+++.+||+.||.+|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 432110000 01156889999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=233.36 Aligned_cols=174 Identities=16% Similarity=0.218 Sum_probs=135.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.++ |.+.+. ..+++..+..++.||+.||.|||+.|++||||||.||+++.++.+|
T Consensus 143 ~lv~E~~~~~-l~~~~~-----------------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 143 YLVMELMDAN-LCQVIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp EEEEECCSEE-HHHHHT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCCCC-HHHHHh-----------------hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEE
Confidence 4788888765 666663 2489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
|+|||+++...... ......+++.|+|||.+.+..++.++||||+||++|+|+ +|+.||.+.+....+..+......
T Consensus 205 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 205 ILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp ECCCCCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999997543321 223457789999999999999999999999999999999 799999988876655554331000
Q ss_pred C-------------------CCCCC---------------------ChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 W-------------------KHSSK---------------------TPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ~-------------------~~~~~---------------------~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+ +.... .++++.+|+.+||+.||++|||++|+++|
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000 04678999999999999999999999976
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=217.21 Aligned_cols=179 Identities=18% Similarity=0.209 Sum_probs=149.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+| |.+++..... ..+++..+..++.|+++||.|||+.|++|+||+|.||+++.++.+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~-------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~ 148 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE-------------KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTL 148 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT-------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred EEEEehhccCC-HHHHHHhCcc-------------cccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcE
Confidence 34788999877 8888876433 469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCC--CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEF--STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~--~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+++|||++....... ........++..|+|||.+.+... +.++|+||+|+++|+|+ +|..||.+....+....+..
T Consensus 149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~i~~ 227 (305)
T 2wtk_C 149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNIT-TGLYPFEGDNIYKLFENIGK 227 (305)
T ss_dssp EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHH
T ss_pred EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHH-hCCCCCCCchHHHHHHHHhc
Confidence 999999987543221 111234567889999999876443 67899999999999999 79999999888888777766
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. ...+..+++.+.+++.+||+.||.+||++++++++
T Consensus 228 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 228 GS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 53 33456789999999999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=217.72 Aligned_cols=177 Identities=18% Similarity=0.288 Sum_probs=139.5
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++|| +.+++|.+++...+ .+++..+..++.|+++||.|||+.|++|+||+|.||+++. +.+++
T Consensus 105 lv~e-~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKK---------------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEE
T ss_pred EEEe-cCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEE
Confidence 6677 78899999998653 4899999999999999999999999999999999999964 78999
Q ss_pred cCCCCCcccchhhh-hhhhcCCccccccccccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCC-HH
Q psy15108 99 SLSGLSKDTYQKEY-YKYRNAILPLRWLPYEAVFD-----------DEFSTKSDVYAYACLIWEIFNKGEMPFPDLS-DD 165 (223)
Q Consensus 99 ~df~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-----------~~~~~~~Di~slG~il~~l~~~~~~p~~~~~-~~ 165 (223)
+|||++........ .......++..|+|||.+.. ..++.++||||||+++|+|+ +|..||.... ..
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~~~ 246 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIINQI 246 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHH-HSSCTTTTCCSHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHH-hCCCchhhHHHHH
Confidence 99999976543321 12234567899999999865 36788999999999999999 7999997654 33
Q ss_pred HHHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15108 166 QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213 (223)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L 213 (223)
.....+.........+...+.++.+++.+||+.||.+||++++++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 444444444444555667789999999999999999999999999763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=225.55 Aligned_cols=179 Identities=17% Similarity=0.249 Sum_probs=138.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|||||.+|+|.++++.... ....++..++.++.|++.||.|||+.|++||||||.||+++.++.++
T Consensus 137 ~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 204 (332)
T 3qd2_B 137 YIQMQLCRKENLKDWMNRRCS------------LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK 204 (332)
T ss_dssp EEEEECCCSSCHHHHHHTCCS------------GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred EEEEEecCCCCHHHHHhcccC------------ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEE
Confidence 488999999999999986533 23467788999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh-----------hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy15108 98 ISLSGLSKDTYQKE-----------YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166 (223)
Q Consensus 98 l~df~~~~~~~~~~-----------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~ 166 (223)
++|||++....... ........+++.|+|||.+.+..++.++|+||+|+++|+|+ ++..|+.. ...
T Consensus 205 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~~~~~~~~--~~~ 281 (332)
T 3qd2_B 205 VGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL-YSFSTQME--RVR 281 (332)
T ss_dssp ECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHH-SCCCCHHH--HHH
T ss_pred EeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHH-HcCCChhH--HHH
Confidence 99999987654322 11223456889999999999889999999999999999999 66554321 122
Q ss_pred HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 167 VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+.... ........++++.+++.+||+.||.+||++++++++
T Consensus 282 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 282 IITDVRNLK-FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHTTC-CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHhhccC-CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 222222221 111112345678999999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=230.78 Aligned_cols=177 Identities=19% Similarity=0.243 Sum_probs=137.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC---
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL--- 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~--- 94 (223)
.+||||+.+|+|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++..+
T Consensus 215 ~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~ 279 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGN---------------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDC 279 (419)
T ss_dssp EEEEECCTTCBGGGGTSSS---------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSC
T ss_pred EEEEEcCCCCcHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcc
Confidence 3789999999999988643 3599999999999999999999999999999999999997544
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD---DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLSQ 170 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~~ 170 (223)
.++++|||++....... ......+++.|+|||.+.. ..++.++|+||+|+++|+|+ +|..||...... .....
T Consensus 280 ~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~~ 356 (419)
T 3i6u_A 280 LIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL-SGYPPFSEHRTQVSLKDQ 356 (419)
T ss_dssp CEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHH-HSSCSSCCCSSSCCHHHH
T ss_pred eEEEeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHH-HCCCCCCCCcchHHHHHH
Confidence 49999999997654332 2234567899999999853 55788999999999999999 799999765432 33344
Q ss_pred HHhCcccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKKLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+........ ....+++.+.+++.+||+.||.+||+++++++|
T Consensus 357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 444322221 124578899999999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=218.19 Aligned_cols=188 Identities=20% Similarity=0.237 Sum_probs=144.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++...... +......+++..++.++.|++.||.|||+.|++|+||+|.||+++.++.+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAK-------GEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHT-------TTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCE
T ss_pred cEEEehhccCCchHHHHHHHhhc-------cccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCE
Confidence 34789999999999999864321 11123469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh----hhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKE----YYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
+++|||++....... ........++..|+|||.+.. ..++.++|+||+|+++|+|+ +|..||............
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~ 239 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA-TGAAPYHKYPPMKVLMLT 239 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH-HSSCTTTTSCGGGHHHHH
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH-hCCCCCccCchhhHHHHH
Confidence 999999876543221 111234467888999999865 56889999999999999999 799999887765554443
Q ss_pred HhCccc--------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKLC--------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... ......++.++.+++.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 332111 11234578899999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=230.31 Aligned_cols=188 Identities=14% Similarity=0.199 Sum_probs=148.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee----ecC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI----SSD 93 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~----~~~ 93 (223)
.+||||+.+|+|.++++.... ...+++..++.++.||+.||.|||+.|++||||||.||++ +..
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 152 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSN------------AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ 152 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGG------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSC
T ss_pred EEEEecCCCCCHHHHHHhhhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCc
Confidence 488999999999999976533 1349999999999999999999999999999999999998 666
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCccccccccccccc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCC--
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD--------DEFSTKSDVYAYACLIWEIFNKGEMPFPDLS-- 163 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slG~il~~l~~~~~~p~~~~~-- 163 (223)
+.++++|||++....... ......++..|+|||.+.. ..++.++|||||||++|+|+ +|..||....
T Consensus 153 ~~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~-tg~~Pf~~~~~~ 229 (396)
T 4eut_A 153 SVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA-TGSLPFRPFEGP 229 (396)
T ss_dssp EEEEECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHH-HSSCSEECTTCT
T ss_pred eeEEEecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHH-HCCCCCCCCCcc
Confidence 779999999997654432 2234568899999999764 45678999999999999999 7999996432
Q ss_pred --HHHHHHHHHhCcccC-------------------C----CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 164 --DDQVLSQLESKKLCW-------------------K----HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 164 --~~~~~~~~~~~~~~~-------------------~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
..+....+..+.+.. + ....++..+.+++.+||+.||++||+++++++.+.+++.
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 234444444332110 0 112245678899999999999999999999999999886
Q ss_pred hc
Q psy15108 219 ND 220 (223)
Q Consensus 219 ~~ 220 (223)
..
T Consensus 310 ~~ 311 (396)
T 4eut_A 310 RM 311 (396)
T ss_dssp CE
T ss_pred ce
Confidence 53
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=226.10 Aligned_cols=179 Identities=18% Similarity=0.226 Sum_probs=141.1
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC-CCeE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD-LSVK 97 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~-~~~~ 97 (223)
+|+||+.+ +|.+++..... ....+++..+..++.||++||.|||+.|++||||||.||+++.+ +.+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~~-----------~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~k 197 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSR-----------AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 197 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHH-----------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEE
T ss_pred eehhcccc-cHHHHHHHHhh-----------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEE
Confidence 68888885 67777764322 22469999999999999999999999999999999999999965 5689
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC--
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK-- 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~-- 174 (223)
|+|||+++...... ......++..|+|||.+.+. .++.++||||+||++|+|+ +|..||.+.+....+..+...
T Consensus 198 l~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~G~~pf~~~~~~~~l~~i~~~lg 274 (420)
T 1j1b_A 198 LCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIKVLG 274 (420)
T ss_dssp ECCCTTCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eccchhhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999997543322 12345678899999998764 6899999999999999999 799999988765554443321
Q ss_pred ---------------cccCC----------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 ---------------KLCWK----------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ---------------~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+ .....++++.+|+.+||+.||.+||++.|+++|
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00010 123467889999999999999999999999876
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=225.04 Aligned_cols=179 Identities=17% Similarity=0.167 Sum_probs=141.0
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee-cCCCeE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS-SDLSVK 97 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~-~~~~~~ 97 (223)
+||||+.++.+..+...... ...+++..+..++.||++||.|||+.|++||||||+||+++ .++.++
T Consensus 115 lv~e~~~~~l~~~~~~~~~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKL------------KQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHT------------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred EEeeccCccHHHHHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEE
Confidence 78899887654444432211 24699999999999999999999999999999999999999 788999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc-
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK- 175 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~- 175 (223)
++|||+++...... ......++..|+|||.+.+. .++.++||||+||++|+|+ +|..||.+.+....+..+....
T Consensus 183 L~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~l~~i~~~~g 259 (394)
T 4e7w_A 183 LIDFGSAKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM-QGQPLFPGESGIDQLVEIIKVLG 259 (394)
T ss_dssp ECCCTTCEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EeeCCCcccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999997543322 22345678899999998765 4899999999999999999 7999999888765554443210
Q ss_pred -------------c---c----------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 -------------L---C----------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 -------------~---~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. . .......++++.+++.+||+.||.+||++.++++|
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 0 00123477899999999999999999999999876
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=222.51 Aligned_cols=178 Identities=23% Similarity=0.319 Sum_probs=140.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||.||+++.++.++
T Consensus 100 ~lv~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~k 164 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFP---------------NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVK 164 (331)
T ss_dssp EEEEECCSEEHHHHHHHST---------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEecCCcchHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEE
Confidence 3789999999999987654 3499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc-
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK- 175 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~- 175 (223)
++|||++....... .......++..|+|||.+.+. .++.++||||+|+++|+|+ +|..||.+.........+....
T Consensus 165 l~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~ 242 (331)
T 4aaa_A 165 LCDFGFARTLAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF-MGEPLFPGDSDIDQLYHIMMCLG 242 (331)
T ss_dssp ECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEeCCCceeecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhC
Confidence 99999987543322 122345678889999998765 6889999999999999999 7999998887665544432210
Q ss_pred ------------------ccCC----------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ------------------LCWK----------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ------------------~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+ ....+++++.+++.+||+.||.+||+++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp SCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 013568899999999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=216.12 Aligned_cols=181 Identities=19% Similarity=0.254 Sum_probs=143.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-CCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS-DLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~-~~~~ 96 (223)
.+|+||+++++|.+++..... ...+++..+..++.|++.||.|||+.|++|+||+|.||+++. ++.+
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~ 162 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWG------------PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVL 162 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTC------------CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCE
T ss_pred EEEEEeCCCCCHHHHHHhhcc------------CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCE
Confidence 378999999999999986532 135789999999999999999999999999999999999997 7899
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE--FSTKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~~~~~ 173 (223)
+++|||++........ ......++..|+|||.+.... ++.++|+||||+++|+|+ +|..||...... ........
T Consensus 163 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~~ 240 (295)
T 2clq_A 163 KISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA-TGKPPFYELGEPQAAMFKVGM 240 (295)
T ss_dssp EECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHH-HTSCTTGGGSSHHHHHHHHHH
T ss_pred EEeecccccccCCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHH-HCCCCccCCCchhHHHHhhcc
Confidence 9999999875433221 123456788999999987543 788999999999999999 699999755432 22222222
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.......+..++.++.+++.+||+.||++||++++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 223344566789999999999999999999999999865
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=222.58 Aligned_cols=179 Identities=18% Similarity=0.213 Sum_probs=144.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+ +|.+++.... ..+++..+..++.|+++||.|||+.|++||||||.||+++.++.+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS--------------LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC--------------SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred eEEEEEcCCC-CHHHHHHhcC--------------cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCE
Confidence 4478888886 8999987543 358999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++....... .......++..|+|||.+.+. .++.++||||+||++|+|+ +|..||.+.........+....
T Consensus 152 kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~~~~~~~~~~~~~~i~~~~ 229 (346)
T 1ua2_A 152 KLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL-LRVPFLPGDSDLDQLTRIFETL 229 (346)
T ss_dssp EECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHH-HCCCCCCCCCHHHHHHHHHHHc
Confidence 999999987543221 122345678899999998654 4788999999999999999 6999999888776666554321
Q ss_pred cc-----CC---------------------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LC-----WK---------------------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~-----~~---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. ++ .....++++.+++.+||+.||.+|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 10 00 013456889999999999999999999999876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=224.39 Aligned_cols=178 Identities=15% Similarity=0.197 Sum_probs=147.9
Q ss_pred CCCCCCCCCCChHHH------HHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeee
Q psy15108 18 SGSGKPRVKGDLKQF------LLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLI 90 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~------l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~ 90 (223)
.+||||+.+|+|.++ +... ....+++..++.++.|++.||.|||+ .|++|+||+|.||++
T Consensus 119 ~lv~e~~~~~~L~~~~~~~~~l~~~-------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 119 YIIYEYMENDSILKFDEYFFVLDKN-------------YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp EEEEECCTTCBSSEESSSEESSCSS-------------SCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEeccCCCcHHHHHHHhhhhhhc-------------cccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 378999999999998 4331 13569999999999999999999999 999999999999999
Q ss_pred ecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCc-ccchHHHHHHHHHHHhCCCCCCCCCCH-HHH
Q psy15108 91 SSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFST-KSDVYAYACLIWEIFNKGEMPFPDLSD-DQV 167 (223)
Q Consensus 91 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~-~~Di~slG~il~~l~~~~~~p~~~~~~-~~~ 167 (223)
+.++.++++|||.+...... ......++..|+|||.+.+. .++. ++|+||+|+++++|+ +|..||..... .+.
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF-YNVVPFSLKISLVEL 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH-HSSCSSCCSSCSHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH-hCCCCCCCCCcHHHH
Confidence 99999999999998764332 23445678899999999877 5555 899999999999999 79999987776 666
Q ss_pred HHHHHhCcccCCCC-----------------CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 168 LSQLESKKLCWKHS-----------------SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~~~~~~~-----------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+.......+.. ..++.++.+++.+||+.||.+||+++++++|
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 66666554333321 5678999999999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=224.19 Aligned_cols=175 Identities=17% Similarity=0.139 Sum_probs=141.4
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCcccCCCCCCCeeee--cCC
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHIS--DKRLIHKDIAARNCLIS--SDL 94 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~~~nil~~--~~~ 94 (223)
+||||+. |+|.+++..... ..+++..+..++.|++.||.||| +.|++||||||+||+++ .++
T Consensus 133 lv~e~~~-~~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNF-------------RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTT-------------SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred EEEecCC-CCHHHHHhhcCc-------------CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 7889885 699999987643 45999999999999999999999 47999999999999995 467
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++|+|||++...... .....+++.|+|||.+.+..++.++|||||||++|+|+ +|..||.+.+..+.+..+...
T Consensus 199 ~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-tg~~pf~~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH-TGEPLFSGANEVDQMNKIVEV 273 (382)
T ss_dssp CEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHH
T ss_pred cEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHH
Confidence 8999999999755322 23457788999999999889999999999999999999 799999988877666555431
Q ss_pred cccCC-----------------------------------CC--C-------------------------CChHHHHHHH
Q psy15108 175 KLCWK-----------------------------------HS--S-------------------------KTPEYITSLH 192 (223)
Q Consensus 175 ~~~~~-----------------------------------~~--~-------------------------~~~~~~~~li 192 (223)
...++ .+ . ...+++.+|+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 353 (382)
T 2vx3_A 274 LGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353 (382)
T ss_dssp HCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred hCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence 10000 00 0 0014689999
Q ss_pred HHhcCCCCCCCCCHHHHHHH
Q psy15108 193 EKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 193 ~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+||+.||++|||++|+++|
T Consensus 354 ~~mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 354 LRMLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HHHTCSCTTTSCCHHHHTTS
T ss_pred HHhcCCChhhCCCHHHHhcC
Confidence 99999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-33 Score=222.19 Aligned_cols=176 Identities=17% Similarity=0.247 Sum_probs=141.7
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|++|+. |+|.++++. ..+++..+..++.|++.||.|||+.|++||||||.||+++.++.+++
T Consensus 107 iv~e~~~-~~L~~~l~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT----------------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp EEEECCS-EEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEcccC-cCHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEE
Confidence 6677776 699999975 25899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhh--hhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 99 SLSGLSKDTYQKEYY--KYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 99 ~df~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+|||++......... ......+++.|+|||.+.+ ..++.++||||+|+++|+|+ +|..||.+.........+....
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~~~ 248 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGIL 248 (364)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHH-HSSCSSCCSSGGGHHHHHHHHH
T ss_pred EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHH-HCCCCCCCCChHHHHHHHHHHh
Confidence 999999765433211 1234578899999998654 44899999999999999999 7999998877665554443210
Q ss_pred cc--------------------C---------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LC--------------------W---------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~--------------------~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. . ......+.++.+++.+||+.||.+|||++++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0 0114567889999999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=223.37 Aligned_cols=174 Identities=17% Similarity=0.240 Sum_probs=133.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+. |+|.+++.. .+++..+..++.||+.||.|||+.|++||||||+||+++.++.++
T Consensus 106 ~lv~e~~~-~~l~~~~~~-----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 106 YIVMELMD-ANLCQVIQM-----------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp EEEEECCS-EEHHHHHHS-----------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred EEEEEcCC-CCHHHHHhh-----------------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEE
Confidence 47888887 578888852 489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++....... ......++..|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+....+..+......
T Consensus 168 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 168 ILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp ECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999997553322 223456788999999999888999999999999999999 799999988876665554432100
Q ss_pred C--------------------C--------------CCC------CChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 W--------------------K--------------HSS------KTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ~--------------------~--------------~~~------~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+ . .+. ..+.++.+++.+||+.||.+|||++++++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 0 000 015678999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.6e-33 Score=220.60 Aligned_cols=179 Identities=18% Similarity=0.234 Sum_probs=142.6
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+ +|.+.+.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++
T Consensus 100 ~lv~e~~~~-~l~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~k 164 (351)
T 3mi9_A 100 YLVFDFCEH-DLAGLLSNVL--------------VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 164 (351)
T ss_dssp EEEEECCSE-EHHHHHHCTT--------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEeccCC-CHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEE
Confidence 378899885 8888886543 3599999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh---hhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 98 ISLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 98 l~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
++|||++....... ........+++.|+|||.+.+ ..++.++||||+||++|+|+ +|..||.+.........+..
T Consensus 165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW-TRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHH
T ss_pred EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHH
Confidence 99999987543211 112234567889999999875 45799999999999999999 79999998887766665543
Q ss_pred CcccC--CCCCC----------------------------ChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCW--KHSSK----------------------------TPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~--~~~~~----------------------------~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ..... .++++.+++.+||+.||.+|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 21111 11011 15678999999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=214.34 Aligned_cols=177 Identities=18% Similarity=0.236 Sum_probs=136.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+.+|+|.+++...+. .+++..++.++.|+++||.|||+.|++|+||+|.||+++.++.++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 91 FIQMEYCENGTLYDLIHSENL--------------NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp EEEEECCCSCBHHHHHHHSCG--------------GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred EEEEecCCCCCHHHhhhcccc--------------ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence 378999999999999986543 588999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh-------------hhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCC-
Q psy15108 98 ISLSGLSKDTYQKE-------------YYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDL- 162 (223)
Q Consensus 98 l~df~~~~~~~~~~-------------~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~- 162 (223)
++|||++....... ........++..|+|||.+.+. .++.++|+||+|+++|+|+ + ||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~---p~~~~~ 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-Y---PFSTGM 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHH-S---CCSSHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHH-h---ccCCch
Confidence 99999987543211 1112345678889999998754 6889999999999999999 4 55432
Q ss_pred CHHHHHHHHHhCcc--cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 163 SDDQVLSQLESKKL--CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 163 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........+..... ....+...+..+.+++.+||+.||.+||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 23334444443322 222345667889999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=225.56 Aligned_cols=179 Identities=18% Similarity=0.281 Sum_probs=131.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+ +|+|.++++.. ..+++..+..++.||+.||.|||+.|++||||||.||+++.++.+|
T Consensus 133 ~lv~e~~-~~~L~~~~~~~---------------~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~k 196 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP---------------VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVK 196 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS---------------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEE
T ss_pred EEEEecc-ccchhhhcccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEe
Confidence 3778875 68999999754 3499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhh--------------------------hhhhhcCCccccccccccc-ccCCCCcccchHHHHHHHHH
Q psy15108 98 ISLSGLSKDTYQKE--------------------------YYKYRNAILPLRWLPYEAV-FDDEFSTKSDVYAYACLIWE 150 (223)
Q Consensus 98 l~df~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slG~il~~ 150 (223)
|+|||+++...... ........+|+.|+|||++ ....++.++||||+||++||
T Consensus 197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 99999997643211 0122345678999999986 45668999999999999999
Q ss_pred HHhC----------CCCCCCCCCH--------------------HHHHHHHHh-----------------------Cc--
Q psy15108 151 IFNK----------GEMPFPDLSD--------------------DQVLSQLES-----------------------KK-- 175 (223)
Q Consensus 151 l~~~----------~~~p~~~~~~--------------------~~~~~~~~~-----------------------~~-- 175 (223)
|++. +..+|.+... ...+..+.. ..
T Consensus 277 lltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 356 (458)
T 3rp9_A 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPK 356 (458)
T ss_dssp HHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCC
T ss_pred HHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCC
Confidence 9931 5666655431 011111100 00
Q ss_pred ----ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ----LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
......+..++++.+|+.+||+.||.+|||++|+++|
T Consensus 357 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 357 REGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0001123458889999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-33 Score=221.75 Aligned_cols=177 Identities=16% Similarity=0.216 Sum_probs=137.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+. |+|.+++...+ ..+++..+..++.||+.||.|||+.|++|+||||.||+++.++.++
T Consensus 110 ~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 110 YLVTELMR-TDLAQVIHDQR--------------IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEEEECCS-EEHHHHHHCTT--------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred EEEEccCC-CCHHHHHHhcc--------------cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 37788888 79999997543 3699999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++....... ......++..|+|||.+.+ ..++.++||||+|+++|+|+ +|..||.+.........+.....
T Consensus 175 l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 175 ICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp ECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHcC
Confidence 99999987443322 2234567888999999876 56899999999999999999 79999998877666555432100
Q ss_pred cC------------------------------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 CW------------------------------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~~------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+ ......++.+.+++.+||+.||.+|||++++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00 0123457889999999999999999999999876
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=223.32 Aligned_cols=178 Identities=19% Similarity=0.285 Sum_probs=132.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|+||+. |+|.++++.. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++
T Consensus 106 ~lv~e~~~-~~L~~~~~~~---------------~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~k 169 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTP---------------IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVK 169 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS---------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred EEEEecCC-cCHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEE
Confidence 37788766 6999999754 3499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhh---------------------hhhhcCCccccccccccc-ccCCCCcccchHHHHHHHHHHHhC-
Q psy15108 98 ISLSGLSKDTYQKEY---------------------YKYRNAILPLRWLPYEAV-FDDEFSTKSDVYAYACLIWEIFNK- 154 (223)
Q Consensus 98 l~df~~~~~~~~~~~---------------------~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slG~il~~l~~~- 154 (223)
|+|||+++....... .......++..|+|||.+ ....++.++||||+||++|+|+ +
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell-~g 248 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL-NM 248 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH-TT
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH-hc
Confidence 999999976543221 112456789999999986 4566899999999999999999 4
Q ss_pred ----------CCCCCCCCCH-----------------HHH------------------------HHHHHhCcccCC----
Q psy15108 155 ----------GEMPFPDLSD-----------------DQV------------------------LSQLESKKLCWK---- 179 (223)
Q Consensus 155 ----------~~~p~~~~~~-----------------~~~------------------------~~~~~~~~~~~~---- 179 (223)
+..+|.+.+. ... ...+........
T Consensus 249 ~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (432)
T 3n9x_A 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLK 328 (432)
T ss_dssp CTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred ccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHH
Confidence 4444443320 000 111111100000
Q ss_pred -CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 180 -HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 180 -~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+..++++.+++.+||+.||.+|||++|+++|
T Consensus 329 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 329 QKYPSISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 014578899999999999999999999999976
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-33 Score=223.01 Aligned_cols=173 Identities=18% Similarity=0.255 Sum_probs=128.7
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++++++ +++|.++++. ..+++..+..++.||++||.|||+.|++||||||.||+++.++.++
T Consensus 110 ~lv~e~~-~~~L~~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC----------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp EEEEECC-CEECC---------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred EEEeccc-CCCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEE
Confidence 3556665 7999999864 2589999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||+++..... .....++..|+|||.+.+ ..++.++||||+||++++|+ +|..||.+.+....+..+.....
T Consensus 173 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 173 ILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHHC
T ss_pred Eeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998754322 234567889999999876 56889999999999999999 79999998887665554432100
Q ss_pred c--------------------CC---------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 C--------------------WK---------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~--------------------~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. .. .....++.+.+++.+||+.||.+|||++++++|
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 00 013457889999999999999999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-33 Score=220.39 Aligned_cols=178 Identities=19% Similarity=0.251 Sum_probs=142.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC-
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS- 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~- 95 (223)
..+|+||+.+|+|.+++... ..+++..+..++.||+.||.|||+.|++|+||||.||+++.++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN---------------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT---------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSS
T ss_pred eEEEEecCCCCcHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCC
Confidence 44789999999999999754 35999999999999999999999999999999999999987654
Q ss_pred --eEEcCCCCCcccchhhhhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHH
Q psy15108 96 --VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLS 169 (223)
Q Consensus 96 --~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~ 169 (223)
++++|||++........ .....++..|+|||.+. ...++.++||||||+++|+|+ +|..||...... ....
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~ 230 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL-SGYPPFSEHRTQVSLKD 230 (322)
T ss_dssp CCEEECCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH-HSSCSSCSTTCSSCHHH
T ss_pred CeEEEccCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH-hCCCCCcccchHHHHHH
Confidence 99999999976543321 22345788899999964 456889999999999999999 799999765432 3333
Q ss_pred HHHhCcccC--CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 170 QLESKKLCW--KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 170 ~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.+....... .....+++++.+++.+||+.||.+||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 343332221 1124678899999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-33 Score=224.76 Aligned_cols=177 Identities=20% Similarity=0.296 Sum_probs=137.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCC-
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDL- 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~- 94 (223)
..+||||+ +|+|.+++..... ..+++..++.++.||+.||.|||++ |++||||||.||+++.++
T Consensus 120 ~~lv~e~~-~~~l~~~~~~~~~-------------~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 120 ICMVFEVL-GHHLLKWIIKSNY-------------QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEECCC-CCBHHHHHHHTTT-------------SCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred EEEEEecc-CccHHHHHHhccc-------------CCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 33788988 7777777766533 4699999999999999999999998 999999999999998664
Q ss_pred ------------------------------------------------CeEEcCCCCCcccchhhhhhhhcCCccccccc
Q psy15108 95 ------------------------------------------------SVKISLSGLSKDTYQKEYYKYRNAILPLRWLP 126 (223)
Q Consensus 95 ------------------------------------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (223)
.++++|||++...... .....++..|+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~a 261 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccC
Confidence 7999999998754322 234567899999
Q ss_pred ccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh---C---------cc------------
Q psy15108 127 YEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD------DQVLSQLES---K---------KL------------ 176 (223)
Q Consensus 127 pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~------~~~~~~~~~---~---------~~------------ 176 (223)
||.+.+..++.++|||||||++|+|+ +|..||..... ......+.. . ..
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELA-TGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHH-HSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHh-hCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 99999888999999999999999999 79999975542 111111111 0 00
Q ss_pred ----------------cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 ----------------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+...+..+.+++.+||+.||++|||++++++|
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 001112235678899999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=217.32 Aligned_cols=175 Identities=13% Similarity=0.188 Sum_probs=138.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC-C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-S 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-~ 95 (223)
..+|+||+.+++|.++++ .+++..+..++.|++.||.|||+.|++||||||.||+++.++ .
T Consensus 108 ~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~ 169 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ------------------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK 169 (330)
T ss_dssp EEEEEECCCCCCHHHHGG------------------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE
T ss_pred eEEEEeccCchhHHHHHH------------------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCE
Confidence 347899999999999984 389999999999999999999999999999999999999776 7
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHh
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDL-SDDQVLSQLES 173 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~-~~~~~~~~~~~ 173 (223)
++++|||++....... ......++..|+|||.+.+ ..++.++||||+||++|+|+ +|..||... ........+..
T Consensus 170 ~kl~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~l~~~~~ 246 (330)
T 3nsz_A 170 LRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI-FRKEPFFHGHDNYDQLVRIAK 246 (330)
T ss_dssp EEECCCTTCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HTCSSSSCCSSHHHHHHHHHH
T ss_pred EEEEeCCCceEcCCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHH-hCCCCcccCCchHHHHHHHHH
Confidence 9999999997543322 2234567888999999876 56899999999999999999 788888543 22222221111
Q ss_pred -------------Ccc----------------------cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 -------------KKL----------------------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 -------------~~~----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
... .......+++++.+++.+||+.||.+|||++++++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 001112268899999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=217.26 Aligned_cols=179 Identities=17% Similarity=0.175 Sum_probs=141.8
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCcccCCCCCCCeeeec-CCC
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHIS--DKRLIHKDIAARNCLISS-DLS 95 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~~~nil~~~-~~~ 95 (223)
+||||+.+ +|.+.+..... ....+++..+..++.|++.|+.||| +.|++||||||.||+++. ++.
T Consensus 103 lv~e~~~~-~l~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYYR-----------RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp EEEECCSC-BHHHHHHHHHT-----------TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred EEeecccc-cHHHHHHHHhh-----------cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 67888886 55555543222 2346899999999999999999999 999999999999999997 889
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++|+|||++....... ......++..|+|||.+.+.. ++.++||||+||++|+|+ +|..||.+.........+...
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell-~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM-LGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHH-hCCCCcCCCChHHHHHHHHHH
Confidence 9999999997654332 223456788899999986554 899999999999999999 799999988877666655431
Q ss_pred cc------------------------------cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KL------------------------------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. ........++++.+++.+||+.||.+|||+.|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 011122357889999999999999999999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=221.87 Aligned_cols=176 Identities=20% Similarity=0.302 Sum_probs=136.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecC---
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSD--- 93 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~--- 93 (223)
.+++||+ +++|.+++..... ..+++..+..++.||+.||.|||++ |++||||||.||+++..
T Consensus 106 ~lv~e~~-~~~L~~~~~~~~~-------------~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 106 VMVFEVL-GENLLALIKKYEH-------------RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEECCC-CEEHHHHHHHTTT-------------SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEEecC-CCCHHHHHHHhhc-------------cCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 3678888 9999999987543 4599999999999999999999998 99999999999999543
Q ss_pred ---CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------
Q psy15108 94 ---LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD------ 164 (223)
Q Consensus 94 ---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~------ 164 (223)
+.++++|||++...... .....++..|+|||.+.+..++.++||||||+++|+|+ +|..||.....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI-TGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHH-HSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCcccccCCh
Confidence 36999999998754322 23456789999999999888999999999999999999 79999976542
Q ss_pred HHHHHHHHhCc----------------------------------------ccCCCCCCChHHHHHHHHHhcCCCCCCCC
Q psy15108 165 DQVLSQLESKK----------------------------------------LCWKHSSKTPEYITSLHEKCIHPHPHQRP 204 (223)
Q Consensus 165 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 204 (223)
......+.... .....+...+.++.+++.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11122211100 00112234467889999999999999999
Q ss_pred CHHHHHHH
Q psy15108 205 TFPSIVTQ 212 (223)
Q Consensus 205 s~~~ll~~ 212 (223)
|++++++|
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=218.84 Aligned_cols=172 Identities=17% Similarity=0.233 Sum_probs=138.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|++|+. |+|.+++. ..+++..+..++.|++.||.|||+.|++||||||.||+++.++.++
T Consensus 123 ~lv~e~~~-~~l~~~~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG-----------------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp EEEEECCC-EEHHHHTT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred EEEEcccc-ccHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEE
Confidence 46778877 68888873 2499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
|+|||++...... .....++..|+|||.+.+ ..++.++||||+|+++++|+ +|..||.+.+..+....+.....
T Consensus 185 L~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 185 ILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp ECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhC
Confidence 9999998754322 234567889999999876 67899999999999999999 79999998887666555432100
Q ss_pred c-----------------------C------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 C-----------------------W------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 ~-----------------------~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. . .....+++++.+++.+||+.||.+|||++++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 0 0123567889999999999999999999999876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=217.33 Aligned_cols=168 Identities=19% Similarity=0.252 Sum_probs=139.7
Q ss_pred CCCCCCCCC-CChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee-cCCC
Q psy15108 18 SGSGKPRVK-GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS-SDLS 95 (223)
Q Consensus 18 ~~v~~~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~-~~~~ 95 (223)
.+++|++.+ ++|.+++...+ .+++..++.++.|+++||.|||+.|++||||||.||+++ .++.
T Consensus 124 ~lv~e~~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITERG---------------ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEEEECCSSEEEHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE
T ss_pred EEEEEcCCCCccHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC
Confidence 377888876 99999998754 499999999999999999999999999999999999999 6789
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||++....... .....++..|+|||.+....+ +.++|+||||+++|+|+ +|..||..... +...
T Consensus 189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~------~~~~ 258 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV-CGDIPFEHDEE------IIRG 258 (320)
T ss_dssp EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH-HSSCSCCSHHH------HHHC
T ss_pred EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHH-HCCCCCCChhh------hhcc
Confidence 9999999987554321 234567889999999877665 67899999999999999 79999975321 1222
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+..+++++.+++.+||+.||++||++++++++
T Consensus 259 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 --QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 223356788999999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=216.07 Aligned_cols=177 Identities=17% Similarity=0.198 Sum_probs=140.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+++||+. |+|.+++.. ..+++..+..++.|++.||.|||+.|++||||||.||+++.++.++
T Consensus 90 ~lv~e~~~-~~L~~~~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----------------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred EEEEeccC-ccHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEE
Confidence 37788887 699999975 2489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhh---------hhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy15108 98 ISLSGLSKDTYQKEYY---------KYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167 (223)
Q Consensus 98 l~df~~~~~~~~~~~~---------~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~ 167 (223)
++|||++......... ......++..|+|||.+.. ..++.++|+||+|+++|+|+ +|..||.+.+....
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~ 231 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFPGRDYRHQ 231 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHH-HSSCSCCCSSHHHH
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHH-hCCCCCCCCCcHHH
Confidence 9999998765432111 1123467889999998754 66889999999999999999 79999998876554
Q ss_pred HHHHHhCccc------------------------CC------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 168 LSQLESKKLC------------------------WK------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~~~------------------------~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+...... .+ ....+++++.+++.+||+.||.+||+++++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 4433221000 00 013578889999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=216.27 Aligned_cols=172 Identities=17% Similarity=0.230 Sum_probs=137.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.++|+|+. |+|.+++. ..+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++
T Consensus 105 ~lv~e~~~-~~l~~~~~-----------------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG-----------------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp EEEEECCS-EEGGGTTT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEE
T ss_pred EEEecccc-CCHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEE
Confidence 46778877 68887773 2489999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|+ +|..||.+.+.......+.....
T Consensus 167 l~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 167 ILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTLFKGKDYLDQLTQILKVTG 241 (353)
T ss_dssp ECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHH-HSSCSSBSSCHHHHHHHHHHHHC
T ss_pred EeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998754322 234567889999999876 56889999999999999999 79999998876655544432100
Q ss_pred -----------------------------cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 -----------------------------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 -----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........++++.+++.+||+.||.+||+++++++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011224568899999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=214.27 Aligned_cols=177 Identities=17% Similarity=0.218 Sum_probs=140.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee-cCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS-SDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~-~~~~~ 96 (223)
.+|+||+. |+|.++++. .++++..++.++.|+++||.|||+.|++|+||||+||+++ .++.+
T Consensus 98 ~lv~e~~~-~~L~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 98 YIVQEYME-TDLANVLEQ----------------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp EEEEECCS-EEHHHHHTT----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred eEEeeccC-CCHHHHhhc----------------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 37889987 699999953 3589999999999999999999999999999999999998 45689
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+++|||++....... ........++..|+|||.+.. ..++.++|+||||+++|+|+ +|..||.+....+....+..
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHH
Confidence 999999987653221 111223455788999998765 56889999999999999999 79999998887665555433
Q ss_pred Cccc-----------------------C-----CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLC-----------------------W-----KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~-----------------------~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... . .....++.++.+++.+||+.||.+||+++++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 2110 0 0124578899999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-32 Score=211.71 Aligned_cols=177 Identities=14% Similarity=0.221 Sum_probs=133.1
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~~ 96 (223)
.+||||+ ++.+..+..... ..+++..+..++.|+++||.|||+. |++|+||+|.||+++.++.+
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~ 164 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQ--------------GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQI 164 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHT--------------SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCE
T ss_pred EEEEecc-CCcHHHHHHHhc--------------cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCE
Confidence 3788998 555655555432 3699999999999999999999995 99999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDL-SDDQVLSQ 170 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~-~~~~~~~~ 170 (223)
+++|||++....... ......++..|+|||.+. ...++.++||||+|+++|+|+ +|..||... ........
T Consensus 165 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~ 241 (318)
T 2dyl_A 165 KLCDFGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA-TGQFPYKNCKTDFEVLTK 241 (318)
T ss_dssp EECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHH-HSSCTTTTCCSHHHHHHH
T ss_pred EEEECCCchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHH-hCCCCCCCCCccHHHHHH
Confidence 999999986543322 123346788899999984 455788999999999999999 699999864 44455555
Q ss_pred HHhCcc-cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKKL-CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+..... ..+....++.++.+++.+||+.||.+||++++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 242 VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 544422 222234678999999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=220.02 Aligned_cols=187 Identities=17% Similarity=0.203 Sum_probs=131.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeee----ecC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLI----SSD 93 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~----~~~ 93 (223)
.+|+||+. |+|.+++...+..... .....+++..++.++.||+.||.|||+.|++||||||.||++ +..
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKAN------KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred EEEEeCCC-CCHHHHHHHhcccccc------ccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 36788876 6899998765431100 112359999999999999999999999999999999999999 667
Q ss_pred CCeEEcCCCCCcccchhh--hhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----
Q psy15108 94 LSVKISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD----- 165 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~----- 165 (223)
+.++|+|||++....... ........+++.|+|||.+.+. .++.++||||+||++|+|+ +|..||.+....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHH-HSSCTTCCCC------C
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHH-hCCCCCCCccccccccc
Confidence 899999999997654321 1223446778999999998774 4899999999999999999 799999755431
Q ss_pred ----HHHHHHHhCcccC------------------------------------CCCCCChHHHHHHHHHhcCCCCCCCCC
Q psy15108 166 ----QVLSQLESKKLCW------------------------------------KHSSKTPEYITSLHEKCIHPHPHQRPT 205 (223)
Q Consensus 166 ----~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps 205 (223)
..+..+......+ ......+..+.+|+.+||+.||.+|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 2222221100000 001122567889999999999999999
Q ss_pred HHHHHHH
Q psy15108 206 FPSIVTQ 212 (223)
Q Consensus 206 ~~~ll~~ 212 (223)
++|+++|
T Consensus 328 a~e~L~h 334 (405)
T 3rgf_A 328 SEQAMQD 334 (405)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999976
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-33 Score=227.90 Aligned_cols=172 Identities=14% Similarity=0.115 Sum_probs=135.7
Q ss_pred CCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcC
Q psy15108 21 GKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISL 100 (223)
Q Consensus 21 ~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~d 100 (223)
+.++.+++|.++++..... ......+++..++.++.|+++||.|||++|++||||||+||+++.++.+||+|
T Consensus 183 ~~~~~~~~L~~ll~~l~~~--------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 183 LYPRMQSNLQTFGEVLLSH--------SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp EEECCSEEHHHHHHHHHHH--------TTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECC
T ss_pred EeehhcCCHHHHHHHhhcc--------cccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEe
Confidence 3445779999999643210 01224688999999999999999999999999999999999999999999999
Q ss_pred CCCCcccchhhhhhhhcCCccccccccccc----------ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy15108 101 SGLSKDTYQKEYYKYRNAILPLRWLPYEAV----------FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170 (223)
Q Consensus 101 f~~~~~~~~~~~~~~~~~~~~~~~~~pe~~----------~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~ 170 (223)
||+++..... .....+ +.|+|||.+ ....++.++|||||||++|+|+ +|+.||...........
T Consensus 255 FG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell-tg~~Pf~~~~~~~~~~~ 328 (413)
T 3dzo_A 255 FEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW-CADLPNTDDAALGGSEW 328 (413)
T ss_dssp GGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH-HSSCCCCTTGGGSCSGG
T ss_pred ccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH-HCCCCCCCcchhhhHHH
Confidence 9998754332 233455 889999998 4555788999999999999999 69999987655433222
Q ss_pred HHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 171 LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+ ......+++++.+++.+||+.||++||++.+++++
T Consensus 329 ~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 329 I------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp G------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred H------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2 22234678999999999999999999998777543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=221.03 Aligned_cols=184 Identities=20% Similarity=0.303 Sum_probs=130.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC----
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD---- 93 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~---- 93 (223)
.+|+|||. |+|.+++...+... ......++..++.++.||+.||.|||+.|++||||||+||+++..
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~ 155 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSD--------ENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFT 155 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC--------------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHH
T ss_pred EEEEecCC-CCHHHHHhccCCCc--------hhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccc
Confidence 37899995 69999998654300 000112344567899999999999999999999999999999754
Q ss_pred ---------CCeEEcCCCCCcccchhhh---hhhhcCCccccccccccccc-------CCCCcccchHHHHHHHHHHHhC
Q psy15108 94 ---------LSVKISLSGLSKDTYQKEY---YKYRNAILPLRWLPYEAVFD-------DEFSTKSDVYAYACLIWEIFNK 154 (223)
Q Consensus 94 ---------~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~slG~il~~l~~~ 154 (223)
+.++++|||++........ .......+++.|+|||.+.+ ..++.++||||+||++|+|++.
T Consensus 156 ~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~ 235 (434)
T 2rio_A 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235 (434)
T ss_dssp SCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhC
Confidence 4799999999976543321 11234578899999999865 5688999999999999999955
Q ss_pred CCCCCCCCCHHHHHHHHHhCcccCCCC-----CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 155 GEMPFPDLSDDQVLSQLESKKLCWKHS-----SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 155 ~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
|..||....... ..+.......... ..++.++.+++.+||+.||.+||++.++++|
T Consensus 236 g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 236 GKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp SCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 999997655433 2222222222211 1245789999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-32 Score=212.05 Aligned_cols=169 Identities=17% Similarity=0.269 Sum_probs=140.3
Q ss_pred CCCCCCC-CCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee-cCC
Q psy15108 17 KSGSGKP-RVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS-SDL 94 (223)
Q Consensus 17 ~~~v~~~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~-~~~ 94 (223)
..++++| +.+++|.+++...+ .+++..++.++.|+++||.|||+.|++|+||+|.||+++ .++
T Consensus 113 ~~~v~e~~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 113 FMLVLERPLPAQDLFDYITEKG---------------PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp CEEEEECCSSEEEHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT
T ss_pred EEEEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC
Confidence 4477888 78999999998754 499999999999999999999999999999999999999 788
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFS-TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
.++++|||++....... .....++..|++||.+....+. .++|+||+|+++|+++ +|..||.... . +..
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~--~----~~~ 247 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV-CGDIPFERDQ--E----ILE 247 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH-HSSCSCCSHH--H----HHH
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH-HCCCCCCChH--H----Hhh
Confidence 99999999987554322 2345678889999998766654 5899999999999999 6999997532 1 122
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ....+..++..+.+++.+||+.||++||++++++++
T Consensus 248 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2 233456788999999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=220.62 Aligned_cols=180 Identities=19% Similarity=0.284 Sum_probs=131.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-----
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS----- 92 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~----- 92 (223)
.+|||||. |+|.+++..... .+++..+..++.||++||.|||+.|++||||||+||+++.
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~ 158 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDF--------------AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHG 158 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSC--------------CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTT
T ss_pred EEEEECCC-CCHHHHHHhcCC--------------CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCC
Confidence 37788886 699999986543 3555567899999999999999999999999999999953
Q ss_pred CCCeEEcCCCCCcccchhh--hhhhhcCCcccccccccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy15108 93 DLSVKISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167 (223)
Q Consensus 93 ~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~ 167 (223)
...++++|||++....... ........+++.|+|||.+. ...++.++||||+||++|+|++.|..||........
T Consensus 159 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~ 238 (432)
T 3p23_A 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238 (432)
T ss_dssp BCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH
T ss_pred ceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH
Confidence 2357899999987654322 12234467899999999987 355678999999999999999559999976555443
Q ss_pred HHHHHhCcccCCC-CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 168 LSQLESKKLCWKH-SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 168 ~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...+......... ....+..+.+++.+||+.||.+||+++++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 239 NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 3322222111111 12235668899999999999999999999854
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=212.31 Aligned_cols=180 Identities=14% Similarity=0.244 Sum_probs=122.3
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCCCCCeeeecCCCeE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-RLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~~~nil~~~~~~~~ 97 (223)
+|+||+.+ +|.+++..... .....+++..+..++.|++.||.|||+. |++|+||+|.||+++.++.++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYS----------VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHH----------TTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred EEEeecCC-ChHHHHHHHHh----------hhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence 77888885 88888875322 0124689999999999999999999999 999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccc----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAV----FDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLSQLE 172 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~~~~ 172 (223)
++|||++....... ......++..|+|||.+ ....++.++||||||+++|+|+ +|..||...... .....+.
T Consensus 167 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~~ 243 (327)
T 3aln_A 167 LCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA-TGRFPYPKWNSVFDQLTQVV 243 (327)
T ss_dssp ECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHH-HSCCCSSCC-------CCCC
T ss_pred EccCCCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHH-HCCCCCCCcchHHHHHHHHh
Confidence 99999987654332 12233678889999998 4556889999999999999999 699999765432 2221111
Q ss_pred hCccc---CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKLC---WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ......+++.+.+++.+||+.||.+||++++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 11111 11123578999999999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=207.50 Aligned_cols=159 Identities=14% Similarity=0.258 Sum_probs=125.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec---C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---D 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~---~ 93 (223)
..+||||+.+|+|.+++...+. ..+++..++.++.|++.||.|||+.|++|+||||.||+++. +
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 156 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD-------------QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 156 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT-------------CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT
T ss_pred EEEEEeecCCCcHHHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCC
Confidence 3478999999999999987543 46999999999999999999999999999999999999998 7
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+.++++|||++.... +..++.++|+||+|+++|+|+ +|..||...........+..
T Consensus 157 ~~~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~-tg~~pf~~~~~~~~~~~~~~ 212 (299)
T 3m2w_A 157 AILKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAISPGMKT 212 (299)
T ss_dssp CCEEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHH-HSSCSCCC-------CCSCC
T ss_pred CcEEEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHH-HCCCCCCCCcchhhhHHHHH
Confidence 889999999885321 133577899999999999999 79999977654433221111
Q ss_pred Ccc--cCCCC----CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKL--CWKHS----SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~--~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
... ....+ ..+++++.+++.+||+.||.+||+++++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 101 01111 4578899999999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-30 Score=218.26 Aligned_cols=189 Identities=18% Similarity=0.221 Sum_probs=143.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC-
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS- 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~- 95 (223)
..+|+||+.+|+|.+++..... ...+++..++.++.|++.||.|||+.|++|+||+|.||+++.++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~------------~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN------------CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC------------TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSS
T ss_pred EEEEEEeCCCCCHHHHHHhccc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCc
Confidence 4589999999999999986432 235899999999999999999999999999999999999997655
Q ss_pred --eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH-----
Q psy15108 96 --VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL----- 168 (223)
Q Consensus 96 --~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~----- 168 (223)
++++|||++....... ......++..|+|||.+.+..++.++||||+|+++|+++ +|..||........+
T Consensus 161 ~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLl-tG~~Pf~~~~~~~~~~~~i~ 237 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECI-TGFRPFLPNWQPVQWHGKVR 237 (676)
T ss_dssp CEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHH-SSCSSCCSSCHHHHSSTTCC
T ss_pred eeEEEccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHH-HCCCCCCcccchhhhhhhhh
Confidence 8999999997654332 223457789999999999889999999999999999999 899999764332110
Q ss_pred ----HHHH-----hCcccC--------CCCCCChHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHHHhhhc
Q psy15108 169 ----SQLE-----SKKLCW--------KHSSKTPEYITSLHEKCIHPHPHQRPTFPS-----IVTQLSDAMCND 220 (223)
Q Consensus 169 ----~~~~-----~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~-----ll~~L~~~~~~~ 220 (223)
..+. .+...+ .....+++.+.+++..||..||.+||++++ ..+.+..++...
T Consensus 238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000 000000 112235788999999999999999999988 456666666544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=192.10 Aligned_cols=155 Identities=12% Similarity=0.126 Sum_probs=122.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+++|.++++. .....++..++.|+++||.|||++|++||||||.||+++.++.++
T Consensus 107 ~lv~e~~~g~~L~~~l~~-----------------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~k 169 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT-----------------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVV 169 (286)
T ss_dssp EEEEECCCEEEHHHHHTT-----------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEE
T ss_pred EEEEEecCCCCHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEE
Confidence 388999999999999952 145667899999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHhC
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS---QLESK 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~---~~~~~ 174 (223)
+++++. ++ .++.++||||||+++|+|+ +|..||.+........ .....
T Consensus 170 l~~~~~---------------------~~-------~~~~~~Di~slG~il~ell-tg~~Pf~~~~~~~~~~~~~~~~~~ 220 (286)
T 3uqc_A 170 LAYPAT---------------------MP-------DANPQDDIRGIGASLYALL-VNRWPLPEAGVRSGLAPAERDTAG 220 (286)
T ss_dssp ECSCCC---------------------CT-------TCCHHHHHHHHHHHHHHHH-HSEECSCCCSBCCCSEECCBCTTS
T ss_pred EEeccc---------------------cC-------CCCchhHHHHHHHHHHHHH-HCCCCCCcCCcchhhHHHHHHhcc
Confidence 885432 22 3678999999999999999 7999998765422110 00011
Q ss_pred ccc--CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLC--WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
... ......+++++.+++.+||+.||.+| |+.++++.|+++...
T Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 010 01235678999999999999999999 999999999987643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=210.96 Aligned_cols=168 Identities=15% Similarity=0.076 Sum_probs=129.5
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+.+++|.+++.. .+++..++.++.||++||.|||++|++||||||.||+++.+ .++
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----------------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~k 221 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----------------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLK 221 (681)
T ss_dssp EEEEECCCCEECC----C-----------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEE
T ss_pred EEEEEeCCCCcHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEE
Confidence 588999999999988753 48999999999999999999999999999999999999875 899
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
|+|||++...... ....+++.|++||.+.+. ++.++|||||||++++|+ +|..||.+...... ..
T Consensus 222 l~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~-~g~~~~~~~~~~~~--------~~ 286 (681)
T 2pzi_A 222 LIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALT-LDLPTRNGRYVDGL--------PE 286 (681)
T ss_dssp ECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHH-SCCCEETTEECSSC--------CT
T ss_pred EEecccchhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHH-hCCCCCcccccccc--------cc
Confidence 9999998754322 345688999999998654 488999999999999999 78877764211000 00
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHHHhh
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPT-FPSIVTQLSDAMC 218 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~~L~~~~~ 218 (223)
.......++.+.+++.+||+.||.+||+ .+++...|..++.
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000112467899999999999999996 5666666666543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-28 Score=193.26 Aligned_cols=168 Identities=13% Similarity=0.053 Sum_probs=127.3
Q ss_pred CCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCcccCCCCCCCeeeecCC
Q psy15108 16 DKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHIS-DKRLIHKDIAARNCLISSDL 94 (223)
Q Consensus 16 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~di~~~nil~~~~~ 94 (223)
...+||||+.+|++.+.+.. ..+++..+..++.||+.||.||| +.|++||||||+||+++.++
T Consensus 136 ~~~lv~E~~~~g~ll~~~~~----------------~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~ 199 (336)
T 2vuw_A 136 QLFIVLEFEFGGIDLEQMRT----------------KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTS 199 (336)
T ss_dssp CEEEEEEEECCCEETGGGTT----------------TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECS
T ss_pred eEEEEEEecCCCccHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccC
Confidence 35599999999987776632 24899999999999999999999 99999999999999999887
Q ss_pred --------------------CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHH-HHHHHh
Q psy15108 95 --------------------SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACL-IWEIFN 153 (223)
Q Consensus 95 --------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~i-l~~l~~ 153 (223)
.+||+|||+++.... ....++..|+|||.+.+.. +.++||||++++ .++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~- 271 (336)
T 2vuw_A 200 LKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRW- 271 (336)
T ss_dssp CSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCT-
T ss_pred CcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccc-
Confidence 899999999986543 2347889999999998666 889999998777 55566
Q ss_pred CCCCCCCCCCH-HHHHHHHHhC-cccCCC----CCCChHHHHHHHHHhcCCCCCCCCCHHHHH-HH
Q psy15108 154 KGEMPFPDLSD-DQVLSQLESK-KLCWKH----SSKTPEYITSLHEKCIHPHPHQRPTFPSIV-TQ 212 (223)
Q Consensus 154 ~~~~p~~~~~~-~~~~~~~~~~-~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll-~~ 212 (223)
.|..||.+... ......+... ...... ...+++++.+++.+||+.| |++|++ +|
T Consensus 272 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 272 GEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp TSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred cccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 68888853211 1122222211 111111 1235788999999999977 899988 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-25 Score=185.79 Aligned_cols=115 Identities=11% Similarity=-0.008 Sum_probs=80.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
-+||||++||+|.++|+..+ ++++. .|+.||+.||.|+|++||+||||||.|||++.++.+|
T Consensus 318 yLVMEyv~G~~L~d~i~~~~---------------~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vK 379 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGE---------------EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHAR 379 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTC---------------CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHHhCC---------------CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEE
Confidence 39999999999999998643 47765 4789999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIF 152 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~ 152 (223)
|+|||+++....... ......+++.|++||.+.+ .+..++|+|++|++++++.
T Consensus 380 L~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~ 432 (569)
T 4azs_A 380 LIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLP 432 (569)
T ss_dssp ECCCTTEESCC---C-CSHHHHHHHHHHHHHHC------------------CCCC
T ss_pred EeecccCeeCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhc
Confidence 999999976543321 2234568899999999865 4567899999999876654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.5e-18 Score=145.64 Aligned_cols=117 Identities=13% Similarity=0.062 Sum_probs=94.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.++++. +..++.|+++||.|||+++++||||||+||+++. .+
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-----------------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~ 468 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-----------------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DL 468 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-----------------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SE
T ss_pred cEEEEECCCCCCHHHHHHH-----------------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eE
Confidence 4488999999999999951 5689999999999999999999999999999998 99
Q ss_pred EEcCCCCCcccchhhhh------hhhcCCccccccccccccc--CCCCcccchHHHHHHHHHHHhCCCCCC
Q psy15108 97 KISLSGLSKDTYQKEYY------KYRNAILPLRWLPYEAVFD--DEFSTKSDVYAYACLIWEIFNKGEMPF 159 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~~l~~~~~~p~ 159 (223)
+++|||+++........ ......+++.|++||.+.. ..|+...|+|+..+-..+.. ..+.+|
T Consensus 469 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v-~~r~rY 538 (540)
T 3en9_A 469 YIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV-ERRARY 538 (540)
T ss_dssp EECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH-HTCSCC
T ss_pred EEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH-Hhcccc
Confidence 99999999876543211 2245678899999999876 55777889999887766655 344333
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.3e-15 Score=117.94 Aligned_cols=66 Identities=12% Similarity=0.075 Sum_probs=57.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+++|+|.+ +. . .....++.|+++|+.|||+.|++||||||.||+++ ++.++
T Consensus 176 ~lvmE~~~g~~L~~-l~-------------------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 176 AVLMELIDAKELYR-VR-------------------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp EEEEECCCCEEGGG-CC-------------------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred EEEEEecCCCcHHH-cc-------------------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence 48899999999988 42 1 12346999999999999999999999999999999 99999
Q ss_pred EcCCCCCcc
Q psy15108 98 ISLSGLSKD 106 (223)
Q Consensus 98 l~df~~~~~ 106 (223)
++|||+++.
T Consensus 233 l~DFG~a~~ 241 (282)
T 1zar_A 233 IIDFPQSVE 241 (282)
T ss_dssp ECCCTTCEE
T ss_pred EEECCCCeE
Confidence 999999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.2e-12 Score=99.87 Aligned_cols=69 Identities=13% Similarity=0.054 Sum_probs=57.4
Q ss_pred CCCCCCCC-C----ChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCcccCCCCCCCeeeec
Q psy15108 19 GSGKPRVK-G----DLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHIS-DKRLIHKDIAARNCLISS 92 (223)
Q Consensus 19 ~v~~~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~di~~~nil~~~ 92 (223)
+||||+.+ | +|.++... .++..+..++.|++.|+.+|| +.|++||||||.||+++.
T Consensus 145 lVmE~~g~~g~~~~~L~~~~~~------------------~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~ 206 (258)
T 1zth_A 145 LLMEFIGEDELPAPTLVELGRE------------------LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID 206 (258)
T ss_dssp EEEECCEETTEECCBHHHHGGG------------------GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS
T ss_pred EEEEecCCCCCccccHHHHhhc------------------cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC
Confidence 78999943 4 67665421 335567889999999999999 999999999999999988
Q ss_pred CCCeEEcCCCCCccc
Q psy15108 93 DLSVKISLSGLSKDT 107 (223)
Q Consensus 93 ~~~~~l~df~~~~~~ 107 (223)
.++++|||++...
T Consensus 207 --~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 --KVYFIDMGQAVTL 219 (258)
T ss_dssp --SEEECCCTTCEET
T ss_pred --cEEEEECcccccC
Confidence 8999999998643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.3e-10 Score=92.92 Aligned_cols=68 Identities=13% Similarity=0.010 Sum_probs=55.7
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC----
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL---- 94 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~---- 94 (223)
+||||+.+++|.++.. ......++.|++.++.+||+.|++||||||.|||++.++
T Consensus 188 LVME~i~G~~L~~l~~---------------------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 188 IVMSLVDALPMRQVSS---------------------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp EEEECCSCEEGGGCCC---------------------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred EEEEecCCccHhhhcc---------------------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 7999999998865431 123456789999999999999999999999999998776
Q ss_pred ------CeEEcCCCCCccc
Q psy15108 95 ------SVKISLSGLSKDT 107 (223)
Q Consensus 95 ------~~~l~df~~~~~~ 107 (223)
.+.++||+-+...
T Consensus 247 ~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECCCTTCEET
T ss_pred ccccccceEEEEeCCcccC
Confidence 3789999877543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.43 E-value=6.3e-06 Score=60.20 Aligned_cols=143 Identities=10% Similarity=0.097 Sum_probs=93.9
Q ss_pred CCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCCeEEcCCCCC
Q psy15108 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLSVKISLSGLS 104 (223)
Q Consensus 26 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~~~l~df~~~ 104 (223)
.=||.++|+..+. +++++++|.+++|.+.+|.-+-. ..-...-+.+..|++..+|.+.+.+- .+
T Consensus 32 ~vSL~eIL~~~~~--------------PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~-~s 96 (229)
T 2yle_A 32 ALSLEEILRLYNQ--------------PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPA-AD 96 (229)
T ss_dssp EEEHHHHHHHHTS--------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC---
T ss_pred cccHHHHHHHcCC--------------CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecccc-cc
Confidence 3479999998765 89999999999999999887621 11123445678899999999987741 11
Q ss_pred cccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccCCCCCCC
Q psy15108 105 KDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKT 184 (223)
Q Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (223)
. .....+.+||... ...+.+.-|||+|+++|.-+-.|-. ......+
T Consensus 97 ~-------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~--------------------e~eE~eL 142 (229)
T 2yle_A 97 D-------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK--------------------ENEEREL 142 (229)
T ss_dssp -----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC--------------------TTEEECC
T ss_pred c-------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC--------------------cccchhh
Confidence 0 0112245776642 3445677899999999988832221 1123456
Q ss_pred hHHHHHHHHHhcCC-------------------------CCCCCCCHHHHHHHHHHHh
Q psy15108 185 PEYITSLHEKCIHP-------------------------HPHQRPTFPSIVTQLSDAM 217 (223)
Q Consensus 185 ~~~~~~li~~~l~~-------------------------dp~~Rps~~~ll~~L~~~~ 217 (223)
++.+.+||..|... .+..|+++++|++.=..-+
T Consensus 143 S~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl 200 (229)
T 2yle_A 143 SPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHL 200 (229)
T ss_dssp CHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTS
T ss_pred CHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhc
Confidence 78888888888755 3467899999987654433
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=9.8e-07 Score=66.94 Aligned_cols=67 Identities=9% Similarity=-0.109 Sum_probs=51.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-----------------------
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD----------------------- 75 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~----------------------- 75 (223)
++|++++|.+|.+.+. +......++.++.+++..||+
T Consensus 87 lv~e~i~G~~l~~~~~--------------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE--------------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp EEEECCSSEEHHHHCC--------------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred EEEEecCCeehhhccC--------------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 7899999999887631 122234677888888888887
Q ss_pred ------------------------------------CCcccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 76 ------------------------------------KRLIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 76 ------------------------------------~~i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
..++|+|+++.||+++....+.++||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448899999999999875556799999774
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.84 E-value=2.3e-06 Score=66.43 Aligned_cols=30 Identities=23% Similarity=0.226 Sum_probs=25.4
Q ss_pred CcccCCCCCCCeeeec--CCCeEEcCCCCCcc
Q psy15108 77 RLIHKDIAARNCLISS--DLSVKISLSGLSKD 106 (223)
Q Consensus 77 ~i~H~di~~~nil~~~--~~~~~l~df~~~~~ 106 (223)
.++|+|+++.||+++. ...+.++||+.+..
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 4799999999999998 45578999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.77 E-value=8e-06 Score=64.87 Aligned_cols=71 Identities=10% Similarity=-0.005 Sum_probs=56.0
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-----------------------
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD----------------------- 75 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~----------------------- 75 (223)
+||++++|.++.+.. ...++..+...++.++++.|..||+
T Consensus 118 ~vme~v~G~~l~~~~-----------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS-----------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIE 180 (359)
T ss_dssp EEEECCCCBCCCCTT-----------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHH
T ss_pred EEEEecCCeecCCCc-----------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHH
Confidence 688899887764311 1246788888889999999999986
Q ss_pred -----------------------------------CCcccCCCCCCCeeeecCCC--eEEcCCCCCcc
Q psy15108 76 -----------------------------------KRLIHKDIAARNCLISSDLS--VKISLSGLSKD 106 (223)
Q Consensus 76 -----------------------------------~~i~H~di~~~nil~~~~~~--~~l~df~~~~~ 106 (223)
.+++|+|+++.||+++.++. +.++||+.+..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 181 RWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999987653 58999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00021 Score=53.62 Aligned_cols=28 Identities=14% Similarity=0.093 Sum_probs=24.6
Q ss_pred cccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 78 LIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 78 i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
++|+|++|.||+++.++.+.++||+.+.
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 8999999999999876556799999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0027 Score=49.11 Aligned_cols=30 Identities=27% Similarity=0.253 Sum_probs=24.6
Q ss_pred CcccCCCCCCCeeeec---CCC-eEEcCCCCCcc
Q psy15108 77 RLIHKDIAARNCLISS---DLS-VKISLSGLSKD 106 (223)
Q Consensus 77 ~i~H~di~~~nil~~~---~~~-~~l~df~~~~~ 106 (223)
.++|+|+++.||+++. ++. +.++||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 5699999999999987 355 47999997753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.97 E-value=0.011 Score=46.06 Aligned_cols=31 Identities=16% Similarity=0.192 Sum_probs=27.5
Q ss_pred cCCcccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 75 DKRLIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 75 ~~~i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
..+++|+|+++.||+++.++.+.++||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 3679999999999999877889999999775
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.31 E-value=0.021 Score=46.20 Aligned_cols=33 Identities=18% Similarity=0.265 Sum_probs=28.7
Q ss_pred hcCCcccCCCCCCCeeeecCCCeEEcCCCCCccc
Q psy15108 74 SDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT 107 (223)
Q Consensus 74 H~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~ 107 (223)
+...++|+|+++.||+++.++ +.++||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 567899999999999998776 999999988643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=93.05 E-value=0.049 Score=40.89 Aligned_cols=29 Identities=14% Similarity=0.100 Sum_probs=25.2
Q ss_pred CcccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 77 RLIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 77 ~i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
.++|+|+++.||+++..+.+-|+||+.+.
T Consensus 194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 37899999999999987667799999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=92.94 E-value=0.075 Score=41.30 Aligned_cols=33 Identities=24% Similarity=0.194 Sum_probs=27.6
Q ss_pred cCCcccCCCCCCCeeeecC----CCeEEcCCCCCccc
Q psy15108 75 DKRLIHKDIAARNCLISSD----LSVKISLSGLSKDT 107 (223)
Q Consensus 75 ~~~i~H~di~~~nil~~~~----~~~~l~df~~~~~~ 107 (223)
...++|+|+.+.||+++.+ +.+.++||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4579999999999999874 67899999988643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.73 E-value=0.15 Score=39.36 Aligned_cols=30 Identities=20% Similarity=0.096 Sum_probs=25.2
Q ss_pred cCCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 75 DKRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 75 ~~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
...++|+|+++.||+++ + .+.++||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 34689999999999998 4 889999987753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.80 E-value=0.057 Score=41.68 Aligned_cols=31 Identities=16% Similarity=0.112 Sum_probs=26.2
Q ss_pred CCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
.+++|+|+.+.||+++.+..+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4789999999999998775567999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=91.32 E-value=0.26 Score=39.23 Aligned_cols=31 Identities=19% Similarity=0.228 Sum_probs=26.5
Q ss_pred cCCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 75 DKRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 75 ~~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
...++|+|+.+.||+++.+ .+.++||+.+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 5689999999999999765 589999988764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=91.16 E-value=0.083 Score=41.41 Aligned_cols=32 Identities=16% Similarity=0.027 Sum_probs=26.3
Q ss_pred cCCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 75 DKRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 75 ~~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
...++|+|+.+.||+++....+.++||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 45789999999999999644578999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.04 E-value=0.22 Score=38.88 Aligned_cols=31 Identities=29% Similarity=0.181 Sum_probs=27.1
Q ss_pred CCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999998877899999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=90.64 E-value=0.36 Score=39.52 Aligned_cols=15 Identities=27% Similarity=0.346 Sum_probs=14.1
Q ss_pred CcccCCCCCCCeeee
Q psy15108 77 RLIHKDIAARNCLIS 91 (223)
Q Consensus 77 ~i~H~di~~~nil~~ 91 (223)
.++|+|+.+.||+++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 689999999999998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.87 E-value=0.4 Score=37.76 Aligned_cols=30 Identities=13% Similarity=0.129 Sum_probs=24.7
Q ss_pred CCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
.+++|+|+.+.||+++.+ .+.++||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~-~~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNK-CLRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC--CEEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCC-cEEEEEecCCCC
Confidence 368999999999999765 489999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=89.45 E-value=0.48 Score=36.14 Aligned_cols=30 Identities=20% Similarity=-0.028 Sum_probs=25.2
Q ss_pred CCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
..++|+|+.+.||+ ..++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 35899999999999 5667789999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=88.71 E-value=0.36 Score=39.09 Aligned_cols=30 Identities=13% Similarity=0.145 Sum_probs=24.7
Q ss_pred CcccCCCCCCCeeeecC----------------------------CCeEEcCCCCCcc
Q psy15108 77 RLIHKDIAARNCLISSD----------------------------LSVKISLSGLSKD 106 (223)
Q Consensus 77 ~i~H~di~~~nil~~~~----------------------------~~~~l~df~~~~~ 106 (223)
.++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 68999999999999875 6789999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=86.53 E-value=0.39 Score=38.25 Aligned_cols=30 Identities=27% Similarity=0.200 Sum_probs=26.6
Q ss_pred CcccCCCCCCCeeeecC----CCeEEcCCCCCcc
Q psy15108 77 RLIHKDIAARNCLISSD----LSVKISLSGLSKD 106 (223)
Q Consensus 77 ~i~H~di~~~nil~~~~----~~~~l~df~~~~~ 106 (223)
.++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 68999999999999876 6899999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.88 E-value=0.56 Score=37.54 Aligned_cols=31 Identities=16% Similarity=0.094 Sum_probs=25.2
Q ss_pred CcccCCCCCCCeeee------cCCCeEEcCCCCCccc
Q psy15108 77 RLIHKDIAARNCLIS------SDLSVKISLSGLSKDT 107 (223)
Q Consensus 77 ~i~H~di~~~nil~~------~~~~~~l~df~~~~~~ 107 (223)
.++|+|+.+.||++. ....+.++||..+...
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 367999999999994 3467899999988643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 223 | ||||
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-30 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-30 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-30 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-29 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-29 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-29 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-29 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-28 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-27 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-27 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-25 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-24 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-24 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-23 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-22 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-22 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-21 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-20 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-20 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-19 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-19 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-18 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-18 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-18 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-18 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-18 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-17 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-17 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-17 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-17 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-17 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-17 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-16 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-16 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-15 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-15 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-15 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-15 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-15 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-14 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-14 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-13 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-12 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-12 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-10 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-09 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-09 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-08 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 0.004 |
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 6e-33
Identities = 49/167 (29%), Positives = 87/167 (52%), Gaps = 1/167 (0%)
Query: 49 PRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY 108
T Q + M V +E++ K+ +H+D+AARNCL++ VK+S GLS+
Sbjct: 92 EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151
Query: 109 QKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168
EY + P+RW P E + +FS+KSD++A+ L+WEI++ G+MP+ ++ +
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 211
Query: 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ + L E + ++ C H +RPTF +++ + D
Sbjct: 212 EHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (292), Expect = 3e-32
Identities = 62/197 (31%), Positives = 110/197 (55%), Gaps = 11/197 (5%)
Query: 27 GDLKQFLLATRK---------DSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR 77
GDL +FL + D ++ P LS ++ + +A QVA G+ ++S+++
Sbjct: 101 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160
Query: 78 LIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYR-NAILPLRWLPYEAVFDDEFS 136
+H+D+A RNCL+ ++ VKI+ GLS++ Y +YYK N +P+RW+P E++F + ++
Sbjct: 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT 220
Query: 137 TKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCI 196
T+SDV+AY ++WEIF+ G P+ ++ ++V+ + + P + +L C
Sbjct: 221 TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCW 279
Query: 197 HPHPHQRPTFPSIVTQL 213
P RP+F SI L
Sbjct: 280 SKLPADRPSFCSIHRIL 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-32
Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 27 GDLKQFLLATRKD--------SKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRL 78
GDL +L + R+ K + + L+ + AYQVA G+E + K
Sbjct: 126 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 185
Query: 79 IHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFST 137
+H+D+AARN L++ VKI GL++D Y NA LP++W+ E++F+ ++
Sbjct: 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245
Query: 138 KSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIH 197
KSDV++Y L+WEIF+ G P+P + D +L E I + + C
Sbjct: 246 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWA 305
Query: 198 PHPHQRPTFPSIVTQL 213
+RP+FP++ + L
Sbjct: 306 FDSRKRPSFPNLTSFL 321
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 8e-32
Identities = 49/159 (30%), Positives = 83/159 (52%), Gaps = 1/159 (0%)
Query: 57 SQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYR 116
Q V MA Q+A G+ ++ +H+D+ A N L+ +L K++ GL++ EY +
Sbjct: 113 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172
Query: 117 NAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176
A P++W EA F+ KSDV+++ L+ E+ KG +P+P + + +VL Q+E +
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGY 231
Query: 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ PE + L +C P +RPTF + L D
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-30
Identities = 65/193 (33%), Positives = 109/193 (56%), Gaps = 3/193 (1%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRS-LSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L+++L A R + S + LS+ V+ AYQVA G+E+++ K+ IH+D+AA
Sbjct: 104 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RN L++ D +KI+ GL++D + +YY K N LP++W+ EA+FD ++ +SDV+++
Sbjct: 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
L+WEIF G P+P + +++ L+ S + + C H P QRP
Sbjct: 224 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 205 TFPSIVTQLSDAM 217
TF +V L +
Sbjct: 283 TFKQLVEDLDRIV 295
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 5e-30
Identities = 40/161 (24%), Positives = 85/161 (52%), Gaps = 1/161 (0%)
Query: 55 STSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYK 114
+ + M V G+ ++ + +IH+D+AARNCL+ + +K+S G+++ +Y
Sbjct: 99 AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158
Query: 115 YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174
P++W E +S+KSDV+++ L+WE+F++G++P+ + S+ +V+ + +
Sbjct: 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 218
Query: 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+K ++ + C P RP F ++ QL++
Sbjct: 219 FRLYK-PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 5e-30
Identities = 39/195 (20%), Positives = 85/195 (43%), Gaps = 23/195 (11%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
L L + + +A Q A G++++ K +IH+D+ +
Sbjct: 88 SSLYHHLHIIET--------------KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN 133
Query: 87 NCLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVF---DDEFSTKSDVY 142
N + DL+VKI GL+ + +++ + W+ E + + +S +SDVY
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 143 AYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW----KHSSKTPEYITSLHEKCIHP 198
A+ +++E+ G++P+ ++++ + + + K S P+ + L +C+
Sbjct: 194 AFGIVLYELMT-GQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 252
Query: 199 HPHQRPTFPSIVTQL 213
+RP FP I+ +
Sbjct: 253 KRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (272), Expect = 1e-29
Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 1/168 (0%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT 107
P L+ ++ + MA Q+A G+ I ++ IH+D+ A N L+S LS KI+ GL++
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159
Query: 108 YQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
EY A P++W EA+ F+ KSDV+++ L+ EI G +P+P +++ +V
Sbjct: 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
Query: 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ LE + PE + L C P RPTF + + L D
Sbjct: 220 IQNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-29
Identities = 56/192 (29%), Positives = 101/192 (52%), Gaps = 4/192 (2%)
Query: 27 GDLKQFLLATRKDSKDKSGS-GKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L FL +R D + + +LS+ Q + A VA G++++S K+ IH+D+AA
Sbjct: 96 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 155
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYA 145
RN L+ + KI+ GLS+ Q+ Y K LP+RW+ E++ ++T SDV++Y
Sbjct: 156 RNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 213
Query: 146 CLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
L+WEI + G P+ ++ ++ +L + + + L +C P++RP+
Sbjct: 214 VLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-LEKPLNCDDEVYDLMRQCWREKPYERPS 272
Query: 206 FPSIVTQLSDAM 217
F I+ L+ +
Sbjct: 273 FAQILVSLNRML 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (272), Expect = 2e-29
Identities = 51/169 (30%), Positives = 89/169 (52%), Gaps = 5/169 (2%)
Query: 55 STSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK----DTYQK 110
+ Q V M +A G+++++D +H+D+AARN L++S+L K+S GLS+ DT
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 111 EYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQ 170
Y +P+RW EA+ +F++ SDV++Y ++WE+ + GE P+ D+++ V++
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 171 LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219
+E + P + L C + RP F IV L + N
Sbjct: 246 IE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-29
Identities = 47/176 (26%), Positives = 87/176 (49%), Gaps = 3/176 (1%)
Query: 49 PRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY 108
+ R + + + +QV++G++++ + +H+D+AARN L+ + KIS GLSK
Sbjct: 99 QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158
Query: 109 QKEYYKYRN--AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166
E Y P++W E + +FS+KSDV+++ L+WE F+ G+ P+ + +
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
Query: 167 VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDVN 222
V + LE + + P + L C RP F ++ +L + + VN
Sbjct: 219 VTAMLEKGER-MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-29
Identities = 61/193 (31%), Positives = 111/193 (57%), Gaps = 7/193 (3%)
Query: 26 KGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
+GDLK +L + R + P + S S+ + MA ++A G+ +++ + +H+D+AA
Sbjct: 107 RGDLKSYLRSLRPAMANN-----PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 161
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYYKYRN-AILPLRWLPYEAVFDDEFSTKSDVYAY 144
RNC+++ D +VKI G+++D Y+ +YY+ +LP+RW+ E++ D F+T SDV+++
Sbjct: 162 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 221
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
++WEI E P+ LS++QVL + L K P+ + L C +P RP
Sbjct: 222 GVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRP 280
Query: 205 TFPSIVTQLSDAM 217
+F I++ + + M
Sbjct: 281 SFLEIISSIKEEM 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-29
Identities = 55/168 (32%), Positives = 89/168 (52%), Gaps = 1/168 (0%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
R SL + + AYQ++ L ++ KR +H+DIAARN L+SS+ VK+ GLS+
Sbjct: 101 RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160
Query: 110 KEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169
YYK LP++W+ E++ F++ SDV+ + +WEI G PF + ++ V+
Sbjct: 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220
Query: 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217
++E+ + P + SL KC P +RP F + QLS +
Sbjct: 221 RIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-29
Identities = 58/193 (30%), Positives = 103/193 (53%), Gaps = 2/193 (1%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRS-LSTSQAVTMAYQVALGLEHISDKRLIHKDIAA 85
G+L +L + R + + + + L+ + ++QVA G+E ++ ++ IH+D+AA
Sbjct: 103 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162
Query: 86 RNCLISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAY 144
RN L+S VKI GL++D Y+ Y + +A LPL+W+ E +FD ++ +SDV+++
Sbjct: 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 222
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
L+WEIF+ G P+P + D+ + + + T + C H P QRP
Sbjct: 223 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 282
Query: 205 TFPSIVTQLSDAM 217
TF +V L + +
Sbjct: 283 TFSELVEHLGNLL 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 9e-29
Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 5/168 (2%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT 107
L + + V +E++ +H+D+AARN L+S D K+S GL+K+
Sbjct: 94 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153
Query: 108 YQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
+ LP++W EA+ + +FSTKSDV+++ L+WEI++ G +P+P + V
Sbjct: 154 SSTQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209
Query: 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ ++E K P + + + C H RP+F + QL
Sbjct: 210 VPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 9e-29
Identities = 41/161 (25%), Positives = 79/161 (49%), Gaps = 2/161 (1%)
Query: 55 STSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYK 114
+ + Q+A G+ ++ D+RL+H+D+AARN L+ + VKI+ GL+K +E
Sbjct: 109 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168
Query: 115 YRNAI-LPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173
+ +P++W+ E++ ++ +SDV++Y +WE+ G P+ + ++ S LE
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE- 227
Query: 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
K + + KC RP F ++ + S
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-28
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 2/169 (1%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
A QVA G+ ++ KR IH+D+AARN L+++ VKI GL + Q
Sbjct: 104 HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163
Query: 110 KE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
+ Y + +P W E++ FS SD + + +WE+F G+ P+ L+ Q+
Sbjct: 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223
Query: 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216
L +++ + P+ I ++ +C P RPTF ++ L +A
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 4e-28
Identities = 48/191 (25%), Positives = 91/191 (47%), Gaps = 17/191 (8%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
G L +FL+ R+ + S + +QV++G++++ +K +H+D+AAR
Sbjct: 93 GPLHKFLVGKRE--------------EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAAR 138
Query: 87 NCLISSDLSVKISLSGLSKDTYQKEYYKYRN--AILPLRWLPYEAVFDDEFSTKSDVYAY 144
N L+ + KIS GLSK + Y PL+W E + +FS++SDV++Y
Sbjct: 139 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 198
Query: 145 ACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
+WE + G+ P+ + +V++ +E K + + P + +L C RP
Sbjct: 199 GVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-ECPPECPPELYALMSDCWIYKWEDRP 257
Query: 205 TFPSIVTQLSD 215
F ++ ++
Sbjct: 258 DFLTVEQRMRA 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-27
Identities = 50/169 (29%), Positives = 95/169 (56%), Gaps = 4/169 (2%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
+ + + QVA G++ ++ K+ +H+D+AARNC++ +VK++ GL++D Y
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 110 KEYYKYRN---AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166
KE+ N A LP++W+ E++ +F+TKSDV+++ L+WE+ +G P+PD++
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242
Query: 167 VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215
+ L + P+ + + KC HP RP+F +V+++S
Sbjct: 243 ITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 6e-27
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 4/195 (2%)
Query: 27 GDLKQFLLATRKD---SKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDI 83
GDL FL R SK + +L ++ +YQVA G+ ++ K IH+D+
Sbjct: 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171
Query: 84 AARNCLISSDLSVKISLSGLSKDTYQKEYYKYRN-AILPLRWLPYEAVFDDEFSTKSDVY 142
AARN L++ KI GL++D Y + A LP++W+ E++F+ ++ +SDV+
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 143 AYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQ 202
+Y +WE+F+ G P+P + D ++ + P + + + C P +
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 203 RPTFPSIVTQLSDAM 217
RPTF IV + +
Sbjct: 292 RPTFKQIVQLIEKQI 306
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.4 bits (247), Expect = 8e-26
Identities = 53/166 (31%), Positives = 85/166 (51%), Gaps = 1/166 (0%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT 107
+ + +S + MA Q++ +E++ K IH+D+AARNCL+ + VK++ GLS+
Sbjct: 106 ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165
Query: 108 YQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
Y + A P++W E++ ++FS KSDV+A+ L+WEI G P+P + QV
Sbjct: 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225
Query: 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQL 213
LE K + PE + L C +P RP+F I
Sbjct: 226 YELLE-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 1e-25
Identities = 48/166 (28%), Positives = 85/166 (51%), Gaps = 3/166 (1%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
S Q V M +A G++++++ +H+D+AARN L++S+L K+S GLS+
Sbjct: 107 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166
Query: 114 KYR--NAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
Y +P+RW EA+ +F++ SDV+++ ++WE+ GE P+ +LS+ +V+ +
Sbjct: 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 226
Query: 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAM 217
P I L +C +RP F IV+ L +
Sbjct: 227 N-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.7 bits (235), Expect = 3e-24
Identities = 33/161 (20%), Positives = 62/161 (38%), Gaps = 6/161 (3%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
++ + T ++A L + KR+IH+DI N L+ S +KI+ G S
Sbjct: 99 KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158
Query: 110 KEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169
L +LP E + K D+++ L +E G+ PF + +
Sbjct: 159 SRRTTLCG---TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYK 214
Query: 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210
++ + + E L + + +P QRP ++
Sbjct: 215 RISRVEFTF--PDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (234), Expect = 6e-24
Identities = 36/163 (22%), Positives = 68/163 (41%), Gaps = 6/163 (3%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
R L+ SQ + Q L ++ D ++IH+D+ A N L + D +K++ G+S +
Sbjct: 105 RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164
Query: 112 YYKYRNAILPLRWLP----YEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
+ P P E D + K+DV++ + E+ E P +L+ +V
Sbjct: 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-IEPPHHELNPMRV 223
Query: 168 LSQ-LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
L + +S+ S+ +KC+ + R T +
Sbjct: 224 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 91.6 bits (227), Expect = 9e-23
Identities = 29/162 (17%), Positives = 62/162 (38%), Gaps = 9/162 (5%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
+ L + + + GL ++ +IH+D+ A N L+S VK+ G +
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169
Query: 112 YYKYRNAILPLRWLPYEAVF---DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168
+ + W+ E + + ++ K DV++ E+ + P +++ L
Sbjct: 170 SF-----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSAL 223
Query: 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210
+ + S EY + + C+ P RPT ++
Sbjct: 224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.8 bits (225), Expect = 1e-22
Identities = 29/189 (15%), Positives = 75/189 (39%), Gaps = 19/189 (10%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDK-----RLIHK 81
GDL + K+ + L + + Q+ L L+ + ++H+
Sbjct: 90 GDLASVITKGTKERQ-----------YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138
Query: 82 DIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDV 141
D+ N + +VK+ GL++ + + + ++ E + ++ KSD+
Sbjct: 139 DLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDI 197
Query: 142 YAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPH 201
++ CL++E+ PF S ++ ++ K + + + + + + ++ +
Sbjct: 198 WSLGCLLYELCA-LMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDY 255
Query: 202 QRPTFPSIV 210
RP+ I+
Sbjct: 256 HRPSVEEIL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.8 bits (225), Expect = 2e-22
Identities = 29/156 (18%), Positives = 60/156 (38%), Gaps = 3/156 (1%)
Query: 55 STSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYK 114
Q + + LE + ++IH+DI + N L+ D SVK++ G E K
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSK 172
Query: 115 YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174
+ W+ E V + K D+++ + E+ GE P+ + + + L + +
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATN 231
Query: 175 KLC-WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
++ K +C+ +R + +
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 87.8 bits (217), Expect = 4e-21
Identities = 30/162 (18%), Positives = 57/162 (35%), Gaps = 3/162 (1%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
+S +AV QV GL H+ + +H D+ N + ++ S ++ L +
Sbjct: 117 EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
Query: 110 KEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169
+ + E +D+++ L + + + G PF +DD+ L
Sbjct: 177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLR 235
Query: 170 QLESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSI 209
++S S S E K + P+ R T
Sbjct: 236 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.7 bits (209), Expect = 2e-20
Identities = 32/160 (20%), Positives = 58/160 (36%), Gaps = 2/160 (1%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
+ A +Q+ G+ ++ + H+DI N L+ ++KIS GL+
Sbjct: 98 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157
Query: 112 YYKYRNAIL-PLRWLPYEAVFDDEFST-KSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169
+ N + L ++ E + EF DV++ ++ + Q S
Sbjct: 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217
Query: 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
+ KK K +L K + +P R T P I
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 84.7 bits (209), Expect = 2e-20
Identities = 22/164 (13%), Positives = 58/164 (35%), Gaps = 7/164 (4%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK----DT 107
+LS + + + + + ++H+D+ N L+ D+++K++ G S
Sbjct: 105 VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164
Query: 108 YQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
+E + + P + + D+++ +++ + G PF +
Sbjct: 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLM 223
Query: 168 LSQLESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSI 209
L + S + + + L + + P +R T
Sbjct: 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.5 bits (203), Expect = 2e-19
Identities = 27/163 (16%), Positives = 65/163 (39%), Gaps = 4/163 (2%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
S+A A ++ LGL+ + K ++++D+ N L+ D +KI+ G+ K+
Sbjct: 96 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155
Query: 110 KEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169
+ ++ E + +++ D +++ L++E+ G+ PF ++++
Sbjct: 156 GDAKTNTF-CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFH 213
Query: 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212
+ + + L K P +R + Q
Sbjct: 214 SIRMDNPFY--PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.6 bits (201), Expect = 3e-19
Identities = 30/159 (18%), Positives = 69/159 (43%), Gaps = 4/159 (2%)
Query: 49 PRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY 108
++ S + ++ LE++ K +IH+D+ N L++ D+ ++I+ G +K
Sbjct: 100 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159
Query: 109 QKEYYKYRNAIL-PLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
+ N+ + +++ E + + SD++A C+I+++ G PF ++ +
Sbjct: 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEYLI 218
Query: 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
++ KL + K L EK + +R
Sbjct: 219 FQKI--IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGC 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 80.5 bits (198), Expect = 1e-18
Identities = 24/164 (14%), Positives = 54/164 (32%), Gaps = 3/164 (1%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT 107
+S ++ + Q GL+H+ + ++H DI N + + + + + T
Sbjct: 118 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177
Query: 108 YQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
+ + E V + +D++A L + + + G PF D +
Sbjct: 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLET 236
Query: 168 LSQLESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSI 209
L ++ + S + + P +R T
Sbjct: 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 2e-18
Identities = 25/161 (15%), Positives = 58/161 (36%), Gaps = 3/161 (1%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDT 107
L+ + V+ +QV L+ + + H DI N + + S I + +
Sbjct: 93 NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152
Query: 108 YQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
K +R + E D ST +D+++ L++ + + G PF ++ Q+
Sbjct: 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQI 211
Query: 168 LSQLESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTF 206
+ + + + + + ++ + R T
Sbjct: 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTA 252
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.9 bits (194), Expect = 2e-18
Identities = 32/165 (19%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 50 RVRSLSTSQAVTMAYQVALGLE--HISDKRLIHKDIAARNCLISS-DLSVKISLSGLSKD 106
R + + + Q+ GL+ H +IH+D+ N I+ SVKI GL+
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT- 163
Query: 107 TYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD-D 165
K + I ++ E ++++++ DVYA+ + E+ E P+ + +
Sbjct: 164 --LKRASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAA 219
Query: 166 QVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIV 210
Q+ ++ S + + E CI + +R + ++
Sbjct: 220 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.0 bits (194), Expect = 4e-18
Identities = 32/148 (21%), Positives = 62/148 (41%), Gaps = 7/148 (4%)
Query: 58 QAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRN 117
A A +V L LE++ K +I++D+ N L+ + +KI+ G +K Y
Sbjct: 105 VAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGT 164
Query: 118 AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177
++ E V ++ D +++ LI+E+ G PF D + + ++ + +L
Sbjct: 165 ----PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNAELR 219
Query: 178 WKHSSKTPEYITSLHEKCIHPHPHQRPT 205
+ E + L + I QR
Sbjct: 220 F--PPFFNEDVKDLLSRLITRDLSQRLG 245
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.6 bits (193), Expect = 6e-18
Identities = 24/159 (15%), Positives = 59/159 (37%), Gaps = 7/159 (4%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHI-SDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY 108
+ + ++ V GL ++ +++H+D+ N L++S +K+ G+S
Sbjct: 97 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156
Query: 109 QKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168
+ + ++ E + +S +SD+++ + E+ G P P ++
Sbjct: 157 DSMANSF---VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKEL- 211
Query: 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFP 207
+L +++TP + RP
Sbjct: 212 -ELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMA 249
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (191), Expect = 1e-17
Identities = 27/156 (17%), Positives = 66/156 (42%), Gaps = 4/156 (2%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
R R + +A ++ LE++ + ++++DI N ++ D +KI+ GL K+
Sbjct: 98 RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GI 156
Query: 110 KEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169
+ + +L E + D+++ D + +++E+ G +PF + +++
Sbjct: 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFE 215
Query: 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
+ +++ + SL + P QR
Sbjct: 216 LILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLG 249
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 77.2 bits (189), Expect = 1e-17
Identities = 30/181 (16%), Positives = 55/181 (30%), Gaps = 16/181 (8%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---DLSVKISLSGLSK--- 105
R S + +A Q+ +E+I K IH+D+ N L+ V I GL+K
Sbjct: 98 RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157
Query: 106 ---DTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDL 162
Y + +N R+ E S + D+ + ++ G +P+ L
Sbjct: 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGL 216
Query: 163 SDDQVLSQLESKKLC------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216
+ E P + C +P + + +
Sbjct: 217 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
Query: 217 M 217
Sbjct: 277 F 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 76.8 bits (188), Expect = 2e-17
Identities = 29/183 (15%), Positives = 55/183 (30%), Gaps = 18/183 (9%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-----SVKISLSGLSK- 105
R S A Q+ ++ I +K L+++DI N LI + + G+ K
Sbjct: 96 RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155
Query: 106 -----DTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFP 160
Y + +N R++ E S + D+ A + G +P+
Sbjct: 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQ 214
Query: 161 DLSDDQVLSQLESKKLC------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
L + E + + PE + P + + S
Sbjct: 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
Query: 215 DAM 217
+
Sbjct: 275 KVL 277
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (187), Expect = 3e-17
Identities = 36/216 (16%), Positives = 75/216 (34%), Gaps = 36/216 (16%)
Query: 27 GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAAR 86
G L +L ++ + L+ S A +A+ + + H+D+ ++
Sbjct: 86 GSLFDYL--------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137
Query: 87 NCLISSDLSVKISLSGLSK---DTYQKEYYKYRNAILPLRWLPYEAVFDD------EFST 137
N L+ + + I+ GL+ + + R++ E + D E
Sbjct: 138 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 197
Query: 138 KSDVYAYACLIWEIF---------NKGEMPFPDLSDDQVLSQLESKKLCWK--------- 179
++D+YA + WEI ++P+ DL + K +C +
Sbjct: 198 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 257
Query: 180 -HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLS 214
S + + + +C + + R T I LS
Sbjct: 258 WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.3 bits (187), Expect = 5e-17
Identities = 22/167 (13%), Positives = 65/167 (38%), Gaps = 12/167 (7%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---DLSVKISLSGLSKDTY 108
++ + +A + + ++++ + H+D+ N L +S + +K++ G +K+T
Sbjct: 106 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165
Query: 109 QKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168
++ E + +++ D+++ +++ + G PF +
Sbjct: 166 SHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAIS 222
Query: 169 SQLESKKLCWKHSSKTPEY------ITSLHEKCIHPHPHQRPTFPSI 209
++++ ++ PE+ + L + P QR T
Sbjct: 223 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 74.8 bits (183), Expect = 9e-17
Identities = 32/160 (20%), Positives = 62/160 (38%), Gaps = 5/160 (3%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQ 109
++ +A+ + L +IH+D+ N +IS+ +VK+ G+++
Sbjct: 104 TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163
Query: 110 KEYYKYRNAILP--LRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167
+ A + ++L E D +SDVY+ C+++E+ GE PF S V
Sbjct: 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL-TGEPPFTGDSPVSV 222
Query: 168 LSQL--ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPT 205
Q E + ++ K + +P R
Sbjct: 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 2e-16
Identities = 30/185 (16%), Positives = 69/185 (37%), Gaps = 28/185 (15%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
+ + +Q+ GL R++H+D+ +N LI+++ ++K++ GL++
Sbjct: 97 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 112 YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
+ P + +ST D+++ C+ E+ FP S+ L ++
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215
Query: 172 ESK-----KLCWKHSSKTPEYITS----------------------LHEKCIHPHPHQRP 204
++ W + P+Y S L + +H P++R
Sbjct: 216 FRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275
Query: 205 TFPSI 209
+ +
Sbjct: 276 SAKAA 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 3e-16
Identities = 27/156 (17%), Positives = 63/156 (40%), Gaps = 5/156 (3%)
Query: 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYY 113
+ + ++ L LEH+ +I++DI N L+ S+ V ++ GLSK+ E
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
Query: 114 KYRNAILPLRWLPYEAVFDDE--FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
+ + + ++ + V + D ++ L++E+ G PF + +++
Sbjct: 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEI 244
Query: 172 ESKKLCWKHS--SKTPEYITSLHEKCIHPHPHQRPT 205
+ L + + L ++ + P +R
Sbjct: 245 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLG 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.3 bits (176), Expect = 9e-16
Identities = 29/162 (17%), Positives = 66/162 (40%), Gaps = 2/162 (1%)
Query: 58 QAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRN 117
+ +Q+ GL + ++H+D+ +N LI+ + +K++ GL++
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
Query: 118 AILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177
+ P +ST D+++ C+ E+ N G FP D L ++ +L
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI--FRLL 219
Query: 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219
+ + +T L + +P + ++V +L+ +
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRD 261
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 72.1 bits (176), Expect = 1e-15
Identities = 31/156 (19%), Positives = 58/156 (37%), Gaps = 7/156 (4%)
Query: 49 PRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY 108
R+ S A A Q+ L E++ LI++D+ N LI ++++ G +K
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 109 QKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168
+ + L E + ++ D +A LI+E+ G PF Q+
Sbjct: 193 GRTWTLCGTP----EALAPEIILSKGYNKAVDWWALGVLIYEMA-AGYPPFFADQPIQIY 247
Query: 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP 204
++ S K + S + L + +R
Sbjct: 248 EKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 71.5 bits (174), Expect = 1e-15
Identities = 33/168 (19%), Positives = 76/168 (45%), Gaps = 3/168 (1%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
L + A + Q+ G+ + D+R++H+D+ +N LI+ + +KI+ GL++
Sbjct: 95 GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154
Query: 112 YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
+ P + ++ST D+++ C+ E+ N G FP +S+ L ++
Sbjct: 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRI 213
Query: 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219
++ +SK +T L + + ++ + S + L ++ +
Sbjct: 214 F--RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 70.4 bits (172), Expect = 5e-15
Identities = 29/163 (17%), Positives = 61/163 (37%), Gaps = 8/163 (4%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---DLSVKISLSGLSKDTY 108
+ A + +QV ++++ D ++H+D+ N L S D + IS GLSK
Sbjct: 102 GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--M 159
Query: 109 QKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168
+ A ++ E + +S D ++ + + + G PF D +D ++
Sbjct: 160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC-GYPPFYDENDAKLF 218
Query: 169 SQLESKKLCW--KHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
Q+ + + + + + P +R T
Sbjct: 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.1 bits (171), Expect = 6e-15
Identities = 28/154 (18%), Positives = 68/154 (44%), Gaps = 12/154 (7%)
Query: 57 SQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYR 116
+ A ++ LGLEH+ ++ ++++D+ N L+ V+IS GL+ D +K+ +
Sbjct: 107 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 166
Query: 117 NAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175
++ E + + + +D ++ C+++++ G PF + E +
Sbjct: 167 G---THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKD---KHEIDR 219
Query: 176 LCWKHSSKTPEYIT----SLHEKCIHPHPHQRPT 205
+ + + P+ + SL E + ++R
Sbjct: 220 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLG 253
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.9 bits (170), Expect = 7e-15
Identities = 30/180 (16%), Positives = 70/180 (38%), Gaps = 5/180 (2%)
Query: 45 GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLS 104
G + + S+ + + GL +I +++H+D+ A N LI+ D +K++ GL+
Sbjct: 105 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 164
Query: 105 KD---TYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFP 160
+ + +Y N ++ L + P E + + ++ D++ C++ E++
Sbjct: 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQ 223
Query: 161 DLSDDQVLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220
++ L+ + L+EK +R + + D D
Sbjct: 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 9e-15
Identities = 34/183 (18%), Positives = 73/183 (39%), Gaps = 28/183 (15%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
+ T M +Q+ GL+ + R++H+D+ +N L++S +K++ GL++
Sbjct: 111 PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SF 168
Query: 112 YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
+ ++ L + E + ++T D+++ C+ E+F + F SD L ++
Sbjct: 169 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKI 227
Query: 172 -------------------------ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTF 206
+S + K + E L KC+ +P +R +
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
Query: 207 PSI 209
S
Sbjct: 288 YSA 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.2 bits (166), Expect = 2e-14
Identities = 25/167 (14%), Positives = 64/167 (38%), Gaps = 9/167 (5%)
Query: 49 PRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD----LSVKISLSGLS 104
SL+ +A Q+ G+ ++ ++ H D+ N ++ +KI GL+
Sbjct: 105 AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164
Query: 105 KDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSD 164
+++N ++ E V + ++D+++ + + + + G PF +
Sbjct: 165 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTK 221
Query: 165 DQVLSQLESKKLCW--KHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
+ L+ + + + ++ S T + + P +R T
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.4 bits (164), Expect = 4e-14
Identities = 31/160 (19%), Positives = 58/160 (36%), Gaps = 14/160 (8%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD-LSVKISLSGLSKDTYQK 110
+L A + +QV + H + ++H+DI N LI + +K+ G
Sbjct: 105 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 164
Query: 111 EYYKYRNAILPLRWLPYEAVFDDEFSTKS-DVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169
Y + + P E + + +S V++ L++++ G++PF
Sbjct: 165 VYTDF---DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV-CGDIPFEHDE------ 214
Query: 170 QLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
E + + L C+ P RPTF I
Sbjct: 215 --EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (161), Expect = 1e-13
Identities = 30/180 (16%), Positives = 57/180 (31%), Gaps = 27/180 (15%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
L+ S GLE++ ++H+D+ N L+ + +K++ GL+K
Sbjct: 95 LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154
Query: 112 YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
+ P + D++A C++ E+ P SD L+++
Sbjct: 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRI 213
Query: 172 ESKKLC-----WKHSSKTPEYIT---------------------SLHEKCIHPHPHQRPT 205
W P+Y+T L + +P R T
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 273
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (155), Expect = 1e-12
Identities = 30/182 (16%), Positives = 57/182 (31%), Gaps = 30/182 (16%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDI-AARNCLISSDLSVKISLSGLSKDTYQK 110
++L YQ+ L +I + H+DI L +K+ G +K +
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 111 EYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL-- 168
E P ++++ DV++ C++ E+ G+ FP S L
Sbjct: 177 EPN-VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVE 234
Query: 169 -------------------------SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQR 203
Q+++ +TP +L + + P R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 204 PT 205
T
Sbjct: 295 LT 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (154), Expect = 1e-12
Identities = 26/173 (15%), Positives = 60/173 (34%), Gaps = 4/173 (2%)
Query: 50 RVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSK--DT 107
+ + LS YQ+ GL++I ++H+D+ N L+++ +KI GL++ D
Sbjct: 102 KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161
Query: 108 YQKEYYKYRNAILPLRWLPYEAVFDDEFSTKS-DVYAYACLIWEIFNKGEMPFPDLSDDQ 166
+ + E + + + TKS D+++ C++ E+ + FP
Sbjct: 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLD 220
Query: 167 VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219
L+ + + + + + +
Sbjct: 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 273
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.6 bits (133), Expect = 8e-10
Identities = 28/168 (16%), Positives = 57/168 (33%), Gaps = 4/168 (2%)
Query: 52 RSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKE 111
L + + YQ+ GL +I +IH+D+ N ++ D +KI GL++ +
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174
Query: 112 YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171
+ P + ++ D+++ C++ E+ G+ F L ++
Sbjct: 175 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKEI 231
Query: 172 ESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219
++ F SI+T S N
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVN 279
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 53.7 bits (128), Expect = 3e-09
Identities = 23/168 (13%), Positives = 58/168 (34%), Gaps = 6/168 (3%)
Query: 45 GSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD-LSVKISLSGL 103
K ++L+ Y++ L++ ++H+D+ N +I + +++ GL
Sbjct: 117 TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176
Query: 104 SKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS 163
++ + + Y R P V + D+++ C++ + + E F
Sbjct: 177 AEFYHPGQEYNVR-VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235
Query: 164 DDQVLSQ----LESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFP 207
+ L + L ++ L E ++ + F
Sbjct: 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.2 bits (124), Expect = 9e-09
Identities = 29/173 (16%), Positives = 64/173 (36%), Gaps = 8/173 (4%)
Query: 49 PRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY 108
+ + L+ + YQ+ GL++I +IH+D+ N ++ D +KI GL+
Sbjct: 113 VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---R 169
Query: 109 QKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVL 168
+ P + ++ D+++ C++ E+ G FP L
Sbjct: 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQL 228
Query: 169 SQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRP--TFPSIVTQLSDAMCN 219
+ +L ++ + I+S + Q P F ++ + +
Sbjct: 229 KLI--LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 279
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (123), Expect = 1e-08
Identities = 26/155 (16%), Positives = 63/155 (40%), Gaps = 9/155 (5%)
Query: 55 STSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYK 114
+ + YQ+ G++H+ +IH+D+ N ++ SD ++KI GL++
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 176
Query: 115 YRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174
++ + E + + D+++ C++ E+ ++ FP
Sbjct: 177 PY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQW-----N 228
Query: 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSI 209
K+ + + PE++ L + + RP + +
Sbjct: 229 KVIEQLGTPCPEFMKKLQPT-VRNYVENRPKYAGL 262
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.2 bits (121), Expect = 2e-08
Identities = 26/148 (17%), Positives = 56/148 (37%), Gaps = 12/148 (8%)
Query: 48 KPRVRSLSTSQAVTMAYQVALGLEHISDKR-LIHKDIAARNCLISSD------LSVKISL 100
K R + ++ Q+ LGL+++ + +IH DI N L+ + +KI+
Sbjct: 116 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 175
Query: 101 SGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFP 160
G + + + + E + + +D+++ ACLI+E+ G+ F
Sbjct: 176 LGNACWYDEHYTNSIQT----REYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFE 230
Query: 161 DLSDDQVLSQLESKKLCWKHSSKTPEYI 188
+ + + P Y+
Sbjct: 231 PDEGHSYTKDDDHIAQIIELLGELPSYL 258
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 34.8 bits (79), Expect = 0.004
Identities = 12/95 (12%), Positives = 30/95 (31%), Gaps = 16/95 (16%)
Query: 62 MAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTY--QKEYYKYRNAI 119
+ + + + ++H D++ N L+S + I S + R+
Sbjct: 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDF-PQSVEVGEEGWREILERDVR 166
Query: 120 LPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNK 154
+ + F + T+ D I ++
Sbjct: 167 NIITY------FSRTYRTEKD-------INSAIDR 188
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 223 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.4 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.13 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 92.51 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 91.54 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 90.75 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 89.14 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=276.80 Aligned_cols=188 Identities=23% Similarity=0.485 Sum_probs=155.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+. .+++..++.++.||++||.|||+++++||||||+||+++.++.+
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~--------------~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~ 140 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRG--------------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI 140 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTT--------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCE
T ss_pred eEEEEEecCCCcHHHHhhcccc--------------CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCe
Confidence 4588999999999999986533 68999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++..............++..|+|||.+.+..++.++|||||||++|||++.+..||...+..+....+..+ .
T Consensus 141 Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~ 219 (263)
T d1sm2a_ 141 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-F 219 (263)
T ss_dssp EECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-C
T ss_pred EecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-C
Confidence 999999998665444333445677889999999999999999999999999999996678888888888888887776 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
+...+..+++++.+++..||+.||++|||+++++++|+++.++
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 5566778899999999999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-44 Score=279.75 Aligned_cols=188 Identities=28% Similarity=0.463 Sum_probs=155.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|+|.+++..... .+++.+++.++.||++||.|||+++++||||||+||+++.++.+
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~--------------~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~ 167 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDG--------------QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVC 167 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTT--------------CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred EEEEEEecCCCcceeeeccccC--------------CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcE
Confidence 4488999999999999986433 69999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh----hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEY----YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
||+|||+++....... .......+|+.|+|||.+....++.++|||||||++|||++.|..||.+....+....+.
T Consensus 168 Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp EECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred EECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999976543321 112234568899999999988999999999999999999966899999999988888887
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.+ .+.+.+..+++++.+++.+||+.||++|||++++++.|++++.+
T Consensus 248 ~~-~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 248 QD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TT-CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cC-CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 76 55666778999999999999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=279.83 Aligned_cols=189 Identities=26% Similarity=0.438 Sum_probs=163.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.++++..+ .+++..++.++.||+.||.|||+++++||||||+||+++.++.+
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~---------------~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~ 146 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNR---------------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 146 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCT---------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred EEEEEEcCCCCcHHHHHhhcc---------------CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcc
Confidence 448999999999999998654 49999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+++|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++.|..||.+....++...+..+
T Consensus 147 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~ 226 (277)
T d1xbba_ 147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 226 (277)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred cccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999997643322 112234567889999999998889999999999999999996699999999988888887776
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhcc
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDV 221 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 221 (223)
.+++.+..+|+++.+++.+||+.||++|||++++.+.|+..+.+.+
T Consensus 227 -~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 227 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred -CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 5566678899999999999999999999999999999888765544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=285.38 Aligned_cols=203 Identities=29% Similarity=0.494 Sum_probs=156.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccC-CCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDK-SGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+|||||++|+|.++|+..+....+. ..........+++.+++.++.||++||.|||+++++||||||+||+++.++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence 447899999999999998765422110 0011112346899999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+||+|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++.+..||.+....+.+......
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~ 252 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 9999999997544332 222344578899999999999999999999999999999996667788877654444443333
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
...+..+..+++++.+++.+||+.||++|||++|++++|+++++.
T Consensus 253 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 356667778999999999999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=274.83 Aligned_cols=187 Identities=21% Similarity=0.387 Sum_probs=151.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|||.++++..+ ..+++..++.++.||++||.|||+++++||||||+||+++.++.+
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~ 143 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIE--------------TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTV 143 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSE
T ss_pred EEEEEecCCCCCHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCE
Confidence 458999999999999997643 359999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HH
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFD---DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS-QL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~-~~ 171 (223)
||+|||+++...... ........+|+.|+|||.+.. ..++.++|||||||++|||+ +|..||.+........ .+
T Consensus 144 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~-tg~~Pf~~~~~~~~~~~~~ 222 (276)
T d1uwha_ 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM-TGQLPYSNINNRDQIIFMV 222 (276)
T ss_dssp EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHH-HSSCTTTTCCCHHHHHHHH
T ss_pred EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHH-HCCCCCCCCChHHHHHHHH
Confidence 999999997654332 223345678999999999864 34788999999999999999 6999998876554433 33
Q ss_pred HhCccc---CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 172 ESKKLC---WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 172 ~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
..+... ...+..+++++.+++.+||+.||++|||+++++++|+.+.+
T Consensus 223 ~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp HHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 333222 12356789999999999999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=277.54 Aligned_cols=187 Identities=25% Similarity=0.422 Sum_probs=162.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++...+ ..+++..+..++.||++||.|||+++++||||||+||+++.++.+
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~ 148 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKR--------------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 148 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCT--------------TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEE
T ss_pred EEEEEEeCCCCcHHHHhhccc--------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCce
Confidence 448999999999999986543 369999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhh--hhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
|++|||+++....... .......+|+.|+|||.+....++.++|||||||++|||++.|..||.+....++...+..+
T Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~ 228 (285)
T d1u59a_ 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 228 (285)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT
T ss_pred eeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999986543321 12234467889999999988889999999999999999996699999998888888887776
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.+++.+..+|+++.+++.+||+.||++|||+.++.+.|+....
T Consensus 229 -~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 229 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 4566678899999999999999999999999999999887654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=275.61 Aligned_cols=189 Identities=30% Similarity=0.482 Sum_probs=165.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++..... .++++..++.++.||++||.|||+++++||||||+||+++.++.+
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~-------------~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~ 148 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSG-------------IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC 148 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHH-------------HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE
T ss_pred eEEEEEeCCCCcHHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccce
Confidence 4589999999999998875544 469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++..............+++.|+|||.+....++.++|||||||++|||++.+..|+......+....+..+ .
T Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-~ 227 (272)
T d1qpca_ 149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-Y 227 (272)
T ss_dssp EECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-C
T ss_pred eeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-C
Confidence 999999998665443333445677889999999988889999999999999999996577778888888888777766 5
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
++..+..+++++.+++.+||+.||++|||++++++.|++.+..
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 5666788999999999999999999999999999999988754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-44 Score=275.63 Aligned_cols=189 Identities=29% Similarity=0.478 Sum_probs=161.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|+|.+++..... ..+++..++.++.||++||.|||++|++||||||+|||++.++.+
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~-------------~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~ 154 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNR-------------QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 154 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCT-------------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred eEEEeecccCcchHHHhhhccc-------------cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcE
Confidence 4488999999999999987543 569999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++..............++..|+|||.+.+..++.++|||||||++|||++.+..|+.+.+.......+..+ .
T Consensus 155 Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~ 233 (287)
T d1opja_ 155 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-Y 233 (287)
T ss_dssp EECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-C
T ss_pred EEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-C
Confidence 999999998655443333334457788999999999999999999999999999995456666666776666665554 5
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.++.+..+++++.+++.+||+.||++|||++++++.|+.++.+
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 6677788999999999999999999999999999999887654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-44 Score=273.48 Aligned_cols=189 Identities=31% Similarity=0.519 Sum_probs=155.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++..... ++++..++.++.||++||.|||+++++||||||+||+++.++.+
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~--------------~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~ 147 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKY--------------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 147 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTT--------------TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred EEEEEEeccCCcHHhhhhccCC--------------CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcE
Confidence 4589999999999999876543 69999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
|++|||+++..............+|+.|+|||.+....++.++|||||||++|||++.|..||.+.+..+....+..+ .
T Consensus 148 Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-~ 226 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-E 226 (273)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-C
T ss_pred EEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C
Confidence 999999998654444333445567889999999999999999999999999999996699999999988888888776 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
..+.+..+++++.++|.+||+.||++|||+++|+++|++++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 45667889999999999999999999999999999999988653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=280.91 Aligned_cols=199 Identities=29% Similarity=0.479 Sum_probs=161.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCC--------CCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSG--------SGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNC 88 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~ni 88 (223)
..+|||||++|+|.++|+..+........ ........+++..++.++.||++||.|||+++|+||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 44899999999999999876532111000 0011234689999999999999999999999999999999999
Q ss_pred eeecCCCeEEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy15108 89 LISSDLSVKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV 167 (223)
Q Consensus 89 l~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~ 167 (223)
+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++.|..||.+.+..+.
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999765443211 223455688999999999999999999999999999999668999998777666
Q ss_pred HHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 168 LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
+..+.....+++.+..+++++++||.+||+.||++|||++||+++|..
T Consensus 276 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 666666557777788899999999999999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=271.21 Aligned_cols=174 Identities=20% Similarity=0.255 Sum_probs=155.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|||||++|+|.+++...+ .+++..+..++.||++||.|||++|++||||||+||+++.++.+|
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~---------------~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~k 146 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLS---------------KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELK 146 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEeecCCCcHHHHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEe
Confidence 38999999999999998764 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
++|||++....... .....||+.|+|||.+.+..++.++||||+||++|+|+ +|+.||.+.+..+....+.....
T Consensus 147 l~DFG~a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell-~G~~Pf~~~~~~~~~~~i~~~~~- 221 (263)
T d2j4za1 147 IADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEF- 221 (263)
T ss_dssp ECCCCSCSCCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHHTTCC-
T ss_pred ecccceeeecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHh-cCCCCCCCCCHHHHHHHHHcCCC-
Confidence 99999997654322 23457899999999999999999999999999999999 79999999988888888776543
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+..+++++++++.+||+.||++|||++|+++|
T Consensus 222 -~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 3456789999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=271.04 Aligned_cols=187 Identities=27% Similarity=0.476 Sum_probs=158.6
Q ss_pred CCCCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC
Q psy15108 15 KDKSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL 94 (223)
Q Consensus 15 ~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~ 94 (223)
+...+|+||+++|+|.++|..++. ..+++..+++++.||++|+.|||+.+++||||||+||+++.++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~ 140 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGR-------------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 140 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHH-------------HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred CcEEEEEeccCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC
Confidence 335589999999999999987654 3589999999999999999999999999999999999999999
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++++|||+++..... .....++..|+|||.+.+..++.++|||||||++|||++.|..||...+..++...+..+
T Consensus 141 ~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~ 216 (262)
T d1byga_ 141 VAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 216 (262)
T ss_dssp CEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred CEeecccccceecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999754332 233456788999999998899999999999999999996689999998888888887765
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.+++.+..+++++++++.+||..||++|||+.+++++|+++-..
T Consensus 217 -~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 217 -YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 56677788999999999999999999999999999999987644
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=267.12 Aligned_cols=184 Identities=29% Similarity=0.535 Sum_probs=163.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.+|+|.+++..... .+++..+++++.|+++||.|||+.|++||||||+||+++.++.+
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~--------------~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~ 139 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRH--------------RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 139 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGG--------------CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCE
T ss_pred eEEEEEccCCCcHHHhhhcccc--------------CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcE
Confidence 4478999999999999886544 68999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++..............++..|+|||.+....++.++||||||+++|||+|.|..||.+....++...+..+ .
T Consensus 140 kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-~ 218 (258)
T d1k2pa_ 140 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-L 218 (258)
T ss_dssp EECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-C
T ss_pred EECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-C
Confidence 999999997655443333344667889999999999999999999999999999996689999999998888888776 5
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSD 215 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~ 215 (223)
++..+..+++++.+++.+||+.||++|||+++++++|.+
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 667778899999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=271.64 Aligned_cols=181 Identities=16% Similarity=0.277 Sum_probs=147.9
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----cccCCCCCCCeeeec
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR-----LIHKDIAARNCLISS 92 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----i~H~di~~~nil~~~ 92 (223)
.+|||||++|||.+++.+... ....+++..++.++.|+++||.|||+++ |+||||||+||+++.
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~-----------~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~ 149 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTK-----------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 149 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHH-----------HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT
T ss_pred EEEEecCCCCcHHHHHHhccc-----------cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC
Confidence 479999999999999986543 2356999999999999999999999876 999999999999999
Q ss_pred CCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 93 DLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 93 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
++.+||+|||+++....... ......+++.|+|||++.+..++.++||||+||++|+|+ +|..||.+.+..+....+.
T Consensus 150 ~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~-tg~~Pf~~~~~~~~~~~i~ 227 (269)
T d2java1 150 KQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC-ALMPPFTAFSQKELAGKIR 227 (269)
T ss_dssp TSCEEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHH
T ss_pred CCcEEEeeccceeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHh-hCCCCCCCCCHHHHHHHHH
Confidence 99999999999876543221 224467889999999999889999999999999999999 7999999999888888887
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... ...+..+++++.+++.+||+.||++|||++|+++|
T Consensus 228 ~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 228 EGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 7643 34567789999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=265.10 Aligned_cols=188 Identities=28% Similarity=0.470 Sum_probs=155.7
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+++||+.+|+|.+++..... .+++.++..++.||+.|+.|||+.+++||||||+|||++.++.+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~--------------~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~ 149 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDG--------------EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC 149 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTT--------------CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred eEEEEEecccCcchhhhhcccc--------------cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeE
Confidence 3378999999999999886543 69999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
||+|||+++...... ........+|..|+|||.+.+..++.++|||||||++|||++.+..|+......++...+..+
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~ 229 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc
Confidence 999999997654332 112233467889999999999999999999999999999995567777777777777777666
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
.+++.+..++.++.+++.+||+.||++||+++++++.|+++++.
T Consensus 230 -~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 -FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 56667788999999999999999999999999999999988753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=268.05 Aligned_cols=180 Identities=21% Similarity=0.275 Sum_probs=154.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|+|.+++.+.+. ++++.++..++.||++||.|||++||+||||||+||+++.++.+
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~--------------~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~ 149 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELER--------------PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDI 149 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHHhcCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCE
Confidence 3489999999999999876543 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF-----DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
||+|||++....... .......+++.|+|||.+. ...++.++||||+||++|+|+ +|..||.+.+..+....+
T Consensus 150 Kl~DFG~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyeml-tg~~Pf~~~~~~~~~~~i 227 (288)
T d2jfla1 150 KLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKI 227 (288)
T ss_dssp EECCCTTCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHH-HSSCTTTTSCGGGHHHHH
T ss_pred EEEechhhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHh-hCCCCCCCCCHHHHHHHH
Confidence 999999997554332 2334578899999999974 445789999999999999999 799999998888877777
Q ss_pred HhCcc-cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKL-CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..... ....+..+++++++++.+||+.||++|||++|+++|
T Consensus 228 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 66533 334456789999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=265.48 Aligned_cols=189 Identities=29% Similarity=0.475 Sum_probs=158.1
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+++|+|.+++..... ..+++.+++.++.||+.||.|||+++++||||||+||+++.++.+
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~-------------~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~ 152 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETG-------------KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 152 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHH-------------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred eEEEEEecCCCchhhhhhhccc-------------ccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcE
Confidence 5589999999999999986544 469999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++..............+++.|+|||.+....++.++|||||||++|||++.+..|+......+.+..+..+ .
T Consensus 153 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-~ 231 (285)
T d1fmka3 153 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-Y 231 (285)
T ss_dssp EECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-C
T ss_pred EEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-C
Confidence 999999998655444333444677899999999999999999999999999999996577777777777788777765 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..+.+..+++++++++.+||+.||++||++++|++.|++.+.+
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 5567788999999999999999999999999999999887654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=265.17 Aligned_cols=186 Identities=27% Similarity=0.421 Sum_probs=162.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+|||++|+|.+++..+.. ++++..++.++.||++||.|||+++++||||||+||+++.++.+
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~--------------~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~v 150 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQG--------------HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV 150 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG--------------GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE
T ss_pred hheeeeeecCcchhhhhhcccC--------------CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccce
Confidence 4488999999999999887654 59999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 97 KISLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
|++|||++....... ........++..|+|||.+.+..++.++||||||+++|||++.|..||.+.+..+....+...
T Consensus 151 kl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230 (273)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred eeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC
Confidence 999999998654332 112233456788999999998889999999999999999996689999999999998888877
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDA 216 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~ 216 (223)
...++.+..+++++.+++.+||+.||++|||+++|++.|.++
T Consensus 231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 677777888999999999999999999999999999988764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=267.80 Aligned_cols=178 Identities=17% Similarity=0.276 Sum_probs=153.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|+|.+++.. ..+++.++..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 92 ~~ivmEy~~gg~L~~~~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~v 155 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV 155 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCE
T ss_pred EEEEEEecCCCcHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcE
Confidence 3489999999999998864 258999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-Cc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-KK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~-~~ 175 (223)
|++|||+++...... .......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+.......+.. ..
T Consensus 156 kl~DFG~a~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyeml-tG~~Pf~~~~~~~~~~~~~~~~~ 233 (293)
T d1yhwa1 156 KLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENPLRALYLIATNGT 233 (293)
T ss_dssp EECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHHHHHCS
T ss_pred eeccchhheeecccc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHh-hCCCCCCCCCHHHHHHHHHhCCC
Confidence 999999997654322 1234567899999999999989999999999999999999 79999998887666655543 33
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+..+++++++++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3445556789999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-42 Score=267.76 Aligned_cols=178 Identities=17% Similarity=0.206 Sum_probs=144.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee---cC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS---SD 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~---~~ 93 (223)
..+|||||++|||.++|...+ .+++..+..++.||+.||.|||++|++||||||.||++. .+
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~---------------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~ 146 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKG---------------FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDED 146 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTT
T ss_pred EEEEEeccCCCcHHHhhhccc---------------CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCC
Confidence 348899999999999998643 499999999999999999999999999999999999995 46
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+.+|++|||+++...... ......||+.|+|||.+.+..++.++||||+||++|+|+ +|..||.+....+....+..
T Consensus 147 ~~vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell-~g~~Pf~~~~~~~~~~~i~~ 223 (307)
T d1a06a_ 147 SKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL-CGYPPFYDENDAKLFEQILK 223 (307)
T ss_dssp CCEEECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHT
T ss_pred ceEEEeccceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHH-hCCCCCCCCCHHHHHHHHhc
Confidence 889999999997554332 234467899999999999999999999999999999999 79999999988888888877
Q ss_pred CcccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...... ....+++++.+++.+||+.||++|||++|+++|
T Consensus 224 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 654433 335789999999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=267.98 Aligned_cols=178 Identities=16% Similarity=0.222 Sum_probs=153.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|+|.+++...+. +++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~---------------l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~v 147 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGS---------------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI 147 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE
T ss_pred EEEEEEccCCCCHHHhhhccCC---------------CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceE
Confidence 4489999999999999987654 9999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||+++...... ........||+.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+..+....+....
T Consensus 148 kl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell-~g~~Pf~~~~~~~~~~~i~~~~ 226 (288)
T d1uu3a_ 148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV-AGLPPFRAGNEYLIFQKIIKLE 226 (288)
T ss_dssp EECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHTTC
T ss_pred EecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHh-hCCCCCCCcCHHHHHHHHHcCC
Confidence 999999997654332 22234567899999999999999999999999999999999 7999999999888888887764
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ..+..++++++++|.+||+.||.+|||++|++++
T Consensus 227 ~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 Y--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp C--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 3 3456789999999999999999999999987543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=263.44 Aligned_cols=202 Identities=32% Similarity=0.561 Sum_probs=166.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccc-cCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSK-DKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~ 95 (223)
..+|||||.+|+|.++|+.++.... ............+++..++.++.||+.||.|||+.+++||||||+||+++.++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~ 173 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 173 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCC
Confidence 4478999999999999986643111 001111123356999999999999999999999999999999999999999999
Q ss_pred eEEcCCCCCcccchhhhh-hhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYY-KYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+|++|||+++........ ......+++.|+|||.+.+..++.++|||||||++|+|++.|..||.+.+..++...+..+
T Consensus 174 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~ 253 (299)
T d1fgka_ 174 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253 (299)
T ss_dssp EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC
Confidence 999999999865443211 2234567788999999999999999999999999999996689999999988888777665
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..++.+..+++++.+++.+||+.||.+|||++|+++.|++++.-
T Consensus 254 -~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 254 -HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 66677888999999999999999999999999999999998753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-42 Score=262.02 Aligned_cols=175 Identities=19% Similarity=0.281 Sum_probs=147.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCCCCCeeee-cCC
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKR--LIHKDIAARNCLIS-SDL 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~~~nil~~-~~~ 94 (223)
.+|||||++|+|.++++..+ .+++..+..++.||++||.|||+++ ++||||||+||+++ .++
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~ 152 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFK---------------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG 152 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS
T ss_pred EEEEeCCCCCcHHHHHhccc---------------cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC
Confidence 37899999999999998764 4999999999999999999999998 99999999999996 478
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHh
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS-DDQVLSQLES 173 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~-~~~~~~~~~~ 173 (223)
.+||+|||+++..... ......||+.|+|||.+.+ .++.++||||+||++|+|+ +|..||.+.. .......+..
T Consensus 153 ~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~-~g~~Pf~~~~~~~~~~~~i~~ 227 (270)
T d1t4ha_ 153 SVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA-TSEYPYSECQNAAQIYRRVTS 227 (270)
T ss_dssp CEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHH-HSSCTTTTCSSHHHHHHHHTT
T ss_pred CEEEeecCcceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHH-HCCCCCCCcccHHHHHHHHHc
Confidence 9999999999743322 2235678999999998854 6999999999999999999 7999997654 4455566665
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+......+...++++.+++.+||+.||++|||++|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 544444455678899999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=268.30 Aligned_cols=187 Identities=23% Similarity=0.426 Sum_probs=160.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..++++|+.+|+|.+++..... .+++..++.++.||++||.|||+++++||||||+||+++.++.+
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~--------------~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKD--------------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSS--------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEE
T ss_pred eeEEEEeccCCccccccccccc--------------CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCe
Confidence 3477899999999999987543 69999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
||+|||+++...... ........+|..|+|||.+.+..++.++|||||||++|||+|.|..||.+.+..++...+..+
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~- 229 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 229 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-
T ss_pred EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-
Confidence 999999987654322 112233467889999999999999999999999999999996699999998888887777666
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.+++.+..+++++.+++.+||+.||.+|||+++++++|.++..
T Consensus 230 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 5566677899999999999999999999999999999988754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=267.71 Aligned_cols=178 Identities=21% Similarity=0.220 Sum_probs=147.8
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|||||.+|+|.++|+.++ .+++..+..++.||++||.|||++|++||||||+||+++.++.+||
T Consensus 80 ivmEy~~gg~L~~~l~~~~---------------~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL 144 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDI---------------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKI 144 (271)
T ss_dssp EEEECCTTEEGGGGSBTTT---------------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE
T ss_pred EEEeccCCCcHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEE
Confidence 8899999999999996543 4999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhh-hhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhCc
Q psy15108 99 SLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLSQLESKK 175 (223)
Q Consensus 99 ~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~~~~~~~ 175 (223)
+|||+++...... ........||+.|+|||.+.+..+ +.++||||+||++|+|+ +|..||...... ..........
T Consensus 145 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml-~G~~pf~~~~~~~~~~~~~~~~~ 223 (271)
T d1nvra_ 145 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML-AGELPWDQPSDSCQEYSDWKEKK 223 (271)
T ss_dssp CCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHH-HSSCSCSSSSTTSHHHHHHHTTC
T ss_pred ccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCC
Confidence 9999998654332 122345678999999999988776 56799999999999999 799999765543 3333344433
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........+++++.+++.+||+.||++|||++|+++|
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3333345678999999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-41 Score=263.32 Aligned_cols=201 Identities=29% Similarity=0.534 Sum_probs=162.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccC---------CCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDK---------SGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARN 87 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~---------~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~n 87 (223)
...++||+.+|+|.++|+......... ..........+++..++.++.|++.||.|||+++++||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 447899999999999998654321110 00111233468999999999999999999999999999999999
Q ss_pred eeeecCCCeEEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy15108 88 CLISSDLSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ 166 (223)
Q Consensus 88 il~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~ 166 (223)
|+++.++.+||+|||+++...... ........+++.|+|||.+.+..++.++|||||||++|||++.+..||.+.+..+
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 999999999999999987554333 2223345677889999999999999999999999999999955567899999999
Q ss_pred HHHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 167 VLSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
....+..+ ..++.+..+++++.+++..||+.+|++|||+.||++.|+++.+
T Consensus 251 ~~~~v~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 251 VIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 88888776 4556677899999999999999999999999999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-41 Score=265.58 Aligned_cols=174 Identities=17% Similarity=0.242 Sum_probs=152.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|||||.+|+|..++...+ ++++..+..++.||++||.|||++|++||||||+||+++.++.+|
T Consensus 91 ~iv~E~~~~g~l~~~~~~~~---------------~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~K 155 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHKK---------------PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK 155 (309)
T ss_dssp EEEEECCSEEHHHHHHHHTS---------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEE
T ss_pred EEEEEecCCCchHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEE
Confidence 38899999999987776543 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD---DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
|+|||++..... .....||+.|+|||++.+ ..|+.++||||+||++|+|+ +|..||.+....+....+...
T Consensus 156 l~DFG~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~-~g~~Pf~~~~~~~~~~~i~~~ 229 (309)
T d1u5ra_ 156 LGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALYHIAQN 229 (309)
T ss_dssp ECCCTTCBSSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCHHHHHHHHHHS
T ss_pred EeecccccccCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHH-HCCCCCCCCCHHHHHHHHHhC
Confidence 999999975433 234678999999999853 45888999999999999999 799999998888877777776
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
......+..+++++++++.+||+.||.+|||++|+++|
T Consensus 230 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 55555566789999999999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=266.54 Aligned_cols=189 Identities=28% Similarity=0.568 Sum_probs=155.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|+|.+++..... .+++..++.++.|+++||.|||+.+++||||||+||+++.++.+
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~--------------~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~ 169 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETH--------------NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 169 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTC--------------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCE
T ss_pred eEEEEEEeecCchhhhhccccc--------------cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCE
Confidence 3489999999999999986443 57889999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh---hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 97 KISLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 97 ~l~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
||+|||+++...... ........++..|+|||.+....++.++||||||+++|||++.+..|+...+.......+..
T Consensus 170 kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~ 249 (311)
T d1r0pa_ 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249 (311)
T ss_dssp EECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT
T ss_pred EEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 999999997654332 11223456788999999999999999999999999999999445544444455555666665
Q ss_pred CcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhc
Q psy15108 174 KKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCND 220 (223)
Q Consensus 174 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 220 (223)
+ .++..+..+++++.+++..||+.||++||++.||+++|++++.+-
T Consensus 250 g-~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 250 G-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred C-CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 5 455667788999999999999999999999999999999988653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-41 Score=263.26 Aligned_cols=175 Identities=17% Similarity=0.262 Sum_probs=155.4
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|||||++|+|.+++...+. ++++.+..++.||+.||.|||++|++||||||+||+++.++.+|+
T Consensus 82 iv~ey~~gg~L~~~~~~~~~---------------~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl 146 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERV---------------FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKI 146 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSC---------------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred cceeccCCCchhhhhhcccC---------------CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEE
Confidence 89999999999999987654 999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW 178 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 178 (223)
+|||+++....... ......||+.|+|||++.+..|+.++|+||+||++|+|+ +|..||.+.+..+....+.....
T Consensus 147 ~DFG~a~~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml-~G~~pf~~~~~~~~~~~i~~~~~-- 222 (337)
T d1o6la_ 147 TDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDHERLFELILMEEI-- 222 (337)
T ss_dssp CCCTTCBCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCCC--
T ss_pred eecccccccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHH-HCCCCCCCcCHHHHHHHHhcCCC--
Confidence 99999975433221 234467899999999999999999999999999999999 79999999999888888877654
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 179 KHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 179 ~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
..+..++++++++|.+||+.||.+|++ ++++++|
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 446778999999999999999999995 7888875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=263.42 Aligned_cols=199 Identities=27% Similarity=0.451 Sum_probs=162.0
Q ss_pred CCCCCCCCCCChHHHHHHhhhcccc-CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKD-KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
.+||||+++|+|.++|+.+...... ...........+++..+..++.||+.|+.|||+.+++||||||+||+++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 3789999999999999754210000 000000123569999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++...... ......++..|++||.+....++.++|||||||++|||++.+..||.+.+..++...+..+ .
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-~ 243 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-Y 243 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-C
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-C
Confidence 999999987543322 1223457888999999999999999999999999999995567789999988888887766 4
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
+++.+..+++++.++|.+||+.||++|||+++++++|++++++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 5666778999999999999999999999999999999998854
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=264.42 Aligned_cols=181 Identities=17% Similarity=0.256 Sum_probs=144.8
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~ 95 (223)
..+||||+++|+|.+++++.+. +++..+..++.|+++||.|||+ +||+||||||+||+++.++.
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~---------------l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~ 143 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGR---------------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE 143 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC
T ss_pred EEEEEEcCCCCcHHHHHhhcCC---------------CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC
Confidence 3489999999999999987644 9999999999999999999997 59999999999999999999
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH--------
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQV-------- 167 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~-------- 167 (223)
+||+|||+|+..... ......||+.|+|||++.+..|+.++||||+||++|||+ +|+.||.+.+....
T Consensus 144 vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell-~G~~Pf~~~~~~~~~~~~~~~~ 219 (322)
T d1s9ja_ 144 IKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA-VGRYPIPPPDAKELELMFGCQV 219 (322)
T ss_dssp EEECCCCCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHH-HSSCCSSCCCTTHHHHHC----
T ss_pred EEEeeCCCccccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHHHHh
Confidence 999999999754332 234568899999999999999999999999999999999 79999976543221
Q ss_pred ----------------------------------HHHHHhCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH-
Q psy15108 168 ----------------------------------LSQLESKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ- 212 (223)
Q Consensus 168 ----------------------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~- 212 (223)
...+.............+.++.+++.+||+.||++|||++|+++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp 299 (322)
T d1s9ja_ 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299 (322)
T ss_dssp --------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence 111111111111112357889999999999999999999999986
Q ss_pred -HHHH
Q psy15108 213 -LSDA 216 (223)
Q Consensus 213 -L~~~ 216 (223)
+++.
T Consensus 300 f~~~~ 304 (322)
T d1s9ja_ 300 FIKRS 304 (322)
T ss_dssp HHHHH
T ss_pred hhCcC
Confidence 5443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-41 Score=267.29 Aligned_cols=179 Identities=18% Similarity=0.216 Sum_probs=154.5
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec--CC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS--DL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~--~~ 94 (223)
.-+|||||++|+|.+++...+ +.+++..+..++.||+.||.|||++|++||||||+||+++. ++
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~ 163 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEH--------------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN 163 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTT--------------SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSC
T ss_pred EEEEEEcCCCCCHHHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCC
Confidence 338999999999999996432 35999999999999999999999999999999999999964 57
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.+||+|||+++...... ......+|+.|+|||++.+..++.++||||+||++|+|+ +|..||.+.+..+.+..+...
T Consensus 164 ~vkL~DFG~a~~~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell-~G~~Pf~~~~~~~~~~~i~~~ 240 (350)
T d1koaa2 164 ELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL-SGLSPFGGENDDETLRNVKSC 240 (350)
T ss_dssp CEEECCCTTCEECCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHT
T ss_pred eEEEeecchheeccccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH-hCCCCCCCCCHHHHHHHHHhC
Confidence 89999999997654332 223467899999999999999999999999999999999 699999999888888888776
Q ss_pred cccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
....+. ...+++++++++.+||+.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 544332 24578999999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-41 Score=261.67 Aligned_cols=206 Identities=27% Similarity=0.477 Sum_probs=166.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhcccc---CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKD---KSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~---~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~ 93 (223)
..++||||++|+|.++|+........ .+.........+++..+..++.||++|+.|||+++++||||||+||+++.+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence 44789999999999999876531111 111222344579999999999999999999999999999999999999999
Q ss_pred CCeEEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy15108 94 LSVKISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLE 172 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~ 172 (223)
+.++++|||.++...... ........+++.|+|||.+....++.++||||||+++|||++.|..||...+..+.+..+.
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i 261 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998654332 2223345778999999999989999999999999999999966787787777666655555
Q ss_pred hCcccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhhccC
Q psy15108 173 SKKLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCNDVN 222 (223)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 222 (223)
....++..+..+++++.+||.+||+.||++|||++++++.|++.+.++-|
T Consensus 262 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~~ 311 (311)
T d1t46a_ 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (311)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCCC
Confidence 54466667778899999999999999999999999999999998877644
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-41 Score=266.84 Aligned_cols=179 Identities=18% Similarity=0.217 Sum_probs=155.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeee--cCC
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLIS--SDL 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~--~~~ 94 (223)
..+|||||.+|+|.+++...+ .++++.++..++.||+.||.|||++|++||||||.|||++ .++
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~--------------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~ 166 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAED--------------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS 166 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTT--------------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCC
T ss_pred EEEEEEcCCCChHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCC
Confidence 348999999999999886543 3699999999999999999999999999999999999997 568
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.+||+|||++....... ......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+..+....+...
T Consensus 167 ~vkL~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell-tG~~Pf~~~~~~~~~~~i~~~ 243 (352)
T d1koba_ 167 SVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL-SGLSPFAGEDDLETLQNVKRC 243 (352)
T ss_dssp CEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH-HSCCSSCCSSHHHHHHHHHHC
T ss_pred eEEEeecccceecCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhC
Confidence 89999999997654432 223457789999999999999999999999999999999 799999999998888888776
Q ss_pred cccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...++ ....+++++.+++.+||+.||.+|||++|+++|
T Consensus 244 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 54433 335789999999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-41 Score=259.08 Aligned_cols=177 Identities=16% Similarity=0.241 Sum_probs=154.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC---
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL--- 94 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~--- 94 (223)
.+|||||++|+|.++|+..+. +++..+..++.|+++||.|||+.+++||||||+||+++.++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~---------------l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKES---------------LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSS
T ss_pred EEEEEcCCCccccchhccccc---------------cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcc
Confidence 388999999999999987644 99999999999999999999999999999999999998775
Q ss_pred -CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 95 -SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 95 -~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
.+|++|||++....... ......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+..+....+..
T Consensus 154 ~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell-~g~~Pf~~~~~~~~~~~i~~ 230 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL-SGASPFLGDTKQETLANVSA 230 (293)
T ss_dssp CCEEECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHT
T ss_pred cceEecchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHH-cCCCCCCCCCHHHHHHHHHh
Confidence 48999999997654332 234457788999999999888999999999999999999 79999999998888888877
Q ss_pred CcccCC--CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 KKLCWK--HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.....+ .+..+++++++++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 231 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 654433 235688999999999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-40 Score=254.64 Aligned_cols=177 Identities=16% Similarity=0.243 Sum_probs=153.3
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+++|||.++|+.++ ++++.++..++.||++||+|||++|++||||||+||+++.++.+|
T Consensus 86 ~ivmE~~~~g~L~~~l~~~~---------------~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~k 150 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTEKV---------------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 150 (277)
T ss_dssp EEEEECCTTCBHHHHHHHHS---------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEcCCCchHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeE
Confidence 38999999999999998764 499999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVF------DDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQL 171 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~------~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~ 171 (223)
|+|||++....... ......++..|.+||.+. ...++.++||||+||++|+|+ +|+.||.+.+.......+
T Consensus 151 l~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml-~g~~Pf~~~~~~~~~~~i 227 (277)
T d1phka_ 151 LTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPFWHRKQMLMLRMI 227 (277)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHH
T ss_pred EccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhc-cCCCCCCCCCHHHHHHHH
Confidence 99999997654432 234467889999999875 234678999999999999999 699999999988888887
Q ss_pred HhCcccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 172 ESKKLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 172 ~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+...++. ...+++++++++.+||+.||++||+++|+++|
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 776554333 34689999999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-40 Score=255.24 Aligned_cols=197 Identities=30% Similarity=0.572 Sum_probs=166.9
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|+||+.+|+|.+++...+...... .....+++..+..++.|+++||.|||+++++||||||.||+++.++.+
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANN-----PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHC-----TTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccc-----cccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 458899999999999998664321111 112357999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhh-hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKE-YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
||+|||+++...... ........+++.|++||.+.+..++.++||||||+++|||++.+..||.+.+..+....+..+
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~- 251 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG- 251 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-
Confidence 999999998654433 222334567899999999999999999999999999999997668999999999998888776
Q ss_pred ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 176 LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 176 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
..+..+..+++.+.+++.+||+.+|++|||+++++++|++.+++
T Consensus 252 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 45666778999999999999999999999999999999887654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.6e-40 Score=255.92 Aligned_cols=174 Identities=20% Similarity=0.232 Sum_probs=155.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||.+|+|.+++..... +++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~---------------~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~v 143 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQR---------------FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHI 143 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSS---------------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCE
T ss_pred eeeEeeecCCcccccccccccc---------------ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCE
Confidence 3488999999999999987644 8999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
||+|||+++..... .....|++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+..+....+.....
T Consensus 144 kL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyeml-tG~~Pf~~~~~~~~~~~i~~~~~ 218 (316)
T d1fota_ 144 KITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML-AGYTPFYDSNTMKTYEKILNAEL 218 (316)
T ss_dssp EECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHHHCCC
T ss_pred EEecCccceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHH-hCCCCCCCcCHHHHHHHHHcCCC
Confidence 99999999765432 23467899999999999889999999999999999999 79999999999888888877643
Q ss_pred cCCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 177 CWKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 177 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
..+..+++++.+++.+||+.||.+|+ +++++++|
T Consensus 219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 34567899999999999999999996 89999876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.9e-40 Score=253.04 Aligned_cols=183 Identities=19% Similarity=0.243 Sum_probs=150.7
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+||||+++|+|.+++...+. +++.+++.++.||++||.|||++|++||||||+||+++.++..++
T Consensus 88 lvmE~~~g~~L~~~~~~~~~---------------l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGP---------------MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCS---------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEE
T ss_pred EEEECCCCCEehhhhcccCC---------------CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccccee
Confidence 89999999999999987644 999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhh--hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 99 SLSGLSKDTYQKE--YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 99 ~df~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
+|||.+....... ........+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+..+....+.....
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyell-tG~~Pf~~~~~~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL-TGEPPFTGDSPVSVAYQHVREDP 231 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHCCC
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHH-hCCCCCCCcCHHHHHHHHHhcCC
Confidence 9999886543222 22334567899999999999888999999999999999999 79999999888777766655433
Q ss_pred cC--CCCCCChHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHh
Q psy15108 177 CW--KHSSKTPEYITSLHEKCIHPHPHQRP-TFPSIVTQLSDAM 217 (223)
Q Consensus 177 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~ 217 (223)
.+ .....+|+++.+++.+||+.||.+|| ++++++..|.++.
T Consensus 232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 32 23457899999999999999999999 8999999988764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=262.83 Aligned_cols=180 Identities=13% Similarity=0.235 Sum_probs=145.4
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec---C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---D 93 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~---~ 93 (223)
.-+|||||++|||.++|+.++. ..+++.++..++.||+.||.|||+.|++||||||+||+++. .
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~-------------~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~ 150 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD-------------QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 150 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC-------------CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTT
T ss_pred EEEEEECCCCCcHHHHHHhcCC-------------CCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccc
Confidence 3489999999999999986533 46999999999999999999999999999999999999985 4
Q ss_pred CCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Q psy15108 94 LSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES 173 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~ 173 (223)
+.+|++|||+++...... ......+++.|+|||.+.+..|+.++||||+||++|+|+ +|..||.+.+.......+..
T Consensus 151 ~~~Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ll-tg~~Pf~~~~~~~~~~~~~~ 227 (335)
T d2ozaa1 151 AILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAISPGMKT 227 (335)
T ss_dssp CCEEECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHT-TSSCSCEETTCC--------
T ss_pred ccccccccceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHh-hCCCCCCCCCHHHHHHHHHH
Confidence 569999999997654332 234567899999999999889999999999999999999 89999987765544443332
Q ss_pred C----cccCCCC--CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 K----KLCWKHS--SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 ~----~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ....+.+ ..+++++.+++.+||+.||++|||+.|+++|
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2 1222111 2467889999999999999999999999886
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-40 Score=260.03 Aligned_cols=173 Identities=19% Similarity=0.200 Sum_probs=154.4
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+|++|+.+|+|.+++...+. +++..+..++.||+.||.|||++|++||||||+|||++.++.+|
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~---------------l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ik 181 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGR---------------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCC---------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred ccccccccccchhhhHhhcCC---------------CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEE
Confidence 378999999999999987644 99999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
|+|||+++..... .....|++.|+|||++.+..++.++||||+||++|+|+ +|..||.+.+.......+.....
T Consensus 182 L~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyeml-tG~~Pf~~~~~~~~~~~i~~~~~- 255 (350)
T d1rdqe_ 182 VTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA-AGYPPFFADQPIQIYEKIVSGKV- 255 (350)
T ss_dssp ECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCCC-
T ss_pred eeeceeeeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHH-hCCCCCCCcCHHHHHHHHhcCCC-
Confidence 9999999765432 23467889999999999999999999999999999999 79999999998888888877643
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy15108 178 WKHSSKTPEYITSLHEKCIHPHPHQRP-----TFPSIVTQ 212 (223)
Q Consensus 178 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~ 212 (223)
..+..+++++.+++.+||+.||.+|+ +++++++|
T Consensus 256 -~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 -RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 34567899999999999999999994 89999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=259.28 Aligned_cols=175 Identities=18% Similarity=0.275 Sum_probs=154.5
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+||||+++|+|.++++..+. +++..+..++.||+.||.|||+++++||||||+|||++.++.+|+
T Consensus 80 ivmEy~~~g~L~~~i~~~~~---------------~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl 144 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHK---------------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKI 144 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSS---------------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEeecCCCcHHHHhhccCC---------------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceec
Confidence 89999999999999987644 999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcccC
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLCW 178 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 178 (223)
+|||+++...... .......+++.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+..+....+....+
T Consensus 145 ~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyeml-tG~~PF~~~~~~~~~~~i~~~~~-- 220 (320)
T d1xjda_ 145 ADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML-IGQSPFHGQDEEELFHSIRMDNP-- 220 (320)
T ss_dssp CCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHCCC--
T ss_pred cccchhhhccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCC--
Confidence 9999997544322 1234467899999999999999999999999999999999 79999999999888888876643
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCCHH-HHHHH
Q psy15108 179 KHSSKTPEYITSLHEKCIHPHPHQRPTFP-SIVTQ 212 (223)
Q Consensus 179 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~~ 212 (223)
..+..+++++.+++.+||+.||.+||++. ++++|
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 44567899999999999999999999995 67653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-39 Score=259.71 Aligned_cols=177 Identities=18% Similarity=0.246 Sum_probs=147.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+|||||++|+|.++|+..+. +++..+..++.||+.||.|||++|++||||||+|||++.++.+
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~---------------~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~i 146 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGV---------------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHV 146 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCS---------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCE
T ss_pred EEEEEEecCCCcHHHHHHhccc---------------ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcE
Confidence 3388999999999999987644 8999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-C
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLES-K 174 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~-~ 174 (223)
||+|||+++...... .....||+.|+|||.+.. ..++.++||||+||++|+|+ +|..||.+............ .
T Consensus 147 Kl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyeml-tG~~Pf~~~~~~~~~~~~~~~~ 222 (364)
T d1omwa3 147 RISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-RGHSPFRQHKTKDKHEIDRMTL 222 (364)
T ss_dssp EECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH-HSSCSSCSSCSSCHHHHHHHSS
T ss_pred EEeeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcc
Confidence 999999997654332 244678999999999864 56899999999999999999 79999986553322222211 1
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
......+..+++++.++|.+||+.||.+||+ ++++++|
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1334445678999999999999999999999 6888865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-40 Score=256.38 Aligned_cols=179 Identities=15% Similarity=0.182 Sum_probs=154.0
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC--C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD--L 94 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~--~ 94 (223)
.-+|||||.+|+|.++|+..+ ..+++.++..++.||++||.|||+.|++||||||+||+++.+ .
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~--------------~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~ 141 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSA--------------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS 141 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS--------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC
T ss_pred EEEEEecCCCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCce
Confidence 348999999999999997543 259999999999999999999999999999999999999854 5
Q ss_pred CeEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 95 SVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 95 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
.++++|||++....... ......+++.|++||...+..++.++||||+||++|+|+ +|..||.+.+..+....+...
T Consensus 142 ~ikl~DFG~~~~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll-~G~~Pf~~~~~~~~~~~i~~~ 218 (321)
T d1tkia_ 142 TIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL-SGINPFLAETNQQIIENIMNA 218 (321)
T ss_dssp CEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH-HSSCTTCCSSHHHHHHHHHHT
T ss_pred EEEEcccchhhccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhC
Confidence 78999999997654332 223456788999999998888999999999999999999 799999999998888888776
Q ss_pred cccCCC--CCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKH--SSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
...++. ...+++++++++.+||..||.+|||++|+++|
T Consensus 219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 544332 24678999999999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-38 Score=244.90 Aligned_cols=177 Identities=19% Similarity=0.256 Sum_probs=147.6
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+++||+.+|++........ ..+++..+..++.|++.||.|||+++|+||||||+|||++..+.+++
T Consensus 92 ~~~e~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPE--------------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp EEEECCSCBHHHHHHHSCT--------------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred EEEEeccCCchhhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeee
Confidence 6788998887765554332 46899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc--
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL-- 176 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~-- 176 (223)
+|||++....... ......+|+.|+|||.+.+.+++.++||||+||++|+|+ +|..||.+.+..+.+..+.....
T Consensus 158 ~dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 158 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cchhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHH-HCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 9999987554333 345678899999999999999999999999999999999 79999998887776665533100
Q ss_pred -----------------------cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 -----------------------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 -----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........++.+++|+.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 001234567889999999999999999999999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=246.21 Aligned_cols=179 Identities=17% Similarity=0.134 Sum_probs=145.6
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
..+||||+.++++..++... ..+++..+..++.||++||.|||++|++||||||+||+++.++.+
T Consensus 75 ~~ivmE~~~~~~~~~~~~~~---------------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~ 139 (299)
T d1ua2a_ 75 ISLVFDFMETDLEVIIKDNS---------------LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVL 139 (299)
T ss_dssp CEEEEECCSEEHHHHHTTCC---------------SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred eeehhhhhcchHHhhhhhcc---------------cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCcc
Confidence 44889999999887776533 359999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
||+|||++....... .......+++.|+|||.+... .++.++||||+||++|+|+ +|..||.+....+.+..+....
T Consensus 140 KL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~-~g~~pf~~~~~~~~l~~i~~~~ 217 (299)
T d1ua2a_ 140 KLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL-LRVPFLPGDSDLDQLTRIFETL 217 (299)
T ss_dssp EECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHHH
T ss_pred ccccCccccccCCCc-ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHH-hCcCCCCCCCHHHHHHHHHHhc
Confidence 999999997544322 122345788999999998654 5789999999999999999 6899999888877666654311
Q ss_pred ccCC--------------------------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWK--------------------------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
..+. .....++++.+|+.+||+.||++|||++|+++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 218 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000 012457889999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=241.82 Aligned_cols=168 Identities=19% Similarity=0.257 Sum_probs=140.4
Q ss_pred CCCCCCCCC-CChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecC-CC
Q psy15108 18 SGSGKPRVK-GDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSD-LS 95 (223)
Q Consensus 18 ~~v~~~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~-~~ 95 (223)
-+||||+.+ +++.+++...+ .+++..+..++.||++||.|||++|++||||||+||+++.+ +.
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~---------------~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERG---------------ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHC---------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE
T ss_pred EEEEEeccCcchHHHHHhccC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCe
Confidence 378999976 68899998754 49999999999999999999999999999999999999865 78
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEF-STKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
++++|||++...... ......||+.|+|||.+.+..+ +.++||||+||++|+|+ +|..||...+ .+...
T Consensus 150 vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell-~g~~Pf~~~~------~i~~~ 219 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV-CGDIPFEHDE------EIIRG 219 (273)
T ss_dssp EEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH-HSSCSCCSHH------HHHHC
T ss_pred EEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHh-hCCCCCCCch------HHhhc
Confidence 999999999754332 2345678999999999887765 56789999999999999 7999997532 22332
Q ss_pred cccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
. ...+..+++++++++.+||+.||++|||++|+++|
T Consensus 220 ~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 Q--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c--cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 2 33456789999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=241.01 Aligned_cols=185 Identities=18% Similarity=0.186 Sum_probs=142.5
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc--------CCcccCCCCCCCee
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISD--------KRLIHKDIAARNCL 89 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--------~~i~H~di~~~nil 89 (223)
-+||||+.+|+|.++|++. ++++.+++.++.|++.|+.|+|+ +||+||||||+||+
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~----------------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NIL 140 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY----------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC----------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEE
T ss_pred EEEEecccCCCHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceE
Confidence 3799999999999999753 48999999999999999999996 59999999999999
Q ss_pred eecCCCeEEcCCCCCcccchhh---hhhhhcCCcccccccccccccCC------CCcccchHHHHHHHHHHHhCCCCCCC
Q psy15108 90 ISSDLSVKISLSGLSKDTYQKE---YYKYRNAILPLRWLPYEAVFDDE------FSTKSDVYAYACLIWEIFNKGEMPFP 160 (223)
Q Consensus 90 ~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~------~~~~~Di~slG~il~~l~~~~~~p~~ 160 (223)
++.++.+||+|||++....... ........+++.|+|||.+.... ++.++|||||||++|||+ +|..|+.
T Consensus 141 l~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~-tg~~~~~ 219 (303)
T d1vjya_ 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA-RRCSIGG 219 (303)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH-HTBCBTT
T ss_pred EcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh-hCCCCCC
Confidence 9999999999999997654332 11234567899999999986542 466899999999999999 5765542
Q ss_pred C---------------CCHHHHHHHHHhCcccCCCCC-----CChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 161 D---------------LSDDQVLSQLESKKLCWKHSS-----KTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 161 ~---------------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
. .........+.....++..+. ..+..+.+++.+||+.||++|||+.|++++|+++.++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1 122233333333333332222 2335688999999999999999999999999988754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-37 Score=238.59 Aligned_cols=184 Identities=17% Similarity=0.198 Sum_probs=143.5
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec---CCC
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS---DLS 95 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~---~~~ 95 (223)
+||||+ +|+|.+.+..... .+++..+..++.|++.||+|||++|++||||||+||+++. +..
T Consensus 80 ivme~~-~~~l~~~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~ 144 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCSR--------------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL 144 (299)
T ss_dssp EEEECC-CCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC
T ss_pred EEEEEc-CCchhhhhhhccC--------------CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCce
Confidence 567766 6777777765433 6999999999999999999999999999999999998753 456
Q ss_pred eEEcCCCCCcccchhh------hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy15108 96 VKISLSGLSKDTYQKE------YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLS 169 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~ 169 (223)
++++|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|+|+ +|..||..........
T Consensus 145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~-tg~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 145 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN-LGSLPWQGLKAATKRQ 223 (299)
T ss_dssp EEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHH-HSSCTTCCCC------
T ss_pred eeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHH-hCCCcccccchHHHHH
Confidence 9999999998654332 11234457899999999999999999999999999999999 7999998765443322
Q ss_pred HH---HhCcc---cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhh
Q psy15108 170 QL---ESKKL---CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMC 218 (223)
Q Consensus 170 ~~---~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 218 (223)
.+ ..... .......+|+++.+++..||+.+|++||+++++.+.|+.++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 224 KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 22 11111 111245788999999999999999999999999988887754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-37 Score=239.50 Aligned_cols=179 Identities=17% Similarity=0.214 Sum_probs=148.2
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
..++||+.+|+|.+++...+. +++..+..++.||+.|+.|+|+++++||||||+||+++.++.++
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~---------------~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRER---------------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSC---------------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred eeeeecccccHHHHHHHhccc---------------ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEE
Confidence 378999999999999987654 89999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE--FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
++|||+++..............+++.|++||.+.... ++.++||||+||++|+|+ +|..||.+.........+....
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyell-tG~~PF~~~~~~~~~~~i~~~~ 248 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL-TGASPFTVDGEKNSQAEISRRI 248 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH-HSSCTTSCTTSCCCHHHHHHHH
T ss_pred EeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999766555444445667888999999987543 677899999999999999 7999997765443333332221
Q ss_pred --ccCCCCCCChHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q psy15108 176 --LCWKHSSKTPEYITSLHEKCIHPHPHQRPT-----FPSIVTQ 212 (223)
Q Consensus 176 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~ 212 (223)
..++.+..+++++.+++.+||+.||++||+ ++|+++|
T Consensus 249 ~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 249 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 234445678999999999999999999994 7888874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-36 Score=234.01 Aligned_cols=185 Identities=17% Similarity=0.189 Sum_probs=149.2
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeec-----C
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISS-----D 93 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~-----~ 93 (223)
+||||+ +|+|.++++..+. .+++..+..++.|++.||.|||++|++||||||.||+++. .
T Consensus 78 ~vme~~-~~~l~~~~~~~~~--------------~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~ 142 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGR--------------KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNA 142 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTT--------------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTT
T ss_pred EEEEec-CCCHHHHHHhhcc--------------chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccC
Confidence 677776 7999999987543 6999999999999999999999999999999999999974 4
Q ss_pred CCeEEcCCCCCcccchhh------hhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---H
Q psy15108 94 LSVKISLSGLSKDTYQKE------YYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLS---D 164 (223)
Q Consensus 94 ~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~---~ 164 (223)
+.++++|||+++...... ........||+.|+|||.+.+..++.++|||||||++|+|+ +|..||.+.. .
T Consensus 143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell-tg~~Pf~~~~~~~~ 221 (293)
T d1csna_ 143 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL-RGSLPWQGLKAATN 221 (293)
T ss_dssp TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTSSCCSCCH
T ss_pred CceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHH-hCCCcCCCccchhH
Confidence 679999999998654321 11233457899999999999999999999999999999999 7999997553 3
Q ss_pred HHHHHHHHhCcc---cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHhhh
Q psy15108 165 DQVLSQLESKKL---CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQLSDAMCN 219 (223)
Q Consensus 165 ~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 219 (223)
......+..... .......+|+++.+++..|++.+|++||+++.+.+.|++++++
T Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 222 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 333333322211 1122456889999999999999999999999999998887653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-36 Score=238.01 Aligned_cols=177 Identities=18% Similarity=0.261 Sum_probs=142.5
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
.+++|+.+|+|.++++. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||
T Consensus 87 ~l~~~~~~g~L~~~l~~----------------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----------------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp EEEEECCCEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEeecCCchhhhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEE
Confidence 45688999999999974 25899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhh--hhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 99 SLSGLSKDTYQKEY--YKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 99 ~df~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+|||++........ .......+++.|+|||.+.. ..++.++|+||+||++++|+ +|..||.+.+............
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml-~g~~pf~~~~~~~~~~~~~~~~ 229 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLDQLNHILGIL 229 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHh-hCCCCCCCCCHHHHHHHHhhhc
Confidence 99999976544321 12345678899999999854 45788999999999999999 7999998776544433321100
Q ss_pred --------------------ccC---------CCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 --------------------LCW---------KHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 --------------------~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
... ......+.++++++.+||+.||.+|||++|+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0123556789999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=235.50 Aligned_cols=178 Identities=19% Similarity=0.254 Sum_probs=141.2
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+||||+.++ +.+++..... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+|+
T Consensus 78 iv~e~~~~~-~~~~~~~~~~-------------~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl 143 (298)
T d1gz8a_ 78 LVFEFLHQD-LKKFMDASAL-------------TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKL 143 (298)
T ss_dssp EEEECCSEE-HHHHHHHTTT-------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred EEEeecCCc-hhhhhhhhcc-------------cCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCccee
Confidence 788888754 5555544332 46999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
+|||+++...... .......+++.|+|||...... ++.++|+||+||++|+|+ +|+.||.+.+.......+......
T Consensus 144 ~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~-~G~~Pf~~~~~~~~~~~i~~~~~~ 221 (298)
T d1gz8a_ 144 ADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV-TRRALFPGDSEIDQLFRIFRTLGT 221 (298)
T ss_dssp CSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ccCCcceeccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHh-hCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999986543221 2234457889999999877666 478999999999999999 699999988876655554321000
Q ss_pred CC---------------------------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 WK---------------------------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ~~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
+. .....++++++++.+||+.||++|||++|+++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 012456889999999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-36 Score=236.35 Aligned_cols=179 Identities=19% Similarity=0.200 Sum_probs=141.0
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC-CeE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-SVK 97 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-~~~ 97 (223)
+|||||.+|.+..+...... ...+++.++..++.||++||+|||++||+||||||+|||++.++ .+|
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~------------~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~k 163 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRA------------KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 163 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHT------------TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEE
T ss_pred EEEeccCCccHHHHHhhhhc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCcee
Confidence 78999987654444432221 24699999999999999999999999999999999999999775 789
Q ss_pred EcCCCCCcccchhhhhhhhcCCccccccccccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc-
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFD-DEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK- 175 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~- 175 (223)
|+|||++....... ......++..|+|||.+.+ ..++.++||||+||++|+|+ +|..||...+....+..+....
T Consensus 164 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~-~g~~pf~~~~~~~~l~~i~~~~g 240 (350)
T d1q5ka_ 164 LCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIKVLG 240 (350)
T ss_dssp ECCCTTCEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HTSCSSCCSSHHHHHHHHHHHHC
T ss_pred EecccchhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehh-hCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999987654332 2344578889999998765 46899999999999999999 7999998887666554442200
Q ss_pred ----------------cc----------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 ----------------LC----------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ----------------~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. .......++++.+|+.+||+.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 01123467889999999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.2e-36 Score=231.97 Aligned_cols=177 Identities=21% Similarity=0.256 Sum_probs=138.0
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++++|+.++++..+.+.. ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++.+|+
T Consensus 77 i~~e~~~~~~~~~~~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl 141 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCE---------------GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141 (286)
T ss_dssp EEEECCSEEHHHHHHTST---------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred EEEEeehhhhHHHHHhhc---------------CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEe
Confidence 667777776666665433 35999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCccc
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKLC 177 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 177 (223)
+|||.+....... .......+++.|.+||.+.... ++.++|+||+||++|+|+ +|+.||.+.+......++......
T Consensus 142 ~DfG~a~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~-~G~~pf~~~~~~~~~~~i~~~~~~ 219 (286)
T d1ob3a_ 142 ADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGT 219 (286)
T ss_dssp CCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccceecccCc-cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHH-HCCCCCCCCCHHHHHHHHHHhhCC
Confidence 9999987543322 1223446788899999987554 689999999999999999 799999988776665554321000
Q ss_pred ---------------------------CCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 178 ---------------------------WKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 178 ---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.......++.+.+++.+||+.||++|||++|+++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01124567889999999999999999999999865
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-35 Score=231.83 Aligned_cols=173 Identities=17% Similarity=0.233 Sum_probs=141.8
Q ss_pred CCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeE
Q psy15108 18 SGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVK 97 (223)
Q Consensus 18 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~ 97 (223)
.+||||+ +++|..+++. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++
T Consensus 99 ~lv~e~~-~~~l~~~~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH----------------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp EEEEECC-SEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred EEEEecc-cccHHHHHHh----------------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccc
Confidence 3678888 6778887754 3599999999999999999999999999999999999999999999
Q ss_pred EcCCCCCcccchhhhhhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc
Q psy15108 98 ISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL 176 (223)
Q Consensus 98 l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 176 (223)
++|||++...... .....+++.|+|||.+.+. .++.++||||+||++|+|+ +|..||.+.+.......+.....
T Consensus 162 l~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell-~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 162 ILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp ECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHH-HCcCCCCCCChHHHHHHHHhccC
Confidence 9999999765432 2456788999999998764 4688999999999999999 79999988876655443322100
Q ss_pred -----------------------------cCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 -----------------------------CWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 -----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
........++++.+|+.+||..||.+|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 011224567889999999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-35 Score=230.36 Aligned_cols=178 Identities=16% Similarity=0.200 Sum_probs=140.5
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+++||+.++++..+.... ..+++..+..++.|+++||.|||++|++||||||+||+++.++.+++
T Consensus 94 iv~e~~~~~~~~~~~~~~---------------~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl 158 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNVL---------------VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL 158 (318)
T ss_dssp EEEECCCEEHHHHHTCTT---------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred EEEeccCCCccchhhhcc---------------cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEe
Confidence 678999888776554332 35899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhh---hhhhcCCcccccccccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Q psy15108 99 SLSGLSKDTYQKEY---YKYRNAILPLRWLPYEAVFDD-EFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESK 174 (223)
Q Consensus 99 ~df~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~ 174 (223)
+|||++........ .......+|+.|+|||.+... .++.++||||+||++|+|+ +|+.||.+.+.......+...
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~-~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW-TRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHh-hCCCCCCCCCHHHHHHHHHHh
Confidence 99999975443221 122345689999999998755 5889999999999999999 799999988877666554432
Q ss_pred cccC--CCC----------------------------CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 175 KLCW--KHS----------------------------SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 175 ~~~~--~~~----------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... ... ...++++++|+.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1110 000 0024567889999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-35 Score=231.30 Aligned_cols=175 Identities=18% Similarity=0.233 Sum_probs=141.2
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCe
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSV 96 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~ 96 (223)
...+++|+.+|+|.++++. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----------------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred eEEEEEeecCCchhhhccc----------------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccc
Confidence 3467899999999999953 359999999999999999999999999999999999999999999
Q ss_pred EEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCc
Q psy15108 97 KISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKK 175 (223)
Q Consensus 97 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~ 175 (223)
+++|||++...... .....++..|+|||...+.. ++.++|+||+||++|+|+ +|..||.+.+.......+....
T Consensus 161 kl~dfg~a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll-~g~~pF~~~~~~~~~~~i~~~~ 235 (348)
T d2gfsa1 161 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLV 235 (348)
T ss_dssp EECCC----CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHH-HSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccchhcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHH-hCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998654332 34566788899999876654 578999999999999999 7999999888766655543321
Q ss_pred ccCC-----------------------------CCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 LCWK-----------------------------HSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 ~~~~-----------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.... .....++++++||.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 1100 013467889999999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-34 Score=226.30 Aligned_cols=175 Identities=14% Similarity=0.205 Sum_probs=136.3
Q ss_pred CCCCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCC-C
Q psy15108 17 KSGSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDL-S 95 (223)
Q Consensus 17 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~-~ 95 (223)
..+|||||.+|+|.++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 107 ~~~v~e~~~~~~L~~~~------------------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~ 168 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY------------------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK 168 (328)
T ss_dssp EEEEEECCCSCBGGGTT------------------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE
T ss_pred eeEEEeecCCCcHHHHh------------------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCe
Confidence 33689999999997764 2599999999999999999999999999999999999999765 5
Q ss_pred eEEcCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh
Q psy15108 96 VKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPFPDLSDD-QVLSQLES 173 (223)
Q Consensus 96 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~~~~~~~-~~~~~~~~ 173 (223)
++++|||++....... ......++..|+|||.+.+.. ++.++|+||+||++++++ +|..||...... .....+..
T Consensus 169 vkl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~-~g~~pf~~~~~~~~~~~~i~~ 245 (328)
T d3bqca1 169 LRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI-FRKEPFFHGHDNYDQLVRIAK 245 (328)
T ss_dssp EEECCGGGCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HTCSSSSCCSSHHHHHHHHHH
T ss_pred eeecccccceeccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhc-cCCCCCCCCchhHHHHHHHHH
Confidence 8999999997554332 234556788999999987654 789999999999999999 788888655422 11111100
Q ss_pred -------------Cc----------------------ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 174 -------------KK----------------------LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 174 -------------~~----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.. ........+++++.+||.+||+.||++|||++|+++|
T Consensus 246 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0001112357889999999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-34 Score=219.88 Aligned_cols=177 Identities=18% Similarity=0.228 Sum_probs=139.9
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
++++++.+++|..++...+ .+++..+..++.|+++||+|||++||+||||||+||+++..+.+++
T Consensus 78 iv~~~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl 142 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNG---------------DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142 (292)
T ss_dssp EEEECCSEEHHHHHHHTTT---------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred EEeeecccccccccccccc---------------ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceee
Confidence 7789999999988887543 4899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCC-CCcccchHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHhCc-
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDE-FSTKSDVYAYACLIWEIFNKGEMPF-PDLSDDQVLSQLESKK- 175 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~~l~~~~~~p~-~~~~~~~~~~~~~~~~- 175 (223)
+|||.+....... .......++..|.|||.+.... ++.++||||+||++|+|+ +|..|| .+.+..+....+....
T Consensus 143 ~DFG~a~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell-~g~~p~~~~~~~~~~~~~~~~~~~ 220 (292)
T d1unla_ 143 ANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA-NAGRPLFPGNDVDDQLKRIFRLLG 220 (292)
T ss_dssp CCCTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT-TTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred eecchhhcccCCC-ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHh-hCCCCCCCCCCHHHHHHHHHhhcC
Confidence 9999997653322 1223345667889999887655 688999999999999999 677765 4555555544433210
Q ss_pred --------------------------ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 --------------------------LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 --------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.........++.+.+|+.+||+.||++|||++|+++|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111224557889999999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-34 Score=225.80 Aligned_cols=173 Identities=14% Similarity=0.220 Sum_probs=131.1
Q ss_pred CCCCCCCCCChHHHHHHhhhccccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEE
Q psy15108 19 GSGKPRVKGDLKQFLLATRKDSKDKSGSGKPRVRSLSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKI 98 (223)
Q Consensus 19 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l 98 (223)
+|||||.++.+. .+. ..+++..++.++.|++.||.|||++|++||||||.||+++.++.+++
T Consensus 99 iv~Ey~~~~l~~-~~~-----------------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 99 LVMELMDANLCQ-VIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEECCSEEHHH-HHT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred EEEeccchHHHH-hhh-----------------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceee
Confidence 789999766554 442 25899999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccchhhhhhhhcCCcccccccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCcc--
Q psy15108 99 SLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQVLSQLESKKL-- 176 (223)
Q Consensus 99 ~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~~~~~~~~~~~-- 176 (223)
+|||++....... ......+|..|+|||.+.+..++.++|+||+||++++|+ +|+.||.+.+......++.....
T Consensus 161 ~df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell-~g~~pF~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 161 LDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp CCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred echhhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHh-hCCCCCCCCCHHHHHHHHHHhccCC
Confidence 9999887554332 234456788999999999999999999999999999999 79999988776655444322100
Q ss_pred --------------------cCC------------CC------CCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 177 --------------------CWK------------HS------SKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 177 --------------------~~~------------~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
... .+ ...++++.+|+.+||..||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00 1124678899999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=9.6e-30 Score=202.17 Aligned_cols=156 Identities=22% Similarity=0.343 Sum_probs=119.1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCCCCCeeeecCCC------eEEcCCCCCcccchhhhhhhhcCCccccc
Q psy15108 52 RSLSTSQAVTMAYQVALGLEHISD-KRLIHKDIAARNCLISSDLS------VKISLSGLSKDTYQKEYYKYRNAILPLRW 124 (223)
Q Consensus 52 ~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~~~nil~~~~~~------~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 124 (223)
..+++..+..++.||++|+.|||+ .||+||||||+|||++..+. ++++|||.+...... .....+++.|
T Consensus 120 ~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y 195 (362)
T d1q8ya_ 120 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREY 195 (362)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGG
T ss_pred cCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc----cccccccccc
Confidence 578999999999999999999997 89999999999999986643 899999998654322 2456788999
Q ss_pred ccccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHh------------Cc-----------
Q psy15108 125 LPYEAVFDDEFSTKSDVYAYACLIWEIFNKGEMPFPDLSDDQ------VLSQLES------------KK----------- 175 (223)
Q Consensus 125 ~~pe~~~~~~~~~~~Di~slG~il~~l~~~~~~p~~~~~~~~------~~~~~~~------------~~----------- 175 (223)
+|||.+....++.++|+||+||++++|+ +|+.||...+... ....... ..
T Consensus 196 ~aPE~~~~~~~~~~~DiwSlG~il~el~-~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~ 274 (362)
T d1q8ya_ 196 RSPEVLLGAPWGCGADIWSTACLIFELI-TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 274 (362)
T ss_dssp CCHHHHHTCCCCTHHHHHHHHHHHHHHH-HSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--C
T ss_pred cChhhccccCCCccccccchHHHHHHHH-HCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchh
Confidence 9999999899999999999999999999 7999997543211 1110000 00
Q ss_pred -----------------ccCCCCCCChHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15108 176 -----------------LCWKHSSKTPEYITSLHEKCIHPHPHQRPTFPSIVTQ 212 (223)
Q Consensus 176 -----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 212 (223)
.........++++.+|+.+||..||.+|||++|+++|
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 275 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp BSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred hhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001112235778999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.40 E-value=1.6e-14 Score=103.62 Aligned_cols=88 Identities=11% Similarity=0.147 Sum_probs=60.8
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCcccCCCCCCCeeeecCCCeEEcCCCCCcccchhhhhhhhcCCcccccccccccccC
Q psy15108 54 LSTSQAVTMAYQVALGLEHISDKRLIHKDIAARNCLISSDLSVKISLSGLSKDTYQKEYYKYRNAILPLRWLPYEAVFDD 133 (223)
Q Consensus 54 l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~~~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 133 (223)
++...+..++.|+++++.|||+.|++||||||.||+++.. .++++|||.+...........-..-.+ .+ . ....+
T Consensus 100 l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~--~~-~-~~f~r 174 (191)
T d1zara2 100 VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVR--NI-I-TYFSR 174 (191)
T ss_dssp CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHH--HH-H-HHHHH
T ss_pred hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHH--HH-H-HHHcC
Confidence 4556677899999999999999999999999999999865 588999999876542221110000000 00 0 11235
Q ss_pred CCCcccchHHHHH
Q psy15108 134 EFSTKSDVYAYAC 146 (223)
Q Consensus 134 ~~~~~~Di~slG~ 146 (223)
.|+.++|+||+.-
T Consensus 175 ~y~~~~d~~s~~~ 187 (191)
T d1zara2 175 TYRTEKDINSAID 187 (191)
T ss_dssp HHCCCCCHHHHHH
T ss_pred CCCCcccHHHHHH
Confidence 6788899999653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.13 E-value=0.022 Score=42.17 Aligned_cols=44 Identities=14% Similarity=-0.045 Sum_probs=32.5
Q ss_pred HHHHHHHHHHhhc----CCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 63 AYQVALGLEHISD----KRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 63 ~~~i~~~l~~LH~----~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
+..+...+..... .|++|+|+.+.|++++.+...-++||+.+..
T Consensus 166 l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 166 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 3344444444433 4799999999999999887778999998753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=92.51 E-value=0.03 Score=40.00 Aligned_cols=30 Identities=17% Similarity=0.138 Sum_probs=25.4
Q ss_pred CcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 77 RLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 77 ~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
.++|+|+.+.||+++.++.+-++||+.+..
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEEeeccCcceeecCCceEEEeechhccc
Confidence 478999999999999766667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=91.54 E-value=0.034 Score=39.47 Aligned_cols=29 Identities=14% Similarity=0.067 Sum_probs=25.1
Q ss_pred CcccCCCCCCCeeeecCCCeEEcCCCCCc
Q psy15108 77 RLIHKDIAARNCLISSDLSVKISLSGLSK 105 (223)
Q Consensus 77 ~i~H~di~~~nil~~~~~~~~l~df~~~~ 105 (223)
.++|+|+.+.||+++.+..+-++||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 47999999999999987667799999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=90.75 E-value=0.15 Score=38.90 Aligned_cols=30 Identities=20% Similarity=0.238 Sum_probs=26.0
Q ss_pred CCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 76 KRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 76 ~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
..++|+|+.+.|||++.+ .++++|+..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 479999999999999876 589999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=89.14 E-value=0.24 Score=36.52 Aligned_cols=46 Identities=11% Similarity=-0.012 Sum_probs=31.0
Q ss_pred HHHHHHHHHHHHHHhh----cCCcccCCCCCCCeeeecCCCeEEcCCCCCcc
Q psy15108 59 AVTMAYQVALGLEHIS----DKRLIHKDIAARNCLISSDLSVKISLSGLSKD 106 (223)
Q Consensus 59 ~~~i~~~i~~~l~~LH----~~~i~H~di~~~nil~~~~~~~~l~df~~~~~ 106 (223)
....+.++...+.-.- ..+++|+|+.+.||+++.+ ..++||+-+..
T Consensus 171 ~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 171 FLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 3444455555544332 2368999999999999743 45899998763
|